data_2keq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2keq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.597 0 CA-C-O 121.49 0.494 . . . . 0.0 113.837 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.27 171.57 19.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.287 1.035 . . . . 0.0 112.209 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.2 mt -122.05 146.8 46.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.83 2.052 . . . . 0.0 109.527 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -68.9 164.72 21.48 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -53.0 -46.26 68.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.95 -1.093 . . . . 0.0 112.338 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -62.98 -10.63 14.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.617 1.567 . . . . 0.0 114.905 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.8 m -71.55 111.07 6.55 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.863 0.865 . . . . 0.0 110.584 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.8 134.01 34.41 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.615 -0.678 . . . . 0.0 112.265 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.4 mm -107.55 124.53 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.019 1.728 . . . . 0.0 108.113 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -64.44 131.16 46.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.672 0.389 . . . . 0.0 110.815 169.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 p -134.77 150.54 50.56 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.645 1.178 . . . . 0.0 112.36 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.0 t -77.34 -32.78 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.976 0.51 . . . . 0.0 111.823 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -68.77 -31.05 69.8 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -140.13 -50.61 0.48 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.85 -149.35 19.86 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.109 0.861 . . . . 0.0 112.095 -172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.1 107.88 2.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.015 1.326 . . . . 0.0 111.209 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -133.21 148.91 71.04 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.751 1.22 . . . . 0.0 112.745 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.39 126.55 15.79 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.944 3.096 . . . . 0.0 112.332 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -54.51 -35.57 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.043 0.937 . . . . 0.0 112.637 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.74 -36.53 93.45 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.604 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -70.31 -34.35 72.6 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.033 1.416 . . . . 0.0 111.554 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.0 mt -63.86 -36.51 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.643 0.777 . . . . 0.0 110.121 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.37 -38.06 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.837 0.855 . . . . 0.0 112.856 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.58 -26.45 65.4 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.821 -1.174 . . . . 0.0 113.025 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -114.45 2.63 14.7 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.077 1.351 . . . . 0.0 112.878 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 49.09 47.81 21.52 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 127.533 2.333 . . . . 0.0 113.133 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -73.71 129.69 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.613 1.165 . . . . 0.0 109.445 -174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 132.74 36.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 122.703 1.239 . . . . 0.0 111.208 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.0 p -160.39 175.36 12.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.393 1.477 . . . . 0.0 111.659 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 147.03 30.08 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.45 1.5 . . . . 0.0 109.157 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 m -125.46 172.99 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.581 1.952 . . . . 0.0 110.181 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -114.28 139.89 49.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.956 1.302 . . . . 0.0 110.886 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 t -162.03 150.07 14.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.901 1.281 . . . . 0.0 111.566 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.72 144.49 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.195 0.907 . . . . 0.0 113.399 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.44 -178.35 6.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.809 0.844 . . . . 0.0 112.516 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -55.66 -22.53 23.43 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.352 1.461 . . . . 0.0 113.765 173.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -91.94 -10.62 38.81 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.228 1.411 . . . . 0.0 113.719 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.62 14.14 58.71 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.41 1.005 . . . . 0.0 114.916 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -88.93 118.89 28.97 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.574 1.187 . . . . 0.0 110.177 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.45 103.99 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.496 0.719 . . . . 0.0 109.375 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -103.64 178.66 4.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.113 1.765 . . . . 0.0 111.211 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 p -127.7 140.05 52.32 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.126 0.97 . . . . 0.0 112.643 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -144.74 148.02 37.87 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.707 1.203 . . . . 0.0 113.332 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.4 152.67 49.64 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.025 2.483 . . . . 0.0 112.835 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.84 133.31 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.147 0.979 . . . . 0.0 109.784 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.64 -49.46 7.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.008 0.523 . . . . 0.0 111.828 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -148.98 176.01 10.81 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.727 1.611 . . . . 0.0 111.767 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -131.62 129.91 41.47 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.682 1.593 . . . . 0.0 109.311 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -131.78 136.06 47.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.132 0.968 . . . . 0.0 111.3 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -126.8 114.28 17.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.215 1.806 . . . . 0.0 110.118 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -78.2 -29.58 48.46 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.058 0.943 . . . . 0.0 112.058 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.66 -56.67 1.63 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.413 1.483 . . . . 0.0 112.58 172.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -166.68 111.31 0.77 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.207 1.803 . . . . 0.0 109.827 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -129.56 166.0 20.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.519 1.128 . . . . 0.0 112.606 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -61.94 100.6 0.16 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.665 1.186 . . . . 0.0 113.096 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.3 137.93 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.659 1.184 . . . . 0.0 110.787 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -118.31 141.74 48.22 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.085 1.354 . . . . 0.0 109.489 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -65.96 129.53 40.11 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.387 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -116.46 106.88 14.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.585 1.154 . . . . 0.0 107.948 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.2 t -116.57 141.71 47.84 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.068 0.947 . . . . 0.0 110.82 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp -102.82 166.01 10.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.34 1.456 . . . . 0.0 112.647 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -65.23 -25.73 67.81 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.29 -23.0 35.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.025 1.33 . . . . 0.0 113.096 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.96 -2.66 25.7 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.0 1.286 . . . . 0.0 114.717 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.3 m -57.83 136.97 57.05 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.731 1.265 . . . . 0.0 110.867 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.29 124.51 42.56 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.616 1.166 . . . . 0.0 109.939 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.6 mt -135.13 151.02 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 127.334 2.254 . . . . 0.0 108.299 -171.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -137.4 108.96 6.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.871 1.268 . . . . 0.0 109.986 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.96 170.89 17.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.019 0.928 . . . . 0.0 113.377 -172.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.5 p -91.03 153.08 20.39 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.542 1.137 . . . . 0.0 111.987 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -65.15 -5.04 5.78 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -99.16 -6.33 28.45 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.556 1.143 . . . . 0.0 112.315 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -85.73 126.88 34.31 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.39 155.24 20.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.755 0.788 . . . . 0.0 110.43 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -138.22 143.12 40.01 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.308 0.643 . . . . 0.0 109.33 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.1 ttp -73.11 103.03 3.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.305 0.642 . . . . 0.0 111.513 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.4 p -62.38 171.86 1.75 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.9 m -54.27 -25.33 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.78 -11.99 24.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.773 1.229 . . . . 0.0 113.191 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.2 -6.17 32.16 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.0 1.762 . . . . 0.0 114.332 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -61.25 141.21 57.69 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.986 1.393 . . . . 0.0 111.777 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -101.26 83.22 2.44 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.4 1.08 . . . . 0.0 109.771 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.09 146.77 37.86 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 124.437 1.095 . . . . 0.0 110.76 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.43 148.6 73.71 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.068 2.512 . . . . 0.0 111.783 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 tt -60.57 -26.98 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -55.41 -32.9 63.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.176 0.99 . . . . 0.0 112.92 170.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.44 -31.29 16.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.353 1.061 . . . . 0.0 111.754 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.28 -42.22 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.232 -0.917 . . . . 0.0 110.738 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -62.23 -39.31 92.4 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.28 -44.77 64.59 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -77.76 -11.12 59.85 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 56.51 37.82 29.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.425 1.49 . . . . 0.0 111.751 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.8 mt -78.48 150.9 32.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 122.042 0.925 . . . . 0.0 111.37 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -93.72 167.43 11.66 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.901 0.88 . . . . 0.0 111.069 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.01 144.93 43.42 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.308 1.043 . . . . 0.0 111.437 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -68.59 148.36 50.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.712 0.805 . . . . 0.0 111.618 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.02 152.04 44.78 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.783 1.233 . . . . 0.0 113.694 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 t -77.31 -35.84 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 128.37 2.668 . . . . 0.0 112.74 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -91.47 10.81 26.18 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.361 1.065 . . . . 0.0 113.495 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.25 7.0 m-80 56.38 31.91 19.6 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.076 1.75 . . . . 0.0 112.426 -172.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.9 mt -64.54 155.23 82.02 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 113.659 -1.61 . . . . 0.0 111.622 170.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.98 127.51 17.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.341 2.694 . . . . 0.0 109.987 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -77.69 131.13 37.57 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.751 -0.593 . . . . 0.0 109.595 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -142.08 127.65 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.644 1.178 . . . . 0.0 110.957 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 166.49 3.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.597 1.959 . . . . 0.0 113.202 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.8 mt -61.33 116.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.152 1.381 . . . . 0.0 109.691 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.73 -42.1 61.63 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.832 0.853 . . . . 0.0 111.627 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 p -149.24 146.02 27.39 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.018 1.327 . . . . 0.0 111.295 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -143.84 142.79 31.02 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.266 1.827 . . . . 0.0 109.853 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -155.41 151.04 27.35 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.996 2.118 . . . . 0.0 110.416 169.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -67.03 131.2 45.36 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.365 0.666 . . . . 0.0 110.072 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.6 mt -98.27 -45.13 6.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.944 0.498 . . . . 0.0 111.871 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.01 -146.3 15.56 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.179 0.895 . . . . 0.0 112.095 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.59 94.67 4.31 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.246 1.022 . . . . 0.0 111.78 -169.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -110.86 155.79 22.09 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.397 1.479 . . . . 0.0 109.904 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.46 118.32 8.6 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.201 0.6 . . . . 0.0 110.642 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.84 150.45 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.35 0.595 . . . . 0.0 111.46 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -138.44 159.41 42.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.673 1.589 . . . . 0.0 111.494 -170.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -157.29 114.38 3.04 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.418 1.087 . . . . 0.0 110.556 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.0 pt -68.12 154.74 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 O-C-N 121.267 -0.896 . . . . 0.0 110.908 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.46 152.23 17.41 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.69 1.138 . . . . 0.0 111.5 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 124.972 1.309 . . . . 0.0 110.069 -171.796 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -168.31 146.77 4.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.593 1.157 . . . . 0.0 112.121 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.03 165.32 25.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.124 0.97 . . . . 0.0 113.321 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 67.2 mt -130.57 164.87 23.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.054 2.142 . . . . 0.0 111.621 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -32.61 58.1 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -86.71 9.11 19.84 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.402 1.481 . . . . 0.0 112.519 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.4 0.06 85.94 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.747 1.641 . . . . 0.0 114.046 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -67.37 166.67 14.02 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.205 1.503 . . . . 0.0 113.073 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.97 123.4 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.286 1.034 . . . . 0.0 109.65 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.22 149.99 21.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.984 1.314 . . . . 0.0 109.671 172.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.2 t -142.2 138.73 31.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.151 0.98 . . . . 0.0 112.587 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.529 1.532 . . . . 0.0 112.28 -174.287 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 CA-C-O 121.591 0.551 . . . . 0.0 114.084 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.32 179.83 7.99 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.137 1.375 . . . . 0.0 112.506 -174.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.5 mt -123.33 146.43 47.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.271 1.829 . . . . 0.0 110.378 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 t -68.62 163.85 22.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.206 0.602 . . . . 0.0 112.378 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -51.75 -44.52 63.35 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.421 -0.799 . . . . 0.0 112.49 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -59.8 -19.77 52.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.655 1.982 . . . . 0.0 113.857 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.8 m -72.32 87.24 1.13 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.644 1.178 . . . . 0.0 111.718 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -77.42 145.96 36.85 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.115 0.959 . . . . 0.0 112.74 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.3 mm -119.53 125.92 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 126.889 2.075 . . . . 0.0 107.18 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -61.1 132.16 52.86 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 122.076 -0.39 . . . . 0.0 111.17 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.7 p -133.05 148.46 52.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.659 1.184 . . . . 0.0 112.698 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.9 -34.61 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.258 0.623 . . . . 0.0 111.9 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -65.11 -28.85 69.72 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -143.86 -62.92 0.39 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.28 -148.35 18.77 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.007 0.813 . . . . 0.0 112.056 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.05 107.05 3.46 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.685 1.194 . . . . 0.0 111.331 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.76 148.63 70.28 Favored Pre-proline 0 N--CA 1.479 1.012 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.03 127.63 18.05 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.694 3.596 . . . . 0.0 112.822 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.44 -35.09 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.615 0.766 . . . . 0.0 113.027 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.61 -36.56 93.5 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.334 -0.703 . . . . 0.0 112.787 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -71.56 -32.22 67.85 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.114 1.457 . . . . 0.0 111.398 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.61 -37.44 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.972 0.909 . . . . 0.0 110.181 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.5 t -88.02 -37.87 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 118.691 0.678 . . . . 0.0 112.586 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -69.24 -25.85 64.49 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.481 1.037 . . . . 0.0 113.008 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -116.24 4.87 13.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.945 1.298 . . . . 0.0 112.45 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 48.46 47.89 19.8 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.136 2.575 . . . . 0.0 113.258 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -72.64 121.86 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.029 1.332 . . . . 0.0 109.469 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -83.27 122.29 28.24 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.44 1.114 . . . . 0.0 110.733 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -152.1 -177.02 5.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.003 1.721 . . . . 0.0 110.909 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -125.24 141.38 52.12 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.184 1.393 . . . . 0.0 108.424 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.48 177.29 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.614 1.965 . . . . 0.0 110.6 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -122.73 140.06 53.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.717 1.207 . . . . 0.0 111.36 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.4 t -161.38 149.61 15.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.355 1.462 . . . . 0.0 110.924 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.39 160.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 119.043 0.838 . . . . 0.0 111.126 167.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -102.23 -174.47 2.58 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.998 1.719 . . . . 0.0 113.089 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.52 -11.54 25.01 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -102.93 -0.86 30.42 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.804 1.642 . . . . 0.0 112.36 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.98 31.48 39.16 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.68 1.133 . . . . 0.0 114.565 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -116.56 121.99 43.37 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.697 1.249 . . . . 0.0 109.991 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.7 mt -63.91 118.82 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.736 0.814 . . . . 0.0 109.305 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -122.87 177.02 5.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.193 1.797 . . . . 0.0 111.014 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.3 p -125.61 139.88 53.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.141 0.977 . . . . 0.0 113.097 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -147.89 148.29 29.61 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.695 1.198 . . . . 0.0 112.808 -175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.15 155.11 52.26 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.165 2.577 . . . . 0.0 112.836 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.94 134.34 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.142 0.977 . . . . 0.0 110.146 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.87 -45.11 9.47 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.466 0.707 . . . . 0.0 112.199 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -149.23 173.28 13.63 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.923 1.689 . . . . 0.0 111.912 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -132.93 132.36 41.91 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.784 1.633 . . . . 0.0 108.973 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -133.28 135.61 44.99 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.04 0.924 . . . . 0.0 111.162 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -126.65 113.08 16.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.348 1.459 . . . . 0.0 110.323 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -79.35 -32.02 43.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.924 1.289 . . . . 0.0 112.866 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.05 -51.2 2.51 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.867 1.222 . . . . 0.0 113.684 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -173.15 96.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.746 1.273 . . . . 0.0 111.258 -170.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -129.67 165.11 22.49 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 112.682 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.83 103.85 0.98 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.105 1.362 . . . . 0.0 113.421 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 t -95.41 139.62 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.03 1.332 . . . . 0.0 111.544 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -123.92 139.28 54.11 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.498 1.919 . . . . 0.0 109.922 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.79 134.2 53.61 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.282 0.633 . . . . 0.0 110.357 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -126.62 95.73 4.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.989 1.316 . . . . 0.0 108.579 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.1 t -105.71 140.76 38.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.243 1.017 . . . . 0.0 110.132 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tp -103.86 162.9 12.73 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.911 1.284 . . . . 0.0 112.01 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -66.93 -21.19 65.99 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.1 -29.27 61.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.765 1.226 . . . . 0.0 112.839 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.92 -2.22 25.76 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.941 1.258 . . . . 0.0 114.108 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 m -57.37 138.75 54.55 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.273 1.037 . . . . 0.0 111.205 170.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 tp -128.58 125.62 38.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.335 1.054 . . . . 0.0 111.042 -170.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.4 mt -137.86 151.92 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 126.907 2.083 . . . . 0.0 108.017 -169.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -138.42 115.06 10.59 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.782 1.233 . . . . 0.0 110.804 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.24 167.71 23.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.676 1.19 . . . . 0.0 112.208 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.5 p -82.02 154.16 25.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.712 0.805 . . . . 0.0 111.715 170.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -66.59 -8.57 28.02 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -96.2 -10.83 27.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.813 1.645 . . . . 0.0 112.787 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -81.65 133.04 35.32 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -87.65 165.67 15.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.145 0.974 . . . . 0.0 111.553 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -142.85 147.39 35.33 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.323 1.049 . . . . 0.0 109.824 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 43.3 ttm -79.56 104.05 9.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.677 1.191 . . . . 0.0 110.347 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.2 p -68.87 170.81 8.94 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.715 -0.615 . . . . 0.0 112.062 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.0 m -57.79 -23.22 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -90.03 -3.02 58.21 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.407 1.083 . . . . 0.0 113.042 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.76 66.34 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.327 0.965 . . . . 0.0 113.656 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -86.01 124.9 32.98 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.497 1.119 . . . . 0.0 109.996 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.13 92.84 6.92 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.531 1.132 . . . . 0.0 109.855 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.36 147.12 44.42 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 124.381 1.072 . . . . 0.0 111.418 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.08 146.67 82.73 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.414 2.742 . . . . 0.0 111.687 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.7 tt -58.6 -27.91 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -53.23 -35.99 60.55 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.487 1.115 . . . . 0.0 112.852 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -86.75 -33.29 20.01 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.026 0.53 . . . . 0.0 111.827 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.8 mt -61.44 -38.04 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.311 -0.868 . . . . 0.0 111.06 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -67.75 -32.57 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -82.05 -40.11 22.49 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.443 -0.786 . . . . 0.0 112.514 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.3 mmm-85 -77.0 -13.95 59.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 55.01 29.98 13.34 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.587 1.555 . . . . 0.0 113.117 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -76.23 129.48 36.77 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.653 0.781 . . . . 0.0 111.168 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.17 149.15 47.84 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.617 0.723 . . . . 0.0 112.478 171.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.06 155.94 21.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.515 0.726 . . . . 0.0 112.587 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.5 ttp -78.13 135.79 37.74 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.984 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 166.7 10.22 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.391 1.476 . . . . 0.0 112.947 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.77 -19.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.602 1.961 . . . . 0.0 112.788 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -109.68 15.02 23.1 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.028 1.731 . . . . 0.0 112.263 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 65.05 14.15 9.16 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.632 1.573 . . . . 0.0 113.423 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.2 mt -43.9 154.82 0.35 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 127.264 2.226 . . . . 0.0 112.761 169.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.95 148.76 89.93 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.598 2.199 . . . . 0.0 110.904 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -69.66 123.07 20.41 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.45 -0.782 . . . . 0.0 111.152 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.5 pt -148.86 151.76 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.705 1.602 . . . . 0.0 111.055 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.23 179.7 4.21 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.822 1.649 . . . . 0.0 111.249 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 19.4 mt -62.06 110.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.688 1.195 . . . . 0.0 110.618 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.71 -42.02 64.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.166 1.387 . . . . 0.0 111.763 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p -148.75 148.26 29.78 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.263 1.425 . . . . 0.0 111.183 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.9 ttp85 -143.0 141.0 31.25 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.0 1.72 . . . . 0.0 110.174 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -159.85 148.96 17.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.144 1.778 . . . . 0.0 110.703 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -64.99 125.41 24.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.628 0.771 . . . . 0.0 111.459 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.34 -44.39 8.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.401 0.68 . . . . 0.0 111.866 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.62 -147.31 17.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.124 0.868 . . . . 0.0 112.872 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -128.73 80.89 1.99 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 123.083 1.421 . . . . 0.0 111.83 -169.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -100.0 158.91 15.49 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.918 1.687 . . . . 0.0 110.471 -169.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 118.43 7.72 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.79 -0.569 . . . . 0.0 110.739 169.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.94 152.77 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.302 0.641 . . . . 0.0 111.285 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -140.72 158.97 43.2 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.637 1.575 . . . . 0.0 111.737 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -155.72 131.3 9.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.419 1.088 . . . . 0.0 111.089 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.4 pt -87.27 155.36 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 121.323 -0.86 . . . . 0.0 111.08 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.7 155.14 16.27 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.434 1.492 . . . . 0.0 111.703 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.479 1.018 0 C-N-CA 124.63 1.172 . . . . 0.0 110.846 -169.203 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 CA--C 1.543 0.676 0 CA-C-O 121.002 0.429 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -163.27 154.23 16.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.456 1.102 . . . . 0.0 112.353 -169.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.81 159.44 30.09 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 45.0 mt -116.89 162.2 18.12 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.975 2.11 . . . . 0.0 112.195 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -55.2 -36.09 65.54 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -73.87 -17.04 61.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.11 0.964 . . . . 0.0 112.381 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.15 34.41 3.7 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.045 1.307 . . . . 0.0 114.699 171.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -135.53 165.34 25.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.721 1.608 . . . . 0.0 111.026 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -107.64 129.35 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.563 0.745 . . . . 0.0 110.015 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -110.75 155.26 22.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.582 1.553 . . . . 0.0 110.163 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.1 p -142.95 122.21 13.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.818 0.847 . . . . 0.0 112.605 -168.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 124.695 1.198 . . . . 0.0 113.671 -176.312 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.092 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -157.79 175.4 13.93 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 117.759 0.779 . . . . 0.0 113.077 -167.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.67 147.24 44.79 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.467 1.507 . . . . 0.0 111.218 -170.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 t -64.77 162.79 15.35 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -54.2 -44.43 71.59 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.151 -0.968 . . . . 0.0 112.002 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -57.69 -23.89 53.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.873 1.669 . . . . 0.0 113.697 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.5 m -66.92 103.59 1.18 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.443 1.497 . . . . 0.0 111.472 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -87.56 141.19 28.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.836 0.826 . . . . 0.0 112.361 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.4 mm -120.4 119.54 60.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 126.628 1.971 . . . . 0.0 106.956 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.07 131.65 51.26 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.406 0.283 . . . . 0.0 110.772 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.4 p -126.2 157.7 37.53 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.166 . . . . 0.0 112.768 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.94 -35.45 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.576 0.75 . . . . 0.0 111.182 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -67.22 -29.53 69.21 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.24 -54.28 0.47 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.23 -148.95 19.93 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.962 0.792 . . . . 0.0 112.434 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.73 109.66 3.93 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.822 1.249 . . . . 0.0 111.099 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.3 mt -136.65 150.2 69.48 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.03 1.332 . . . . 0.0 112.642 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.52 129.56 22.81 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.962 3.108 . . . . 0.0 112.379 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 tt -55.2 -38.96 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.411 0.684 . . . . 0.0 112.318 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.54 -31.74 79.58 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.583 -0.698 . . . . 0.0 113.347 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -70.88 -37.81 73.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.192 0.996 . . . . 0.0 111.26 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.59 -40.34 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 123.662 0.785 . . . . 0.0 109.336 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.3 t -74.46 -42.87 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.23 -21.26 56.6 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.788 1.176 . . . . 0.0 113.465 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -110.37 2.28 18.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.359 1.464 . . . . 0.0 112.197 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 47.38 48.86 16.23 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.998 2.119 . . . . 0.0 113.178 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.0 mt -72.11 126.11 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.868 0.867 . . . . 0.0 109.621 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -85.67 104.47 15.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.41 0.624 . . . . 0.0 111.191 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 64.7 m -133.56 -173.45 3.23 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.451 1.5 . . . . 0.0 111.487 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.31 143.65 51.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.961 1.705 . . . . 0.0 108.754 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.12 171.03 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.697 1.599 . . . . 0.0 111.156 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.04 143.28 45.01 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.951 1.3 . . . . 0.0 111.248 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 t -160.72 150.67 17.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.912 1.685 . . . . 0.0 110.381 -170.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.0 142.66 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.215 1.37 . . . . 0.0 110.729 168.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.64 178.56 7.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.838 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.27 -25.27 63.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.749 1.22 . . . . 0.0 112.754 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -87.79 -1.13 57.77 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.327 1.451 . . . . 0.0 113.339 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.08 29.6 53.49 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 121.251 -0.906 . . . . 0.0 114.373 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -109.39 122.57 47.67 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.539 1.536 . . . . 0.0 109.63 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.4 mt -69.82 117.84 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.498 0.719 . . . . 0.0 109.489 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -124.9 178.4 5.52 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.67 1.988 . . . . 0.0 111.285 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 p -126.08 142.68 51.42 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.386 1.074 . . . . 0.0 112.958 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -144.73 146.13 30.7 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 124.909 1.283 . . . . 0.0 112.898 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.07 152.86 67.89 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.866 2.377 . . . . 0.0 111.985 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.28 119.15 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 168.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.81 -50.45 17.15 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -151.59 179.49 8.34 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.672 1.989 . . . . 0.0 110.909 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -134.82 132.72 38.98 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.342 1.457 . . . . 0.0 109.856 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -134.02 138.82 45.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.833 0.853 . . . . 0.0 111.627 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -132.37 121.03 22.85 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.56 1.544 . . . . 0.0 110.203 -172.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -87.76 -25.65 23.29 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.124 1.37 . . . . 0.0 112.982 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.16 -49.22 2.99 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.589 1.566 . . . . 0.0 114.937 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -171.75 101.25 0.18 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.128 1.464 . . . . 0.0 111.455 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -131.43 167.47 19.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.553 1.141 . . . . 0.0 112.247 172.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.84 105.81 0.9 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.937 1.295 . . . . 0.0 113.554 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.37 140.85 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.473 1.109 . . . . 0.0 111.939 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.455 ' CZ ' ' HE3' ' A' ' 70' ' ' LYS . 46.9 m-85 -125.08 154.55 41.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.585 1.554 . . . . 0.0 110.874 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.68 110.3 22.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.567 1.147 . . . . 0.0 109.169 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -96.7 102.85 14.7 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.852 0.861 . . . . 0.0 109.255 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.5 t -82.34 147.05 29.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.203 1.001 . . . . 0.0 111.057 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -106.99 160.79 15.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.951 1.3 . . . . 0.0 113.47 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.68 -20.47 65.3 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.29 -14.99 36.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.048 1.339 . . . . 0.0 112.945 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.18 -5.11 23.62 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.441 1.496 . . . . 0.0 114.57 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 t -71.82 171.47 11.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.219 1.009 . . . . 0.0 113.213 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -140.74 141.32 34.88 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.896 1.678 . . . . 0.0 111.57 -170.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.5 mt -133.62 143.61 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 126.23 1.812 . . . . 0.0 108.699 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -133.47 101.51 5.17 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.807 1.243 . . . . 0.0 111.376 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.35 166.66 31.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.847 0.859 . . . . 0.0 113.275 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.0 p -78.37 163.03 26.01 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.231 0.538 . . . . 0.0 110.773 168.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 6.5 mtmp? -74.51 -4.83 39.18 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -97.83 -20.76 17.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.588 1.555 . . . . 0.0 112.607 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -71.72 131.01 42.53 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -84.84 157.43 20.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.519 -0.738 . . . . 0.0 111.118 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -139.5 143.62 37.55 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.024 1.33 . . . . 0.0 109.921 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.2 ttp -84.64 110.34 18.67 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.454 1.102 . . . . 0.0 111.278 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.4 p -71.14 176.42 4.48 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -54.96 -26.84 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -94.14 -9.33 36.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.631 1.173 . . . . 0.0 113.521 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.06 8.97 56.43 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.314 0.959 . . . . 0.0 114.875 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -65.81 146.98 54.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.777 1.288 . . . . 0.0 111.165 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 29.2 mtm -110.95 80.51 1.31 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.526 1.53 . . . . 0.0 109.849 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.1 mt -119.64 147.25 43.36 Favored Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 125.396 1.478 . . . . 0.0 110.465 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -63.08 144.43 92.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.643 2.229 . . . . 0.0 110.672 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.7 tt -55.91 -27.14 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -56.01 -40.45 73.41 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.179 1.391 . . . . 0.0 113.006 169.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -79.56 -35.71 39.4 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.993 -0.442 . . . . 0.0 110.855 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 72.2 mt -62.58 -40.58 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 119.076 0.853 . . . . 0.0 111.391 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -58.91 -39.35 81.26 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.736 0.814 . . . . 0.0 113.157 172.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -81.49 -38.56 26.13 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.624 1.17 . . . . 0.0 113.085 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -75.47 -16.64 60.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.337 1.055 . . . . 0.0 112.896 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 56.86 34.39 24.69 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.08 1.352 . . . . 0.0 112.452 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -86.98 144.55 26.87 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.876 0.87 . . . . 0.0 111.873 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -81.22 167.67 19.34 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.7 0.8 . . . . 0.0 112.564 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.3 157.89 30.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.392 1.092 . . . . 0.0 113.901 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.6 ttm -73.05 154.44 40.44 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.05 1.74 . . . . 0.0 112.601 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.66 159.38 42.12 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.564 1.546 . . . . 0.0 114.683 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.0 p -93.53 -28.14 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 126.707 2.003 . . . . 0.0 113.04 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -83.39 20.81 1.26 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.464 1.506 . . . . 0.0 112.735 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.27 10.4 p30 46.39 19.77 0.08 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.708 2.803 . . . . 0.0 115.675 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.6 mt -60.68 156.99 41.11 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.146 1.378 . . . . 0.0 112.89 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.89 143.98 81.44 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.081 2.521 . . . . 0.0 110.721 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -77.74 125.61 29.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.171 0.589 . . . . 0.0 110.284 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.0 pt -140.34 131.37 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.457 1.103 . . . . 0.0 112.67 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 172.86 13.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.445 1.898 . . . . 0.0 112.701 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -69.95 113.36 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.417 1.087 . . . . 0.0 110.334 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.81 -48.83 75.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.46 1.504 . . . . 0.0 111.856 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 p -152.24 158.11 42.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.326 1.851 . . . . 0.0 111.171 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -126.1 148.84 49.27 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.881 1.672 . . . . 0.0 109.672 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -149.97 133.99 17.03 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.657 1.183 . . . . 0.0 110.688 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -70.87 129.32 38.75 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.244 0.618 . . . . 0.0 110.982 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.9 mt -96.7 -41.39 8.52 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.065 0.546 . . . . 0.0 111.845 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.24 -140.15 9.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.173 0.892 . . . . 0.0 112.58 -174.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -131.71 81.57 1.98 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.964 1.364 . . . . 0.0 113.056 -168.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -98.11 157.82 15.91 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.88 1.672 . . . . 0.0 110.069 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.2 121.68 14.81 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 121.64 -0.662 . . . . 0.0 109.695 170.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -123.19 149.23 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.502 0.668 . . . . 0.0 111.84 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -136.22 158.77 43.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.574 1.55 . . . . 0.0 111.791 -168.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -154.22 122.76 6.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.819 1.248 . . . . 0.0 110.177 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.1 pt -77.76 159.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.392 -0.817 . . . . 0.0 111.386 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.16 151.92 18.42 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.535 1.064 . . . . 0.0 111.73 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 127.16 2.184 . . . . 0.0 109.756 -179.396 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.2 p30 . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -157.47 152.13 25.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.555 1.142 . . . . 0.0 111.999 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.86 149.97 26.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.053 0.941 . . . . 0.0 113.178 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.61 176.07 5.27 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.296 1.839 . . . . 0.0 112.419 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -50.33 -49.5 53.71 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.495 1.518 . . . . 0.0 114.651 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -78.6 -9.36 59.34 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.313 1.045 . . . . 0.0 112.775 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 102.09 -7.32 54.61 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.392 1.472 . . . . 0.0 114.997 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -51.26 150.93 3.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.538 1.169 . . . . 0.0 111.444 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.4 107.72 22.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.1 143.54 28.0 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 170.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.3 m -132.51 104.4 6.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.487 1.115 . . . . 0.0 109.996 -172.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.0 t30 . . . . . 0 C--O 1.255 1.374 0 C-N-CA 124.236 1.014 . . . . 0.0 113.396 -174.337 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -159.6 175.54 13.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.945 1.298 . . . . 0.0 111.977 -174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.58 144.47 39.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.642 1.577 . . . . 0.0 110.422 -172.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -67.05 164.02 18.73 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.564 -0.71 . . . . 0.0 112.51 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.01 -44.38 64.1 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.977 -1.077 . . . . 0.0 112.026 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -64.24 -13.12 47.22 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.683 1.593 . . . . 0.0 114.383 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.7 m -75.18 81.81 2.33 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.332 1.453 . . . . 0.0 110.894 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -71.12 142.34 50.77 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.773 0.797 . . . . 0.0 111.501 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.5 mm -118.61 128.59 75.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 126.13 1.772 . . . . 0.0 106.373 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -58.17 130.85 48.54 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 122.289 -0.257 . . . . 0.0 110.919 170.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.6 p -131.88 145.15 51.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.223 1.409 . . . . 0.0 111.853 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.15 -32.62 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 121.877 -0.514 . . . . 0.0 111.922 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.74 -35.73 81.55 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -140.33 -48.71 0.44 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -170.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.59 -146.68 18.49 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.982 0.81 . . . . 0.0 113.163 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.4 96.84 1.52 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.268 1.427 . . . . 0.0 111.652 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.45 145.73 55.66 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.612 1.165 . . . . 0.0 112.407 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.14 128.4 21.6 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.78 3.653 . . . . 0.0 113.261 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.84 -37.43 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.746 0.818 . . . . 0.0 112.944 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.56 -32.84 84.54 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.618 -0.546 . . . . 0.0 112.956 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -72.52 -36.79 68.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.98 0.89 . . . . 0.0 111.298 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.89 -39.03 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.656 0.782 . . . . 0.0 109.479 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.52 -42.16 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.909 0.884 . . . . 0.0 113.11 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -75.1 -21.97 58.57 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.374 0.988 . . . . 0.0 113.507 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -109.79 1.72 19.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.145 1.378 . . . . 0.0 112.407 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.42 54.23 8.81 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.875 2.07 . . . . 0.0 113.357 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.5 mt -75.03 119.58 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.632 0.773 . . . . 0.0 110.104 -172.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.3 80.49 1.85 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.912 1.685 . . . . 0.0 112.221 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.6 p -119.49 178.49 4.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.02 1.328 . . . . 0.0 112.625 -171.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.5 m -119.25 149.46 41.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.243 1.417 . . . . 0.0 108.339 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.3 175.88 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.794 1.637 . . . . 0.0 110.967 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -121.24 142.59 49.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.428 1.491 . . . . 0.0 110.382 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.9 t -165.18 154.17 12.36 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.686 1.195 . . . . 0.0 110.835 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.4 m -84.91 145.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.665 1.12 . . . . 0.0 112.468 172.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.91 179.1 7.63 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.95 0.9 . . . . 0.0 111.917 172.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -60.59 -20.21 59.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -90.78 -0.73 57.8 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.218 1.407 . . . . 0.0 113.273 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.23 32.26 48.86 Favored Glycine 0 CA--C 1.536 1.387 0 O-C-N 121.33 -0.856 . . . . 0.0 114.099 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -112.64 121.51 44.98 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.494 1.518 . . . . 0.0 109.554 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.96 113.17 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -116.71 178.29 4.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.055 1.742 . . . . 0.0 110.528 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -128.02 143.31 51.07 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.859 0.863 . . . . 0.0 113.106 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -144.59 147.06 34.65 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.295 1.038 . . . . 0.0 113.605 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.62 150.07 50.25 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.108 2.539 . . . . 0.0 112.307 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.53 147.33 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.169 0.988 . . . . 0.0 110.808 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.64 -44.69 3.46 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.036 0.934 . . . . 0.0 111.992 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -142.41 178.17 7.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.759 1.623 . . . . 0.0 111.479 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -137.58 120.52 16.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.309 1.443 . . . . 0.0 109.29 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -118.77 138.73 52.48 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.075 0.941 . . . . 0.0 111.161 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -131.71 115.7 16.36 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.879 1.672 . . . . 0.0 110.046 -171.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -79.84 -32.13 40.53 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.982 1.313 . . . . 0.0 113.052 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.87 -53.24 1.43 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.762 1.648 . . . . 0.0 114.86 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -171.04 99.55 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.214 1.507 . . . . 0.0 111.577 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -134.51 168.05 19.67 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.486 1.114 . . . . 0.0 113.119 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -67.35 97.67 0.58 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.16 1.784 . . . . 0.0 114.278 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.9 t -94.01 138.79 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.194 1.398 . . . . 0.0 111.376 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -119.43 147.07 44.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.333 1.053 . . . . 0.0 110.448 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -82.33 123.99 29.58 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.585 1.154 . . . . 0.0 109.417 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -112.81 105.18 13.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.418 1.087 . . . . 0.0 108.722 174.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.3 t -96.19 122.17 38.76 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mp -79.24 156.72 28.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.697 0.799 . . . . 0.0 110.794 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -67.56 -18.49 65.03 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.62 -26.16 50.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.55 0.74 . . . . 0.0 112.764 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.23 -12.36 7.58 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.433 1.492 . . . . 0.0 114.275 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.1 m -60.02 148.24 36.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.41 1.084 . . . . 0.0 112.405 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -127.92 135.65 50.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.465 1.506 . . . . 0.0 110.715 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.0 mt -135.69 142.9 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.765 1.626 . . . . 0.0 108.095 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -134.03 110.85 9.92 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.784 1.234 . . . . 0.0 111.383 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.69 166.51 30.17 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.636 1.175 . . . . 0.0 110.541 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -70.18 150.04 46.89 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.55 -0.719 . . . . 0.0 111.408 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -61.07 -21.04 63.28 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -85.76 -16.18 39.71 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.883 2.073 . . . . 0.0 112.6 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -73.38 135.66 44.28 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -89.85 154.29 19.99 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.813 0.845 . . . . 0.0 111.932 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -137.2 144.36 42.83 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.084 -1.01 . . . . 0.0 111.465 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 37.6 ttm -73.81 104.0 4.55 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.002 0.921 . . . . 0.0 110.344 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.2 p -67.88 167.15 14.14 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.745 -0.597 . . . . 0.0 111.193 172.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.88 -26.79 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -79.63 -12.15 59.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.515 1.126 . . . . 0.0 113.292 175.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.95 3.7 65.59 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.127 1.346 . . . . 0.0 114.025 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -69.61 161.14 30.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.08 0.952 . . . . 0.0 110.699 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.4 ptp -127.46 80.88 1.98 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.836 1.254 . . . . 0.0 109.763 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.51 150.1 39.68 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 125.075 1.35 . . . . 0.0 110.403 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.38 142.07 77.38 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.491 2.127 . . . . 0.0 110.349 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.4 tt -60.34 -23.23 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.65 -27.72 65.02 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 170.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -89.59 -38.62 13.82 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.428 1.091 . . . . 0.0 111.852 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.35 -38.45 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 121.286 -0.884 . . . . 0.0 111.311 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.18 -36.76 80.71 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -78.92 -41.97 28.21 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.443 0.697 . . . . 0.0 112.467 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -74.34 -13.49 60.75 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 55.64 28.49 12.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.621 1.568 . . . . 0.0 112.86 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.9 128.63 35.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.554 0.742 . . . . 0.0 110.048 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.75 154.19 42.41 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 122.366 1.079 . . . . 0.0 112.329 171.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.3 mt -96.15 152.26 18.72 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.696 1.198 . . . . 0.0 111.924 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 35.3 ttm -72.38 138.39 47.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.501 0.32 . . . . 0.0 110.479 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 162.57 16.25 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.065 1.346 . . . . 0.0 113.782 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.7 -23.09 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.384 1.474 . . . . 0.0 113.978 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -101.44 8.56 42.06 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.003 0.921 . . . . 0.0 113.392 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 m120 67.33 22.15 9.61 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.663 1.585 . . . . 0.0 112.234 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.1 mt -54.34 159.19 3.32 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.497 1.519 . . . . 0.0 112.049 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.65 145.72 82.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.388 2.059 . . . . 0.0 110.722 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -67.13 121.7 16.2 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.519 -0.738 . . . . 0.0 111.162 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.2 pt -144.82 137.61 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.84 1.656 . . . . 0.0 110.317 -174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.6 175.52 5.63 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.715 1.606 . . . . 0.0 111.042 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.72 104.82 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.454 1.102 . . . . 0.0 110.513 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.9 -41.16 78.61 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.759 1.224 . . . . 0.0 112.363 -175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.6 p -146.78 154.72 41.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.537 1.535 . . . . 0.0 111.288 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -133.81 139.16 46.11 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.621 1.568 . . . . 0.0 110.987 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -141.45 130.26 22.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.474 1.51 . . . . 0.0 110.02 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.04 121.74 16.22 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 122.503 0.321 . . . . 0.0 110.392 173.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.3 mt -87.09 -40.34 14.75 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.874 0.469 . . . . 0.0 111.795 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.21 -144.87 15.87 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.329 0.966 . . . . 0.0 112.583 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -124.6 81.46 1.95 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.935 1.35 . . . . 0.0 112.486 -168.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -98.74 158.06 15.87 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.613 1.565 . . . . 0.0 110.948 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.44 119.13 9.82 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.644 0.778 . . . . 0.0 110.323 171.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.87 149.43 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.483 0.713 . . . . 0.0 111.216 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -139.09 158.4 44.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.861 1.664 . . . . 0.0 111.771 -168.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -156.28 121.48 4.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.747 1.219 . . . . 0.0 110.297 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.8 pt -73.27 155.74 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 120.911 -1.118 . . . . 0.0 111.467 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.89 147.61 16.36 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.662 1.125 . . . . 0.0 111.74 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.88 0 C-N-CA 126.965 2.106 . . . . 0.0 109.845 -169.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -162.14 160.78 27.66 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.389 1.476 . . . . 0.0 112.516 -173.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.44 148.84 21.78 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.489 1.116 . . . . 0.0 113.864 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 54.2 mt -100.73 166.44 10.87 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.267 1.827 . . . . 0.0 113.018 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -57.73 -33.18 68.16 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -75.81 -13.71 60.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.704 0.801 . . . . 0.0 112.625 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.89 30.29 5.83 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 117.579 -1.679 . . . . 0.0 114.841 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.0 165.33 22.38 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.783 1.792 . . . . 0.0 111.778 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.06 139.24 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.104 0.962 . . . . 0.0 110.13 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.04 152.92 46.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.609 1.564 . . . . 0.0 110.654 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.5 t -136.48 140.82 43.35 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.143 1.377 . . . . 0.0 112.342 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -169.487 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.267 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.42 170.07 17.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -106.73 152.32 23.97 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.784 1.233 . . . . 0.0 110.974 -175.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 t -63.2 161.7 13.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -52.49 -43.86 65.28 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.79 0.836 . . . . 0.0 112.221 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -60.9 -23.22 65.05 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.67 1.588 . . . . 0.0 113.52 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.7 m -66.15 114.73 5.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.101 0.961 . . . . 0.0 111.557 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -94.58 140.42 29.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.647 0.736 . . . . 0.0 112.439 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 mm -118.03 125.24 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 126.365 1.866 . . . . 0.0 108.103 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 tp -64.25 129.48 40.1 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.558 0.743 . . . . 0.0 111.369 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.9 p -128.4 156.58 42.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.122 1.369 . . . . 0.0 112.063 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 t -78.05 -31.64 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 O-C-N 121.739 -0.601 . . . . 0.0 111.88 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.04 -35.13 79.7 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -139.93 -44.97 0.43 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.33 -143.78 14.96 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.194 0.902 . . . . 0.0 111.288 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.0 mt -67.32 111.77 4.19 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.079 1.351 . . . . 0.0 111.279 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.1 mt -139.76 151.73 66.59 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.829 1.252 . . . . 0.0 113.323 176.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.55 128.72 20.73 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.131 3.221 . . . . 0.0 112.638 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 tt -58.24 -35.91 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.83 -31.54 81.24 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.867 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -71.24 -37.53 71.98 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.491 1.145 . . . . 0.0 111.322 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.45 -37.74 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.523 0.729 . . . . 0.0 110.762 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.6 t -85.7 -36.4 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.35 0.66 . . . . 0.0 112.657 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.77 -25.39 63.79 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.264 -0.897 . . . . 0.0 113.298 174.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -113.44 2.84 15.56 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.086 1.354 . . . . 0.0 113.0 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 46.82 47.98 15.07 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 127.538 2.335 . . . . 0.0 112.702 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.9 mt -70.61 121.31 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.798 1.239 . . . . 0.0 109.38 -174.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -82.37 120.18 25.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.912 0.863 . . . . 0.0 110.93 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.6 p -153.01 164.01 38.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.55 1.14 . . . . 0.0 112.75 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.7 145.8 24.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.074 1.35 . . . . 0.0 109.813 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.47 176.74 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.391 1.876 . . . . 0.0 110.756 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -121.75 144.26 48.9 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.179 1.392 . . . . 0.0 110.697 -176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.2 t -158.73 167.23 30.05 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.586 1.554 . . . . 0.0 110.599 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.78 123.98 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.156 1.382 . . . . 0.0 110.086 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.5 179.52 4.02 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.6 -18.88 65.3 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -90.21 -2.26 58.03 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.643 1.577 . . . . 0.0 112.086 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.79 29.89 62.52 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.053 1.787 . . . . 0.0 114.614 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -111.85 140.15 46.73 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.155 1.382 . . . . 0.0 110.497 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.3 mt -67.95 133.07 32.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -138.47 166.67 23.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.558 1.543 . . . . 0.0 111.452 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 p -118.08 143.53 46.37 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.418 1.087 . . . . 0.0 111.714 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -150.83 146.71 19.7 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.656 1.182 . . . . 0.0 111.951 -172.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.34 151.59 48.59 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.881 2.387 . . . . 0.0 112.495 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.2 139.46 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.103 0.961 . . . . 0.0 111.449 169.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.45 -35.29 9.61 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.186 0.995 . . . . 0.0 113.075 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.14 175.48 13.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.782 1.233 . . . . 0.0 112.777 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -124.14 135.66 53.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.565 1.546 . . . . 0.0 108.809 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -124.36 119.67 29.92 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.04 1.336 . . . . 0.0 110.86 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.57 110.02 16.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 110.432 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -87.37 -30.21 20.94 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.597 1.159 . . . . 0.0 112.988 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.9 -52.01 2.91 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.044 1.307 . . . . 0.0 114.099 171.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -170.97 98.46 0.21 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.588 1.194 . . . . 0.0 111.201 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -129.96 162.98 27.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.33 1.052 . . . . 0.0 112.155 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.39 102.3 1.39 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.69 1.196 . . . . 0.0 113.191 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.6 t -94.93 138.27 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.445 1.498 . . . . 0.0 110.925 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -124.89 144.92 50.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.274 1.43 . . . . 0.0 110.029 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -65.18 127.61 32.41 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.968 0.907 . . . . 0.0 110.469 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -119.51 86.58 2.58 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.874 1.67 . . . . 0.0 108.419 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.0 t -89.7 144.56 25.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.161 0.984 . . . . 0.0 110.787 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.02 163.92 12.88 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.369 1.067 . . . . 0.0 112.668 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.42 -20.33 63.79 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -76.05 -26.52 56.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.526 1.13 . . . . 0.0 112.555 171.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.16 -1.97 23.98 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.969 1.271 . . . . 0.0 113.998 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.59 147.22 42.43 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.937 1.295 . . . . 0.0 111.269 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.1 mt -134.84 130.78 36.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.117 1.367 . . . . 0.0 110.645 -172.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.6 mt -137.91 151.41 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.462 1.905 . . . . 0.0 107.757 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -136.26 106.15 6.26 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.663 1.185 . . . . 0.0 110.165 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.46 166.32 24.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.099 1.36 . . . . 0.0 111.89 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.1 p -86.85 157.32 19.57 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.924 0.869 . . . . 0.0 112.627 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -72.61 -5.01 34.39 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -91.34 -15.58 28.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.341 1.057 . . . . 0.0 112.556 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -77.63 131.67 37.89 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.699 -0.626 . . . . 0.0 111.147 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -90.03 153.97 20.17 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.19 0.996 . . . . 0.0 111.172 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -139.0 143.82 38.65 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.568 0.747 . . . . 0.0 110.416 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.2 ttm -74.11 104.35 4.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.155 0.982 . . . . 0.0 110.533 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.7 p -68.75 171.04 8.36 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.199 0.523 . . . . 0.0 111.936 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.1 m -56.57 -24.79 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 173.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -92.17 -6.15 51.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.145 0.978 . . . . 0.0 113.268 174.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.41 24.04 52.21 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.789 1.185 . . . . 0.0 113.793 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -88.82 120.26 30.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.081 0.952 . . . . 0.0 110.661 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.1 mmt -80.62 80.33 7.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.359 1.064 . . . . 0.0 111.68 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.3 mt -112.96 147.43 37.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 124.754 1.222 . . . . 0.0 110.888 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.84 146.92 84.57 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.57 2.18 . . . . 0.0 110.992 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.24 -25.05 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -55.89 -34.43 65.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.833 1.253 . . . . 0.0 113.014 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.0 -41.54 25.63 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.927 0.891 . . . . 0.0 110.496 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.88 -36.16 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.991 0.916 . . . . 0.0 111.498 -174.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -66.72 -35.44 80.12 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.24 -35.7 21.41 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.491 -0.756 . . . . 0.0 112.642 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -74.11 -17.52 60.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.403 1.081 . . . . 0.0 113.018 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 54.78 33.64 20.1 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.249 1.42 . . . . 0.0 112.963 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.4 mt -76.02 143.39 41.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.768 0.827 . . . . 0.0 111.907 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -88.53 148.07 24.3 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.815 0.846 . . . . 0.0 110.92 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.9 156.86 22.18 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.385 -0.822 . . . . 0.0 112.367 168.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 7.9 ttp -88.84 158.57 18.07 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.75 1.22 . . . . 0.0 111.378 169.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.12 165.57 25.4 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.061 1.345 . . . . 0.0 112.9 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.1 m -88.44 -21.77 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.01 13.52 34.53 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.206 1.002 . . . . 0.0 113.084 -171.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.1 m120 58.44 29.25 18.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.195 1.798 . . . . 0.0 112.429 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 mt -57.66 153.93 28.18 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.223 173.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.83 140.19 50.04 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.648 2.899 . . . . 0.0 111.15 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -79.82 120.59 24.28 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.017 0.527 . . . . 0.0 111.01 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.5 pt -142.8 153.5 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.908 1.683 . . . . 0.0 111.56 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.62 -179.6 3.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.911 1.684 . . . . 0.0 111.806 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.1 mt -64.43 114.65 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.107 0.963 . . . . 0.0 110.214 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.42 -41.16 73.27 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.839 1.256 . . . . 0.0 112.316 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.75 157.81 34.1 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.223 1.409 . . . . 0.0 111.009 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -137.12 143.83 42.72 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.491 1.516 . . . . 0.0 110.562 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -151.09 134.51 16.21 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.49 1.516 . . . . 0.0 109.506 169.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -63.6 123.4 18.72 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.705 0.684 . . . . 0.0 110.375 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.2 mt -90.04 -44.02 10.12 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.01 0.524 . . . . 0.0 111.692 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 148.38 -148.11 19.3 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.329 0.966 . . . . 0.0 112.979 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -126.6 67.87 1.24 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 123.576 1.655 . . . . 0.0 112.469 -168.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -85.74 158.02 20.13 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 126.723 2.009 . . . . 0.0 110.635 -169.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.04 119.65 9.9 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.135 0.574 . . . . 0.0 110.5 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -123.06 150.49 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.41 0.624 . . . . 0.0 111.839 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -140.06 157.84 45.0 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.215 1.806 . . . . 0.0 112.264 -168.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -152.67 167.37 29.17 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.916 1.687 . . . . 0.0 110.969 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.8 145.72 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.417 1.487 . . . . 0.0 111.338 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.09 160.44 23.06 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.79 0.709 . . . . 0.0 112.865 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 126.36 1.864 . . . . 0.0 110.487 178.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 CA--C 1.549 0.925 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -163.34 166.55 22.87 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.836 1.254 . . . . 0.0 111.809 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.92 140.49 31.38 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.015 0.926 . . . . 0.0 112.949 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 65.3 mt -91.73 170.49 9.87 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.143 1.777 . . . . 0.0 111.882 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -47.17 -58.12 4.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.779 1.632 . . . . 0.0 115.22 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -67.13 -39.64 86.65 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.556 0.342 . . . . 0.0 110.861 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.33 -2.97 0.85 Allowed Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.475 -1.181 . . . . 0.0 115.331 172.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -59.49 160.89 6.39 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.176 1.488 . . . . 0.0 112.332 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.91 129.14 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.63 0.729 . . . . 0.0 110.179 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -118.52 145.65 45.16 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.991 1.716 . . . . 0.0 109.977 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.3 t -136.78 149.15 47.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.542 1.137 . . . . 0.0 114.006 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.8 t30 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.895 1.678 . . . . 0.0 113.648 -172.046 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.793 0 CA-C-O 122.307 0.948 . . . . 0.0 115.198 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -151.17 169.13 22.64 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.345 1.058 . . . . 0.0 112.207 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.8 mt -120.78 146.87 46.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.386 1.874 . . . . 0.0 109.514 -172.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 t -70.15 160.34 32.26 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.585 -0.697 . . . . 0.0 111.437 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -49.09 -40.9 33.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.292 1.037 . . . . 0.0 112.344 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.88 -24.8 54.47 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.983 1.713 . . . . 0.0 113.777 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.2 m -72.14 102.65 3.09 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.293 1.037 . . . . 0.0 110.942 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -87.52 145.87 26.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.747 0.784 . . . . 0.0 111.67 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -122.81 128.84 75.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 126.501 1.92 . . . . 0.0 107.317 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.2 tp -61.95 127.76 32.94 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.834 0.454 . . . . 0.0 111.37 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.3 p -125.57 150.44 47.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.847 1.259 . . . . 0.0 112.368 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.42 -32.39 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.287 0.635 . . . . 0.0 111.982 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -66.22 -30.42 70.87 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -142.56 -56.55 0.44 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -173.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.26 -147.81 19.44 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.835 0.731 . . . . 0.0 112.681 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.4 104.75 1.97 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.084 1.353 . . . . 0.0 111.347 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.4 mt -134.61 148.68 68.35 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.434 1.094 . . . . 0.0 113.451 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.52 129.53 24.05 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.462 3.441 . . . . 0.0 112.665 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.1 tt -56.29 -35.31 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.609 0.764 . . . . 0.0 112.888 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.79 -34.36 89.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.566 -0.574 . . . . 0.0 112.724 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -73.92 -29.63 62.15 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.654 1.227 . . . . 0.0 112.015 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.6 mt -71.77 -41.96 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.452 1.101 . . . . 0.0 109.769 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.29 -39.99 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.756 0.822 . . . . 0.0 113.004 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.11 -26.3 65.74 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.308 0.958 . . . . 0.0 112.643 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.45 2.04 15.27 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.616 1.166 . . . . 0.0 113.398 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 46.89 50.68 13.4 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.344 2.258 . . . . 0.0 112.139 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.3 mt -67.05 120.19 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.873 0.869 . . . . 0.0 108.868 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -84.4 98.57 10.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.945 0.879 . . . . 0.0 110.321 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p -132.02 -171.14 2.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.08 1.352 . . . . 0.0 111.463 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.25 142.23 50.9 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.458 1.503 . . . . 0.0 108.008 -176.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.48 172.94 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.802 1.641 . . . . 0.0 110.169 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -117.55 145.19 44.43 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.012 1.325 . . . . 0.0 110.194 -173.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.4 t -159.07 167.03 30.31 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.29 1.436 . . . . 0.0 110.139 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -113.31 127.29 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.158 1.383 . . . . 0.0 110.824 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.17 179.61 6.77 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.276 1.036 . . . . 0.0 111.951 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -57.34 -24.84 57.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.142 1.377 . . . . 0.0 113.405 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -88.73 -6.4 57.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.816 1.646 . . . . 0.0 113.827 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.78 4.14 89.0 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.263 0.935 . . . . 0.0 114.786 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -77.37 128.48 34.35 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.11 0.955 . . . . 0.0 109.906 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.68 107.38 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -107.48 175.22 5.56 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.574 1.549 . . . . 0.0 110.403 175.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.6 p -130.99 149.03 52.8 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.703 0.801 . . . . 0.0 112.789 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -146.07 144.52 21.9 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.788 1.235 . . . . 0.0 111.997 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.44 151.21 47.57 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.819 2.346 . . . . 0.0 112.172 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.31 122.0 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 169.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.03 -47.63 12.41 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.27 -0.269 . . . . 0.0 111.56 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -148.7 179.14 8.05 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.021 1.729 . . . . 0.0 111.585 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -137.47 142.08 41.55 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.732 1.613 . . . . 0.0 110.289 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -136.79 132.38 34.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.999 0.92 . . . . 0.0 111.614 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -124.06 119.66 30.16 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.471 1.508 . . . . 0.0 110.595 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -84.82 -32.25 23.41 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.692 1.197 . . . . 0.0 113.086 -173.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 -53.33 1.33 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.528 1.537 . . . . 0.0 113.975 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -170.09 101.51 0.29 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.086 1.354 . . . . 0.0 111.087 -173.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -131.57 160.87 34.04 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.531 1.133 . . . . 0.0 111.899 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.91 106.52 1.25 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.405 1.082 . . . . 0.0 112.925 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.65 134.75 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.25 1.42 . . . . 0.0 111.358 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -119.78 140.78 50.22 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.76 1.224 . . . . 0.0 110.31 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.11 132.01 35.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.127 0.971 . . . . 0.0 108.799 168.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.18 89.04 3.05 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.112 1.365 . . . . 0.0 108.541 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 45.6 t -71.88 129.29 38.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.662 0.785 . . . . 0.0 110.377 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -88.54 164.87 15.21 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.201 1.0 . . . . 0.0 112.304 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.17 -23.02 67.16 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -82.18 -26.59 33.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.654 1.182 . . . . 0.0 113.084 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.95 -4.58 16.41 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.029 1.299 . . . . 0.0 114.264 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 m -58.54 141.34 52.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.556 1.178 . . . . 0.0 110.802 173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.32 122.2 40.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.939 0.896 . . . . 0.0 109.52 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -110.97 131.09 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -124.66 97.35 5.25 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.38 1.072 . . . . 0.0 109.884 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.9 169.82 17.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.54 1.136 . . . . 0.0 113.03 -168.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 p -84.75 152.2 23.86 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.443 1.097 . . . . 0.0 111.486 169.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -62.65 -12.27 22.3 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.35 -13.49 34.99 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.32 1.448 . . . . 0.0 112.376 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -82.87 134.77 35.08 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.599 0.636 . . . . 0.0 109.666 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -86.91 156.75 19.7 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.657 0.783 . . . . 0.0 111.345 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -137.69 142.64 41.09 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.783 0.833 . . . . 0.0 109.286 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 31.1 ttp -79.52 106.17 11.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.024 0.529 . . . . 0.0 110.0 -174.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.4 p -66.47 169.33 7.67 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.008 0.523 . . . . 0.0 111.909 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 m -56.44 -27.87 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.8 -14.48 54.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.386 1.074 . . . . 0.0 113.283 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.68 6.06 56.45 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.445 1.497 . . . . 0.0 114.705 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -71.7 155.34 40.59 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.692 1.246 . . . . 0.0 111.384 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.7 ptp -116.86 74.24 0.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.803 1.241 . . . . 0.0 110.961 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.73 147.0 33.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.487 1.115 . . . . 0.0 110.977 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.78 146.96 92.53 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.034 2.49 . . . . 0.0 111.159 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tt -59.27 -24.78 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -54.78 -38.69 67.58 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.861 1.265 . . . . 0.0 112.61 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -81.28 -38.75 26.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.19 0.596 . . . . 0.0 110.848 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.2 mt -61.88 -40.89 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.389 -0.82 . . . . 0.0 111.665 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -64.33 -39.36 93.74 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.88 -40.12 25.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.968 0.907 . . . . 0.0 113.069 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -81.03 -11.96 59.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.754 1.222 . . . . 0.0 112.938 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 57.87 32.91 22.58 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.403 1.481 . . . . 0.0 112.737 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 mt -70.31 133.48 47.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.663 1.185 . . . . 0.0 110.971 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -72.11 154.58 41.0 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.546 -0.721 . . . . 0.0 111.76 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.5 mt -105.89 147.66 28.49 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.936 0.894 . . . . 0.0 112.406 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.8 ttm -70.17 151.64 45.18 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.511 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.27 174.04 10.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.481 1.112 . . . . 0.0 112.545 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.0 -0.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 125.775 1.63 . . . . 0.0 114.694 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.29 12.55 21.68 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.299 1.44 . . . . 0.0 113.265 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.8 m120 59.98 25.05 14.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.228 1.811 . . . . 0.0 113.02 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.8 mt -63.75 159.1 56.16 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.976 1.71 . . . . 0.0 112.013 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.19 146.2 80.76 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.004 2.47 . . . . 0.0 111.477 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -76.43 113.54 14.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.095 0.558 . . . . 0.0 109.708 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.95 150.58 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.318 1.447 . . . . 0.0 111.232 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.09 174.23 6.03 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.652 1.581 . . . . 0.0 111.21 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.4 mt -66.18 113.37 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.881 0.872 . . . . 0.0 109.878 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.28 74.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.026 1.331 . . . . 0.0 111.628 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.7 p -153.38 160.76 42.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.212 1.805 . . . . 0.0 111.784 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -117.4 145.26 44.22 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.081 1.752 . . . . 0.0 110.456 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -147.0 121.67 9.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.25 1.02 . . . . 0.0 110.871 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -64.18 135.84 56.68 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.84 -0.538 . . . . 0.0 111.175 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.5 mt -105.99 -37.98 6.47 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.255 0.622 . . . . 0.0 112.167 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.23 -144.78 15.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.458 1.028 . . . . 0.0 112.462 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -128.8 78.77 1.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 123.193 1.473 . . . . 0.0 112.141 -169.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -96.84 160.35 14.41 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.916 1.686 . . . . 0.0 111.074 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.44 119.32 8.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.392 0.677 . . . . 0.0 110.433 169.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.97 150.67 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.451 0.644 . . . . 0.0 111.384 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -138.44 158.76 43.65 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.67 1.588 . . . . 0.0 112.217 -168.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -158.23 133.4 8.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.425 1.09 . . . . 0.0 110.992 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.8 pt -82.3 158.4 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.389 -0.819 . . . . 0.0 111.354 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.22 139.9 15.79 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.84 1.209 . . . . 0.0 111.424 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.472 0.664 0 C-N-CA 126.652 1.981 . . . . 0.0 110.002 178.772 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -153.96 154.93 34.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.842 1.657 . . . . 0.0 111.984 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.24 131.65 34.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.526 1.131 . . . . 0.0 112.688 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 38.5 mt -82.87 170.59 14.82 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.172 1.389 . . . . 0.0 112.669 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -55.66 -41.15 73.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -75.32 -33.28 61.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.39 0.676 . . . . 0.0 111.577 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.4 -9.15 5.02 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.163 1.363 . . . . 0.0 114.304 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.74 173.1 5.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.614 1.707 . . . . 0.0 111.79 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.29 122.0 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.472 0.709 . . . . 0.0 109.843 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.63 131.48 44.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.336 1.054 . . . . 0.0 108.369 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 p -108.61 143.35 37.78 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.581 1.552 . . . . 0.0 110.775 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--O 1.255 1.394 0 CA-C-O 117.653 -1.165 . . . . 0.0 113.1 -167.811 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.274 0 N-CA-C 112.182 -0.367 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.08 179.19 7.69 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.989 1.315 . . . . 0.0 112.55 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.6 150.27 36.93 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.034 1.733 . . . . 0.0 111.015 -173.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 t -69.52 163.77 24.67 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.5 -0.75 . . . . 0.0 112.186 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -50.2 -43.82 52.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.914 0.885 . . . . 0.0 112.011 172.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -62.54 -15.77 52.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.993 1.317 . . . . 0.0 114.322 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.8 m -70.94 102.21 2.35 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.081 0.953 . . . . 0.0 111.043 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -86.24 137.65 32.46 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.357 0.663 . . . . 0.0 112.11 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.2 mm -122.9 119.13 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.896 1.678 . . . . 0.0 107.929 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.24 127.88 33.53 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 122.253 -0.279 . . . . 0.0 111.161 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.6 p -124.93 155.94 38.78 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.72 1.608 . . . . 0.0 112.375 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.6 t -81.24 -33.68 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.992 0.517 . . . . 0.0 111.72 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.31 -25.78 61.7 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -137.88 -53.85 0.65 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.95 0.9 . . . . 0.0 113.281 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.73 -146.46 18.27 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.1 0.857 . . . . 0.0 112.352 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -74.44 107.31 6.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.067 1.747 . . . . 0.0 110.925 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.56 157.07 48.74 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.25 132.86 26.91 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.172 3.248 . . . . 0.0 112.925 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.6 tt -56.42 -34.79 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.767 0.827 . . . . 0.0 112.987 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.9 -34.22 89.34 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.731 -0.606 . . . . 0.0 112.784 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -71.59 -32.72 68.34 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.481 1.141 . . . . 0.0 111.921 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.9 mt -67.48 -43.38 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.124 0.969 . . . . 0.0 110.153 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.5 t -82.66 -36.67 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.832 0.853 . . . . 0.0 112.669 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -65.8 -27.07 68.0 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.141 0.882 . . . . 0.0 112.857 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -116.33 2.65 13.25 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.32 1.048 . . . . 0.0 113.529 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 46.62 52.62 10.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.924 2.49 . . . . 0.0 112.528 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.7 mt -74.11 119.99 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.278 1.031 . . . . 0.0 109.936 -172.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -71.95 108.37 5.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.916 0.887 . . . . 0.0 110.532 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.5 p -148.15 161.09 42.16 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.363 1.078 . . . . 0.0 113.844 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 151.83 19.23 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.909 1.684 . . . . 0.0 109.907 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.35 170.99 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 125.251 1.42 . . . . 0.0 111.347 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -114.87 142.23 46.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.477 1.511 . . . . 0.0 111.093 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.8 t -164.44 152.69 12.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.174 1.389 . . . . 0.0 110.653 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 m -81.67 154.64 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.625 1.102 . . . . 0.0 112.698 170.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -96.08 -174.81 3.2 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.648 1.579 . . . . 0.0 113.221 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -62.77 -13.35 32.04 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -98.55 -5.41 32.12 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.4 1.48 . . . . 0.0 112.361 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.19 26.28 44.78 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.728 1.156 . . . . 0.0 114.588 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -109.82 122.82 48.4 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.135 1.468 . . . . 0.0 110.165 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 mt -67.69 103.12 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.979 0.912 . . . . 0.0 109.41 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -100.86 179.08 4.5 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.737 1.615 . . . . 0.0 111.031 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 p -126.84 143.1 51.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.192 0.997 . . . . 0.0 112.957 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -144.96 144.25 23.33 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 125.004 1.322 . . . . 0.0 112.442 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.51 149.21 43.87 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.098 2.532 . . . . 0.0 112.11 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.34 137.91 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.873 0.869 . . . . 0.0 110.745 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.64 -34.74 12.48 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -167.43 178.6 5.39 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.972 1.709 . . . . 0.0 112.308 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.2 m-90 -132.69 137.28 46.88 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.214 1.405 . . . . 0.0 110.217 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -127.59 114.78 17.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.685 1.194 . . . . 0.0 111.313 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.29 108.19 19.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.424 1.49 . . . . 0.0 109.877 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -78.49 -29.36 46.68 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.304 1.042 . . . . 0.0 112.752 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.31 -45.85 2.22 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.268 1.413 . . . . 0.0 114.026 171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 177.21 102.75 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.436 1.495 . . . . 0.0 112.183 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -132.22 166.66 21.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.747 1.219 . . . . 0.0 112.373 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.86 100.09 0.91 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.401 1.48 . . . . 0.0 113.851 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.86 141.7 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.346 1.458 . . . . 0.0 111.617 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -123.4 140.2 53.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.176 1.791 . . . . 0.0 110.217 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.11 130.05 44.79 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.979 0.912 . . . . 0.0 109.959 172.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -128.15 97.04 4.64 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.381 1.072 . . . . 0.0 108.232 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 45.9 t -111.34 142.16 43.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.166 0.987 . . . . 0.0 110.355 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -104.04 162.26 13.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.772 1.229 . . . . 0.0 112.117 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.85 -20.57 65.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.444 1.098 . . . . 0.0 113.723 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -76.11 -28.25 57.43 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.601 1.161 . . . . 0.0 113.031 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.91 -0.25 19.67 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.737 1.161 . . . . 0.0 114.547 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 m -58.27 146.86 32.65 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.319 1.06 . . . . 0.0 111.173 171.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.0 124.93 27.1 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.486 1.114 . . . . 0.0 110.435 -171.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.2 mt -137.61 150.51 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.942 2.097 . . . . 0.0 108.091 -170.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -136.62 110.91 8.43 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.57 1.148 . . . . 0.0 110.062 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.24 160.57 40.75 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.333 1.453 . . . . 0.0 111.518 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 p -75.31 151.0 38.33 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.385 -0.822 . . . . 0.0 111.782 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -63.19 -19.14 64.24 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.35 -15.18 56.09 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.772 1.629 . . . . 0.0 112.679 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -79.58 132.95 36.42 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.736 0.814 . . . . 0.0 110.038 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -93.79 146.68 23.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.592 1.157 . . . . 0.0 112.385 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -128.74 151.84 49.1 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.845 -1.159 . . . . 0.0 111.483 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.3 ttp -92.78 100.48 12.95 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.447 0.699 . . . . 0.0 110.563 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.7 p -69.33 172.6 6.82 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.583 0.753 . . . . 0.0 112.342 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 m -52.56 -29.55 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -86.94 -10.04 54.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.082 0.953 . . . . 0.0 113.342 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.96 10.89 62.21 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.793 1.187 . . . . 0.0 114.135 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -67.61 158.72 31.45 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.235 1.018 . . . . 0.0 111.024 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 37.0 mtm -126.21 70.99 1.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.783 1.633 . . . . 0.0 109.848 -173.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 mt -111.81 149.28 40.57 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 124.895 1.278 . . . . 0.0 110.599 -170.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.41 149.37 88.13 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.646 2.231 . . . . 0.0 110.379 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.51 -28.57 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -55.19 -35.22 64.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.678 1.191 . . . . 0.0 113.007 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.49 -37.9 59.88 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.283 1.033 . . . . 0.0 111.471 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.7 mt -68.24 -38.51 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.603 1.161 . . . . 0.0 109.945 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.96 -37.15 86.34 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -75.09 -46.72 32.74 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -79.43 -5.4 54.61 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 56.48 35.48 26.05 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.626 1.57 . . . . 0.0 112.531 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.99 132.18 47.97 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.524 1.13 . . . . 0.0 110.825 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -75.31 136.85 40.85 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.838 -0.539 . . . . 0.0 110.328 171.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.96 152.64 44.22 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.289 -0.882 . . . . 0.0 111.35 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.9 ttm -71.06 150.82 45.17 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.378 168.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.81 161.53 25.07 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.61 1.564 . . . . 0.0 112.598 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -113.6 -13.57 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.941 1.696 . . . . 0.0 114.133 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -109.48 11.55 24.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.046 1.338 . . . . 0.0 112.866 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.9 m120 64.2 25.89 13.7 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.537 1.535 . . . . 0.0 112.672 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.5 mt -55.67 157.12 7.96 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.671 1.588 . . . . 0.0 111.999 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.76 141.53 79.19 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.695 2.264 . . . . 0.0 110.397 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -66.04 128.64 36.87 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.792 -0.568 . . . . 0.0 110.712 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.4 pt -147.16 149.91 15.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 126.538 1.935 . . . . 0.0 109.897 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 -179.95 3.92 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.309 1.444 . . . . 0.0 111.333 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 25.1 mt -63.56 105.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.251 1.02 . . . . 0.0 110.028 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.45 77.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.156 1.382 . . . . 0.0 111.576 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 p -149.44 149.18 30.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.852 1.661 . . . . 0.0 111.076 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -143.43 144.0 31.85 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.908 1.683 . . . . 0.0 110.36 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -159.37 148.71 18.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.423 1.889 . . . . 0.0 110.042 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -65.11 128.39 35.59 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.546 0.612 . . . . 0.0 110.995 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.7 mt -93.53 -46.18 7.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.085 0.554 . . . . 0.0 111.748 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 147.73 -151.24 23.51 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.415 1.007 . . . . 0.0 112.544 -172.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -123.28 86.1 2.52 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 122.689 1.233 . . . . 0.0 112.135 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -102.01 154.56 18.86 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.248 1.419 . . . . 0.0 110.075 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.68 116.61 4.52 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.164 0.586 . . . . 0.0 109.964 169.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.06 151.66 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.541 0.686 . . . . 0.0 110.942 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -141.11 157.38 45.36 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.814 1.645 . . . . 0.0 111.412 -168.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -156.32 146.02 20.98 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.522 0.729 . . . . 0.0 109.872 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.7 pt -100.15 143.68 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.777 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -93.96 151.77 20.42 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.45 0.548 . . . . 0.0 111.772 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.475 0.802 0 C-N-CA 125.758 1.623 . . . . 0.0 108.869 -176.593 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -161.62 156.97 23.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.641 1.576 . . . . 0.0 112.254 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.35 147.08 26.2 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.716 1.206 . . . . 0.0 112.962 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.05 168.86 9.57 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.671 1.588 . . . . 0.0 112.076 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -48.83 -51.02 31.77 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.126 1.37 . . . . 0.0 114.025 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -73.42 -20.47 60.72 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -172.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 127.14 -4.27 7.31 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.791 1.186 . . . . 0.0 114.91 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.31 171.87 11.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.081 1.44 . . . . 0.0 112.279 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.84 138.61 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.247 1.019 . . . . 0.0 109.999 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.5 149.1 50.28 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.306 1.842 . . . . 0.0 109.351 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.0 t -134.96 123.21 23.01 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -171.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.485 2.314 . . . . 0.0 114.074 178.849 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.181 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.99 175.94 10.64 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.22 1.008 . . . . 0.0 113.166 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -108.92 150.02 28.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.87 1.668 . . . . 0.0 111.071 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -65.81 161.76 20.27 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.405 0.682 . . . . 0.0 112.149 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -52.23 -44.15 64.66 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.823 0.849 . . . . 0.0 112.481 172.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.35 -23.75 64.51 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.791 1.636 . . . . 0.0 113.84 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -63.23 112.92 2.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.176 0.991 . . . . 0.0 111.341 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -96.55 135.3 38.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.42 0.688 . . . . 0.0 111.048 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.6 mm -118.43 122.81 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.653 1.581 . . . . 0.0 107.954 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -64.93 124.38 21.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.279 0.231 . . . . 0.0 111.289 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.2 p -121.83 153.65 38.07 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.632 1.173 . . . . 0.0 112.146 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.9 -30.41 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 121.877 -0.514 . . . . 0.0 111.8 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -65.62 -36.42 83.66 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -140.46 -49.45 0.45 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.32 -146.52 18.5 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.966 0.794 . . . . 0.0 112.51 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.3 mt -66.78 96.31 0.4 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.665 1.586 . . . . 0.0 112.639 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.66 147.8 62.21 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.887 1.275 . . . . 0.0 111.92 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.45 129.14 21.81 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 124.289 3.326 . . . . 0.0 112.794 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.5 tt -56.78 -37.25 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.004 0.921 . . . . 0.0 113.035 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.29 -31.35 78.77 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.662 -0.649 . . . . 0.0 113.291 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -76.23 -30.98 58.13 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.952 0.876 . . . . 0.0 111.817 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.58 -40.51 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.244 1.018 . . . . 0.0 109.642 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.71 -39.83 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.521 0.728 . . . . 0.0 112.951 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.1 -21.81 56.26 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.389 0.995 . . . . 0.0 113.513 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -109.51 1.87 20.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.778 1.231 . . . . 0.0 112.299 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.98 51.26 13.04 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.975 2.11 . . . . 0.0 112.663 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.5 mt -71.59 120.82 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.213 0.605 . . . . 0.0 109.48 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.04 105.6 6.14 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.222 1.009 . . . . 0.0 110.665 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.5 p -144.53 164.73 30.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.457 1.122 . . . . 0.0 113.44 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.5 145.67 26.55 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.315 1.446 . . . . 0.0 109.849 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.22 176.05 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.958 1.703 . . . . 0.0 111.098 -176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -118.24 142.95 46.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.769 1.628 . . . . 0.0 110.537 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.9 t -155.58 152.99 29.45 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.226 1.41 . . . . 0.0 110.419 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -94.27 125.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.456 0.702 . . . . 0.0 109.472 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -70.81 176.45 4.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.392 1.091 . . . . 0.0 112.445 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -60.21 -27.33 67.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.887 1.275 . . . . 0.0 113.066 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -86.2 -2.17 58.12 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.684 1.594 . . . . 0.0 113.498 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.23 19.05 78.85 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.582 1.086 . . . . 0.0 114.592 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -93.97 129.68 40.36 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.023 1.329 . . . . 0.0 109.485 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.2 mt -74.65 134.71 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -138.67 167.91 20.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.626 1.57 . . . . 0.0 111.683 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 p -115.94 144.95 43.35 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.473 1.109 . . . . 0.0 112.187 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -153.26 148.48 20.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.16 0.984 . . . . 0.0 112.767 -176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.62 150.21 45.03 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.963 2.442 . . . . 0.0 112.562 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -58.77 140.33 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.922 0.889 . . . . 0.0 110.568 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.48 -31.07 11.07 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.006 0.922 . . . . 0.0 112.64 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -167.71 175.14 7.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.946 1.698 . . . . 0.0 112.17 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -134.26 124.19 25.5 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.938 1.295 . . . . 0.0 109.303 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -113.77 129.13 56.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.993 0.917 . . . . 0.0 110.839 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -120.24 103.83 9.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.53 1.532 . . . . 0.0 110.043 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -72.77 -29.86 63.64 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.709 1.204 . . . . 0.0 112.967 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.16 -52.74 2.84 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.262 1.411 . . . . 0.0 113.62 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -170.76 105.54 0.26 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.967 1.307 . . . . 0.0 110.269 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -132.66 168.13 18.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.987 0.915 . . . . 0.0 112.349 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -68.82 100.84 1.23 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.854 1.261 . . . . 0.0 113.342 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.9 t -94.36 138.03 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.926 1.29 . . . . 0.0 111.557 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.489 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 53.2 m-85 -120.14 144.41 47.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 110.206 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.36 134.09 55.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.598 0.759 . . . . 0.0 110.652 171.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.502 ' HH ' ' CD1' ' A' ' 94' ' ' LEU . 1.9 t80 -127.03 83.34 2.16 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.425 1.49 . . . . 0.0 108.384 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.8 t -98.06 147.77 24.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.001 0.92 . . . . 0.0 110.899 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.09 158.36 23.31 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.199 1.4 . . . . 0.0 112.34 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -69.17 -18.34 63.91 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -77.25 -28.34 53.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.13 0.972 . . . . 0.0 112.786 172.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.62 -9.76 8.63 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.36 1.457 . . . . 0.0 114.253 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.2 m -59.54 150.78 26.07 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.46 1.13 . . . . 0.0 112.153 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.1 tp -137.91 125.6 22.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.162 0.985 . . . . 0.0 110.855 -173.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.6 mt -133.93 148.77 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.367 1.867 . . . . 0.0 107.941 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -131.6 121.41 24.33 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.935 1.294 . . . . 0.0 110.505 174.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.34 163.92 36.35 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.386 1.474 . . . . 0.0 111.197 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -75.37 154.04 37.45 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.434 -0.791 . . . . 0.0 111.973 173.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 4.8 mtmt -62.93 -20.4 65.17 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -87.47 -9.96 53.17 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.235 1.814 . . . . 0.0 113.054 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -77.68 134.42 38.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.75 0.82 . . . . 0.0 109.755 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -98.02 150.1 21.75 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.289 1.042 . . . . 0.0 111.889 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -136.3 132.57 35.89 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.018 -1.052 . . . . 0.0 109.766 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.1 ttp -72.24 108.87 5.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.206 0.527 . . . . 0.0 110.998 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -68.73 172.12 6.83 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.377 0.671 . . . . 0.0 112.172 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -55.91 -22.75 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -87.1 -6.14 58.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.414 1.085 . . . . 0.0 113.314 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.57 9.23 72.49 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.759 1.171 . . . . 0.0 113.966 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -81.13 130.16 34.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.258 1.029 . . . . 0.0 110.886 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.28 87.31 7.37 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.933 1.293 . . . . 0.0 110.793 169.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.1 mt -112.59 145.4 32.87 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.007 0.923 . . . . 0.0 110.238 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.72 147.06 85.44 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.674 2.25 . . . . 0.0 110.875 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -58.39 -26.84 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -53.79 -37.39 63.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.61 1.164 . . . . 0.0 113.19 169.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -80.43 -39.24 28.61 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.73 0.812 . . . . 0.0 110.669 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.46 -38.85 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.682 0.793 . . . . 0.0 111.103 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -64.78 -38.57 91.45 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -75.86 -38.64 57.73 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.482 -0.761 . . . . 0.0 112.682 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -75.47 -13.36 60.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 57.87 31.53 20.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.522 1.529 . . . . 0.0 111.982 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.8 mt -84.54 157.36 21.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.617 1.199 . . . . 0.0 112.201 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -113.54 156.6 23.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.011 2.124 . . . . 0.0 112.923 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.502 ' CD1' ' HH ' ' A' ' 58' ' ' TYR . 18.6 mt -88.21 149.75 23.68 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.552 0.741 . . . . 0.0 112.361 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.3 ttp -72.82 153.67 40.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.455 0.702 . . . . 0.0 111.222 170.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.39 167.3 15.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.412 1.485 . . . . 0.0 112.174 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.27 -12.52 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.981 1.313 . . . . 0.0 114.151 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.08 8.77 36.54 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.069 1.348 . . . . 0.0 113.073 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 52.41 35.39 17.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.987 1.715 . . . . 0.0 113.42 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.75 156.97 86.32 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.064 170.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.66 129.73 27.36 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.213 2.609 . . . . 0.0 111.134 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.19 134.44 44.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.727 0.811 . . . . 0.0 109.748 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.7 pt -143.17 130.75 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.371 1.468 . . . . 0.0 111.044 -169.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.5 171.57 12.42 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.487 1.115 . . . . 0.0 112.351 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.9 mt -63.97 112.52 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.319 1.448 . . . . 0.0 110.111 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.29 -35.81 35.3 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.707 0.803 . . . . 0.0 112.327 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.4 p -146.68 149.88 34.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.106 1.762 . . . . 0.0 110.676 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.07 143.03 32.89 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.795 1.638 . . . . 0.0 110.082 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -160.92 140.53 10.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.827 1.651 . . . . 0.0 110.256 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -65.35 121.98 16.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.842 0.457 . . . . 0.0 110.89 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.3 mt -90.95 -44.57 9.27 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.039 0.536 . . . . 0.0 111.891 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 150.73 -142.46 9.6 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.515 0.579 . . . . 0.0 113.324 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -130.67 86.27 2.36 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.82 1.248 . . . . 0.0 111.754 -168.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -104.43 157.26 17.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.909 1.284 . . . . 0.0 111.047 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 117.66 6.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.386 0.674 . . . . 0.0 110.364 169.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.3 m -124.14 151.7 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.372 0.606 . . . . 0.0 111.088 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -141.02 157.75 44.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.559 1.544 . . . . 0.0 111.74 -168.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -157.01 128.31 6.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.194 0.998 . . . . 0.0 110.799 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.5 pt -80.66 147.45 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.3 -0.875 . . . . 0.0 110.863 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.21 156.04 18.55 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.434 1.016 . . . . 0.0 111.731 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 124.662 1.185 . . . . 0.0 110.261 -169.223 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -166.51 158.43 13.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.711 1.205 . . . . 0.0 112.611 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.4 134.59 35.58 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.31 1.044 . . . . 0.0 112.339 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 38.1 mt -86.57 166.24 15.58 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.732 1.213 . . . . 0.0 111.516 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -52.74 -32.8 45.14 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -88.1 -6.53 57.86 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.505 1.122 . . . . 0.0 113.239 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.88 -11.65 34.78 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.427 1.013 . . . . 0.0 114.973 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -73.13 167.42 21.18 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.36 1.58 . . . . 0.0 112.842 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.69 120.66 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.931 0.893 . . . . 0.0 110.202 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.66 141.15 30.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.442 1.897 . . . . 0.0 109.801 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.7 m -139.16 137.12 35.8 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.472 1.109 . . . . 0.0 113.175 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 125.189 1.396 . . . . 0.0 113.86 -177.835 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.185 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -156.12 174.8 14.84 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.572 0.701 . . . . 0.0 112.826 -168.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.8 mt -120.89 147.0 46.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.928 1.691 . . . . 0.0 109.964 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 t -66.75 161.17 24.19 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -50.93 -44.64 60.28 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.557 0.743 . . . . 0.0 111.993 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -15.93 41.23 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.5 m -73.54 98.72 2.86 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.595 0.758 . . . . 0.0 110.14 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.15 133.14 42.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.455 0.645 . . . . 0.0 110.746 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.87 126.74 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 125.466 1.507 . . . . 0.0 107.216 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.3 122.56 18.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 170.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.7 p -123.71 150.98 43.66 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.76 1.224 . . . . 0.0 111.966 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.4 t -77.68 -33.59 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.9 -0.5 . . . . 0.0 112.005 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -66.16 -27.63 68.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -144.57 -52.84 0.31 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.37 -150.07 21.1 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.817 0.722 . . . . 0.0 112.217 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.85 108.26 2.93 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.333 1.453 . . . . 0.0 110.939 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.0 mt -134.99 148.89 68.74 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.475 1.11 . . . . 0.0 113.041 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.66 126.56 16.99 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.967 3.111 . . . . 0.0 112.024 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 tt -54.92 -36.48 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.18 -36.0 92.68 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.805 -0.56 . . . . 0.0 112.992 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -68.76 -37.65 79.53 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.558 1.179 . . . . 0.0 111.433 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.46 -38.41 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.761 0.824 . . . . 0.0 109.767 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.53 -39.49 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.158 0.983 . . . . 0.0 113.259 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.28 -27.5 66.37 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.496 1.044 . . . . 0.0 112.667 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -112.71 0.72 15.4 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.719 1.208 . . . . 0.0 112.773 -176.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.95 52.31 11.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.87 2.468 . . . . 0.0 112.418 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.6 mt -72.98 123.78 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.082 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.8 102.41 2.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.893 0.877 . . . . 0.0 110.287 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.5 p -132.25 -178.13 4.77 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.994 1.318 . . . . 0.0 112.496 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.94 147.27 51.05 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.439 1.496 . . . . 0.0 108.227 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.91 158.65 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.657 1.183 . . . . 0.0 111.203 -173.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -96.2 138.19 34.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.38 1.072 . . . . 0.0 110.4 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 t -155.57 153.77 30.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.898 1.279 . . . . 0.0 110.527 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.88 125.47 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.078 0.551 . . . . 0.0 110.316 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -68.42 175.29 3.45 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.835 1.254 . . . . 0.0 112.267 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.71 -25.87 68.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.844 1.258 . . . . 0.0 113.155 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -85.56 -4.76 59.26 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.366 1.466 . . . . 0.0 113.555 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.9 19.02 62.1 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.738 1.161 . . . . 0.0 114.758 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -94.95 128.88 42.08 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.627 1.171 . . . . 0.0 110.259 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.1 mt -74.12 123.52 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -135.11 174.15 10.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.828 2.051 . . . . 0.0 111.504 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -116.93 139.19 50.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.185 0.994 . . . . 0.0 111.905 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -141.22 141.0 21.99 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.545 1.138 . . . . 0.0 111.863 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.14 152.24 39.89 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.885 2.39 . . . . 0.0 112.027 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.66 138.45 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.787 0.835 . . . . 0.0 111.037 169.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.13 -51.95 4.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.544 0.738 . . . . 0.0 111.142 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -144.62 -178.6 6.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.87 1.668 . . . . 0.0 111.034 -173.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -138.98 126.81 22.15 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.399 1.08 . . . . 0.0 109.313 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -122.16 134.72 54.73 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.105 0.955 . . . . 0.0 110.795 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -127.52 122.25 32.84 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.208 1.403 . . . . 0.0 109.996 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -88.96 -34.19 16.96 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.177 0.991 . . . . 0.0 112.326 -173.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.45 -42.55 2.32 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.114 1.34 . . . . 0.0 114.889 172.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -178.69 88.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.066 1.412 . . . . 0.0 114.629 -168.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -125.18 158.98 32.62 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.979 1.311 . . . . 0.0 112.291 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.57 106.76 1.22 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.021 1.328 . . . . 0.0 112.695 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 t -98.59 139.44 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.346 1.458 . . . . 0.0 110.586 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -124.48 140.66 52.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.986 1.315 . . . . 0.0 109.513 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.84 135.1 35.88 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.177 0.991 . . . . 0.0 108.987 169.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -122.07 98.53 5.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.61 1.564 . . . . 0.0 109.011 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.8 t -75.86 132.97 40.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.138 0.575 . . . . 0.0 109.982 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mp -93.28 162.48 13.99 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.614 0.721 . . . . 0.0 112.783 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.81 -22.44 66.56 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.03 -21.27 51.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.954 0.902 . . . . 0.0 112.926 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.04 -1.32 25.59 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.441 1.495 . . . . 0.0 114.531 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.8 p -72.71 171.32 12.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.488 1.144 . . . . 0.0 113.017 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.5 mt -132.6 145.6 51.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.192 1.397 . . . . 0.0 110.983 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.6 mt -137.68 139.64 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.471 1.908 . . . . 0.0 107.323 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -131.26 98.18 4.48 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.608 1.163 . . . . 0.0 110.429 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.73 166.29 27.06 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.282 1.039 . . . . 0.0 113.724 -172.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 p -82.43 155.46 24.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.723 1.209 . . . . 0.0 111.535 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -61.55 -23.95 66.31 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -86.74 -11.29 51.52 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.37 1.068 . . . . 0.0 112.605 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -80.02 132.04 35.92 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -87.4 162.72 17.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.509 0.671 . . . . 0.0 111.098 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -138.19 141.23 40.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 43.1 ttm -69.54 107.39 3.36 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -66.89 166.47 13.37 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.204 0.526 . . . . 0.0 111.122 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 m -57.64 -24.33 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.07 -14.39 59.51 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.487 1.115 . . . . 0.0 113.478 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.46 10.9 61.5 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.095 1.331 . . . . 0.0 114.383 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -82.96 164.08 20.63 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.426 1.113 . . . . 0.0 111.522 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.36 81.94 1.86 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.985 1.314 . . . . 0.0 111.33 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.6 mt -113.22 148.41 39.46 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.526 1.131 . . . . 0.0 110.787 -172.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.04 146.03 81.08 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.97 2.447 . . . . 0.0 111.246 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.6 tt -58.43 -26.03 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.55 -35.09 67.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.389 1.076 . . . . 0.0 113.023 170.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -39.03 27.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.531 1.132 . . . . 0.0 111.102 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.47 -39.45 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.397 1.079 . . . . 0.0 110.919 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -63.73 -34.44 77.87 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -77.14 -48.19 18.35 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.944 0.793 . . . . 0.0 113.055 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -74.55 -12.35 60.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 57.9 35.52 25.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.663 1.585 . . . . 0.0 112.476 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.8 mt -76.74 146.92 37.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.159 0.983 . . . . 0.0 111.834 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.63 164.76 20.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.665 0.786 . . . . 0.0 112.043 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.6 mt -111.05 147.14 35.43 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.5 1.12 . . . . 0.0 111.682 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 31.7 ttm -74.79 141.92 44.3 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.723 -0.611 . . . . 0.0 110.664 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.12 173.19 9.4 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.515 1.126 . . . . 0.0 113.06 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.61 -19.63 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 126.17 1.788 . . . . 0.0 113.8 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.8 4.23 30.05 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.94 1.296 . . . . 0.0 113.916 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.77 31.96 21.22 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.506 1.522 . . . . 0.0 112.859 -175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.9 mt -70.92 158.79 87.33 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.913 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.24 149.83 85.12 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.154 2.569 . . . . 0.0 111.396 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -70.4 123.59 22.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.4 0.68 . . . . 0.0 110.401 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.21 137.92 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.218 1.407 . . . . 0.0 111.386 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.23 176.35 5.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.834 1.654 . . . . 0.0 111.379 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mt -69.71 103.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.511 1.524 . . . . 0.0 110.007 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.93 -42.59 80.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.966 1.306 . . . . 0.0 111.633 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -152.48 162.98 40.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.642 1.977 . . . . 0.0 111.113 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -127.47 144.82 51.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.902 1.681 . . . . 0.0 110.793 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -145.83 116.58 7.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.512 1.125 . . . . 0.0 110.527 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -63.16 127.44 31.26 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.575 -0.703 . . . . 0.0 111.16 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.9 mt -94.74 -42.99 8.45 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.831 0.452 . . . . 0.0 112.094 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 140.64 -147.99 19.64 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.712 1.148 . . . . 0.0 112.588 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -120.8 71.27 0.92 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.476 1.51 . . . . 0.0 112.362 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -90.8 157.34 17.44 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.688 1.595 . . . . 0.0 111.216 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.18 118.92 9.93 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.95 0.9 . . . . 0.0 110.35 170.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.1 150.27 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.42 0.688 . . . . 0.0 111.448 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -137.11 157.96 45.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.051 1.74 . . . . 0.0 111.994 -169.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -158.1 119.1 3.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.713 1.205 . . . . 0.0 110.607 -174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 pt -72.68 148.19 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 O-C-N 120.754 -1.216 . . . . 0.0 111.927 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.49 151.47 19.34 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.488 1.042 . . . . 0.0 111.868 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 125.426 1.49 . . . . 0.0 109.416 -171.796 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 CA--C 1.546 0.827 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -160.49 153.4 21.36 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.015 1.326 . . . . 0.0 112.912 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.62 140.68 37.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.496 1.118 . . . . 0.0 113.227 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 74.4 mt -92.62 178.59 5.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.198 1.799 . . . . 0.0 112.528 173.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -46.8 -59.33 3.13 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.734 2.013 . . . . 0.0 115.121 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.94 -22.21 61.49 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.508 0.723 . . . . 0.0 112.163 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.34 -5.73 8.73 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.123 1.344 . . . . 0.0 114.359 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -61.02 136.15 58.0 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.933 1.867 . . . . 0.0 110.743 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.07 118.3 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.6 153.46 17.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.064 1.346 . . . . 0.0 109.256 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.2 p -136.66 147.36 46.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.434 1.094 . . . . 0.0 112.768 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.9 p30 . . . . . 0 C--O 1.252 1.234 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -167.678 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.182 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -171.04 173.8 4.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.738 1.615 . . . . 0.0 112.588 -172.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.9 mt -118.92 149.83 40.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.381 2.273 . . . . 0.0 110.966 -172.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -73.22 160.41 31.97 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.264 -0.897 . . . . 0.0 111.802 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -50.07 -48.18 53.18 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.358 1.063 . . . . 0.0 112.666 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -66.37 -1.14 3.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.913 2.085 . . . . 0.0 114.944 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.2 m -74.27 104.66 5.12 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.081 0.952 . . . . 0.0 110.264 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.09 129.21 34.84 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.514 0.674 . . . . 0.0 111.614 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.6 mm -111.64 121.09 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 126.093 1.757 . . . . 0.0 107.227 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.39 129.81 42.36 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.378 0.671 . . . . 0.0 111.239 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -129.96 152.06 49.83 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.032 1.333 . . . . 0.0 111.781 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.3 t -74.65 -31.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 121.703 -0.623 . . . . 0.0 112.119 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -65.76 -33.99 77.14 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -141.68 -50.53 0.41 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.88 -137.68 9.22 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 118.816 0.735 . . . . 0.0 112.366 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.0 mt -81.29 96.69 7.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.004 1.722 . . . . 0.0 111.619 -175.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -127.36 147.41 62.01 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.794 1.238 . . . . 0.0 112.341 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.38 130.87 23.37 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.14 3.227 . . . . 0.0 112.675 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 tt -55.21 -36.15 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.9 0.88 . . . . 0.0 113.124 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.7 -34.4 83.26 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.671 -0.643 . . . . 0.0 113.177 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -72.69 -31.54 65.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.339 1.07 . . . . 0.0 111.728 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.1 mt -69.2 -38.07 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.827 0.851 . . . . 0.0 109.896 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.9 t -82.18 -38.07 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.22 1.008 . . . . 0.0 113.07 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.13 -23.68 63.06 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.302 -0.874 . . . . 0.0 112.974 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.31 4.88 11.85 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.074 1.35 . . . . 0.0 112.508 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 45.03 51.72 8.67 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.062 2.545 . . . . 0.0 112.692 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 53.8 mt -72.29 120.15 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.984 0.914 . . . . 0.0 109.134 -171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.99 99.68 3.93 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.352 1.061 . . . . 0.0 110.587 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.4 p -141.15 162.22 36.02 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.588 1.185 . . . . 0.0 114.128 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.76 154.4 19.56 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.655 1.582 . . . . 0.0 110.505 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.65 173.94 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.734 1.614 . . . . 0.0 110.982 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -119.31 140.61 50.03 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.992 1.717 . . . . 0.0 109.929 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.2 t -159.77 165.96 31.38 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.946 1.298 . . . . 0.0 110.568 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.94 127.52 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.842 1.257 . . . . 0.0 111.366 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.13 177.88 7.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.562 1.145 . . . . 0.0 112.238 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -61.21 -23.01 65.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.274 1.43 . . . . 0.0 113.361 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -89.48 -3.04 58.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.203 1.401 . . . . 0.0 113.548 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.69 89.15 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.419 1.009 . . . . 0.0 114.608 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -81.41 134.93 35.62 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.291 1.046 . . . . 0.0 109.587 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.7 mt -72.22 122.17 24.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -121.41 169.12 10.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.913 1.685 . . . . 0.0 110.433 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.8 p -126.67 144.0 51.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.383 0.673 . . . . 0.0 112.02 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -150.48 147.68 22.12 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.468 1.107 . . . . 0.0 112.041 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.82 148.61 36.39 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.16 2.573 . . . . 0.0 112.738 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.31 145.64 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.408 1.083 . . . . 0.0 111.133 168.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.08 -32.26 7.3 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.892 1.277 . . . . 0.0 112.847 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -164.85 174.13 10.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.569 1.547 . . . . 0.0 112.36 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -137.49 110.68 7.83 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.061 1.345 . . . . 0.0 110.05 -174.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -98.62 115.23 28.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.834 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -102.1 107.0 17.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.91 1.284 . . . . 0.0 108.947 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -78.82 -24.5 44.46 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.355 1.062 . . . . 0.0 112.991 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.57 -44.18 3.31 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.287 1.422 . . . . 0.0 114.786 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 176.83 98.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.883 1.273 . . . . 0.0 113.143 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -129.79 167.42 18.12 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.226 1.411 . . . . 0.0 112.761 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.85 101.07 0.45 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.41 1.484 . . . . 0.0 114.041 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.1 t -92.03 143.33 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.147 1.379 . . . . 0.0 112.191 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -127.1 141.74 51.69 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.014 2.126 . . . . 0.0 110.129 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.15 132.89 51.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.351 0.66 . . . . 0.0 110.948 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.9 75.36 1.49 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.739 1.257 . . . . 0.0 108.779 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.6 t -82.22 146.92 29.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.223 1.009 . . . . 0.0 111.132 173.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.09 163.5 15.09 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.693 1.197 . . . . 0.0 112.825 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.02 -24.29 66.73 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.055 1.342 . . . . 0.0 113.051 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.03 -29.64 31.86 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.763 1.225 . . . . 0.0 113.169 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.83 -0.73 10.01 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.516 1.055 . . . . 0.0 114.69 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 m -63.13 139.94 58.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.803 1.301 . . . . 0.0 110.97 170.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.77 132.99 53.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.208 1.403 . . . . 0.0 109.856 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.1 mt -136.8 152.89 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.758 2.023 . . . . 0.0 107.658 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -138.65 115.96 11.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.707 1.203 . . . . 0.0 110.579 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.55 172.32 14.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.172 1.389 . . . . 0.0 112.35 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 p -93.09 151.9 19.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.993 1.317 . . . . 0.0 111.522 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -62.84 -16.56 58.94 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -88.01 -17.15 31.83 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.449 1.099 . . . . 0.0 112.463 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -78.21 137.46 38.15 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -95.02 160.35 14.61 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.217 1.007 . . . . 0.0 110.268 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -142.46 133.76 26.24 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.559 -0.713 . . . . 0.0 109.666 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.5 ttm -77.66 111.22 13.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.98 0.895 . . . . 0.0 111.359 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.1 p -65.31 167.45 8.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.788 1.235 . . . . 0.0 112.828 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.6 m -52.91 -28.77 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -83.79 -11.7 56.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.052 0.941 . . . . 0.0 113.461 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.64 -0.41 61.19 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.381 0.991 . . . . 0.0 114.082 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -76.4 137.67 39.9 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 119.2 1.5 . . . . 0.0 109.745 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.8 ptp -106.63 98.42 8.09 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.715 1.606 . . . . 0.0 108.776 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.63 152.79 59.11 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.084 1.353 . . . . 0.0 109.324 -174.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.53 147.1 86.35 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.266 1.977 . . . . 0.0 110.949 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.4 tt -59.46 -23.33 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -54.49 -35.97 63.66 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.015 1.326 . . . . 0.0 112.632 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -84.48 -39.81 18.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 111.499 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.8 mt -59.88 -36.17 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 119.129 0.877 . . . . 0.0 111.425 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -69.22 -33.41 73.26 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -78.6 -39.23 37.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.438 -0.789 . . . . 0.0 112.399 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -74.51 -14.78 60.86 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.834 0.854 . . . . 0.0 113.178 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 55.35 37.57 29.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.487 1.515 . . . . 0.0 111.905 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.9 mt -92.02 159.5 15.68 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.709 1.242 . . . . 0.0 112.34 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -114.34 154.44 28.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.033 2.133 . . . . 0.0 113.198 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.89 154.06 22.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.773 1.229 . . . . 0.0 112.726 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -70.26 148.7 48.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.758 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -114.1 155.75 25.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.646 1.579 . . . . 0.0 110.894 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.2 5.37 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 125.014 1.325 . . . . 0.0 114.413 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -121.34 20.45 11.27 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.886 1.674 . . . . 0.0 112.421 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.34 16.82 10.4 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 127.023 2.129 . . . . 0.0 113.647 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.1 mt -72.8 157.36 88.89 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.433 1.893 . . . . 0.0 112.54 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.92 166.33 29.89 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.205 3.27 . . . . 0.0 112.25 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -107.02 131.66 53.82 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.494 1.118 . . . . 0.0 110.556 -173.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.1 pt -146.97 135.55 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.443 1.497 . . . . 0.0 110.627 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 175.49 8.9 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.347 1.459 . . . . 0.0 112.127 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.8 mt -63.16 112.04 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.1 1.36 . . . . 0.0 110.206 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.31 -43.38 81.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.257 1.023 . . . . 0.0 111.957 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 p -150.12 147.64 28.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.247 1.819 . . . . 0.0 110.393 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -141.19 139.39 33.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.171 1.389 . . . . 0.0 110.812 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -158.29 150.59 21.96 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.181 1.393 . . . . 0.0 110.51 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -66.03 124.81 23.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.306 0.642 . . . . 0.0 110.891 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.6 mt -90.03 -43.06 10.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.217 0.607 . . . . 0.0 111.955 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 143.01 -149.39 21.3 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.434 1.016 . . . . 0.0 112.096 -173.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -124.11 96.42 4.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.387 1.075 . . . . 0.0 112.041 -169.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -114.36 155.34 26.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.482 1.513 . . . . 0.0 110.035 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.03 116.86 5.71 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.415 0.686 . . . . 0.0 110.326 173.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.41 152.45 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.64 0.776 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -137.95 156.21 48.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.828 1.651 . . . . 0.0 111.851 -168.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -154.09 116.39 4.33 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.67 1.188 . . . . 0.0 110.635 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.0 pt -77.94 142.99 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 120.963 -1.086 . . . . 0.0 111.354 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.75 158.02 17.94 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.392 0.996 . . . . 0.0 111.473 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.479 0.983 0 C-N-CA 124.586 1.154 . . . . 0.0 110.183 -169.226 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -166.16 165.14 17.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.383 1.073 . . . . 0.0 112.55 -171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.36 155.26 17.49 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.221 1.008 . . . . 0.0 113.442 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.6 mt -108.37 166.69 10.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.742 2.017 . . . . 0.0 111.568 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -43.2 -50.02 6.43 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.825 1.65 . . . . 0.0 115.296 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -84.67 4.13 33.89 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.192 0.997 . . . . 0.0 113.261 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.78 -4.85 53.52 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.445 1.498 . . . . 0.0 114.92 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -69.36 163.61 24.78 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.734 1.267 . . . . 0.0 111.664 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.1 mm -118.23 142.26 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.531 -0.731 . . . . 0.0 110.555 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.77 143.29 49.48 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.411 1.485 . . . . 0.0 110.385 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.7 t -139.86 144.72 37.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.048 1.739 . . . . 0.0 113.091 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--O 1.256 1.414 0 N-CA-C 117.268 2.321 . . . . 0.0 117.268 -169.63 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 CA-C-O 121.771 0.65 . . . . 0.0 114.368 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.48 173.02 14.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.15 1.38 . . . . 0.0 110.788 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -117.12 146.75 42.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.999 1.72 . . . . 0.0 109.769 -173.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -74.76 160.39 30.78 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.681 -0.637 . . . . 0.0 111.385 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -47.04 -49.55 21.1 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.475 1.51 . . . . 0.0 113.001 -169.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 pm0 -66.94 -1.85 4.54 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.24 2.216 . . . . 0.0 115.089 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.2 m -73.77 104.16 4.58 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.008 0.923 . . . . 0.0 110.013 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.65 129.34 34.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.56 0.695 . . . . 0.0 112.399 -173.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mm -106.33 123.81 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.364 1.465 . . . . 0.0 107.706 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.09 122.89 18.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.588 0.355 . . . . 0.0 110.266 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.1 p -124.2 150.35 45.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.765 1.226 . . . . 0.0 112.087 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.47 -33.43 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.191 0.596 . . . . 0.0 111.993 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -67.82 -30.7 70.18 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -141.28 -50.03 0.42 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.42 -148.99 19.7 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.598 1.094 . . . . 0.0 111.689 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 mt -61.7 111.96 2.06 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.281 1.433 . . . . 0.0 110.516 171.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 mt -139.96 149.09 57.6 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.365 1.066 . . . . 0.0 113.47 174.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.4 127.44 19.99 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.186 3.257 . . . . 0.0 112.394 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 tt -56.22 -36.36 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.0 -32.49 84.37 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.721 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -71.44 -38.04 71.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.383 1.091 . . . . 0.0 111.31 175.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -64.82 -38.24 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.395 0.678 . . . . 0.0 110.808 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.4 t -83.79 -37.96 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.08 0.952 . . . . 0.0 112.416 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -71.77 -24.56 61.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.088 0.858 . . . . 0.0 113.195 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -114.07 5.84 16.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.226 1.41 . . . . 0.0 113.037 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 48.21 48.92 18.26 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.331 2.252 . . . . 0.0 112.725 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.4 mt -77.73 118.08 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.006 0.923 . . . . 0.0 110.355 -169.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.68 112.17 7.57 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.323 1.049 . . . . 0.0 110.656 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.3 p -150.03 170.87 17.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.43 1.092 . . . . 0.0 112.995 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.4 m -116.86 143.29 45.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.412 1.485 . . . . 0.0 108.906 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.74 165.02 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.898 1.679 . . . . 0.0 110.959 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -102.51 143.75 31.83 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.227 1.411 . . . . 0.0 110.082 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -154.67 151.12 28.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.25 1.42 . . . . 0.0 109.892 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 t -92.91 124.82 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -69.07 173.96 5.01 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.581 1.181 . . . . 0.0 111.79 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -58.16 -27.79 64.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.453 1.901 . . . . 0.0 113.226 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -82.52 -10.06 59.16 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.247 1.419 . . . . 0.0 113.3 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.14 22.5 59.01 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.85 1.214 . . . . 0.0 114.483 -171.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -95.5 132.34 40.7 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.437 1.095 . . . . 0.0 109.85 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.5 mt -74.01 133.4 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.54 1.064 . . . . 0.0 108.899 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.69 174.95 10.01 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.016 1.726 . . . . 0.0 111.036 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.8 p -120.53 143.89 48.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.276 1.03 . . . . 0.0 112.361 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -147.03 142.82 17.42 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.73 1.212 . . . . 0.0 112.433 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -74.97 149.8 37.37 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.012 2.474 . . . . 0.0 112.258 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -59.38 135.89 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.375 0.67 . . . . 0.0 110.43 168.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.62 -47.01 7.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.594 0.758 . . . . 0.0 111.548 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -150.19 177.52 9.85 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.167 1.787 . . . . 0.0 111.397 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -134.23 137.83 44.65 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.139 1.776 . . . . 0.0 108.796 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -132.54 119.65 20.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.598 0.759 . . . . 0.0 111.218 -171.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -116.53 108.21 15.69 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.328 1.451 . . . . 0.0 110.736 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -80.73 -28.89 36.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.756 1.222 . . . . 0.0 113.331 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.41 -52.82 3.1 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.092 1.33 . . . . 0.0 114.219 173.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -171.85 104.91 0.19 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.056 1.428 . . . . 0.0 111.013 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -129.88 169.08 15.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.972 0.909 . . . . 0.0 112.052 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.31 105.42 2.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.23 1.012 . . . . 0.0 112.875 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.7 t -100.38 140.39 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.048 1.339 . . . . 0.0 111.492 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.462 ' CG ' ' HE3' ' A' ' 70' ' ' LYS . 43.5 m-85 -123.91 146.19 48.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.929 1.292 . . . . 0.0 110.601 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -66.0 128.13 34.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.288 1.035 . . . . 0.0 110.485 173.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.472 ' HH ' ' CD1' ' A' ' 94' ' ' LEU . 2.0 t80 -121.87 81.72 1.86 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.592 1.557 . . . . 0.0 108.151 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.3 t -88.05 141.66 28.39 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.962 0.905 . . . . 0.0 110.614 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -105.2 165.64 10.96 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.268 1.027 . . . . 0.0 113.267 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -68.03 -20.7 65.02 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.68 -27.94 36.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.73 1.212 . . . . 0.0 112.96 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.76 -3.75 17.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.931 1.253 . . . . 0.0 114.389 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -60.61 148.16 39.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.719 1.26 . . . . 0.0 111.577 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.5 mt -133.15 128.26 35.69 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.365 1.466 . . . . 0.0 110.11 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.1 mt -135.24 149.56 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 126.681 1.992 . . . . 0.0 107.399 -175.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -137.1 112.27 9.1 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.216 1.006 . . . . 0.0 110.111 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.4 169.47 18.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.311 1.445 . . . . 0.0 111.815 -172.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.6 p -87.44 162.02 17.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.546 0.738 . . . . 0.0 112.837 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HE3' ' CG ' ' A' ' 56' ' ' PHE . 19.7 mmtp -72.99 -7.97 53.6 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -90.9 -8.96 47.93 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.784 0.72 . . . . 0.0 112.083 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -82.56 132.89 35.19 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.785 -0.572 . . . . 0.0 110.091 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -95.19 152.02 18.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.995 0.918 . . . . 0.0 110.285 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -137.94 135.14 35.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.08 0.552 . . . . 0.0 110.626 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 44.7 ttp -73.6 103.98 4.39 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 111.201 -174.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.6 p -66.05 171.8 4.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.134 0.974 . . . . 0.0 112.155 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.26 -22.91 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -93.33 -6.82 46.47 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.214 1.006 . . . . 0.0 113.194 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.4 26.65 24.95 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.323 0.963 . . . . 0.0 113.944 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -88.04 142.05 28.08 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.456 1.128 . . . . 0.0 111.754 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.3 mmt -97.26 77.34 2.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.784 1.634 . . . . 0.0 110.971 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -116.01 148.09 40.64 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.852 0.861 . . . . 0.0 111.44 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.34 148.55 79.97 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.409 2.739 . . . . 0.0 111.771 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.83 -28.76 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -54.05 -30.76 49.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.641 1.177 . . . . 0.0 113.933 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -91.86 -31.14 15.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.44 0.696 . . . . 0.0 111.553 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.84 -38.82 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.042 0.837 . . . . 0.0 111.158 177.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -64.01 -38.1 89.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -78.66 -37.78 41.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.212 0.605 . . . . 0.0 112.553 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -82.41 -8.83 59.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.778 0.831 . . . . 0.0 112.952 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 57.14 35.55 26.41 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.482 1.513 . . . . 0.0 112.383 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.2 mt -85.53 124.01 31.61 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.011 0.91 . . . . 0.0 111.97 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.5 153.72 30.83 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.547 1.139 . . . . 0.0 112.407 169.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.472 ' CD1' ' HH ' ' A' ' 58' ' ' TYR . 11.2 mt -89.86 150.61 22.14 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.212 -0.93 . . . . 0.0 112.455 169.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.1 ttp -72.4 156.85 38.63 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.654 0.782 . . . . 0.0 111.163 169.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -138.25 170.1 16.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.528 1.531 . . . . 0.0 111.739 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.18 -2.69 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.62 14.95 29.74 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.127 0.971 . . . . 0.0 113.393 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 56.16 28.57 13.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.405 1.882 . . . . 0.0 112.993 -173.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 70.8 mt -88.32 156.29 51.26 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.385 1.474 . . . . 0.0 112.083 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.36 135.67 32.01 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.906 3.07 . . . . 0.0 112.686 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -75.3 126.25 30.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.73 0.812 . . . . 0.0 110.773 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.2 pt -142.98 151.61 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.555 1.542 . . . . 0.0 111.335 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.3 pttt -95.59 -173.47 2.89 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.21 1.804 . . . . 0.0 111.961 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.1 mt -68.49 122.28 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.764 1.226 . . . . 0.0 109.001 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.46 -44.57 19.02 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.331 1.052 . . . . 0.0 112.49 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.8 p -146.88 152.62 39.0 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.655 1.582 . . . . 0.0 111.03 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.93 145.17 43.93 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.053 1.741 . . . . 0.0 110.235 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -158.0 135.43 10.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.179 1.792 . . . . 0.0 110.017 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -67.85 120.44 14.16 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.382 0.537 . . . . 0.0 110.032 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.7 -42.14 12.85 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.711 0.404 . . . . 0.0 111.702 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.04 -142.19 11.96 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.208 0.909 . . . . 0.0 112.848 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -121.93 97.07 5.32 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.358 1.463 . . . . 0.0 111.626 -168.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -118.09 154.66 31.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.457 1.103 . . . . 0.0 111.286 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.9 117.21 5.61 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.652 0.781 . . . . 0.0 110.709 171.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.44 151.02 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.504 0.668 . . . . 0.0 111.043 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -138.61 159.41 42.16 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.613 1.565 . . . . 0.0 111.408 -169.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -148.82 168.04 24.02 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.705 0.802 . . . . 0.0 111.921 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.2 pt -126.12 139.91 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.449 1.1 . . . . 0.0 110.112 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.33 153.98 20.05 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.843 1.211 . . . . 0.0 111.183 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 124.525 1.13 . . . . 0.0 109.784 -174.285 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -160.59 161.49 32.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.983 1.313 . . . . 0.0 111.631 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.78 130.48 37.55 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.866 0.866 . . . . 0.0 113.007 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 41.9 mt -72.79 165.71 24.32 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.469 1.108 . . . . 0.0 111.116 168.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -51.47 -32.57 27.6 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -90.01 -12.24 39.21 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.879 1.271 . . . . 0.0 113.999 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.62 -12.25 18.41 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 118.506 -1.163 . . . . 0.0 115.246 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -60.63 158.45 12.49 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.698 1.749 . . . . 0.0 112.462 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.66 126.02 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.122 0.963 . . . . 0.0 110.859 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -107.56 157.06 18.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.651 1.58 . . . . 0.0 109.729 172.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.6 t -134.84 128.13 32.11 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 112.839 -176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.936 1.694 . . . . 0.0 113.179 -175.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -151.24 171.61 17.14 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.456 1.102 . . . . 0.0 111.848 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.8 mt -127.64 148.13 50.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.182 1.793 . . . . 0.0 110.856 -168.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p -61.56 162.11 8.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.774 1.23 . . . . 0.0 114.196 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -53.62 -45.61 70.18 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.141 -0.974 . . . . 0.0 112.158 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.52 -5.84 16.99 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.7 m -71.44 97.65 1.68 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.118 -0.989 . . . . 0.0 110.318 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -74.09 135.74 42.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.598 0.759 . . . . 0.0 110.919 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.38 120.54 63.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 126.107 1.763 . . . . 0.0 106.702 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.78 120.69 15.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.73 0.412 . . . . 0.0 110.053 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 p -121.63 153.37 38.2 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.303 1.041 . . . . 0.0 112.424 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.19 -34.38 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.404 0.682 . . . . 0.0 111.758 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.64 -26.42 61.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -140.1 -51.79 0.5 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.92 -152.69 20.41 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.212 0.911 . . . . 0.0 111.707 -171.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 109.37 1.7 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.078 0.951 . . . . 0.0 110.96 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.8 mt -133.8 149.39 71.74 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.93 1.292 . . . . 0.0 112.943 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.42 126.73 14.61 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.886 3.058 . . . . 0.0 112.818 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 tt -55.81 -35.71 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.81 -38.16 96.05 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.895 -0.503 . . . . 0.0 112.469 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -71.58 -34.84 70.27 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.409 1.104 . . . . 0.0 111.657 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.9 mt -66.13 -39.65 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.038 0.935 . . . . 0.0 110.032 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.22 -38.08 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.319 1.048 . . . . 0.0 113.046 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -70.41 -27.43 64.28 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.323 0.965 . . . . 0.0 113.218 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -112.19 3.12 17.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.273 1.029 . . . . 0.0 113.103 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 46.9 50.23 13.82 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.26 2.224 . . . . 0.0 111.911 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.8 mt -68.12 118.5 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.021 0.928 . . . . 0.0 108.678 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.02 118.13 14.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.288 0.566 . . . . 0.0 109.511 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.5 p -151.55 166.77 30.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.096 1.358 . . . . 0.0 112.334 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.16 152.54 20.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.272 1.429 . . . . 0.0 109.74 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.31 167.53 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.189 1.396 . . . . 0.0 110.961 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -108.67 148.97 29.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.151 1.38 . . . . 0.0 111.086 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -168.37 151.74 5.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.607 1.563 . . . . 0.0 110.673 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.12 144.45 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.834 1.197 . . . . 0.0 113.275 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.73 178.45 8.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.544 1.138 . . . . 0.0 113.333 170.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -61.98 -11.11 11.74 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -105.18 0.26 27.17 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.9 1.68 . . . . 0.0 112.312 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.14 22.96 39.43 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.171 1.367 . . . . 0.0 115.253 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -108.08 123.56 48.88 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.158 1.479 . . . . 0.0 110.331 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.61 102.63 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.972 0.909 . . . . 0.0 109.41 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -100.88 179.05 4.51 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.103 1.761 . . . . 0.0 111.275 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.2 p -126.35 144.2 50.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.342 1.057 . . . . 0.0 112.843 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -145.58 137.3 13.01 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.537 1.135 . . . . 0.0 112.308 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.23 143.13 27.99 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.286 2.658 . . . . 0.0 110.944 174.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 p -54.13 147.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.727 0.811 . . . . 0.0 111.601 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.76 -42.93 3.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.712 0.805 . . . . 0.0 112.127 175.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -145.15 172.08 13.61 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.853 1.261 . . . . 0.0 111.875 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -135.49 132.56 37.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.579 1.552 . . . . 0.0 109.664 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -127.15 130.85 50.57 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.51 1.124 . . . . 0.0 111.465 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -126.51 119.77 28.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.441 1.496 . . . . 0.0 110.492 -173.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -91.11 -23.1 20.39 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.631 1.172 . . . . 0.0 113.387 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.61 -46.18 3.53 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 126.812 2.148 . . . . 0.0 114.775 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -173.46 107.55 0.15 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.737 1.615 . . . . 0.0 112.156 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -128.04 159.97 33.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.302 1.441 . . . . 0.0 111.212 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -59.26 104.78 0.28 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.517 1.527 . . . . 0.0 112.953 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.08 136.53 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.119 1.368 . . . . 0.0 111.181 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -118.52 138.21 52.68 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.691 1.196 . . . . 0.0 109.989 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -74.29 134.88 42.59 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.034 0.934 . . . . 0.0 108.946 168.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -129.86 89.2 2.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.122 1.369 . . . . 0.0 109.229 170.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.5 t -74.96 141.99 43.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.059 0.944 . . . . 0.0 110.896 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tp -93.89 170.1 9.8 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.941 1.296 . . . . 0.0 113.249 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -63.99 -26.47 68.59 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.99 -18.53 28.83 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.86 -3.21 28.83 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.126 1.346 . . . . 0.0 114.316 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 m -59.63 150.79 26.43 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.086 1.443 . . . . 0.0 111.449 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -127.11 135.98 51.49 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.492 0.717 . . . . 0.0 110.775 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.3 mt -128.42 126.44 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.435 1.494 . . . . 0.0 107.385 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -123.63 103.11 8.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.876 1.27 . . . . 0.0 109.556 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.66 170.51 15.71 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.563 1.145 . . . . 0.0 112.554 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.1 p -86.69 150.68 24.01 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.869 1.267 . . . . 0.0 111.632 171.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -65.1 -7.52 12.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.703 1.601 . . . . 0.0 115.055 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.8 -11.72 30.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.326 1.85 . . . . 0.0 111.921 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -83.01 130.94 35.19 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.638 0.654 . . . . 0.0 109.793 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -91.34 155.93 18.15 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.822 0.849 . . . . 0.0 110.238 176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -138.81 137.57 36.74 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.598 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.5 ttp -79.14 106.49 11.21 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.089 0.556 . . . . 0.0 110.515 -171.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.3 p -65.5 172.34 3.38 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.54 0.736 . . . . 0.0 112.746 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.32 -24.97 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.47 -9.28 50.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.556 1.143 . . . . 0.0 113.519 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.99 9.8 60.47 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.054 1.312 . . . . 0.0 114.599 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -69.96 149.92 47.25 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.512 1.156 . . . . 0.0 111.69 -178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.4 mtm -111.94 82.15 1.58 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.23 1.812 . . . . 0.0 108.698 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 37.1 mt -122.85 147.06 50.03 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 125.242 1.417 . . . . 0.0 110.225 -174.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.93 148.32 85.87 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.167 2.578 . . . . 0.0 111.246 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.3 tt -59.71 -25.99 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -56.44 -33.17 65.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.424 1.09 . . . . 0.0 112.998 170.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -85.25 -36.81 20.69 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.459 0.704 . . . . 0.0 111.597 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.85 -40.45 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.131 -0.981 . . . . 0.0 111.417 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -63.44 -38.52 91.45 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -76.74 -42.96 39.1 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.447 -0.783 . . . . 0.0 112.869 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -77.58 -13.17 59.98 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.143 0.977 . . . . 0.0 112.957 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 56.22 37.08 28.49 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.655 1.582 . . . . 0.0 111.854 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.6 mt -75.07 138.52 42.19 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.438 1.095 . . . . 0.0 111.318 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -73.27 157.31 37.32 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.909 0.861 . . . . 0.0 112.104 173.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.3 mt -112.94 143.35 44.39 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.843 1.257 . . . . 0.0 111.234 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 39.8 ttm -62.29 156.92 20.9 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.465 1.506 . . . . 0.0 111.953 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -132.21 158.43 41.77 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.565 1.546 . . . . 0.0 112.509 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.68 -10.93 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -107.69 16.93 23.18 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.915 1.686 . . . . 0.0 112.672 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.269 7.6 m-80 56.49 36.67 27.93 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.194 1.798 . . . . 0.0 112.551 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.97 159.61 68.08 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 112.743 -2.026 . . . . 0.0 112.015 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.68 155.92 58.12 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.561 2.841 . . . . 0.0 112.108 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -89.92 114.22 25.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.852 0.861 . . . . 0.0 110.003 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.6 pt -142.32 131.01 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.805 1.642 . . . . 0.0 111.106 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.61 173.35 10.55 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.061 1.745 . . . . 0.0 112.633 174.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.8 mt -66.01 115.86 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.097 1.359 . . . . 0.0 110.363 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.72 -42.57 73.83 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.819 1.248 . . . . 0.0 112.654 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.77 162.3 40.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.059 0.944 . . . . 0.0 111.828 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.56 145.5 42.95 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.543 1.537 . . . . 0.0 111.615 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.66 133.58 13.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.303 1.041 . . . . 0.0 110.747 177.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -65.7 133.05 50.26 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.415 -0.803 . . . . 0.0 110.707 170.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.2 mt -102.21 -45.23 5.19 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.479 0.712 . . . . 0.0 111.847 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 152.03 -147.59 17.55 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.089 0.852 . . . . 0.0 112.922 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.77 62.6 1.22 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 123.252 1.501 . . . . 0.0 113.013 -167.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -81.07 156.53 25.78 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.556 1.942 . . . . 0.0 110.826 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.42 119.33 8.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.839 0.855 . . . . 0.0 110.184 171.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.42 150.09 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.601 0.715 . . . . 0.0 111.367 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -138.74 159.36 42.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.651 1.58 . . . . 0.0 111.551 -168.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -154.74 130.81 10.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.543 1.137 . . . . 0.0 110.745 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.8 pt -93.52 156.44 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.009 -1.057 . . . . 0.0 111.488 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.38 153.22 19.8 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.157 0.884 . . . . 0.0 112.835 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 124.599 1.16 . . . . 0.0 111.03 -176.271 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 . . . . . 0 CA--C 1.551 0.987 0 CA-C-O 121.225 0.536 . . . . 0.0 112.191 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -166.84 154.93 9.8 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.101 1.36 . . . . 0.0 111.396 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.06 149.52 35.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.863 1.265 . . . . 0.0 112.488 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 88.7 mt -128.5 -176.71 3.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.07 2.148 . . . . 0.0 111.716 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -51.08 150.55 3.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.961 0.504 . . . . 0.0 110.432 165.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 52.54 18.84 1.04 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.887 1.275 . . . . 0.0 114.342 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.01 22.13 75.74 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 117.624 -1.653 . . . . 0.0 115.94 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -65.25 157.06 29.96 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.248 2.024 . . . . 0.0 112.369 170.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.02 121.1 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.778 1.231 . . . . 0.0 108.778 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -107.38 103.63 13.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.925 0.89 . . . . 0.0 110.416 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.4 t -89.26 157.86 18.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.539 0.735 . . . . 0.0 112.331 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.7 t30 . . . . . 0 C--O 1.255 1.362 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 172.259 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.816 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -171.36 175.55 4.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.918 0.887 . . . . 0.0 113.193 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.7 mt -120.32 147.39 45.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.859 2.064 . . . . 0.0 110.37 -175.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -72.8 161.82 30.26 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.857 -0.527 . . . . 0.0 111.946 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -51.96 -46.75 64.91 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.319 1.048 . . . . 0.0 112.464 -173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -61.96 -8.01 4.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.375 1.87 . . . . 0.0 115.141 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.9 m -71.44 107.36 4.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.906 0.883 . . . . 0.0 110.33 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.55 133.09 33.84 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.348 0.594 . . . . 0.0 111.435 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -118.49 115.1 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.332 1.453 . . . . 0.0 107.139 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.1 128.33 34.93 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 122.062 -0.399 . . . . 0.0 110.87 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.4 p -129.18 156.07 44.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.166 1.387 . . . . 0.0 113.013 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.56 -30.87 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 122.955 0.502 . . . . 0.0 112.04 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -65.78 -31.65 72.74 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -140.97 -59.59 0.5 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.628 0.771 . . . . 0.0 113.07 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.13 -133.44 5.83 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.13 108.55 12.71 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.262 1.425 . . . . 0.0 109.952 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.8 156.69 51.89 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.23 129.39 17.01 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.932 3.088 . . . . 0.0 112.713 -175.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.81 -37.57 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.511 0.724 . . . . 0.0 112.837 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 -30.95 79.28 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.608 -0.682 . . . . 0.0 113.051 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.79 -36.16 70.24 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.734 0.767 . . . . 0.0 111.445 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.92 -43.12 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.998 0.519 . . . . 0.0 109.885 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.09 -41.28 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -75.59 -22.49 56.88 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -109.87 1.56 19.29 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.132 1.373 . . . . 0.0 112.493 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.65 48.71 14.3 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.166 2.186 . . . . 0.0 113.322 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.27 124.8 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.471 0.708 . . . . 0.0 109.626 -174.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -83.02 86.23 7.03 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.737 0.78 . . . . 0.0 110.683 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 p -117.44 -177.96 3.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.852 1.261 . . . . 0.0 111.952 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.16 144.67 48.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.426 1.49 . . . . 0.0 108.351 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.67 174.22 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.718 1.607 . . . . 0.0 111.077 -177.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -117.21 139.33 50.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.69 1.596 . . . . 0.0 110.319 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -156.99 151.9 25.94 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.864 1.265 . . . . 0.0 111.177 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.1 p -99.12 131.84 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.679 1.192 . . . . 0.0 111.461 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.7 -176.76 6.17 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.998 1.319 . . . . 0.0 113.67 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.58 -29.69 69.34 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -79.85 -11.21 59.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.277 1.031 . . . . 0.0 113.189 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.27 14.27 59.06 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.464 1.031 . . . . 0.0 114.227 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -91.75 126.23 36.76 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.897 1.348 . . . . 0.0 109.481 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.0 mt -71.95 88.43 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.345 1.058 . . . . 0.0 108.78 172.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -81.88 171.08 14.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.114 0.966 . . . . 0.0 111.136 171.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 p -126.92 145.52 50.65 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.832 0.853 . . . . 0.0 111.777 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -145.39 146.38 29.79 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 124.259 1.023 . . . . 0.0 112.677 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.07 156.19 56.11 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.208 2.605 . . . . 0.0 112.474 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.1 t -67.55 119.8 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.993 0.917 . . . . 0.0 109.816 171.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.22 -36.27 35.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.374 0.67 . . . . 0.0 112.578 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -162.14 175.67 11.46 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.381 1.473 . . . . 0.0 112.64 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -135.71 117.36 14.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.08 1.352 . . . . 0.0 109.34 -175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -108.35 130.58 55.2 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.062 0.934 . . . . 0.0 110.369 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.21 103.12 9.22 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.791 1.636 . . . . 0.0 109.514 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -69.78 -33.26 72.15 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.374 1.07 . . . . 0.0 111.908 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.52 -40.39 3.01 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.87 1.224 . . . . 0.0 113.382 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 178.32 109.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.283 1.433 . . . . 0.0 111.62 -174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -133.96 164.96 26.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.131 0.972 . . . . 0.0 112.55 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.07 100.06 0.3 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.489 1.516 . . . . 0.0 113.204 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 t -92.41 137.24 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.038 1.335 . . . . 0.0 110.959 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -119.51 137.13 54.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.295 1.438 . . . . 0.0 109.486 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -56.89 126.0 25.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.99 0.916 . . . . 0.0 110.267 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -118.58 82.88 1.92 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.893 1.277 . . . . 0.0 108.449 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.9 t -94.17 137.51 33.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.666 0.787 . . . . 0.0 110.646 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.82 162.03 13.32 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.223 1.009 . . . . 0.0 112.111 173.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -18.75 62.02 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -78.12 -26.51 48.0 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.123 0.969 . . . . 0.0 112.729 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.74 2.98 18.8 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.629 1.109 . . . . 0.0 114.806 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 m -67.69 132.4 47.4 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.304 1.552 . . . . 0.0 110.356 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.67 132.37 56.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.087 1.355 . . . . 0.0 109.877 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.6 mt -139.01 155.17 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 126.408 1.883 . . . . 0.0 108.478 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -137.96 111.01 7.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.028 1.331 . . . . 0.0 110.675 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.71 166.78 24.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.906 1.283 . . . . 0.0 111.659 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.3 p -88.24 160.14 17.82 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.942 0.877 . . . . 0.0 112.344 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -67.76 -3.8 10.47 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -103.29 -13.0 16.88 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.141 0.977 . . . . 0.0 112.58 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -76.92 121.01 22.83 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 173.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -82.57 149.74 27.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.268 0.627 . . . . 0.0 109.776 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -132.06 143.82 50.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.523 -0.736 . . . . 0.0 109.737 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.4 ttp -75.22 104.43 5.79 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.074 0.55 . . . . 0.0 110.468 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.4 p -66.27 167.99 9.44 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.941 0.496 . . . . 0.0 111.683 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.3 m -55.07 -26.33 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -84.36 -13.17 53.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.273 1.029 . . . . 0.0 113.376 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.99 30.41 12.93 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.574 1.083 . . . . 0.0 113.557 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -98.75 147.24 25.08 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.241 1.02 . . . . 0.0 110.718 177.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.98 89.91 3.8 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.812 1.245 . . . . 0.0 109.871 176.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.1 mt -121.69 145.79 43.99 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.323 1.049 . . . . 0.0 110.438 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.68 147.48 81.58 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.092 2.528 . . . . 0.0 111.355 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 tt -58.0 -27.47 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -54.52 -38.42 66.51 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.583 1.153 . . . . 0.0 112.872 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -82.22 -34.72 28.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.283 0.633 . . . . 0.0 111.586 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.61 -39.21 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.6 -0.688 . . . . 0.0 110.368 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -63.96 -34.81 78.82 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -75.14 -44.77 45.08 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.524 -0.735 . . . . 0.0 112.669 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -76.33 -12.67 60.11 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 56.08 31.48 18.23 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.298 1.439 . . . . 0.0 112.108 -174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 69.5 mt -79.2 150.29 31.7 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.258 1.023 . . . . 0.0 111.586 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.98 155.78 17.32 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.617 0.767 . . . . 0.0 111.491 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt -84.47 159.36 20.77 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.414 -0.804 . . . . 0.0 112.623 168.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.6 ttp -86.52 155.74 20.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.795 1.238 . . . . 0.0 111.294 169.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.52 164.46 27.76 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.337 1.455 . . . . 0.0 112.04 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.6 m -93.02 -19.63 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -99.0 15.65 25.06 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.505 1.122 . . . . 0.0 113.088 -172.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 55.57 32.91 20.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.868 1.667 . . . . 0.0 112.099 -173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.53 154.29 73.7 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.676 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.08 144.76 70.84 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.746 2.964 . . . . 0.0 111.26 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -79.79 116.87 20.2 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.681 -0.637 . . . . 0.0 110.635 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.4 pt -142.53 132.77 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.926 1.69 . . . . 0.0 111.261 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 175.72 6.97 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.889 1.676 . . . . 0.0 112.347 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.9 mt -63.66 112.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.197 1.399 . . . . 0.0 110.035 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.65 -43.62 62.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.993 0.917 . . . . 0.0 111.742 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 p -149.02 147.75 28.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.115 1.766 . . . . 0.0 110.056 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -140.6 142.16 35.08 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.415 1.486 . . . . 0.0 110.212 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -152.32 131.64 12.85 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.929 1.692 . . . . 0.0 108.951 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -61.69 121.21 12.26 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.947 0.339 . . . . 0.0 110.545 171.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.9 mt -88.39 -40.54 13.45 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 122.645 0.378 . . . . 0.0 111.721 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.04 -145.22 15.71 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.653 1.121 . . . . 0.0 112.261 -173.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -128.22 74.93 1.58 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 123.206 1.479 . . . . 0.0 113.401 -167.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -89.54 155.19 19.44 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.458 1.503 . . . . 0.0 109.908 -171.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.15 117.26 5.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.436 0.694 . . . . 0.0 109.851 171.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.63 154.25 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.422 0.63 . . . . 0.0 110.919 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -140.94 157.38 45.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.669 1.588 . . . . 0.0 111.322 -170.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -156.93 117.12 3.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.755 1.222 . . . . 0.0 110.159 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.8 pt -71.46 155.44 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 121.028 -1.045 . . . . 0.0 111.205 172.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -107.07 152.38 16.89 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.494 1.045 . . . . 0.0 111.74 170.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 126.711 2.004 . . . . 0.0 110.108 -175.983 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 . . . . . 0 CA--C 1.545 0.769 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -172.55 157.13 3.83 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.052 1.741 . . . . 0.0 111.061 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.77 144.75 29.95 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.821 0.848 . . . . 0.0 112.461 173.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 28.9 mt -89.76 173.09 8.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.095 1.358 . . . . 0.0 112.188 171.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -48.62 -49.73 35.85 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.708 1.603 . . . . 0.0 114.561 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -73.38 -37.7 65.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.211 0.604 . . . . 0.0 111.652 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 139.68 -6.11 2.91 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.478 -1.179 . . . . 0.0 115.359 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -57.0 155.35 8.28 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.563 1.681 . . . . 0.0 112.619 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.58 110.81 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 122.033 0.921 . . . . 0.0 109.676 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.36 116.75 29.54 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.391 1.076 . . . . 0.0 108.64 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.2 m -109.56 79.87 1.26 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.377 1.071 . . . . 0.0 111.433 -173.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.3 t30 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 127.597 2.359 . . . . 0.0 115.997 -168.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.312 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.26 178.03 10.62 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.512 1.125 . . . . 0.0 112.653 -169.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.11 148.56 32.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.452 1.501 . . . . 0.0 110.652 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -62.41 161.39 11.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.644 0.777 . . . . 0.0 112.653 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -52.5 -47.01 66.86 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.889 . . . . 0.0 112.541 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -63.65 -20.45 65.7 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.266 1.827 . . . . 0.0 113.403 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.2 m -59.64 105.25 0.35 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.402 1.081 . . . . 0.0 110.862 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -86.23 129.81 34.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.363 0.601 . . . . 0.0 111.0 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.2 mm -113.49 124.95 70.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.075 1.35 . . . . 0.0 107.529 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.39 129.9 44.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.08 0.552 . . . . 0.0 110.899 171.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.8 p -133.02 148.68 52.24 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.296 1.438 . . . . 0.0 111.431 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.8 -31.3 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 122.071 -0.393 . . . . 0.0 111.892 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -64.83 -36.46 84.4 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -141.49 -44.76 0.36 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -172.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.17 -136.82 9.11 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.134 0.879 . . . . 0.0 112.347 -172.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.4 91.19 7.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.885 1.674 . . . . 0.0 111.823 -173.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -122.1 146.09 45.64 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.905 0.882 . . . . 0.0 112.638 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.76 125.33 13.59 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.367 3.378 . . . . 0.0 112.727 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.84 -37.36 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.965 0.906 . . . . 0.0 113.368 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.4 -32.39 79.23 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.559 -0.713 . . . . 0.0 113.097 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -71.88 -35.37 69.76 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 117.787 0.793 . . . . 0.0 111.602 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -67.5 -39.68 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.529 0.732 . . . . 0.0 109.709 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.03 -41.08 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.727 0.811 . . . . 0.0 112.471 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -76.35 -24.4 54.2 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.346 0.976 . . . . 0.0 113.339 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -104.67 -0.01 27.97 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.79 1.236 . . . . 0.0 112.854 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 48.29 49.57 17.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.655 1.982 . . . . 0.0 112.422 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.3 mt -68.61 121.02 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.179 0.992 . . . . 0.0 109.272 -174.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.39 107.77 11.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.439 1.095 . . . . 0.0 110.656 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.0 p -148.16 166.91 26.45 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.256 1.027 . . . . 0.0 113.466 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.5 148.29 23.89 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.433 1.493 . . . . 0.0 109.857 177.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 m -128.95 171.48 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.018 1.727 . . . . 0.0 110.924 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -115.4 140.09 49.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.462 1.505 . . . . 0.0 110.283 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 t -156.15 152.02 27.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.966 1.306 . . . . 0.0 110.672 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.52 128.31 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.199 0.6 . . . . 0.0 109.933 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -69.93 173.79 6.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.601 1.16 . . . . 0.0 111.807 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -62.22 -25.51 67.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.318 1.447 . . . . 0.0 113.328 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -86.23 -2.5 58.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.112 1.365 . . . . 0.0 113.398 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.08 22.52 60.9 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.603 1.097 . . . . 0.0 114.808 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -99.85 129.9 45.99 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.804 1.242 . . . . 0.0 109.991 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.1 mt -70.25 130.59 34.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -134.13 169.72 16.74 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.579 1.552 . . . . 0.0 110.938 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 p -119.55 140.87 49.83 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.956 0.902 . . . . 0.0 111.681 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -149.85 147.36 22.35 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.317 1.047 . . . . 0.0 112.423 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.05 149.91 47.45 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.117 2.545 . . . . 0.0 112.658 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -57.84 137.11 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.741 0.816 . . . . 0.0 110.409 168.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.16 -50.59 5.76 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.993 0.517 . . . . 0.0 111.42 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -149.97 173.55 13.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.029 1.731 . . . . 0.0 111.042 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -129.25 131.67 47.07 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.566 1.546 . . . . 0.0 108.994 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -130.06 138.81 50.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.202 1.001 . . . . 0.0 110.715 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.65 121.49 28.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.914 1.285 . . . . 0.0 110.801 -174.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -86.36 -34.0 20.36 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.216 1.006 . . . . 0.0 112.559 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.76 -44.93 2.71 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.253 1.406 . . . . 0.0 115.17 172.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -174.32 88.78 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 123.083 1.42 . . . . 0.0 114.568 -168.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -127.48 163.19 24.66 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.201 1.0 . . . . 0.0 112.91 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -67.73 103.53 1.43 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.062 1.345 . . . . 0.0 112.714 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -96.5 139.32 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.431 1.492 . . . . 0.0 110.991 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.424 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 75.5 m-85 -123.11 142.48 50.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.512 1.525 . . . . 0.0 109.976 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -65.88 131.26 45.84 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.733 0.813 . . . . 0.0 110.301 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -124.66 87.06 2.65 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.084 1.353 . . . . 0.0 108.439 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.2 t -95.28 146.71 24.16 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.97 0.908 . . . . 0.0 110.627 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.8 164.76 12.44 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.924 1.289 . . . . 0.0 112.368 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -66.86 -23.62 66.04 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.549 1.139 . . . . 0.0 113.284 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.56 -23.56 46.05 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.103 1.361 . . . . 0.0 112.961 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.55 0.68 30.86 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.756 1.17 . . . . 0.0 114.345 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.8 m -57.14 136.41 56.4 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.384 1.092 . . . . 0.0 110.558 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.92 122.78 38.34 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.753 1.221 . . . . 0.0 109.758 -172.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.1 mt -134.07 150.89 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.547 1.939 . . . . 0.0 107.86 -172.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 63.6 mtt85 -136.38 117.37 14.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.616 1.166 . . . . 0.0 109.864 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.6 163.5 38.34 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.518 1.127 . . . . 0.0 111.558 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 p -75.01 151.68 38.76 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.446 -0.784 . . . . 0.0 112.065 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -63.12 -17.22 62.09 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 176.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -86.42 -16.28 37.67 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.485 1.514 . . . . 0.0 113.33 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -74.46 135.36 42.29 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.176 0.59 . . . . 0.0 109.436 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 149.19 21.85 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.037 0.922 . . . . 0.0 112.174 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -134.26 127.25 31.46 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.428 -1.42 . . . . 0.0 110.182 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ttp -71.93 111.28 7.04 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.046 0.45 . . . . 0.0 111.084 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.6 p -70.37 171.94 9.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.057 0.543 . . . . 0.0 112.215 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -54.44 -27.2 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.1 -8.19 54.3 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.698 1.199 . . . . 0.0 113.133 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.82 1.09 63.67 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.962 1.267 . . . . 0.0 114.326 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.97 146.71 52.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.523 1.161 . . . . 0.0 111.212 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.2 mtm -117.87 76.55 1.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.31 1.444 . . . . 0.0 109.465 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.64 150.84 43.95 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.006 1.322 . . . . 0.0 110.979 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.34 148.92 80.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.977 2.451 . . . . 0.0 111.559 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 tt -55.66 -29.07 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -53.15 -37.51 61.9 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.643 1.177 . . . . 0.0 113.138 170.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -90.33 -32.83 16.32 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.584 1.153 . . . . 0.0 111.605 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.72 -38.33 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.389 -0.819 . . . . 0.0 111.191 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.64 -34.79 78.66 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.41 -45.98 51.35 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.46 -8.8 58.92 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 58.14 37.68 26.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.673 1.189 . . . . 0.0 111.549 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.5 mt -83.92 155.67 22.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.901 1.334 . . . . 0.0 112.162 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -110.92 155.42 22.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.764 2.426 . . . . 0.0 112.969 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.7 155.09 19.44 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.692 0.797 . . . . 0.0 112.444 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.4 ttp -74.99 138.46 42.25 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.711 173.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.85 157.51 27.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.996 1.318 . . . . 0.0 110.684 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.4 m -118.69 -4.18 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.99 13.42 25.07 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.683 1.593 . . . . 0.0 112.587 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 58.89 30.1 19.71 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.763 2.025 . . . . 0.0 112.466 -174.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.6 mt -88.85 155.77 50.01 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.21 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.55 154.32 64.7 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.841 3.027 . . . . 0.0 111.951 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.36 132.14 35.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.476 0.711 . . . . 0.0 110.339 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 pt -146.87 137.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.972 1.309 . . . . 0.0 111.489 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.87 175.98 9.96 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.991 1.317 . . . . 0.0 112.509 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.8 mt -62.17 111.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.081 1.353 . . . . 0.0 110.03 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.73 -45.18 83.62 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.131 0.972 . . . . 0.0 111.883 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 p -151.35 150.67 30.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.287 1.835 . . . . 0.0 110.555 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -133.05 142.87 49.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.725 1.61 . . . . 0.0 110.083 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -156.9 140.6 16.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.696 1.598 . . . . 0.0 109.865 175.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -66.84 128.64 37.08 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.876 -0.515 . . . . 0.0 111.127 172.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.78 -46.43 7.55 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.849 0.459 . . . . 0.0 111.691 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 147.53 -150.94 23.24 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.246 0.927 . . . . 0.0 112.778 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -122.18 79.59 1.61 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.932 1.349 . . . . 0.0 112.763 -168.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -98.36 157.93 15.89 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.793 1.637 . . . . 0.0 110.466 -169.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.57 120.8 13.04 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.633 0.773 . . . . 0.0 110.031 169.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.9 m -125.14 152.68 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.332 0.653 . . . . 0.0 111.182 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -140.93 156.49 46.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.159 1.384 . . . . 0.0 111.942 -168.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -152.4 130.91 12.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.671 1.189 . . . . 0.0 110.8 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.8 pt -91.59 154.11 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.74 173.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.06 159.76 13.91 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.906 1.241 . . . . 0.0 111.44 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 124.717 1.207 . . . . 0.0 109.649 -172.571 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -165.13 167.12 18.52 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.054 1.342 . . . . 0.0 112.297 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.38 131.02 40.46 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.622 1.169 . . . . 0.0 112.461 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 32.6 mt -70.33 166.9 19.25 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.304 1.441 . . . . 0.0 111.678 169.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -48.94 -34.59 13.16 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.49 -6.87 24.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.394 1.078 . . . . 0.0 112.526 -172.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.17 -17.59 7.52 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.962 1.267 . . . . 0.0 115.261 171.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -64.32 154.46 35.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.832 1.316 . . . . 0.0 112.697 -174.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.5 mm -104.47 140.31 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.434 1.015 . . . . 0.0 111.012 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.96 140.38 53.04 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.394 1.878 . . . . 0.0 109.418 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.0 t -138.74 124.91 20.19 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.118 1.367 . . . . 0.0 112.383 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.9 t30 . . . . . 0 C--O 1.255 1.384 0 C-N-CA 126.446 1.898 . . . . 0.0 113.991 -168.169 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.404 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -159.54 173.34 16.29 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.715 0.757 . . . . 0.0 112.671 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.61 146.95 38.94 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.844 1.258 . . . . 0.0 110.771 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -65.2 164.1 13.9 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -50.97 -43.73 60.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.4 -19.73 64.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.692 1.197 . . . . 0.0 112.846 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 m -63.67 108.24 1.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.203 1.401 . . . . 0.0 111.133 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -86.47 128.12 34.93 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.116 0.484 . . . . 0.0 110.431 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.8 mm -99.58 122.3 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.396 1.479 . . . . 0.0 107.295 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.2 tp -69.91 122.61 19.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.2 p -125.9 152.11 46.01 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.9 0.88 . . . . 0.0 112.652 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -71.37 -34.05 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.876 0.47 . . . . 0.0 111.942 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -67.74 -32.72 73.53 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -141.78 -48.5 0.38 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.26 -151.39 19.87 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.172 0.892 . . . . 0.0 111.541 -172.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.87 108.49 1.49 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.352 1.061 . . . . 0.0 111.181 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.4 mt -132.23 147.76 67.05 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.74 1.216 . . . . 0.0 112.871 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.93 123.88 11.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.957 3.104 . . . . 0.0 112.212 -177.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 tt -55.21 -36.82 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.77 -33.73 88.01 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.797 -0.564 . . . . 0.0 113.018 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -77.36 -33.64 55.28 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.684 0.794 . . . . 0.0 112.042 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.7 mt -65.69 -38.85 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.141 0.976 . . . . 0.0 109.664 173.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.0 t -78.15 -38.32 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.366 1.067 . . . . 0.0 112.756 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 -25.48 46.64 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.26 0.936 . . . . 0.0 113.467 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -100.91 -2.59 31.54 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.722 1.209 . . . . 0.0 113.23 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 50.11 49.47 20.35 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.475 1.91 . . . . 0.0 112.339 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.4 mt -71.02 121.51 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.23 1.012 . . . . 0.0 109.591 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -74.81 114.03 12.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.409 0.623 . . . . 0.0 110.725 172.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.9 p -143.72 171.67 13.88 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.068 1.347 . . . . 0.0 112.278 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 m -112.83 150.13 32.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.909 1.284 . . . . 0.0 109.035 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.6 m -125.37 178.42 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.053 1.341 . . . . 0.0 111.222 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.83 141.27 49.68 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.841 1.256 . . . . 0.0 110.538 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.42 153.21 15.22 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.14 1.776 . . . . 0.0 109.185 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.5 m -89.09 143.7 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.442 1.019 . . . . 0.0 111.973 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.56 177.57 7.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.495 1.118 . . . . 0.0 111.395 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -62.8 -17.56 61.36 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.887 1.275 . . . . 0.0 113.04 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -95.16 -0.03 53.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.06 1.744 . . . . 0.0 113.133 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.66 35.65 40.08 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 121.33 -0.856 . . . . 0.0 114.147 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -119.31 123.23 43.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.455 1.502 . . . . 0.0 109.71 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -64.08 117.55 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -120.7 167.62 12.27 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.502 1.521 . . . . 0.0 111.669 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.1 p -115.6 137.96 51.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.282 1.033 . . . . 0.0 111.468 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -146.19 140.35 15.38 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.509 1.124 . . . . 0.0 111.412 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.19 148.94 40.02 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.863 2.375 . . . . 0.0 112.027 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.5 147.94 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.504 1.122 . . . . 0.0 111.114 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.17 -42.27 3.76 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.28 1.032 . . . . 0.0 112.237 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -142.6 178.44 7.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.896 1.679 . . . . 0.0 111.656 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -138.08 125.07 21.33 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.244 1.418 . . . . 0.0 109.117 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -118.57 137.82 52.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.345 1.058 . . . . 0.0 110.73 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.82 123.05 34.23 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.248 1.419 . . . . 0.0 110.61 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -89.72 -29.51 18.68 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.508 1.123 . . . . 0.0 112.77 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.58 -58.95 4.84 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.667 1.603 . . . . 0.0 114.002 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -158.92 98.83 1.5 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.77 1.228 . . . . 0.0 112.853 -168.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -133.03 163.13 29.92 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.336 1.054 . . . . 0.0 112.248 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.5 105.97 1.64 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.612 1.165 . . . . 0.0 113.246 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.42 137.44 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.0 0.92 . . . . 0.0 111.54 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -122.61 141.8 51.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.428 1.091 . . . . 0.0 110.849 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -85.84 96.08 9.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.93 1.692 . . . . 0.0 111.009 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -79.09 108.11 12.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.591 0.757 . . . . 0.0 109.418 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.0 t -88.63 132.55 34.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.361 1.064 . . . . 0.0 110.439 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tp -90.06 168.95 11.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.851 1.261 . . . . 0.0 112.628 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.5 -24.96 66.48 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.94 -27.23 36.17 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.482 1.513 . . . . 0.0 113.019 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.38 0.62 31.14 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.428 1.014 . . . . 0.0 114.13 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.0 m -65.36 141.18 58.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.667 1.234 . . . . 0.0 110.628 169.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 mp -119.62 141.02 49.69 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.256 1.422 . . . . 0.0 110.052 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -136.77 136.85 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.731 1.612 . . . . 0.0 108.398 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -123.96 103.3 8.24 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.134 0.974 . . . . 0.0 110.161 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.69 165.07 29.83 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.376 1.084 . . . . 0.0 111.828 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.9 p -78.4 149.2 33.37 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.464 1.106 . . . . 0.0 111.081 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -62.71 -12.78 25.91 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -91.63 -15.44 28.55 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.145 1.778 . . . . 0.0 112.527 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -78.04 134.54 37.76 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -87.49 160.13 18.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.362 0.665 . . . . 0.0 111.696 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -140.52 140.06 35.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.759 0.823 . . . . 0.0 110.501 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 44.1 ttm -74.01 108.76 7.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.389 1.075 . . . . 0.0 111.604 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.0 p -67.17 172.62 4.49 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -56.39 -23.18 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -98.01 -8.29 28.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.193 1.397 . . . . 0.0 113.165 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.14 1.49 48.16 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.065 1.317 . . . . 0.0 115.094 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -66.32 139.24 58.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.963 1.382 . . . . 0.0 111.44 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.73 76.05 1.77 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.221 1.408 . . . . 0.0 110.956 174.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.3 mt -102.4 147.63 34.27 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 124.165 0.986 . . . . 0.0 110.458 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -64.07 145.92 90.21 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.062 2.508 . . . . 0.0 110.989 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.1 tt -56.69 -28.36 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.82 -30.32 68.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.868 1.267 . . . . 0.0 113.416 172.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.42 -41.09 13.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.682 1.193 . . . . 0.0 111.155 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.2 mt -58.34 -41.21 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.514 1.126 . . . . 0.0 111.789 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -59.68 -33.19 71.26 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.234 1.014 . . . . 0.0 113.165 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -78.48 -46.92 18.51 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -13.73 62.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 56.01 35.36 25.43 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.711 1.604 . . . . 0.0 112.223 -175.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.2 mt -79.72 147.19 32.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.823 0.82 . . . . 0.0 111.373 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.45 172.33 13.16 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.697 0.761 . . . . 0.0 110.846 171.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.6 mt -116.2 157.51 24.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.342 1.057 . . . . 0.0 111.137 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.5 ttm -60.01 158.26 11.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.654 0.782 . . . . 0.0 111.809 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -127.13 163.23 24.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.096 1.758 . . . . 0.0 111.832 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.44 -26.43 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 125.006 1.322 . . . . 0.0 114.045 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -106.09 15.15 26.8 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.55 1.54 . . . . 0.0 112.288 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 56.93 34.42 24.83 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 123.473 1.606 . . . . 0.0 112.493 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.94 159.64 84.85 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 112.676 -2.056 . . . . 0.0 111.375 170.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.19 134.3 31.11 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.094 2.529 . . . . 0.0 111.361 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -72.27 122.88 21.86 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.897 0.879 . . . . 0.0 109.893 172.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.6 pt -146.47 142.06 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.38 1.072 . . . . 0.0 111.49 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 171.29 14.76 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.268 1.827 . . . . 0.0 112.997 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.34 109.25 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.236 1.015 . . . . 0.0 109.489 172.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.93 70.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.413 1.085 . . . . 0.0 112.149 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -152.5 167.99 27.0 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.996 1.719 . . . . 0.0 111.268 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -137.36 146.39 44.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.321 1.448 . . . . 0.0 110.677 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -139.39 120.26 14.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.582 1.153 . . . . 0.0 109.957 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -64.04 123.12 18.2 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.94 -0.475 . . . . 0.0 110.303 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 41.4 mt -90.39 -42.96 10.62 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.372 0.269 . . . . 0.0 111.688 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.83 -131.85 4.97 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.853 0.74 . . . . 0.0 112.92 -174.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -131.26 72.43 1.5 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.661 1.584 . . . . 0.0 113.101 -167.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -94.41 160.86 14.47 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.831 1.653 . . . . 0.0 111.421 -170.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.05 120.67 12.47 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.519 0.728 . . . . 0.0 111.344 169.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.07 151.99 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.491 0.716 . . . . 0.0 110.635 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -143.67 162.0 37.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.393 -168.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -155.73 120.38 4.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.027 0.931 . . . . 0.0 110.142 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.1 pt -80.4 137.27 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.727 -1.233 . . . . 0.0 111.64 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.02 134.21 12.23 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.022 0.82 . . . . 0.0 111.152 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.471 0.594 0 C-N-CA 124.026 0.93 . . . . 0.0 110.553 -178.554 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.551 1.01 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -160.53 157.37 27.35 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.116 0.967 . . . . 0.0 112.149 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.05 149.48 44.84 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.64 1.176 . . . . 0.0 113.112 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.7 mt -134.93 174.68 10.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.123 2.169 . . . . 0.0 111.241 -172.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.97 146.99 4.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.246 1.018 . . . . 0.0 111.704 168.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 50.22 23.04 1.07 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.161 1.384 . . . . 0.0 114.451 -173.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.59 25.9 66.62 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 120.861 -1.149 . . . . 0.0 115.636 172.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -75.13 155.31 37.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.961 1.381 . . . . 0.0 112.174 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.06 103.06 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.67 148.1 25.6 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.3 t -132.84 147.43 52.3 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.912 1.685 . . . . 0.0 111.086 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 C--O 1.251 1.176 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.079 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.845 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -155.48 170.68 21.39 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.866 0.867 . . . . 0.0 112.11 -169.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -111.99 144.42 41.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.099 1.359 . . . . 0.0 110.029 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -67.94 159.77 29.92 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.65 -0.656 . . . . 0.0 111.868 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -48.47 -43.96 35.16 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.415 1.086 . . . . 0.0 112.761 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -13.42 29.83 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.7 m -70.51 112.35 6.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.528 1.131 . . . . 0.0 110.275 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -91.57 136.02 33.43 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.36 0.6 . . . . 0.0 111.54 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 mm -113.18 123.65 69.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 126.156 1.783 . . . . 0.0 107.512 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -62.37 129.69 41.86 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.371 0.668 . . . . 0.0 110.613 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.6 p -132.31 145.81 51.54 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.934 1.294 . . . . 0.0 111.269 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 t -75.21 -32.67 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.497 -0.752 . . . . 0.0 111.683 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -61.93 -32.56 72.97 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -142.75 -53.39 0.4 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -174.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.37 -144.25 15.9 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.181 0.896 . . . . 0.0 112.196 -171.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 mt -72.77 105.07 4.19 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.254 1.822 . . . . 0.0 111.013 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.0 mt -134.54 147.28 62.68 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.332 1.053 . . . . 0.0 113.744 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.44 127.94 19.22 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.062 3.175 . . . . 0.0 112.468 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.9 tt -55.57 -37.74 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.953 0.901 . . . . 0.0 112.859 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.35 -35.19 91.66 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.63 -0.539 . . . . 0.0 112.393 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -71.31 -33.38 69.64 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.485 1.143 . . . . 0.0 111.9 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.36 -41.82 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.584 0.754 . . . . 0.0 110.308 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.68 -42.83 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.76 0.709 . . . . 0.0 112.566 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -65.98 -29.08 69.41 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.057 0.844 . . . . 0.0 112.3 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -113.15 3.95 16.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.603 1.161 . . . . 0.0 113.484 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 48.3 50.53 16.35 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.931 2.092 . . . . 0.0 112.274 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.9 mt -68.86 117.99 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.119 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -74.23 97.81 3.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.375 1.07 . . . . 0.0 110.131 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.4 p -138.03 164.87 28.0 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.38 1.086 . . . . 0.0 113.195 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.49 154.94 17.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.523 1.529 . . . . 0.0 110.449 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.27 178.77 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.076 1.75 . . . . 0.0 110.756 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -126.18 134.68 51.2 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.511 1.524 . . . . 0.0 110.368 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -161.19 155.44 22.83 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.147 0.979 . . . . 0.0 112.068 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.8 m -79.38 146.89 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.634 1.106 . . . . 0.0 113.19 172.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.9 p30 -83.3 -178.81 7.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.174 0.99 . . . . 0.0 112.398 169.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -55.21 -31.55 61.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.495 1.118 . . . . 0.0 113.584 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -85.16 -10.13 57.06 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.723 0.809 . . . . 0.0 112.571 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.43 21.27 27.37 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.859 1.695 . . . . 0.0 114.678 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -101.9 123.29 45.57 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.193 1.496 . . . . 0.0 109.945 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.7 113.49 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.455 0.57 . . . . 0.0 109.734 177.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -116.87 177.18 4.8 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.882 2.073 . . . . 0.0 111.477 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -124.18 142.46 51.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.227 1.011 . . . . 0.0 112.832 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -154.37 152.77 26.94 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.346 1.059 . . . . 0.0 112.74 -176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.22 153.5 66.77 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.105 2.536 . . . . 0.0 112.992 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.79 140.8 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.713 1.205 . . . . 0.0 110.363 168.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.0 -52.44 5.08 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.924 -0.485 . . . . 0.0 111.333 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -150.99 177.87 9.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.153 1.781 . . . . 0.0 111.132 -175.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -135.7 137.32 41.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.069 1.348 . . . . 0.0 110.406 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -134.0 131.83 39.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.092 0.957 . . . . 0.0 111.862 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -111.71 140.8 46.03 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.591 1.556 . . . . 0.0 108.919 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -106.84 -36.32 6.7 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.79 -54.65 1.66 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.338 1.447 . . . . 0.0 113.791 175.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -169.79 104.7 0.33 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.92 1.36 . . . . 0.0 111.098 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -132.54 158.85 41.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.887 0.875 . . . . 0.0 112.896 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.92 98.55 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.427 1.491 . . . . 0.0 114.062 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.0 142.8 12.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.498 1.519 . . . . 0.0 111.593 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -128.08 135.97 50.56 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.654 1.582 . . . . 0.0 109.708 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.2 134.21 56.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.362 0.665 . . . . 0.0 110.474 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.86 96.94 4.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.694 1.197 . . . . 0.0 108.523 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 34.2 t -106.28 145.18 31.95 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.228 1.011 . . . . 0.0 110.597 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -107.93 164.56 12.16 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.625 1.17 . . . . 0.0 112.917 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -67.87 -21.54 65.16 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -80.27 -23.27 40.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.851 1.26 . . . . 0.0 113.044 172.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.02 -3.85 22.5 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.193 1.378 . . . . 0.0 114.597 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -57.0 139.17 53.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.749 1.274 . . . . 0.0 111.122 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.55 125.76 40.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.656 1.183 . . . . 0.0 109.899 -174.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.2 mt -136.21 150.7 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 108.382 -170.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -135.39 112.01 10.0 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.662 1.185 . . . . 0.0 111.316 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.14 20.83 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.626 1.571 . . . . 0.0 111.188 -175.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.9 p -84.56 161.71 20.09 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.495 -0.753 . . . . 0.0 112.077 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -67.91 -8.26 35.29 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 173.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -100.32 -12.98 19.01 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.301 1.44 . . . . 0.0 112.167 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -77.73 131.86 37.86 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 172.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -88.37 164.44 15.53 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.704 0.764 . . . . 0.0 111.308 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -138.36 135.45 35.36 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.414 0.686 . . . . 0.0 109.151 175.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.9 ttp -74.18 102.0 4.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.827 1.251 . . . . 0.0 109.6 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.6 p -64.23 172.74 2.3 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.755 1.222 . . . . 0.0 112.335 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.74 -28.91 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.4 -10.07 58.65 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.277 1.031 . . . . 0.0 113.593 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.73 -0.07 79.35 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.7 1.143 . . . . 0.0 113.954 -175.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -68.46 129.03 38.72 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.669 1.235 . . . . 0.0 109.49 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -96.25 88.42 4.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.271 1.428 . . . . 0.0 109.821 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.6 mt -115.4 147.19 38.14 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.394 1.077 . . . . 0.0 110.594 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.71 147.2 89.75 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.225 2.616 . . . . 0.0 111.323 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.11 -26.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.21 -37.88 70.25 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.591 1.156 . . . . 0.0 112.733 169.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -80.48 -39.68 27.57 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.247 0.619 . . . . 0.0 110.571 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.05 -36.7 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.26 -0.9 . . . . 0.0 111.346 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -66.49 -35.84 81.27 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.4 -36.92 28.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.716 0.806 . . . . 0.0 112.927 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -75.87 -17.98 59.6 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.573 1.149 . . . . 0.0 112.896 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 55.48 37.78 29.36 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.305 1.442 . . . . 0.0 112.63 -173.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.8 mt -82.69 146.82 28.84 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.93 0.892 . . . . 0.0 112.919 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.14 158.67 18.48 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.47 1.108 . . . . 0.0 112.049 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.7 mt -103.1 149.38 24.66 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 33.3 ttm -70.95 153.29 42.79 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 111.624 171.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -141.18 160.66 39.63 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.563 1.945 . . . . 0.0 112.539 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 p -101.11 -26.21 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 126.019 1.728 . . . . 0.0 113.567 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.68 5.29 9.57 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.29 1.436 . . . . 0.0 113.541 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 57.34 27.12 13.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.324 1.849 . . . . 0.0 112.344 -172.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 mt -70.97 155.52 93.26 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.416 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.07 147.65 84.47 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.234 2.622 . . . . 0.0 110.985 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -91.98 125.73 36.79 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.68 -0.638 . . . . 0.0 109.517 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -143.0 139.38 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.144 1.378 . . . . 0.0 111.454 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 173.5 11.86 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.59 1.556 . . . . 0.0 112.891 176.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.8 mt -64.39 118.79 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.348 1.459 . . . . 0.0 110.461 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.24 -44.56 65.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.333 1.053 . . . . 0.0 111.99 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -149.81 147.41 27.95 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.794 1.637 . . . . 0.0 111.137 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -140.27 142.08 35.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.139 1.776 . . . . 0.0 110.061 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -154.76 149.34 26.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.871 2.068 . . . . 0.0 110.566 170.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.14 130.77 45.27 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.751 0.42 . . . . 0.0 109.872 168.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.4 mt -103.2 -52.72 2.97 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.692 0.797 . . . . 0.0 110.857 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 167.19 -141.35 6.84 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 120.961 0.2 . . . . 0.0 113.263 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -131.41 64.6 1.58 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.188 1.47 . . . . 0.0 111.829 -168.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -85.18 158.86 20.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.805 2.042 . . . . 0.0 112.554 -167.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 114.11 4.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.063 0.945 . . . . 0.0 111.109 172.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.91 152.96 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.908 0.883 . . . . 0.0 110.314 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -143.19 158.8 43.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.858 1.663 . . . . 0.0 111.06 -170.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -153.03 134.36 14.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.016 0.927 . . . . 0.0 111.338 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.5 pt -89.99 155.14 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 121.426 -0.797 . . . . 0.0 111.133 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.88 153.37 16.99 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.02 1.295 . . . . 0.0 111.245 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.476 0.865 0 C-N-CA 125.488 1.515 . . . . 0.0 108.984 -172.586 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -174.54 154.72 2.11 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.985 1.314 . . . . 0.0 111.573 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.95 124.15 28.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.788 0.835 . . . . 0.0 112.088 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.51 173.52 5.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.688 1.195 . . . . 0.0 111.139 169.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -45.84 -42.59 12.56 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -91.35 -6.45 52.97 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.648 1.179 . . . . 0.0 113.409 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.95 -13.79 16.96 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 117.761 -1.577 . . . . 0.0 115.557 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -54.45 142.81 25.93 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.079 1.439 . . . . 0.0 112.23 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.76 92.22 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.871 0.843 . . . . 0.0 109.276 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.5 141.37 51.97 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.6 t -138.69 133.79 32.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.007 1.323 . . . . 0.0 110.973 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 C--O 1.254 1.302 0 C-N-CA 124.183 0.993 . . . . 0.0 113.493 -171.445 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.095 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -164.6 177.31 8.17 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.038 0.935 . . . . 0.0 113.354 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 mt -122.3 151.01 41.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.673 1.989 . . . . 0.0 110.166 -171.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -66.29 159.93 25.58 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.633 -0.667 . . . . 0.0 112.246 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -50.49 -44.74 56.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.464 1.106 . . . . 0.0 112.956 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -64.15 -10.88 25.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.231 1.412 . . . . 0.0 114.163 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.7 m -66.79 94.81 0.33 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.324 1.449 . . . . 0.0 111.523 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -73.45 136.05 44.2 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.282 0.563 . . . . 0.0 111.965 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.3 mm -117.89 122.68 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.099 1.759 . . . . 0.0 107.407 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.6 tp -64.65 124.51 22.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.518 0.727 . . . . 0.0 110.696 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.7 p -125.89 156.12 40.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.683 1.193 . . . . 0.0 112.299 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.97 -31.43 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.076 0.55 . . . . 0.0 111.713 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.49 -34.87 78.72 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -141.22 -50.87 0.43 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.49 -145.14 17.19 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.682 0.673 . . . . 0.0 111.954 -172.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.9 mt -70.79 106.98 3.77 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.288 1.035 . . . . 0.0 111.091 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.8 mt -133.95 149.46 71.76 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.802 1.241 . . . . 0.0 112.697 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.05 128.15 20.03 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.06 3.173 . . . . 0.0 112.196 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 tt -54.63 -36.31 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.812 0.845 . . . . 0.0 112.755 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.97 -35.51 91.98 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 119.306 -0.719 . . . . 0.0 113.004 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -70.84 -34.08 71.31 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.785 1.292 . . . . 0.0 111.745 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.3 mt -69.49 -38.88 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.048 0.939 . . . . 0.0 110.169 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.2 t -83.75 -36.84 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.035 0.934 . . . . 0.0 113.154 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -66.98 -26.35 66.77 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.865 0.757 . . . . 0.0 112.67 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -115.61 1.48 13.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.637 1.175 . . . . 0.0 113.471 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 47.15 53.28 10.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.148 2.179 . . . . 0.0 112.476 -177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.16 115.13 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.491 0.716 . . . . 0.0 109.3 -173.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.15 108.49 3.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.441 1.096 . . . . 0.0 110.27 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.7 p -147.23 168.13 22.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.391 1.076 . . . . 0.0 112.57 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.56 148.97 25.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.656 1.582 . . . . 0.0 108.931 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.88 161.78 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.447 1.499 . . . . 0.0 110.702 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -100.17 153.26 19.4 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.418 1.087 . . . . 0.0 110.512 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.8 t -168.51 146.95 4.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.712 1.205 . . . . 0.0 111.505 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -75.23 130.36 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.127 1.371 . . . . 0.0 112.56 169.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -85.1 179.33 7.28 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.738 0.815 . . . . 0.0 111.748 171.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -57.7 -21.61 41.54 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.856 1.263 . . . . 0.0 113.43 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.76 -13.56 57.59 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.089 1.355 . . . . 0.0 113.242 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.06 4.46 89.9 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.078 1.323 . . . . 0.0 115.084 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -91.34 131.87 36.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.224 1.012 . . . . 0.0 109.787 175.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -69.91 123.82 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.504 0.722 . . . . 0.0 109.554 172.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -120.57 172.15 8.05 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.894 1.678 . . . . 0.0 110.708 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 p -121.47 139.11 53.9 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.072 0.949 . . . . 0.0 112.254 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.75 147.03 34.0 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.797 1.239 . . . . 0.0 112.946 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.3 150.18 52.39 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.118 2.546 . . . . 0.0 112.593 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.81 141.9 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.069 0.948 . . . . 0.0 111.148 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.69 -32.76 11.24 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.641 0.776 . . . . 0.0 112.611 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -170.45 179.33 3.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.316 1.847 . . . . 0.0 111.929 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -136.11 122.8 21.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.018 1.327 . . . . 0.0 109.554 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -109.43 118.42 36.59 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.682 1.193 . . . . 0.0 110.773 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.27 114.68 28.33 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.304 1.442 . . . . 0.0 109.958 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -83.33 -30.53 27.42 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.067 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.11 -44.27 2.82 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.629 1.585 . . . . 0.0 113.538 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 178.81 100.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.429 1.109 . . . . 0.0 113.073 -171.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -129.12 163.97 24.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.527 1.131 . . . . 0.0 113.415 173.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -63.27 100.41 0.24 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.994 1.718 . . . . 0.0 113.154 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.2 t -90.92 137.31 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.027 1.331 . . . . 0.0 111.21 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -120.78 136.7 54.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.44 1.496 . . . . 0.0 109.407 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.06 125.84 25.37 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.85 0.86 . . . . 0.0 110.178 172.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -117.46 99.19 6.83 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.019 1.327 . . . . 0.0 108.032 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.6 t -110.01 147.24 33.9 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.855 0.862 . . . . 0.0 110.674 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.91 164.31 12.71 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.21 1.404 . . . . 0.0 112.429 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -67.47 -24.01 65.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.991 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.96 -25.24 37.49 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.814 1.246 . . . . 0.0 113.272 174.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.07 -7.37 11.81 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.072 1.32 . . . . 0.0 114.75 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -55.47 143.53 28.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.766 1.283 . . . . 0.0 111.542 175.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.47 124.3 31.69 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.535 1.134 . . . . 0.0 110.203 -173.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 43.8 mt -135.11 151.88 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 127.121 2.168 . . . . 0.0 108.225 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -136.59 113.04 9.99 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.575 1.15 . . . . 0.0 110.552 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.89 166.34 25.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.849 1.26 . . . . 0.0 111.967 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 p -83.73 152.11 24.88 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.75 0.82 . . . . 0.0 111.354 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -61.46 -15.17 34.89 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -89.32 -16.76 30.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.885 1.674 . . . . 0.0 112.246 -176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -80.17 131.5 35.73 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -89.15 156.92 18.5 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.271 0.558 . . . . 0.0 111.444 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -135.93 141.03 44.46 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.657 0.783 . . . . 0.0 109.271 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 46.7 ttm -68.83 108.38 3.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.946 0.898 . . . . 0.0 110.124 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.6 p -70.81 169.84 13.77 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.776 -0.578 . . . . 0.0 112.026 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.4 m -54.56 -23.94 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 174.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -87.63 -7.25 57.7 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.024 . . . . 0.0 113.317 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.45 7.16 65.44 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.402 1.477 . . . . 0.0 113.939 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -79.95 126.64 31.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.228 1.014 . . . . 0.0 110.346 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.28 92.22 6.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.3 1.04 . . . . 0.0 110.433 169.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.7 mt -116.77 146.3 37.41 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.95 0.9 . . . . 0.0 110.978 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.13 146.46 86.91 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.226 2.617 . . . . 0.0 111.061 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.8 tt -59.05 -27.74 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -55.9 -35.55 66.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.531 1.132 . . . . 0.0 113.109 169.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -85.03 -34.71 22.26 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.895 -0.503 . . . . 0.0 111.405 175.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.55 -39.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 119.385 0.993 . . . . 0.0 110.762 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -64.69 -39.16 93.18 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -76.74 -39.35 52.07 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -78.12 -13.15 59.98 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 56.87 30.11 17.32 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.785 1.234 . . . . 0.0 112.151 -174.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.41 142.95 46.93 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.996 0.918 . . . . 0.0 111.302 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -90.78 135.37 33.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.071 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 mp -66.42 150.78 48.4 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.059 -1.026 . . . . 0.0 111.141 168.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.8 ttp -72.66 172.37 10.79 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.326 0.584 . . . . 0.0 111.791 171.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -137.12 164.05 29.35 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.729 1.612 . . . . 0.0 111.433 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 m -106.8 -22.75 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -107.35 21.6 17.25 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.962 1.305 . . . . 0.0 112.386 -172.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 56.08 29.42 14.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.776 1.63 . . . . 0.0 112.454 -172.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.6 mt -63.35 159.26 51.26 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.921 171.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.92 143.99 56.95 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.249 2.633 . . . . 0.0 111.426 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.98 121.23 31.87 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.752 0.821 . . . . 0.0 109.015 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.4 pt -142.22 122.47 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.732 1.213 . . . . 0.0 110.738 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -67.34 170.52 7.17 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.285 1.834 . . . . 0.0 112.962 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.7 mt -61.58 120.1 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.306 1.442 . . . . 0.0 110.194 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.96 -47.29 66.0 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.718 0.807 . . . . 0.0 111.614 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 p -152.29 151.88 31.47 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.351 1.46 . . . . 0.0 111.001 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.65 141.79 48.8 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.057 1.743 . . . . 0.0 110.048 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 134.55 15.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.484 1.913 . . . . 0.0 109.484 177.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -65.1 133.81 52.43 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.081 0.152 . . . . 0.0 110.755 170.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.2 mt -100.97 -42.65 6.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.009 0.524 . . . . 0.0 112.009 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.49 -149.94 21.71 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.665 1.126 . . . . 0.0 111.798 -173.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -123.27 100.16 6.71 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.542 1.137 . . . . 0.0 111.458 -170.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -115.13 155.22 27.5 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.253 1.421 . . . . 0.0 109.88 -171.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 116.78 6.27 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.305 0.642 . . . . 0.0 110.144 172.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.14 150.94 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.396 0.678 . . . . 0.0 110.887 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -139.29 156.15 47.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.305 1.442 . . . . 0.0 111.743 -170.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -157.5 121.35 4.17 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.814 1.245 . . . . 0.0 110.071 -173.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.7 pt -80.52 143.73 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 120.706 -1.246 . . . . 0.0 111.523 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.71 153.97 20.51 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.902 0.763 . . . . 0.0 111.799 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 125.216 1.406 . . . . 0.0 109.739 -173.182 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -166.28 150.86 7.89 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.222 1.409 . . . . 0.0 110.817 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.39 142.16 30.34 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.842 0.857 . . . . 0.0 112.309 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.3 mt -102.16 171.21 7.62 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.675 1.19 . . . . 0.0 112.054 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -19.33 8.28 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -103.74 11.18 36.21 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.516 1.526 . . . . 0.0 112.958 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.04 21.52 75.92 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 121.336 -0.852 . . . . 0.0 113.844 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.39 163.72 16.61 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.644 1.578 . . . . 0.0 111.985 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.01 100.81 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.746 1.218 . . . . 0.0 108.948 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.98 149.68 26.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.9 t -140.83 141.09 34.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.379 0.672 . . . . 0.0 112.477 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.919 1.287 . . . . 0.0 113.097 -173.498 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 CA-C-O 121.134 0.297 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.92 177.91 9.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.445 1.498 . . . . 0.0 112.14 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.99 144.33 44.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.982 1.713 . . . . 0.0 110.383 -172.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -68.86 163.67 23.77 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.633 -0.667 . . . . 0.0 112.441 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -50.83 -42.86 58.82 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.642 -0.661 . . . . 0.0 112.411 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -65.73 -13.95 60.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.814 1.246 . . . . 0.0 114.116 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.2 m -71.0 120.39 16.5 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.515 0.726 . . . . 0.0 110.725 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -102.27 138.38 39.29 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.495 0.664 . . . . 0.0 111.633 -176.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.15 116.66 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 126.198 1.799 . . . . 0.0 107.585 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tt -63.12 124.49 21.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.706 0.402 . . . . 0.0 111.19 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.3 p -118.53 155.84 30.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.85 1.26 . . . . 0.0 112.144 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.8 -35.72 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.789 0.836 . . . . 0.0 111.14 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -67.36 -32.42 73.35 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -140.13 -50.29 0.47 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.53 -143.91 15.71 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.147 0.879 . . . . 0.0 112.656 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.36 96.14 0.65 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.381 1.872 . . . . 0.0 112.846 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -129.87 149.63 73.62 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.844 1.258 . . . . 0.0 112.591 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.68 130.26 23.01 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.404 3.403 . . . . 0.0 113.127 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 tt -57.44 -37.59 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.002 0.921 . . . . 0.0 112.922 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.36 -31.34 78.65 Favored Glycine 0 CA--C 1.529 0.917 0 O-C-N 121.718 -0.614 . . . . 0.0 112.846 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -72.06 -38.68 69.43 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.094 0.947 . . . . 0.0 111.317 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.73 -39.34 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.619 0.767 . . . . 0.0 109.76 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.5 t -80.99 -38.92 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.874 0.87 . . . . 0.0 112.938 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.72 -23.94 56.14 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.74 1.155 . . . . 0.0 113.297 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -108.58 2.02 21.8 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.202 1.401 . . . . 0.0 112.12 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.89 52.12 11.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.32 2.248 . . . . 0.0 113.04 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.6 mt -76.35 122.4 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.964 0.906 . . . . 0.0 110.055 -170.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.77 96.59 3.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.655 1.182 . . . . 0.0 111.595 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 68.3 m -135.4 173.45 11.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.072 1.349 . . . . 0.0 112.732 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 m -121.42 140.21 52.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.705 1.602 . . . . 0.0 108.969 -176.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.9 m -125.35 163.21 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.637 1.575 . . . . 0.0 111.19 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -97.94 147.59 24.31 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.597 1.159 . . . . 0.0 110.362 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -157.55 156.21 31.55 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.806 1.642 . . . . 0.0 109.577 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 t -102.6 127.42 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.807 0.843 . . . . 0.0 109.757 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -69.24 175.25 4.01 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.931 1.292 . . . . 0.0 112.58 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -61.47 -26.73 68.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.024 1.33 . . . . 0.0 113.424 175.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -87.84 0.75 55.39 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.242 1.417 . . . . 0.0 113.41 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.98 18.88 76.13 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.771 1.176 . . . . 0.0 114.655 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -92.3 132.89 36.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.598 1.159 . . . . 0.0 110.122 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.14 131.08 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -137.77 176.74 8.43 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.537 1.935 . . . . 0.0 110.715 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 p -125.87 143.53 51.03 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.273 1.029 . . . . 0.0 112.397 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -143.2 141.62 19.81 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.654 1.182 . . . . 0.0 112.336 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.73 150.12 49.69 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.832 2.355 . . . . 0.0 111.464 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.55 136.81 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.381 0.672 . . . . 0.0 110.856 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.45 -45.9 5.95 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.533 0.733 . . . . 0.0 111.832 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -146.16 178.99 7.81 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.287 1.835 . . . . 0.0 111.278 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -135.05 120.64 19.36 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.498 1.519 . . . . 0.0 109.23 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -116.19 119.26 35.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.185 0.994 . . . . 0.0 110.79 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -107.61 113.43 26.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.322 1.449 . . . . 0.0 109.908 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -82.19 -29.93 31.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.778 0.831 . . . . 0.0 112.965 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.54 -54.62 2.37 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.474 1.511 . . . . 0.0 113.888 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -170.33 103.09 0.27 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.157 1.383 . . . . 0.0 111.057 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -132.28 164.88 25.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.226 1.011 . . . . 0.0 111.69 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.55 99.65 0.23 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.594 1.558 . . . . 0.0 113.638 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 t -95.99 141.22 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.499 1.52 . . . . 0.0 111.589 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.83 137.76 54.61 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.239 1.816 . . . . 0.0 109.975 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.66 133.52 56.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.864 0.865 . . . . 0.0 110.715 171.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -127.55 89.29 2.93 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.023 1.329 . . . . 0.0 108.314 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.4 t -97.48 149.24 22.39 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.348 1.059 . . . . 0.0 110.731 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.15 163.53 15.82 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.212 1.405 . . . . 0.0 112.387 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.36 -20.54 63.84 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -81.45 -17.86 47.28 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.238 1.015 . . . . 0.0 113.171 170.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.26 -3.62 33.19 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.042 1.306 . . . . 0.0 114.207 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.9 m -57.71 142.31 45.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.522 1.129 . . . . 0.0 110.994 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -130.9 126.18 35.46 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.712 0.805 . . . . 0.0 111.351 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.5 mt -135.22 152.38 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 126.85 2.06 . . . . 0.0 107.674 -171.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.99 115.29 11.07 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.848 1.259 . . . . 0.0 110.528 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.09 163.24 34.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.626 1.171 . . . . 0.0 111.291 -176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.4 p -78.94 153.2 30.6 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.575 -0.703 . . . . 0.0 111.415 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.49 -24.17 65.08 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -84.05 -10.08 58.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.617 1.167 . . . . 0.0 112.836 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -82.44 133.96 35.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -97.12 156.12 16.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.536 1.134 . . . . 0.0 111.521 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.48 141.26 46.7 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.08 -1.012 . . . . 0.0 110.822 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.8 ttm -73.03 100.13 2.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.043 0.937 . . . . 0.0 109.594 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.5 p -66.96 170.74 6.26 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.8 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -56.09 -20.33 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.94 -4.01 28.46 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.653 1.181 . . . . 0.0 113.307 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 3.79 72.8 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.244 1.402 . . . . 0.0 113.913 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -65.42 122.97 18.39 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.381 1.072 . . . . 0.0 110.55 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.6 mtt -84.71 73.28 10.62 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.703 2.001 . . . . 0.0 110.766 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 43.6 mt -105.93 147.71 35.25 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 123.483 0.713 . . . . 0.0 110.97 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.78 148.27 86.43 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.11 2.54 . . . . 0.0 110.924 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 tt -53.46 -34.62 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.84 -33.12 70.05 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -77.15 -34.78 56.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.625 0.77 . . . . 0.0 111.15 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.1 mt -67.4 -39.4 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.782 0.833 . . . . 0.0 110.367 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -64.2 -34.26 77.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.953 0.901 . . . . 0.0 112.956 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -73.94 -47.25 38.89 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.01 -9.23 58.56 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 58.7 34.18 23.6 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.892 1.277 . . . . 0.0 112.325 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.89 143.85 35.48 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 122.172 0.987 . . . . 0.0 111.905 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.3 158.83 24.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.447 1.099 . . . . 0.0 111.623 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.51 152.2 21.03 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.39 -0.819 . . . . 0.0 111.922 169.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -75.15 146.5 41.27 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.176 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 166.05 23.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.047 1.339 . . . . 0.0 114.135 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.7 m -105.03 -30.03 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.561 1.544 . . . . 0.0 113.07 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.03 -2.73 56.08 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.326 1.05 . . . . 0.0 113.108 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.278 8.6 m-80 59.14 36.0 23.87 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.988 1.375 . . . . 0.0 112.991 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.9 mt -61.89 157.71 48.36 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.839 167.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.5 140.86 84.11 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.633 2.222 . . . . 0.0 110.39 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -66.56 126.05 27.69 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.999 -0.438 . . . . 0.0 110.496 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.5 pt -143.75 132.89 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.946 1.298 . . . . 0.0 111.013 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 176.31 7.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.202 1.401 . . . . 0.0 111.74 176.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.8 mt -64.13 109.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.731 1.212 . . . . 0.0 110.19 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.6 94.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.481 1.112 . . . . 0.0 112.287 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.0 p -151.43 153.25 34.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.939 1.696 . . . . 0.0 111.25 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -137.3 143.19 42.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.956 1.702 . . . . 0.0 110.335 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -152.33 148.31 27.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.591 2.356 . . . . 0.0 110.454 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -72.02 124.17 24.36 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.897 0.479 . . . . 0.0 110.081 168.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.2 mt -91.09 -44.81 9.05 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.022 0.529 . . . . 0.0 111.649 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.13 -145.73 13.9 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.056 0.836 . . . . 0.0 113.116 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -122.44 51.76 1.36 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 123.103 1.43 . . . . 0.0 113.66 -166.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -72.7 158.17 36.12 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 127.64 2.376 . . . . 0.0 112.53 -168.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.58 118.16 6.69 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.992 0.917 . . . . 0.0 111.417 171.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.8 m -126.09 156.2 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.41 0.684 . . . . 0.0 111.789 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -144.31 159.01 43.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.733 1.613 . . . . 0.0 111.559 -168.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -155.78 128.73 8.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.43 1.092 . . . . 0.0 109.952 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.43 142.55 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 121.292 -0.88 . . . . 0.0 111.281 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.65 136.36 14.87 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 126.01 1.724 . . . . 0.0 109.922 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -163.3 164.79 24.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.443 1.497 . . . . 0.0 112.437 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.75 141.41 28.53 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.675 1.19 . . . . 0.0 112.949 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.4 mt -91.53 171.76 8.97 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.658 1.983 . . . . 0.0 111.997 175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -50.49 -50.84 51.61 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.794 1.638 . . . . 0.0 115.171 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -68.06 -26.96 66.11 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.211 0.604 . . . . 0.0 111.825 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 120.48 -3.0 12.4 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.667 1.603 . . . . 0.0 114.096 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -69.07 163.82 23.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.144 1.472 . . . . 0.0 111.874 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.14 136.97 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 122.033 0.92 . . . . 0.0 110.629 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -121.51 151.48 40.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.37 1.868 . . . . 0.0 109.593 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.6 t -142.81 135.93 28.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.826 0.851 . . . . 0.0 113.089 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.2 t30 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.76 1.224 . . . . 0.0 113.131 -176.099 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.095 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.41 176.73 10.81 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.309 0.644 . . . . 0.0 112.544 -169.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.7 mt -116.74 147.41 42.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.352 1.861 . . . . 0.0 110.415 -173.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t -62.88 161.77 12.25 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -52.37 -44.77 65.46 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.146 -0.971 . . . . 0.0 111.474 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -56.34 -25.47 49.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.721 1.609 . . . . 0.0 114.044 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.6 m -65.5 103.62 0.87 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.883 1.273 . . . . 0.0 112.023 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -85.15 136.09 33.69 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.642 -0.661 . . . . 0.0 111.864 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 mm -109.4 131.94 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.535 1.534 . . . . 0.0 107.875 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -69.7 122.76 19.79 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 122.082 -0.386 . . . . 0.0 111.433 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.7 p -120.63 151.19 39.78 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.716 1.206 . . . . 0.0 112.315 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 t -75.74 -37.34 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.169 0.587 . . . . 0.0 111.84 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.04 -28.4 68.83 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -141.37 -51.12 0.43 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.29 -156.52 23.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.261 0.934 . . . . 0.0 112.505 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.87 105.9 0.43 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.431 1.092 . . . . 0.0 111.163 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.5 mt -135.52 149.75 70.26 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 124.746 1.218 . . . . 0.0 112.888 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.13 128.45 21.71 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.975 3.117 . . . . 0.0 112.351 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.4 tt -56.47 -35.94 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.793 0.837 . . . . 0.0 113.058 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.28 -33.97 88.66 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.548 -0.585 . . . . 0.0 113.072 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -69.33 -35.06 75.55 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.207 1.003 . . . . 0.0 111.806 174.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.3 mt -69.43 -41.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.581 0.752 . . . . 0.0 110.311 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -78.99 -39.67 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.808 0.731 . . . . 0.0 112.435 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.94 -23.67 60.71 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.32 0.964 . . . . 0.0 113.19 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.16 4.09 19.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.975 1.31 . . . . 0.0 112.65 176.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 50.16 45.73 25.41 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.916 1.686 . . . . 0.0 112.643 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.23 127.69 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.944 0.898 . . . . 0.0 109.399 -172.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -78.73 111.21 14.62 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.365 0.602 . . . . 0.0 110.319 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.8 p -133.9 -172.39 2.97 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.263 1.425 . . . . 0.0 111.005 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.3 157.03 35.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.687 1.595 . . . . 0.0 109.103 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.1 m -140.25 163.52 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.588 1.155 . . . . 0.0 111.026 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -104.43 139.96 38.62 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.204 1.402 . . . . 0.0 110.43 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -159.43 150.92 20.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.442 1.497 . . . . 0.0 110.528 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 m -83.41 148.11 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.423 1.01 . . . . 0.0 112.941 171.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.84 -179.92 7.4 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.836 0.854 . . . . 0.0 111.405 169.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -60.76 -20.68 61.88 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.89 1.276 . . . . 0.0 113.023 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -91.75 0.62 57.48 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.682 1.593 . . . . 0.0 113.277 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.2 26.67 63.47 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 121.114 -0.991 . . . . 0.0 114.223 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -107.58 120.21 41.56 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.621 1.568 . . . . 0.0 109.231 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.45 125.98 23.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 123.594 0.758 . . . . 0.0 109.431 173.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -129.09 173.08 10.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.359 1.863 . . . . 0.0 111.403 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -117.18 142.4 47.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.946 1.298 . . . . 0.0 112.413 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -146.71 142.68 17.51 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.27 1.028 . . . . 0.0 112.873 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.5 154.5 50.28 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.116 2.544 . . . . 0.0 111.813 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.7 t -62.36 140.8 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.615 -0.678 . . . . 0.0 110.062 169.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.9 -40.95 4.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.311 0.645 . . . . 0.0 112.27 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -138.13 164.45 29.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.565 1.146 . . . . 0.0 112.306 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -133.87 131.36 39.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.294 1.838 . . . . 0.0 108.362 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.26 130.78 50.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.022 1.329 . . . . 0.0 111.157 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -139.45 136.56 34.76 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.568 -1.333 . . . . 0.0 112.535 -171.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -111.39 -32.75 6.62 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.201 -1.363 . . . . 0.0 114.62 -168.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.49 -60.75 2.5 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.306 1.431 . . . . 0.0 114.152 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -157.26 96.47 1.56 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.436 1.494 . . . . 0.0 112.616 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -130.11 162.1 29.57 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.391 1.076 . . . . 0.0 113.365 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.23 106.6 2.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.538 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 t -100.26 139.12 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.905 1.282 . . . . 0.0 111.247 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.418 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 38.9 m-85 -124.58 140.61 52.78 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.765 1.226 . . . . 0.0 109.973 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -85.02 123.59 30.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.058 1.343 . . . . 0.0 109.485 169.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.1 100.24 8.45 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.352 1.461 . . . . 0.0 108.934 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.6 t -83.41 145.3 29.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.22 1.008 . . . . 0.0 111.355 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mp -103.92 157.7 16.91 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.434 1.494 . . . . 0.0 112.276 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.56 -20.19 65.37 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -84.22 -16.23 44.06 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 176.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.32 -2.56 25.19 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.302 1.429 . . . . 0.0 114.405 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.4 m -70.16 157.82 36.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.923 1.289 . . . . 0.0 112.746 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.88 148.79 50.49 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.418 1.487 . . . . 0.0 110.855 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -140.01 143.91 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.963 2.105 . . . . 0.0 107.912 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -136.37 112.12 9.45 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.672 1.189 . . . . 0.0 112.382 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.33 172.12 18.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.498 1.119 . . . . 0.0 112.786 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.9 p -86.98 161.78 18.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.341 0.657 . . . . 0.0 110.964 168.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HE3' ' CD1' ' A' ' 56' ' ' PHE . 2.2 mptm? -59.88 -25.81 65.37 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 175.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -85.07 -15.52 43.72 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.16 1.384 . . . . 0.0 112.766 -174.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -73.19 132.52 43.32 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 153.03 18.02 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.253 0.933 . . . . 0.0 112.787 176.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -131.94 137.14 47.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.252 -0.905 . . . . 0.0 109.143 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.1 ttp -81.47 113.14 19.33 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.291 0.567 . . . . 0.0 110.066 -173.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.2 p -69.87 171.43 9.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.466 0.706 . . . . 0.0 112.035 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -57.35 -23.67 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 174.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -82.26 -12.93 57.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.663 1.185 . . . . 0.0 113.394 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.06 3.35 70.19 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.247 0.927 . . . . 0.0 114.112 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -77.36 151.85 34.7 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.425 1.112 . . . . 0.0 110.826 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 ptp -119.78 93.93 4.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.565 1.146 . . . . 0.0 110.635 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.4 mt -120.4 149.06 49.03 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.109 1.364 . . . . 0.0 109.905 -170.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.74 145.98 91.57 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.546 2.164 . . . . 0.0 111.344 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.69 -28.69 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -57.85 -37.14 73.35 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.524 1.53 . . . . 0.0 113.289 171.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.07 -43.51 21.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.194 0.997 . . . . 0.0 110.511 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.61 -41.14 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.526 1.13 . . . . 0.0 111.438 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.3 -35.53 80.68 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -80.69 -40.82 24.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.754 0.822 . . . . 0.0 113.03 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -76.95 -13.76 59.94 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.222 1.009 . . . . 0.0 113.284 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 57.75 35.53 25.63 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.872 1.669 . . . . 0.0 112.872 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.89 148.11 25.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.008 0.923 . . . . 0.0 112.561 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -87.19 163.12 17.1 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.551 1.14 . . . . 0.0 113.174 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.2 mt -113.42 153.93 27.81 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.785 1.234 . . . . 0.0 112.5 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 10.7 ttp -81.98 145.08 30.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.189 0.595 . . . . 0.0 111.214 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.92 177.75 7.04 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.773 1.229 . . . . 0.0 113.874 -173.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 p -121.44 -25.69 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 126.149 1.78 . . . . 0.0 114.597 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -85.04 6.37 25.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.09 1.356 . . . . 0.0 113.382 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 56.42 32.11 20.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.969 1.708 . . . . 0.0 112.349 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.0 mt -67.41 158.31 82.64 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.76 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.04 147.13 88.68 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.935 2.423 . . . . 0.0 111.166 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -71.46 118.74 14.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.667 0.787 . . . . 0.0 109.989 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.6 126.37 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.895 1.278 . . . . 0.0 112.018 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.85 175.03 7.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.61 1.564 . . . . 0.0 112.393 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.12 106.9 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.68 1.592 . . . . 0.0 110.933 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.8 -41.05 62.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.573 1.149 . . . . 0.0 112.074 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.3 p -152.37 165.89 33.58 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.145 1.778 . . . . 0.0 111.84 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -136.05 143.54 44.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.602 1.561 . . . . 0.0 111.436 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -139.6 130.71 26.48 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.653 1.181 . . . . 0.0 110.88 171.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -67.55 131.31 45.39 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.918 -0.489 . . . . 0.0 110.931 173.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.2 mt -96.64 -42.78 7.86 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.015 0.526 . . . . 0.0 112.32 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.79 -151.59 23.23 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.421 1.01 . . . . 0.0 113.014 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -118.56 69.11 0.79 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.267 1.508 . . . . 0.0 112.417 -168.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -91.85 160.05 15.49 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 127.064 2.146 . . . . 0.0 111.443 -168.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.3 121.31 14.95 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 123.4 0.68 . . . . 0.0 111.075 169.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.81 148.41 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.476 0.655 . . . . 0.0 111.465 174.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -141.55 157.56 44.96 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.171 1.789 . . . . 0.0 111.884 -169.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -148.76 165.75 30.49 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.475 1.51 . . . . 0.0 112.653 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.7 pt -136.76 153.9 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.195 1.798 . . . . 0.0 111.104 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.91 166.69 24.56 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.856 0.741 . . . . 0.0 114.242 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.475 0.787 0 C-N-CA 124.924 1.29 . . . . 0.0 110.608 -174.489 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -161.51 158.81 27.08 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.201 1.4 . . . . 0.0 112.307 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.57 128.62 36.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.836 1.254 . . . . 0.0 111.693 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.8 mt -72.54 175.23 6.49 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.282 1.433 . . . . 0.0 113.319 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -51.03 -35.69 35.66 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -93.4 -5.21 49.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.417 1.087 . . . . 0.0 112.86 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.12 -20.12 28.93 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 125.307 1.432 . . . . 0.0 114.447 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -53.51 133.21 40.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.379 1.072 . . . . 0.0 111.476 -173.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.5 mm -82.27 130.31 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.979 0.895 . . . . 0.0 110.938 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -108.79 141.24 41.09 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 126.951 2.1 . . . . 0.0 108.964 170.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.4 t -146.97 140.1 25.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.236 1.014 . . . . 0.0 113.291 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 CA--C 1.556 1.198 0 C-N-CA 125.846 1.658 . . . . 0.0 114.572 -173.569 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 122.206 0.892 . . . . 0.0 113.566 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.94 171.19 15.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.902 1.681 . . . . 0.0 111.202 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.0 mt -120.15 140.41 51.14 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.794 2.038 . . . . 0.0 110.067 -168.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 t -72.59 162.46 29.44 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.47 -0.769 . . . . 0.0 111.62 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -48.35 -43.3 33.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.416 1.086 . . . . 0.0 112.79 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -10.21 5.41 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -75.95 107.82 8.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.449 1.1 . . . . 0.0 110.034 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -100.41 138.2 37.8 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.455 -0.778 . . . . 0.0 112.013 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.7 mm -121.34 116.88 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.99 127.08 29.81 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.212 0.605 . . . . 0.0 111.003 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.8 p -121.7 157.19 31.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.451 1.101 . . . . 0.0 112.697 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -78.01 -34.63 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.438 0.695 . . . . 0.0 111.462 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.67 -30.69 65.99 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -137.77 -48.73 0.57 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.71 -147.67 17.27 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.346 0.974 . . . . 0.0 112.664 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -64.23 104.46 0.75 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.711 2.005 . . . . 0.0 110.722 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.1 mt -141.06 150.6 59.58 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 124.814 1.246 . . . . 0.0 114.021 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.89 133.15 28.39 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.774 3.649 . . . . 0.0 113.829 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 tt -59.0 -34.5 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.202 1.001 . . . . 0.0 113.174 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.96 -35.23 91.73 Favored Glycine 0 C--N 1.338 0.652 0 O-C-N 121.875 -0.516 . . . . 0.0 112.157 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -72.73 -32.57 65.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.07 0.935 . . . . 0.0 111.553 176.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -64.76 -38.56 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.309 0.643 . . . . 0.0 110.64 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.4 t -86.38 -38.23 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 118.953 0.797 . . . . 0.0 112.462 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -68.21 -27.58 66.51 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.313 -0.867 . . . . 0.0 113.099 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -114.91 5.61 15.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.956 1.302 . . . . 0.0 113.104 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 49.38 44.2 23.65 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 127.336 2.254 . . . . 0.0 112.798 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.8 mt -67.35 127.21 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.496 1.118 . . . . 0.0 109.522 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -99.01 104.25 16.27 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.634 1.174 . . . . 0.0 111.273 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 62.3 m -136.4 -178.44 5.17 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.505 1.522 . . . . 0.0 111.487 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.8 m -116.21 144.51 44.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.286 1.434 . . . . 0.0 108.534 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.32 160.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.001 1.72 . . . . 0.0 110.083 -175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -99.24 147.67 24.91 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.379 1.072 . . . . 0.0 110.3 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 t -159.43 160.17 34.52 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.296 1.438 . . . . 0.0 109.899 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -100.01 125.07 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.966 0.906 . . . . 0.0 110.201 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -69.62 176.48 3.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.993 1.317 . . . . 0.0 112.584 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -63.5 -26.16 68.59 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.136 1.374 . . . . 0.0 112.949 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.31 -5.31 59.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.045 1.338 . . . . 0.0 113.687 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.86 21.82 58.84 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.464 1.03 . . . . 0.0 114.873 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -96.81 133.1 41.83 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.657 1.183 . . . . 0.0 109.83 172.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.7 mt -74.09 129.26 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -137.59 179.63 6.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.961 2.105 . . . . 0.0 110.949 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.0 p -129.25 144.7 51.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.421 1.089 . . . . 0.0 113.124 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -149.15 142.32 15.9 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.063 1.345 . . . . 0.0 112.314 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.1 155.2 42.42 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.124 2.549 . . . . 0.0 112.981 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.0 t -62.62 132.52 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.344 0.657 . . . . 0.0 110.085 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.71 -48.21 7.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.411 0.684 . . . . 0.0 112.105 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -149.67 172.3 15.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.865 1.666 . . . . 0.0 111.525 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -132.27 129.44 39.61 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.947 1.699 . . . . 0.0 109.096 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -133.4 138.1 46.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.083 0.944 . . . . 0.0 111.418 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -129.08 118.69 22.93 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.123 1.369 . . . . 0.0 110.609 -172.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -84.01 -33.5 24.52 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.806 1.242 . . . . 0.0 112.708 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.01 -51.4 1.46 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.111 1.339 . . . . 0.0 113.62 173.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -172.57 106.35 0.17 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.414 1.485 . . . . 0.0 110.518 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -132.49 168.0 18.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.32 1.048 . . . . 0.0 112.402 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -67.87 101.76 1.14 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.05 140.61 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.765 1.226 . . . . 0.0 111.496 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -122.6 141.26 51.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.657 1.583 . . . . 0.0 110.534 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.55 126.11 26.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.224 1.41 . . . . 0.0 110.583 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -122.78 82.96 2.05 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.451 1.9 . . . . 0.0 108.476 177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 t -86.33 147.84 25.87 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.803 0.841 . . . . 0.0 111.175 171.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.55 165.38 11.71 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.308 1.443 . . . . 0.0 112.814 175.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.61 -23.71 66.88 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -82.35 -19.82 38.52 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.86 -1.4 27.29 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.191 1.377 . . . . 0.0 114.596 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.6 m -57.91 140.98 50.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.498 1.649 . . . . 0.0 110.922 170.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tp -127.01 130.05 49.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.384 1.074 . . . . 0.0 109.884 -174.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mt -139.65 150.26 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.715 1.606 . . . . 0.0 108.145 -170.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -134.0 109.74 9.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.853 1.261 . . . . 0.0 110.86 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.17 169.62 17.24 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.498 1.119 . . . . 0.0 112.519 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 p -86.19 149.26 25.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.89 1.276 . . . . 0.0 111.467 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -62.23 -17.39 58.19 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -86.54 -14.4 43.08 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.053 1.341 . . . . 0.0 112.971 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -79.42 135.52 36.7 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.153 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -93.82 152.41 18.93 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.026 0.917 . . . . 0.0 113.234 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.86 129.2 32.0 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.953 0.901 . . . . 0.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ttp -74.85 111.47 10.09 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.155 0.503 . . . . 0.0 110.416 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 p -71.09 173.48 7.53 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.472 0.653 . . . . 0.0 112.313 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.88 -24.01 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -91.41 -6.52 52.71 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.501 1.12 . . . . 0.0 113.205 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.81 5.81 59.69 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.345 0.974 . . . . 0.0 113.941 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -77.55 126.32 30.7 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.189 0.994 . . . . 0.0 110.906 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.62 78.57 7.74 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.138 1.375 . . . . 0.0 110.702 173.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 mt -104.68 147.77 34.96 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 123.553 0.741 . . . . 0.0 110.673 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.49 147.71 87.07 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.578 2.185 . . . . 0.0 110.603 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.5 tt -60.67 -28.88 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.28 -27.8 62.44 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.419 1.488 . . . . 0.0 113.331 169.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.51 -40.7 18.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.275 1.03 . . . . 0.0 111.528 173.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.82 -37.86 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.317 1.047 . . . . 0.0 110.93 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.8 -35.66 77.04 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.29 -48.24 17.94 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.325 -0.859 . . . . 0.0 113.063 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -14.21 62.23 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 55.75 32.82 20.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.987 1.315 . . . . 0.0 112.225 -172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 42.4 mt -70.43 140.31 51.99 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.997 0.919 . . . . 0.0 111.47 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.01 146.59 25.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.44 0.696 . . . . 0.0 110.847 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 mp -79.2 153.26 30.14 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.449 -0.782 . . . . 0.0 111.553 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.5 ttm -72.45 149.23 44.4 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.87 -0.519 . . . . 0.0 110.812 172.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.64 167.77 15.23 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.001 1.32 . . . . 0.0 113.892 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.75 -23.76 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 125.774 1.63 . . . . 0.0 113.235 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -88.98 5.22 45.22 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.997 1.319 . . . . 0.0 112.71 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 64.49 19.8 11.93 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.496 1.518 . . . . 0.0 112.32 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.1 mt -49.53 156.81 1.06 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.441 1.496 . . . . 0.0 112.028 169.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.3 145.22 88.15 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.64 2.226 . . . . 0.0 110.68 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -68.47 120.44 14.54 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.693 -0.629 . . . . 0.0 110.177 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.4 pt -145.1 159.79 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.289 1.436 . . . . 0.0 111.586 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -128.11 -179.69 5.13 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.28 1.832 . . . . 0.0 111.939 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.0 mt -56.78 110.65 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 125.671 1.589 . . . . 0.0 110.777 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.63 -40.84 66.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.609 1.164 . . . . 0.0 112.273 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.1 p -150.61 162.42 40.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.187 1.795 . . . . 0.0 111.022 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.04 144.13 40.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.634 1.174 . . . . 0.0 111.53 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -156.7 127.12 6.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.488 1.515 . . . . 0.0 110.486 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.06 123.29 18.66 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.775 -0.578 . . . . 0.0 110.234 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 mt -90.56 -42.71 10.66 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.737 0.415 . . . . 0.0 111.812 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.21 -136.27 6.68 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.887 0.756 . . . . 0.0 112.865 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.6 tttp -133.43 77.8 1.74 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.705 1.241 . . . . 0.0 113.089 -168.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -95.24 157.1 16.04 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.335 1.454 . . . . 0.0 110.858 -171.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.79 118.19 6.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.603 0.761 . . . . 0.0 110.525 169.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.6 m -123.02 151.83 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.455 0.645 . . . . 0.0 111.432 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -139.8 159.14 42.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.811 1.644 . . . . 0.0 111.436 -168.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -154.61 134.24 12.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.362 1.065 . . . . 0.0 111.149 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.3 pt -91.94 154.3 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.551 -0.718 . . . . 0.0 110.83 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.13 157.94 16.96 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.765 1.174 . . . . 0.0 111.803 173.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 125.112 1.365 . . . . 0.0 110.169 -175.215 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -164.74 155.48 14.56 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.477 1.111 . . . . 0.0 112.725 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.8 137.35 36.8 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.109 1.364 . . . . 0.0 112.905 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.85 168.14 19.1 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.137 1.775 . . . . 0.0 113.394 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -35.45 50.52 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -82.99 -28.34 29.78 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.662 1.185 . . . . 0.0 112.769 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 130.69 -19.59 4.99 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.586 1.565 . . . . 0.0 114.545 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -60.17 159.32 9.89 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.829 1.252 . . . . 0.0 112.229 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.2 mm -116.48 128.69 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 119.328 0.967 . . . . 0.0 111.024 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.37 145.47 29.45 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.568 1.547 . . . . 0.0 109.628 170.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.9 m -138.95 142.06 38.42 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.398 1.079 . . . . 0.0 111.608 177.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 C--O 1.253 1.279 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -168.814 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.898 0 CA-C-O 118.939 -0.923 . . . . 0.0 115.151 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 60.2 -166.95 10.11 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 118.992 1.396 . . . . 0.0 113.837 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.27 171.57 19.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.287 1.035 . . . . 0.0 112.209 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.2 mt -122.05 146.8 46.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.83 2.052 . . . . 0.0 109.527 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -68.9 164.72 21.48 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -53.0 -46.26 68.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.95 -1.093 . . . . 0.0 112.338 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -62.98 -10.63 14.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.617 1.567 . . . . 0.0 114.905 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.8 m -71.55 111.07 6.55 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.863 0.865 . . . . 0.0 110.584 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.8 134.01 34.41 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.615 -0.678 . . . . 0.0 112.265 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.4 mm -107.55 124.53 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.019 1.728 . . . . 0.0 108.113 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -64.44 131.16 46.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.672 0.389 . . . . 0.0 110.815 169.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 p -134.77 150.54 50.56 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.645 1.178 . . . . 0.0 112.36 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.0 t -77.34 -32.78 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.976 0.51 . . . . 0.0 111.823 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -68.77 -31.05 69.8 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -140.13 -50.61 0.48 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.85 -149.35 19.86 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.109 0.861 . . . . 0.0 112.095 -172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.1 107.88 2.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.015 1.326 . . . . 0.0 111.209 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -133.21 148.91 71.04 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.751 1.22 . . . . 0.0 112.745 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.39 126.55 15.79 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.944 3.096 . . . . 0.0 112.332 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -54.51 -35.57 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.043 0.937 . . . . 0.0 112.637 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.74 -36.53 93.45 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.604 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -70.31 -34.35 72.6 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.033 1.416 . . . . 0.0 111.554 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.0 mt -63.86 -36.51 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.643 0.777 . . . . 0.0 110.121 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.37 -38.06 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.837 0.855 . . . . 0.0 112.856 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.58 -26.45 65.4 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.821 -1.174 . . . . 0.0 113.025 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -114.45 2.63 14.7 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.077 1.351 . . . . 0.0 112.878 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 49.09 47.81 21.52 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 127.533 2.333 . . . . 0.0 113.133 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -73.71 129.69 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.613 1.165 . . . . 0.0 109.445 -174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 132.74 36.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 122.703 1.239 . . . . 0.0 111.208 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.0 p -160.39 175.36 12.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.393 1.477 . . . . 0.0 111.659 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 147.03 30.08 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.45 1.5 . . . . 0.0 109.157 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 m -125.46 172.99 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.581 1.952 . . . . 0.0 110.181 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -114.28 139.89 49.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.956 1.302 . . . . 0.0 110.886 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 t -162.03 150.07 14.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.901 1.281 . . . . 0.0 111.566 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.72 144.49 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.195 0.907 . . . . 0.0 113.399 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.44 -178.35 6.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.809 0.844 . . . . 0.0 112.516 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -55.66 -22.53 23.43 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.352 1.461 . . . . 0.0 113.765 173.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -91.94 -10.62 38.81 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.228 1.411 . . . . 0.0 113.719 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.62 14.14 58.71 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.41 1.005 . . . . 0.0 114.916 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -88.93 118.89 28.97 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.574 1.187 . . . . 0.0 110.177 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.45 103.99 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.496 0.719 . . . . 0.0 109.375 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -103.64 178.66 4.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.113 1.765 . . . . 0.0 111.211 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 p -127.7 140.05 52.32 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.126 0.97 . . . . 0.0 112.643 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -144.74 148.02 37.87 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.707 1.203 . . . . 0.0 113.332 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.4 152.67 49.64 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.025 2.483 . . . . 0.0 112.835 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.84 133.31 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.147 0.979 . . . . 0.0 109.784 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.64 -49.46 7.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.008 0.523 . . . . 0.0 111.828 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -148.98 176.01 10.81 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.727 1.611 . . . . 0.0 111.767 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -131.62 129.91 41.47 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.682 1.593 . . . . 0.0 109.311 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -131.78 136.06 47.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.132 0.968 . . . . 0.0 111.3 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -126.8 114.28 17.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.215 1.806 . . . . 0.0 110.118 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -78.2 -29.58 48.46 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.058 0.943 . . . . 0.0 112.058 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.66 -56.67 1.63 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.413 1.483 . . . . 0.0 112.58 172.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -166.68 111.31 0.77 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.207 1.803 . . . . 0.0 109.827 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -129.56 166.0 20.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.519 1.128 . . . . 0.0 112.606 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -61.94 100.6 0.16 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.665 1.186 . . . . 0.0 113.096 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.3 137.93 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.659 1.184 . . . . 0.0 110.787 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -118.31 141.74 48.22 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.085 1.354 . . . . 0.0 109.489 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -65.96 129.53 40.11 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.387 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -116.46 106.88 14.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.585 1.154 . . . . 0.0 107.948 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.2 t -116.57 141.71 47.84 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.068 0.947 . . . . 0.0 110.82 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp -102.82 166.01 10.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.34 1.456 . . . . 0.0 112.647 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -65.23 -25.73 67.81 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.29 -23.0 35.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.025 1.33 . . . . 0.0 113.096 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.96 -2.66 25.7 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.0 1.286 . . . . 0.0 114.717 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.3 m -57.83 136.97 57.05 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.731 1.265 . . . . 0.0 110.867 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.29 124.51 42.56 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.616 1.166 . . . . 0.0 109.939 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.6 mt -135.13 151.02 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 127.334 2.254 . . . . 0.0 108.299 -171.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -137.4 108.96 6.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.871 1.268 . . . . 0.0 109.986 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.96 170.89 17.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.019 0.928 . . . . 0.0 113.377 -172.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.5 p -91.03 153.08 20.39 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.542 1.137 . . . . 0.0 111.987 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -65.15 -5.04 5.78 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -99.16 -6.33 28.45 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.556 1.143 . . . . 0.0 112.315 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -85.73 126.88 34.31 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.39 155.24 20.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.755 0.788 . . . . 0.0 110.43 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -138.22 143.12 40.01 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.308 0.643 . . . . 0.0 109.33 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.1 ttp -73.11 103.03 3.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.305 0.642 . . . . 0.0 111.513 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.4 p -62.38 171.86 1.75 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.9 m -54.27 -25.33 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.78 -11.99 24.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.773 1.229 . . . . 0.0 113.191 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.2 -6.17 32.16 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.0 1.762 . . . . 0.0 114.332 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -61.25 141.21 57.69 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.986 1.393 . . . . 0.0 111.777 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -101.26 83.22 2.44 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.4 1.08 . . . . 0.0 109.771 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.09 146.77 37.86 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 124.437 1.095 . . . . 0.0 110.76 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.43 148.6 73.71 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.068 2.512 . . . . 0.0 111.783 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 tt -60.57 -26.98 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -55.41 -32.9 63.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.176 0.99 . . . . 0.0 112.92 170.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.44 -31.29 16.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.353 1.061 . . . . 0.0 111.754 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.28 -42.22 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.232 -0.917 . . . . 0.0 110.738 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -62.23 -39.31 92.4 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.28 -44.77 64.59 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -77.76 -11.12 59.85 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 56.51 37.82 29.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.425 1.49 . . . . 0.0 111.751 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.8 mt -78.48 150.9 32.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 122.042 0.925 . . . . 0.0 111.37 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -93.72 167.43 11.66 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.901 0.88 . . . . 0.0 111.069 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.01 144.93 43.42 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.308 1.043 . . . . 0.0 111.437 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -68.59 148.36 50.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.712 0.805 . . . . 0.0 111.618 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.02 152.04 44.78 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.783 1.233 . . . . 0.0 113.694 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 t -77.31 -35.84 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 128.37 2.668 . . . . 0.0 112.74 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -91.47 10.81 26.18 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.361 1.065 . . . . 0.0 113.495 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.25 7.0 m-80 56.38 31.91 19.6 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.076 1.75 . . . . 0.0 112.426 -172.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.9 mt -64.54 155.23 82.02 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 113.659 -1.61 . . . . 0.0 111.622 170.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.98 127.51 17.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.341 2.694 . . . . 0.0 109.987 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -77.69 131.13 37.57 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.751 -0.593 . . . . 0.0 109.595 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -142.08 127.65 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.644 1.178 . . . . 0.0 110.957 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 166.49 3.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.597 1.959 . . . . 0.0 113.202 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.8 mt -61.33 116.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.152 1.381 . . . . 0.0 109.691 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.73 -42.1 61.63 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.832 0.853 . . . . 0.0 111.627 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 p -149.24 146.02 27.39 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.018 1.327 . . . . 0.0 111.295 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -143.84 142.79 31.02 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.266 1.827 . . . . 0.0 109.853 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -155.41 151.04 27.35 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.996 2.118 . . . . 0.0 110.416 169.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -67.03 131.2 45.36 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.365 0.666 . . . . 0.0 110.072 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.6 mt -98.27 -45.13 6.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.944 0.498 . . . . 0.0 111.871 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.01 -146.3 15.56 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.179 0.895 . . . . 0.0 112.095 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.59 94.67 4.31 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.246 1.022 . . . . 0.0 111.78 -169.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -110.86 155.79 22.09 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.397 1.479 . . . . 0.0 109.904 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.46 118.32 8.6 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.201 0.6 . . . . 0.0 110.642 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.84 150.45 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.35 0.595 . . . . 0.0 111.46 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -138.44 159.41 42.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.673 1.589 . . . . 0.0 111.494 -170.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -157.29 114.38 3.04 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.418 1.087 . . . . 0.0 110.556 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.0 pt -68.12 154.74 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 O-C-N 121.267 -0.896 . . . . 0.0 110.908 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.46 152.23 17.41 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.69 1.138 . . . . 0.0 111.5 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.05 142.56 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.972 1.309 . . . . 0.0 110.069 -171.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -80.76 -49.22 11.42 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -52.58 24.74 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.842 0.857 . . . . 0.0 112.968 -172.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -149.77 125.99 10.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.558 1.943 . . . . 0.0 108.719 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -75.62 59.37 1.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.78 1.232 . . . . 0.0 112.136 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -148.66 165.88 30.01 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.9 1.68 . . . . 0.0 112.83 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -168.31 146.77 4.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.593 1.157 . . . . 0.0 112.121 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.03 165.32 25.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.124 0.97 . . . . 0.0 113.321 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 67.2 mt -130.57 164.87 23.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.054 2.142 . . . . 0.0 111.621 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -32.61 58.1 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -86.71 9.11 19.84 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.402 1.481 . . . . 0.0 112.519 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.4 0.06 85.94 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.747 1.641 . . . . 0.0 114.046 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -67.37 166.67 14.02 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.205 1.503 . . . . 0.0 113.073 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.97 123.4 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.286 1.034 . . . . 0.0 109.65 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.22 149.99 21.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.984 1.314 . . . . 0.0 109.671 172.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.2 t -142.2 138.73 31.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.151 0.98 . . . . 0.0 112.587 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.529 1.532 . . . . 0.0 112.28 -174.287 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 CA-C-O 121.272 0.373 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -66.57 166.58 38.64 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.21 2.338 . . . . 0.0 114.084 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.32 179.83 7.99 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.137 1.375 . . . . 0.0 112.506 -174.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.5 mt -123.33 146.43 47.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.271 1.829 . . . . 0.0 110.378 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 t -68.62 163.85 22.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.206 0.602 . . . . 0.0 112.378 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -51.75 -44.52 63.35 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.421 -0.799 . . . . 0.0 112.49 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -59.8 -19.77 52.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.655 1.982 . . . . 0.0 113.857 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.8 m -72.32 87.24 1.13 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.644 1.178 . . . . 0.0 111.718 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -77.42 145.96 36.85 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.115 0.959 . . . . 0.0 112.74 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.3 mm -119.53 125.92 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 126.889 2.075 . . . . 0.0 107.18 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -61.1 132.16 52.86 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 122.076 -0.39 . . . . 0.0 111.17 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.7 p -133.05 148.46 52.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.659 1.184 . . . . 0.0 112.698 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.9 -34.61 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.258 0.623 . . . . 0.0 111.9 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -65.11 -28.85 69.72 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -143.86 -62.92 0.39 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.28 -148.35 18.77 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.007 0.813 . . . . 0.0 112.056 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.05 107.05 3.46 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.685 1.194 . . . . 0.0 111.331 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.76 148.63 70.28 Favored Pre-proline 0 N--CA 1.479 1.012 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.03 127.63 18.05 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.694 3.596 . . . . 0.0 112.822 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.44 -35.09 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.615 0.766 . . . . 0.0 113.027 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.61 -36.56 93.5 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.334 -0.703 . . . . 0.0 112.787 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -71.56 -32.22 67.85 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.114 1.457 . . . . 0.0 111.398 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.61 -37.44 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.972 0.909 . . . . 0.0 110.181 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.5 t -88.02 -37.87 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 118.691 0.678 . . . . 0.0 112.586 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -69.24 -25.85 64.49 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.481 1.037 . . . . 0.0 113.008 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -116.24 4.87 13.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.945 1.298 . . . . 0.0 112.45 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 48.46 47.89 19.8 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.136 2.575 . . . . 0.0 113.258 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -72.64 121.86 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.029 1.332 . . . . 0.0 109.469 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -83.27 122.29 28.24 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.44 1.114 . . . . 0.0 110.733 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -152.1 -177.02 5.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.003 1.721 . . . . 0.0 110.909 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -125.24 141.38 52.12 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.184 1.393 . . . . 0.0 108.424 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.48 177.29 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.614 1.965 . . . . 0.0 110.6 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -122.73 140.06 53.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.717 1.207 . . . . 0.0 111.36 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.4 t -161.38 149.61 15.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.355 1.462 . . . . 0.0 110.924 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.39 160.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 119.043 0.838 . . . . 0.0 111.126 167.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -102.23 -174.47 2.58 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.998 1.719 . . . . 0.0 113.089 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.52 -11.54 25.01 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -102.93 -0.86 30.42 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.804 1.642 . . . . 0.0 112.36 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.98 31.48 39.16 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.68 1.133 . . . . 0.0 114.565 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -116.56 121.99 43.37 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.697 1.249 . . . . 0.0 109.991 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.7 mt -63.91 118.82 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.736 0.814 . . . . 0.0 109.305 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -122.87 177.02 5.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.193 1.797 . . . . 0.0 111.014 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.3 p -125.61 139.88 53.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.141 0.977 . . . . 0.0 113.097 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -147.89 148.29 29.61 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.695 1.198 . . . . 0.0 112.808 -175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.15 155.11 52.26 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.165 2.577 . . . . 0.0 112.836 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.94 134.34 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.142 0.977 . . . . 0.0 110.146 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.87 -45.11 9.47 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.466 0.707 . . . . 0.0 112.199 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -149.23 173.28 13.63 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.923 1.689 . . . . 0.0 111.912 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -132.93 132.36 41.91 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.784 1.633 . . . . 0.0 108.973 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -133.28 135.61 44.99 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.04 0.924 . . . . 0.0 111.162 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -126.65 113.08 16.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.348 1.459 . . . . 0.0 110.323 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -79.35 -32.02 43.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.924 1.289 . . . . 0.0 112.866 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.05 -51.2 2.51 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.867 1.222 . . . . 0.0 113.684 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -173.15 96.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.746 1.273 . . . . 0.0 111.258 -170.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -129.67 165.11 22.49 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 112.682 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.83 103.85 0.98 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.105 1.362 . . . . 0.0 113.421 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 t -95.41 139.62 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.03 1.332 . . . . 0.0 111.544 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -123.92 139.28 54.11 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.498 1.919 . . . . 0.0 109.922 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.79 134.2 53.61 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.282 0.633 . . . . 0.0 110.357 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -126.62 95.73 4.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.989 1.316 . . . . 0.0 108.579 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.1 t -105.71 140.76 38.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.243 1.017 . . . . 0.0 110.132 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tp -103.86 162.9 12.73 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.911 1.284 . . . . 0.0 112.01 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -66.93 -21.19 65.99 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.1 -29.27 61.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.765 1.226 . . . . 0.0 112.839 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.92 -2.22 25.76 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.941 1.258 . . . . 0.0 114.108 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 m -57.37 138.75 54.55 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.273 1.037 . . . . 0.0 111.205 170.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 tp -128.58 125.62 38.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.335 1.054 . . . . 0.0 111.042 -170.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.4 mt -137.86 151.92 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 126.907 2.083 . . . . 0.0 108.017 -169.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -138.42 115.06 10.59 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.782 1.233 . . . . 0.0 110.804 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.24 167.71 23.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.676 1.19 . . . . 0.0 112.208 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.5 p -82.02 154.16 25.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.712 0.805 . . . . 0.0 111.715 170.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -66.59 -8.57 28.02 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -96.2 -10.83 27.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.813 1.645 . . . . 0.0 112.787 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -81.65 133.04 35.32 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -87.65 165.67 15.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.145 0.974 . . . . 0.0 111.553 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -142.85 147.39 35.33 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.323 1.049 . . . . 0.0 109.824 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 43.3 ttm -79.56 104.05 9.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.677 1.191 . . . . 0.0 110.347 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.2 p -68.87 170.81 8.94 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.715 -0.615 . . . . 0.0 112.062 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.0 m -57.79 -23.22 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -90.03 -3.02 58.21 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.407 1.083 . . . . 0.0 113.042 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.76 66.34 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.327 0.965 . . . . 0.0 113.656 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -86.01 124.9 32.98 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.497 1.119 . . . . 0.0 109.996 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.13 92.84 6.92 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.531 1.132 . . . . 0.0 109.855 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.36 147.12 44.42 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 124.381 1.072 . . . . 0.0 111.418 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.08 146.67 82.73 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.414 2.742 . . . . 0.0 111.687 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.7 tt -58.6 -27.91 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -53.23 -35.99 60.55 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.487 1.115 . . . . 0.0 112.852 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -86.75 -33.29 20.01 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.026 0.53 . . . . 0.0 111.827 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.8 mt -61.44 -38.04 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.311 -0.868 . . . . 0.0 111.06 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -67.75 -32.57 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -82.05 -40.11 22.49 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.443 -0.786 . . . . 0.0 112.514 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.3 mmm-85 -77.0 -13.95 59.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 55.01 29.98 13.34 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.587 1.555 . . . . 0.0 113.117 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -76.23 129.48 36.77 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.653 0.781 . . . . 0.0 111.168 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.17 149.15 47.84 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.617 0.723 . . . . 0.0 112.478 171.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.06 155.94 21.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.515 0.726 . . . . 0.0 112.587 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.5 ttp -78.13 135.79 37.74 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.984 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 166.7 10.22 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.391 1.476 . . . . 0.0 112.947 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.77 -19.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.602 1.961 . . . . 0.0 112.788 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -109.68 15.02 23.1 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.028 1.731 . . . . 0.0 112.263 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 65.05 14.15 9.16 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.632 1.573 . . . . 0.0 113.423 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.2 mt -43.9 154.82 0.35 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 127.264 2.226 . . . . 0.0 112.761 169.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.95 148.76 89.93 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.598 2.199 . . . . 0.0 110.904 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -69.66 123.07 20.41 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.45 -0.782 . . . . 0.0 111.152 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.5 pt -148.86 151.76 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.705 1.602 . . . . 0.0 111.055 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.23 179.7 4.21 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.822 1.649 . . . . 0.0 111.249 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 19.4 mt -62.06 110.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.688 1.195 . . . . 0.0 110.618 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.71 -42.02 64.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.166 1.387 . . . . 0.0 111.763 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p -148.75 148.26 29.78 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.263 1.425 . . . . 0.0 111.183 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.9 ttp85 -143.0 141.0 31.25 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.0 1.72 . . . . 0.0 110.174 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -159.85 148.96 17.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.144 1.778 . . . . 0.0 110.703 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -64.99 125.41 24.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.628 0.771 . . . . 0.0 111.459 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.34 -44.39 8.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.401 0.68 . . . . 0.0 111.866 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.62 -147.31 17.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.124 0.868 . . . . 0.0 112.872 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -128.73 80.89 1.99 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 123.083 1.421 . . . . 0.0 111.83 -169.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -100.0 158.91 15.49 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.918 1.687 . . . . 0.0 110.471 -169.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 118.43 7.72 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.79 -0.569 . . . . 0.0 110.739 169.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.94 152.77 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.302 0.641 . . . . 0.0 111.285 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -140.72 158.97 43.2 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.637 1.575 . . . . 0.0 111.737 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -155.72 131.3 9.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.419 1.088 . . . . 0.0 111.089 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.4 pt -87.27 155.36 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 121.323 -0.86 . . . . 0.0 111.08 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.7 155.14 16.27 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.434 1.492 . . . . 0.0 111.703 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.7 156.97 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.63 1.172 . . . . 0.0 110.846 -169.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.05 -40.14 92.49 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -144.52 -53.28 0.31 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.768 1.227 . . . . 0.0 113.188 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.47 90.13 7.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.092 0.957 . . . . 0.0 109.518 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -66.61 34.92 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.809 2.443 . . . . 0.0 113.75 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -147.04 160.39 42.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.82 2.048 . . . . 0.0 111.826 -168.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -163.27 154.23 16.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.456 1.102 . . . . 0.0 112.353 -169.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.81 159.44 30.09 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 45.0 mt -116.89 162.2 18.12 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.975 2.11 . . . . 0.0 112.195 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -55.2 -36.09 65.54 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -73.87 -17.04 61.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.11 0.964 . . . . 0.0 112.381 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.15 34.41 3.7 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.045 1.307 . . . . 0.0 114.699 171.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -135.53 165.34 25.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.721 1.608 . . . . 0.0 111.026 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -107.64 129.35 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.563 0.745 . . . . 0.0 110.015 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -110.75 155.26 22.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.582 1.553 . . . . 0.0 110.163 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.1 p -142.95 122.21 13.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.818 0.847 . . . . 0.0 112.605 -168.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 124.695 1.198 . . . . 0.0 113.671 -176.312 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.057 0 N-CA-C 115.567 0.987 . . . . 0.0 115.567 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -157.58 158.46 29.03 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 128.481 2.943 . . . . 0.0 108.243 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -157.79 175.4 13.93 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 117.759 0.779 . . . . 0.0 113.077 -167.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.67 147.24 44.79 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.467 1.507 . . . . 0.0 111.218 -170.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 t -64.77 162.79 15.35 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -54.2 -44.43 71.59 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.151 -0.968 . . . . 0.0 112.002 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -57.69 -23.89 53.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.873 1.669 . . . . 0.0 113.697 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.5 m -66.92 103.59 1.18 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.443 1.497 . . . . 0.0 111.472 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -87.56 141.19 28.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.836 0.826 . . . . 0.0 112.361 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.4 mm -120.4 119.54 60.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 126.628 1.971 . . . . 0.0 106.956 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.07 131.65 51.26 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.406 0.283 . . . . 0.0 110.772 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.4 p -126.2 157.7 37.53 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.166 . . . . 0.0 112.768 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.94 -35.45 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.576 0.75 . . . . 0.0 111.182 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -67.22 -29.53 69.21 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.24 -54.28 0.47 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.23 -148.95 19.93 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.962 0.792 . . . . 0.0 112.434 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.73 109.66 3.93 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.822 1.249 . . . . 0.0 111.099 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.3 mt -136.65 150.2 69.48 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.03 1.332 . . . . 0.0 112.642 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.52 129.56 22.81 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.962 3.108 . . . . 0.0 112.379 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 tt -55.2 -38.96 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.411 0.684 . . . . 0.0 112.318 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.54 -31.74 79.58 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.583 -0.698 . . . . 0.0 113.347 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -70.88 -37.81 73.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.192 0.996 . . . . 0.0 111.26 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.59 -40.34 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 123.662 0.785 . . . . 0.0 109.336 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.3 t -74.46 -42.87 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.23 -21.26 56.6 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.788 1.176 . . . . 0.0 113.465 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -110.37 2.28 18.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.359 1.464 . . . . 0.0 112.197 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 47.38 48.86 16.23 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.998 2.119 . . . . 0.0 113.178 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.0 mt -72.11 126.11 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.868 0.867 . . . . 0.0 109.621 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -85.67 104.47 15.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.41 0.624 . . . . 0.0 111.191 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 64.7 m -133.56 -173.45 3.23 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.451 1.5 . . . . 0.0 111.487 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.31 143.65 51.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.961 1.705 . . . . 0.0 108.754 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.12 171.03 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.697 1.599 . . . . 0.0 111.156 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.04 143.28 45.01 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.951 1.3 . . . . 0.0 111.248 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 t -160.72 150.67 17.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.912 1.685 . . . . 0.0 110.381 -170.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.0 142.66 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.215 1.37 . . . . 0.0 110.729 168.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.64 178.56 7.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.838 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.27 -25.27 63.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.749 1.22 . . . . 0.0 112.754 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -87.79 -1.13 57.77 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.327 1.451 . . . . 0.0 113.339 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.08 29.6 53.49 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 121.251 -0.906 . . . . 0.0 114.373 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -109.39 122.57 47.67 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.539 1.536 . . . . 0.0 109.63 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.4 mt -69.82 117.84 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.498 0.719 . . . . 0.0 109.489 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -124.9 178.4 5.52 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.67 1.988 . . . . 0.0 111.285 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 p -126.08 142.68 51.42 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.386 1.074 . . . . 0.0 112.958 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -144.73 146.13 30.7 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 124.909 1.283 . . . . 0.0 112.898 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.07 152.86 67.89 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.866 2.377 . . . . 0.0 111.985 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.28 119.15 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 168.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.81 -50.45 17.15 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -151.59 179.49 8.34 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.672 1.989 . . . . 0.0 110.909 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -134.82 132.72 38.98 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.342 1.457 . . . . 0.0 109.856 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -134.02 138.82 45.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.833 0.853 . . . . 0.0 111.627 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -132.37 121.03 22.85 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.56 1.544 . . . . 0.0 110.203 -172.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -87.76 -25.65 23.29 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.124 1.37 . . . . 0.0 112.982 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.16 -49.22 2.99 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.589 1.566 . . . . 0.0 114.937 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -171.75 101.25 0.18 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.128 1.464 . . . . 0.0 111.455 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -131.43 167.47 19.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.553 1.141 . . . . 0.0 112.247 172.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.84 105.81 0.9 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.937 1.295 . . . . 0.0 113.554 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.37 140.85 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.473 1.109 . . . . 0.0 111.939 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.455 ' CZ ' ' HE3' ' A' ' 70' ' ' LYS . 46.9 m-85 -125.08 154.55 41.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.585 1.554 . . . . 0.0 110.874 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.68 110.3 22.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.567 1.147 . . . . 0.0 109.169 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -96.7 102.85 14.7 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.852 0.861 . . . . 0.0 109.255 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.5 t -82.34 147.05 29.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.203 1.001 . . . . 0.0 111.057 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -106.99 160.79 15.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.951 1.3 . . . . 0.0 113.47 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.68 -20.47 65.3 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.29 -14.99 36.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.048 1.339 . . . . 0.0 112.945 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.18 -5.11 23.62 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.441 1.496 . . . . 0.0 114.57 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 t -71.82 171.47 11.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.219 1.009 . . . . 0.0 113.213 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -140.74 141.32 34.88 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.896 1.678 . . . . 0.0 111.57 -170.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.5 mt -133.62 143.61 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 126.23 1.812 . . . . 0.0 108.699 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -133.47 101.51 5.17 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.807 1.243 . . . . 0.0 111.376 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.35 166.66 31.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.847 0.859 . . . . 0.0 113.275 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.0 p -78.37 163.03 26.01 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.231 0.538 . . . . 0.0 110.773 168.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 6.5 mtmp? -74.51 -4.83 39.18 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -97.83 -20.76 17.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.588 1.555 . . . . 0.0 112.607 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -71.72 131.01 42.53 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -84.84 157.43 20.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.519 -0.738 . . . . 0.0 111.118 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -139.5 143.62 37.55 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.024 1.33 . . . . 0.0 109.921 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.2 ttp -84.64 110.34 18.67 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.454 1.102 . . . . 0.0 111.278 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.4 p -71.14 176.42 4.48 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -54.96 -26.84 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -94.14 -9.33 36.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.631 1.173 . . . . 0.0 113.521 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.06 8.97 56.43 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.314 0.959 . . . . 0.0 114.875 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -65.81 146.98 54.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.777 1.288 . . . . 0.0 111.165 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 29.2 mtm -110.95 80.51 1.31 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.526 1.53 . . . . 0.0 109.849 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.1 mt -119.64 147.25 43.36 Favored Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 125.396 1.478 . . . . 0.0 110.465 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -63.08 144.43 92.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.643 2.229 . . . . 0.0 110.672 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.7 tt -55.91 -27.14 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -56.01 -40.45 73.41 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.179 1.391 . . . . 0.0 113.006 169.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -79.56 -35.71 39.4 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.993 -0.442 . . . . 0.0 110.855 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 72.2 mt -62.58 -40.58 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 119.076 0.853 . . . . 0.0 111.391 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -58.91 -39.35 81.26 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.736 0.814 . . . . 0.0 113.157 172.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -81.49 -38.56 26.13 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.624 1.17 . . . . 0.0 113.085 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -75.47 -16.64 60.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.337 1.055 . . . . 0.0 112.896 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 56.86 34.39 24.69 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.08 1.352 . . . . 0.0 112.452 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -86.98 144.55 26.87 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.876 0.87 . . . . 0.0 111.873 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -81.22 167.67 19.34 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.7 0.8 . . . . 0.0 112.564 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.3 157.89 30.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.392 1.092 . . . . 0.0 113.901 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.6 ttm -73.05 154.44 40.44 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.05 1.74 . . . . 0.0 112.601 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.66 159.38 42.12 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.564 1.546 . . . . 0.0 114.683 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.0 p -93.53 -28.14 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 126.707 2.003 . . . . 0.0 113.04 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -83.39 20.81 1.26 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.464 1.506 . . . . 0.0 112.735 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.27 10.4 p30 46.39 19.77 0.08 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.708 2.803 . . . . 0.0 115.675 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.6 mt -60.68 156.99 41.11 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.146 1.378 . . . . 0.0 112.89 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.89 143.98 81.44 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.081 2.521 . . . . 0.0 110.721 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -77.74 125.61 29.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.171 0.589 . . . . 0.0 110.284 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.0 pt -140.34 131.37 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.457 1.103 . . . . 0.0 112.67 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 172.86 13.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.445 1.898 . . . . 0.0 112.701 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -69.95 113.36 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.417 1.087 . . . . 0.0 110.334 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.81 -48.83 75.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.46 1.504 . . . . 0.0 111.856 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 p -152.24 158.11 42.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.326 1.851 . . . . 0.0 111.171 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -126.1 148.84 49.27 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.881 1.672 . . . . 0.0 109.672 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -149.97 133.99 17.03 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.657 1.183 . . . . 0.0 110.688 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -70.87 129.32 38.75 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.244 0.618 . . . . 0.0 110.982 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.9 mt -96.7 -41.39 8.52 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.065 0.546 . . . . 0.0 111.845 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.24 -140.15 9.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.173 0.892 . . . . 0.0 112.58 -174.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -131.71 81.57 1.98 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.964 1.364 . . . . 0.0 113.056 -168.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -98.11 157.82 15.91 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.88 1.672 . . . . 0.0 110.069 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.2 121.68 14.81 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 121.64 -0.662 . . . . 0.0 109.695 170.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -123.19 149.23 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.502 0.668 . . . . 0.0 111.84 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -136.22 158.77 43.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.574 1.55 . . . . 0.0 111.791 -168.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -154.22 122.76 6.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.819 1.248 . . . . 0.0 110.177 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.1 pt -77.76 159.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.392 -0.817 . . . . 0.0 111.386 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.16 151.92 18.42 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.535 1.064 . . . . 0.0 111.73 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 m -150.27 -172.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 127.16 2.184 . . . . 0.0 109.756 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -62.74 -177.01 0.13 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.338 1.455 . . . . 0.0 113.84 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -41.61 -38.98 1.49 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 127.008 2.123 . . . . 0.0 114.327 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -73.09 73.6 1.21 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.263 1.825 . . . . 0.0 110.775 170.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -66.19 53.5 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 127.746 2.418 . . . . 0.0 114.633 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -142.16 163.79 31.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.341 1.456 . . . . 0.0 112.659 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -157.47 152.13 25.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.555 1.142 . . . . 0.0 111.999 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.86 149.97 26.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.053 0.941 . . . . 0.0 113.178 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.61 176.07 5.27 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.296 1.839 . . . . 0.0 112.419 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -50.33 -49.5 53.71 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.495 1.518 . . . . 0.0 114.651 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -78.6 -9.36 59.34 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.313 1.045 . . . . 0.0 112.775 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 102.09 -7.32 54.61 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.392 1.472 . . . . 0.0 114.997 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -51.26 150.93 3.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.538 1.169 . . . . 0.0 111.444 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.4 107.72 22.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.1 143.54 28.0 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 170.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.3 m -132.51 104.4 6.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.487 1.115 . . . . 0.0 109.996 -172.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.0 t30 . . . . . 0 C--O 1.255 1.374 0 C-N-CA 124.236 1.014 . . . . 0.0 113.396 -174.337 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -125.22 159.39 19.79 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.795 2.14 . . . . 0.0 110.748 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -159.6 175.54 13.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.945 1.298 . . . . 0.0 111.977 -174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.58 144.47 39.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.642 1.577 . . . . 0.0 110.422 -172.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -67.05 164.02 18.73 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.564 -0.71 . . . . 0.0 112.51 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.01 -44.38 64.1 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.977 -1.077 . . . . 0.0 112.026 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -64.24 -13.12 47.22 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.683 1.593 . . . . 0.0 114.383 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.7 m -75.18 81.81 2.33 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.332 1.453 . . . . 0.0 110.894 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -71.12 142.34 50.77 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.773 0.797 . . . . 0.0 111.501 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.5 mm -118.61 128.59 75.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 126.13 1.772 . . . . 0.0 106.373 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -58.17 130.85 48.54 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 122.289 -0.257 . . . . 0.0 110.919 170.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.6 p -131.88 145.15 51.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.223 1.409 . . . . 0.0 111.853 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.15 -32.62 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 121.877 -0.514 . . . . 0.0 111.922 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.74 -35.73 81.55 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -140.33 -48.71 0.44 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -170.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.59 -146.68 18.49 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.982 0.81 . . . . 0.0 113.163 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.4 96.84 1.52 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.268 1.427 . . . . 0.0 111.652 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.45 145.73 55.66 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.612 1.165 . . . . 0.0 112.407 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.14 128.4 21.6 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.78 3.653 . . . . 0.0 113.261 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.84 -37.43 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.746 0.818 . . . . 0.0 112.944 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.56 -32.84 84.54 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.618 -0.546 . . . . 0.0 112.956 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -72.52 -36.79 68.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.98 0.89 . . . . 0.0 111.298 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.89 -39.03 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.656 0.782 . . . . 0.0 109.479 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.52 -42.16 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.909 0.884 . . . . 0.0 113.11 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -75.1 -21.97 58.57 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.374 0.988 . . . . 0.0 113.507 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -109.79 1.72 19.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.145 1.378 . . . . 0.0 112.407 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.42 54.23 8.81 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.875 2.07 . . . . 0.0 113.357 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.5 mt -75.03 119.58 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.632 0.773 . . . . 0.0 110.104 -172.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.3 80.49 1.85 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.912 1.685 . . . . 0.0 112.221 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.6 p -119.49 178.49 4.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.02 1.328 . . . . 0.0 112.625 -171.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.5 m -119.25 149.46 41.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.243 1.417 . . . . 0.0 108.339 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.3 175.88 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.794 1.637 . . . . 0.0 110.967 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -121.24 142.59 49.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.428 1.491 . . . . 0.0 110.382 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.9 t -165.18 154.17 12.36 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.686 1.195 . . . . 0.0 110.835 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.4 m -84.91 145.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.665 1.12 . . . . 0.0 112.468 172.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.91 179.1 7.63 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.95 0.9 . . . . 0.0 111.917 172.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -60.59 -20.21 59.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -90.78 -0.73 57.8 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.218 1.407 . . . . 0.0 113.273 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.23 32.26 48.86 Favored Glycine 0 CA--C 1.536 1.387 0 O-C-N 121.33 -0.856 . . . . 0.0 114.099 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -112.64 121.51 44.98 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.494 1.518 . . . . 0.0 109.554 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.96 113.17 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -116.71 178.29 4.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.055 1.742 . . . . 0.0 110.528 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -128.02 143.31 51.07 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.859 0.863 . . . . 0.0 113.106 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -144.59 147.06 34.65 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.295 1.038 . . . . 0.0 113.605 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.62 150.07 50.25 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.108 2.539 . . . . 0.0 112.307 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.53 147.33 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.169 0.988 . . . . 0.0 110.808 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.64 -44.69 3.46 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.036 0.934 . . . . 0.0 111.992 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -142.41 178.17 7.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.759 1.623 . . . . 0.0 111.479 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -137.58 120.52 16.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.309 1.443 . . . . 0.0 109.29 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -118.77 138.73 52.48 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.075 0.941 . . . . 0.0 111.161 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -131.71 115.7 16.36 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.879 1.672 . . . . 0.0 110.046 -171.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -79.84 -32.13 40.53 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.982 1.313 . . . . 0.0 113.052 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.87 -53.24 1.43 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.762 1.648 . . . . 0.0 114.86 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -171.04 99.55 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.214 1.507 . . . . 0.0 111.577 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -134.51 168.05 19.67 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.486 1.114 . . . . 0.0 113.119 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -67.35 97.67 0.58 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.16 1.784 . . . . 0.0 114.278 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.9 t -94.01 138.79 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.194 1.398 . . . . 0.0 111.376 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -119.43 147.07 44.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.333 1.053 . . . . 0.0 110.448 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -82.33 123.99 29.58 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.585 1.154 . . . . 0.0 109.417 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -112.81 105.18 13.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.418 1.087 . . . . 0.0 108.722 174.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.3 t -96.19 122.17 38.76 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mp -79.24 156.72 28.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.697 0.799 . . . . 0.0 110.794 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -67.56 -18.49 65.03 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.62 -26.16 50.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.55 0.74 . . . . 0.0 112.764 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.23 -12.36 7.58 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.433 1.492 . . . . 0.0 114.275 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.1 m -60.02 148.24 36.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.41 1.084 . . . . 0.0 112.405 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -127.92 135.65 50.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.465 1.506 . . . . 0.0 110.715 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.0 mt -135.69 142.9 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.765 1.626 . . . . 0.0 108.095 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -134.03 110.85 9.92 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.784 1.234 . . . . 0.0 111.383 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.69 166.51 30.17 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.636 1.175 . . . . 0.0 110.541 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -70.18 150.04 46.89 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.55 -0.719 . . . . 0.0 111.408 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -61.07 -21.04 63.28 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -85.76 -16.18 39.71 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.883 2.073 . . . . 0.0 112.6 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -73.38 135.66 44.28 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -89.85 154.29 19.99 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.813 0.845 . . . . 0.0 111.932 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -137.2 144.36 42.83 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.084 -1.01 . . . . 0.0 111.465 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 37.6 ttm -73.81 104.0 4.55 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.002 0.921 . . . . 0.0 110.344 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.2 p -67.88 167.15 14.14 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.745 -0.597 . . . . 0.0 111.193 172.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.88 -26.79 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -79.63 -12.15 59.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.515 1.126 . . . . 0.0 113.292 175.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.95 3.7 65.59 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.127 1.346 . . . . 0.0 114.025 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -69.61 161.14 30.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.08 0.952 . . . . 0.0 110.699 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.4 ptp -127.46 80.88 1.98 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.836 1.254 . . . . 0.0 109.763 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.51 150.1 39.68 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 125.075 1.35 . . . . 0.0 110.403 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.38 142.07 77.38 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.491 2.127 . . . . 0.0 110.349 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.4 tt -60.34 -23.23 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.65 -27.72 65.02 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 170.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -89.59 -38.62 13.82 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.428 1.091 . . . . 0.0 111.852 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.35 -38.45 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 121.286 -0.884 . . . . 0.0 111.311 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.18 -36.76 80.71 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -78.92 -41.97 28.21 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.443 0.697 . . . . 0.0 112.467 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -74.34 -13.49 60.75 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 55.64 28.49 12.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.621 1.568 . . . . 0.0 112.86 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.9 128.63 35.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.554 0.742 . . . . 0.0 110.048 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.75 154.19 42.41 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 122.366 1.079 . . . . 0.0 112.329 171.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.3 mt -96.15 152.26 18.72 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.696 1.198 . . . . 0.0 111.924 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 35.3 ttm -72.38 138.39 47.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.501 0.32 . . . . 0.0 110.479 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 162.57 16.25 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.065 1.346 . . . . 0.0 113.782 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.7 -23.09 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.384 1.474 . . . . 0.0 113.978 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -101.44 8.56 42.06 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.003 0.921 . . . . 0.0 113.392 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 m120 67.33 22.15 9.61 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.663 1.585 . . . . 0.0 112.234 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.1 mt -54.34 159.19 3.32 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.497 1.519 . . . . 0.0 112.049 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.65 145.72 82.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.388 2.059 . . . . 0.0 110.722 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -67.13 121.7 16.2 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.519 -0.738 . . . . 0.0 111.162 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.2 pt -144.82 137.61 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.84 1.656 . . . . 0.0 110.317 -174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.6 175.52 5.63 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.715 1.606 . . . . 0.0 111.042 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.72 104.82 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.454 1.102 . . . . 0.0 110.513 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.9 -41.16 78.61 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.759 1.224 . . . . 0.0 112.363 -175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.6 p -146.78 154.72 41.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.537 1.535 . . . . 0.0 111.288 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -133.81 139.16 46.11 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.621 1.568 . . . . 0.0 110.987 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -141.45 130.26 22.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.474 1.51 . . . . 0.0 110.02 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.04 121.74 16.22 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 122.503 0.321 . . . . 0.0 110.392 173.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.3 mt -87.09 -40.34 14.75 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.874 0.469 . . . . 0.0 111.795 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.21 -144.87 15.87 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.329 0.966 . . . . 0.0 112.583 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -124.6 81.46 1.95 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.935 1.35 . . . . 0.0 112.486 -168.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -98.74 158.06 15.87 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.613 1.565 . . . . 0.0 110.948 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.44 119.13 9.82 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.644 0.778 . . . . 0.0 110.323 171.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.87 149.43 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.483 0.713 . . . . 0.0 111.216 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -139.09 158.4 44.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.861 1.664 . . . . 0.0 111.771 -168.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -156.28 121.48 4.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.747 1.219 . . . . 0.0 110.297 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.8 pt -73.27 155.74 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 120.911 -1.118 . . . . 0.0 111.467 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.89 147.61 16.36 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.662 1.125 . . . . 0.0 111.74 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.88 152.43 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.965 2.106 . . . . 0.0 109.845 -169.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -101.13 -33.69 10.01 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -169.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -72.82 -48.24 39.56 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.988 0.915 . . . . 0.0 112.44 -174.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -162.71 162.92 27.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.077 2.551 . . . . 0.0 109.559 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -104.01 57.74 0.72 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.134 0.974 . . . . 0.0 112.167 -169.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -155.62 156.57 35.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.401 1.08 . . . . 0.0 113.776 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -162.14 160.78 27.66 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.389 1.476 . . . . 0.0 112.516 -173.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.44 148.84 21.78 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.489 1.116 . . . . 0.0 113.864 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 54.2 mt -100.73 166.44 10.87 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.267 1.827 . . . . 0.0 113.018 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -57.73 -33.18 68.16 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -75.81 -13.71 60.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.704 0.801 . . . . 0.0 112.625 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.89 30.29 5.83 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 117.579 -1.679 . . . . 0.0 114.841 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.0 165.33 22.38 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.783 1.792 . . . . 0.0 111.778 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.06 139.24 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.104 0.962 . . . . 0.0 110.13 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.04 152.92 46.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.609 1.564 . . . . 0.0 110.654 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.5 t -136.48 140.82 43.35 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.143 1.377 . . . . 0.0 112.342 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -169.487 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 CA-C-O 120.972 0.206 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -143.94 174.24 24.4 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 129.132 3.253 . . . . 0.0 110.23 -171.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.42 170.07 17.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -106.73 152.32 23.97 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.784 1.233 . . . . 0.0 110.974 -175.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 t -63.2 161.7 13.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -52.49 -43.86 65.28 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.79 0.836 . . . . 0.0 112.221 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -60.9 -23.22 65.05 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.67 1.588 . . . . 0.0 113.52 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.7 m -66.15 114.73 5.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.101 0.961 . . . . 0.0 111.557 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -94.58 140.42 29.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.647 0.736 . . . . 0.0 112.439 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 mm -118.03 125.24 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 126.365 1.866 . . . . 0.0 108.103 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 tp -64.25 129.48 40.1 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.558 0.743 . . . . 0.0 111.369 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.9 p -128.4 156.58 42.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.122 1.369 . . . . 0.0 112.063 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 t -78.05 -31.64 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 O-C-N 121.739 -0.601 . . . . 0.0 111.88 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.04 -35.13 79.7 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -139.93 -44.97 0.43 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.33 -143.78 14.96 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.194 0.902 . . . . 0.0 111.288 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.0 mt -67.32 111.77 4.19 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.079 1.351 . . . . 0.0 111.279 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.1 mt -139.76 151.73 66.59 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.829 1.252 . . . . 0.0 113.323 176.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.55 128.72 20.73 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.131 3.221 . . . . 0.0 112.638 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 tt -58.24 -35.91 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.83 -31.54 81.24 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.867 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -71.24 -37.53 71.98 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.491 1.145 . . . . 0.0 111.322 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.45 -37.74 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.523 0.729 . . . . 0.0 110.762 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.6 t -85.7 -36.4 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.35 0.66 . . . . 0.0 112.657 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.77 -25.39 63.79 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.264 -0.897 . . . . 0.0 113.298 174.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -113.44 2.84 15.56 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.086 1.354 . . . . 0.0 113.0 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 46.82 47.98 15.07 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 127.538 2.335 . . . . 0.0 112.702 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.9 mt -70.61 121.31 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.798 1.239 . . . . 0.0 109.38 -174.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -82.37 120.18 25.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.912 0.863 . . . . 0.0 110.93 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.6 p -153.01 164.01 38.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.55 1.14 . . . . 0.0 112.75 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.7 145.8 24.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.074 1.35 . . . . 0.0 109.813 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.47 176.74 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.391 1.876 . . . . 0.0 110.756 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -121.75 144.26 48.9 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.179 1.392 . . . . 0.0 110.697 -176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.2 t -158.73 167.23 30.05 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.586 1.554 . . . . 0.0 110.599 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.78 123.98 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.156 1.382 . . . . 0.0 110.086 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.5 179.52 4.02 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.6 -18.88 65.3 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -90.21 -2.26 58.03 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.643 1.577 . . . . 0.0 112.086 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.79 29.89 62.52 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.053 1.787 . . . . 0.0 114.614 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -111.85 140.15 46.73 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.155 1.382 . . . . 0.0 110.497 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.3 mt -67.95 133.07 32.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -138.47 166.67 23.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.558 1.543 . . . . 0.0 111.452 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 p -118.08 143.53 46.37 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.418 1.087 . . . . 0.0 111.714 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -150.83 146.71 19.7 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.656 1.182 . . . . 0.0 111.951 -172.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.34 151.59 48.59 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.881 2.387 . . . . 0.0 112.495 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.2 139.46 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.103 0.961 . . . . 0.0 111.449 169.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.45 -35.29 9.61 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.186 0.995 . . . . 0.0 113.075 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.14 175.48 13.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.782 1.233 . . . . 0.0 112.777 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -124.14 135.66 53.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.565 1.546 . . . . 0.0 108.809 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -124.36 119.67 29.92 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.04 1.336 . . . . 0.0 110.86 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.57 110.02 16.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 110.432 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -87.37 -30.21 20.94 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.597 1.159 . . . . 0.0 112.988 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.9 -52.01 2.91 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.044 1.307 . . . . 0.0 114.099 171.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -170.97 98.46 0.21 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.588 1.194 . . . . 0.0 111.201 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -129.96 162.98 27.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.33 1.052 . . . . 0.0 112.155 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.39 102.3 1.39 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.69 1.196 . . . . 0.0 113.191 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.6 t -94.93 138.27 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.445 1.498 . . . . 0.0 110.925 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -124.89 144.92 50.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.274 1.43 . . . . 0.0 110.029 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -65.18 127.61 32.41 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.968 0.907 . . . . 0.0 110.469 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -119.51 86.58 2.58 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.874 1.67 . . . . 0.0 108.419 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.0 t -89.7 144.56 25.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.161 0.984 . . . . 0.0 110.787 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.02 163.92 12.88 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.369 1.067 . . . . 0.0 112.668 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.42 -20.33 63.79 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -76.05 -26.52 56.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.526 1.13 . . . . 0.0 112.555 171.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.16 -1.97 23.98 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.969 1.271 . . . . 0.0 113.998 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.59 147.22 42.43 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.937 1.295 . . . . 0.0 111.269 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.1 mt -134.84 130.78 36.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.117 1.367 . . . . 0.0 110.645 -172.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.6 mt -137.91 151.41 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.462 1.905 . . . . 0.0 107.757 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -136.26 106.15 6.26 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.663 1.185 . . . . 0.0 110.165 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.46 166.32 24.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.099 1.36 . . . . 0.0 111.89 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.1 p -86.85 157.32 19.57 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.924 0.869 . . . . 0.0 112.627 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -72.61 -5.01 34.39 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -91.34 -15.58 28.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.341 1.057 . . . . 0.0 112.556 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -77.63 131.67 37.89 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.699 -0.626 . . . . 0.0 111.147 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -90.03 153.97 20.17 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.19 0.996 . . . . 0.0 111.172 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -139.0 143.82 38.65 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.568 0.747 . . . . 0.0 110.416 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.2 ttm -74.11 104.35 4.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.155 0.982 . . . . 0.0 110.533 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.7 p -68.75 171.04 8.36 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.199 0.523 . . . . 0.0 111.936 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.1 m -56.57 -24.79 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 173.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -92.17 -6.15 51.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.145 0.978 . . . . 0.0 113.268 174.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.41 24.04 52.21 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.789 1.185 . . . . 0.0 113.793 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -88.82 120.26 30.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.081 0.952 . . . . 0.0 110.661 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.1 mmt -80.62 80.33 7.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.359 1.064 . . . . 0.0 111.68 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.3 mt -112.96 147.43 37.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 124.754 1.222 . . . . 0.0 110.888 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.84 146.92 84.57 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.57 2.18 . . . . 0.0 110.992 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.24 -25.05 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -55.89 -34.43 65.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.833 1.253 . . . . 0.0 113.014 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.0 -41.54 25.63 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.927 0.891 . . . . 0.0 110.496 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.88 -36.16 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.991 0.916 . . . . 0.0 111.498 -174.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -66.72 -35.44 80.12 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.24 -35.7 21.41 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.491 -0.756 . . . . 0.0 112.642 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -74.11 -17.52 60.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.403 1.081 . . . . 0.0 113.018 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 54.78 33.64 20.1 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.249 1.42 . . . . 0.0 112.963 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.4 mt -76.02 143.39 41.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.768 0.827 . . . . 0.0 111.907 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -88.53 148.07 24.3 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.815 0.846 . . . . 0.0 110.92 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.9 156.86 22.18 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.385 -0.822 . . . . 0.0 112.367 168.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 7.9 ttp -88.84 158.57 18.07 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.75 1.22 . . . . 0.0 111.378 169.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.12 165.57 25.4 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.061 1.345 . . . . 0.0 112.9 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.1 m -88.44 -21.77 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.01 13.52 34.53 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.206 1.002 . . . . 0.0 113.084 -171.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.1 m120 58.44 29.25 18.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.195 1.798 . . . . 0.0 112.429 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 mt -57.66 153.93 28.18 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.223 173.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.83 140.19 50.04 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.648 2.899 . . . . 0.0 111.15 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -79.82 120.59 24.28 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.017 0.527 . . . . 0.0 111.01 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.5 pt -142.8 153.5 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.908 1.683 . . . . 0.0 111.56 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.62 -179.6 3.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.911 1.684 . . . . 0.0 111.806 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.1 mt -64.43 114.65 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.107 0.963 . . . . 0.0 110.214 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.42 -41.16 73.27 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.839 1.256 . . . . 0.0 112.316 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.75 157.81 34.1 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.223 1.409 . . . . 0.0 111.009 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -137.12 143.83 42.72 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.491 1.516 . . . . 0.0 110.562 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -151.09 134.51 16.21 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.49 1.516 . . . . 0.0 109.506 169.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -63.6 123.4 18.72 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.705 0.684 . . . . 0.0 110.375 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.2 mt -90.04 -44.02 10.12 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.01 0.524 . . . . 0.0 111.692 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 148.38 -148.11 19.3 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.329 0.966 . . . . 0.0 112.979 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -126.6 67.87 1.24 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 123.576 1.655 . . . . 0.0 112.469 -168.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -85.74 158.02 20.13 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 126.723 2.009 . . . . 0.0 110.635 -169.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.04 119.65 9.9 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.135 0.574 . . . . 0.0 110.5 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -123.06 150.49 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.41 0.624 . . . . 0.0 111.839 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -140.06 157.84 45.0 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.215 1.806 . . . . 0.0 112.264 -168.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -152.67 167.37 29.17 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.916 1.687 . . . . 0.0 110.969 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.8 145.72 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.417 1.487 . . . . 0.0 111.338 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.09 160.44 23.06 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.79 0.709 . . . . 0.0 112.865 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.68 151.1 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.36 1.864 . . . . 0.0 110.487 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -82.86 150.24 26.65 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.474 -0.766 . . . . 0.0 111.938 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 56.43 16.72 2.58 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 126.159 1.783 . . . . 0.0 114.843 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -159.01 164.92 35.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.124 1.37 . . . . 0.0 111.858 -169.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -142.92 21.06 1.96 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -156.0 173.26 17.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.433 1.493 . . . . 0.0 112.683 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -163.34 166.55 22.87 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.836 1.254 . . . . 0.0 111.809 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.92 140.49 31.38 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.015 0.926 . . . . 0.0 112.949 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 65.3 mt -91.73 170.49 9.87 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.143 1.777 . . . . 0.0 111.882 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -47.17 -58.12 4.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.779 1.632 . . . . 0.0 115.22 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -67.13 -39.64 86.65 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.556 0.342 . . . . 0.0 110.861 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.33 -2.97 0.85 Allowed Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.475 -1.181 . . . . 0.0 115.331 172.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -59.49 160.89 6.39 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.176 1.488 . . . . 0.0 112.332 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.91 129.14 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.63 0.729 . . . . 0.0 110.179 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -118.52 145.65 45.16 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.991 1.716 . . . . 0.0 109.977 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.3 t -136.78 149.15 47.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.542 1.137 . . . . 0.0 114.006 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.8 t30 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.895 1.678 . . . . 0.0 113.648 -172.046 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.876 0 CA-C-O 119.108 -0.829 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 62.98 179.15 4.54 Favored Glycine 0 C--N 1.341 0.854 0 C-N-CA 126.039 1.78 . . . . 0.0 115.198 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -151.17 169.13 22.64 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.345 1.058 . . . . 0.0 112.207 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.8 mt -120.78 146.87 46.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.386 1.874 . . . . 0.0 109.514 -172.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 t -70.15 160.34 32.26 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.585 -0.697 . . . . 0.0 111.437 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -49.09 -40.9 33.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.292 1.037 . . . . 0.0 112.344 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.88 -24.8 54.47 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.983 1.713 . . . . 0.0 113.777 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.2 m -72.14 102.65 3.09 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.293 1.037 . . . . 0.0 110.942 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -87.52 145.87 26.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.747 0.784 . . . . 0.0 111.67 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -122.81 128.84 75.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 126.501 1.92 . . . . 0.0 107.317 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.2 tp -61.95 127.76 32.94 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.834 0.454 . . . . 0.0 111.37 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.3 p -125.57 150.44 47.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.847 1.259 . . . . 0.0 112.368 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.42 -32.39 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.287 0.635 . . . . 0.0 111.982 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -66.22 -30.42 70.87 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -142.56 -56.55 0.44 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -173.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.26 -147.81 19.44 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.835 0.731 . . . . 0.0 112.681 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.4 104.75 1.97 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.084 1.353 . . . . 0.0 111.347 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.4 mt -134.61 148.68 68.35 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.434 1.094 . . . . 0.0 113.451 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.52 129.53 24.05 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.462 3.441 . . . . 0.0 112.665 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.1 tt -56.29 -35.31 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.609 0.764 . . . . 0.0 112.888 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.79 -34.36 89.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.566 -0.574 . . . . 0.0 112.724 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -73.92 -29.63 62.15 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.654 1.227 . . . . 0.0 112.015 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.6 mt -71.77 -41.96 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.452 1.101 . . . . 0.0 109.769 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.29 -39.99 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.756 0.822 . . . . 0.0 113.004 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.11 -26.3 65.74 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.308 0.958 . . . . 0.0 112.643 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.45 2.04 15.27 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.616 1.166 . . . . 0.0 113.398 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 46.89 50.68 13.4 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.344 2.258 . . . . 0.0 112.139 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.3 mt -67.05 120.19 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.873 0.869 . . . . 0.0 108.868 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -84.4 98.57 10.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.945 0.879 . . . . 0.0 110.321 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p -132.02 -171.14 2.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.08 1.352 . . . . 0.0 111.463 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.25 142.23 50.9 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.458 1.503 . . . . 0.0 108.008 -176.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.48 172.94 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.802 1.641 . . . . 0.0 110.169 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -117.55 145.19 44.43 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.012 1.325 . . . . 0.0 110.194 -173.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.4 t -159.07 167.03 30.31 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.29 1.436 . . . . 0.0 110.139 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -113.31 127.29 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.158 1.383 . . . . 0.0 110.824 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.17 179.61 6.77 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.276 1.036 . . . . 0.0 111.951 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -57.34 -24.84 57.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.142 1.377 . . . . 0.0 113.405 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -88.73 -6.4 57.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.816 1.646 . . . . 0.0 113.827 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.78 4.14 89.0 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.263 0.935 . . . . 0.0 114.786 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -77.37 128.48 34.35 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.11 0.955 . . . . 0.0 109.906 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.68 107.38 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -107.48 175.22 5.56 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.574 1.549 . . . . 0.0 110.403 175.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.6 p -130.99 149.03 52.8 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.703 0.801 . . . . 0.0 112.789 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -146.07 144.52 21.9 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.788 1.235 . . . . 0.0 111.997 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.44 151.21 47.57 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.819 2.346 . . . . 0.0 112.172 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.31 122.0 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 169.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.03 -47.63 12.41 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.27 -0.269 . . . . 0.0 111.56 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -148.7 179.14 8.05 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.021 1.729 . . . . 0.0 111.585 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -137.47 142.08 41.55 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.732 1.613 . . . . 0.0 110.289 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -136.79 132.38 34.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.999 0.92 . . . . 0.0 111.614 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -124.06 119.66 30.16 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.471 1.508 . . . . 0.0 110.595 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -84.82 -32.25 23.41 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.692 1.197 . . . . 0.0 113.086 -173.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 -53.33 1.33 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.528 1.537 . . . . 0.0 113.975 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -170.09 101.51 0.29 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.086 1.354 . . . . 0.0 111.087 -173.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -131.57 160.87 34.04 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.531 1.133 . . . . 0.0 111.899 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.91 106.52 1.25 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.405 1.082 . . . . 0.0 112.925 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.65 134.75 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.25 1.42 . . . . 0.0 111.358 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -119.78 140.78 50.22 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.76 1.224 . . . . 0.0 110.31 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.11 132.01 35.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.127 0.971 . . . . 0.0 108.799 168.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.18 89.04 3.05 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.112 1.365 . . . . 0.0 108.541 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 45.6 t -71.88 129.29 38.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.662 0.785 . . . . 0.0 110.377 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -88.54 164.87 15.21 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.201 1.0 . . . . 0.0 112.304 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.17 -23.02 67.16 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -82.18 -26.59 33.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.654 1.182 . . . . 0.0 113.084 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.95 -4.58 16.41 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.029 1.299 . . . . 0.0 114.264 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 m -58.54 141.34 52.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.556 1.178 . . . . 0.0 110.802 173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.32 122.2 40.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.939 0.896 . . . . 0.0 109.52 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -110.97 131.09 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -124.66 97.35 5.25 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.38 1.072 . . . . 0.0 109.884 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.9 169.82 17.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.54 1.136 . . . . 0.0 113.03 -168.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 p -84.75 152.2 23.86 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.443 1.097 . . . . 0.0 111.486 169.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -62.65 -12.27 22.3 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.35 -13.49 34.99 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.32 1.448 . . . . 0.0 112.376 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -82.87 134.77 35.08 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.599 0.636 . . . . 0.0 109.666 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -86.91 156.75 19.7 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.657 0.783 . . . . 0.0 111.345 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -137.69 142.64 41.09 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.783 0.833 . . . . 0.0 109.286 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 31.1 ttp -79.52 106.17 11.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.024 0.529 . . . . 0.0 110.0 -174.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.4 p -66.47 169.33 7.67 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.008 0.523 . . . . 0.0 111.909 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 m -56.44 -27.87 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.8 -14.48 54.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.386 1.074 . . . . 0.0 113.283 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.68 6.06 56.45 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.445 1.497 . . . . 0.0 114.705 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -71.7 155.34 40.59 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.692 1.246 . . . . 0.0 111.384 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.7 ptp -116.86 74.24 0.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.803 1.241 . . . . 0.0 110.961 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.73 147.0 33.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.487 1.115 . . . . 0.0 110.977 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.78 146.96 92.53 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.034 2.49 . . . . 0.0 111.159 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tt -59.27 -24.78 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -54.78 -38.69 67.58 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.861 1.265 . . . . 0.0 112.61 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -81.28 -38.75 26.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.19 0.596 . . . . 0.0 110.848 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.2 mt -61.88 -40.89 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.389 -0.82 . . . . 0.0 111.665 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -64.33 -39.36 93.74 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.88 -40.12 25.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.968 0.907 . . . . 0.0 113.069 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -81.03 -11.96 59.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.754 1.222 . . . . 0.0 112.938 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 57.87 32.91 22.58 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.403 1.481 . . . . 0.0 112.737 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 mt -70.31 133.48 47.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.663 1.185 . . . . 0.0 110.971 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -72.11 154.58 41.0 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.546 -0.721 . . . . 0.0 111.76 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.5 mt -105.89 147.66 28.49 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.936 0.894 . . . . 0.0 112.406 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.8 ttm -70.17 151.64 45.18 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.511 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.27 174.04 10.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.481 1.112 . . . . 0.0 112.545 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.0 -0.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 125.775 1.63 . . . . 0.0 114.694 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.29 12.55 21.68 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.299 1.44 . . . . 0.0 113.265 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.8 m120 59.98 25.05 14.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.228 1.811 . . . . 0.0 113.02 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.8 mt -63.75 159.1 56.16 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.976 1.71 . . . . 0.0 112.013 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.19 146.2 80.76 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.004 2.47 . . . . 0.0 111.477 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -76.43 113.54 14.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.095 0.558 . . . . 0.0 109.708 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.95 150.58 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.318 1.447 . . . . 0.0 111.232 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.09 174.23 6.03 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.652 1.581 . . . . 0.0 111.21 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.4 mt -66.18 113.37 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.881 0.872 . . . . 0.0 109.878 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.28 74.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.026 1.331 . . . . 0.0 111.628 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.7 p -153.38 160.76 42.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.212 1.805 . . . . 0.0 111.784 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -117.4 145.26 44.22 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.081 1.752 . . . . 0.0 110.456 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -147.0 121.67 9.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.25 1.02 . . . . 0.0 110.871 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -64.18 135.84 56.68 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.84 -0.538 . . . . 0.0 111.175 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.5 mt -105.99 -37.98 6.47 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.255 0.622 . . . . 0.0 112.167 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.23 -144.78 15.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.458 1.028 . . . . 0.0 112.462 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -128.8 78.77 1.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 123.193 1.473 . . . . 0.0 112.141 -169.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -96.84 160.35 14.41 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.916 1.686 . . . . 0.0 111.074 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.44 119.32 8.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.392 0.677 . . . . 0.0 110.433 169.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.97 150.67 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.451 0.644 . . . . 0.0 111.384 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -138.44 158.76 43.65 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.67 1.588 . . . . 0.0 112.217 -168.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -158.23 133.4 8.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.425 1.09 . . . . 0.0 110.992 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.8 pt -82.3 158.4 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.389 -0.819 . . . . 0.0 111.354 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.22 139.9 15.79 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.84 1.209 . . . . 0.0 111.424 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 m -146.21 151.57 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.652 1.981 . . . . 0.0 110.002 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -117.9 -24.86 6.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.327 1.051 . . . . 0.0 112.916 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -65.7 -28.96 69.45 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.576 1.55 . . . . 0.0 112.91 174.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -157.59 -171.3 3.52 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.111 1.765 . . . . 0.0 110.928 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.06 38.31 2.77 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.924 1.69 . . . . 0.0 112.797 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.37 160.59 13.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.26 1.024 . . . . 0.0 113.29 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -153.96 154.93 34.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.842 1.657 . . . . 0.0 111.984 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.24 131.65 34.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.526 1.131 . . . . 0.0 112.688 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 38.5 mt -82.87 170.59 14.82 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.172 1.389 . . . . 0.0 112.669 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -55.66 -41.15 73.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -75.32 -33.28 61.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.39 0.676 . . . . 0.0 111.577 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.4 -9.15 5.02 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.163 1.363 . . . . 0.0 114.304 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.74 173.1 5.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.614 1.707 . . . . 0.0 111.79 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.29 122.0 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.472 0.709 . . . . 0.0 109.843 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.63 131.48 44.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.336 1.054 . . . . 0.0 108.369 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 p -108.61 143.35 37.78 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.581 1.552 . . . . 0.0 110.775 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--O 1.255 1.394 0 CA-C-O 117.653 -1.165 . . . . 0.0 113.1 -167.811 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 112.382 -0.287 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -139.12 164.1 25.89 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 126.684 2.088 . . . . 0.0 112.182 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.08 179.19 7.69 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.989 1.315 . . . . 0.0 112.55 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.6 150.27 36.93 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.034 1.733 . . . . 0.0 111.015 -173.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 t -69.52 163.77 24.67 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.5 -0.75 . . . . 0.0 112.186 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -50.2 -43.82 52.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.914 0.885 . . . . 0.0 112.011 172.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -62.54 -15.77 52.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.993 1.317 . . . . 0.0 114.322 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.8 m -70.94 102.21 2.35 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.081 0.953 . . . . 0.0 111.043 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -86.24 137.65 32.46 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.357 0.663 . . . . 0.0 112.11 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.2 mm -122.9 119.13 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.896 1.678 . . . . 0.0 107.929 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.24 127.88 33.53 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 122.253 -0.279 . . . . 0.0 111.161 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.6 p -124.93 155.94 38.78 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.72 1.608 . . . . 0.0 112.375 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.6 t -81.24 -33.68 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.992 0.517 . . . . 0.0 111.72 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.31 -25.78 61.7 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -137.88 -53.85 0.65 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.95 0.9 . . . . 0.0 113.281 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.73 -146.46 18.27 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.1 0.857 . . . . 0.0 112.352 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -74.44 107.31 6.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.067 1.747 . . . . 0.0 110.925 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.56 157.07 48.74 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.25 132.86 26.91 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.172 3.248 . . . . 0.0 112.925 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.6 tt -56.42 -34.79 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.767 0.827 . . . . 0.0 112.987 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.9 -34.22 89.34 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.731 -0.606 . . . . 0.0 112.784 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -71.59 -32.72 68.34 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.481 1.141 . . . . 0.0 111.921 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.9 mt -67.48 -43.38 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.124 0.969 . . . . 0.0 110.153 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.5 t -82.66 -36.67 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.832 0.853 . . . . 0.0 112.669 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -65.8 -27.07 68.0 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.141 0.882 . . . . 0.0 112.857 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -116.33 2.65 13.25 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.32 1.048 . . . . 0.0 113.529 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 46.62 52.62 10.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.924 2.49 . . . . 0.0 112.528 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.7 mt -74.11 119.99 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.278 1.031 . . . . 0.0 109.936 -172.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -71.95 108.37 5.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.916 0.887 . . . . 0.0 110.532 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.5 p -148.15 161.09 42.16 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.363 1.078 . . . . 0.0 113.844 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 151.83 19.23 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.909 1.684 . . . . 0.0 109.907 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.35 170.99 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 125.251 1.42 . . . . 0.0 111.347 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -114.87 142.23 46.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.477 1.511 . . . . 0.0 111.093 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.8 t -164.44 152.69 12.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.174 1.389 . . . . 0.0 110.653 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 m -81.67 154.64 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.625 1.102 . . . . 0.0 112.698 170.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -96.08 -174.81 3.2 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.648 1.579 . . . . 0.0 113.221 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -62.77 -13.35 32.04 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -98.55 -5.41 32.12 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.4 1.48 . . . . 0.0 112.361 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.19 26.28 44.78 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.728 1.156 . . . . 0.0 114.588 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -109.82 122.82 48.4 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.135 1.468 . . . . 0.0 110.165 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 mt -67.69 103.12 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.979 0.912 . . . . 0.0 109.41 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -100.86 179.08 4.5 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.737 1.615 . . . . 0.0 111.031 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 p -126.84 143.1 51.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.192 0.997 . . . . 0.0 112.957 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -144.96 144.25 23.33 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 125.004 1.322 . . . . 0.0 112.442 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.51 149.21 43.87 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.098 2.532 . . . . 0.0 112.11 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.34 137.91 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.873 0.869 . . . . 0.0 110.745 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.64 -34.74 12.48 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -167.43 178.6 5.39 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.972 1.709 . . . . 0.0 112.308 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.2 m-90 -132.69 137.28 46.88 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.214 1.405 . . . . 0.0 110.217 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -127.59 114.78 17.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.685 1.194 . . . . 0.0 111.313 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.29 108.19 19.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.424 1.49 . . . . 0.0 109.877 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -78.49 -29.36 46.68 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.304 1.042 . . . . 0.0 112.752 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.31 -45.85 2.22 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.268 1.413 . . . . 0.0 114.026 171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 177.21 102.75 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.436 1.495 . . . . 0.0 112.183 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -132.22 166.66 21.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.747 1.219 . . . . 0.0 112.373 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.86 100.09 0.91 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.401 1.48 . . . . 0.0 113.851 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.86 141.7 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.346 1.458 . . . . 0.0 111.617 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -123.4 140.2 53.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.176 1.791 . . . . 0.0 110.217 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.11 130.05 44.79 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.979 0.912 . . . . 0.0 109.959 172.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -128.15 97.04 4.64 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.381 1.072 . . . . 0.0 108.232 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 45.9 t -111.34 142.16 43.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.166 0.987 . . . . 0.0 110.355 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -104.04 162.26 13.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.772 1.229 . . . . 0.0 112.117 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.85 -20.57 65.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.444 1.098 . . . . 0.0 113.723 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -76.11 -28.25 57.43 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.601 1.161 . . . . 0.0 113.031 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.91 -0.25 19.67 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.737 1.161 . . . . 0.0 114.547 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 m -58.27 146.86 32.65 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.319 1.06 . . . . 0.0 111.173 171.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.0 124.93 27.1 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.486 1.114 . . . . 0.0 110.435 -171.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.2 mt -137.61 150.51 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.942 2.097 . . . . 0.0 108.091 -170.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -136.62 110.91 8.43 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.57 1.148 . . . . 0.0 110.062 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.24 160.57 40.75 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.333 1.453 . . . . 0.0 111.518 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 p -75.31 151.0 38.33 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.385 -0.822 . . . . 0.0 111.782 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -63.19 -19.14 64.24 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.35 -15.18 56.09 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.772 1.629 . . . . 0.0 112.679 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -79.58 132.95 36.42 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.736 0.814 . . . . 0.0 110.038 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -93.79 146.68 23.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.592 1.157 . . . . 0.0 112.385 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -128.74 151.84 49.1 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.845 -1.159 . . . . 0.0 111.483 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.3 ttp -92.78 100.48 12.95 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.447 0.699 . . . . 0.0 110.563 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.7 p -69.33 172.6 6.82 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.583 0.753 . . . . 0.0 112.342 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 m -52.56 -29.55 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -86.94 -10.04 54.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.082 0.953 . . . . 0.0 113.342 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.96 10.89 62.21 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.793 1.187 . . . . 0.0 114.135 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -67.61 158.72 31.45 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.235 1.018 . . . . 0.0 111.024 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 37.0 mtm -126.21 70.99 1.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.783 1.633 . . . . 0.0 109.848 -173.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 mt -111.81 149.28 40.57 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 124.895 1.278 . . . . 0.0 110.599 -170.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.41 149.37 88.13 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.646 2.231 . . . . 0.0 110.379 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.51 -28.57 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -55.19 -35.22 64.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.678 1.191 . . . . 0.0 113.007 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.49 -37.9 59.88 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.283 1.033 . . . . 0.0 111.471 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.7 mt -68.24 -38.51 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.603 1.161 . . . . 0.0 109.945 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.96 -37.15 86.34 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -75.09 -46.72 32.74 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -79.43 -5.4 54.61 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 56.48 35.48 26.05 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.626 1.57 . . . . 0.0 112.531 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.99 132.18 47.97 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.524 1.13 . . . . 0.0 110.825 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -75.31 136.85 40.85 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.838 -0.539 . . . . 0.0 110.328 171.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.96 152.64 44.22 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.289 -0.882 . . . . 0.0 111.35 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.9 ttm -71.06 150.82 45.17 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.378 168.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.81 161.53 25.07 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.61 1.564 . . . . 0.0 112.598 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -113.6 -13.57 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.941 1.696 . . . . 0.0 114.133 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -109.48 11.55 24.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.046 1.338 . . . . 0.0 112.866 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.9 m120 64.2 25.89 13.7 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.537 1.535 . . . . 0.0 112.672 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.5 mt -55.67 157.12 7.96 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.671 1.588 . . . . 0.0 111.999 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.76 141.53 79.19 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.695 2.264 . . . . 0.0 110.397 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -66.04 128.64 36.87 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.792 -0.568 . . . . 0.0 110.712 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.4 pt -147.16 149.91 15.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 126.538 1.935 . . . . 0.0 109.897 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 -179.95 3.92 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.309 1.444 . . . . 0.0 111.333 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 25.1 mt -63.56 105.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.251 1.02 . . . . 0.0 110.028 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.45 77.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.156 1.382 . . . . 0.0 111.576 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 p -149.44 149.18 30.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.852 1.661 . . . . 0.0 111.076 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -143.43 144.0 31.85 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.908 1.683 . . . . 0.0 110.36 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -159.37 148.71 18.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.423 1.889 . . . . 0.0 110.042 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -65.11 128.39 35.59 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.546 0.612 . . . . 0.0 110.995 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.7 mt -93.53 -46.18 7.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.085 0.554 . . . . 0.0 111.748 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 147.73 -151.24 23.51 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.415 1.007 . . . . 0.0 112.544 -172.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -123.28 86.1 2.52 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 122.689 1.233 . . . . 0.0 112.135 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -102.01 154.56 18.86 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.248 1.419 . . . . 0.0 110.075 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.68 116.61 4.52 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.164 0.586 . . . . 0.0 109.964 169.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.06 151.66 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.541 0.686 . . . . 0.0 110.942 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -141.11 157.38 45.36 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.814 1.645 . . . . 0.0 111.412 -168.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -156.32 146.02 20.98 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.522 0.729 . . . . 0.0 109.872 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.7 pt -100.15 143.68 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.777 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -93.96 151.77 20.42 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.45 0.548 . . . . 0.0 111.772 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.5 t -148.68 133.24 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.758 1.623 . . . . 0.0 108.869 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -79.26 -36.56 39.66 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -69.31 -68.26 0.42 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.672 1.589 . . . . 0.0 111.879 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.33 118.47 9.49 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.762 1.225 . . . . 0.0 109.967 -174.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -71.75 47.41 0.14 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.522 2.329 . . . . 0.0 113.754 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.21 163.33 37.58 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.347 -1.47 . . . . 0.0 114.04 -174.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -161.62 156.97 23.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.641 1.576 . . . . 0.0 112.254 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.35 147.08 26.2 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.716 1.206 . . . . 0.0 112.962 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.05 168.86 9.57 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.671 1.588 . . . . 0.0 112.076 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -48.83 -51.02 31.77 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.126 1.37 . . . . 0.0 114.025 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -73.42 -20.47 60.72 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -172.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 127.14 -4.27 7.31 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.791 1.186 . . . . 0.0 114.91 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.31 171.87 11.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.081 1.44 . . . . 0.0 112.279 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.84 138.61 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.247 1.019 . . . . 0.0 109.999 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.5 149.1 50.28 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.306 1.842 . . . . 0.0 109.351 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.0 t -134.96 123.21 23.01 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -171.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.485 2.314 . . . . 0.0 114.074 178.849 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.913 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -116.84 168.24 12.74 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 127.453 2.454 . . . . 0.0 110.948 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.99 175.94 10.64 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.22 1.008 . . . . 0.0 113.166 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -108.92 150.02 28.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.87 1.668 . . . . 0.0 111.071 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -65.81 161.76 20.27 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.405 0.682 . . . . 0.0 112.149 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -52.23 -44.15 64.66 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.823 0.849 . . . . 0.0 112.481 172.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.35 -23.75 64.51 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.791 1.636 . . . . 0.0 113.84 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -63.23 112.92 2.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.176 0.991 . . . . 0.0 111.341 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -96.55 135.3 38.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.42 0.688 . . . . 0.0 111.048 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.6 mm -118.43 122.81 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.653 1.581 . . . . 0.0 107.954 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -64.93 124.38 21.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.279 0.231 . . . . 0.0 111.289 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.2 p -121.83 153.65 38.07 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.632 1.173 . . . . 0.0 112.146 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.9 -30.41 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 121.877 -0.514 . . . . 0.0 111.8 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -65.62 -36.42 83.66 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -140.46 -49.45 0.45 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.32 -146.52 18.5 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.966 0.794 . . . . 0.0 112.51 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.3 mt -66.78 96.31 0.4 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.665 1.586 . . . . 0.0 112.639 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.66 147.8 62.21 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.887 1.275 . . . . 0.0 111.92 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.45 129.14 21.81 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 124.289 3.326 . . . . 0.0 112.794 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.5 tt -56.78 -37.25 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.004 0.921 . . . . 0.0 113.035 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.29 -31.35 78.77 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.662 -0.649 . . . . 0.0 113.291 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -76.23 -30.98 58.13 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.952 0.876 . . . . 0.0 111.817 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.58 -40.51 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.244 1.018 . . . . 0.0 109.642 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.71 -39.83 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.521 0.728 . . . . 0.0 112.951 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.1 -21.81 56.26 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.389 0.995 . . . . 0.0 113.513 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -109.51 1.87 20.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.778 1.231 . . . . 0.0 112.299 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.98 51.26 13.04 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.975 2.11 . . . . 0.0 112.663 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.5 mt -71.59 120.82 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.213 0.605 . . . . 0.0 109.48 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.04 105.6 6.14 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.222 1.009 . . . . 0.0 110.665 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.5 p -144.53 164.73 30.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.457 1.122 . . . . 0.0 113.44 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.5 145.67 26.55 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.315 1.446 . . . . 0.0 109.849 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.22 176.05 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.958 1.703 . . . . 0.0 111.098 -176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -118.24 142.95 46.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.769 1.628 . . . . 0.0 110.537 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.9 t -155.58 152.99 29.45 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.226 1.41 . . . . 0.0 110.419 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -94.27 125.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.456 0.702 . . . . 0.0 109.472 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -70.81 176.45 4.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.392 1.091 . . . . 0.0 112.445 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -60.21 -27.33 67.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.887 1.275 . . . . 0.0 113.066 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -86.2 -2.17 58.12 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.684 1.594 . . . . 0.0 113.498 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.23 19.05 78.85 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.582 1.086 . . . . 0.0 114.592 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -93.97 129.68 40.36 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.023 1.329 . . . . 0.0 109.485 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.2 mt -74.65 134.71 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -138.67 167.91 20.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.626 1.57 . . . . 0.0 111.683 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 p -115.94 144.95 43.35 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.473 1.109 . . . . 0.0 112.187 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -153.26 148.48 20.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.16 0.984 . . . . 0.0 112.767 -176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.62 150.21 45.03 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.963 2.442 . . . . 0.0 112.562 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -58.77 140.33 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.922 0.889 . . . . 0.0 110.568 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.48 -31.07 11.07 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.006 0.922 . . . . 0.0 112.64 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -167.71 175.14 7.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.946 1.698 . . . . 0.0 112.17 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -134.26 124.19 25.5 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.938 1.295 . . . . 0.0 109.303 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -113.77 129.13 56.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.993 0.917 . . . . 0.0 110.839 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -120.24 103.83 9.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.53 1.532 . . . . 0.0 110.043 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -72.77 -29.86 63.64 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.709 1.204 . . . . 0.0 112.967 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.16 -52.74 2.84 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.262 1.411 . . . . 0.0 113.62 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -170.76 105.54 0.26 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.967 1.307 . . . . 0.0 110.269 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -132.66 168.13 18.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.987 0.915 . . . . 0.0 112.349 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -68.82 100.84 1.23 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.854 1.261 . . . . 0.0 113.342 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.9 t -94.36 138.03 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.926 1.29 . . . . 0.0 111.557 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.489 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 53.2 m-85 -120.14 144.41 47.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 110.206 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.36 134.09 55.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.598 0.759 . . . . 0.0 110.652 171.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.502 ' HH ' ' CD1' ' A' ' 94' ' ' LEU . 1.9 t80 -127.03 83.34 2.16 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.425 1.49 . . . . 0.0 108.384 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.8 t -98.06 147.77 24.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.001 0.92 . . . . 0.0 110.899 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.09 158.36 23.31 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.199 1.4 . . . . 0.0 112.34 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -69.17 -18.34 63.91 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -77.25 -28.34 53.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.13 0.972 . . . . 0.0 112.786 172.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.62 -9.76 8.63 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.36 1.457 . . . . 0.0 114.253 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.2 m -59.54 150.78 26.07 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.46 1.13 . . . . 0.0 112.153 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.1 tp -137.91 125.6 22.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.162 0.985 . . . . 0.0 110.855 -173.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.6 mt -133.93 148.77 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.367 1.867 . . . . 0.0 107.941 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -131.6 121.41 24.33 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.935 1.294 . . . . 0.0 110.505 174.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.34 163.92 36.35 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.386 1.474 . . . . 0.0 111.197 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -75.37 154.04 37.45 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.434 -0.791 . . . . 0.0 111.973 173.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 4.8 mtmt -62.93 -20.4 65.17 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -87.47 -9.96 53.17 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.235 1.814 . . . . 0.0 113.054 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -77.68 134.42 38.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.75 0.82 . . . . 0.0 109.755 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -98.02 150.1 21.75 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.289 1.042 . . . . 0.0 111.889 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -136.3 132.57 35.89 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.018 -1.052 . . . . 0.0 109.766 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.1 ttp -72.24 108.87 5.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.206 0.527 . . . . 0.0 110.998 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -68.73 172.12 6.83 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.377 0.671 . . . . 0.0 112.172 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -55.91 -22.75 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -87.1 -6.14 58.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.414 1.085 . . . . 0.0 113.314 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.57 9.23 72.49 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.759 1.171 . . . . 0.0 113.966 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -81.13 130.16 34.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.258 1.029 . . . . 0.0 110.886 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.28 87.31 7.37 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.933 1.293 . . . . 0.0 110.793 169.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.1 mt -112.59 145.4 32.87 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.007 0.923 . . . . 0.0 110.238 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.72 147.06 85.44 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.674 2.25 . . . . 0.0 110.875 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -58.39 -26.84 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -53.79 -37.39 63.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.61 1.164 . . . . 0.0 113.19 169.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -80.43 -39.24 28.61 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.73 0.812 . . . . 0.0 110.669 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.46 -38.85 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.682 0.793 . . . . 0.0 111.103 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -64.78 -38.57 91.45 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -75.86 -38.64 57.73 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.482 -0.761 . . . . 0.0 112.682 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -75.47 -13.36 60.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 57.87 31.53 20.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.522 1.529 . . . . 0.0 111.982 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.8 mt -84.54 157.36 21.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.617 1.199 . . . . 0.0 112.201 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -113.54 156.6 23.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.011 2.124 . . . . 0.0 112.923 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.502 ' CD1' ' HH ' ' A' ' 58' ' ' TYR . 18.6 mt -88.21 149.75 23.68 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.552 0.741 . . . . 0.0 112.361 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.3 ttp -72.82 153.67 40.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.455 0.702 . . . . 0.0 111.222 170.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.39 167.3 15.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.412 1.485 . . . . 0.0 112.174 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.27 -12.52 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.981 1.313 . . . . 0.0 114.151 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.08 8.77 36.54 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.069 1.348 . . . . 0.0 113.073 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 52.41 35.39 17.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.987 1.715 . . . . 0.0 113.42 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.75 156.97 86.32 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.064 170.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.66 129.73 27.36 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.213 2.609 . . . . 0.0 111.134 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.19 134.44 44.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.727 0.811 . . . . 0.0 109.748 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.7 pt -143.17 130.75 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.371 1.468 . . . . 0.0 111.044 -169.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.5 171.57 12.42 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.487 1.115 . . . . 0.0 112.351 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.9 mt -63.97 112.52 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.319 1.448 . . . . 0.0 110.111 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.29 -35.81 35.3 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.707 0.803 . . . . 0.0 112.327 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.4 p -146.68 149.88 34.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.106 1.762 . . . . 0.0 110.676 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.07 143.03 32.89 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.795 1.638 . . . . 0.0 110.082 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -160.92 140.53 10.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.827 1.651 . . . . 0.0 110.256 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -65.35 121.98 16.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.842 0.457 . . . . 0.0 110.89 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.3 mt -90.95 -44.57 9.27 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.039 0.536 . . . . 0.0 111.891 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 150.73 -142.46 9.6 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.515 0.579 . . . . 0.0 113.324 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -130.67 86.27 2.36 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.82 1.248 . . . . 0.0 111.754 -168.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -104.43 157.26 17.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.909 1.284 . . . . 0.0 111.047 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 117.66 6.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.386 0.674 . . . . 0.0 110.364 169.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.3 m -124.14 151.7 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.372 0.606 . . . . 0.0 111.088 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -141.02 157.75 44.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.559 1.544 . . . . 0.0 111.74 -168.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -157.01 128.31 6.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.194 0.998 . . . . 0.0 110.799 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.5 pt -80.66 147.45 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.3 -0.875 . . . . 0.0 110.863 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.21 156.04 18.55 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.434 1.016 . . . . 0.0 111.731 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.3 t -143.05 153.48 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.662 1.185 . . . . 0.0 110.261 -169.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -60.84 117.3 5.24 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.791 -1.193 . . . . 0.0 111.937 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 51.83 22.43 1.72 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 126.545 1.938 . . . . 0.0 114.747 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -151.37 166.17 31.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.97 0.908 . . . . 0.0 112.646 -169.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -151.87 23.82 0.67 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.773 1.229 . . . . 0.0 113.068 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.13 162.95 29.59 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -166.51 158.43 13.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.711 1.205 . . . . 0.0 112.611 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.4 134.59 35.58 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.31 1.044 . . . . 0.0 112.339 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 38.1 mt -86.57 166.24 15.58 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.732 1.213 . . . . 0.0 111.516 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -52.74 -32.8 45.14 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -88.1 -6.53 57.86 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.505 1.122 . . . . 0.0 113.239 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.88 -11.65 34.78 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.427 1.013 . . . . 0.0 114.973 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -73.13 167.42 21.18 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.36 1.58 . . . . 0.0 112.842 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.69 120.66 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.931 0.893 . . . . 0.0 110.202 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.66 141.15 30.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.442 1.897 . . . . 0.0 109.801 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.7 m -139.16 137.12 35.8 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.472 1.109 . . . . 0.0 113.175 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 125.189 1.396 . . . . 0.0 113.86 -177.835 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.856 -0.497 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -152.02 160.43 28.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 129.442 3.401 . . . . 0.0 108.537 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -156.12 174.8 14.84 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.572 0.701 . . . . 0.0 112.826 -168.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.8 mt -120.89 147.0 46.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.928 1.691 . . . . 0.0 109.964 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 t -66.75 161.17 24.19 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -50.93 -44.64 60.28 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.557 0.743 . . . . 0.0 111.993 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -15.93 41.23 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.5 m -73.54 98.72 2.86 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.595 0.758 . . . . 0.0 110.14 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.15 133.14 42.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.455 0.645 . . . . 0.0 110.746 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.87 126.74 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 125.466 1.507 . . . . 0.0 107.216 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.3 122.56 18.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 170.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.7 p -123.71 150.98 43.66 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.76 1.224 . . . . 0.0 111.966 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.4 t -77.68 -33.59 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.9 -0.5 . . . . 0.0 112.005 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -66.16 -27.63 68.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -144.57 -52.84 0.31 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.37 -150.07 21.1 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.817 0.722 . . . . 0.0 112.217 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.85 108.26 2.93 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.333 1.453 . . . . 0.0 110.939 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.0 mt -134.99 148.89 68.74 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.475 1.11 . . . . 0.0 113.041 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.66 126.56 16.99 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.967 3.111 . . . . 0.0 112.024 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 tt -54.92 -36.48 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.18 -36.0 92.68 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.805 -0.56 . . . . 0.0 112.992 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -68.76 -37.65 79.53 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.558 1.179 . . . . 0.0 111.433 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.46 -38.41 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.761 0.824 . . . . 0.0 109.767 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.53 -39.49 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.158 0.983 . . . . 0.0 113.259 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.28 -27.5 66.37 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.496 1.044 . . . . 0.0 112.667 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -112.71 0.72 15.4 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.719 1.208 . . . . 0.0 112.773 -176.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.95 52.31 11.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.87 2.468 . . . . 0.0 112.418 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.6 mt -72.98 123.78 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.082 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.8 102.41 2.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.893 0.877 . . . . 0.0 110.287 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.5 p -132.25 -178.13 4.77 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.994 1.318 . . . . 0.0 112.496 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.94 147.27 51.05 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.439 1.496 . . . . 0.0 108.227 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.91 158.65 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.657 1.183 . . . . 0.0 111.203 -173.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -96.2 138.19 34.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.38 1.072 . . . . 0.0 110.4 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 t -155.57 153.77 30.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.898 1.279 . . . . 0.0 110.527 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.88 125.47 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.078 0.551 . . . . 0.0 110.316 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -68.42 175.29 3.45 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.835 1.254 . . . . 0.0 112.267 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.71 -25.87 68.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.844 1.258 . . . . 0.0 113.155 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -85.56 -4.76 59.26 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.366 1.466 . . . . 0.0 113.555 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.9 19.02 62.1 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.738 1.161 . . . . 0.0 114.758 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -94.95 128.88 42.08 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.627 1.171 . . . . 0.0 110.259 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.1 mt -74.12 123.52 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -135.11 174.15 10.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.828 2.051 . . . . 0.0 111.504 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -116.93 139.19 50.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.185 0.994 . . . . 0.0 111.905 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -141.22 141.0 21.99 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.545 1.138 . . . . 0.0 111.863 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.14 152.24 39.89 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.885 2.39 . . . . 0.0 112.027 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.66 138.45 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.787 0.835 . . . . 0.0 111.037 169.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.13 -51.95 4.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.544 0.738 . . . . 0.0 111.142 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -144.62 -178.6 6.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.87 1.668 . . . . 0.0 111.034 -173.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -138.98 126.81 22.15 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.399 1.08 . . . . 0.0 109.313 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -122.16 134.72 54.73 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.105 0.955 . . . . 0.0 110.795 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -127.52 122.25 32.84 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.208 1.403 . . . . 0.0 109.996 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -88.96 -34.19 16.96 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.177 0.991 . . . . 0.0 112.326 -173.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.45 -42.55 2.32 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.114 1.34 . . . . 0.0 114.889 172.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -178.69 88.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.066 1.412 . . . . 0.0 114.629 -168.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -125.18 158.98 32.62 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.979 1.311 . . . . 0.0 112.291 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.57 106.76 1.22 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.021 1.328 . . . . 0.0 112.695 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 t -98.59 139.44 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.346 1.458 . . . . 0.0 110.586 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -124.48 140.66 52.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.986 1.315 . . . . 0.0 109.513 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.84 135.1 35.88 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.177 0.991 . . . . 0.0 108.987 169.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -122.07 98.53 5.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.61 1.564 . . . . 0.0 109.011 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.8 t -75.86 132.97 40.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.138 0.575 . . . . 0.0 109.982 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mp -93.28 162.48 13.99 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.614 0.721 . . . . 0.0 112.783 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.81 -22.44 66.56 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.03 -21.27 51.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.954 0.902 . . . . 0.0 112.926 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.04 -1.32 25.59 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.441 1.495 . . . . 0.0 114.531 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.8 p -72.71 171.32 12.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.488 1.144 . . . . 0.0 113.017 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.5 mt -132.6 145.6 51.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.192 1.397 . . . . 0.0 110.983 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.6 mt -137.68 139.64 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.471 1.908 . . . . 0.0 107.323 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -131.26 98.18 4.48 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.608 1.163 . . . . 0.0 110.429 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.73 166.29 27.06 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.282 1.039 . . . . 0.0 113.724 -172.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 p -82.43 155.46 24.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.723 1.209 . . . . 0.0 111.535 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -61.55 -23.95 66.31 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -86.74 -11.29 51.52 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.37 1.068 . . . . 0.0 112.605 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -80.02 132.04 35.92 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -87.4 162.72 17.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.509 0.671 . . . . 0.0 111.098 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -138.19 141.23 40.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 43.1 ttm -69.54 107.39 3.36 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -66.89 166.47 13.37 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.204 0.526 . . . . 0.0 111.122 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 m -57.64 -24.33 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.07 -14.39 59.51 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.487 1.115 . . . . 0.0 113.478 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.46 10.9 61.5 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.095 1.331 . . . . 0.0 114.383 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -82.96 164.08 20.63 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.426 1.113 . . . . 0.0 111.522 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.36 81.94 1.86 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.985 1.314 . . . . 0.0 111.33 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.6 mt -113.22 148.41 39.46 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.526 1.131 . . . . 0.0 110.787 -172.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.04 146.03 81.08 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.97 2.447 . . . . 0.0 111.246 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.6 tt -58.43 -26.03 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.55 -35.09 67.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.389 1.076 . . . . 0.0 113.023 170.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -39.03 27.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.531 1.132 . . . . 0.0 111.102 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.47 -39.45 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.397 1.079 . . . . 0.0 110.919 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -63.73 -34.44 77.87 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -77.14 -48.19 18.35 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.944 0.793 . . . . 0.0 113.055 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -74.55 -12.35 60.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 57.9 35.52 25.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.663 1.585 . . . . 0.0 112.476 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.8 mt -76.74 146.92 37.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.159 0.983 . . . . 0.0 111.834 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.63 164.76 20.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.665 0.786 . . . . 0.0 112.043 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.6 mt -111.05 147.14 35.43 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.5 1.12 . . . . 0.0 111.682 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 31.7 ttm -74.79 141.92 44.3 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.723 -0.611 . . . . 0.0 110.664 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.12 173.19 9.4 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.515 1.126 . . . . 0.0 113.06 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.61 -19.63 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 126.17 1.788 . . . . 0.0 113.8 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.8 4.23 30.05 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.94 1.296 . . . . 0.0 113.916 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.77 31.96 21.22 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.506 1.522 . . . . 0.0 112.859 -175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.9 mt -70.92 158.79 87.33 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.913 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.24 149.83 85.12 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.154 2.569 . . . . 0.0 111.396 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -70.4 123.59 22.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.4 0.68 . . . . 0.0 110.401 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.21 137.92 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.218 1.407 . . . . 0.0 111.386 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.23 176.35 5.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.834 1.654 . . . . 0.0 111.379 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mt -69.71 103.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.511 1.524 . . . . 0.0 110.007 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.93 -42.59 80.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.966 1.306 . . . . 0.0 111.633 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -152.48 162.98 40.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.642 1.977 . . . . 0.0 111.113 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -127.47 144.82 51.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.902 1.681 . . . . 0.0 110.793 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -145.83 116.58 7.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.512 1.125 . . . . 0.0 110.527 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -63.16 127.44 31.26 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.575 -0.703 . . . . 0.0 111.16 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.9 mt -94.74 -42.99 8.45 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.831 0.452 . . . . 0.0 112.094 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 140.64 -147.99 19.64 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.712 1.148 . . . . 0.0 112.588 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -120.8 71.27 0.92 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.476 1.51 . . . . 0.0 112.362 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -90.8 157.34 17.44 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.688 1.595 . . . . 0.0 111.216 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.18 118.92 9.93 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.95 0.9 . . . . 0.0 110.35 170.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.1 150.27 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.42 0.688 . . . . 0.0 111.448 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -137.11 157.96 45.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.051 1.74 . . . . 0.0 111.994 -169.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -158.1 119.1 3.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.713 1.205 . . . . 0.0 110.607 -174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 pt -72.68 148.19 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 O-C-N 120.754 -1.216 . . . . 0.0 111.927 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.49 151.47 19.34 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.488 1.042 . . . . 0.0 111.868 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.7 t -147.45 146.27 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.426 1.49 . . . . 0.0 109.416 -171.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -103.93 -43.74 5.22 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -70.61 -45.19 65.76 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.59 -172.54 3.05 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.475 1.91 . . . . 0.0 109.846 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -143.69 39.23 1.38 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.299 -0.875 . . . . 0.0 112.467 -173.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -161.92 161.86 28.92 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.968 -1.083 . . . . 0.0 113.156 -172.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -160.49 153.4 21.36 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.015 1.326 . . . . 0.0 112.912 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.62 140.68 37.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.496 1.118 . . . . 0.0 113.227 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 74.4 mt -92.62 178.59 5.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.198 1.799 . . . . 0.0 112.528 173.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -46.8 -59.33 3.13 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.734 2.013 . . . . 0.0 115.121 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.94 -22.21 61.49 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.508 0.723 . . . . 0.0 112.163 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.34 -5.73 8.73 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.123 1.344 . . . . 0.0 114.359 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -61.02 136.15 58.0 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.933 1.867 . . . . 0.0 110.743 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.07 118.3 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.6 153.46 17.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.064 1.346 . . . . 0.0 109.256 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.2 p -136.66 147.36 46.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.434 1.094 . . . . 0.0 112.768 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.9 p30 . . . . . 0 C--O 1.252 1.234 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -167.678 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.86 0 N-CA-C 112.78 -0.128 . . . . 0.0 112.78 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -125.06 174.4 17.29 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.478 2.466 . . . . 0.0 110.815 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -171.04 173.8 4.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.738 1.615 . . . . 0.0 112.588 -172.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.9 mt -118.92 149.83 40.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.381 2.273 . . . . 0.0 110.966 -172.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -73.22 160.41 31.97 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.264 -0.897 . . . . 0.0 111.802 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -50.07 -48.18 53.18 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.358 1.063 . . . . 0.0 112.666 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -66.37 -1.14 3.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.913 2.085 . . . . 0.0 114.944 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.2 m -74.27 104.66 5.12 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.081 0.952 . . . . 0.0 110.264 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.09 129.21 34.84 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.514 0.674 . . . . 0.0 111.614 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.6 mm -111.64 121.09 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 126.093 1.757 . . . . 0.0 107.227 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.39 129.81 42.36 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.378 0.671 . . . . 0.0 111.239 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -129.96 152.06 49.83 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.032 1.333 . . . . 0.0 111.781 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.3 t -74.65 -31.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 121.703 -0.623 . . . . 0.0 112.119 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -65.76 -33.99 77.14 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -141.68 -50.53 0.41 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.88 -137.68 9.22 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 118.816 0.735 . . . . 0.0 112.366 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.0 mt -81.29 96.69 7.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.004 1.722 . . . . 0.0 111.619 -175.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -127.36 147.41 62.01 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.794 1.238 . . . . 0.0 112.341 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.38 130.87 23.37 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.14 3.227 . . . . 0.0 112.675 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 tt -55.21 -36.15 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.9 0.88 . . . . 0.0 113.124 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.7 -34.4 83.26 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.671 -0.643 . . . . 0.0 113.177 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -72.69 -31.54 65.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.339 1.07 . . . . 0.0 111.728 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.1 mt -69.2 -38.07 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.827 0.851 . . . . 0.0 109.896 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.9 t -82.18 -38.07 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.22 1.008 . . . . 0.0 113.07 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.13 -23.68 63.06 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.302 -0.874 . . . . 0.0 112.974 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.31 4.88 11.85 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.074 1.35 . . . . 0.0 112.508 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 45.03 51.72 8.67 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.062 2.545 . . . . 0.0 112.692 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 53.8 mt -72.29 120.15 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.984 0.914 . . . . 0.0 109.134 -171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.99 99.68 3.93 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.352 1.061 . . . . 0.0 110.587 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.4 p -141.15 162.22 36.02 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.588 1.185 . . . . 0.0 114.128 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.76 154.4 19.56 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.655 1.582 . . . . 0.0 110.505 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.65 173.94 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.734 1.614 . . . . 0.0 110.982 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -119.31 140.61 50.03 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.992 1.717 . . . . 0.0 109.929 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.2 t -159.77 165.96 31.38 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.946 1.298 . . . . 0.0 110.568 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.94 127.52 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.842 1.257 . . . . 0.0 111.366 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.13 177.88 7.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.562 1.145 . . . . 0.0 112.238 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -61.21 -23.01 65.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.274 1.43 . . . . 0.0 113.361 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -89.48 -3.04 58.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.203 1.401 . . . . 0.0 113.548 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.69 89.15 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.419 1.009 . . . . 0.0 114.608 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -81.41 134.93 35.62 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.291 1.046 . . . . 0.0 109.587 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.7 mt -72.22 122.17 24.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -121.41 169.12 10.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.913 1.685 . . . . 0.0 110.433 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.8 p -126.67 144.0 51.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.383 0.673 . . . . 0.0 112.02 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -150.48 147.68 22.12 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.468 1.107 . . . . 0.0 112.041 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.82 148.61 36.39 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.16 2.573 . . . . 0.0 112.738 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.31 145.64 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.408 1.083 . . . . 0.0 111.133 168.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.08 -32.26 7.3 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.892 1.277 . . . . 0.0 112.847 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -164.85 174.13 10.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.569 1.547 . . . . 0.0 112.36 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -137.49 110.68 7.83 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.061 1.345 . . . . 0.0 110.05 -174.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -98.62 115.23 28.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.834 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -102.1 107.0 17.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.91 1.284 . . . . 0.0 108.947 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -78.82 -24.5 44.46 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.355 1.062 . . . . 0.0 112.991 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.57 -44.18 3.31 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.287 1.422 . . . . 0.0 114.786 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 176.83 98.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.883 1.273 . . . . 0.0 113.143 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -129.79 167.42 18.12 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.226 1.411 . . . . 0.0 112.761 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.85 101.07 0.45 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.41 1.484 . . . . 0.0 114.041 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.1 t -92.03 143.33 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.147 1.379 . . . . 0.0 112.191 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -127.1 141.74 51.69 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.014 2.126 . . . . 0.0 110.129 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.15 132.89 51.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.351 0.66 . . . . 0.0 110.948 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.9 75.36 1.49 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.739 1.257 . . . . 0.0 108.779 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.6 t -82.22 146.92 29.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.223 1.009 . . . . 0.0 111.132 173.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.09 163.5 15.09 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.693 1.197 . . . . 0.0 112.825 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.02 -24.29 66.73 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.055 1.342 . . . . 0.0 113.051 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.03 -29.64 31.86 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.763 1.225 . . . . 0.0 113.169 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.83 -0.73 10.01 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.516 1.055 . . . . 0.0 114.69 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 m -63.13 139.94 58.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.803 1.301 . . . . 0.0 110.97 170.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.77 132.99 53.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.208 1.403 . . . . 0.0 109.856 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.1 mt -136.8 152.89 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.758 2.023 . . . . 0.0 107.658 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -138.65 115.96 11.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.707 1.203 . . . . 0.0 110.579 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.55 172.32 14.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.172 1.389 . . . . 0.0 112.35 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 p -93.09 151.9 19.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.993 1.317 . . . . 0.0 111.522 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -62.84 -16.56 58.94 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -88.01 -17.15 31.83 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.449 1.099 . . . . 0.0 112.463 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -78.21 137.46 38.15 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -95.02 160.35 14.61 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.217 1.007 . . . . 0.0 110.268 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -142.46 133.76 26.24 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.559 -0.713 . . . . 0.0 109.666 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.5 ttm -77.66 111.22 13.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.98 0.895 . . . . 0.0 111.359 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.1 p -65.31 167.45 8.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.788 1.235 . . . . 0.0 112.828 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.6 m -52.91 -28.77 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -83.79 -11.7 56.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.052 0.941 . . . . 0.0 113.461 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.64 -0.41 61.19 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.381 0.991 . . . . 0.0 114.082 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -76.4 137.67 39.9 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 119.2 1.5 . . . . 0.0 109.745 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.8 ptp -106.63 98.42 8.09 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.715 1.606 . . . . 0.0 108.776 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.63 152.79 59.11 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.084 1.353 . . . . 0.0 109.324 -174.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.53 147.1 86.35 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.266 1.977 . . . . 0.0 110.949 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.4 tt -59.46 -23.33 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -54.49 -35.97 63.66 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.015 1.326 . . . . 0.0 112.632 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -84.48 -39.81 18.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 111.499 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.8 mt -59.88 -36.17 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 119.129 0.877 . . . . 0.0 111.425 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -69.22 -33.41 73.26 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -78.6 -39.23 37.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.438 -0.789 . . . . 0.0 112.399 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -74.51 -14.78 60.86 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.834 0.854 . . . . 0.0 113.178 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 55.35 37.57 29.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.487 1.515 . . . . 0.0 111.905 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.9 mt -92.02 159.5 15.68 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.709 1.242 . . . . 0.0 112.34 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -114.34 154.44 28.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.033 2.133 . . . . 0.0 113.198 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.89 154.06 22.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.773 1.229 . . . . 0.0 112.726 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -70.26 148.7 48.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.758 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -114.1 155.75 25.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.646 1.579 . . . . 0.0 110.894 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.2 5.37 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 125.014 1.325 . . . . 0.0 114.413 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -121.34 20.45 11.27 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.886 1.674 . . . . 0.0 112.421 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.34 16.82 10.4 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 127.023 2.129 . . . . 0.0 113.647 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.1 mt -72.8 157.36 88.89 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.433 1.893 . . . . 0.0 112.54 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.92 166.33 29.89 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.205 3.27 . . . . 0.0 112.25 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -107.02 131.66 53.82 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.494 1.118 . . . . 0.0 110.556 -173.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.1 pt -146.97 135.55 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.443 1.497 . . . . 0.0 110.627 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 175.49 8.9 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.347 1.459 . . . . 0.0 112.127 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.8 mt -63.16 112.04 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.1 1.36 . . . . 0.0 110.206 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.31 -43.38 81.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.257 1.023 . . . . 0.0 111.957 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 p -150.12 147.64 28.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.247 1.819 . . . . 0.0 110.393 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -141.19 139.39 33.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.171 1.389 . . . . 0.0 110.812 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -158.29 150.59 21.96 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.181 1.393 . . . . 0.0 110.51 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -66.03 124.81 23.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.306 0.642 . . . . 0.0 110.891 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.6 mt -90.03 -43.06 10.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.217 0.607 . . . . 0.0 111.955 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 143.01 -149.39 21.3 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.434 1.016 . . . . 0.0 112.096 -173.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -124.11 96.42 4.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.387 1.075 . . . . 0.0 112.041 -169.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -114.36 155.34 26.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.482 1.513 . . . . 0.0 110.035 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.03 116.86 5.71 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.415 0.686 . . . . 0.0 110.326 173.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.41 152.45 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.64 0.776 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -137.95 156.21 48.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.828 1.651 . . . . 0.0 111.851 -168.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -154.09 116.39 4.33 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.67 1.188 . . . . 0.0 110.635 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.0 pt -77.94 142.99 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 120.963 -1.086 . . . . 0.0 111.354 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.75 158.02 17.94 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.392 0.996 . . . . 0.0 111.473 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 t -142.59 159.26 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.586 1.154 . . . . 0.0 110.183 -169.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -79.73 125.25 29.41 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.475 -1.391 . . . . 0.0 111.755 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.3 tpp85 51.29 24.03 1.92 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.729 2.012 . . . . 0.0 114.503 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -159.28 160.12 34.85 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.306 1.842 . . . . 0.0 109.88 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -143.98 24.1 1.67 Allowed 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.352 -0.843 . . . . 0.0 113.19 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -145.08 160.37 41.51 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.157 1.383 . . . . 0.0 114.115 -168.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -166.16 165.14 17.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.383 1.073 . . . . 0.0 112.55 -171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.36 155.26 17.49 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.221 1.008 . . . . 0.0 113.442 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.6 mt -108.37 166.69 10.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.742 2.017 . . . . 0.0 111.568 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -43.2 -50.02 6.43 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.825 1.65 . . . . 0.0 115.296 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -84.67 4.13 33.89 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.192 0.997 . . . . 0.0 113.261 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.78 -4.85 53.52 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.445 1.498 . . . . 0.0 114.92 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -69.36 163.61 24.78 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.734 1.267 . . . . 0.0 111.664 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.1 mm -118.23 142.26 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.531 -0.731 . . . . 0.0 110.555 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.77 143.29 49.48 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.411 1.485 . . . . 0.0 110.385 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.7 t -139.86 144.72 37.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.048 1.739 . . . . 0.0 113.091 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--O 1.256 1.414 0 N-CA-C 117.268 2.321 . . . . 0.0 117.268 -169.63 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 66.44 -169.15 33.54 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.854 1.216 . . . . 0.0 114.368 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.48 173.02 14.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.15 1.38 . . . . 0.0 110.788 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -117.12 146.75 42.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.999 1.72 . . . . 0.0 109.769 -173.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -74.76 160.39 30.78 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.681 -0.637 . . . . 0.0 111.385 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -47.04 -49.55 21.1 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.475 1.51 . . . . 0.0 113.001 -169.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 pm0 -66.94 -1.85 4.54 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.24 2.216 . . . . 0.0 115.089 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.2 m -73.77 104.16 4.58 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.008 0.923 . . . . 0.0 110.013 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.65 129.34 34.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.56 0.695 . . . . 0.0 112.399 -173.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mm -106.33 123.81 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.364 1.465 . . . . 0.0 107.706 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.09 122.89 18.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.588 0.355 . . . . 0.0 110.266 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.1 p -124.2 150.35 45.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.765 1.226 . . . . 0.0 112.087 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.47 -33.43 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.191 0.596 . . . . 0.0 111.993 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -67.82 -30.7 70.18 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -141.28 -50.03 0.42 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.42 -148.99 19.7 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.598 1.094 . . . . 0.0 111.689 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 mt -61.7 111.96 2.06 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.281 1.433 . . . . 0.0 110.516 171.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 mt -139.96 149.09 57.6 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.365 1.066 . . . . 0.0 113.47 174.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.4 127.44 19.99 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.186 3.257 . . . . 0.0 112.394 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 tt -56.22 -36.36 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.0 -32.49 84.37 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.721 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -71.44 -38.04 71.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.383 1.091 . . . . 0.0 111.31 175.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -64.82 -38.24 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.395 0.678 . . . . 0.0 110.808 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.4 t -83.79 -37.96 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.08 0.952 . . . . 0.0 112.416 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -71.77 -24.56 61.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.088 0.858 . . . . 0.0 113.195 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -114.07 5.84 16.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.226 1.41 . . . . 0.0 113.037 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 48.21 48.92 18.26 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.331 2.252 . . . . 0.0 112.725 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.4 mt -77.73 118.08 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.006 0.923 . . . . 0.0 110.355 -169.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.68 112.17 7.57 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.323 1.049 . . . . 0.0 110.656 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.3 p -150.03 170.87 17.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.43 1.092 . . . . 0.0 112.995 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.4 m -116.86 143.29 45.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.412 1.485 . . . . 0.0 108.906 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.74 165.02 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.898 1.679 . . . . 0.0 110.959 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -102.51 143.75 31.83 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.227 1.411 . . . . 0.0 110.082 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -154.67 151.12 28.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.25 1.42 . . . . 0.0 109.892 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 t -92.91 124.82 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -69.07 173.96 5.01 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.581 1.181 . . . . 0.0 111.79 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -58.16 -27.79 64.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.453 1.901 . . . . 0.0 113.226 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -82.52 -10.06 59.16 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.247 1.419 . . . . 0.0 113.3 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.14 22.5 59.01 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.85 1.214 . . . . 0.0 114.483 -171.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -95.5 132.34 40.7 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.437 1.095 . . . . 0.0 109.85 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.5 mt -74.01 133.4 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.54 1.064 . . . . 0.0 108.899 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.69 174.95 10.01 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.016 1.726 . . . . 0.0 111.036 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.8 p -120.53 143.89 48.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.276 1.03 . . . . 0.0 112.361 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -147.03 142.82 17.42 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.73 1.212 . . . . 0.0 112.433 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -74.97 149.8 37.37 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.012 2.474 . . . . 0.0 112.258 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -59.38 135.89 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.375 0.67 . . . . 0.0 110.43 168.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.62 -47.01 7.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.594 0.758 . . . . 0.0 111.548 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -150.19 177.52 9.85 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.167 1.787 . . . . 0.0 111.397 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -134.23 137.83 44.65 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.139 1.776 . . . . 0.0 108.796 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -132.54 119.65 20.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.598 0.759 . . . . 0.0 111.218 -171.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -116.53 108.21 15.69 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.328 1.451 . . . . 0.0 110.736 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -80.73 -28.89 36.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.756 1.222 . . . . 0.0 113.331 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.41 -52.82 3.1 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.092 1.33 . . . . 0.0 114.219 173.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -171.85 104.91 0.19 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.056 1.428 . . . . 0.0 111.013 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -129.88 169.08 15.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.972 0.909 . . . . 0.0 112.052 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.31 105.42 2.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.23 1.012 . . . . 0.0 112.875 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.7 t -100.38 140.39 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.048 1.339 . . . . 0.0 111.492 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.462 ' CG ' ' HE3' ' A' ' 70' ' ' LYS . 43.5 m-85 -123.91 146.19 48.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.929 1.292 . . . . 0.0 110.601 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -66.0 128.13 34.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.288 1.035 . . . . 0.0 110.485 173.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.472 ' HH ' ' CD1' ' A' ' 94' ' ' LEU . 2.0 t80 -121.87 81.72 1.86 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.592 1.557 . . . . 0.0 108.151 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.3 t -88.05 141.66 28.39 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.962 0.905 . . . . 0.0 110.614 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -105.2 165.64 10.96 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.268 1.027 . . . . 0.0 113.267 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -68.03 -20.7 65.02 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.68 -27.94 36.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.73 1.212 . . . . 0.0 112.96 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.76 -3.75 17.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.931 1.253 . . . . 0.0 114.389 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -60.61 148.16 39.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.719 1.26 . . . . 0.0 111.577 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.5 mt -133.15 128.26 35.69 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.365 1.466 . . . . 0.0 110.11 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.1 mt -135.24 149.56 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 126.681 1.992 . . . . 0.0 107.399 -175.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -137.1 112.27 9.1 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.216 1.006 . . . . 0.0 110.111 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.4 169.47 18.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.311 1.445 . . . . 0.0 111.815 -172.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.6 p -87.44 162.02 17.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.546 0.738 . . . . 0.0 112.837 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HE3' ' CG ' ' A' ' 56' ' ' PHE . 19.7 mmtp -72.99 -7.97 53.6 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -90.9 -8.96 47.93 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.784 0.72 . . . . 0.0 112.083 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -82.56 132.89 35.19 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.785 -0.572 . . . . 0.0 110.091 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -95.19 152.02 18.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.995 0.918 . . . . 0.0 110.285 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -137.94 135.14 35.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.08 0.552 . . . . 0.0 110.626 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 44.7 ttp -73.6 103.98 4.39 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 111.201 -174.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.6 p -66.05 171.8 4.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.134 0.974 . . . . 0.0 112.155 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.26 -22.91 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -93.33 -6.82 46.47 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.214 1.006 . . . . 0.0 113.194 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.4 26.65 24.95 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.323 0.963 . . . . 0.0 113.944 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -88.04 142.05 28.08 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.456 1.128 . . . . 0.0 111.754 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.3 mmt -97.26 77.34 2.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.784 1.634 . . . . 0.0 110.971 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -116.01 148.09 40.64 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.852 0.861 . . . . 0.0 111.44 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.34 148.55 79.97 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.409 2.739 . . . . 0.0 111.771 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.83 -28.76 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -54.05 -30.76 49.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.641 1.177 . . . . 0.0 113.933 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -91.86 -31.14 15.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.44 0.696 . . . . 0.0 111.553 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.84 -38.82 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.042 0.837 . . . . 0.0 111.158 177.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -64.01 -38.1 89.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -78.66 -37.78 41.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.212 0.605 . . . . 0.0 112.553 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -82.41 -8.83 59.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.778 0.831 . . . . 0.0 112.952 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 57.14 35.55 26.41 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.482 1.513 . . . . 0.0 112.383 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.2 mt -85.53 124.01 31.61 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.011 0.91 . . . . 0.0 111.97 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.5 153.72 30.83 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.547 1.139 . . . . 0.0 112.407 169.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.472 ' CD1' ' HH ' ' A' ' 58' ' ' TYR . 11.2 mt -89.86 150.61 22.14 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.212 -0.93 . . . . 0.0 112.455 169.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.1 ttp -72.4 156.85 38.63 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.654 0.782 . . . . 0.0 111.163 169.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -138.25 170.1 16.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.528 1.531 . . . . 0.0 111.739 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.18 -2.69 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.62 14.95 29.74 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.127 0.971 . . . . 0.0 113.393 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 56.16 28.57 13.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.405 1.882 . . . . 0.0 112.993 -173.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 70.8 mt -88.32 156.29 51.26 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.385 1.474 . . . . 0.0 112.083 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.36 135.67 32.01 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.906 3.07 . . . . 0.0 112.686 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -75.3 126.25 30.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.73 0.812 . . . . 0.0 110.773 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.2 pt -142.98 151.61 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.555 1.542 . . . . 0.0 111.335 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.3 pttt -95.59 -173.47 2.89 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.21 1.804 . . . . 0.0 111.961 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.1 mt -68.49 122.28 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.764 1.226 . . . . 0.0 109.001 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.46 -44.57 19.02 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.331 1.052 . . . . 0.0 112.49 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.8 p -146.88 152.62 39.0 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.655 1.582 . . . . 0.0 111.03 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.93 145.17 43.93 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.053 1.741 . . . . 0.0 110.235 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -158.0 135.43 10.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.179 1.792 . . . . 0.0 110.017 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -67.85 120.44 14.16 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.382 0.537 . . . . 0.0 110.032 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.7 -42.14 12.85 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.711 0.404 . . . . 0.0 111.702 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.04 -142.19 11.96 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.208 0.909 . . . . 0.0 112.848 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -121.93 97.07 5.32 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.358 1.463 . . . . 0.0 111.626 -168.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -118.09 154.66 31.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.457 1.103 . . . . 0.0 111.286 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.9 117.21 5.61 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.652 0.781 . . . . 0.0 110.709 171.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.44 151.02 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.504 0.668 . . . . 0.0 111.043 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -138.61 159.41 42.16 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.613 1.565 . . . . 0.0 111.408 -169.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -148.82 168.04 24.02 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.705 0.802 . . . . 0.0 111.921 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.2 pt -126.12 139.91 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.449 1.1 . . . . 0.0 110.112 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.33 153.98 20.05 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.843 1.211 . . . . 0.0 111.183 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.77 156.26 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.525 1.13 . . . . 0.0 109.784 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -58.51 -35.0 71.58 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -173.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -158.26 -40.19 0.06 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -100.6 79.5 2.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 108.889 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -52.39 -22.77 5.01 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.681 2.392 . . . . 0.0 115.481 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -73.75 165.16 25.61 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.132 1.373 . . . . 0.0 113.716 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -160.59 161.49 32.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.983 1.313 . . . . 0.0 111.631 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.78 130.48 37.55 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.866 0.866 . . . . 0.0 113.007 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 41.9 mt -72.79 165.71 24.32 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.469 1.108 . . . . 0.0 111.116 168.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -51.47 -32.57 27.6 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -90.01 -12.24 39.21 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.879 1.271 . . . . 0.0 113.999 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.62 -12.25 18.41 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 118.506 -1.163 . . . . 0.0 115.246 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -60.63 158.45 12.49 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.698 1.749 . . . . 0.0 112.462 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.66 126.02 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.122 0.963 . . . . 0.0 110.859 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -107.56 157.06 18.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.651 1.58 . . . . 0.0 109.729 172.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.6 t -134.84 128.13 32.11 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 112.839 -176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.936 1.694 . . . . 0.0 113.179 -175.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 CA-C-O 119.739 -0.478 . . . . 0.0 113.498 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 62.03 -176.16 6.16 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 126.138 1.828 . . . . 0.0 116.55 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -151.24 171.61 17.14 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.456 1.102 . . . . 0.0 111.848 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.8 mt -127.64 148.13 50.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.182 1.793 . . . . 0.0 110.856 -168.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p -61.56 162.11 8.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.774 1.23 . . . . 0.0 114.196 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -53.62 -45.61 70.18 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.141 -0.974 . . . . 0.0 112.158 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.52 -5.84 16.99 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.7 m -71.44 97.65 1.68 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.118 -0.989 . . . . 0.0 110.318 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -74.09 135.74 42.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.598 0.759 . . . . 0.0 110.919 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.38 120.54 63.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 126.107 1.763 . . . . 0.0 106.702 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.78 120.69 15.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.73 0.412 . . . . 0.0 110.053 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 p -121.63 153.37 38.2 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.303 1.041 . . . . 0.0 112.424 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.19 -34.38 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.404 0.682 . . . . 0.0 111.758 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.64 -26.42 61.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -140.1 -51.79 0.5 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.92 -152.69 20.41 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.212 0.911 . . . . 0.0 111.707 -171.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 109.37 1.7 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.078 0.951 . . . . 0.0 110.96 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.8 mt -133.8 149.39 71.74 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.93 1.292 . . . . 0.0 112.943 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.42 126.73 14.61 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.886 3.058 . . . . 0.0 112.818 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 tt -55.81 -35.71 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.81 -38.16 96.05 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.895 -0.503 . . . . 0.0 112.469 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -71.58 -34.84 70.27 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.409 1.104 . . . . 0.0 111.657 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.9 mt -66.13 -39.65 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.038 0.935 . . . . 0.0 110.032 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.22 -38.08 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.319 1.048 . . . . 0.0 113.046 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -70.41 -27.43 64.28 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.323 0.965 . . . . 0.0 113.218 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -112.19 3.12 17.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.273 1.029 . . . . 0.0 113.103 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 46.9 50.23 13.82 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.26 2.224 . . . . 0.0 111.911 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.8 mt -68.12 118.5 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.021 0.928 . . . . 0.0 108.678 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.02 118.13 14.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.288 0.566 . . . . 0.0 109.511 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.5 p -151.55 166.77 30.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.096 1.358 . . . . 0.0 112.334 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.16 152.54 20.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.272 1.429 . . . . 0.0 109.74 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.31 167.53 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.189 1.396 . . . . 0.0 110.961 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -108.67 148.97 29.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.151 1.38 . . . . 0.0 111.086 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -168.37 151.74 5.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.607 1.563 . . . . 0.0 110.673 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.12 144.45 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.834 1.197 . . . . 0.0 113.275 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.73 178.45 8.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.544 1.138 . . . . 0.0 113.333 170.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -61.98 -11.11 11.74 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -105.18 0.26 27.17 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.9 1.68 . . . . 0.0 112.312 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.14 22.96 39.43 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.171 1.367 . . . . 0.0 115.253 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -108.08 123.56 48.88 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.158 1.479 . . . . 0.0 110.331 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.61 102.63 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.972 0.909 . . . . 0.0 109.41 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -100.88 179.05 4.51 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.103 1.761 . . . . 0.0 111.275 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.2 p -126.35 144.2 50.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.342 1.057 . . . . 0.0 112.843 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -145.58 137.3 13.01 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.537 1.135 . . . . 0.0 112.308 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.23 143.13 27.99 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.286 2.658 . . . . 0.0 110.944 174.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 p -54.13 147.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.727 0.811 . . . . 0.0 111.601 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.76 -42.93 3.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.712 0.805 . . . . 0.0 112.127 175.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -145.15 172.08 13.61 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.853 1.261 . . . . 0.0 111.875 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -135.49 132.56 37.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.579 1.552 . . . . 0.0 109.664 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -127.15 130.85 50.57 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.51 1.124 . . . . 0.0 111.465 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -126.51 119.77 28.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.441 1.496 . . . . 0.0 110.492 -173.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -91.11 -23.1 20.39 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.631 1.172 . . . . 0.0 113.387 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.61 -46.18 3.53 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 126.812 2.148 . . . . 0.0 114.775 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -173.46 107.55 0.15 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.737 1.615 . . . . 0.0 112.156 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -128.04 159.97 33.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.302 1.441 . . . . 0.0 111.212 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -59.26 104.78 0.28 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.517 1.527 . . . . 0.0 112.953 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.08 136.53 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.119 1.368 . . . . 0.0 111.181 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -118.52 138.21 52.68 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.691 1.196 . . . . 0.0 109.989 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -74.29 134.88 42.59 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.034 0.934 . . . . 0.0 108.946 168.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -129.86 89.2 2.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.122 1.369 . . . . 0.0 109.229 170.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.5 t -74.96 141.99 43.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.059 0.944 . . . . 0.0 110.896 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tp -93.89 170.1 9.8 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.941 1.296 . . . . 0.0 113.249 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -63.99 -26.47 68.59 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.99 -18.53 28.83 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.86 -3.21 28.83 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.126 1.346 . . . . 0.0 114.316 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 m -59.63 150.79 26.43 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.086 1.443 . . . . 0.0 111.449 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -127.11 135.98 51.49 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.492 0.717 . . . . 0.0 110.775 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.3 mt -128.42 126.44 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.435 1.494 . . . . 0.0 107.385 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -123.63 103.11 8.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.876 1.27 . . . . 0.0 109.556 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.66 170.51 15.71 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.563 1.145 . . . . 0.0 112.554 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.1 p -86.69 150.68 24.01 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.869 1.267 . . . . 0.0 111.632 171.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -65.1 -7.52 12.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.703 1.601 . . . . 0.0 115.055 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.8 -11.72 30.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.326 1.85 . . . . 0.0 111.921 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -83.01 130.94 35.19 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.638 0.654 . . . . 0.0 109.793 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -91.34 155.93 18.15 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.822 0.849 . . . . 0.0 110.238 176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -138.81 137.57 36.74 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.598 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.5 ttp -79.14 106.49 11.21 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.089 0.556 . . . . 0.0 110.515 -171.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.3 p -65.5 172.34 3.38 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.54 0.736 . . . . 0.0 112.746 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.32 -24.97 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.47 -9.28 50.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.556 1.143 . . . . 0.0 113.519 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.99 9.8 60.47 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.054 1.312 . . . . 0.0 114.599 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -69.96 149.92 47.25 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.512 1.156 . . . . 0.0 111.69 -178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.4 mtm -111.94 82.15 1.58 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.23 1.812 . . . . 0.0 108.698 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 37.1 mt -122.85 147.06 50.03 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 125.242 1.417 . . . . 0.0 110.225 -174.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.93 148.32 85.87 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.167 2.578 . . . . 0.0 111.246 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.3 tt -59.71 -25.99 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -56.44 -33.17 65.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.424 1.09 . . . . 0.0 112.998 170.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -85.25 -36.81 20.69 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.459 0.704 . . . . 0.0 111.597 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.85 -40.45 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.131 -0.981 . . . . 0.0 111.417 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -63.44 -38.52 91.45 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -76.74 -42.96 39.1 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.447 -0.783 . . . . 0.0 112.869 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -77.58 -13.17 59.98 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.143 0.977 . . . . 0.0 112.957 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 56.22 37.08 28.49 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.655 1.582 . . . . 0.0 111.854 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.6 mt -75.07 138.52 42.19 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.438 1.095 . . . . 0.0 111.318 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -73.27 157.31 37.32 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.909 0.861 . . . . 0.0 112.104 173.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.3 mt -112.94 143.35 44.39 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.843 1.257 . . . . 0.0 111.234 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 39.8 ttm -62.29 156.92 20.9 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.465 1.506 . . . . 0.0 111.953 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -132.21 158.43 41.77 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.565 1.546 . . . . 0.0 112.509 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.68 -10.93 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -107.69 16.93 23.18 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.915 1.686 . . . . 0.0 112.672 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.269 7.6 m-80 56.49 36.67 27.93 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.194 1.798 . . . . 0.0 112.551 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.97 159.61 68.08 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 112.743 -2.026 . . . . 0.0 112.015 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.68 155.92 58.12 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.561 2.841 . . . . 0.0 112.108 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -89.92 114.22 25.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.852 0.861 . . . . 0.0 110.003 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.6 pt -142.32 131.01 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.805 1.642 . . . . 0.0 111.106 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.61 173.35 10.55 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.061 1.745 . . . . 0.0 112.633 174.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.8 mt -66.01 115.86 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.097 1.359 . . . . 0.0 110.363 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.72 -42.57 73.83 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.819 1.248 . . . . 0.0 112.654 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.77 162.3 40.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.059 0.944 . . . . 0.0 111.828 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.56 145.5 42.95 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.543 1.537 . . . . 0.0 111.615 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.66 133.58 13.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.303 1.041 . . . . 0.0 110.747 177.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -65.7 133.05 50.26 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.415 -0.803 . . . . 0.0 110.707 170.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.2 mt -102.21 -45.23 5.19 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.479 0.712 . . . . 0.0 111.847 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 152.03 -147.59 17.55 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.089 0.852 . . . . 0.0 112.922 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.77 62.6 1.22 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 123.252 1.501 . . . . 0.0 113.013 -167.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -81.07 156.53 25.78 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.556 1.942 . . . . 0.0 110.826 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.42 119.33 8.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.839 0.855 . . . . 0.0 110.184 171.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.42 150.09 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.601 0.715 . . . . 0.0 111.367 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -138.74 159.36 42.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.651 1.58 . . . . 0.0 111.551 -168.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -154.74 130.81 10.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.543 1.137 . . . . 0.0 110.745 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.8 pt -93.52 156.44 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.009 -1.057 . . . . 0.0 111.488 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.38 153.22 19.8 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.157 0.884 . . . . 0.0 112.835 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.5 t -140.19 153.25 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.599 1.16 . . . . 0.0 111.03 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -72.26 -34.4 68.19 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.77 0.828 . . . . 0.0 112.355 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -74.83 -57.18 4.07 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.069 1.747 . . . . 0.0 113.437 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -149.91 179.2 8.24 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.831 2.452 . . . . 0.0 109.642 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -121.23 -7.7 9.3 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.921 -1.112 . . . . 0.0 113.922 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -76.95 161.16 28.59 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 118.934 0.788 . . . . 0.0 112.191 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -166.84 154.93 9.8 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.101 1.36 . . . . 0.0 111.396 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.06 149.52 35.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.863 1.265 . . . . 0.0 112.488 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 88.7 mt -128.5 -176.71 3.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.07 2.148 . . . . 0.0 111.716 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -51.08 150.55 3.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.961 0.504 . . . . 0.0 110.432 165.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 52.54 18.84 1.04 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.887 1.275 . . . . 0.0 114.342 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.01 22.13 75.74 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 117.624 -1.653 . . . . 0.0 115.94 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -65.25 157.06 29.96 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.248 2.024 . . . . 0.0 112.369 170.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.02 121.1 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.778 1.231 . . . . 0.0 108.778 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -107.38 103.63 13.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.925 0.89 . . . . 0.0 110.416 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.4 t -89.26 157.86 18.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.539 0.735 . . . . 0.0 112.331 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.7 t30 . . . . . 0 C--O 1.255 1.362 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 172.259 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -135.18 -175.43 13.84 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 127.762 2.601 . . . . 0.0 111.685 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -171.36 175.55 4.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.918 0.887 . . . . 0.0 113.193 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.7 mt -120.32 147.39 45.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.859 2.064 . . . . 0.0 110.37 -175.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -72.8 161.82 30.26 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.857 -0.527 . . . . 0.0 111.946 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -51.96 -46.75 64.91 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.319 1.048 . . . . 0.0 112.464 -173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -61.96 -8.01 4.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.375 1.87 . . . . 0.0 115.141 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.9 m -71.44 107.36 4.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.906 0.883 . . . . 0.0 110.33 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.55 133.09 33.84 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.348 0.594 . . . . 0.0 111.435 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -118.49 115.1 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.332 1.453 . . . . 0.0 107.139 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.1 128.33 34.93 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 122.062 -0.399 . . . . 0.0 110.87 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.4 p -129.18 156.07 44.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.166 1.387 . . . . 0.0 113.013 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.56 -30.87 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 122.955 0.502 . . . . 0.0 112.04 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -65.78 -31.65 72.74 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -140.97 -59.59 0.5 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.628 0.771 . . . . 0.0 113.07 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.13 -133.44 5.83 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.13 108.55 12.71 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.262 1.425 . . . . 0.0 109.952 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.8 156.69 51.89 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.23 129.39 17.01 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.932 3.088 . . . . 0.0 112.713 -175.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.81 -37.57 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.511 0.724 . . . . 0.0 112.837 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 -30.95 79.28 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.608 -0.682 . . . . 0.0 113.051 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.79 -36.16 70.24 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.734 0.767 . . . . 0.0 111.445 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.92 -43.12 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.998 0.519 . . . . 0.0 109.885 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.09 -41.28 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -75.59 -22.49 56.88 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -109.87 1.56 19.29 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.132 1.373 . . . . 0.0 112.493 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.65 48.71 14.3 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.166 2.186 . . . . 0.0 113.322 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.27 124.8 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.471 0.708 . . . . 0.0 109.626 -174.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -83.02 86.23 7.03 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.737 0.78 . . . . 0.0 110.683 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 p -117.44 -177.96 3.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.852 1.261 . . . . 0.0 111.952 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.16 144.67 48.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.426 1.49 . . . . 0.0 108.351 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.67 174.22 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.718 1.607 . . . . 0.0 111.077 -177.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -117.21 139.33 50.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.69 1.596 . . . . 0.0 110.319 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -156.99 151.9 25.94 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.864 1.265 . . . . 0.0 111.177 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.1 p -99.12 131.84 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.679 1.192 . . . . 0.0 111.461 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.7 -176.76 6.17 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.998 1.319 . . . . 0.0 113.67 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.58 -29.69 69.34 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -79.85 -11.21 59.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.277 1.031 . . . . 0.0 113.189 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.27 14.27 59.06 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.464 1.031 . . . . 0.0 114.227 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -91.75 126.23 36.76 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.897 1.348 . . . . 0.0 109.481 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.0 mt -71.95 88.43 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.345 1.058 . . . . 0.0 108.78 172.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -81.88 171.08 14.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.114 0.966 . . . . 0.0 111.136 171.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 p -126.92 145.52 50.65 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.832 0.853 . . . . 0.0 111.777 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -145.39 146.38 29.79 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 124.259 1.023 . . . . 0.0 112.677 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.07 156.19 56.11 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.208 2.605 . . . . 0.0 112.474 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.1 t -67.55 119.8 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.993 0.917 . . . . 0.0 109.816 171.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.22 -36.27 35.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.374 0.67 . . . . 0.0 112.578 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -162.14 175.67 11.46 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.381 1.473 . . . . 0.0 112.64 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -135.71 117.36 14.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.08 1.352 . . . . 0.0 109.34 -175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -108.35 130.58 55.2 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.062 0.934 . . . . 0.0 110.369 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.21 103.12 9.22 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.791 1.636 . . . . 0.0 109.514 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -69.78 -33.26 72.15 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.374 1.07 . . . . 0.0 111.908 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.52 -40.39 3.01 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.87 1.224 . . . . 0.0 113.382 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 178.32 109.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.283 1.433 . . . . 0.0 111.62 -174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -133.96 164.96 26.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.131 0.972 . . . . 0.0 112.55 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.07 100.06 0.3 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.489 1.516 . . . . 0.0 113.204 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 t -92.41 137.24 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.038 1.335 . . . . 0.0 110.959 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -119.51 137.13 54.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.295 1.438 . . . . 0.0 109.486 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -56.89 126.0 25.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.99 0.916 . . . . 0.0 110.267 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -118.58 82.88 1.92 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.893 1.277 . . . . 0.0 108.449 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.9 t -94.17 137.51 33.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.666 0.787 . . . . 0.0 110.646 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.82 162.03 13.32 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.223 1.009 . . . . 0.0 112.111 173.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -18.75 62.02 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -78.12 -26.51 48.0 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.123 0.969 . . . . 0.0 112.729 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.74 2.98 18.8 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.629 1.109 . . . . 0.0 114.806 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 m -67.69 132.4 47.4 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.304 1.552 . . . . 0.0 110.356 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.67 132.37 56.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.087 1.355 . . . . 0.0 109.877 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.6 mt -139.01 155.17 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 126.408 1.883 . . . . 0.0 108.478 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -137.96 111.01 7.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.028 1.331 . . . . 0.0 110.675 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.71 166.78 24.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.906 1.283 . . . . 0.0 111.659 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.3 p -88.24 160.14 17.82 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.942 0.877 . . . . 0.0 112.344 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -67.76 -3.8 10.47 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -103.29 -13.0 16.88 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.141 0.977 . . . . 0.0 112.58 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -76.92 121.01 22.83 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 173.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -82.57 149.74 27.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.268 0.627 . . . . 0.0 109.776 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -132.06 143.82 50.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.523 -0.736 . . . . 0.0 109.737 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.4 ttp -75.22 104.43 5.79 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.074 0.55 . . . . 0.0 110.468 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.4 p -66.27 167.99 9.44 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.941 0.496 . . . . 0.0 111.683 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.3 m -55.07 -26.33 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -84.36 -13.17 53.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.273 1.029 . . . . 0.0 113.376 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.99 30.41 12.93 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.574 1.083 . . . . 0.0 113.557 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -98.75 147.24 25.08 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.241 1.02 . . . . 0.0 110.718 177.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.98 89.91 3.8 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.812 1.245 . . . . 0.0 109.871 176.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.1 mt -121.69 145.79 43.99 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.323 1.049 . . . . 0.0 110.438 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.68 147.48 81.58 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.092 2.528 . . . . 0.0 111.355 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 tt -58.0 -27.47 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -54.52 -38.42 66.51 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.583 1.153 . . . . 0.0 112.872 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -82.22 -34.72 28.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.283 0.633 . . . . 0.0 111.586 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.61 -39.21 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.6 -0.688 . . . . 0.0 110.368 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -63.96 -34.81 78.82 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -75.14 -44.77 45.08 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.524 -0.735 . . . . 0.0 112.669 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -76.33 -12.67 60.11 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 56.08 31.48 18.23 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.298 1.439 . . . . 0.0 112.108 -174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 69.5 mt -79.2 150.29 31.7 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.258 1.023 . . . . 0.0 111.586 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.98 155.78 17.32 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.617 0.767 . . . . 0.0 111.491 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt -84.47 159.36 20.77 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.414 -0.804 . . . . 0.0 112.623 168.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.6 ttp -86.52 155.74 20.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.795 1.238 . . . . 0.0 111.294 169.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.52 164.46 27.76 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.337 1.455 . . . . 0.0 112.04 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.6 m -93.02 -19.63 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -99.0 15.65 25.06 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.505 1.122 . . . . 0.0 113.088 -172.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 55.57 32.91 20.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.868 1.667 . . . . 0.0 112.099 -173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.53 154.29 73.7 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.676 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.08 144.76 70.84 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.746 2.964 . . . . 0.0 111.26 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -79.79 116.87 20.2 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.681 -0.637 . . . . 0.0 110.635 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.4 pt -142.53 132.77 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.926 1.69 . . . . 0.0 111.261 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 175.72 6.97 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.889 1.676 . . . . 0.0 112.347 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.9 mt -63.66 112.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.197 1.399 . . . . 0.0 110.035 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.65 -43.62 62.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.993 0.917 . . . . 0.0 111.742 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 p -149.02 147.75 28.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.115 1.766 . . . . 0.0 110.056 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -140.6 142.16 35.08 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.415 1.486 . . . . 0.0 110.212 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -152.32 131.64 12.85 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.929 1.692 . . . . 0.0 108.951 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -61.69 121.21 12.26 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.947 0.339 . . . . 0.0 110.545 171.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.9 mt -88.39 -40.54 13.45 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 122.645 0.378 . . . . 0.0 111.721 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.04 -145.22 15.71 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.653 1.121 . . . . 0.0 112.261 -173.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -128.22 74.93 1.58 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 123.206 1.479 . . . . 0.0 113.401 -167.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -89.54 155.19 19.44 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.458 1.503 . . . . 0.0 109.908 -171.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.15 117.26 5.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.436 0.694 . . . . 0.0 109.851 171.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.63 154.25 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.422 0.63 . . . . 0.0 110.919 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -140.94 157.38 45.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.669 1.588 . . . . 0.0 111.322 -170.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -156.93 117.12 3.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.755 1.222 . . . . 0.0 110.159 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.8 pt -71.46 155.44 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 121.028 -1.045 . . . . 0.0 111.205 172.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -107.07 152.38 16.89 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.494 1.045 . . . . 0.0 111.74 170.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.56 158.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.711 2.004 . . . . 0.0 110.108 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -71.81 -37.78 70.3 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.6 -168.1 0.79 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.202 1.001 . . . . 0.0 111.579 174.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -49.53 130.8 20.78 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.604 -0.685 . . . . 0.0 109.81 167.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -63.88 102.78 0.5 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.349 0.66 . . . . 0.0 110.817 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -162.5 171.16 17.48 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.413 1.485 . . . . 0.0 113.228 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -172.55 157.13 3.83 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.052 1.741 . . . . 0.0 111.061 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.77 144.75 29.95 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.821 0.848 . . . . 0.0 112.461 173.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 28.9 mt -89.76 173.09 8.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.095 1.358 . . . . 0.0 112.188 171.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -48.62 -49.73 35.85 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.708 1.603 . . . . 0.0 114.561 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -73.38 -37.7 65.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.211 0.604 . . . . 0.0 111.652 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 139.68 -6.11 2.91 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.478 -1.179 . . . . 0.0 115.359 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -57.0 155.35 8.28 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.563 1.681 . . . . 0.0 112.619 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.58 110.81 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 122.033 0.921 . . . . 0.0 109.676 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.36 116.75 29.54 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.391 1.076 . . . . 0.0 108.64 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.2 m -109.56 79.87 1.26 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.377 1.071 . . . . 0.0 111.433 -173.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.3 t30 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 127.597 2.359 . . . . 0.0 115.997 -168.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -142.76 158.6 27.14 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.385 1.945 . . . . 0.0 111.074 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.26 178.03 10.62 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.512 1.125 . . . . 0.0 112.653 -169.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.11 148.56 32.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.452 1.501 . . . . 0.0 110.652 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -62.41 161.39 11.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.644 0.777 . . . . 0.0 112.653 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -52.5 -47.01 66.86 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.889 . . . . 0.0 112.541 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -63.65 -20.45 65.7 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.266 1.827 . . . . 0.0 113.403 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.2 m -59.64 105.25 0.35 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.402 1.081 . . . . 0.0 110.862 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -86.23 129.81 34.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.363 0.601 . . . . 0.0 111.0 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.2 mm -113.49 124.95 70.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.075 1.35 . . . . 0.0 107.529 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.39 129.9 44.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.08 0.552 . . . . 0.0 110.899 171.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.8 p -133.02 148.68 52.24 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.296 1.438 . . . . 0.0 111.431 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.8 -31.3 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 122.071 -0.393 . . . . 0.0 111.892 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -64.83 -36.46 84.4 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -141.49 -44.76 0.36 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -172.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.17 -136.82 9.11 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.134 0.879 . . . . 0.0 112.347 -172.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.4 91.19 7.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.885 1.674 . . . . 0.0 111.823 -173.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -122.1 146.09 45.64 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.905 0.882 . . . . 0.0 112.638 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.76 125.33 13.59 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.367 3.378 . . . . 0.0 112.727 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.84 -37.36 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.965 0.906 . . . . 0.0 113.368 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.4 -32.39 79.23 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.559 -0.713 . . . . 0.0 113.097 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -71.88 -35.37 69.76 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 117.787 0.793 . . . . 0.0 111.602 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -67.5 -39.68 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.529 0.732 . . . . 0.0 109.709 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.03 -41.08 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.727 0.811 . . . . 0.0 112.471 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -76.35 -24.4 54.2 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.346 0.976 . . . . 0.0 113.339 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -104.67 -0.01 27.97 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.79 1.236 . . . . 0.0 112.854 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 48.29 49.57 17.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.655 1.982 . . . . 0.0 112.422 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.3 mt -68.61 121.02 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.179 0.992 . . . . 0.0 109.272 -174.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.39 107.77 11.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.439 1.095 . . . . 0.0 110.656 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.0 p -148.16 166.91 26.45 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.256 1.027 . . . . 0.0 113.466 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.5 148.29 23.89 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.433 1.493 . . . . 0.0 109.857 177.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 m -128.95 171.48 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.018 1.727 . . . . 0.0 110.924 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -115.4 140.09 49.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.462 1.505 . . . . 0.0 110.283 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 t -156.15 152.02 27.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.966 1.306 . . . . 0.0 110.672 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.52 128.31 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.199 0.6 . . . . 0.0 109.933 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -69.93 173.79 6.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.601 1.16 . . . . 0.0 111.807 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -62.22 -25.51 67.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.318 1.447 . . . . 0.0 113.328 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -86.23 -2.5 58.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.112 1.365 . . . . 0.0 113.398 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.08 22.52 60.9 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.603 1.097 . . . . 0.0 114.808 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -99.85 129.9 45.99 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.804 1.242 . . . . 0.0 109.991 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.1 mt -70.25 130.59 34.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -134.13 169.72 16.74 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.579 1.552 . . . . 0.0 110.938 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 p -119.55 140.87 49.83 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.956 0.902 . . . . 0.0 111.681 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -149.85 147.36 22.35 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.317 1.047 . . . . 0.0 112.423 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.05 149.91 47.45 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.117 2.545 . . . . 0.0 112.658 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -57.84 137.11 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.741 0.816 . . . . 0.0 110.409 168.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.16 -50.59 5.76 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.993 0.517 . . . . 0.0 111.42 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -149.97 173.55 13.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.029 1.731 . . . . 0.0 111.042 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -129.25 131.67 47.07 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.566 1.546 . . . . 0.0 108.994 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -130.06 138.81 50.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.202 1.001 . . . . 0.0 110.715 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.65 121.49 28.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.914 1.285 . . . . 0.0 110.801 -174.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -86.36 -34.0 20.36 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.216 1.006 . . . . 0.0 112.559 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.76 -44.93 2.71 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.253 1.406 . . . . 0.0 115.17 172.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -174.32 88.78 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 123.083 1.42 . . . . 0.0 114.568 -168.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -127.48 163.19 24.66 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.201 1.0 . . . . 0.0 112.91 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -67.73 103.53 1.43 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.062 1.345 . . . . 0.0 112.714 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -96.5 139.32 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.431 1.492 . . . . 0.0 110.991 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.424 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 75.5 m-85 -123.11 142.48 50.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.512 1.525 . . . . 0.0 109.976 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -65.88 131.26 45.84 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.733 0.813 . . . . 0.0 110.301 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -124.66 87.06 2.65 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.084 1.353 . . . . 0.0 108.439 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.2 t -95.28 146.71 24.16 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.97 0.908 . . . . 0.0 110.627 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.8 164.76 12.44 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.924 1.289 . . . . 0.0 112.368 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -66.86 -23.62 66.04 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.549 1.139 . . . . 0.0 113.284 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.56 -23.56 46.05 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.103 1.361 . . . . 0.0 112.961 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.55 0.68 30.86 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.756 1.17 . . . . 0.0 114.345 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.8 m -57.14 136.41 56.4 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.384 1.092 . . . . 0.0 110.558 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.92 122.78 38.34 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.753 1.221 . . . . 0.0 109.758 -172.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.1 mt -134.07 150.89 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.547 1.939 . . . . 0.0 107.86 -172.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 63.6 mtt85 -136.38 117.37 14.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.616 1.166 . . . . 0.0 109.864 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.6 163.5 38.34 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.518 1.127 . . . . 0.0 111.558 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 p -75.01 151.68 38.76 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.446 -0.784 . . . . 0.0 112.065 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -63.12 -17.22 62.09 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 176.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -86.42 -16.28 37.67 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.485 1.514 . . . . 0.0 113.33 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -74.46 135.36 42.29 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.176 0.59 . . . . 0.0 109.436 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 149.19 21.85 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.037 0.922 . . . . 0.0 112.174 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -134.26 127.25 31.46 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.428 -1.42 . . . . 0.0 110.182 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ttp -71.93 111.28 7.04 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.046 0.45 . . . . 0.0 111.084 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.6 p -70.37 171.94 9.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.057 0.543 . . . . 0.0 112.215 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -54.44 -27.2 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.1 -8.19 54.3 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.698 1.199 . . . . 0.0 113.133 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.82 1.09 63.67 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.962 1.267 . . . . 0.0 114.326 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.97 146.71 52.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.523 1.161 . . . . 0.0 111.212 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.2 mtm -117.87 76.55 1.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.31 1.444 . . . . 0.0 109.465 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.64 150.84 43.95 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.006 1.322 . . . . 0.0 110.979 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.34 148.92 80.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.977 2.451 . . . . 0.0 111.559 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 tt -55.66 -29.07 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -53.15 -37.51 61.9 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.643 1.177 . . . . 0.0 113.138 170.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -90.33 -32.83 16.32 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.584 1.153 . . . . 0.0 111.605 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.72 -38.33 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.389 -0.819 . . . . 0.0 111.191 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.64 -34.79 78.66 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.41 -45.98 51.35 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.46 -8.8 58.92 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 58.14 37.68 26.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.673 1.189 . . . . 0.0 111.549 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.5 mt -83.92 155.67 22.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.901 1.334 . . . . 0.0 112.162 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -110.92 155.42 22.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.764 2.426 . . . . 0.0 112.969 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.7 155.09 19.44 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.692 0.797 . . . . 0.0 112.444 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.4 ttp -74.99 138.46 42.25 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.711 173.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.85 157.51 27.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.996 1.318 . . . . 0.0 110.684 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.4 m -118.69 -4.18 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.99 13.42 25.07 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.683 1.593 . . . . 0.0 112.587 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 58.89 30.1 19.71 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.763 2.025 . . . . 0.0 112.466 -174.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.6 mt -88.85 155.77 50.01 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.21 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.55 154.32 64.7 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.841 3.027 . . . . 0.0 111.951 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.36 132.14 35.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.476 0.711 . . . . 0.0 110.339 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 pt -146.87 137.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.972 1.309 . . . . 0.0 111.489 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.87 175.98 9.96 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.991 1.317 . . . . 0.0 112.509 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.8 mt -62.17 111.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.081 1.353 . . . . 0.0 110.03 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.73 -45.18 83.62 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.131 0.972 . . . . 0.0 111.883 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 p -151.35 150.67 30.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.287 1.835 . . . . 0.0 110.555 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -133.05 142.87 49.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.725 1.61 . . . . 0.0 110.083 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -156.9 140.6 16.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.696 1.598 . . . . 0.0 109.865 175.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -66.84 128.64 37.08 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.876 -0.515 . . . . 0.0 111.127 172.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.78 -46.43 7.55 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.849 0.459 . . . . 0.0 111.691 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 147.53 -150.94 23.24 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.246 0.927 . . . . 0.0 112.778 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -122.18 79.59 1.61 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.932 1.349 . . . . 0.0 112.763 -168.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -98.36 157.93 15.89 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.793 1.637 . . . . 0.0 110.466 -169.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.57 120.8 13.04 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.633 0.773 . . . . 0.0 110.031 169.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.9 m -125.14 152.68 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.332 0.653 . . . . 0.0 111.182 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -140.93 156.49 46.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.159 1.384 . . . . 0.0 111.942 -168.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -152.4 130.91 12.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.671 1.189 . . . . 0.0 110.8 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.8 pt -91.59 154.11 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.74 173.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.06 159.76 13.91 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.906 1.241 . . . . 0.0 111.44 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 t -141.93 154.91 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.717 1.207 . . . . 0.0 109.649 -172.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.47 107.31 0.65 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.837 -1.164 . . . . 0.0 111.885 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 52.78 26.29 4.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.638 1.975 . . . . 0.0 114.385 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -145.24 166.7 24.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.002 1.721 . . . . 0.0 111.798 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -151.37 37.36 0.6 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.202 1.001 . . . . 0.0 112.43 -174.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -147.57 161.18 41.64 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.905 -1.122 . . . . 0.0 113.407 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -165.13 167.12 18.52 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.054 1.342 . . . . 0.0 112.297 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.38 131.02 40.46 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.622 1.169 . . . . 0.0 112.461 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 32.6 mt -70.33 166.9 19.25 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.304 1.441 . . . . 0.0 111.678 169.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -48.94 -34.59 13.16 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.49 -6.87 24.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.394 1.078 . . . . 0.0 112.526 -172.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.17 -17.59 7.52 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.962 1.267 . . . . 0.0 115.261 171.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -64.32 154.46 35.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.832 1.316 . . . . 0.0 112.697 -174.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.5 mm -104.47 140.31 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.434 1.015 . . . . 0.0 111.012 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.96 140.38 53.04 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.394 1.878 . . . . 0.0 109.418 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.0 t -138.74 124.91 20.19 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.118 1.367 . . . . 0.0 112.383 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.9 t30 . . . . . 0 C--O 1.255 1.384 0 C-N-CA 126.446 1.898 . . . . 0.0 113.991 -168.169 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -144.71 164.9 27.71 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 128.551 2.977 . . . . 0.0 109.135 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -159.54 173.34 16.29 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.715 0.757 . . . . 0.0 112.671 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.61 146.95 38.94 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.844 1.258 . . . . 0.0 110.771 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -65.2 164.1 13.9 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -50.97 -43.73 60.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.4 -19.73 64.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.692 1.197 . . . . 0.0 112.846 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 m -63.67 108.24 1.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.203 1.401 . . . . 0.0 111.133 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -86.47 128.12 34.93 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.116 0.484 . . . . 0.0 110.431 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.8 mm -99.58 122.3 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.396 1.479 . . . . 0.0 107.295 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.2 tp -69.91 122.61 19.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.2 p -125.9 152.11 46.01 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.9 0.88 . . . . 0.0 112.652 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -71.37 -34.05 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.876 0.47 . . . . 0.0 111.942 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -67.74 -32.72 73.53 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -141.78 -48.5 0.38 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.26 -151.39 19.87 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.172 0.892 . . . . 0.0 111.541 -172.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.87 108.49 1.49 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.352 1.061 . . . . 0.0 111.181 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.4 mt -132.23 147.76 67.05 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.74 1.216 . . . . 0.0 112.871 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.93 123.88 11.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.957 3.104 . . . . 0.0 112.212 -177.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 tt -55.21 -36.82 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.77 -33.73 88.01 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.797 -0.564 . . . . 0.0 113.018 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -77.36 -33.64 55.28 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.684 0.794 . . . . 0.0 112.042 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.7 mt -65.69 -38.85 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.141 0.976 . . . . 0.0 109.664 173.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.0 t -78.15 -38.32 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.366 1.067 . . . . 0.0 112.756 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 -25.48 46.64 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.26 0.936 . . . . 0.0 113.467 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -100.91 -2.59 31.54 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.722 1.209 . . . . 0.0 113.23 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 50.11 49.47 20.35 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.475 1.91 . . . . 0.0 112.339 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.4 mt -71.02 121.51 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.23 1.012 . . . . 0.0 109.591 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -74.81 114.03 12.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.409 0.623 . . . . 0.0 110.725 172.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.9 p -143.72 171.67 13.88 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.068 1.347 . . . . 0.0 112.278 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 m -112.83 150.13 32.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.909 1.284 . . . . 0.0 109.035 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.6 m -125.37 178.42 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.053 1.341 . . . . 0.0 111.222 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.83 141.27 49.68 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.841 1.256 . . . . 0.0 110.538 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.42 153.21 15.22 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.14 1.776 . . . . 0.0 109.185 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.5 m -89.09 143.7 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.442 1.019 . . . . 0.0 111.973 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.56 177.57 7.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.495 1.118 . . . . 0.0 111.395 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -62.8 -17.56 61.36 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.887 1.275 . . . . 0.0 113.04 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -95.16 -0.03 53.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.06 1.744 . . . . 0.0 113.133 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.66 35.65 40.08 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 121.33 -0.856 . . . . 0.0 114.147 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -119.31 123.23 43.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.455 1.502 . . . . 0.0 109.71 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -64.08 117.55 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -120.7 167.62 12.27 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.502 1.521 . . . . 0.0 111.669 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.1 p -115.6 137.96 51.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.282 1.033 . . . . 0.0 111.468 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -146.19 140.35 15.38 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.509 1.124 . . . . 0.0 111.412 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.19 148.94 40.02 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.863 2.375 . . . . 0.0 112.027 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.5 147.94 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.504 1.122 . . . . 0.0 111.114 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.17 -42.27 3.76 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.28 1.032 . . . . 0.0 112.237 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -142.6 178.44 7.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.896 1.679 . . . . 0.0 111.656 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -138.08 125.07 21.33 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.244 1.418 . . . . 0.0 109.117 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -118.57 137.82 52.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.345 1.058 . . . . 0.0 110.73 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.82 123.05 34.23 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.248 1.419 . . . . 0.0 110.61 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -89.72 -29.51 18.68 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.508 1.123 . . . . 0.0 112.77 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.58 -58.95 4.84 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.667 1.603 . . . . 0.0 114.002 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -158.92 98.83 1.5 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.77 1.228 . . . . 0.0 112.853 -168.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -133.03 163.13 29.92 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.336 1.054 . . . . 0.0 112.248 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.5 105.97 1.64 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.612 1.165 . . . . 0.0 113.246 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.42 137.44 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.0 0.92 . . . . 0.0 111.54 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -122.61 141.8 51.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.428 1.091 . . . . 0.0 110.849 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -85.84 96.08 9.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.93 1.692 . . . . 0.0 111.009 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -79.09 108.11 12.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.591 0.757 . . . . 0.0 109.418 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.0 t -88.63 132.55 34.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.361 1.064 . . . . 0.0 110.439 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tp -90.06 168.95 11.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.851 1.261 . . . . 0.0 112.628 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.5 -24.96 66.48 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.94 -27.23 36.17 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.482 1.513 . . . . 0.0 113.019 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.38 0.62 31.14 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.428 1.014 . . . . 0.0 114.13 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.0 m -65.36 141.18 58.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.667 1.234 . . . . 0.0 110.628 169.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 mp -119.62 141.02 49.69 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.256 1.422 . . . . 0.0 110.052 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -136.77 136.85 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.731 1.612 . . . . 0.0 108.398 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -123.96 103.3 8.24 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.134 0.974 . . . . 0.0 110.161 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.69 165.07 29.83 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.376 1.084 . . . . 0.0 111.828 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.9 p -78.4 149.2 33.37 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.464 1.106 . . . . 0.0 111.081 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -62.71 -12.78 25.91 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -91.63 -15.44 28.55 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.145 1.778 . . . . 0.0 112.527 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -78.04 134.54 37.76 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -87.49 160.13 18.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.362 0.665 . . . . 0.0 111.696 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -140.52 140.06 35.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.759 0.823 . . . . 0.0 110.501 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 44.1 ttm -74.01 108.76 7.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.389 1.075 . . . . 0.0 111.604 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.0 p -67.17 172.62 4.49 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -56.39 -23.18 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -98.01 -8.29 28.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.193 1.397 . . . . 0.0 113.165 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.14 1.49 48.16 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.065 1.317 . . . . 0.0 115.094 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -66.32 139.24 58.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.963 1.382 . . . . 0.0 111.44 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.73 76.05 1.77 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.221 1.408 . . . . 0.0 110.956 174.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.3 mt -102.4 147.63 34.27 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 124.165 0.986 . . . . 0.0 110.458 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -64.07 145.92 90.21 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.062 2.508 . . . . 0.0 110.989 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.1 tt -56.69 -28.36 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.82 -30.32 68.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.868 1.267 . . . . 0.0 113.416 172.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.42 -41.09 13.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.682 1.193 . . . . 0.0 111.155 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.2 mt -58.34 -41.21 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.514 1.126 . . . . 0.0 111.789 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -59.68 -33.19 71.26 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.234 1.014 . . . . 0.0 113.165 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -78.48 -46.92 18.51 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -13.73 62.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 56.01 35.36 25.43 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.711 1.604 . . . . 0.0 112.223 -175.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.2 mt -79.72 147.19 32.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.823 0.82 . . . . 0.0 111.373 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.45 172.33 13.16 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.697 0.761 . . . . 0.0 110.846 171.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.6 mt -116.2 157.51 24.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.342 1.057 . . . . 0.0 111.137 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.5 ttm -60.01 158.26 11.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.654 0.782 . . . . 0.0 111.809 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -127.13 163.23 24.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.096 1.758 . . . . 0.0 111.832 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.44 -26.43 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 125.006 1.322 . . . . 0.0 114.045 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -106.09 15.15 26.8 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.55 1.54 . . . . 0.0 112.288 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 56.93 34.42 24.83 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 123.473 1.606 . . . . 0.0 112.493 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.94 159.64 84.85 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 112.676 -2.056 . . . . 0.0 111.375 170.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.19 134.3 31.11 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.094 2.529 . . . . 0.0 111.361 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -72.27 122.88 21.86 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.897 0.879 . . . . 0.0 109.893 172.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.6 pt -146.47 142.06 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.38 1.072 . . . . 0.0 111.49 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 171.29 14.76 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.268 1.827 . . . . 0.0 112.997 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.34 109.25 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.236 1.015 . . . . 0.0 109.489 172.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.93 70.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.413 1.085 . . . . 0.0 112.149 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -152.5 167.99 27.0 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.996 1.719 . . . . 0.0 111.268 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -137.36 146.39 44.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.321 1.448 . . . . 0.0 110.677 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -139.39 120.26 14.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.582 1.153 . . . . 0.0 109.957 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -64.04 123.12 18.2 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.94 -0.475 . . . . 0.0 110.303 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 41.4 mt -90.39 -42.96 10.62 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.372 0.269 . . . . 0.0 111.688 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.83 -131.85 4.97 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.853 0.74 . . . . 0.0 112.92 -174.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -131.26 72.43 1.5 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.661 1.584 . . . . 0.0 113.101 -167.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -94.41 160.86 14.47 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.831 1.653 . . . . 0.0 111.421 -170.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.05 120.67 12.47 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.519 0.728 . . . . 0.0 111.344 169.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.07 151.99 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.491 0.716 . . . . 0.0 110.635 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -143.67 162.0 37.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.393 -168.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -155.73 120.38 4.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.027 0.931 . . . . 0.0 110.142 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.1 pt -80.4 137.27 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.727 -1.233 . . . . 0.0 111.64 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.02 134.21 12.23 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.022 0.82 . . . . 0.0 111.152 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -156.55 132.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.026 0.93 . . . . 0.0 110.553 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -80.99 150.84 28.75 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.907 0.883 . . . . 0.0 111.114 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 64.24 101.66 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.798 2.039 . . . . 0.0 111.616 -171.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.51 86.32 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.305 1.842 . . . . 0.0 112.54 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -53.54 -24.39 13.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.01 160.32 2.06 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 174.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -160.53 157.37 27.35 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.116 0.967 . . . . 0.0 112.149 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.05 149.48 44.84 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.64 1.176 . . . . 0.0 113.112 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.7 mt -134.93 174.68 10.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.123 2.169 . . . . 0.0 111.241 -172.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.97 146.99 4.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.246 1.018 . . . . 0.0 111.704 168.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 50.22 23.04 1.07 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.161 1.384 . . . . 0.0 114.451 -173.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.59 25.9 66.62 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 120.861 -1.149 . . . . 0.0 115.636 172.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -75.13 155.31 37.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.961 1.381 . . . . 0.0 112.174 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.06 103.06 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.67 148.1 25.6 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.3 t -132.84 147.43 52.3 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.912 1.685 . . . . 0.0 111.086 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 C--O 1.251 1.176 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.079 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -147.58 160.42 28.29 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.945 2.212 . . . . 0.0 111.769 -172.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -155.48 170.68 21.39 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.866 0.867 . . . . 0.0 112.11 -169.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -111.99 144.42 41.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.099 1.359 . . . . 0.0 110.029 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -67.94 159.77 29.92 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.65 -0.656 . . . . 0.0 111.868 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -48.47 -43.96 35.16 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.415 1.086 . . . . 0.0 112.761 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -13.42 29.83 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.7 m -70.51 112.35 6.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.528 1.131 . . . . 0.0 110.275 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -91.57 136.02 33.43 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.36 0.6 . . . . 0.0 111.54 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 mm -113.18 123.65 69.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 126.156 1.783 . . . . 0.0 107.512 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -62.37 129.69 41.86 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.371 0.668 . . . . 0.0 110.613 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.6 p -132.31 145.81 51.54 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.934 1.294 . . . . 0.0 111.269 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 t -75.21 -32.67 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.497 -0.752 . . . . 0.0 111.683 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -61.93 -32.56 72.97 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -142.75 -53.39 0.4 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -174.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.37 -144.25 15.9 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.181 0.896 . . . . 0.0 112.196 -171.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 mt -72.77 105.07 4.19 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.254 1.822 . . . . 0.0 111.013 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.0 mt -134.54 147.28 62.68 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.332 1.053 . . . . 0.0 113.744 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.44 127.94 19.22 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.062 3.175 . . . . 0.0 112.468 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.9 tt -55.57 -37.74 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.953 0.901 . . . . 0.0 112.859 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.35 -35.19 91.66 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.63 -0.539 . . . . 0.0 112.393 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -71.31 -33.38 69.64 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.485 1.143 . . . . 0.0 111.9 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.36 -41.82 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.584 0.754 . . . . 0.0 110.308 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.68 -42.83 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.76 0.709 . . . . 0.0 112.566 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -65.98 -29.08 69.41 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.057 0.844 . . . . 0.0 112.3 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -113.15 3.95 16.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.603 1.161 . . . . 0.0 113.484 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 48.3 50.53 16.35 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.931 2.092 . . . . 0.0 112.274 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.9 mt -68.86 117.99 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.119 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -74.23 97.81 3.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.375 1.07 . . . . 0.0 110.131 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.4 p -138.03 164.87 28.0 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.38 1.086 . . . . 0.0 113.195 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.49 154.94 17.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.523 1.529 . . . . 0.0 110.449 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.27 178.77 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.076 1.75 . . . . 0.0 110.756 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -126.18 134.68 51.2 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.511 1.524 . . . . 0.0 110.368 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -161.19 155.44 22.83 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.147 0.979 . . . . 0.0 112.068 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.8 m -79.38 146.89 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.634 1.106 . . . . 0.0 113.19 172.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.9 p30 -83.3 -178.81 7.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.174 0.99 . . . . 0.0 112.398 169.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -55.21 -31.55 61.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.495 1.118 . . . . 0.0 113.584 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -85.16 -10.13 57.06 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.723 0.809 . . . . 0.0 112.571 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.43 21.27 27.37 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.859 1.695 . . . . 0.0 114.678 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -101.9 123.29 45.57 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.193 1.496 . . . . 0.0 109.945 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.7 113.49 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.455 0.57 . . . . 0.0 109.734 177.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -116.87 177.18 4.8 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.882 2.073 . . . . 0.0 111.477 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -124.18 142.46 51.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.227 1.011 . . . . 0.0 112.832 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -154.37 152.77 26.94 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.346 1.059 . . . . 0.0 112.74 -176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.22 153.5 66.77 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.105 2.536 . . . . 0.0 112.992 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.79 140.8 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.713 1.205 . . . . 0.0 110.363 168.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.0 -52.44 5.08 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.924 -0.485 . . . . 0.0 111.333 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -150.99 177.87 9.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.153 1.781 . . . . 0.0 111.132 -175.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -135.7 137.32 41.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.069 1.348 . . . . 0.0 110.406 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -134.0 131.83 39.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.092 0.957 . . . . 0.0 111.862 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -111.71 140.8 46.03 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.591 1.556 . . . . 0.0 108.919 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -106.84 -36.32 6.7 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.79 -54.65 1.66 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.338 1.447 . . . . 0.0 113.791 175.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -169.79 104.7 0.33 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.92 1.36 . . . . 0.0 111.098 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -132.54 158.85 41.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.887 0.875 . . . . 0.0 112.896 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.92 98.55 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.427 1.491 . . . . 0.0 114.062 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.0 142.8 12.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.498 1.519 . . . . 0.0 111.593 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -128.08 135.97 50.56 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.654 1.582 . . . . 0.0 109.708 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.2 134.21 56.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.362 0.665 . . . . 0.0 110.474 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.86 96.94 4.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.694 1.197 . . . . 0.0 108.523 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 34.2 t -106.28 145.18 31.95 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.228 1.011 . . . . 0.0 110.597 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -107.93 164.56 12.16 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.625 1.17 . . . . 0.0 112.917 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -67.87 -21.54 65.16 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -80.27 -23.27 40.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.851 1.26 . . . . 0.0 113.044 172.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.02 -3.85 22.5 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.193 1.378 . . . . 0.0 114.597 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -57.0 139.17 53.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.749 1.274 . . . . 0.0 111.122 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.55 125.76 40.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.656 1.183 . . . . 0.0 109.899 -174.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.2 mt -136.21 150.7 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 108.382 -170.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -135.39 112.01 10.0 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.662 1.185 . . . . 0.0 111.316 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.14 20.83 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.626 1.571 . . . . 0.0 111.188 -175.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.9 p -84.56 161.71 20.09 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.495 -0.753 . . . . 0.0 112.077 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -67.91 -8.26 35.29 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 173.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -100.32 -12.98 19.01 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.301 1.44 . . . . 0.0 112.167 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -77.73 131.86 37.86 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 172.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -88.37 164.44 15.53 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.704 0.764 . . . . 0.0 111.308 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -138.36 135.45 35.36 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.414 0.686 . . . . 0.0 109.151 175.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.9 ttp -74.18 102.0 4.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.827 1.251 . . . . 0.0 109.6 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.6 p -64.23 172.74 2.3 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.755 1.222 . . . . 0.0 112.335 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.74 -28.91 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.4 -10.07 58.65 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.277 1.031 . . . . 0.0 113.593 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.73 -0.07 79.35 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.7 1.143 . . . . 0.0 113.954 -175.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -68.46 129.03 38.72 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.669 1.235 . . . . 0.0 109.49 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -96.25 88.42 4.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.271 1.428 . . . . 0.0 109.821 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.6 mt -115.4 147.19 38.14 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.394 1.077 . . . . 0.0 110.594 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.71 147.2 89.75 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.225 2.616 . . . . 0.0 111.323 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.11 -26.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.21 -37.88 70.25 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.591 1.156 . . . . 0.0 112.733 169.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -80.48 -39.68 27.57 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.247 0.619 . . . . 0.0 110.571 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.05 -36.7 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.26 -0.9 . . . . 0.0 111.346 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -66.49 -35.84 81.27 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.4 -36.92 28.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.716 0.806 . . . . 0.0 112.927 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -75.87 -17.98 59.6 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.573 1.149 . . . . 0.0 112.896 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 55.48 37.78 29.36 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.305 1.442 . . . . 0.0 112.63 -173.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.8 mt -82.69 146.82 28.84 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.93 0.892 . . . . 0.0 112.919 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.14 158.67 18.48 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.47 1.108 . . . . 0.0 112.049 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.7 mt -103.1 149.38 24.66 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 33.3 ttm -70.95 153.29 42.79 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 111.624 171.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -141.18 160.66 39.63 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.563 1.945 . . . . 0.0 112.539 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 p -101.11 -26.21 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 126.019 1.728 . . . . 0.0 113.567 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.68 5.29 9.57 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.29 1.436 . . . . 0.0 113.541 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 57.34 27.12 13.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.324 1.849 . . . . 0.0 112.344 -172.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 mt -70.97 155.52 93.26 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.416 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.07 147.65 84.47 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.234 2.622 . . . . 0.0 110.985 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -91.98 125.73 36.79 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.68 -0.638 . . . . 0.0 109.517 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -143.0 139.38 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.144 1.378 . . . . 0.0 111.454 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 173.5 11.86 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.59 1.556 . . . . 0.0 112.891 176.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.8 mt -64.39 118.79 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.348 1.459 . . . . 0.0 110.461 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.24 -44.56 65.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.333 1.053 . . . . 0.0 111.99 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -149.81 147.41 27.95 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.794 1.637 . . . . 0.0 111.137 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -140.27 142.08 35.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.139 1.776 . . . . 0.0 110.061 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -154.76 149.34 26.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.871 2.068 . . . . 0.0 110.566 170.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.14 130.77 45.27 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.751 0.42 . . . . 0.0 109.872 168.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.4 mt -103.2 -52.72 2.97 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.692 0.797 . . . . 0.0 110.857 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 167.19 -141.35 6.84 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 120.961 0.2 . . . . 0.0 113.263 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -131.41 64.6 1.58 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.188 1.47 . . . . 0.0 111.829 -168.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -85.18 158.86 20.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.805 2.042 . . . . 0.0 112.554 -167.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 114.11 4.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.063 0.945 . . . . 0.0 111.109 172.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.91 152.96 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.908 0.883 . . . . 0.0 110.314 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -143.19 158.8 43.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.858 1.663 . . . . 0.0 111.06 -170.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -153.03 134.36 14.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.016 0.927 . . . . 0.0 111.338 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.5 pt -89.99 155.14 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 121.426 -0.797 . . . . 0.0 111.133 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.88 153.37 16.99 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.02 1.295 . . . . 0.0 111.245 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.5 154.34 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.488 1.515 . . . . 0.0 108.984 -172.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -57.6 111.81 1.24 Allowed 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.065 -1.647 . . . . 0.0 112.093 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 49.94 25.15 1.53 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.739 2.016 . . . . 0.0 115.11 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -146.75 160.52 42.14 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.962 1.305 . . . . 0.0 112.153 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -142.58 33.28 1.45 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.111 0.964 . . . . 0.0 111.028 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -131.95 161.32 33.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.493 1.517 . . . . 0.0 113.207 -175.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -174.54 154.72 2.11 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.985 1.314 . . . . 0.0 111.573 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.95 124.15 28.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.788 0.835 . . . . 0.0 112.088 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.51 173.52 5.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.688 1.195 . . . . 0.0 111.139 169.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -45.84 -42.59 12.56 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -91.35 -6.45 52.97 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.648 1.179 . . . . 0.0 113.409 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.95 -13.79 16.96 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 117.761 -1.577 . . . . 0.0 115.557 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -54.45 142.81 25.93 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.079 1.439 . . . . 0.0 112.23 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.76 92.22 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.871 0.843 . . . . 0.0 109.276 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.5 141.37 51.97 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.6 t -138.69 133.79 32.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.007 1.323 . . . . 0.0 110.973 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 C--O 1.254 1.302 0 C-N-CA 124.183 0.993 . . . . 0.0 113.493 -171.445 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -146.55 174.74 26.31 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 127.336 2.398 . . . . 0.0 111.128 -172.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -164.6 177.31 8.17 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.038 0.935 . . . . 0.0 113.354 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 mt -122.3 151.01 41.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.673 1.989 . . . . 0.0 110.166 -171.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -66.29 159.93 25.58 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.633 -0.667 . . . . 0.0 112.246 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -50.49 -44.74 56.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.464 1.106 . . . . 0.0 112.956 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -64.15 -10.88 25.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.231 1.412 . . . . 0.0 114.163 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.7 m -66.79 94.81 0.33 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.324 1.449 . . . . 0.0 111.523 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -73.45 136.05 44.2 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.282 0.563 . . . . 0.0 111.965 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.3 mm -117.89 122.68 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.099 1.759 . . . . 0.0 107.407 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.6 tp -64.65 124.51 22.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.518 0.727 . . . . 0.0 110.696 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.7 p -125.89 156.12 40.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.683 1.193 . . . . 0.0 112.299 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.97 -31.43 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.076 0.55 . . . . 0.0 111.713 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.49 -34.87 78.72 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -141.22 -50.87 0.43 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.49 -145.14 17.19 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.682 0.673 . . . . 0.0 111.954 -172.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.9 mt -70.79 106.98 3.77 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.288 1.035 . . . . 0.0 111.091 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.8 mt -133.95 149.46 71.76 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.802 1.241 . . . . 0.0 112.697 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.05 128.15 20.03 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.06 3.173 . . . . 0.0 112.196 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 tt -54.63 -36.31 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.812 0.845 . . . . 0.0 112.755 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.97 -35.51 91.98 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 119.306 -0.719 . . . . 0.0 113.004 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -70.84 -34.08 71.31 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.785 1.292 . . . . 0.0 111.745 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.3 mt -69.49 -38.88 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.048 0.939 . . . . 0.0 110.169 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.2 t -83.75 -36.84 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.035 0.934 . . . . 0.0 113.154 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -66.98 -26.35 66.77 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.865 0.757 . . . . 0.0 112.67 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -115.61 1.48 13.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.637 1.175 . . . . 0.0 113.471 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 47.15 53.28 10.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.148 2.179 . . . . 0.0 112.476 -177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.16 115.13 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.491 0.716 . . . . 0.0 109.3 -173.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.15 108.49 3.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.441 1.096 . . . . 0.0 110.27 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.7 p -147.23 168.13 22.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.391 1.076 . . . . 0.0 112.57 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.56 148.97 25.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.656 1.582 . . . . 0.0 108.931 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.88 161.78 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.447 1.499 . . . . 0.0 110.702 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -100.17 153.26 19.4 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.418 1.087 . . . . 0.0 110.512 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.8 t -168.51 146.95 4.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.712 1.205 . . . . 0.0 111.505 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -75.23 130.36 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.127 1.371 . . . . 0.0 112.56 169.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -85.1 179.33 7.28 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.738 0.815 . . . . 0.0 111.748 171.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -57.7 -21.61 41.54 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.856 1.263 . . . . 0.0 113.43 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.76 -13.56 57.59 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.089 1.355 . . . . 0.0 113.242 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.06 4.46 89.9 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.078 1.323 . . . . 0.0 115.084 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -91.34 131.87 36.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.224 1.012 . . . . 0.0 109.787 175.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -69.91 123.82 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.504 0.722 . . . . 0.0 109.554 172.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -120.57 172.15 8.05 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.894 1.678 . . . . 0.0 110.708 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 p -121.47 139.11 53.9 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.072 0.949 . . . . 0.0 112.254 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.75 147.03 34.0 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.797 1.239 . . . . 0.0 112.946 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.3 150.18 52.39 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.118 2.546 . . . . 0.0 112.593 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.81 141.9 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.069 0.948 . . . . 0.0 111.148 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.69 -32.76 11.24 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.641 0.776 . . . . 0.0 112.611 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -170.45 179.33 3.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.316 1.847 . . . . 0.0 111.929 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -136.11 122.8 21.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.018 1.327 . . . . 0.0 109.554 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -109.43 118.42 36.59 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.682 1.193 . . . . 0.0 110.773 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.27 114.68 28.33 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.304 1.442 . . . . 0.0 109.958 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -83.33 -30.53 27.42 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.067 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.11 -44.27 2.82 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.629 1.585 . . . . 0.0 113.538 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 178.81 100.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.429 1.109 . . . . 0.0 113.073 -171.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -129.12 163.97 24.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.527 1.131 . . . . 0.0 113.415 173.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -63.27 100.41 0.24 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.994 1.718 . . . . 0.0 113.154 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.2 t -90.92 137.31 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.027 1.331 . . . . 0.0 111.21 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -120.78 136.7 54.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.44 1.496 . . . . 0.0 109.407 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.06 125.84 25.37 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.85 0.86 . . . . 0.0 110.178 172.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -117.46 99.19 6.83 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.019 1.327 . . . . 0.0 108.032 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.6 t -110.01 147.24 33.9 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.855 0.862 . . . . 0.0 110.674 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.91 164.31 12.71 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.21 1.404 . . . . 0.0 112.429 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -67.47 -24.01 65.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.991 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.96 -25.24 37.49 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.814 1.246 . . . . 0.0 113.272 174.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.07 -7.37 11.81 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.072 1.32 . . . . 0.0 114.75 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -55.47 143.53 28.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.766 1.283 . . . . 0.0 111.542 175.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.47 124.3 31.69 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.535 1.134 . . . . 0.0 110.203 -173.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 43.8 mt -135.11 151.88 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 127.121 2.168 . . . . 0.0 108.225 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -136.59 113.04 9.99 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.575 1.15 . . . . 0.0 110.552 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.89 166.34 25.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.849 1.26 . . . . 0.0 111.967 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 p -83.73 152.11 24.88 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.75 0.82 . . . . 0.0 111.354 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -61.46 -15.17 34.89 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -89.32 -16.76 30.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.885 1.674 . . . . 0.0 112.246 -176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -80.17 131.5 35.73 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -89.15 156.92 18.5 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.271 0.558 . . . . 0.0 111.444 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -135.93 141.03 44.46 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.657 0.783 . . . . 0.0 109.271 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 46.7 ttm -68.83 108.38 3.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.946 0.898 . . . . 0.0 110.124 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.6 p -70.81 169.84 13.77 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.776 -0.578 . . . . 0.0 112.026 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.4 m -54.56 -23.94 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 174.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -87.63 -7.25 57.7 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.024 . . . . 0.0 113.317 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.45 7.16 65.44 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.402 1.477 . . . . 0.0 113.939 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -79.95 126.64 31.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.228 1.014 . . . . 0.0 110.346 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.28 92.22 6.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.3 1.04 . . . . 0.0 110.433 169.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.7 mt -116.77 146.3 37.41 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.95 0.9 . . . . 0.0 110.978 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.13 146.46 86.91 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.226 2.617 . . . . 0.0 111.061 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.8 tt -59.05 -27.74 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -55.9 -35.55 66.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.531 1.132 . . . . 0.0 113.109 169.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -85.03 -34.71 22.26 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.895 -0.503 . . . . 0.0 111.405 175.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.55 -39.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 119.385 0.993 . . . . 0.0 110.762 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -64.69 -39.16 93.18 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -76.74 -39.35 52.07 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -78.12 -13.15 59.98 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 56.87 30.11 17.32 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.785 1.234 . . . . 0.0 112.151 -174.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.41 142.95 46.93 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.996 0.918 . . . . 0.0 111.302 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -90.78 135.37 33.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.071 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 mp -66.42 150.78 48.4 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.059 -1.026 . . . . 0.0 111.141 168.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.8 ttp -72.66 172.37 10.79 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.326 0.584 . . . . 0.0 111.791 171.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -137.12 164.05 29.35 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.729 1.612 . . . . 0.0 111.433 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 m -106.8 -22.75 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -107.35 21.6 17.25 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.962 1.305 . . . . 0.0 112.386 -172.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 56.08 29.42 14.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.776 1.63 . . . . 0.0 112.454 -172.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.6 mt -63.35 159.26 51.26 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.921 171.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.92 143.99 56.95 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.249 2.633 . . . . 0.0 111.426 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.98 121.23 31.87 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.752 0.821 . . . . 0.0 109.015 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.4 pt -142.22 122.47 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.732 1.213 . . . . 0.0 110.738 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -67.34 170.52 7.17 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.285 1.834 . . . . 0.0 112.962 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.7 mt -61.58 120.1 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.306 1.442 . . . . 0.0 110.194 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.96 -47.29 66.0 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.718 0.807 . . . . 0.0 111.614 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 p -152.29 151.88 31.47 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.351 1.46 . . . . 0.0 111.001 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.65 141.79 48.8 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.057 1.743 . . . . 0.0 110.048 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 134.55 15.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.484 1.913 . . . . 0.0 109.484 177.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -65.1 133.81 52.43 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.081 0.152 . . . . 0.0 110.755 170.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.2 mt -100.97 -42.65 6.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.009 0.524 . . . . 0.0 112.009 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.49 -149.94 21.71 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.665 1.126 . . . . 0.0 111.798 -173.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -123.27 100.16 6.71 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.542 1.137 . . . . 0.0 111.458 -170.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -115.13 155.22 27.5 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.253 1.421 . . . . 0.0 109.88 -171.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 116.78 6.27 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.305 0.642 . . . . 0.0 110.144 172.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.14 150.94 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.396 0.678 . . . . 0.0 110.887 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -139.29 156.15 47.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.305 1.442 . . . . 0.0 111.743 -170.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -157.5 121.35 4.17 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.814 1.245 . . . . 0.0 110.071 -173.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.7 pt -80.52 143.73 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 120.706 -1.246 . . . . 0.0 111.523 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.71 153.97 20.51 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.902 0.763 . . . . 0.0 111.799 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.3 t -147.19 143.55 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.216 1.406 . . . . 0.0 109.739 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -91.01 -47.37 7.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -66.53 -41.16 89.15 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.518 1.127 . . . . 0.0 113.746 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -159.25 123.45 3.92 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.764 1.625 . . . . 0.0 108.709 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -72.93 60.58 0.53 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.299 1.44 . . . . 0.0 112.887 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -154.41 171.66 18.98 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.138 1.775 . . . . 0.0 112.738 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -166.28 150.86 7.89 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.222 1.409 . . . . 0.0 110.817 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.39 142.16 30.34 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.842 0.857 . . . . 0.0 112.309 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.3 mt -102.16 171.21 7.62 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.675 1.19 . . . . 0.0 112.054 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -19.33 8.28 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -103.74 11.18 36.21 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.516 1.526 . . . . 0.0 112.958 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.04 21.52 75.92 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 121.336 -0.852 . . . . 0.0 113.844 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.39 163.72 16.61 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.644 1.578 . . . . 0.0 111.985 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.01 100.81 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.746 1.218 . . . . 0.0 108.948 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.98 149.68 26.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.9 t -140.83 141.09 34.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.379 0.672 . . . . 0.0 112.477 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.919 1.287 . . . . 0.0 113.097 -173.498 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -126.75 162.25 20.91 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.882 1.706 . . . . 0.0 112.854 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.92 177.91 9.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.445 1.498 . . . . 0.0 112.14 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.99 144.33 44.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.982 1.713 . . . . 0.0 110.383 -172.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -68.86 163.67 23.77 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.633 -0.667 . . . . 0.0 112.441 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -50.83 -42.86 58.82 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.642 -0.661 . . . . 0.0 112.411 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -65.73 -13.95 60.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.814 1.246 . . . . 0.0 114.116 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.2 m -71.0 120.39 16.5 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.515 0.726 . . . . 0.0 110.725 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -102.27 138.38 39.29 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.495 0.664 . . . . 0.0 111.633 -176.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.15 116.66 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 126.198 1.799 . . . . 0.0 107.585 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tt -63.12 124.49 21.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.706 0.402 . . . . 0.0 111.19 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.3 p -118.53 155.84 30.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.85 1.26 . . . . 0.0 112.144 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.8 -35.72 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.789 0.836 . . . . 0.0 111.14 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -67.36 -32.42 73.35 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -140.13 -50.29 0.47 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.53 -143.91 15.71 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.147 0.879 . . . . 0.0 112.656 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.36 96.14 0.65 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.381 1.872 . . . . 0.0 112.846 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -129.87 149.63 73.62 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.844 1.258 . . . . 0.0 112.591 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.68 130.26 23.01 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.404 3.403 . . . . 0.0 113.127 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 tt -57.44 -37.59 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.002 0.921 . . . . 0.0 112.922 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.36 -31.34 78.65 Favored Glycine 0 CA--C 1.529 0.917 0 O-C-N 121.718 -0.614 . . . . 0.0 112.846 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -72.06 -38.68 69.43 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.094 0.947 . . . . 0.0 111.317 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.73 -39.34 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.619 0.767 . . . . 0.0 109.76 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.5 t -80.99 -38.92 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.874 0.87 . . . . 0.0 112.938 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.72 -23.94 56.14 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.74 1.155 . . . . 0.0 113.297 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -108.58 2.02 21.8 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.202 1.401 . . . . 0.0 112.12 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.89 52.12 11.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.32 2.248 . . . . 0.0 113.04 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.6 mt -76.35 122.4 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.964 0.906 . . . . 0.0 110.055 -170.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.77 96.59 3.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.655 1.182 . . . . 0.0 111.595 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 68.3 m -135.4 173.45 11.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.072 1.349 . . . . 0.0 112.732 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 m -121.42 140.21 52.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.705 1.602 . . . . 0.0 108.969 -176.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.9 m -125.35 163.21 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.637 1.575 . . . . 0.0 111.19 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -97.94 147.59 24.31 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.597 1.159 . . . . 0.0 110.362 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -157.55 156.21 31.55 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.806 1.642 . . . . 0.0 109.577 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 t -102.6 127.42 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.807 0.843 . . . . 0.0 109.757 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -69.24 175.25 4.01 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.931 1.292 . . . . 0.0 112.58 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -61.47 -26.73 68.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.024 1.33 . . . . 0.0 113.424 175.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -87.84 0.75 55.39 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.242 1.417 . . . . 0.0 113.41 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.98 18.88 76.13 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.771 1.176 . . . . 0.0 114.655 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -92.3 132.89 36.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.598 1.159 . . . . 0.0 110.122 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.14 131.08 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -137.77 176.74 8.43 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.537 1.935 . . . . 0.0 110.715 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 p -125.87 143.53 51.03 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.273 1.029 . . . . 0.0 112.397 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -143.2 141.62 19.81 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.654 1.182 . . . . 0.0 112.336 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.73 150.12 49.69 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.832 2.355 . . . . 0.0 111.464 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.55 136.81 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.381 0.672 . . . . 0.0 110.856 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.45 -45.9 5.95 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.533 0.733 . . . . 0.0 111.832 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -146.16 178.99 7.81 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.287 1.835 . . . . 0.0 111.278 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -135.05 120.64 19.36 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.498 1.519 . . . . 0.0 109.23 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -116.19 119.26 35.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.185 0.994 . . . . 0.0 110.79 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -107.61 113.43 26.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.322 1.449 . . . . 0.0 109.908 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -82.19 -29.93 31.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.778 0.831 . . . . 0.0 112.965 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.54 -54.62 2.37 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.474 1.511 . . . . 0.0 113.888 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -170.33 103.09 0.27 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.157 1.383 . . . . 0.0 111.057 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -132.28 164.88 25.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.226 1.011 . . . . 0.0 111.69 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.55 99.65 0.23 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.594 1.558 . . . . 0.0 113.638 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 t -95.99 141.22 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.499 1.52 . . . . 0.0 111.589 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.83 137.76 54.61 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.239 1.816 . . . . 0.0 109.975 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.66 133.52 56.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.864 0.865 . . . . 0.0 110.715 171.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -127.55 89.29 2.93 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.023 1.329 . . . . 0.0 108.314 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.4 t -97.48 149.24 22.39 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.348 1.059 . . . . 0.0 110.731 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.15 163.53 15.82 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.212 1.405 . . . . 0.0 112.387 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.36 -20.54 63.84 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -81.45 -17.86 47.28 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.238 1.015 . . . . 0.0 113.171 170.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.26 -3.62 33.19 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.042 1.306 . . . . 0.0 114.207 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.9 m -57.71 142.31 45.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.522 1.129 . . . . 0.0 110.994 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -130.9 126.18 35.46 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.712 0.805 . . . . 0.0 111.351 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.5 mt -135.22 152.38 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 126.85 2.06 . . . . 0.0 107.674 -171.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.99 115.29 11.07 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.848 1.259 . . . . 0.0 110.528 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.09 163.24 34.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.626 1.171 . . . . 0.0 111.291 -176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.4 p -78.94 153.2 30.6 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.575 -0.703 . . . . 0.0 111.415 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.49 -24.17 65.08 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -84.05 -10.08 58.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.617 1.167 . . . . 0.0 112.836 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -82.44 133.96 35.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -97.12 156.12 16.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.536 1.134 . . . . 0.0 111.521 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.48 141.26 46.7 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.08 -1.012 . . . . 0.0 110.822 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.8 ttm -73.03 100.13 2.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.043 0.937 . . . . 0.0 109.594 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.5 p -66.96 170.74 6.26 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.8 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -56.09 -20.33 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.94 -4.01 28.46 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.653 1.181 . . . . 0.0 113.307 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 3.79 72.8 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.244 1.402 . . . . 0.0 113.913 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -65.42 122.97 18.39 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.381 1.072 . . . . 0.0 110.55 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.6 mtt -84.71 73.28 10.62 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.703 2.001 . . . . 0.0 110.766 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 43.6 mt -105.93 147.71 35.25 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 123.483 0.713 . . . . 0.0 110.97 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.78 148.27 86.43 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.11 2.54 . . . . 0.0 110.924 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 tt -53.46 -34.62 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.84 -33.12 70.05 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -77.15 -34.78 56.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.625 0.77 . . . . 0.0 111.15 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.1 mt -67.4 -39.4 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.782 0.833 . . . . 0.0 110.367 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -64.2 -34.26 77.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.953 0.901 . . . . 0.0 112.956 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -73.94 -47.25 38.89 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.01 -9.23 58.56 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 58.7 34.18 23.6 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.892 1.277 . . . . 0.0 112.325 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.89 143.85 35.48 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 122.172 0.987 . . . . 0.0 111.905 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.3 158.83 24.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.447 1.099 . . . . 0.0 111.623 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.51 152.2 21.03 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.39 -0.819 . . . . 0.0 111.922 169.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -75.15 146.5 41.27 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.176 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 166.05 23.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.047 1.339 . . . . 0.0 114.135 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.7 m -105.03 -30.03 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.561 1.544 . . . . 0.0 113.07 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.03 -2.73 56.08 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.326 1.05 . . . . 0.0 113.108 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.278 8.6 m-80 59.14 36.0 23.87 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.988 1.375 . . . . 0.0 112.991 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.9 mt -61.89 157.71 48.36 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.839 167.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.5 140.86 84.11 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.633 2.222 . . . . 0.0 110.39 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -66.56 126.05 27.69 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.999 -0.438 . . . . 0.0 110.496 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.5 pt -143.75 132.89 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.946 1.298 . . . . 0.0 111.013 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 176.31 7.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.202 1.401 . . . . 0.0 111.74 176.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.8 mt -64.13 109.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.731 1.212 . . . . 0.0 110.19 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.6 94.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.481 1.112 . . . . 0.0 112.287 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.0 p -151.43 153.25 34.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.939 1.696 . . . . 0.0 111.25 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -137.3 143.19 42.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.956 1.702 . . . . 0.0 110.335 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -152.33 148.31 27.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.591 2.356 . . . . 0.0 110.454 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -72.02 124.17 24.36 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.897 0.479 . . . . 0.0 110.081 168.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.2 mt -91.09 -44.81 9.05 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.022 0.529 . . . . 0.0 111.649 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.13 -145.73 13.9 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.056 0.836 . . . . 0.0 113.116 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -122.44 51.76 1.36 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 123.103 1.43 . . . . 0.0 113.66 -166.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -72.7 158.17 36.12 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 127.64 2.376 . . . . 0.0 112.53 -168.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.58 118.16 6.69 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.992 0.917 . . . . 0.0 111.417 171.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.8 m -126.09 156.2 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.41 0.684 . . . . 0.0 111.789 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -144.31 159.01 43.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.733 1.613 . . . . 0.0 111.559 -168.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -155.78 128.73 8.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.43 1.092 . . . . 0.0 109.952 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.43 142.55 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 121.292 -0.88 . . . . 0.0 111.281 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.65 136.36 14.87 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -152.67 93.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.01 1.724 . . . . 0.0 109.922 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.13 -26.57 68.24 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.132 -0.98 . . . . 0.0 113.454 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -60.37 -45.29 94.04 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.106 1.362 . . . . 0.0 112.665 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -166.33 135.76 3.14 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.353 1.861 . . . . 0.0 109.909 169.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 15.12 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -171.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -132.85 163.68 28.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.696 1.598 . . . . 0.0 114.113 -171.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -163.3 164.79 24.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.443 1.497 . . . . 0.0 112.437 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.75 141.41 28.53 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.675 1.19 . . . . 0.0 112.949 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.4 mt -91.53 171.76 8.97 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.658 1.983 . . . . 0.0 111.997 175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -50.49 -50.84 51.61 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.794 1.638 . . . . 0.0 115.171 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -68.06 -26.96 66.11 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.211 0.604 . . . . 0.0 111.825 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 120.48 -3.0 12.4 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.667 1.603 . . . . 0.0 114.096 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -69.07 163.82 23.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.144 1.472 . . . . 0.0 111.874 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.14 136.97 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 122.033 0.92 . . . . 0.0 110.629 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -121.51 151.48 40.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.37 1.868 . . . . 0.0 109.593 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.6 t -142.81 135.93 28.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.826 0.851 . . . . 0.0 113.089 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.2 t30 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.76 1.224 . . . . 0.0 113.131 -176.099 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -145.26 167.1 27.48 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 127.548 2.499 . . . . 0.0 111.36 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.41 176.73 10.81 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.309 0.644 . . . . 0.0 112.544 -169.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.7 mt -116.74 147.41 42.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.352 1.861 . . . . 0.0 110.415 -173.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t -62.88 161.77 12.25 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -52.37 -44.77 65.46 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.146 -0.971 . . . . 0.0 111.474 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -56.34 -25.47 49.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.721 1.609 . . . . 0.0 114.044 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.6 m -65.5 103.62 0.87 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.883 1.273 . . . . 0.0 112.023 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -85.15 136.09 33.69 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.642 -0.661 . . . . 0.0 111.864 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 mm -109.4 131.94 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.535 1.534 . . . . 0.0 107.875 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -69.7 122.76 19.79 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 122.082 -0.386 . . . . 0.0 111.433 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.7 p -120.63 151.19 39.78 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.716 1.206 . . . . 0.0 112.315 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 t -75.74 -37.34 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.169 0.587 . . . . 0.0 111.84 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.04 -28.4 68.83 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -141.37 -51.12 0.43 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.29 -156.52 23.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.261 0.934 . . . . 0.0 112.505 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.87 105.9 0.43 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.431 1.092 . . . . 0.0 111.163 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.5 mt -135.52 149.75 70.26 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 124.746 1.218 . . . . 0.0 112.888 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.13 128.45 21.71 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.975 3.117 . . . . 0.0 112.351 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.4 tt -56.47 -35.94 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.793 0.837 . . . . 0.0 113.058 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.28 -33.97 88.66 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.548 -0.585 . . . . 0.0 113.072 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -69.33 -35.06 75.55 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.207 1.003 . . . . 0.0 111.806 174.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.3 mt -69.43 -41.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.581 0.752 . . . . 0.0 110.311 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -78.99 -39.67 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.808 0.731 . . . . 0.0 112.435 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.94 -23.67 60.71 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.32 0.964 . . . . 0.0 113.19 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.16 4.09 19.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.975 1.31 . . . . 0.0 112.65 176.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 50.16 45.73 25.41 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.916 1.686 . . . . 0.0 112.643 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.23 127.69 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.944 0.898 . . . . 0.0 109.399 -172.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -78.73 111.21 14.62 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.365 0.602 . . . . 0.0 110.319 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.8 p -133.9 -172.39 2.97 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.263 1.425 . . . . 0.0 111.005 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.3 157.03 35.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.687 1.595 . . . . 0.0 109.103 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.1 m -140.25 163.52 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.588 1.155 . . . . 0.0 111.026 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -104.43 139.96 38.62 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.204 1.402 . . . . 0.0 110.43 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -159.43 150.92 20.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.442 1.497 . . . . 0.0 110.528 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 m -83.41 148.11 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.423 1.01 . . . . 0.0 112.941 171.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.84 -179.92 7.4 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.836 0.854 . . . . 0.0 111.405 169.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -60.76 -20.68 61.88 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.89 1.276 . . . . 0.0 113.023 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -91.75 0.62 57.48 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.682 1.593 . . . . 0.0 113.277 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.2 26.67 63.47 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 121.114 -0.991 . . . . 0.0 114.223 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -107.58 120.21 41.56 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.621 1.568 . . . . 0.0 109.231 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.45 125.98 23.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 123.594 0.758 . . . . 0.0 109.431 173.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -129.09 173.08 10.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.359 1.863 . . . . 0.0 111.403 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -117.18 142.4 47.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.946 1.298 . . . . 0.0 112.413 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -146.71 142.68 17.51 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.27 1.028 . . . . 0.0 112.873 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.5 154.5 50.28 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.116 2.544 . . . . 0.0 111.813 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.7 t -62.36 140.8 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.615 -0.678 . . . . 0.0 110.062 169.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.9 -40.95 4.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.311 0.645 . . . . 0.0 112.27 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -138.13 164.45 29.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.565 1.146 . . . . 0.0 112.306 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -133.87 131.36 39.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.294 1.838 . . . . 0.0 108.362 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.26 130.78 50.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.022 1.329 . . . . 0.0 111.157 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -139.45 136.56 34.76 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.568 -1.333 . . . . 0.0 112.535 -171.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -111.39 -32.75 6.62 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.201 -1.363 . . . . 0.0 114.62 -168.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.49 -60.75 2.5 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.306 1.431 . . . . 0.0 114.152 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -157.26 96.47 1.56 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.436 1.494 . . . . 0.0 112.616 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -130.11 162.1 29.57 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.391 1.076 . . . . 0.0 113.365 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.23 106.6 2.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.538 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 t -100.26 139.12 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.905 1.282 . . . . 0.0 111.247 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.418 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 38.9 m-85 -124.58 140.61 52.78 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.765 1.226 . . . . 0.0 109.973 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -85.02 123.59 30.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.058 1.343 . . . . 0.0 109.485 169.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.1 100.24 8.45 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.352 1.461 . . . . 0.0 108.934 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.6 t -83.41 145.3 29.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.22 1.008 . . . . 0.0 111.355 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mp -103.92 157.7 16.91 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.434 1.494 . . . . 0.0 112.276 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.56 -20.19 65.37 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -84.22 -16.23 44.06 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 176.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.32 -2.56 25.19 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.302 1.429 . . . . 0.0 114.405 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.4 m -70.16 157.82 36.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.923 1.289 . . . . 0.0 112.746 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.88 148.79 50.49 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.418 1.487 . . . . 0.0 110.855 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -140.01 143.91 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.963 2.105 . . . . 0.0 107.912 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -136.37 112.12 9.45 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.672 1.189 . . . . 0.0 112.382 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.33 172.12 18.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.498 1.119 . . . . 0.0 112.786 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.9 p -86.98 161.78 18.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.341 0.657 . . . . 0.0 110.964 168.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HE3' ' CD1' ' A' ' 56' ' ' PHE . 2.2 mptm? -59.88 -25.81 65.37 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 175.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -85.07 -15.52 43.72 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.16 1.384 . . . . 0.0 112.766 -174.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -73.19 132.52 43.32 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 153.03 18.02 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.253 0.933 . . . . 0.0 112.787 176.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -131.94 137.14 47.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.252 -0.905 . . . . 0.0 109.143 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.1 ttp -81.47 113.14 19.33 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.291 0.567 . . . . 0.0 110.066 -173.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.2 p -69.87 171.43 9.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.466 0.706 . . . . 0.0 112.035 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -57.35 -23.67 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 174.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -82.26 -12.93 57.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.663 1.185 . . . . 0.0 113.394 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.06 3.35 70.19 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.247 0.927 . . . . 0.0 114.112 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -77.36 151.85 34.7 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.425 1.112 . . . . 0.0 110.826 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 ptp -119.78 93.93 4.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.565 1.146 . . . . 0.0 110.635 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.4 mt -120.4 149.06 49.03 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.109 1.364 . . . . 0.0 109.905 -170.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.74 145.98 91.57 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.546 2.164 . . . . 0.0 111.344 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.69 -28.69 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -57.85 -37.14 73.35 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.524 1.53 . . . . 0.0 113.289 171.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.07 -43.51 21.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.194 0.997 . . . . 0.0 110.511 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.61 -41.14 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.526 1.13 . . . . 0.0 111.438 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.3 -35.53 80.68 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -80.69 -40.82 24.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.754 0.822 . . . . 0.0 113.03 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -76.95 -13.76 59.94 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.222 1.009 . . . . 0.0 113.284 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 57.75 35.53 25.63 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.872 1.669 . . . . 0.0 112.872 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.89 148.11 25.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.008 0.923 . . . . 0.0 112.561 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -87.19 163.12 17.1 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.551 1.14 . . . . 0.0 113.174 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.2 mt -113.42 153.93 27.81 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.785 1.234 . . . . 0.0 112.5 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 10.7 ttp -81.98 145.08 30.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.189 0.595 . . . . 0.0 111.214 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.92 177.75 7.04 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.773 1.229 . . . . 0.0 113.874 -173.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 p -121.44 -25.69 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 126.149 1.78 . . . . 0.0 114.597 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -85.04 6.37 25.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.09 1.356 . . . . 0.0 113.382 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 56.42 32.11 20.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.969 1.708 . . . . 0.0 112.349 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.0 mt -67.41 158.31 82.64 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.76 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.04 147.13 88.68 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.935 2.423 . . . . 0.0 111.166 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -71.46 118.74 14.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.667 0.787 . . . . 0.0 109.989 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.6 126.37 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.895 1.278 . . . . 0.0 112.018 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.85 175.03 7.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.61 1.564 . . . . 0.0 112.393 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.12 106.9 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.68 1.592 . . . . 0.0 110.933 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.8 -41.05 62.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.573 1.149 . . . . 0.0 112.074 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.3 p -152.37 165.89 33.58 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.145 1.778 . . . . 0.0 111.84 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -136.05 143.54 44.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.602 1.561 . . . . 0.0 111.436 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -139.6 130.71 26.48 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.653 1.181 . . . . 0.0 110.88 171.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -67.55 131.31 45.39 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.918 -0.489 . . . . 0.0 110.931 173.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.2 mt -96.64 -42.78 7.86 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.015 0.526 . . . . 0.0 112.32 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.79 -151.59 23.23 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.421 1.01 . . . . 0.0 113.014 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -118.56 69.11 0.79 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.267 1.508 . . . . 0.0 112.417 -168.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -91.85 160.05 15.49 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 127.064 2.146 . . . . 0.0 111.443 -168.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.3 121.31 14.95 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 123.4 0.68 . . . . 0.0 111.075 169.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.81 148.41 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.476 0.655 . . . . 0.0 111.465 174.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -141.55 157.56 44.96 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.171 1.789 . . . . 0.0 111.884 -169.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -148.76 165.75 30.49 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.475 1.51 . . . . 0.0 112.653 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.7 pt -136.76 153.9 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.195 1.798 . . . . 0.0 111.104 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.91 166.69 24.56 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.856 0.741 . . . . 0.0 114.242 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.15 157.81 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.924 1.29 . . . . 0.0 110.608 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -72.02 -11.43 60.76 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -122.57 -28.56 4.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.264 1.826 . . . . 0.0 114.67 -174.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -152.86 175.23 13.13 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.312 2.245 . . . . 0.0 110.292 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -133.87 23.62 3.92 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.786 -1.196 . . . . 0.0 113.392 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -134.72 160.87 36.79 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -171.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -161.51 158.81 27.08 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.201 1.4 . . . . 0.0 112.307 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.57 128.62 36.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.836 1.254 . . . . 0.0 111.693 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.8 mt -72.54 175.23 6.49 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.282 1.433 . . . . 0.0 113.319 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -51.03 -35.69 35.66 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -93.4 -5.21 49.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.417 1.087 . . . . 0.0 112.86 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.12 -20.12 28.93 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 125.307 1.432 . . . . 0.0 114.447 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -53.51 133.21 40.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.379 1.072 . . . . 0.0 111.476 -173.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.5 mm -82.27 130.31 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.979 0.895 . . . . 0.0 110.938 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -108.79 141.24 41.09 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 126.951 2.1 . . . . 0.0 108.964 170.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.4 t -146.97 140.1 25.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.236 1.014 . . . . 0.0 113.291 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 CA--C 1.556 1.198 0 C-N-CA 125.846 1.658 . . . . 0.0 114.572 -173.569 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.926 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 57.9 -167.72 5.46 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.207 1.384 . . . . 0.0 113.566 -171.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.94 171.19 15.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.902 1.681 . . . . 0.0 111.202 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.0 mt -120.15 140.41 51.14 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.794 2.038 . . . . 0.0 110.067 -168.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 t -72.59 162.46 29.44 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.47 -0.769 . . . . 0.0 111.62 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -48.35 -43.3 33.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.416 1.086 . . . . 0.0 112.79 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -10.21 5.41 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -75.95 107.82 8.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.449 1.1 . . . . 0.0 110.034 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -100.41 138.2 37.8 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.455 -0.778 . . . . 0.0 112.013 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.7 mm -121.34 116.88 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.99 127.08 29.81 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.212 0.605 . . . . 0.0 111.003 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.8 p -121.7 157.19 31.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.451 1.101 . . . . 0.0 112.697 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -78.01 -34.63 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.438 0.695 . . . . 0.0 111.462 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.67 -30.69 65.99 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -137.77 -48.73 0.57 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.71 -147.67 17.27 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.346 0.974 . . . . 0.0 112.664 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -64.23 104.46 0.75 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.711 2.005 . . . . 0.0 110.722 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.1 mt -141.06 150.6 59.58 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 124.814 1.246 . . . . 0.0 114.021 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.89 133.15 28.39 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.774 3.649 . . . . 0.0 113.829 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 tt -59.0 -34.5 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.202 1.001 . . . . 0.0 113.174 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.96 -35.23 91.73 Favored Glycine 0 C--N 1.338 0.652 0 O-C-N 121.875 -0.516 . . . . 0.0 112.157 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -72.73 -32.57 65.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.07 0.935 . . . . 0.0 111.553 176.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -64.76 -38.56 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.309 0.643 . . . . 0.0 110.64 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.4 t -86.38 -38.23 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 118.953 0.797 . . . . 0.0 112.462 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -68.21 -27.58 66.51 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.313 -0.867 . . . . 0.0 113.099 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -114.91 5.61 15.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.956 1.302 . . . . 0.0 113.104 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 49.38 44.2 23.65 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 127.336 2.254 . . . . 0.0 112.798 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.8 mt -67.35 127.21 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.496 1.118 . . . . 0.0 109.522 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -99.01 104.25 16.27 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.634 1.174 . . . . 0.0 111.273 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 62.3 m -136.4 -178.44 5.17 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.505 1.522 . . . . 0.0 111.487 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.8 m -116.21 144.51 44.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.286 1.434 . . . . 0.0 108.534 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.32 160.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.001 1.72 . . . . 0.0 110.083 -175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -99.24 147.67 24.91 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.379 1.072 . . . . 0.0 110.3 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 t -159.43 160.17 34.52 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.296 1.438 . . . . 0.0 109.899 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -100.01 125.07 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.966 0.906 . . . . 0.0 110.201 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -69.62 176.48 3.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.993 1.317 . . . . 0.0 112.584 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -63.5 -26.16 68.59 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.136 1.374 . . . . 0.0 112.949 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.31 -5.31 59.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.045 1.338 . . . . 0.0 113.687 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.86 21.82 58.84 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.464 1.03 . . . . 0.0 114.873 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -96.81 133.1 41.83 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.657 1.183 . . . . 0.0 109.83 172.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.7 mt -74.09 129.26 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -137.59 179.63 6.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.961 2.105 . . . . 0.0 110.949 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.0 p -129.25 144.7 51.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.421 1.089 . . . . 0.0 113.124 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -149.15 142.32 15.9 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.063 1.345 . . . . 0.0 112.314 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.1 155.2 42.42 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.124 2.549 . . . . 0.0 112.981 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.0 t -62.62 132.52 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.344 0.657 . . . . 0.0 110.085 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.71 -48.21 7.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.411 0.684 . . . . 0.0 112.105 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -149.67 172.3 15.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.865 1.666 . . . . 0.0 111.525 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -132.27 129.44 39.61 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.947 1.699 . . . . 0.0 109.096 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -133.4 138.1 46.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.083 0.944 . . . . 0.0 111.418 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -129.08 118.69 22.93 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.123 1.369 . . . . 0.0 110.609 -172.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -84.01 -33.5 24.52 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.806 1.242 . . . . 0.0 112.708 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.01 -51.4 1.46 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.111 1.339 . . . . 0.0 113.62 173.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -172.57 106.35 0.17 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.414 1.485 . . . . 0.0 110.518 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -132.49 168.0 18.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.32 1.048 . . . . 0.0 112.402 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -67.87 101.76 1.14 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.05 140.61 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.765 1.226 . . . . 0.0 111.496 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -122.6 141.26 51.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.657 1.583 . . . . 0.0 110.534 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.55 126.11 26.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.224 1.41 . . . . 0.0 110.583 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -122.78 82.96 2.05 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.451 1.9 . . . . 0.0 108.476 177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 t -86.33 147.84 25.87 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.803 0.841 . . . . 0.0 111.175 171.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.55 165.38 11.71 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.308 1.443 . . . . 0.0 112.814 175.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.61 -23.71 66.88 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -82.35 -19.82 38.52 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.86 -1.4 27.29 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.191 1.377 . . . . 0.0 114.596 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.6 m -57.91 140.98 50.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.498 1.649 . . . . 0.0 110.922 170.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tp -127.01 130.05 49.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.384 1.074 . . . . 0.0 109.884 -174.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mt -139.65 150.26 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.715 1.606 . . . . 0.0 108.145 -170.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -134.0 109.74 9.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.853 1.261 . . . . 0.0 110.86 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.17 169.62 17.24 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.498 1.119 . . . . 0.0 112.519 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 p -86.19 149.26 25.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.89 1.276 . . . . 0.0 111.467 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -62.23 -17.39 58.19 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -86.54 -14.4 43.08 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.053 1.341 . . . . 0.0 112.971 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -79.42 135.52 36.7 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.153 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -93.82 152.41 18.93 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.026 0.917 . . . . 0.0 113.234 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.86 129.2 32.0 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.953 0.901 . . . . 0.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ttp -74.85 111.47 10.09 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.155 0.503 . . . . 0.0 110.416 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 p -71.09 173.48 7.53 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.472 0.653 . . . . 0.0 112.313 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.88 -24.01 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -91.41 -6.52 52.71 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.501 1.12 . . . . 0.0 113.205 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.81 5.81 59.69 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.345 0.974 . . . . 0.0 113.941 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -77.55 126.32 30.7 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.189 0.994 . . . . 0.0 110.906 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.62 78.57 7.74 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.138 1.375 . . . . 0.0 110.702 173.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 mt -104.68 147.77 34.96 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 123.553 0.741 . . . . 0.0 110.673 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.49 147.71 87.07 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.578 2.185 . . . . 0.0 110.603 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.5 tt -60.67 -28.88 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.28 -27.8 62.44 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.419 1.488 . . . . 0.0 113.331 169.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.51 -40.7 18.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.275 1.03 . . . . 0.0 111.528 173.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.82 -37.86 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.317 1.047 . . . . 0.0 110.93 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.8 -35.66 77.04 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.29 -48.24 17.94 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.325 -0.859 . . . . 0.0 113.063 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -14.21 62.23 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 55.75 32.82 20.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.987 1.315 . . . . 0.0 112.225 -172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 42.4 mt -70.43 140.31 51.99 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.997 0.919 . . . . 0.0 111.47 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.01 146.59 25.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.44 0.696 . . . . 0.0 110.847 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 mp -79.2 153.26 30.14 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.449 -0.782 . . . . 0.0 111.553 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.5 ttm -72.45 149.23 44.4 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.87 -0.519 . . . . 0.0 110.812 172.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.64 167.77 15.23 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.001 1.32 . . . . 0.0 113.892 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.75 -23.76 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 125.774 1.63 . . . . 0.0 113.235 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -88.98 5.22 45.22 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.997 1.319 . . . . 0.0 112.71 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 64.49 19.8 11.93 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.496 1.518 . . . . 0.0 112.32 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.1 mt -49.53 156.81 1.06 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.441 1.496 . . . . 0.0 112.028 169.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.3 145.22 88.15 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.64 2.226 . . . . 0.0 110.68 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -68.47 120.44 14.54 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.693 -0.629 . . . . 0.0 110.177 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.4 pt -145.1 159.79 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.289 1.436 . . . . 0.0 111.586 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -128.11 -179.69 5.13 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.28 1.832 . . . . 0.0 111.939 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.0 mt -56.78 110.65 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 125.671 1.589 . . . . 0.0 110.777 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.63 -40.84 66.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.609 1.164 . . . . 0.0 112.273 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.1 p -150.61 162.42 40.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.187 1.795 . . . . 0.0 111.022 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.04 144.13 40.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.634 1.174 . . . . 0.0 111.53 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -156.7 127.12 6.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.488 1.515 . . . . 0.0 110.486 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.06 123.29 18.66 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.775 -0.578 . . . . 0.0 110.234 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 mt -90.56 -42.71 10.66 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.737 0.415 . . . . 0.0 111.812 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.21 -136.27 6.68 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.887 0.756 . . . . 0.0 112.865 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.6 tttp -133.43 77.8 1.74 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.705 1.241 . . . . 0.0 113.089 -168.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -95.24 157.1 16.04 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.335 1.454 . . . . 0.0 110.858 -171.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.79 118.19 6.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.603 0.761 . . . . 0.0 110.525 169.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.6 m -123.02 151.83 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.455 0.645 . . . . 0.0 111.432 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -139.8 159.14 42.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.811 1.644 . . . . 0.0 111.436 -168.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -154.61 134.24 12.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.362 1.065 . . . . 0.0 111.149 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.3 pt -91.94 154.3 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.551 -0.718 . . . . 0.0 110.83 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.13 157.94 16.96 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.765 1.174 . . . . 0.0 111.803 173.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.1 t -147.5 140.3 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.112 1.365 . . . . 0.0 110.169 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -78.67 -44.55 23.42 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -57.47 7.96 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.318 1.047 . . . . 0.0 112.081 -177.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -157.74 128.99 6.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.805 1.642 . . . . 0.0 109.38 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 50.0 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 128.456 2.703 . . . . 0.0 116.183 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -146.31 160.28 42.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.199 1.4 . . . . 0.0 113.038 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -164.74 155.48 14.56 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.477 1.111 . . . . 0.0 112.725 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.8 137.35 36.8 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.109 1.364 . . . . 0.0 112.905 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.85 168.14 19.1 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.137 1.775 . . . . 0.0 113.394 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -35.45 50.52 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -82.99 -28.34 29.78 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.662 1.185 . . . . 0.0 112.769 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 130.69 -19.59 4.99 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.586 1.565 . . . . 0.0 114.545 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -60.17 159.32 9.89 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.829 1.252 . . . . 0.0 112.229 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.2 mm -116.48 128.69 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 119.328 0.967 . . . . 0.0 111.024 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.37 145.47 29.45 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.568 1.547 . . . . 0.0 109.628 170.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.9 m -138.95 142.06 38.42 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.398 1.079 . . . . 0.0 111.608 177.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 C--O 1.253 1.279 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -168.814 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.597 0 CA-C-O 121.49 0.494 . . . . 0.0 113.837 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.27 171.57 19.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.287 1.035 . . . . 0.0 112.209 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.2 mt -122.05 146.8 46.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.83 2.052 . . . . 0.0 109.527 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -68.9 164.72 21.48 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -53.0 -46.26 68.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.95 -1.093 . . . . 0.0 112.338 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -62.98 -10.63 14.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.617 1.567 . . . . 0.0 114.905 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.8 m -71.55 111.07 6.55 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.863 0.865 . . . . 0.0 110.584 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.8 134.01 34.41 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.615 -0.678 . . . . 0.0 112.265 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.4 mm -107.55 124.53 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.019 1.728 . . . . 0.0 108.113 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -64.44 131.16 46.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.672 0.389 . . . . 0.0 110.815 169.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 p -134.77 150.54 50.56 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.645 1.178 . . . . 0.0 112.36 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.0 t -77.34 -32.78 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.976 0.51 . . . . 0.0 111.823 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -68.77 -31.05 69.8 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -140.13 -50.61 0.48 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.85 -149.35 19.86 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.109 0.861 . . . . 0.0 112.095 -172.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.1 107.88 2.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.015 1.326 . . . . 0.0 111.209 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -133.21 148.91 71.04 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.751 1.22 . . . . 0.0 112.745 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.39 126.55 15.79 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.944 3.096 . . . . 0.0 112.332 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.424 ' HA ' HD12 ' A' ' 21' ' ' ILE . 17.5 tt -54.51 -35.57 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.043 0.937 . . . . 0.0 112.637 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.74 -36.53 93.45 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.604 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -70.31 -34.35 72.6 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.033 1.416 . . . . 0.0 111.554 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 18' ' ' ILE . 60.0 mt -63.86 -36.51 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.643 0.777 . . . . 0.0 110.121 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.37 -38.06 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.837 0.855 . . . . 0.0 112.856 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.58 -26.45 65.4 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.821 -1.174 . . . . 0.0 113.025 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -114.45 2.63 14.7 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.077 1.351 . . . . 0.0 112.878 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 49.09 47.81 21.52 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 127.533 2.333 . . . . 0.0 113.133 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -73.71 129.69 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.613 1.165 . . . . 0.0 109.445 -174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 132.74 36.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 122.703 1.239 . . . . 0.0 111.208 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.0 p -160.39 175.36 12.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.393 1.477 . . . . 0.0 111.659 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 147.03 30.08 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.45 1.5 . . . . 0.0 109.157 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 m -125.46 172.99 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.581 1.952 . . . . 0.0 110.181 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -114.28 139.89 49.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.956 1.302 . . . . 0.0 110.886 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 t -162.03 150.07 14.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.901 1.281 . . . . 0.0 111.566 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.72 144.49 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.195 0.907 . . . . 0.0 113.399 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.44 -178.35 6.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.809 0.844 . . . . 0.0 112.516 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -55.66 -22.53 23.43 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.352 1.461 . . . . 0.0 113.765 173.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -91.94 -10.62 38.81 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.228 1.411 . . . . 0.0 113.719 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.62 14.14 58.71 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.41 1.005 . . . . 0.0 114.916 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -88.93 118.89 28.97 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.574 1.187 . . . . 0.0 110.177 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.45 103.99 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.496 0.719 . . . . 0.0 109.375 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -103.64 178.66 4.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.113 1.765 . . . . 0.0 111.211 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 p -127.7 140.05 52.32 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.126 0.97 . . . . 0.0 112.643 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -144.74 148.02 37.87 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.707 1.203 . . . . 0.0 113.332 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.4 152.67 49.64 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.025 2.483 . . . . 0.0 112.835 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.84 133.31 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.147 0.979 . . . . 0.0 109.784 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.64 -49.46 7.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.008 0.523 . . . . 0.0 111.828 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -148.98 176.01 10.81 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.727 1.611 . . . . 0.0 111.767 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -131.62 129.91 41.47 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.682 1.593 . . . . 0.0 109.311 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -131.78 136.06 47.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.132 0.968 . . . . 0.0 111.3 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -126.8 114.28 17.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.215 1.806 . . . . 0.0 110.118 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -78.2 -29.58 48.46 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.058 0.943 . . . . 0.0 112.058 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.66 -56.67 1.63 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.413 1.483 . . . . 0.0 112.58 172.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -166.68 111.31 0.77 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.207 1.803 . . . . 0.0 109.827 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -129.56 166.0 20.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.519 1.128 . . . . 0.0 112.606 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -61.94 100.6 0.16 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.665 1.186 . . . . 0.0 113.096 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.3 137.93 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.659 1.184 . . . . 0.0 110.787 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -118.31 141.74 48.22 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.085 1.354 . . . . 0.0 109.489 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -65.96 129.53 40.11 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.387 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.424 ' CE1' HG12 ' A' ' 105' ' ' ILE . 1.4 t80 -116.46 106.88 14.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.585 1.154 . . . . 0.0 107.948 169.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.2 t -116.57 141.71 47.84 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.068 0.947 . . . . 0.0 110.82 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp -102.82 166.01 10.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.34 1.456 . . . . 0.0 112.647 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -65.23 -25.73 67.81 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.29 -23.0 35.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.025 1.33 . . . . 0.0 113.096 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.96 -2.66 25.7 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.0 1.286 . . . . 0.0 114.717 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.3 m -57.83 136.97 57.05 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.731 1.265 . . . . 0.0 110.867 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.29 124.51 42.56 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.616 1.166 . . . . 0.0 109.939 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.6 mt -135.13 151.02 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 127.334 2.254 . . . . 0.0 108.299 -171.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -137.4 108.96 6.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.871 1.268 . . . . 0.0 109.986 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.96 170.89 17.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.019 0.928 . . . . 0.0 113.377 -172.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.5 p -91.03 153.08 20.39 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.542 1.137 . . . . 0.0 111.987 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -65.15 -5.04 5.78 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -99.16 -6.33 28.45 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.556 1.143 . . . . 0.0 112.315 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.554 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 9.9 t-80 -85.73 126.88 34.31 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.39 155.24 20.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.755 0.788 . . . . 0.0 110.43 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -138.22 143.12 40.01 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.308 0.643 . . . . 0.0 109.33 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.1 ttp -73.11 103.03 3.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.305 0.642 . . . . 0.0 111.513 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.574 ' HA ' HD23 ' A' ' 94' ' ' LEU . 73.4 p -62.38 171.86 1.75 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.9 m -54.27 -25.33 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.78 -11.99 24.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.773 1.229 . . . . 0.0 113.191 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.2 -6.17 32.16 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.0 1.762 . . . . 0.0 114.332 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -61.25 141.21 57.69 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.986 1.393 . . . . 0.0 111.777 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -101.26 83.22 2.44 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.4 1.08 . . . . 0.0 109.771 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.09 146.77 37.86 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 124.437 1.095 . . . . 0.0 110.76 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.43 148.6 73.71 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.068 2.512 . . . . 0.0 111.783 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 tt -60.57 -26.98 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -55.41 -32.9 63.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.176 0.99 . . . . 0.0 112.92 170.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.44 -31.29 16.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.353 1.061 . . . . 0.0 111.754 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.28 -42.22 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.232 -0.917 . . . . 0.0 110.738 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -62.23 -39.31 92.4 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.28 -44.77 64.59 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -77.76 -11.12 59.85 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 56.51 37.82 29.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.425 1.49 . . . . 0.0 111.751 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.8 mt -78.48 150.9 32.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 122.042 0.925 . . . . 0.0 111.37 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -93.72 167.43 11.66 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.901 0.88 . . . . 0.0 111.069 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 76' ' ' THR . 39.3 mt -116.01 144.93 43.42 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.308 1.043 . . . . 0.0 111.437 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -68.59 148.36 50.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.712 0.805 . . . . 0.0 111.618 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.02 152.04 44.78 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.783 1.233 . . . . 0.0 113.694 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 t -77.31 -35.84 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 128.37 2.668 . . . . 0.0 112.74 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -91.47 10.81 26.18 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.361 1.065 . . . . 0.0 113.495 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.25 7.0 m120 56.38 31.91 19.6 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.076 1.75 . . . . 0.0 112.426 -172.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.9 mt -64.54 155.23 82.02 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 113.659 -1.61 . . . . 0.0 111.622 170.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.98 127.51 17.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.341 2.694 . . . . 0.0 109.987 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -77.69 131.13 37.57 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.751 -0.593 . . . . 0.0 109.595 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -142.08 127.65 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.644 1.178 . . . . 0.0 110.957 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 166.49 3.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.597 1.959 . . . . 0.0 113.202 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.424 HG12 ' CE1' ' A' ' 58' ' ' TYR . 6.8 mt -61.33 116.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.152 1.381 . . . . 0.0 109.691 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.73 -42.1 61.63 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.832 0.853 . . . . 0.0 111.627 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 p -149.24 146.02 27.39 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.018 1.327 . . . . 0.0 111.295 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -143.84 142.79 31.02 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.266 1.827 . . . . 0.0 109.853 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -155.41 151.04 27.35 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.996 2.118 . . . . 0.0 110.416 169.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -67.03 131.2 45.36 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.365 0.666 . . . . 0.0 110.072 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.6 mt -98.27 -45.13 6.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.944 0.498 . . . . 0.0 111.871 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.01 -146.3 15.56 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.179 0.895 . . . . 0.0 112.095 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.59 94.67 4.31 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.246 1.022 . . . . 0.0 111.78 -169.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -110.86 155.79 22.09 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.397 1.479 . . . . 0.0 109.904 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.46 118.32 8.6 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.201 0.6 . . . . 0.0 110.642 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.84 150.45 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.35 0.595 . . . . 0.0 111.46 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -138.44 159.41 42.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.673 1.589 . . . . 0.0 111.494 -170.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -157.29 114.38 3.04 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.418 1.087 . . . . 0.0 110.556 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.0 pt -68.12 154.74 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 O-C-N 121.267 -0.896 . . . . 0.0 110.908 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.46 152.23 17.41 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.69 1.138 . . . . 0.0 111.5 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 124.972 1.309 . . . . 0.0 110.069 -171.796 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -168.31 146.77 4.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.593 1.157 . . . . 0.0 112.121 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.03 165.32 25.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.124 0.97 . . . . 0.0 113.321 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 67.2 mt -130.57 164.87 23.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.054 2.142 . . . . 0.0 111.621 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -32.61 58.1 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -86.71 9.11 19.84 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.402 1.481 . . . . 0.0 112.519 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.4 0.06 85.94 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.747 1.641 . . . . 0.0 114.046 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -67.37 166.67 14.02 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.205 1.503 . . . . 0.0 113.073 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.97 123.4 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.286 1.034 . . . . 0.0 109.65 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.554 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -97.22 149.99 21.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.984 1.314 . . . . 0.0 109.671 172.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.2 t -142.2 138.73 31.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.151 0.98 . . . . 0.0 112.587 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.529 1.532 . . . . 0.0 112.28 -174.287 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 CA-C-O 121.591 0.551 . . . . 0.0 114.084 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.32 179.83 7.99 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.137 1.375 . . . . 0.0 112.506 -174.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.5 mt -123.33 146.43 47.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.271 1.829 . . . . 0.0 110.378 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 t -68.62 163.85 22.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.206 0.602 . . . . 0.0 112.378 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -51.75 -44.52 63.35 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.421 -0.799 . . . . 0.0 112.49 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -59.8 -19.77 52.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.655 1.982 . . . . 0.0 113.857 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.8 m -72.32 87.24 1.13 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.644 1.178 . . . . 0.0 111.718 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -77.42 145.96 36.85 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.115 0.959 . . . . 0.0 112.74 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.3 mm -119.53 125.92 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 126.889 2.075 . . . . 0.0 107.18 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -61.1 132.16 52.86 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 122.076 -0.39 . . . . 0.0 111.17 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.7 p -133.05 148.46 52.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.659 1.184 . . . . 0.0 112.698 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.9 -34.61 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.258 0.623 . . . . 0.0 111.9 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -65.11 -28.85 69.72 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -143.86 -62.92 0.39 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.28 -148.35 18.77 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.007 0.813 . . . . 0.0 112.056 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.05 107.05 3.46 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.685 1.194 . . . . 0.0 111.331 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.76 148.63 70.28 Favored Pre-proline 0 N--CA 1.479 1.012 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.03 127.63 18.05 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.694 3.596 . . . . 0.0 112.822 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.44 -35.09 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.615 0.766 . . . . 0.0 113.027 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.61 -36.56 93.5 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.334 -0.703 . . . . 0.0 112.787 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -71.56 -32.22 67.85 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.114 1.457 . . . . 0.0 111.398 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.61 -37.44 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.972 0.909 . . . . 0.0 110.181 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.5 t -88.02 -37.87 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 118.691 0.678 . . . . 0.0 112.586 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -69.24 -25.85 64.49 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.481 1.037 . . . . 0.0 113.008 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -116.24 4.87 13.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.945 1.298 . . . . 0.0 112.45 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 48.46 47.89 19.8 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.136 2.575 . . . . 0.0 113.258 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -72.64 121.86 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.029 1.332 . . . . 0.0 109.469 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -83.27 122.29 28.24 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.44 1.114 . . . . 0.0 110.733 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -152.1 -177.02 5.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.003 1.721 . . . . 0.0 110.909 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -125.24 141.38 52.12 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.184 1.393 . . . . 0.0 108.424 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.48 177.29 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.614 1.965 . . . . 0.0 110.6 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -122.73 140.06 53.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.717 1.207 . . . . 0.0 111.36 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.4 t -161.38 149.61 15.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.355 1.462 . . . . 0.0 110.924 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.39 160.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 119.043 0.838 . . . . 0.0 111.126 167.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -102.23 -174.47 2.58 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.998 1.719 . . . . 0.0 113.089 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.52 -11.54 25.01 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -102.93 -0.86 30.42 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.804 1.642 . . . . 0.0 112.36 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.98 31.48 39.16 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.68 1.133 . . . . 0.0 114.565 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -116.56 121.99 43.37 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.697 1.249 . . . . 0.0 109.991 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.7 mt -63.91 118.82 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.736 0.814 . . . . 0.0 109.305 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -122.87 177.02 5.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.193 1.797 . . . . 0.0 111.014 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.3 p -125.61 139.88 53.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.141 0.977 . . . . 0.0 113.097 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -147.89 148.29 29.61 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.695 1.198 . . . . 0.0 112.808 -175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.15 155.11 52.26 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.165 2.577 . . . . 0.0 112.836 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.94 134.34 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.142 0.977 . . . . 0.0 110.146 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.87 -45.11 9.47 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.466 0.707 . . . . 0.0 112.199 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -149.23 173.28 13.63 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.923 1.689 . . . . 0.0 111.912 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -132.93 132.36 41.91 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.784 1.633 . . . . 0.0 108.973 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -133.28 135.61 44.99 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.04 0.924 . . . . 0.0 111.162 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -126.65 113.08 16.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.348 1.459 . . . . 0.0 110.323 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -79.35 -32.02 43.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.924 1.289 . . . . 0.0 112.866 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.05 -51.2 2.51 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.867 1.222 . . . . 0.0 113.684 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -173.15 96.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.746 1.273 . . . . 0.0 111.258 -170.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -129.67 165.11 22.49 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 112.682 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.83 103.85 0.98 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.105 1.362 . . . . 0.0 113.421 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 t -95.41 139.62 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.03 1.332 . . . . 0.0 111.544 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -123.92 139.28 54.11 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.498 1.919 . . . . 0.0 109.922 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.79 134.2 53.61 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.282 0.633 . . . . 0.0 110.357 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.406 ' CE1' HG12 ' A' ' 105' ' ' ILE . 1.6 t80 -126.62 95.73 4.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.989 1.316 . . . . 0.0 108.579 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.1 t -105.71 140.76 38.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.243 1.017 . . . . 0.0 110.132 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tp -103.86 162.9 12.73 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.911 1.284 . . . . 0.0 112.01 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -66.93 -21.19 65.99 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.1 -29.27 61.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.765 1.226 . . . . 0.0 112.839 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.92 -2.22 25.76 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.941 1.258 . . . . 0.0 114.108 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 m -57.37 138.75 54.55 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.273 1.037 . . . . 0.0 111.205 170.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 tp -128.58 125.62 38.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.335 1.054 . . . . 0.0 111.042 -170.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.4 mt -137.86 151.92 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 126.907 2.083 . . . . 0.0 108.017 -169.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -138.42 115.06 10.59 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.782 1.233 . . . . 0.0 110.804 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.24 167.71 23.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.676 1.19 . . . . 0.0 112.208 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.5 p -82.02 154.16 25.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.712 0.805 . . . . 0.0 111.715 170.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -66.59 -8.57 28.02 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -96.2 -10.83 27.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.813 1.645 . . . . 0.0 112.787 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -81.65 133.04 35.32 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -87.65 165.67 15.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.145 0.974 . . . . 0.0 111.553 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -142.85 147.39 35.33 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.323 1.049 . . . . 0.0 109.824 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 43.3 ttm -79.56 104.05 9.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.677 1.191 . . . . 0.0 110.347 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.2 p -68.87 170.81 8.94 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.715 -0.615 . . . . 0.0 112.062 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.0 m -57.79 -23.22 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -90.03 -3.02 58.21 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.407 1.083 . . . . 0.0 113.042 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.76 66.34 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.327 0.965 . . . . 0.0 113.656 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -86.01 124.9 32.98 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.497 1.119 . . . . 0.0 109.996 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.13 92.84 6.92 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.531 1.132 . . . . 0.0 109.855 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.36 147.12 44.42 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 124.381 1.072 . . . . 0.0 111.418 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.08 146.67 82.73 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.414 2.742 . . . . 0.0 111.687 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.7 tt -58.6 -27.91 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -53.23 -35.99 60.55 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.487 1.115 . . . . 0.0 112.852 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -86.75 -33.29 20.01 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.026 0.53 . . . . 0.0 111.827 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.8 mt -61.44 -38.04 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.311 -0.868 . . . . 0.0 111.06 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -67.75 -32.57 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -82.05 -40.11 22.49 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.443 -0.786 . . . . 0.0 112.514 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.3 mmm-85 -77.0 -13.95 59.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 55.01 29.98 13.34 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.587 1.555 . . . . 0.0 113.117 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -76.23 129.48 36.77 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.653 0.781 . . . . 0.0 111.168 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.17 149.15 47.84 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.617 0.723 . . . . 0.0 112.478 171.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.06 155.94 21.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.515 0.726 . . . . 0.0 112.587 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.5 ttp -78.13 135.79 37.74 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.984 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 166.7 10.22 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.391 1.476 . . . . 0.0 112.947 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.77 -19.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.602 1.961 . . . . 0.0 112.788 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -109.68 15.02 23.1 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.028 1.731 . . . . 0.0 112.263 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.8 m120 65.05 14.15 9.16 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.632 1.573 . . . . 0.0 113.423 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.2 mt -43.9 154.82 0.35 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 127.264 2.226 . . . . 0.0 112.761 169.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.95 148.76 89.93 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.598 2.199 . . . . 0.0 110.904 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -69.66 123.07 20.41 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.45 -0.782 . . . . 0.0 111.152 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.5 pt -148.86 151.76 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.705 1.602 . . . . 0.0 111.055 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.23 179.7 4.21 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.822 1.649 . . . . 0.0 111.249 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.406 HG12 ' CE1' ' A' ' 58' ' ' TYR . 19.4 mt -62.06 110.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.688 1.195 . . . . 0.0 110.618 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.71 -42.02 64.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.166 1.387 . . . . 0.0 111.763 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p -148.75 148.26 29.78 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.263 1.425 . . . . 0.0 111.183 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.9 ttp85 -143.0 141.0 31.25 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.0 1.72 . . . . 0.0 110.174 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -159.85 148.96 17.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.144 1.778 . . . . 0.0 110.703 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -64.99 125.41 24.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.628 0.771 . . . . 0.0 111.459 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.34 -44.39 8.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.401 0.68 . . . . 0.0 111.866 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.62 -147.31 17.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.124 0.868 . . . . 0.0 112.872 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -128.73 80.89 1.99 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 123.083 1.421 . . . . 0.0 111.83 -169.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -100.0 158.91 15.49 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.918 1.687 . . . . 0.0 110.471 -169.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 118.43 7.72 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.79 -0.569 . . . . 0.0 110.739 169.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.94 152.77 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.302 0.641 . . . . 0.0 111.285 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -140.72 158.97 43.2 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.637 1.575 . . . . 0.0 111.737 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -155.72 131.3 9.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.419 1.088 . . . . 0.0 111.089 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.4 pt -87.27 155.36 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 121.323 -0.86 . . . . 0.0 111.08 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.7 155.14 16.27 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.434 1.492 . . . . 0.0 111.703 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.479 1.018 0 C-N-CA 124.63 1.172 . . . . 0.0 110.846 -169.203 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.5 p30 . . . . . 0 CA--C 1.543 0.676 0 CA-C-O 121.002 0.429 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -163.27 154.23 16.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.456 1.102 . . . . 0.0 112.353 -169.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.81 159.44 30.09 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 45.0 mt -116.89 162.2 18.12 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.975 2.11 . . . . 0.0 112.195 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -55.2 -36.09 65.54 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -73.87 -17.04 61.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.11 0.964 . . . . 0.0 112.381 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.15 34.41 3.7 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.045 1.307 . . . . 0.0 114.699 171.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -135.53 165.34 25.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.721 1.608 . . . . 0.0 111.026 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -107.64 129.35 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.563 0.745 . . . . 0.0 110.015 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -110.75 155.26 22.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.582 1.553 . . . . 0.0 110.163 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.1 p -142.95 122.21 13.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.818 0.847 . . . . 0.0 112.605 -168.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 124.695 1.198 . . . . 0.0 113.671 -176.312 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.092 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -157.79 175.4 13.93 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 117.759 0.779 . . . . 0.0 113.077 -167.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.67 147.24 44.79 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.467 1.507 . . . . 0.0 111.218 -170.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 t -64.77 162.79 15.35 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -54.2 -44.43 71.59 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.151 -0.968 . . . . 0.0 112.002 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -57.69 -23.89 53.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.873 1.669 . . . . 0.0 113.697 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.5 m -66.92 103.59 1.18 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.443 1.497 . . . . 0.0 111.472 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -87.56 141.19 28.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.836 0.826 . . . . 0.0 112.361 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.4 mm -120.4 119.54 60.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 126.628 1.971 . . . . 0.0 106.956 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.07 131.65 51.26 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.406 0.283 . . . . 0.0 110.772 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.4 p -126.2 157.7 37.53 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.166 . . . . 0.0 112.768 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.94 -35.45 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.576 0.75 . . . . 0.0 111.182 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -67.22 -29.53 69.21 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.24 -54.28 0.47 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.23 -148.95 19.93 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.962 0.792 . . . . 0.0 112.434 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.73 109.66 3.93 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.822 1.249 . . . . 0.0 111.099 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.3 mt -136.65 150.2 69.48 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.03 1.332 . . . . 0.0 112.642 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.52 129.56 22.81 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.962 3.108 . . . . 0.0 112.379 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 tt -55.2 -38.96 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.411 0.684 . . . . 0.0 112.318 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.54 -31.74 79.58 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.583 -0.698 . . . . 0.0 113.347 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -70.88 -37.81 73.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.192 0.996 . . . . 0.0 111.26 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.59 -40.34 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 123.662 0.785 . . . . 0.0 109.336 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.3 t -74.46 -42.87 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.23 -21.26 56.6 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.788 1.176 . . . . 0.0 113.465 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -110.37 2.28 18.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.359 1.464 . . . . 0.0 112.197 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 47.38 48.86 16.23 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.998 2.119 . . . . 0.0 113.178 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.0 mt -72.11 126.11 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.868 0.867 . . . . 0.0 109.621 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -85.67 104.47 15.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.41 0.624 . . . . 0.0 111.191 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 64.7 m -133.56 -173.45 3.23 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.451 1.5 . . . . 0.0 111.487 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.31 143.65 51.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.961 1.705 . . . . 0.0 108.754 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.12 171.03 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.697 1.599 . . . . 0.0 111.156 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.04 143.28 45.01 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.951 1.3 . . . . 0.0 111.248 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 t -160.72 150.67 17.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.912 1.685 . . . . 0.0 110.381 -170.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.0 142.66 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.215 1.37 . . . . 0.0 110.729 168.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.64 178.56 7.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.838 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.27 -25.27 63.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.749 1.22 . . . . 0.0 112.754 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -87.79 -1.13 57.77 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.327 1.451 . . . . 0.0 113.339 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.08 29.6 53.49 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 121.251 -0.906 . . . . 0.0 114.373 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -109.39 122.57 47.67 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.539 1.536 . . . . 0.0 109.63 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.593 HD13 HG23 ' A' ' 97' ' ' VAL . 55.4 mt -69.82 117.84 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.498 0.719 . . . . 0.0 109.489 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -124.9 178.4 5.52 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.67 1.988 . . . . 0.0 111.285 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 p -126.08 142.68 51.42 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.386 1.074 . . . . 0.0 112.958 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -144.73 146.13 30.7 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 124.909 1.283 . . . . 0.0 112.898 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.07 152.86 67.89 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.866 2.377 . . . . 0.0 111.985 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.28 119.15 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 168.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.81 -50.45 17.15 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -151.59 179.49 8.34 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.672 1.989 . . . . 0.0 110.909 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -134.82 132.72 38.98 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.342 1.457 . . . . 0.0 109.856 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -134.02 138.82 45.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.833 0.853 . . . . 0.0 111.627 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -132.37 121.03 22.85 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.56 1.544 . . . . 0.0 110.203 -172.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -87.76 -25.65 23.29 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.124 1.37 . . . . 0.0 112.982 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.16 -49.22 2.99 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.589 1.566 . . . . 0.0 114.937 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -171.75 101.25 0.18 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.128 1.464 . . . . 0.0 111.455 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -131.43 167.47 19.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.553 1.141 . . . . 0.0 112.247 172.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.84 105.81 0.9 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.937 1.295 . . . . 0.0 113.554 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.37 140.85 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.473 1.109 . . . . 0.0 111.939 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.481 ' CZ ' ' HE3' ' A' ' 70' ' ' LYS . 46.9 m-85 -125.08 154.55 41.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.585 1.554 . . . . 0.0 110.874 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.68 110.3 22.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.567 1.147 . . . . 0.0 109.169 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -96.7 102.85 14.7 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.852 0.861 . . . . 0.0 109.255 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.5 t -82.34 147.05 29.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.203 1.001 . . . . 0.0 111.057 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -106.99 160.79 15.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.951 1.3 . . . . 0.0 113.47 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.68 -20.47 65.3 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.29 -14.99 36.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.048 1.339 . . . . 0.0 112.945 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.18 -5.11 23.62 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.441 1.496 . . . . 0.0 114.57 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 t -71.82 171.47 11.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.219 1.009 . . . . 0.0 113.213 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -140.74 141.32 34.88 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.896 1.678 . . . . 0.0 111.57 -170.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.5 mt -133.62 143.61 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 126.23 1.812 . . . . 0.0 108.699 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -133.47 101.51 5.17 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.807 1.243 . . . . 0.0 111.376 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.35 166.66 31.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.847 0.859 . . . . 0.0 113.275 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.0 p -78.37 163.03 26.01 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.231 0.538 . . . . 0.0 110.773 168.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 6.5 mtmp? -74.51 -4.83 39.18 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -97.83 -20.76 17.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.588 1.555 . . . . 0.0 112.607 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -71.72 131.01 42.53 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -84.84 157.43 20.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.519 -0.738 . . . . 0.0 111.118 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -139.5 143.62 37.55 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.024 1.33 . . . . 0.0 109.921 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.2 ttp -84.64 110.34 18.67 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.454 1.102 . . . . 0.0 111.278 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.4 p -71.14 176.42 4.48 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -54.96 -26.84 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -94.14 -9.33 36.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.631 1.173 . . . . 0.0 113.521 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.06 8.97 56.43 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.314 0.959 . . . . 0.0 114.875 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -65.81 146.98 54.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.777 1.288 . . . . 0.0 111.165 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 29.2 mtm -110.95 80.51 1.31 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.526 1.53 . . . . 0.0 109.849 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.1 mt -119.64 147.25 43.36 Favored Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 125.396 1.478 . . . . 0.0 110.465 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -63.08 144.43 92.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.643 2.229 . . . . 0.0 110.672 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.7 tt -55.91 -27.14 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -56.01 -40.45 73.41 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.179 1.391 . . . . 0.0 113.006 169.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -79.56 -35.71 39.4 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.993 -0.442 . . . . 0.0 110.855 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 94' ' ' LEU . 72.2 mt -62.58 -40.58 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 119.076 0.853 . . . . 0.0 111.391 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -58.91 -39.35 81.26 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.736 0.814 . . . . 0.0 113.157 172.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -81.49 -38.56 26.13 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.624 1.17 . . . . 0.0 113.085 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -75.47 -16.64 60.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.337 1.055 . . . . 0.0 112.896 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 56.86 34.39 24.69 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.08 1.352 . . . . 0.0 112.452 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -86.98 144.55 26.87 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.876 0.87 . . . . 0.0 111.873 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -81.22 167.67 19.34 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.7 0.8 . . . . 0.0 112.564 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 87' ' ' ILE . 4.9 mp -122.3 157.89 30.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.392 1.092 . . . . 0.0 113.901 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.6 ttm -73.05 154.44 40.44 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.05 1.74 . . . . 0.0 112.601 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.66 159.38 42.12 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.564 1.546 . . . . 0.0 114.683 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.593 HG23 HD13 ' A' ' 39' ' ' ILE . 12.0 p -93.53 -28.14 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 126.707 2.003 . . . . 0.0 113.04 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -83.39 20.81 1.26 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.464 1.506 . . . . 0.0 112.735 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.27 10.4 p30 46.39 19.77 0.08 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.708 2.803 . . . . 0.0 115.675 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.6 mt -60.68 156.99 41.11 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.146 1.378 . . . . 0.0 112.89 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.89 143.98 81.44 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.081 2.521 . . . . 0.0 110.721 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -77.74 125.61 29.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.171 0.589 . . . . 0.0 110.284 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.0 pt -140.34 131.37 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.457 1.103 . . . . 0.0 112.67 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 172.86 13.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.445 1.898 . . . . 0.0 112.701 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -69.95 113.36 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.417 1.087 . . . . 0.0 110.334 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.81 -48.83 75.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.46 1.504 . . . . 0.0 111.856 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 p -152.24 158.11 42.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.326 1.851 . . . . 0.0 111.171 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -126.1 148.84 49.27 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.881 1.672 . . . . 0.0 109.672 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -149.97 133.99 17.03 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.657 1.183 . . . . 0.0 110.688 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -70.87 129.32 38.75 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.244 0.618 . . . . 0.0 110.982 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.9 mt -96.7 -41.39 8.52 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.065 0.546 . . . . 0.0 111.845 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.24 -140.15 9.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.173 0.892 . . . . 0.0 112.58 -174.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -131.71 81.57 1.98 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.964 1.364 . . . . 0.0 113.056 -168.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -98.11 157.82 15.91 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.88 1.672 . . . . 0.0 110.069 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -64.2 121.68 14.81 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 121.64 -0.662 . . . . 0.0 109.695 170.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -123.19 149.23 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.502 0.668 . . . . 0.0 111.84 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -136.22 158.77 43.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.574 1.55 . . . . 0.0 111.791 -168.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -154.22 122.76 6.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.819 1.248 . . . . 0.0 110.177 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.1 pt -77.76 159.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.392 -0.817 . . . . 0.0 111.386 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.16 151.92 18.42 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.535 1.064 . . . . 0.0 111.73 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 127.16 2.184 . . . . 0.0 109.756 -179.396 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.2 p30 . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -157.47 152.13 25.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.555 1.142 . . . . 0.0 111.999 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.86 149.97 26.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.053 0.941 . . . . 0.0 113.178 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.61 176.07 5.27 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.296 1.839 . . . . 0.0 112.419 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -50.33 -49.5 53.71 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.495 1.518 . . . . 0.0 114.651 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -78.6 -9.36 59.34 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.313 1.045 . . . . 0.0 112.775 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.491 ' HA2' HG12 ' A' ' 97' ' ' VAL . . . 102.09 -7.32 54.61 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.392 1.472 . . . . 0.0 114.997 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.418 ' CE2' HD13 ' A' ' 94' ' ' LEU . 2.7 m-85 -51.26 150.93 3.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.538 1.169 . . . . 0.0 111.444 174.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.4 107.72 22.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.1 143.54 28.0 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 170.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.3 m -132.51 104.4 6.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.487 1.115 . . . . 0.0 109.996 -172.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.0 t30 . . . . . 0 C--O 1.255 1.374 0 C-N-CA 124.236 1.014 . . . . 0.0 113.396 -174.337 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -159.6 175.54 13.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.945 1.298 . . . . 0.0 111.977 -174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.58 144.47 39.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.642 1.577 . . . . 0.0 110.422 -172.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -67.05 164.02 18.73 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.564 -0.71 . . . . 0.0 112.51 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.01 -44.38 64.1 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.977 -1.077 . . . . 0.0 112.026 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -64.24 -13.12 47.22 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.683 1.593 . . . . 0.0 114.383 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.7 m -75.18 81.81 2.33 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.332 1.453 . . . . 0.0 110.894 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -71.12 142.34 50.77 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.773 0.797 . . . . 0.0 111.501 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.5 mm -118.61 128.59 75.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 126.13 1.772 . . . . 0.0 106.373 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -58.17 130.85 48.54 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 122.289 -0.257 . . . . 0.0 110.919 170.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.6 p -131.88 145.15 51.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.223 1.409 . . . . 0.0 111.853 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.15 -32.62 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 121.877 -0.514 . . . . 0.0 111.922 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.74 -35.73 81.55 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -140.33 -48.71 0.44 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -170.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.59 -146.68 18.49 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.982 0.81 . . . . 0.0 113.163 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.4 96.84 1.52 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.268 1.427 . . . . 0.0 111.652 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.45 145.73 55.66 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.612 1.165 . . . . 0.0 112.407 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.14 128.4 21.6 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.78 3.653 . . . . 0.0 113.261 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.84 -37.43 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.746 0.818 . . . . 0.0 112.944 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.56 -32.84 84.54 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.618 -0.546 . . . . 0.0 112.956 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -72.52 -36.79 68.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.98 0.89 . . . . 0.0 111.298 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.89 -39.03 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.656 0.782 . . . . 0.0 109.479 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.52 -42.16 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.909 0.884 . . . . 0.0 113.11 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -75.1 -21.97 58.57 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.374 0.988 . . . . 0.0 113.507 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -109.79 1.72 19.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.145 1.378 . . . . 0.0 112.407 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.42 54.23 8.81 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.875 2.07 . . . . 0.0 113.357 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.5 mt -75.03 119.58 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.632 0.773 . . . . 0.0 110.104 -172.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.3 80.49 1.85 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.912 1.685 . . . . 0.0 112.221 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.6 p -119.49 178.49 4.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.02 1.328 . . . . 0.0 112.625 -171.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.5 m -119.25 149.46 41.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.243 1.417 . . . . 0.0 108.339 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.3 175.88 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.794 1.637 . . . . 0.0 110.967 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -121.24 142.59 49.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.428 1.491 . . . . 0.0 110.382 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.9 t -165.18 154.17 12.36 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.686 1.195 . . . . 0.0 110.835 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.4 m -84.91 145.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.665 1.12 . . . . 0.0 112.468 172.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.91 179.1 7.63 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.95 0.9 . . . . 0.0 111.917 172.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -60.59 -20.21 59.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -90.78 -0.73 57.8 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.218 1.407 . . . . 0.0 113.273 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.23 32.26 48.86 Favored Glycine 0 CA--C 1.536 1.387 0 O-C-N 121.33 -0.856 . . . . 0.0 114.099 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -112.64 121.51 44.98 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.494 1.518 . . . . 0.0 109.554 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.96 113.17 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -116.71 178.29 4.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.055 1.742 . . . . 0.0 110.528 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -128.02 143.31 51.07 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.859 0.863 . . . . 0.0 113.106 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -144.59 147.06 34.65 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.295 1.038 . . . . 0.0 113.605 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.62 150.07 50.25 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.108 2.539 . . . . 0.0 112.307 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.53 147.33 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.169 0.988 . . . . 0.0 110.808 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.64 -44.69 3.46 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.036 0.934 . . . . 0.0 111.992 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -142.41 178.17 7.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.759 1.623 . . . . 0.0 111.479 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -137.58 120.52 16.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.309 1.443 . . . . 0.0 109.29 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -118.77 138.73 52.48 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.075 0.941 . . . . 0.0 111.161 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -131.71 115.7 16.36 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.879 1.672 . . . . 0.0 110.046 -171.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -79.84 -32.13 40.53 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.982 1.313 . . . . 0.0 113.052 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.87 -53.24 1.43 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.762 1.648 . . . . 0.0 114.86 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -171.04 99.55 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.214 1.507 . . . . 0.0 111.577 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -134.51 168.05 19.67 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.486 1.114 . . . . 0.0 113.119 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -67.35 97.67 0.58 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.16 1.784 . . . . 0.0 114.278 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.9 t -94.01 138.79 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.194 1.398 . . . . 0.0 111.376 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -119.43 147.07 44.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.333 1.053 . . . . 0.0 110.448 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -82.33 123.99 29.58 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.585 1.154 . . . . 0.0 109.417 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -112.81 105.18 13.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.418 1.087 . . . . 0.0 108.722 174.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.3 t -96.19 122.17 38.76 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mp -79.24 156.72 28.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.697 0.799 . . . . 0.0 110.794 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -67.56 -18.49 65.03 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.62 -26.16 50.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.55 0.74 . . . . 0.0 112.764 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.23 -12.36 7.58 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.433 1.492 . . . . 0.0 114.275 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.1 m -60.02 148.24 36.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.41 1.084 . . . . 0.0 112.405 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -127.92 135.65 50.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.465 1.506 . . . . 0.0 110.715 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.0 mt -135.69 142.9 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.765 1.626 . . . . 0.0 108.095 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -134.03 110.85 9.92 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.784 1.234 . . . . 0.0 111.383 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.69 166.51 30.17 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.636 1.175 . . . . 0.0 110.541 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -70.18 150.04 46.89 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.55 -0.719 . . . . 0.0 111.408 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -61.07 -21.04 63.28 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -85.76 -16.18 39.71 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.883 2.073 . . . . 0.0 112.6 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -73.38 135.66 44.28 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -89.85 154.29 19.99 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.813 0.845 . . . . 0.0 111.932 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -137.2 144.36 42.83 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.084 -1.01 . . . . 0.0 111.465 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 37.6 ttm -73.81 104.0 4.55 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.002 0.921 . . . . 0.0 110.344 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.2 p -67.88 167.15 14.14 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.745 -0.597 . . . . 0.0 111.193 172.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.88 -26.79 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -79.63 -12.15 59.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.515 1.126 . . . . 0.0 113.292 175.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.95 3.7 65.59 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.127 1.346 . . . . 0.0 114.025 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -69.61 161.14 30.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.08 0.952 . . . . 0.0 110.699 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.4 ptp -127.46 80.88 1.98 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.836 1.254 . . . . 0.0 109.763 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.51 150.1 39.68 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 125.075 1.35 . . . . 0.0 110.403 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.38 142.07 77.38 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.491 2.127 . . . . 0.0 110.349 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.4 tt -60.34 -23.23 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.65 -27.72 65.02 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 170.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -89.59 -38.62 13.82 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.428 1.091 . . . . 0.0 111.852 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.35 -38.45 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 121.286 -0.884 . . . . 0.0 111.311 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.18 -36.76 80.71 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -78.92 -41.97 28.21 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.443 0.697 . . . . 0.0 112.467 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -74.34 -13.49 60.75 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 55.64 28.49 12.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.621 1.568 . . . . 0.0 112.86 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.9 128.63 35.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.554 0.742 . . . . 0.0 110.048 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.75 154.19 42.41 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 122.366 1.079 . . . . 0.0 112.329 171.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.3 mt -96.15 152.26 18.72 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.696 1.198 . . . . 0.0 111.924 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 35.3 ttm -72.38 138.39 47.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.501 0.32 . . . . 0.0 110.479 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 162.57 16.25 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.065 1.346 . . . . 0.0 113.782 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.7 -23.09 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.384 1.474 . . . . 0.0 113.978 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -101.44 8.56 42.06 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.003 0.921 . . . . 0.0 113.392 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 m120 67.33 22.15 9.61 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.663 1.585 . . . . 0.0 112.234 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.1 mt -54.34 159.19 3.32 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.497 1.519 . . . . 0.0 112.049 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.65 145.72 82.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.388 2.059 . . . . 0.0 110.722 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -67.13 121.7 16.2 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.519 -0.738 . . . . 0.0 111.162 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.2 pt -144.82 137.61 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.84 1.656 . . . . 0.0 110.317 -174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.6 175.52 5.63 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.715 1.606 . . . . 0.0 111.042 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.72 104.82 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.454 1.102 . . . . 0.0 110.513 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.9 -41.16 78.61 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.759 1.224 . . . . 0.0 112.363 -175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.6 p -146.78 154.72 41.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.537 1.535 . . . . 0.0 111.288 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -133.81 139.16 46.11 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.621 1.568 . . . . 0.0 110.987 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -141.45 130.26 22.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.474 1.51 . . . . 0.0 110.02 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.04 121.74 16.22 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 122.503 0.321 . . . . 0.0 110.392 173.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.3 mt -87.09 -40.34 14.75 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.874 0.469 . . . . 0.0 111.795 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.21 -144.87 15.87 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.329 0.966 . . . . 0.0 112.583 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -124.6 81.46 1.95 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.935 1.35 . . . . 0.0 112.486 -168.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -98.74 158.06 15.87 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.613 1.565 . . . . 0.0 110.948 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -64.44 119.13 9.82 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.644 0.778 . . . . 0.0 110.323 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.87 149.43 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.483 0.713 . . . . 0.0 111.216 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -139.09 158.4 44.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.861 1.664 . . . . 0.0 111.771 -168.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -156.28 121.48 4.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.747 1.219 . . . . 0.0 110.297 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.8 pt -73.27 155.74 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 120.911 -1.118 . . . . 0.0 111.467 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.89 147.61 16.36 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.662 1.125 . . . . 0.0 111.74 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.88 0 C-N-CA 126.965 2.106 . . . . 0.0 109.845 -169.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -162.14 160.78 27.66 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.389 1.476 . . . . 0.0 112.516 -173.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.44 148.84 21.78 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.489 1.116 . . . . 0.0 113.864 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 54.2 mt -100.73 166.44 10.87 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.267 1.827 . . . . 0.0 113.018 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -57.73 -33.18 68.16 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -75.81 -13.71 60.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.704 0.801 . . . . 0.0 112.625 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.89 30.29 5.83 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 117.579 -1.679 . . . . 0.0 114.841 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.0 165.33 22.38 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.783 1.792 . . . . 0.0 111.778 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.06 139.24 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.104 0.962 . . . . 0.0 110.13 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.04 152.92 46.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.609 1.564 . . . . 0.0 110.654 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.5 t -136.48 140.82 43.35 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.143 1.377 . . . . 0.0 112.342 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -169.487 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.267 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.42 170.07 17.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.492 ' HG ' HG21 ' A' ' 6' ' ' THR . 2.2 mm? -106.73 152.32 23.97 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.784 1.233 . . . . 0.0 110.974 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 t -63.2 161.7 13.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -52.49 -43.86 65.28 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.79 0.836 . . . . 0.0 112.221 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -60.9 -23.22 65.05 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.67 1.588 . . . . 0.0 113.52 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.492 HG21 ' HG ' ' A' ' 2' ' ' LEU . 87.7 m -66.15 114.73 5.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.101 0.961 . . . . 0.0 111.557 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -94.58 140.42 29.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.647 0.736 . . . . 0.0 112.439 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 mm -118.03 125.24 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 126.365 1.866 . . . . 0.0 108.103 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 tp -64.25 129.48 40.1 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.558 0.743 . . . . 0.0 111.369 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.9 p -128.4 156.58 42.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.122 1.369 . . . . 0.0 112.063 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 t -78.05 -31.64 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 O-C-N 121.739 -0.601 . . . . 0.0 111.88 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.04 -35.13 79.7 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -139.93 -44.97 0.43 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.33 -143.78 14.96 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.194 0.902 . . . . 0.0 111.288 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.0 mt -67.32 111.77 4.19 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.079 1.351 . . . . 0.0 111.279 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.1 mt -139.76 151.73 66.59 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.829 1.252 . . . . 0.0 113.323 176.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.55 128.72 20.73 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.131 3.221 . . . . 0.0 112.638 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 tt -58.24 -35.91 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.83 -31.54 81.24 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.867 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -71.24 -37.53 71.98 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.491 1.145 . . . . 0.0 111.322 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.45 -37.74 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.523 0.729 . . . . 0.0 110.762 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.6 t -85.7 -36.4 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.35 0.66 . . . . 0.0 112.657 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.77 -25.39 63.79 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.264 -0.897 . . . . 0.0 113.298 174.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -113.44 2.84 15.56 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.086 1.354 . . . . 0.0 113.0 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 46.82 47.98 15.07 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 127.538 2.335 . . . . 0.0 112.702 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.9 mt -70.61 121.31 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.798 1.239 . . . . 0.0 109.38 -174.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -82.37 120.18 25.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.912 0.863 . . . . 0.0 110.93 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.6 p -153.01 164.01 38.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.55 1.14 . . . . 0.0 112.75 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.7 145.8 24.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.074 1.35 . . . . 0.0 109.813 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.47 176.74 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.391 1.876 . . . . 0.0 110.756 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -121.75 144.26 48.9 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.179 1.392 . . . . 0.0 110.697 -176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.2 t -158.73 167.23 30.05 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.586 1.554 . . . . 0.0 110.599 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.78 123.98 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.156 1.382 . . . . 0.0 110.086 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.5 179.52 4.02 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.6 -18.88 65.3 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -90.21 -2.26 58.03 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.643 1.577 . . . . 0.0 112.086 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.79 29.89 62.52 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.053 1.787 . . . . 0.0 114.614 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -111.85 140.15 46.73 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.155 1.382 . . . . 0.0 110.497 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.3 mt -67.95 133.07 32.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -138.47 166.67 23.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.558 1.543 . . . . 0.0 111.452 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 p -118.08 143.53 46.37 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.418 1.087 . . . . 0.0 111.714 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -150.83 146.71 19.7 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.656 1.182 . . . . 0.0 111.951 -172.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.34 151.59 48.59 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.881 2.387 . . . . 0.0 112.495 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.2 139.46 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.103 0.961 . . . . 0.0 111.449 169.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.45 -35.29 9.61 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.186 0.995 . . . . 0.0 113.075 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.14 175.48 13.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.782 1.233 . . . . 0.0 112.777 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -124.14 135.66 53.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.565 1.546 . . . . 0.0 108.809 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -124.36 119.67 29.92 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.04 1.336 . . . . 0.0 110.86 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.57 110.02 16.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 110.432 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -87.37 -30.21 20.94 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.597 1.159 . . . . 0.0 112.988 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.9 -52.01 2.91 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.044 1.307 . . . . 0.0 114.099 171.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -170.97 98.46 0.21 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.588 1.194 . . . . 0.0 111.201 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -129.96 162.98 27.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.33 1.052 . . . . 0.0 112.155 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.39 102.3 1.39 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.69 1.196 . . . . 0.0 113.191 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.6 t -94.93 138.27 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.445 1.498 . . . . 0.0 110.925 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -124.89 144.92 50.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.274 1.43 . . . . 0.0 110.029 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -65.18 127.61 32.41 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.968 0.907 . . . . 0.0 110.469 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -119.51 86.58 2.58 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.874 1.67 . . . . 0.0 108.419 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.0 t -89.7 144.56 25.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.161 0.984 . . . . 0.0 110.787 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.02 163.92 12.88 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.369 1.067 . . . . 0.0 112.668 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.42 -20.33 63.79 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -76.05 -26.52 56.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.526 1.13 . . . . 0.0 112.555 171.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.16 -1.97 23.98 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.969 1.271 . . . . 0.0 113.998 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.59 147.22 42.43 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.937 1.295 . . . . 0.0 111.269 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.1 mt -134.84 130.78 36.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.117 1.367 . . . . 0.0 110.645 -172.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.6 mt -137.91 151.41 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.462 1.905 . . . . 0.0 107.757 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -136.26 106.15 6.26 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.663 1.185 . . . . 0.0 110.165 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.46 166.32 24.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.099 1.36 . . . . 0.0 111.89 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.1 p -86.85 157.32 19.57 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.924 0.869 . . . . 0.0 112.627 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -72.61 -5.01 34.39 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -91.34 -15.58 28.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.341 1.057 . . . . 0.0 112.556 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -77.63 131.67 37.89 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.699 -0.626 . . . . 0.0 111.147 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -90.03 153.97 20.17 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.19 0.996 . . . . 0.0 111.172 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -139.0 143.82 38.65 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.568 0.747 . . . . 0.0 110.416 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.2 ttm -74.11 104.35 4.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.155 0.982 . . . . 0.0 110.533 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.7 p -68.75 171.04 8.36 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.199 0.523 . . . . 0.0 111.936 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.1 m -56.57 -24.79 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 173.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -92.17 -6.15 51.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.145 0.978 . . . . 0.0 113.268 174.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.41 24.04 52.21 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.789 1.185 . . . . 0.0 113.793 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -88.82 120.26 30.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.081 0.952 . . . . 0.0 110.661 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.1 mmt -80.62 80.33 7.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.359 1.064 . . . . 0.0 111.68 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.3 mt -112.96 147.43 37.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 124.754 1.222 . . . . 0.0 110.888 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.84 146.92 84.57 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.57 2.18 . . . . 0.0 110.992 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.24 -25.05 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -55.89 -34.43 65.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.833 1.253 . . . . 0.0 113.014 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.0 -41.54 25.63 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.927 0.891 . . . . 0.0 110.496 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.88 -36.16 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.991 0.916 . . . . 0.0 111.498 -174.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -66.72 -35.44 80.12 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.24 -35.7 21.41 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.491 -0.756 . . . . 0.0 112.642 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -74.11 -17.52 60.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.403 1.081 . . . . 0.0 113.018 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 54.78 33.64 20.1 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.249 1.42 . . . . 0.0 112.963 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.4 mt -76.02 143.39 41.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.768 0.827 . . . . 0.0 111.907 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -88.53 148.07 24.3 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.815 0.846 . . . . 0.0 110.92 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.9 156.86 22.18 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.385 -0.822 . . . . 0.0 112.367 168.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 7.9 ttp -88.84 158.57 18.07 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.75 1.22 . . . . 0.0 111.378 169.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.12 165.57 25.4 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.061 1.345 . . . . 0.0 112.9 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.1 m -88.44 -21.77 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.01 13.52 34.53 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.206 1.002 . . . . 0.0 113.084 -171.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.1 m120 58.44 29.25 18.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.195 1.798 . . . . 0.0 112.429 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 mt -57.66 153.93 28.18 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.223 173.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.83 140.19 50.04 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.648 2.899 . . . . 0.0 111.15 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -79.82 120.59 24.28 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.017 0.527 . . . . 0.0 111.01 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.5 pt -142.8 153.5 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.908 1.683 . . . . 0.0 111.56 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.62 -179.6 3.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.911 1.684 . . . . 0.0 111.806 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.1 mt -64.43 114.65 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.107 0.963 . . . . 0.0 110.214 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.42 -41.16 73.27 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.839 1.256 . . . . 0.0 112.316 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.75 157.81 34.1 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.223 1.409 . . . . 0.0 111.009 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -137.12 143.83 42.72 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.491 1.516 . . . . 0.0 110.562 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -151.09 134.51 16.21 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.49 1.516 . . . . 0.0 109.506 169.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -63.6 123.4 18.72 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.705 0.684 . . . . 0.0 110.375 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.2 mt -90.04 -44.02 10.12 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.01 0.524 . . . . 0.0 111.692 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 148.38 -148.11 19.3 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.329 0.966 . . . . 0.0 112.979 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -126.6 67.87 1.24 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 123.576 1.655 . . . . 0.0 112.469 -168.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -85.74 158.02 20.13 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 126.723 2.009 . . . . 0.0 110.635 -169.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.04 119.65 9.9 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.135 0.574 . . . . 0.0 110.5 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -123.06 150.49 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.41 0.624 . . . . 0.0 111.839 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -140.06 157.84 45.0 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.215 1.806 . . . . 0.0 112.264 -168.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -152.67 167.37 29.17 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.916 1.687 . . . . 0.0 110.969 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.8 145.72 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.417 1.487 . . . . 0.0 111.338 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.09 160.44 23.06 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.79 0.709 . . . . 0.0 112.865 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 126.36 1.864 . . . . 0.0 110.487 178.884 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.7 p30 . . . . . 0 CA--C 1.549 0.925 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -163.34 166.55 22.87 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.836 1.254 . . . . 0.0 111.809 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.92 140.49 31.38 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.015 0.926 . . . . 0.0 112.949 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 133' ' ' PHE . 65.3 mt -91.73 170.49 9.87 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.143 1.777 . . . . 0.0 111.882 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -47.17 -58.12 4.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.779 1.632 . . . . 0.0 115.22 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -67.13 -39.64 86.65 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.556 0.342 . . . . 0.0 110.861 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.33 -2.97 0.85 Allowed Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.475 -1.181 . . . . 0.0 115.331 172.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.411 ' HB2' HD12 ' A' ' 129' ' ' LEU . 18.7 m-85 -59.49 160.89 6.39 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.176 1.488 . . . . 0.0 112.332 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.91 129.14 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.63 0.729 . . . . 0.0 110.179 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -118.52 145.65 45.16 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.991 1.716 . . . . 0.0 109.977 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.3 t -136.78 149.15 47.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.542 1.137 . . . . 0.0 114.006 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.8 t30 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.895 1.678 . . . . 0.0 113.648 -172.046 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.793 0 CA-C-O 122.307 0.948 . . . . 0.0 115.198 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -151.17 169.13 22.64 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.345 1.058 . . . . 0.0 112.207 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.8 mt -120.78 146.87 46.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.386 1.874 . . . . 0.0 109.514 -172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 t -70.15 160.34 32.26 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.585 -0.697 . . . . 0.0 111.437 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -49.09 -40.9 33.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.292 1.037 . . . . 0.0 112.344 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.88 -24.8 54.47 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.983 1.713 . . . . 0.0 113.777 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.2 m -72.14 102.65 3.09 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.293 1.037 . . . . 0.0 110.942 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -87.52 145.87 26.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.747 0.784 . . . . 0.0 111.67 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -122.81 128.84 75.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 126.501 1.92 . . . . 0.0 107.317 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.2 tp -61.95 127.76 32.94 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.834 0.454 . . . . 0.0 111.37 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.3 p -125.57 150.44 47.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.847 1.259 . . . . 0.0 112.368 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.42 -32.39 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.287 0.635 . . . . 0.0 111.982 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -66.22 -30.42 70.87 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -142.56 -56.55 0.44 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -173.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.26 -147.81 19.44 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.835 0.731 . . . . 0.0 112.681 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.4 104.75 1.97 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.084 1.353 . . . . 0.0 111.347 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.4 mt -134.61 148.68 68.35 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.434 1.094 . . . . 0.0 113.451 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.52 129.53 24.05 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.462 3.441 . . . . 0.0 112.665 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.1 tt -56.29 -35.31 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.609 0.764 . . . . 0.0 112.888 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.79 -34.36 89.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.566 -0.574 . . . . 0.0 112.724 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -73.92 -29.63 62.15 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.654 1.227 . . . . 0.0 112.015 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.6 mt -71.77 -41.96 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.452 1.101 . . . . 0.0 109.769 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.29 -39.99 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.756 0.822 . . . . 0.0 113.004 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.11 -26.3 65.74 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.308 0.958 . . . . 0.0 112.643 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.45 2.04 15.27 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.616 1.166 . . . . 0.0 113.398 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 46.89 50.68 13.4 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.344 2.258 . . . . 0.0 112.139 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.3 mt -67.05 120.19 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.873 0.869 . . . . 0.0 108.868 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -84.4 98.57 10.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.945 0.879 . . . . 0.0 110.321 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p -132.02 -171.14 2.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.08 1.352 . . . . 0.0 111.463 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.25 142.23 50.9 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.458 1.503 . . . . 0.0 108.008 -176.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.48 172.94 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.802 1.641 . . . . 0.0 110.169 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -117.55 145.19 44.43 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.012 1.325 . . . . 0.0 110.194 -173.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.4 t -159.07 167.03 30.31 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.29 1.436 . . . . 0.0 110.139 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -113.31 127.29 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.158 1.383 . . . . 0.0 110.824 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.17 179.61 6.77 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.276 1.036 . . . . 0.0 111.951 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -57.34 -24.84 57.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.142 1.377 . . . . 0.0 113.405 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -88.73 -6.4 57.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.816 1.646 . . . . 0.0 113.827 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.78 4.14 89.0 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.263 0.935 . . . . 0.0 114.786 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -77.37 128.48 34.35 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.11 0.955 . . . . 0.0 109.906 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.68 107.38 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -107.48 175.22 5.56 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.574 1.549 . . . . 0.0 110.403 175.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.6 p -130.99 149.03 52.8 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.703 0.801 . . . . 0.0 112.789 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -146.07 144.52 21.9 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.788 1.235 . . . . 0.0 111.997 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.44 151.21 47.57 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.819 2.346 . . . . 0.0 112.172 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.31 122.0 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 169.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.03 -47.63 12.41 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.27 -0.269 . . . . 0.0 111.56 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -148.7 179.14 8.05 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.021 1.729 . . . . 0.0 111.585 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -137.47 142.08 41.55 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.732 1.613 . . . . 0.0 110.289 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -136.79 132.38 34.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.999 0.92 . . . . 0.0 111.614 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -124.06 119.66 30.16 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.471 1.508 . . . . 0.0 110.595 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -84.82 -32.25 23.41 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.692 1.197 . . . . 0.0 113.086 -173.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 -53.33 1.33 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.528 1.537 . . . . 0.0 113.975 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -170.09 101.51 0.29 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.086 1.354 . . . . 0.0 111.087 -173.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -131.57 160.87 34.04 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.531 1.133 . . . . 0.0 111.899 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.91 106.52 1.25 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.405 1.082 . . . . 0.0 112.925 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.65 134.75 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.25 1.42 . . . . 0.0 111.358 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -119.78 140.78 50.22 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.76 1.224 . . . . 0.0 110.31 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.11 132.01 35.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.127 0.971 . . . . 0.0 108.799 168.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.18 89.04 3.05 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.112 1.365 . . . . 0.0 108.541 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 45.6 t -71.88 129.29 38.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.662 0.785 . . . . 0.0 110.377 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -88.54 164.87 15.21 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.201 1.0 . . . . 0.0 112.304 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.17 -23.02 67.16 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -82.18 -26.59 33.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.654 1.182 . . . . 0.0 113.084 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.95 -4.58 16.41 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.029 1.299 . . . . 0.0 114.264 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 m -58.54 141.34 52.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.556 1.178 . . . . 0.0 110.802 173.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.32 122.2 40.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.939 0.896 . . . . 0.0 109.52 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -110.97 131.09 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -124.66 97.35 5.25 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.38 1.072 . . . . 0.0 109.884 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.9 169.82 17.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.54 1.136 . . . . 0.0 113.03 -168.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 p -84.75 152.2 23.86 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.443 1.097 . . . . 0.0 111.486 169.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -62.65 -12.27 22.3 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.35 -13.49 34.99 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.32 1.448 . . . . 0.0 112.376 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -82.87 134.77 35.08 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.599 0.636 . . . . 0.0 109.666 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -86.91 156.75 19.7 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.657 0.783 . . . . 0.0 111.345 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -137.69 142.64 41.09 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.783 0.833 . . . . 0.0 109.286 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 31.1 ttp -79.52 106.17 11.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.024 0.529 . . . . 0.0 110.0 -174.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.4 p -66.47 169.33 7.67 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.008 0.523 . . . . 0.0 111.909 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 m -56.44 -27.87 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.8 -14.48 54.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.386 1.074 . . . . 0.0 113.283 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.68 6.06 56.45 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.445 1.497 . . . . 0.0 114.705 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -71.7 155.34 40.59 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.692 1.246 . . . . 0.0 111.384 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.7 ptp -116.86 74.24 0.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.803 1.241 . . . . 0.0 110.961 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.73 147.0 33.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.487 1.115 . . . . 0.0 110.977 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.78 146.96 92.53 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.034 2.49 . . . . 0.0 111.159 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tt -59.27 -24.78 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -54.78 -38.69 67.58 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.861 1.265 . . . . 0.0 112.61 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -81.28 -38.75 26.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.19 0.596 . . . . 0.0 110.848 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.452 HD13 HD21 ' A' ' 94' ' ' LEU . 77.2 mt -61.88 -40.89 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.389 -0.82 . . . . 0.0 111.665 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -64.33 -39.36 93.74 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.88 -40.12 25.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.968 0.907 . . . . 0.0 113.069 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -81.03 -11.96 59.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.754 1.222 . . . . 0.0 112.938 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 57.87 32.91 22.58 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.403 1.481 . . . . 0.0 112.737 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 mt -70.31 133.48 47.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.663 1.185 . . . . 0.0 110.971 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -72.11 154.58 41.0 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.546 -0.721 . . . . 0.0 111.76 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.452 HD21 HD13 ' A' ' 87' ' ' ILE . 62.5 mt -105.89 147.66 28.49 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.936 0.894 . . . . 0.0 112.406 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.8 ttm -70.17 151.64 45.18 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.511 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.27 174.04 10.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.481 1.112 . . . . 0.0 112.545 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.0 -0.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 125.775 1.63 . . . . 0.0 114.694 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.29 12.55 21.68 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.299 1.44 . . . . 0.0 113.265 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.8 m120 59.98 25.05 14.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.228 1.811 . . . . 0.0 113.02 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.8 mt -63.75 159.1 56.16 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.976 1.71 . . . . 0.0 112.013 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.19 146.2 80.76 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.004 2.47 . . . . 0.0 111.477 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -76.43 113.54 14.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.095 0.558 . . . . 0.0 109.708 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.95 150.58 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.318 1.447 . . . . 0.0 111.232 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.09 174.23 6.03 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.652 1.581 . . . . 0.0 111.21 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.4 mt -66.18 113.37 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.881 0.872 . . . . 0.0 109.878 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.28 74.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.026 1.331 . . . . 0.0 111.628 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.7 p -153.38 160.76 42.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.212 1.805 . . . . 0.0 111.784 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -117.4 145.26 44.22 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.081 1.752 . . . . 0.0 110.456 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -147.0 121.67 9.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.25 1.02 . . . . 0.0 110.871 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -64.18 135.84 56.68 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.84 -0.538 . . . . 0.0 111.175 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.5 mt -105.99 -37.98 6.47 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.255 0.622 . . . . 0.0 112.167 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.23 -144.78 15.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.458 1.028 . . . . 0.0 112.462 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -128.8 78.77 1.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 123.193 1.473 . . . . 0.0 112.141 -169.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -96.84 160.35 14.41 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.916 1.686 . . . . 0.0 111.074 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.44 119.32 8.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.392 0.677 . . . . 0.0 110.433 169.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.97 150.67 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.451 0.644 . . . . 0.0 111.384 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -138.44 158.76 43.65 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.67 1.588 . . . . 0.0 112.217 -168.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -158.23 133.4 8.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.425 1.09 . . . . 0.0 110.992 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.8 pt -82.3 158.4 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.389 -0.819 . . . . 0.0 111.354 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.22 139.9 15.79 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.84 1.209 . . . . 0.0 111.424 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.472 0.664 0 C-N-CA 126.652 1.981 . . . . 0.0 110.002 178.772 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -153.96 154.93 34.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.842 1.657 . . . . 0.0 111.984 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.24 131.65 34.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.526 1.131 . . . . 0.0 112.688 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 38.5 mt -82.87 170.59 14.82 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.172 1.389 . . . . 0.0 112.669 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -55.66 -41.15 73.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -75.32 -33.28 61.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.39 0.676 . . . . 0.0 111.577 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.4 -9.15 5.02 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.163 1.363 . . . . 0.0 114.304 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.74 173.1 5.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.614 1.707 . . . . 0.0 111.79 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.29 122.0 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.472 0.709 . . . . 0.0 109.843 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.63 131.48 44.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.336 1.054 . . . . 0.0 108.369 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 p -108.61 143.35 37.78 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.581 1.552 . . . . 0.0 110.775 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--O 1.255 1.394 0 CA-C-O 117.653 -1.165 . . . . 0.0 113.1 -167.811 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.274 0 N-CA-C 112.182 -0.367 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.08 179.19 7.69 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.989 1.315 . . . . 0.0 112.55 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.6 150.27 36.93 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.034 1.733 . . . . 0.0 111.015 -173.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 t -69.52 163.77 24.67 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.5 -0.75 . . . . 0.0 112.186 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -50.2 -43.82 52.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.914 0.885 . . . . 0.0 112.011 172.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -62.54 -15.77 52.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.993 1.317 . . . . 0.0 114.322 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.8 m -70.94 102.21 2.35 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.081 0.953 . . . . 0.0 111.043 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -86.24 137.65 32.46 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.357 0.663 . . . . 0.0 112.11 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.2 mm -122.9 119.13 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.896 1.678 . . . . 0.0 107.929 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.24 127.88 33.53 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 122.253 -0.279 . . . . 0.0 111.161 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.6 p -124.93 155.94 38.78 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.72 1.608 . . . . 0.0 112.375 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.6 t -81.24 -33.68 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.992 0.517 . . . . 0.0 111.72 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.31 -25.78 61.7 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -137.88 -53.85 0.65 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.95 0.9 . . . . 0.0 113.281 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.73 -146.46 18.27 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.1 0.857 . . . . 0.0 112.352 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -74.44 107.31 6.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.067 1.747 . . . . 0.0 110.925 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.439 ' CD1' HD11 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -146.56 157.07 48.74 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 177.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.25 132.86 26.91 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.172 3.248 . . . . 0.0 112.925 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.43 ' HA ' HD12 ' A' ' 21' ' ' ILE . 20.6 tt -56.42 -34.79 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.767 0.827 . . . . 0.0 112.987 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.9 -34.22 89.34 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.731 -0.606 . . . . 0.0 112.784 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -71.59 -32.72 68.34 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.481 1.141 . . . . 0.0 111.921 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' A' ' 16' ' ' LEU . 62.9 mt -67.48 -43.38 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.124 0.969 . . . . 0.0 110.153 176.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.5 t -82.66 -36.67 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.832 0.853 . . . . 0.0 112.669 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -65.8 -27.07 68.0 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.141 0.882 . . . . 0.0 112.857 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -116.33 2.65 13.25 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.32 1.048 . . . . 0.0 113.529 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 46.62 52.62 10.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.924 2.49 . . . . 0.0 112.528 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.7 mt -74.11 119.99 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.278 1.031 . . . . 0.0 109.936 -172.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -71.95 108.37 5.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.916 0.887 . . . . 0.0 110.532 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.5 p -148.15 161.09 42.16 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.363 1.078 . . . . 0.0 113.844 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 151.83 19.23 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.909 1.684 . . . . 0.0 109.907 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.35 170.99 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 125.251 1.42 . . . . 0.0 111.347 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -114.87 142.23 46.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.477 1.511 . . . . 0.0 111.093 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.8 t -164.44 152.69 12.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.174 1.389 . . . . 0.0 110.653 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 m -81.67 154.64 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.625 1.102 . . . . 0.0 112.698 170.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -96.08 -174.81 3.2 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.648 1.579 . . . . 0.0 113.221 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -62.77 -13.35 32.04 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -98.55 -5.41 32.12 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.4 1.48 . . . . 0.0 112.361 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.19 26.28 44.78 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.728 1.156 . . . . 0.0 114.588 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -109.82 122.82 48.4 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.135 1.468 . . . . 0.0 110.165 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 mt -67.69 103.12 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.979 0.912 . . . . 0.0 109.41 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -100.86 179.08 4.5 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.737 1.615 . . . . 0.0 111.031 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 p -126.84 143.1 51.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.192 0.997 . . . . 0.0 112.957 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -144.96 144.25 23.33 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 125.004 1.322 . . . . 0.0 112.442 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.51 149.21 43.87 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.098 2.532 . . . . 0.0 112.11 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.34 137.91 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.873 0.869 . . . . 0.0 110.745 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.64 -34.74 12.48 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -167.43 178.6 5.39 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.972 1.709 . . . . 0.0 112.308 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.2 m-90 -132.69 137.28 46.88 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.214 1.405 . . . . 0.0 110.217 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -127.59 114.78 17.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.685 1.194 . . . . 0.0 111.313 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.29 108.19 19.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.424 1.49 . . . . 0.0 109.877 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -78.49 -29.36 46.68 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.304 1.042 . . . . 0.0 112.752 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.31 -45.85 2.22 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.268 1.413 . . . . 0.0 114.026 171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 177.21 102.75 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.436 1.495 . . . . 0.0 112.183 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -132.22 166.66 21.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.747 1.219 . . . . 0.0 112.373 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.86 100.09 0.91 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.401 1.48 . . . . 0.0 113.851 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.86 141.7 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.346 1.458 . . . . 0.0 111.617 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -123.4 140.2 53.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.176 1.791 . . . . 0.0 110.217 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.11 130.05 44.79 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.979 0.912 . . . . 0.0 109.959 172.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -128.15 97.04 4.64 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.381 1.072 . . . . 0.0 108.232 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 45.9 t -111.34 142.16 43.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.166 0.987 . . . . 0.0 110.355 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -104.04 162.26 13.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.772 1.229 . . . . 0.0 112.117 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.85 -20.57 65.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.444 1.098 . . . . 0.0 113.723 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -76.11 -28.25 57.43 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.601 1.161 . . . . 0.0 113.031 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.91 -0.25 19.67 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.737 1.161 . . . . 0.0 114.547 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 m -58.27 146.86 32.65 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.319 1.06 . . . . 0.0 111.173 171.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.0 124.93 27.1 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.486 1.114 . . . . 0.0 110.435 -171.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.2 mt -137.61 150.51 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.942 2.097 . . . . 0.0 108.091 -170.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -136.62 110.91 8.43 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.57 1.148 . . . . 0.0 110.062 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.24 160.57 40.75 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.333 1.453 . . . . 0.0 111.518 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 p -75.31 151.0 38.33 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.385 -0.822 . . . . 0.0 111.782 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -63.19 -19.14 64.24 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.35 -15.18 56.09 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.772 1.629 . . . . 0.0 112.679 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -79.58 132.95 36.42 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.736 0.814 . . . . 0.0 110.038 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -93.79 146.68 23.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.592 1.157 . . . . 0.0 112.385 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.526 ' HB3' HD11 ' A' ' 94' ' ' LEU . 65.6 m-85 -128.74 151.84 49.1 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.845 -1.159 . . . . 0.0 111.483 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.3 ttp -92.78 100.48 12.95 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.447 0.699 . . . . 0.0 110.563 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.7 p -69.33 172.6 6.82 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.583 0.753 . . . . 0.0 112.342 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 m -52.56 -29.55 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -86.94 -10.04 54.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.082 0.953 . . . . 0.0 113.342 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.96 10.89 62.21 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.793 1.187 . . . . 0.0 114.135 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -67.61 158.72 31.45 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.235 1.018 . . . . 0.0 111.024 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 37.0 mtm -126.21 70.99 1.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.783 1.633 . . . . 0.0 109.848 -173.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 mt -111.81 149.28 40.57 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 124.895 1.278 . . . . 0.0 110.599 -170.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.41 149.37 88.13 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.646 2.231 . . . . 0.0 110.379 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.51 -28.57 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -55.19 -35.22 64.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.678 1.191 . . . . 0.0 113.007 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.49 -37.9 59.88 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.283 1.033 . . . . 0.0 111.471 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.542 HG23 ' HB2' ' A' ' 92' ' ' LEU . 68.7 mt -68.24 -38.51 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.603 1.161 . . . . 0.0 109.945 -176.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.96 -37.15 86.34 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -75.09 -46.72 32.74 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -79.43 -5.4 54.61 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 56.48 35.48 26.05 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.626 1.57 . . . . 0.0 112.531 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.542 ' HB2' HG23 ' A' ' 87' ' ' ILE . 66.0 mt -65.99 132.18 47.97 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.524 1.13 . . . . 0.0 110.825 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -75.31 136.85 40.85 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.838 -0.539 . . . . 0.0 110.328 171.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 74' ' ' PHE . 3.0 mm? -69.96 152.64 44.22 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.289 -0.882 . . . . 0.0 111.35 168.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.9 ttm -71.06 150.82 45.17 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.378 168.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.81 161.53 25.07 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.61 1.564 . . . . 0.0 112.598 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -113.6 -13.57 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.941 1.696 . . . . 0.0 114.133 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -109.48 11.55 24.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.046 1.338 . . . . 0.0 112.866 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.9 m120 64.2 25.89 13.7 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.537 1.535 . . . . 0.0 112.672 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.5 mt -55.67 157.12 7.96 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.671 1.588 . . . . 0.0 111.999 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.76 141.53 79.19 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.695 2.264 . . . . 0.0 110.397 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -66.04 128.64 36.87 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.792 -0.568 . . . . 0.0 110.712 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.4 pt -147.16 149.91 15.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 126.538 1.935 . . . . 0.0 109.897 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 -179.95 3.92 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.309 1.444 . . . . 0.0 111.333 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 25.1 mt -63.56 105.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.251 1.02 . . . . 0.0 110.028 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.45 77.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.156 1.382 . . . . 0.0 111.576 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 p -149.44 149.18 30.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.852 1.661 . . . . 0.0 111.076 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -143.43 144.0 31.85 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.908 1.683 . . . . 0.0 110.36 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -159.37 148.71 18.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.423 1.889 . . . . 0.0 110.042 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -65.11 128.39 35.59 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.546 0.612 . . . . 0.0 110.995 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.7 mt -93.53 -46.18 7.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.085 0.554 . . . . 0.0 111.748 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 147.73 -151.24 23.51 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.415 1.007 . . . . 0.0 112.544 -172.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -123.28 86.1 2.52 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 122.689 1.233 . . . . 0.0 112.135 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -102.01 154.56 18.86 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.248 1.419 . . . . 0.0 110.075 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.68 116.61 4.52 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.164 0.586 . . . . 0.0 109.964 169.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.06 151.66 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.541 0.686 . . . . 0.0 110.942 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -141.11 157.38 45.36 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.814 1.645 . . . . 0.0 111.412 -168.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -156.32 146.02 20.98 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.522 0.729 . . . . 0.0 109.872 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.7 pt -100.15 143.68 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.777 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -93.96 151.77 20.42 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.45 0.548 . . . . 0.0 111.772 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.475 0.802 0 C-N-CA 125.758 1.623 . . . . 0.0 108.869 -176.593 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 p30 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -161.62 156.97 23.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.641 1.576 . . . . 0.0 112.254 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.35 147.08 26.2 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.716 1.206 . . . . 0.0 112.962 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.05 168.86 9.57 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.671 1.588 . . . . 0.0 112.076 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -48.83 -51.02 31.77 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.126 1.37 . . . . 0.0 114.025 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -73.42 -20.47 60.72 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -172.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 127.14 -4.27 7.31 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.791 1.186 . . . . 0.0 114.91 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.31 171.87 11.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.081 1.44 . . . . 0.0 112.279 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.84 138.61 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.247 1.019 . . . . 0.0 109.999 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.5 149.1 50.28 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.306 1.842 . . . . 0.0 109.351 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.0 t -134.96 123.21 23.01 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -171.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.485 2.314 . . . . 0.0 114.074 178.849 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.181 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.99 175.94 10.64 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.22 1.008 . . . . 0.0 113.166 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -108.92 150.02 28.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.87 1.668 . . . . 0.0 111.071 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -65.81 161.76 20.27 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.405 0.682 . . . . 0.0 112.149 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -52.23 -44.15 64.66 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.823 0.849 . . . . 0.0 112.481 172.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.35 -23.75 64.51 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.791 1.636 . . . . 0.0 113.84 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -63.23 112.92 2.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.176 0.991 . . . . 0.0 111.341 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -96.55 135.3 38.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.42 0.688 . . . . 0.0 111.048 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.6 mm -118.43 122.81 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.653 1.581 . . . . 0.0 107.954 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -64.93 124.38 21.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.279 0.231 . . . . 0.0 111.289 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.2 p -121.83 153.65 38.07 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.632 1.173 . . . . 0.0 112.146 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.9 -30.41 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 121.877 -0.514 . . . . 0.0 111.8 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -65.62 -36.42 83.66 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -140.46 -49.45 0.45 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.32 -146.52 18.5 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.966 0.794 . . . . 0.0 112.51 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.3 mt -66.78 96.31 0.4 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.665 1.586 . . . . 0.0 112.639 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.66 147.8 62.21 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.887 1.275 . . . . 0.0 111.92 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.45 129.14 21.81 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 124.289 3.326 . . . . 0.0 112.794 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.5 tt -56.78 -37.25 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.004 0.921 . . . . 0.0 113.035 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.29 -31.35 78.77 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.662 -0.649 . . . . 0.0 113.291 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -76.23 -30.98 58.13 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.952 0.876 . . . . 0.0 111.817 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.58 -40.51 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.244 1.018 . . . . 0.0 109.642 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.71 -39.83 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.521 0.728 . . . . 0.0 112.951 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.1 -21.81 56.26 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.389 0.995 . . . . 0.0 113.513 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -109.51 1.87 20.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.778 1.231 . . . . 0.0 112.299 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.98 51.26 13.04 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.975 2.11 . . . . 0.0 112.663 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.5 mt -71.59 120.82 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.213 0.605 . . . . 0.0 109.48 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.04 105.6 6.14 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.222 1.009 . . . . 0.0 110.665 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.5 p -144.53 164.73 30.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.457 1.122 . . . . 0.0 113.44 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.5 145.67 26.55 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.315 1.446 . . . . 0.0 109.849 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.22 176.05 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.958 1.703 . . . . 0.0 111.098 -176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -118.24 142.95 46.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.769 1.628 . . . . 0.0 110.537 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.9 t -155.58 152.99 29.45 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.226 1.41 . . . . 0.0 110.419 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -94.27 125.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.456 0.702 . . . . 0.0 109.472 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -70.81 176.45 4.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.392 1.091 . . . . 0.0 112.445 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -60.21 -27.33 67.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.887 1.275 . . . . 0.0 113.066 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -86.2 -2.17 58.12 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.684 1.594 . . . . 0.0 113.498 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.23 19.05 78.85 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.582 1.086 . . . . 0.0 114.592 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -93.97 129.68 40.36 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.023 1.329 . . . . 0.0 109.485 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.2 mt -74.65 134.71 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -138.67 167.91 20.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.626 1.57 . . . . 0.0 111.683 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 p -115.94 144.95 43.35 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.473 1.109 . . . . 0.0 112.187 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -153.26 148.48 20.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.16 0.984 . . . . 0.0 112.767 -176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.62 150.21 45.03 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.963 2.442 . . . . 0.0 112.562 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -58.77 140.33 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.922 0.889 . . . . 0.0 110.568 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.48 -31.07 11.07 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.006 0.922 . . . . 0.0 112.64 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -167.71 175.14 7.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.946 1.698 . . . . 0.0 112.17 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -134.26 124.19 25.5 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.938 1.295 . . . . 0.0 109.303 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -113.77 129.13 56.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.993 0.917 . . . . 0.0 110.839 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -120.24 103.83 9.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.53 1.532 . . . . 0.0 110.043 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -72.77 -29.86 63.64 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.709 1.204 . . . . 0.0 112.967 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.16 -52.74 2.84 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.262 1.411 . . . . 0.0 113.62 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -170.76 105.54 0.26 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.967 1.307 . . . . 0.0 110.269 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -132.66 168.13 18.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.987 0.915 . . . . 0.0 112.349 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -68.82 100.84 1.23 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.854 1.261 . . . . 0.0 113.342 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.9 t -94.36 138.03 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.926 1.29 . . . . 0.0 111.557 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.505 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 53.2 m-85 -120.14 144.41 47.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 110.206 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.36 134.09 55.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.598 0.759 . . . . 0.0 110.652 171.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -127.03 83.34 2.16 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.425 1.49 . . . . 0.0 108.384 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.8 t -98.06 147.77 24.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.001 0.92 . . . . 0.0 110.899 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.09 158.36 23.31 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.199 1.4 . . . . 0.0 112.34 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -69.17 -18.34 63.91 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -77.25 -28.34 53.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.13 0.972 . . . . 0.0 112.786 172.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.62 -9.76 8.63 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.36 1.457 . . . . 0.0 114.253 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.2 m -59.54 150.78 26.07 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.46 1.13 . . . . 0.0 112.153 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.1 tp -137.91 125.6 22.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.162 0.985 . . . . 0.0 110.855 -173.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.6 mt -133.93 148.77 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.367 1.867 . . . . 0.0 107.941 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -131.6 121.41 24.33 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.935 1.294 . . . . 0.0 110.505 174.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.34 163.92 36.35 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.386 1.474 . . . . 0.0 111.197 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -75.37 154.04 37.45 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.434 -0.791 . . . . 0.0 111.973 173.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.505 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 4.8 mtmt -62.93 -20.4 65.17 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -87.47 -9.96 53.17 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.235 1.814 . . . . 0.0 113.054 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -77.68 134.42 38.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.75 0.82 . . . . 0.0 109.755 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -98.02 150.1 21.75 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.289 1.042 . . . . 0.0 111.889 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -136.3 132.57 35.89 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.018 -1.052 . . . . 0.0 109.766 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.1 ttp -72.24 108.87 5.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.206 0.527 . . . . 0.0 110.998 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -68.73 172.12 6.83 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.377 0.671 . . . . 0.0 112.172 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -55.91 -22.75 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -87.1 -6.14 58.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.414 1.085 . . . . 0.0 113.314 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.57 9.23 72.49 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.759 1.171 . . . . 0.0 113.966 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -81.13 130.16 34.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.258 1.029 . . . . 0.0 110.886 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.28 87.31 7.37 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.933 1.293 . . . . 0.0 110.793 169.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.1 mt -112.59 145.4 32.87 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.007 0.923 . . . . 0.0 110.238 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.72 147.06 85.44 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.674 2.25 . . . . 0.0 110.875 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -58.39 -26.84 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -53.79 -37.39 63.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.61 1.164 . . . . 0.0 113.19 169.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -80.43 -39.24 28.61 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.73 0.812 . . . . 0.0 110.669 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.46 -38.85 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.682 0.793 . . . . 0.0 111.103 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -64.78 -38.57 91.45 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -75.86 -38.64 57.73 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.482 -0.761 . . . . 0.0 112.682 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -75.47 -13.36 60.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 57.87 31.53 20.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.522 1.529 . . . . 0.0 111.982 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.8 mt -84.54 157.36 21.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.617 1.199 . . . . 0.0 112.201 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -113.54 156.6 23.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.011 2.124 . . . . 0.0 112.923 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.6 mt -88.21 149.75 23.68 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.552 0.741 . . . . 0.0 112.361 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.3 ttp -72.82 153.67 40.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.455 0.702 . . . . 0.0 111.222 170.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.39 167.3 15.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.412 1.485 . . . . 0.0 112.174 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.27 -12.52 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.981 1.313 . . . . 0.0 114.151 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.08 8.77 36.54 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.069 1.348 . . . . 0.0 113.073 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 52.41 35.39 17.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.987 1.715 . . . . 0.0 113.42 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.75 156.97 86.32 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.064 170.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.66 129.73 27.36 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.213 2.609 . . . . 0.0 111.134 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.19 134.44 44.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.727 0.811 . . . . 0.0 109.748 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.7 pt -143.17 130.75 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.371 1.468 . . . . 0.0 111.044 -169.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.5 171.57 12.42 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.487 1.115 . . . . 0.0 112.351 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.9 mt -63.97 112.52 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.319 1.448 . . . . 0.0 110.111 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.29 -35.81 35.3 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.707 0.803 . . . . 0.0 112.327 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.4 p -146.68 149.88 34.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.106 1.762 . . . . 0.0 110.676 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.07 143.03 32.89 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.795 1.638 . . . . 0.0 110.082 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -160.92 140.53 10.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.827 1.651 . . . . 0.0 110.256 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -65.35 121.98 16.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.842 0.457 . . . . 0.0 110.89 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.3 mt -90.95 -44.57 9.27 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.039 0.536 . . . . 0.0 111.891 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 150.73 -142.46 9.6 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.515 0.579 . . . . 0.0 113.324 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -130.67 86.27 2.36 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.82 1.248 . . . . 0.0 111.754 -168.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -104.43 157.26 17.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.909 1.284 . . . . 0.0 111.047 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 117.66 6.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.386 0.674 . . . . 0.0 110.364 169.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.3 m -124.14 151.7 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.372 0.606 . . . . 0.0 111.088 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -141.02 157.75 44.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.559 1.544 . . . . 0.0 111.74 -168.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -157.01 128.31 6.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.194 0.998 . . . . 0.0 110.799 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.5 pt -80.66 147.45 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.3 -0.875 . . . . 0.0 110.863 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.21 156.04 18.55 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.434 1.016 . . . . 0.0 111.731 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 124.662 1.185 . . . . 0.0 110.261 -169.223 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.9 p30 . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -166.51 158.43 13.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.711 1.205 . . . . 0.0 112.611 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.4 134.59 35.58 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.31 1.044 . . . . 0.0 112.339 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 38.1 mt -86.57 166.24 15.58 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.732 1.213 . . . . 0.0 111.516 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -52.74 -32.8 45.14 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -88.1 -6.53 57.86 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.505 1.122 . . . . 0.0 113.239 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.88 -11.65 34.78 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.427 1.013 . . . . 0.0 114.973 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -73.13 167.42 21.18 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.36 1.58 . . . . 0.0 112.842 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.69 120.66 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.931 0.893 . . . . 0.0 110.202 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.66 141.15 30.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.442 1.897 . . . . 0.0 109.801 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.7 m -139.16 137.12 35.8 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.472 1.109 . . . . 0.0 113.175 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 125.189 1.396 . . . . 0.0 113.86 -177.835 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.185 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -156.12 174.8 14.84 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.572 0.701 . . . . 0.0 112.826 -168.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.8 mt -120.89 147.0 46.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.928 1.691 . . . . 0.0 109.964 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 t -66.75 161.17 24.19 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -50.93 -44.64 60.28 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.557 0.743 . . . . 0.0 111.993 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -15.93 41.23 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.5 m -73.54 98.72 2.86 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.595 0.758 . . . . 0.0 110.14 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.15 133.14 42.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.455 0.645 . . . . 0.0 110.746 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.87 126.74 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 125.466 1.507 . . . . 0.0 107.216 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.3 122.56 18.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 170.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.7 p -123.71 150.98 43.66 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.76 1.224 . . . . 0.0 111.966 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.4 t -77.68 -33.59 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.9 -0.5 . . . . 0.0 112.005 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -66.16 -27.63 68.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -144.57 -52.84 0.31 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.37 -150.07 21.1 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.817 0.722 . . . . 0.0 112.217 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.85 108.26 2.93 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.333 1.453 . . . . 0.0 110.939 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.0 mt -134.99 148.89 68.74 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.475 1.11 . . . . 0.0 113.041 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.66 126.56 16.99 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.967 3.111 . . . . 0.0 112.024 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 tt -54.92 -36.48 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.18 -36.0 92.68 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.805 -0.56 . . . . 0.0 112.992 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -68.76 -37.65 79.53 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.558 1.179 . . . . 0.0 111.433 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.46 -38.41 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.761 0.824 . . . . 0.0 109.767 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.53 -39.49 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.158 0.983 . . . . 0.0 113.259 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.28 -27.5 66.37 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.496 1.044 . . . . 0.0 112.667 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -112.71 0.72 15.4 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.719 1.208 . . . . 0.0 112.773 -176.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.95 52.31 11.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.87 2.468 . . . . 0.0 112.418 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.6 mt -72.98 123.78 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.082 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.8 102.41 2.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.893 0.877 . . . . 0.0 110.287 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.5 p -132.25 -178.13 4.77 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.994 1.318 . . . . 0.0 112.496 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.94 147.27 51.05 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.439 1.496 . . . . 0.0 108.227 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.91 158.65 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.657 1.183 . . . . 0.0 111.203 -173.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -96.2 138.19 34.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.38 1.072 . . . . 0.0 110.4 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 t -155.57 153.77 30.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.898 1.279 . . . . 0.0 110.527 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.88 125.47 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.078 0.551 . . . . 0.0 110.316 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -68.42 175.29 3.45 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.835 1.254 . . . . 0.0 112.267 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.71 -25.87 68.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.844 1.258 . . . . 0.0 113.155 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -85.56 -4.76 59.26 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.366 1.466 . . . . 0.0 113.555 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.9 19.02 62.1 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.738 1.161 . . . . 0.0 114.758 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -94.95 128.88 42.08 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.627 1.171 . . . . 0.0 110.259 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.1 mt -74.12 123.52 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -135.11 174.15 10.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.828 2.051 . . . . 0.0 111.504 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -116.93 139.19 50.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.185 0.994 . . . . 0.0 111.905 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -141.22 141.0 21.99 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.545 1.138 . . . . 0.0 111.863 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.14 152.24 39.89 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.885 2.39 . . . . 0.0 112.027 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.66 138.45 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.787 0.835 . . . . 0.0 111.037 169.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.13 -51.95 4.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.544 0.738 . . . . 0.0 111.142 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -144.62 -178.6 6.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.87 1.668 . . . . 0.0 111.034 -173.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -138.98 126.81 22.15 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.399 1.08 . . . . 0.0 109.313 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -122.16 134.72 54.73 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.105 0.955 . . . . 0.0 110.795 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -127.52 122.25 32.84 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.208 1.403 . . . . 0.0 109.996 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -88.96 -34.19 16.96 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.177 0.991 . . . . 0.0 112.326 -173.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.45 -42.55 2.32 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.114 1.34 . . . . 0.0 114.889 172.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -178.69 88.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.066 1.412 . . . . 0.0 114.629 -168.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -125.18 158.98 32.62 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.979 1.311 . . . . 0.0 112.291 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.57 106.76 1.22 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.021 1.328 . . . . 0.0 112.695 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 t -98.59 139.44 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.346 1.458 . . . . 0.0 110.586 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -124.48 140.66 52.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.986 1.315 . . . . 0.0 109.513 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.84 135.1 35.88 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.177 0.991 . . . . 0.0 108.987 169.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -122.07 98.53 5.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.61 1.564 . . . . 0.0 109.011 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.8 t -75.86 132.97 40.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.138 0.575 . . . . 0.0 109.982 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mp -93.28 162.48 13.99 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.614 0.721 . . . . 0.0 112.783 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.81 -22.44 66.56 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.03 -21.27 51.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.954 0.902 . . . . 0.0 112.926 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.04 -1.32 25.59 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.441 1.495 . . . . 0.0 114.531 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.8 p -72.71 171.32 12.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.488 1.144 . . . . 0.0 113.017 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.5 mt -132.6 145.6 51.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.192 1.397 . . . . 0.0 110.983 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.6 mt -137.68 139.64 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.471 1.908 . . . . 0.0 107.323 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.464 HH21 HD22 ' A' ' 111' ' ' LEU . 42.3 mtp180 -131.26 98.18 4.48 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.608 1.163 . . . . 0.0 110.429 -174.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.73 166.29 27.06 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.282 1.039 . . . . 0.0 113.724 -172.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 p -82.43 155.46 24.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.723 1.209 . . . . 0.0 111.535 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -61.55 -23.95 66.31 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -86.74 -11.29 51.52 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.37 1.068 . . . . 0.0 112.605 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -80.02 132.04 35.92 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -87.4 162.72 17.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.509 0.671 . . . . 0.0 111.098 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -138.19 141.23 40.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 43.1 ttm -69.54 107.39 3.36 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -66.89 166.47 13.37 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.204 0.526 . . . . 0.0 111.122 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 m -57.64 -24.33 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.07 -14.39 59.51 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.487 1.115 . . . . 0.0 113.478 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.46 10.9 61.5 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.095 1.331 . . . . 0.0 114.383 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -82.96 164.08 20.63 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.426 1.113 . . . . 0.0 111.522 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.36 81.94 1.86 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.985 1.314 . . . . 0.0 111.33 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.6 mt -113.22 148.41 39.46 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.526 1.131 . . . . 0.0 110.787 -172.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.04 146.03 81.08 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.97 2.447 . . . . 0.0 111.246 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' A' ' 87' ' ' ILE . 6.6 tt -58.43 -26.03 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.55 -35.09 67.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.389 1.076 . . . . 0.0 113.023 170.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -39.03 27.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.531 1.132 . . . . 0.0 111.102 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.525 HD13 HD21 ' A' ' 94' ' ' LEU . 78.6 mt -64.47 -39.45 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.397 1.079 . . . . 0.0 110.919 -175.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -63.73 -34.44 77.87 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -77.14 -48.19 18.35 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.944 0.793 . . . . 0.0 113.055 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -74.55 -12.35 60.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 57.9 35.52 25.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.663 1.585 . . . . 0.0 112.476 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.8 mt -76.74 146.92 37.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.159 0.983 . . . . 0.0 111.834 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.63 164.76 20.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.665 0.786 . . . . 0.0 112.043 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.525 HD21 HD13 ' A' ' 87' ' ' ILE . 84.6 mt -111.05 147.14 35.43 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.5 1.12 . . . . 0.0 111.682 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 31.7 ttm -74.79 141.92 44.3 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.723 -0.611 . . . . 0.0 110.664 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.12 173.19 9.4 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.515 1.126 . . . . 0.0 113.06 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.61 -19.63 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 126.17 1.788 . . . . 0.0 113.8 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.8 4.23 30.05 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.94 1.296 . . . . 0.0 113.916 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.77 31.96 21.22 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.506 1.522 . . . . 0.0 112.859 -175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.9 mt -70.92 158.79 87.33 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.913 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.24 149.83 85.12 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.154 2.569 . . . . 0.0 111.396 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -70.4 123.59 22.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.4 0.68 . . . . 0.0 110.401 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.21 137.92 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.218 1.407 . . . . 0.0 111.386 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.23 176.35 5.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.834 1.654 . . . . 0.0 111.379 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mt -69.71 103.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.511 1.524 . . . . 0.0 110.007 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.93 -42.59 80.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.966 1.306 . . . . 0.0 111.633 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -152.48 162.98 40.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.642 1.977 . . . . 0.0 111.113 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -127.47 144.82 51.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.902 1.681 . . . . 0.0 110.793 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -145.83 116.58 7.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.512 1.125 . . . . 0.0 110.527 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -63.16 127.44 31.26 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.575 -0.703 . . . . 0.0 111.16 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.464 HD22 HH21 ' A' ' 67' ' ' ARG . 68.9 mt -94.74 -42.99 8.45 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.831 0.452 . . . . 0.0 112.094 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 140.64 -147.99 19.64 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.712 1.148 . . . . 0.0 112.588 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -120.8 71.27 0.92 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.476 1.51 . . . . 0.0 112.362 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -90.8 157.34 17.44 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.688 1.595 . . . . 0.0 111.216 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -65.18 118.92 9.93 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.95 0.9 . . . . 0.0 110.35 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.1 150.27 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.42 0.688 . . . . 0.0 111.448 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -137.11 157.96 45.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.051 1.74 . . . . 0.0 111.994 -169.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -158.1 119.1 3.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.713 1.205 . . . . 0.0 110.607 -174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 pt -72.68 148.19 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 O-C-N 120.754 -1.216 . . . . 0.0 111.927 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.49 151.47 19.34 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.488 1.042 . . . . 0.0 111.868 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 125.426 1.49 . . . . 0.0 109.416 -171.796 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.0 p30 . . . . . 0 CA--C 1.546 0.827 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -160.49 153.4 21.36 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.015 1.326 . . . . 0.0 112.912 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.62 140.68 37.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.496 1.118 . . . . 0.0 113.227 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 74.4 mt -92.62 178.59 5.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.198 1.799 . . . . 0.0 112.528 173.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -46.8 -59.33 3.13 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.734 2.013 . . . . 0.0 115.121 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.94 -22.21 61.49 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.508 0.723 . . . . 0.0 112.163 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.34 -5.73 8.73 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.123 1.344 . . . . 0.0 114.359 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -61.02 136.15 58.0 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.933 1.867 . . . . 0.0 110.743 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.07 118.3 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.6 153.46 17.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.064 1.346 . . . . 0.0 109.256 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.2 p -136.66 147.36 46.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.434 1.094 . . . . 0.0 112.768 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.9 p30 . . . . . 0 C--O 1.252 1.234 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -167.678 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.182 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -171.04 173.8 4.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.738 1.615 . . . . 0.0 112.588 -172.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.9 mt -118.92 149.83 40.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.381 2.273 . . . . 0.0 110.966 -172.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -73.22 160.41 31.97 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.264 -0.897 . . . . 0.0 111.802 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -50.07 -48.18 53.18 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.358 1.063 . . . . 0.0 112.666 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -66.37 -1.14 3.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.913 2.085 . . . . 0.0 114.944 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.2 m -74.27 104.66 5.12 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.081 0.952 . . . . 0.0 110.264 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.09 129.21 34.84 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.514 0.674 . . . . 0.0 111.614 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.6 mm -111.64 121.09 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 126.093 1.757 . . . . 0.0 107.227 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.39 129.81 42.36 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.378 0.671 . . . . 0.0 111.239 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -129.96 152.06 49.83 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.032 1.333 . . . . 0.0 111.781 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.3 t -74.65 -31.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 121.703 -0.623 . . . . 0.0 112.119 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -65.76 -33.99 77.14 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -141.68 -50.53 0.41 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.88 -137.68 9.22 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 118.816 0.735 . . . . 0.0 112.366 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.0 mt -81.29 96.69 7.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.004 1.722 . . . . 0.0 111.619 -175.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -127.36 147.41 62.01 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.794 1.238 . . . . 0.0 112.341 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.38 130.87 23.37 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.14 3.227 . . . . 0.0 112.675 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 tt -55.21 -36.15 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.9 0.88 . . . . 0.0 113.124 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.7 -34.4 83.26 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.671 -0.643 . . . . 0.0 113.177 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -72.69 -31.54 65.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.339 1.07 . . . . 0.0 111.728 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.1 mt -69.2 -38.07 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.827 0.851 . . . . 0.0 109.896 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.9 t -82.18 -38.07 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.22 1.008 . . . . 0.0 113.07 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.13 -23.68 63.06 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.302 -0.874 . . . . 0.0 112.974 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.31 4.88 11.85 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.074 1.35 . . . . 0.0 112.508 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 45.03 51.72 8.67 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.062 2.545 . . . . 0.0 112.692 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 53.8 mt -72.29 120.15 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.984 0.914 . . . . 0.0 109.134 -171.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.99 99.68 3.93 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.352 1.061 . . . . 0.0 110.587 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.4 p -141.15 162.22 36.02 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.588 1.185 . . . . 0.0 114.128 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.76 154.4 19.56 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.655 1.582 . . . . 0.0 110.505 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.65 173.94 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.734 1.614 . . . . 0.0 110.982 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -119.31 140.61 50.03 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.992 1.717 . . . . 0.0 109.929 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.2 t -159.77 165.96 31.38 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.946 1.298 . . . . 0.0 110.568 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.94 127.52 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.842 1.257 . . . . 0.0 111.366 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.13 177.88 7.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.562 1.145 . . . . 0.0 112.238 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -61.21 -23.01 65.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.274 1.43 . . . . 0.0 113.361 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -89.48 -3.04 58.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.203 1.401 . . . . 0.0 113.548 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.69 89.15 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.419 1.009 . . . . 0.0 114.608 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -81.41 134.93 35.62 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.291 1.046 . . . . 0.0 109.587 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.7 mt -72.22 122.17 24.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -121.41 169.12 10.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.913 1.685 . . . . 0.0 110.433 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.8 p -126.67 144.0 51.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.383 0.673 . . . . 0.0 112.02 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -150.48 147.68 22.12 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.468 1.107 . . . . 0.0 112.041 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.82 148.61 36.39 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.16 2.573 . . . . 0.0 112.738 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.31 145.64 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.408 1.083 . . . . 0.0 111.133 168.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.08 -32.26 7.3 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.892 1.277 . . . . 0.0 112.847 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -164.85 174.13 10.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.569 1.547 . . . . 0.0 112.36 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -137.49 110.68 7.83 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.061 1.345 . . . . 0.0 110.05 -174.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -98.62 115.23 28.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.834 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -102.1 107.0 17.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.91 1.284 . . . . 0.0 108.947 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -78.82 -24.5 44.46 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.355 1.062 . . . . 0.0 112.991 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.57 -44.18 3.31 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.287 1.422 . . . . 0.0 114.786 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 176.83 98.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.883 1.273 . . . . 0.0 113.143 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -129.79 167.42 18.12 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.226 1.411 . . . . 0.0 112.761 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.85 101.07 0.45 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.41 1.484 . . . . 0.0 114.041 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.1 t -92.03 143.33 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.147 1.379 . . . . 0.0 112.191 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -127.1 141.74 51.69 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.014 2.126 . . . . 0.0 110.129 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.15 132.89 51.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.351 0.66 . . . . 0.0 110.948 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.9 75.36 1.49 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.739 1.257 . . . . 0.0 108.779 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.6 t -82.22 146.92 29.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.223 1.009 . . . . 0.0 111.132 173.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.09 163.5 15.09 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.693 1.197 . . . . 0.0 112.825 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.02 -24.29 66.73 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.055 1.342 . . . . 0.0 113.051 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.03 -29.64 31.86 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.763 1.225 . . . . 0.0 113.169 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.83 -0.73 10.01 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.516 1.055 . . . . 0.0 114.69 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 m -63.13 139.94 58.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.803 1.301 . . . . 0.0 110.97 170.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.77 132.99 53.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.208 1.403 . . . . 0.0 109.856 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.1 mt -136.8 152.89 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.758 2.023 . . . . 0.0 107.658 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -138.65 115.96 11.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.707 1.203 . . . . 0.0 110.579 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.55 172.32 14.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.172 1.389 . . . . 0.0 112.35 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 p -93.09 151.9 19.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.993 1.317 . . . . 0.0 111.522 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -62.84 -16.56 58.94 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -88.01 -17.15 31.83 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.449 1.099 . . . . 0.0 112.463 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -78.21 137.46 38.15 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -95.02 160.35 14.61 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.217 1.007 . . . . 0.0 110.268 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -142.46 133.76 26.24 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.559 -0.713 . . . . 0.0 109.666 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.5 ttm -77.66 111.22 13.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.98 0.895 . . . . 0.0 111.359 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.1 p -65.31 167.45 8.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.788 1.235 . . . . 0.0 112.828 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.6 m -52.91 -28.77 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -83.79 -11.7 56.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.052 0.941 . . . . 0.0 113.461 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.64 -0.41 61.19 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.381 0.991 . . . . 0.0 114.082 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -76.4 137.67 39.9 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 119.2 1.5 . . . . 0.0 109.745 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.8 ptp -106.63 98.42 8.09 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.715 1.606 . . . . 0.0 108.776 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.63 152.79 59.11 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.084 1.353 . . . . 0.0 109.324 -174.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.53 147.1 86.35 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.266 1.977 . . . . 0.0 110.949 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.4 tt -59.46 -23.33 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -54.49 -35.97 63.66 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.015 1.326 . . . . 0.0 112.632 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -84.48 -39.81 18.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 111.499 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.8 mt -59.88 -36.17 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 119.129 0.877 . . . . 0.0 111.425 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -69.22 -33.41 73.26 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -78.6 -39.23 37.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.438 -0.789 . . . . 0.0 112.399 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -74.51 -14.78 60.86 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.834 0.854 . . . . 0.0 113.178 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 55.35 37.57 29.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.487 1.515 . . . . 0.0 111.905 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.9 mt -92.02 159.5 15.68 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.709 1.242 . . . . 0.0 112.34 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -114.34 154.44 28.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.033 2.133 . . . . 0.0 113.198 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.89 154.06 22.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.773 1.229 . . . . 0.0 112.726 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -70.26 148.7 48.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.758 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -114.1 155.75 25.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.646 1.579 . . . . 0.0 110.894 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.2 5.37 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 125.014 1.325 . . . . 0.0 114.413 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -121.34 20.45 11.27 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.886 1.674 . . . . 0.0 112.421 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.34 16.82 10.4 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 127.023 2.129 . . . . 0.0 113.647 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.1 mt -72.8 157.36 88.89 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.433 1.893 . . . . 0.0 112.54 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.92 166.33 29.89 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.205 3.27 . . . . 0.0 112.25 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -107.02 131.66 53.82 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.494 1.118 . . . . 0.0 110.556 -173.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.1 pt -146.97 135.55 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.443 1.497 . . . . 0.0 110.627 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 175.49 8.9 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.347 1.459 . . . . 0.0 112.127 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.8 mt -63.16 112.04 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.1 1.36 . . . . 0.0 110.206 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.31 -43.38 81.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.257 1.023 . . . . 0.0 111.957 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 p -150.12 147.64 28.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.247 1.819 . . . . 0.0 110.393 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -141.19 139.39 33.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.171 1.389 . . . . 0.0 110.812 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -158.29 150.59 21.96 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.181 1.393 . . . . 0.0 110.51 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -66.03 124.81 23.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.306 0.642 . . . . 0.0 110.891 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.6 mt -90.03 -43.06 10.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.217 0.607 . . . . 0.0 111.955 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 143.01 -149.39 21.3 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.434 1.016 . . . . 0.0 112.096 -173.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -124.11 96.42 4.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.387 1.075 . . . . 0.0 112.041 -169.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -114.36 155.34 26.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.482 1.513 . . . . 0.0 110.035 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -63.03 116.86 5.71 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.415 0.686 . . . . 0.0 110.326 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.41 152.45 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.64 0.776 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -137.95 156.21 48.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.828 1.651 . . . . 0.0 111.851 -168.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -154.09 116.39 4.33 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.67 1.188 . . . . 0.0 110.635 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.0 pt -77.94 142.99 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 120.963 -1.086 . . . . 0.0 111.354 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.75 158.02 17.94 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.392 0.996 . . . . 0.0 111.473 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.479 0.983 0 C-N-CA 124.586 1.154 . . . . 0.0 110.183 -169.226 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -166.16 165.14 17.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.383 1.073 . . . . 0.0 112.55 -171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.36 155.26 17.49 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.221 1.008 . . . . 0.0 113.442 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.6 mt -108.37 166.69 10.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.742 2.017 . . . . 0.0 111.568 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -43.2 -50.02 6.43 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.825 1.65 . . . . 0.0 115.296 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -84.67 4.13 33.89 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.192 0.997 . . . . 0.0 113.261 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.78 -4.85 53.52 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.445 1.498 . . . . 0.0 114.92 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -69.36 163.61 24.78 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.734 1.267 . . . . 0.0 111.664 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.1 mm -118.23 142.26 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.531 -0.731 . . . . 0.0 110.555 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.77 143.29 49.48 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.411 1.485 . . . . 0.0 110.385 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.7 t -139.86 144.72 37.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.048 1.739 . . . . 0.0 113.091 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--O 1.256 1.414 0 N-CA-C 117.268 2.321 . . . . 0.0 117.268 -169.63 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 CA-C-O 121.771 0.65 . . . . 0.0 114.368 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.48 173.02 14.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.15 1.38 . . . . 0.0 110.788 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -117.12 146.75 42.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.999 1.72 . . . . 0.0 109.769 -173.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -74.76 160.39 30.78 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.681 -0.637 . . . . 0.0 111.385 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -47.04 -49.55 21.1 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.475 1.51 . . . . 0.0 113.001 -169.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 pm0 -66.94 -1.85 4.54 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.24 2.216 . . . . 0.0 115.089 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.2 m -73.77 104.16 4.58 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.008 0.923 . . . . 0.0 110.013 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.65 129.34 34.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.56 0.695 . . . . 0.0 112.399 -173.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mm -106.33 123.81 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.364 1.465 . . . . 0.0 107.706 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.09 122.89 18.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.588 0.355 . . . . 0.0 110.266 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.1 p -124.2 150.35 45.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.765 1.226 . . . . 0.0 112.087 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.47 -33.43 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.191 0.596 . . . . 0.0 111.993 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -67.82 -30.7 70.18 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -141.28 -50.03 0.42 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.42 -148.99 19.7 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.598 1.094 . . . . 0.0 111.689 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.463 HD22 ' CB ' ' A' ' 130' ' ' LYS . 3.9 mt -61.7 111.96 2.06 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.281 1.433 . . . . 0.0 110.516 171.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 mt -139.96 149.09 57.6 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.365 1.066 . . . . 0.0 113.47 174.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.4 127.44 19.99 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.186 3.257 . . . . 0.0 112.394 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 tt -56.22 -36.36 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.0 -32.49 84.37 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.721 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -71.44 -38.04 71.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.383 1.091 . . . . 0.0 111.31 175.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -64.82 -38.24 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.395 0.678 . . . . 0.0 110.808 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.4 t -83.79 -37.96 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.08 0.952 . . . . 0.0 112.416 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -71.77 -24.56 61.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.088 0.858 . . . . 0.0 113.195 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -114.07 5.84 16.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.226 1.41 . . . . 0.0 113.037 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 48.21 48.92 18.26 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.331 2.252 . . . . 0.0 112.725 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.4 mt -77.73 118.08 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.006 0.923 . . . . 0.0 110.355 -169.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.68 112.17 7.57 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.323 1.049 . . . . 0.0 110.656 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.3 p -150.03 170.87 17.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.43 1.092 . . . . 0.0 112.995 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.4 m -116.86 143.29 45.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.412 1.485 . . . . 0.0 108.906 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.74 165.02 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.898 1.679 . . . . 0.0 110.959 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -102.51 143.75 31.83 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.227 1.411 . . . . 0.0 110.082 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -154.67 151.12 28.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.25 1.42 . . . . 0.0 109.892 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 t -92.91 124.82 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -69.07 173.96 5.01 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.581 1.181 . . . . 0.0 111.79 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -58.16 -27.79 64.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.453 1.901 . . . . 0.0 113.226 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -82.52 -10.06 59.16 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.247 1.419 . . . . 0.0 113.3 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.14 22.5 59.01 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.85 1.214 . . . . 0.0 114.483 -171.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -95.5 132.34 40.7 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.437 1.095 . . . . 0.0 109.85 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.5 mt -74.01 133.4 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.54 1.064 . . . . 0.0 108.899 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.69 174.95 10.01 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.016 1.726 . . . . 0.0 111.036 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.8 p -120.53 143.89 48.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.276 1.03 . . . . 0.0 112.361 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -147.03 142.82 17.42 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.73 1.212 . . . . 0.0 112.433 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -74.97 149.8 37.37 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.012 2.474 . . . . 0.0 112.258 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -59.38 135.89 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.375 0.67 . . . . 0.0 110.43 168.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.62 -47.01 7.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.594 0.758 . . . . 0.0 111.548 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -150.19 177.52 9.85 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.167 1.787 . . . . 0.0 111.397 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -134.23 137.83 44.65 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.139 1.776 . . . . 0.0 108.796 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -132.54 119.65 20.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.598 0.759 . . . . 0.0 111.218 -171.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -116.53 108.21 15.69 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.328 1.451 . . . . 0.0 110.736 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -80.73 -28.89 36.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.756 1.222 . . . . 0.0 113.331 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.41 -52.82 3.1 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.092 1.33 . . . . 0.0 114.219 173.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -171.85 104.91 0.19 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.056 1.428 . . . . 0.0 111.013 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -129.88 169.08 15.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.972 0.909 . . . . 0.0 112.052 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.31 105.42 2.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.23 1.012 . . . . 0.0 112.875 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.7 t -100.38 140.39 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.048 1.339 . . . . 0.0 111.492 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CG ' ' HE3' ' A' ' 70' ' ' LYS . 43.5 m-85 -123.91 146.19 48.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.929 1.292 . . . . 0.0 110.601 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -66.0 128.13 34.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.288 1.035 . . . . 0.0 110.485 173.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -121.87 81.72 1.86 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.592 1.557 . . . . 0.0 108.151 175.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.3 t -88.05 141.66 28.39 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.962 0.905 . . . . 0.0 110.614 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -105.2 165.64 10.96 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.268 1.027 . . . . 0.0 113.267 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -68.03 -20.7 65.02 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.68 -27.94 36.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.73 1.212 . . . . 0.0 112.96 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.76 -3.75 17.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.931 1.253 . . . . 0.0 114.389 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -60.61 148.16 39.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.719 1.26 . . . . 0.0 111.577 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.5 mt -133.15 128.26 35.69 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.365 1.466 . . . . 0.0 110.11 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.1 mt -135.24 149.56 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 126.681 1.992 . . . . 0.0 107.399 -175.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -137.1 112.27 9.1 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.216 1.006 . . . . 0.0 110.111 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.4 169.47 18.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.311 1.445 . . . . 0.0 111.815 -172.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.6 p -87.44 162.02 17.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.546 0.738 . . . . 0.0 112.837 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HE3' ' CG ' ' A' ' 56' ' ' PHE . 19.7 mmtp -72.99 -7.97 53.6 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -90.9 -8.96 47.93 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.784 0.72 . . . . 0.0 112.083 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.479 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 14.3 t-80 -82.56 132.89 35.19 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.785 -0.572 . . . . 0.0 110.091 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -95.19 152.02 18.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.995 0.918 . . . . 0.0 110.285 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -137.94 135.14 35.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.08 0.552 . . . . 0.0 110.626 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 44.7 ttp -73.6 103.98 4.39 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 111.201 -174.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.6 p -66.05 171.8 4.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.134 0.974 . . . . 0.0 112.155 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.26 -22.91 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -93.33 -6.82 46.47 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.214 1.006 . . . . 0.0 113.194 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.4 26.65 24.95 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.323 0.963 . . . . 0.0 113.944 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -88.04 142.05 28.08 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.456 1.128 . . . . 0.0 111.754 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.3 mmt -97.26 77.34 2.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.784 1.634 . . . . 0.0 110.971 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -116.01 148.09 40.64 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.852 0.861 . . . . 0.0 111.44 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.34 148.55 79.97 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.409 2.739 . . . . 0.0 111.771 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.83 -28.76 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -54.05 -30.76 49.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.641 1.177 . . . . 0.0 113.933 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -91.86 -31.14 15.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.44 0.696 . . . . 0.0 111.553 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.84 -38.82 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.042 0.837 . . . . 0.0 111.158 177.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -64.01 -38.1 89.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -78.66 -37.78 41.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.212 0.605 . . . . 0.0 112.553 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -82.41 -8.83 59.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.778 0.831 . . . . 0.0 112.952 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 57.14 35.55 26.41 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.482 1.513 . . . . 0.0 112.383 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.2 mt -85.53 124.01 31.61 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.011 0.91 . . . . 0.0 111.97 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.5 153.72 30.83 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.547 1.139 . . . . 0.0 112.407 169.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.86 150.61 22.14 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.212 -0.93 . . . . 0.0 112.455 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.1 ttp -72.4 156.85 38.63 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.654 0.782 . . . . 0.0 111.163 169.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -138.25 170.1 16.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.528 1.531 . . . . 0.0 111.739 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.18 -2.69 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.62 14.95 29.74 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.127 0.971 . . . . 0.0 113.393 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 56.16 28.57 13.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.405 1.882 . . . . 0.0 112.993 -173.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 70.8 mt -88.32 156.29 51.26 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.385 1.474 . . . . 0.0 112.083 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.36 135.67 32.01 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.906 3.07 . . . . 0.0 112.686 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -75.3 126.25 30.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.73 0.812 . . . . 0.0 110.773 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.2 pt -142.98 151.61 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.555 1.542 . . . . 0.0 111.335 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.3 pttt -95.59 -173.47 2.89 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.21 1.804 . . . . 0.0 111.961 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.1 mt -68.49 122.28 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.764 1.226 . . . . 0.0 109.001 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.46 -44.57 19.02 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.331 1.052 . . . . 0.0 112.49 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.8 p -146.88 152.62 39.0 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.655 1.582 . . . . 0.0 111.03 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.93 145.17 43.93 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.053 1.741 . . . . 0.0 110.235 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -158.0 135.43 10.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.179 1.792 . . . . 0.0 110.017 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -67.85 120.44 14.16 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.382 0.537 . . . . 0.0 110.032 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.7 -42.14 12.85 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.711 0.404 . . . . 0.0 111.702 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.04 -142.19 11.96 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.208 0.909 . . . . 0.0 112.848 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -121.93 97.07 5.32 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.358 1.463 . . . . 0.0 111.626 -168.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -118.09 154.66 31.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.457 1.103 . . . . 0.0 111.286 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.9 117.21 5.61 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.652 0.781 . . . . 0.0 110.709 171.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.44 151.02 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.504 0.668 . . . . 0.0 111.043 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -138.61 159.41 42.16 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.613 1.565 . . . . 0.0 111.408 -169.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -148.82 168.04 24.02 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.705 0.802 . . . . 0.0 111.921 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.2 pt -126.12 139.91 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.449 1.1 . . . . 0.0 110.112 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.33 153.98 20.05 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.843 1.211 . . . . 0.0 111.183 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 124.525 1.13 . . . . 0.0 109.784 -174.285 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 p30 . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -160.59 161.49 32.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.983 1.313 . . . . 0.0 111.631 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.78 130.48 37.55 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.866 0.866 . . . . 0.0 113.007 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 41.9 mt -72.79 165.71 24.32 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.469 1.108 . . . . 0.0 111.116 168.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.463 ' CB ' HD22 ' A' ' 15' ' ' LEU . 5.6 ptmm? -51.47 -32.57 27.6 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -90.01 -12.24 39.21 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.879 1.271 . . . . 0.0 113.999 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.62 -12.25 18.41 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 118.506 -1.163 . . . . 0.0 115.246 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -60.63 158.45 12.49 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.698 1.749 . . . . 0.0 112.462 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.66 126.02 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.122 0.963 . . . . 0.0 110.859 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.479 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -107.56 157.06 18.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.651 1.58 . . . . 0.0 109.729 172.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.6 t -134.84 128.13 32.11 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 112.839 -176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.936 1.694 . . . . 0.0 113.179 -175.976 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -151.24 171.61 17.14 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.456 1.102 . . . . 0.0 111.848 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.448 HD13 HG21 ' A' ' 6' ' ' THR . 56.8 mt -127.64 148.13 50.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.182 1.793 . . . . 0.0 110.856 -168.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p -61.56 162.11 8.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.774 1.23 . . . . 0.0 114.196 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -53.62 -45.61 70.18 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.141 -0.974 . . . . 0.0 112.158 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.52 -5.84 16.99 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.448 HG21 HD13 ' A' ' 2' ' ' LEU . 63.7 m -71.44 97.65 1.68 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.118 -0.989 . . . . 0.0 110.318 173.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -74.09 135.74 42.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.598 0.759 . . . . 0.0 110.919 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.38 120.54 63.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 126.107 1.763 . . . . 0.0 106.702 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.78 120.69 15.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.73 0.412 . . . . 0.0 110.053 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 p -121.63 153.37 38.2 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.303 1.041 . . . . 0.0 112.424 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.19 -34.38 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.404 0.682 . . . . 0.0 111.758 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.64 -26.42 61.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -140.1 -51.79 0.5 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.92 -152.69 20.41 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.212 0.911 . . . . 0.0 111.707 -171.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 109.37 1.7 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.078 0.951 . . . . 0.0 110.96 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.8 mt -133.8 149.39 71.74 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.93 1.292 . . . . 0.0 112.943 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.42 126.73 14.61 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.886 3.058 . . . . 0.0 112.818 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 tt -55.81 -35.71 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.81 -38.16 96.05 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.895 -0.503 . . . . 0.0 112.469 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -71.58 -34.84 70.27 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.409 1.104 . . . . 0.0 111.657 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.9 mt -66.13 -39.65 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.038 0.935 . . . . 0.0 110.032 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.22 -38.08 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.319 1.048 . . . . 0.0 113.046 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -70.41 -27.43 64.28 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.323 0.965 . . . . 0.0 113.218 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -112.19 3.12 17.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.273 1.029 . . . . 0.0 113.103 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 46.9 50.23 13.82 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.26 2.224 . . . . 0.0 111.911 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.8 mt -68.12 118.5 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.021 0.928 . . . . 0.0 108.678 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.02 118.13 14.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.288 0.566 . . . . 0.0 109.511 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.5 p -151.55 166.77 30.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.096 1.358 . . . . 0.0 112.334 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.16 152.54 20.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.272 1.429 . . . . 0.0 109.74 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.31 167.53 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.189 1.396 . . . . 0.0 110.961 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -108.67 148.97 29.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.151 1.38 . . . . 0.0 111.086 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -168.37 151.74 5.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.607 1.563 . . . . 0.0 110.673 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.12 144.45 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.834 1.197 . . . . 0.0 113.275 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.73 178.45 8.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.544 1.138 . . . . 0.0 113.333 170.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -61.98 -11.11 11.74 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -105.18 0.26 27.17 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.9 1.68 . . . . 0.0 112.312 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.14 22.96 39.43 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.171 1.367 . . . . 0.0 115.253 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -108.08 123.56 48.88 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.158 1.479 . . . . 0.0 110.331 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.61 102.63 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.972 0.909 . . . . 0.0 109.41 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -100.88 179.05 4.51 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.103 1.761 . . . . 0.0 111.275 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.2 p -126.35 144.2 50.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.342 1.057 . . . . 0.0 112.843 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -145.58 137.3 13.01 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.537 1.135 . . . . 0.0 112.308 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.23 143.13 27.99 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.286 2.658 . . . . 0.0 110.944 174.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 p -54.13 147.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.727 0.811 . . . . 0.0 111.601 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.76 -42.93 3.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.712 0.805 . . . . 0.0 112.127 175.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -145.15 172.08 13.61 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.853 1.261 . . . . 0.0 111.875 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -135.49 132.56 37.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.579 1.552 . . . . 0.0 109.664 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -127.15 130.85 50.57 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.51 1.124 . . . . 0.0 111.465 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -126.51 119.77 28.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.441 1.496 . . . . 0.0 110.492 -173.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -91.11 -23.1 20.39 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.631 1.172 . . . . 0.0 113.387 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.61 -46.18 3.53 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 126.812 2.148 . . . . 0.0 114.775 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -173.46 107.55 0.15 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.737 1.615 . . . . 0.0 112.156 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -128.04 159.97 33.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.302 1.441 . . . . 0.0 111.212 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -59.26 104.78 0.28 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.517 1.527 . . . . 0.0 112.953 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.08 136.53 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.119 1.368 . . . . 0.0 111.181 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -118.52 138.21 52.68 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.691 1.196 . . . . 0.0 109.989 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -74.29 134.88 42.59 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.034 0.934 . . . . 0.0 108.946 168.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -129.86 89.2 2.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.122 1.369 . . . . 0.0 109.229 170.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.5 t -74.96 141.99 43.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.059 0.944 . . . . 0.0 110.896 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tp -93.89 170.1 9.8 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.941 1.296 . . . . 0.0 113.249 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -63.99 -26.47 68.59 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.99 -18.53 28.83 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.86 -3.21 28.83 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.126 1.346 . . . . 0.0 114.316 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 m -59.63 150.79 26.43 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.086 1.443 . . . . 0.0 111.449 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -127.11 135.98 51.49 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.492 0.717 . . . . 0.0 110.775 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.481 HD11 ' CZ ' ' A' ' 133' ' ' PHE . 11.3 mt -128.42 126.44 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.435 1.494 . . . . 0.0 107.385 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -123.63 103.11 8.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.876 1.27 . . . . 0.0 109.556 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.66 170.51 15.71 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.563 1.145 . . . . 0.0 112.554 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.1 p -86.69 150.68 24.01 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.869 1.267 . . . . 0.0 111.632 171.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -65.1 -7.52 12.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.703 1.601 . . . . 0.0 115.055 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.8 -11.72 30.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.326 1.85 . . . . 0.0 111.921 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.645 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 5.2 t-80 -83.01 130.94 35.19 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.638 0.654 . . . . 0.0 109.793 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -91.34 155.93 18.15 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.822 0.849 . . . . 0.0 110.238 176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -138.81 137.57 36.74 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.598 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.5 ttp -79.14 106.49 11.21 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.089 0.556 . . . . 0.0 110.515 -171.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.3 p -65.5 172.34 3.38 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.54 0.736 . . . . 0.0 112.746 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.32 -24.97 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.47 -9.28 50.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.556 1.143 . . . . 0.0 113.519 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.99 9.8 60.47 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.054 1.312 . . . . 0.0 114.599 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -69.96 149.92 47.25 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.512 1.156 . . . . 0.0 111.69 -178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.4 mtm -111.94 82.15 1.58 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.23 1.812 . . . . 0.0 108.698 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 37.1 mt -122.85 147.06 50.03 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 125.242 1.417 . . . . 0.0 110.225 -174.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.93 148.32 85.87 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.167 2.578 . . . . 0.0 111.246 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.3 tt -59.71 -25.99 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -56.44 -33.17 65.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.424 1.09 . . . . 0.0 112.998 170.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -85.25 -36.81 20.69 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.459 0.704 . . . . 0.0 111.597 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.85 -40.45 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.131 -0.981 . . . . 0.0 111.417 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -63.44 -38.52 91.45 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -76.74 -42.96 39.1 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.447 -0.783 . . . . 0.0 112.869 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -77.58 -13.17 59.98 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.143 0.977 . . . . 0.0 112.957 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 56.22 37.08 28.49 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.655 1.582 . . . . 0.0 111.854 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.6 mt -75.07 138.52 42.19 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.438 1.095 . . . . 0.0 111.318 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -73.27 157.31 37.32 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.909 0.861 . . . . 0.0 112.104 173.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.3 mt -112.94 143.35 44.39 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.843 1.257 . . . . 0.0 111.234 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 39.8 ttm -62.29 156.92 20.9 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.465 1.506 . . . . 0.0 111.953 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -132.21 158.43 41.77 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.565 1.546 . . . . 0.0 112.509 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.68 -10.93 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -107.69 16.93 23.18 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.915 1.686 . . . . 0.0 112.672 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.269 7.6 m-80 56.49 36.67 27.93 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.194 1.798 . . . . 0.0 112.551 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.97 159.61 68.08 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 112.743 -2.026 . . . . 0.0 112.015 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.68 155.92 58.12 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.561 2.841 . . . . 0.0 112.108 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -89.92 114.22 25.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.852 0.861 . . . . 0.0 110.003 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.6 pt -142.32 131.01 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.805 1.642 . . . . 0.0 111.106 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.61 173.35 10.55 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.061 1.745 . . . . 0.0 112.633 174.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.8 mt -66.01 115.86 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.097 1.359 . . . . 0.0 110.363 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.72 -42.57 73.83 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.819 1.248 . . . . 0.0 112.654 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.77 162.3 40.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.059 0.944 . . . . 0.0 111.828 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.56 145.5 42.95 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.543 1.537 . . . . 0.0 111.615 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.66 133.58 13.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.303 1.041 . . . . 0.0 110.747 177.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -65.7 133.05 50.26 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.415 -0.803 . . . . 0.0 110.707 170.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.2 mt -102.21 -45.23 5.19 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.479 0.712 . . . . 0.0 111.847 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 152.03 -147.59 17.55 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.089 0.852 . . . . 0.0 112.922 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.77 62.6 1.22 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 123.252 1.501 . . . . 0.0 113.013 -167.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -81.07 156.53 25.78 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.556 1.942 . . . . 0.0 110.826 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.42 119.33 8.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.839 0.855 . . . . 0.0 110.184 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.42 150.09 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.601 0.715 . . . . 0.0 111.367 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -138.74 159.36 42.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.651 1.58 . . . . 0.0 111.551 -168.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -154.74 130.81 10.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.543 1.137 . . . . 0.0 110.745 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.8 pt -93.52 156.44 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.009 -1.057 . . . . 0.0 111.488 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.38 153.22 19.8 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.157 0.884 . . . . 0.0 112.835 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 124.599 1.16 . . . . 0.0 111.03 -176.271 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 . . . . . 0 CA--C 1.551 0.987 0 CA-C-O 121.225 0.536 . . . . 0.0 112.191 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -166.84 154.93 9.8 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.101 1.36 . . . . 0.0 111.396 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.06 149.52 35.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.863 1.265 . . . . 0.0 112.488 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 88.7 mt -128.5 -176.71 3.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.07 2.148 . . . . 0.0 111.716 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -51.08 150.55 3.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.961 0.504 . . . . 0.0 110.432 165.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 52.54 18.84 1.04 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.887 1.275 . . . . 0.0 114.342 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.01 22.13 75.74 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 117.624 -1.653 . . . . 0.0 115.94 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.481 ' CZ ' HD11 ' A' ' 66' ' ' ILE . 67.5 m-85 -65.25 157.06 29.96 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.248 2.024 . . . . 0.0 112.369 170.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.02 121.1 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.778 1.231 . . . . 0.0 108.778 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.645 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -107.38 103.63 13.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.925 0.89 . . . . 0.0 110.416 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.4 t -89.26 157.86 18.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.539 0.735 . . . . 0.0 112.331 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.7 t30 . . . . . 0 C--O 1.255 1.362 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 172.259 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.816 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -171.36 175.55 4.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.918 0.887 . . . . 0.0 113.193 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.584 HD13 HG21 ' A' ' 6' ' ' THR . 86.7 mt -120.32 147.39 45.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.859 2.064 . . . . 0.0 110.37 -175.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -72.8 161.82 30.26 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.857 -0.527 . . . . 0.0 111.946 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -51.96 -46.75 64.91 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.319 1.048 . . . . 0.0 112.464 -173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -61.96 -8.01 4.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.375 1.87 . . . . 0.0 115.141 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.584 HG21 HD13 ' A' ' 2' ' ' LEU . 19.9 m -71.44 107.36 4.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.906 0.883 . . . . 0.0 110.33 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.55 133.09 33.84 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.348 0.594 . . . . 0.0 111.435 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -118.49 115.1 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.332 1.453 . . . . 0.0 107.139 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.1 128.33 34.93 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 122.062 -0.399 . . . . 0.0 110.87 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.4 p -129.18 156.07 44.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.166 1.387 . . . . 0.0 113.013 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.56 -30.87 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 122.955 0.502 . . . . 0.0 112.04 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -65.78 -31.65 72.74 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -140.97 -59.59 0.5 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.628 0.771 . . . . 0.0 113.07 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.13 -133.44 5.83 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.13 108.55 12.71 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.262 1.425 . . . . 0.0 109.952 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.531 HD13 HD11 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -145.8 156.69 51.89 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.23 129.39 17.01 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.932 3.088 . . . . 0.0 112.713 -175.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.81 -37.57 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.511 0.724 . . . . 0.0 112.837 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 -30.95 79.28 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.608 -0.682 . . . . 0.0 113.051 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.79 -36.16 70.24 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.734 0.767 . . . . 0.0 111.445 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.531 HD11 HD13 ' A' ' 16' ' ' LEU . 64.6 mt -64.92 -43.12 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.998 0.519 . . . . 0.0 109.885 176.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 117' ' ' TYR . 57.8 t -75.09 -41.28 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -75.59 -22.49 56.88 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -109.87 1.56 19.29 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.132 1.373 . . . . 0.0 112.493 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.65 48.71 14.3 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.166 2.186 . . . . 0.0 113.322 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.27 124.8 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.471 0.708 . . . . 0.0 109.626 -174.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -83.02 86.23 7.03 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.737 0.78 . . . . 0.0 110.683 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' VAL . 20.6 p -117.44 -177.96 3.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.852 1.261 . . . . 0.0 111.952 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.16 144.67 48.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.426 1.49 . . . . 0.0 108.351 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.67 174.22 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.718 1.607 . . . . 0.0 111.077 -177.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -117.21 139.33 50.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.69 1.596 . . . . 0.0 110.319 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -156.99 151.9 25.94 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.864 1.265 . . . . 0.0 111.177 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.1 p -99.12 131.84 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.679 1.192 . . . . 0.0 111.461 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.7 -176.76 6.17 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.998 1.319 . . . . 0.0 113.67 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.58 -29.69 69.34 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -79.85 -11.21 59.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.277 1.031 . . . . 0.0 113.189 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.27 14.27 59.06 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.464 1.031 . . . . 0.0 114.227 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -91.75 126.23 36.76 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.897 1.348 . . . . 0.0 109.481 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.0 mt -71.95 88.43 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.345 1.058 . . . . 0.0 108.78 172.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -81.88 171.08 14.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.114 0.966 . . . . 0.0 111.136 171.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 p -126.92 145.52 50.65 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.832 0.853 . . . . 0.0 111.777 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -145.39 146.38 29.79 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 124.259 1.023 . . . . 0.0 112.677 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.07 156.19 56.11 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.208 2.605 . . . . 0.0 112.474 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 28' ' ' CYS . 42.1 t -67.55 119.8 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.993 0.917 . . . . 0.0 109.816 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.22 -36.27 35.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.374 0.67 . . . . 0.0 112.578 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -162.14 175.67 11.46 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.381 1.473 . . . . 0.0 112.64 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -135.71 117.36 14.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.08 1.352 . . . . 0.0 109.34 -175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -108.35 130.58 55.2 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.062 0.934 . . . . 0.0 110.369 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.21 103.12 9.22 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.791 1.636 . . . . 0.0 109.514 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -69.78 -33.26 72.15 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.374 1.07 . . . . 0.0 111.908 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.52 -40.39 3.01 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.87 1.224 . . . . 0.0 113.382 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 178.32 109.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.283 1.433 . . . . 0.0 111.62 -174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -133.96 164.96 26.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.131 0.972 . . . . 0.0 112.55 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.07 100.06 0.3 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.489 1.516 . . . . 0.0 113.204 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 t -92.41 137.24 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.038 1.335 . . . . 0.0 110.959 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -119.51 137.13 54.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.295 1.438 . . . . 0.0 109.486 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -56.89 126.0 25.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.99 0.916 . . . . 0.0 110.267 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -118.58 82.88 1.92 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.893 1.277 . . . . 0.0 108.449 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.9 t -94.17 137.51 33.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.666 0.787 . . . . 0.0 110.646 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.82 162.03 13.32 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.223 1.009 . . . . 0.0 112.111 173.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -18.75 62.02 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -78.12 -26.51 48.0 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.123 0.969 . . . . 0.0 112.729 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.74 2.98 18.8 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.629 1.109 . . . . 0.0 114.806 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 m -67.69 132.4 47.4 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.304 1.552 . . . . 0.0 110.356 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.67 132.37 56.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.087 1.355 . . . . 0.0 109.877 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.6 mt -139.01 155.17 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 126.408 1.883 . . . . 0.0 108.478 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -137.96 111.01 7.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.028 1.331 . . . . 0.0 110.675 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.71 166.78 24.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.906 1.283 . . . . 0.0 111.659 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.3 p -88.24 160.14 17.82 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.942 0.877 . . . . 0.0 112.344 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -67.76 -3.8 10.47 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -103.29 -13.0 16.88 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.141 0.977 . . . . 0.0 112.58 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.45 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 11.0 t-80 -76.92 121.01 22.83 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 173.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -82.57 149.74 27.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.268 0.627 . . . . 0.0 109.776 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -132.06 143.82 50.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.523 -0.736 . . . . 0.0 109.737 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.4 ttp -75.22 104.43 5.79 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.074 0.55 . . . . 0.0 110.468 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.4 p -66.27 167.99 9.44 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.941 0.496 . . . . 0.0 111.683 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.3 m -55.07 -26.33 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -84.36 -13.17 53.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.273 1.029 . . . . 0.0 113.376 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.99 30.41 12.93 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.574 1.083 . . . . 0.0 113.557 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -98.75 147.24 25.08 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.241 1.02 . . . . 0.0 110.718 177.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.98 89.91 3.8 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.812 1.245 . . . . 0.0 109.871 176.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.1 mt -121.69 145.79 43.99 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.323 1.049 . . . . 0.0 110.438 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.68 147.48 81.58 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.092 2.528 . . . . 0.0 111.355 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.427 HG13 HD11 ' A' ' 105' ' ' ILE . 11.0 tt -58.0 -27.47 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -54.52 -38.42 66.51 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.583 1.153 . . . . 0.0 112.872 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -82.22 -34.72 28.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.283 0.633 . . . . 0.0 111.586 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.61 -39.21 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.6 -0.688 . . . . 0.0 110.368 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -63.96 -34.81 78.82 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -75.14 -44.77 45.08 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.524 -0.735 . . . . 0.0 112.669 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -76.33 -12.67 60.11 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 56.08 31.48 18.23 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.298 1.439 . . . . 0.0 112.108 -174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 69.5 mt -79.2 150.29 31.7 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.258 1.023 . . . . 0.0 111.586 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.98 155.78 17.32 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.617 0.767 . . . . 0.0 111.491 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt -84.47 159.36 20.77 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.414 -0.804 . . . . 0.0 112.623 168.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.6 ttp -86.52 155.74 20.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.795 1.238 . . . . 0.0 111.294 169.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.52 164.46 27.76 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.337 1.455 . . . . 0.0 112.04 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.6 m -93.02 -19.63 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -99.0 15.65 25.06 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.505 1.122 . . . . 0.0 113.088 -172.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.3 m120 55.57 32.91 20.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.868 1.667 . . . . 0.0 112.099 -173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.53 154.29 73.7 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.676 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.08 144.76 70.84 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.746 2.964 . . . . 0.0 111.26 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -79.79 116.87 20.2 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.681 -0.637 . . . . 0.0 110.635 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.4 pt -142.53 132.77 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.926 1.69 . . . . 0.0 111.261 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 175.72 6.97 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.889 1.676 . . . . 0.0 112.347 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.427 HD11 HG13 ' A' ' 84' ' ' ILE . 10.9 mt -63.66 112.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.197 1.399 . . . . 0.0 110.035 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.65 -43.62 62.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.993 0.917 . . . . 0.0 111.742 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 p -149.02 147.75 28.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.115 1.766 . . . . 0.0 110.056 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -140.6 142.16 35.08 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.415 1.486 . . . . 0.0 110.212 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -152.32 131.64 12.85 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.929 1.692 . . . . 0.0 108.951 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -61.69 121.21 12.26 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.947 0.339 . . . . 0.0 110.545 171.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.9 mt -88.39 -40.54 13.45 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 122.645 0.378 . . . . 0.0 111.721 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.04 -145.22 15.71 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.653 1.121 . . . . 0.0 112.261 -173.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -128.22 74.93 1.58 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 123.206 1.479 . . . . 0.0 113.401 -167.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -89.54 155.19 19.44 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.458 1.503 . . . . 0.0 109.908 -171.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.15 117.26 5.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.436 0.694 . . . . 0.0 109.851 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.63 154.25 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.422 0.63 . . . . 0.0 110.919 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.463 ' HB3' HG21 ' A' ' 22' ' ' VAL . 6.2 m-85 -140.94 157.38 45.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.669 1.588 . . . . 0.0 111.322 -170.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -156.93 117.12 3.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.755 1.222 . . . . 0.0 110.159 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.8 pt -71.46 155.44 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 121.028 -1.045 . . . . 0.0 111.205 172.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -107.07 152.38 16.89 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.494 1.045 . . . . 0.0 111.74 170.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 126.711 2.004 . . . . 0.0 110.108 -175.983 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 . . . . . 0 CA--C 1.545 0.769 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -172.55 157.13 3.83 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.052 1.741 . . . . 0.0 111.061 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.77 144.75 29.95 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.821 0.848 . . . . 0.0 112.461 173.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 28.9 mt -89.76 173.09 8.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.095 1.358 . . . . 0.0 112.188 171.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -48.62 -49.73 35.85 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.708 1.603 . . . . 0.0 114.561 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -73.38 -37.7 65.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.211 0.604 . . . . 0.0 111.652 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 139.68 -6.11 2.91 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.478 -1.179 . . . . 0.0 115.359 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -57.0 155.35 8.28 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.563 1.681 . . . . 0.0 112.619 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.58 110.81 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 122.033 0.921 . . . . 0.0 109.676 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.45 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -96.36 116.75 29.54 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.391 1.076 . . . . 0.0 108.64 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.2 m -109.56 79.87 1.26 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.377 1.071 . . . . 0.0 111.433 -173.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.3 t30 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 127.597 2.359 . . . . 0.0 115.997 -168.926 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.312 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.26 178.03 10.62 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.512 1.125 . . . . 0.0 112.653 -169.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.11 148.56 32.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.452 1.501 . . . . 0.0 110.652 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -62.41 161.39 11.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.644 0.777 . . . . 0.0 112.653 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -52.5 -47.01 66.86 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.889 . . . . 0.0 112.541 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -63.65 -20.45 65.7 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.266 1.827 . . . . 0.0 113.403 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.2 m -59.64 105.25 0.35 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.402 1.081 . . . . 0.0 110.862 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -86.23 129.81 34.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.363 0.601 . . . . 0.0 111.0 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.2 mm -113.49 124.95 70.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.075 1.35 . . . . 0.0 107.529 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.39 129.9 44.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.08 0.552 . . . . 0.0 110.899 171.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.8 p -133.02 148.68 52.24 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.296 1.438 . . . . 0.0 111.431 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.8 -31.3 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 122.071 -0.393 . . . . 0.0 111.892 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -64.83 -36.46 84.4 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -141.49 -44.76 0.36 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -172.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.17 -136.82 9.11 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.134 0.879 . . . . 0.0 112.347 -172.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.4 91.19 7.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.885 1.674 . . . . 0.0 111.823 -173.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -122.1 146.09 45.64 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.905 0.882 . . . . 0.0 112.638 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.76 125.33 13.59 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.367 3.378 . . . . 0.0 112.727 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.84 -37.36 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.965 0.906 . . . . 0.0 113.368 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.4 -32.39 79.23 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.559 -0.713 . . . . 0.0 113.097 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -71.88 -35.37 69.76 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 117.787 0.793 . . . . 0.0 111.602 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -67.5 -39.68 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.529 0.732 . . . . 0.0 109.709 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.03 -41.08 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.727 0.811 . . . . 0.0 112.471 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -76.35 -24.4 54.2 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.346 0.976 . . . . 0.0 113.339 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -104.67 -0.01 27.97 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.79 1.236 . . . . 0.0 112.854 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 48.29 49.57 17.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.655 1.982 . . . . 0.0 112.422 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.3 mt -68.61 121.02 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.179 0.992 . . . . 0.0 109.272 -174.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.39 107.77 11.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.439 1.095 . . . . 0.0 110.656 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.0 p -148.16 166.91 26.45 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.256 1.027 . . . . 0.0 113.466 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.5 148.29 23.89 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.433 1.493 . . . . 0.0 109.857 177.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 m -128.95 171.48 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.018 1.727 . . . . 0.0 110.924 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -115.4 140.09 49.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.462 1.505 . . . . 0.0 110.283 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 t -156.15 152.02 27.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.966 1.306 . . . . 0.0 110.672 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.52 128.31 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.199 0.6 . . . . 0.0 109.933 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -69.93 173.79 6.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.601 1.16 . . . . 0.0 111.807 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -62.22 -25.51 67.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.318 1.447 . . . . 0.0 113.328 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -86.23 -2.5 58.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.112 1.365 . . . . 0.0 113.398 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.08 22.52 60.9 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.603 1.097 . . . . 0.0 114.808 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -99.85 129.9 45.99 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.804 1.242 . . . . 0.0 109.991 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.1 mt -70.25 130.59 34.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -134.13 169.72 16.74 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.579 1.552 . . . . 0.0 110.938 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 p -119.55 140.87 49.83 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.956 0.902 . . . . 0.0 111.681 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -149.85 147.36 22.35 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.317 1.047 . . . . 0.0 112.423 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.05 149.91 47.45 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.117 2.545 . . . . 0.0 112.658 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -57.84 137.11 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.741 0.816 . . . . 0.0 110.409 168.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.16 -50.59 5.76 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.993 0.517 . . . . 0.0 111.42 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -149.97 173.55 13.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.029 1.731 . . . . 0.0 111.042 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -129.25 131.67 47.07 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.566 1.546 . . . . 0.0 108.994 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -130.06 138.81 50.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.202 1.001 . . . . 0.0 110.715 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.65 121.49 28.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.914 1.285 . . . . 0.0 110.801 -174.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -86.36 -34.0 20.36 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.216 1.006 . . . . 0.0 112.559 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.76 -44.93 2.71 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.253 1.406 . . . . 0.0 115.17 172.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -174.32 88.78 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 123.083 1.42 . . . . 0.0 114.568 -168.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -127.48 163.19 24.66 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.201 1.0 . . . . 0.0 112.91 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -67.73 103.53 1.43 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.062 1.345 . . . . 0.0 112.714 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -96.5 139.32 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.431 1.492 . . . . 0.0 110.991 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.436 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 75.5 m-85 -123.11 142.48 50.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.512 1.525 . . . . 0.0 109.976 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -65.88 131.26 45.84 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.733 0.813 . . . . 0.0 110.301 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -124.66 87.06 2.65 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.084 1.353 . . . . 0.0 108.439 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.2 t -95.28 146.71 24.16 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.97 0.908 . . . . 0.0 110.627 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.8 164.76 12.44 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.924 1.289 . . . . 0.0 112.368 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -66.86 -23.62 66.04 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.549 1.139 . . . . 0.0 113.284 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.56 -23.56 46.05 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.103 1.361 . . . . 0.0 112.961 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.55 0.68 30.86 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.756 1.17 . . . . 0.0 114.345 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.8 m -57.14 136.41 56.4 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.384 1.092 . . . . 0.0 110.558 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.92 122.78 38.34 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.753 1.221 . . . . 0.0 109.758 -172.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.1 mt -134.07 150.89 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.547 1.939 . . . . 0.0 107.86 -172.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 63.6 mtt85 -136.38 117.37 14.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.616 1.166 . . . . 0.0 109.864 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.6 163.5 38.34 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.518 1.127 . . . . 0.0 111.558 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 p -75.01 151.68 38.76 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.446 -0.784 . . . . 0.0 112.065 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -63.12 -17.22 62.09 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 176.445 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -86.42 -16.28 37.67 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.485 1.514 . . . . 0.0 113.33 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -74.46 135.36 42.29 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.176 0.59 . . . . 0.0 109.436 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 149.19 21.85 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.037 0.922 . . . . 0.0 112.174 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -134.26 127.25 31.46 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.428 -1.42 . . . . 0.0 110.182 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ttp -71.93 111.28 7.04 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.046 0.45 . . . . 0.0 111.084 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.6 p -70.37 171.94 9.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.057 0.543 . . . . 0.0 112.215 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -54.44 -27.2 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.1 -8.19 54.3 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.698 1.199 . . . . 0.0 113.133 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.82 1.09 63.67 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.962 1.267 . . . . 0.0 114.326 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.97 146.71 52.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.523 1.161 . . . . 0.0 111.212 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.2 mtm -117.87 76.55 1.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.31 1.444 . . . . 0.0 109.465 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.64 150.84 43.95 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.006 1.322 . . . . 0.0 110.979 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.34 148.92 80.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.977 2.451 . . . . 0.0 111.559 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 tt -55.66 -29.07 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -53.15 -37.51 61.9 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.643 1.177 . . . . 0.0 113.138 170.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -90.33 -32.83 16.32 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.584 1.153 . . . . 0.0 111.605 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.72 -38.33 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.389 -0.819 . . . . 0.0 111.191 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.64 -34.79 78.66 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.41 -45.98 51.35 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.46 -8.8 58.92 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 58.14 37.68 26.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.673 1.189 . . . . 0.0 111.549 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.5 mt -83.92 155.67 22.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.901 1.334 . . . . 0.0 112.162 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -110.92 155.42 22.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.764 2.426 . . . . 0.0 112.969 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.7 155.09 19.44 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.692 0.797 . . . . 0.0 112.444 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.4 ttp -74.99 138.46 42.25 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.711 173.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.85 157.51 27.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.996 1.318 . . . . 0.0 110.684 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.588 HG22 ' HA2' ' A' ' 132' ' ' GLY . 31.4 m -118.69 -4.18 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.99 13.42 25.07 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.683 1.593 . . . . 0.0 112.587 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 58.89 30.1 19.71 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.763 2.025 . . . . 0.0 112.466 -174.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.6 mt -88.85 155.77 50.01 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.21 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.55 154.32 64.7 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.841 3.027 . . . . 0.0 111.951 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.36 132.14 35.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.476 0.711 . . . . 0.0 110.339 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 pt -146.87 137.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.972 1.309 . . . . 0.0 111.489 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.87 175.98 9.96 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.991 1.317 . . . . 0.0 112.509 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.8 mt -62.17 111.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.081 1.353 . . . . 0.0 110.03 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.73 -45.18 83.62 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.131 0.972 . . . . 0.0 111.883 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 p -151.35 150.67 30.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.287 1.835 . . . . 0.0 110.555 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -133.05 142.87 49.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.725 1.61 . . . . 0.0 110.083 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -156.9 140.6 16.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.696 1.598 . . . . 0.0 109.865 175.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -66.84 128.64 37.08 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.876 -0.515 . . . . 0.0 111.127 172.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.78 -46.43 7.55 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.849 0.459 . . . . 0.0 111.691 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 147.53 -150.94 23.24 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.246 0.927 . . . . 0.0 112.778 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -122.18 79.59 1.61 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.932 1.349 . . . . 0.0 112.763 -168.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -98.36 157.93 15.89 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.793 1.637 . . . . 0.0 110.466 -169.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.57 120.8 13.04 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.633 0.773 . . . . 0.0 110.031 169.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.9 m -125.14 152.68 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.332 0.653 . . . . 0.0 111.182 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -140.93 156.49 46.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.159 1.384 . . . . 0.0 111.942 -168.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -152.4 130.91 12.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.671 1.189 . . . . 0.0 110.8 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.8 pt -91.59 154.11 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.74 173.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.06 159.76 13.91 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.906 1.241 . . . . 0.0 111.44 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 124.717 1.207 . . . . 0.0 109.649 -172.571 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 p30 . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -165.13 167.12 18.52 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.054 1.342 . . . . 0.0 112.297 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.38 131.02 40.46 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.622 1.169 . . . . 0.0 112.461 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 32.6 mt -70.33 166.9 19.25 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.304 1.441 . . . . 0.0 111.678 169.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -48.94 -34.59 13.16 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.49 -6.87 24.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.394 1.078 . . . . 0.0 112.526 -172.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . 124.17 -17.59 7.52 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.962 1.267 . . . . 0.0 115.261 171.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -64.32 154.46 35.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.832 1.316 . . . . 0.0 112.697 -174.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.5 mm -104.47 140.31 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.434 1.015 . . . . 0.0 111.012 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.96 140.38 53.04 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.394 1.878 . . . . 0.0 109.418 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.0 t -138.74 124.91 20.19 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.118 1.367 . . . . 0.0 112.383 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.9 t30 . . . . . 0 C--O 1.255 1.384 0 C-N-CA 126.446 1.898 . . . . 0.0 113.991 -168.169 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.404 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -159.54 173.34 16.29 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.715 0.757 . . . . 0.0 112.671 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.61 146.95 38.94 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.844 1.258 . . . . 0.0 110.771 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -65.2 164.1 13.9 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -50.97 -43.73 60.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.4 -19.73 64.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.692 1.197 . . . . 0.0 112.846 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 m -63.67 108.24 1.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.203 1.401 . . . . 0.0 111.133 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -86.47 128.12 34.93 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.116 0.484 . . . . 0.0 110.431 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.8 mm -99.58 122.3 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.396 1.479 . . . . 0.0 107.295 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.2 tp -69.91 122.61 19.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.2 p -125.9 152.11 46.01 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.9 0.88 . . . . 0.0 112.652 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -71.37 -34.05 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.876 0.47 . . . . 0.0 111.942 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -67.74 -32.72 73.53 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -141.78 -48.5 0.38 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.26 -151.39 19.87 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.172 0.892 . . . . 0.0 111.541 -172.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.87 108.49 1.49 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.352 1.061 . . . . 0.0 111.181 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.4 mt -132.23 147.76 67.05 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.74 1.216 . . . . 0.0 112.871 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.93 123.88 11.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.957 3.104 . . . . 0.0 112.212 -177.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 tt -55.21 -36.82 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.77 -33.73 88.01 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.797 -0.564 . . . . 0.0 113.018 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -77.36 -33.64 55.28 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.684 0.794 . . . . 0.0 112.042 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.7 mt -65.69 -38.85 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.141 0.976 . . . . 0.0 109.664 173.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.0 t -78.15 -38.32 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.366 1.067 . . . . 0.0 112.756 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 -25.48 46.64 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.26 0.936 . . . . 0.0 113.467 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -100.91 -2.59 31.54 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.722 1.209 . . . . 0.0 113.23 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 50.11 49.47 20.35 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.475 1.91 . . . . 0.0 112.339 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.4 mt -71.02 121.51 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.23 1.012 . . . . 0.0 109.591 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -74.81 114.03 12.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.409 0.623 . . . . 0.0 110.725 172.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.9 p -143.72 171.67 13.88 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.068 1.347 . . . . 0.0 112.278 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 m -112.83 150.13 32.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.909 1.284 . . . . 0.0 109.035 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.6 m -125.37 178.42 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.053 1.341 . . . . 0.0 111.222 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.83 141.27 49.68 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.841 1.256 . . . . 0.0 110.538 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.42 153.21 15.22 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.14 1.776 . . . . 0.0 109.185 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.5 m -89.09 143.7 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.442 1.019 . . . . 0.0 111.973 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.56 177.57 7.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.495 1.118 . . . . 0.0 111.395 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -62.8 -17.56 61.36 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.887 1.275 . . . . 0.0 113.04 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -95.16 -0.03 53.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.06 1.744 . . . . 0.0 113.133 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.66 35.65 40.08 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 121.33 -0.856 . . . . 0.0 114.147 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -119.31 123.23 43.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.455 1.502 . . . . 0.0 109.71 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -64.08 117.55 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -120.7 167.62 12.27 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.502 1.521 . . . . 0.0 111.669 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.1 p -115.6 137.96 51.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.282 1.033 . . . . 0.0 111.468 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -146.19 140.35 15.38 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.509 1.124 . . . . 0.0 111.412 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.19 148.94 40.02 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.863 2.375 . . . . 0.0 112.027 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.5 147.94 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.504 1.122 . . . . 0.0 111.114 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.17 -42.27 3.76 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.28 1.032 . . . . 0.0 112.237 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -142.6 178.44 7.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.896 1.679 . . . . 0.0 111.656 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -138.08 125.07 21.33 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.244 1.418 . . . . 0.0 109.117 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -118.57 137.82 52.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.345 1.058 . . . . 0.0 110.73 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.82 123.05 34.23 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.248 1.419 . . . . 0.0 110.61 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -89.72 -29.51 18.68 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.508 1.123 . . . . 0.0 112.77 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.58 -58.95 4.84 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.667 1.603 . . . . 0.0 114.002 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -158.92 98.83 1.5 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.77 1.228 . . . . 0.0 112.853 -168.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -133.03 163.13 29.92 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.336 1.054 . . . . 0.0 112.248 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.5 105.97 1.64 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.612 1.165 . . . . 0.0 113.246 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.42 137.44 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.0 0.92 . . . . 0.0 111.54 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -122.61 141.8 51.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.428 1.091 . . . . 0.0 110.849 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -85.84 96.08 9.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.93 1.692 . . . . 0.0 111.009 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -79.09 108.11 12.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.591 0.757 . . . . 0.0 109.418 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.0 t -88.63 132.55 34.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.361 1.064 . . . . 0.0 110.439 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tp -90.06 168.95 11.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.851 1.261 . . . . 0.0 112.628 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.5 -24.96 66.48 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.94 -27.23 36.17 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.482 1.513 . . . . 0.0 113.019 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.38 0.62 31.14 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.428 1.014 . . . . 0.0 114.13 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.0 m -65.36 141.18 58.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.667 1.234 . . . . 0.0 110.628 169.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 mp -119.62 141.02 49.69 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.256 1.422 . . . . 0.0 110.052 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -136.77 136.85 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.731 1.612 . . . . 0.0 108.398 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -123.96 103.3 8.24 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.134 0.974 . . . . 0.0 110.161 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.69 165.07 29.83 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.376 1.084 . . . . 0.0 111.828 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.9 p -78.4 149.2 33.37 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.464 1.106 . . . . 0.0 111.081 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -62.71 -12.78 25.91 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -91.63 -15.44 28.55 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.145 1.778 . . . . 0.0 112.527 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.475 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 2.7 t-80 -78.04 134.54 37.76 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -87.49 160.13 18.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.362 0.665 . . . . 0.0 111.696 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -140.52 140.06 35.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.759 0.823 . . . . 0.0 110.501 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 44.1 ttm -74.01 108.76 7.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.389 1.075 . . . . 0.0 111.604 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.0 p -67.17 172.62 4.49 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -56.39 -23.18 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -98.01 -8.29 28.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.193 1.397 . . . . 0.0 113.165 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.14 1.49 48.16 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.065 1.317 . . . . 0.0 115.094 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -66.32 139.24 58.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.963 1.382 . . . . 0.0 111.44 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.73 76.05 1.77 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.221 1.408 . . . . 0.0 110.956 174.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.3 mt -102.4 147.63 34.27 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 124.165 0.986 . . . . 0.0 110.458 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -64.07 145.92 90.21 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.062 2.508 . . . . 0.0 110.989 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.1 tt -56.69 -28.36 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.82 -30.32 68.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.868 1.267 . . . . 0.0 113.416 172.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.42 -41.09 13.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.682 1.193 . . . . 0.0 111.155 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.52 HD13 HD21 ' A' ' 94' ' ' LEU . 67.2 mt -58.34 -41.21 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.514 1.126 . . . . 0.0 111.789 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -59.68 -33.19 71.26 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.234 1.014 . . . . 0.0 113.165 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -78.48 -46.92 18.51 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -13.73 62.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 56.01 35.36 25.43 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.711 1.604 . . . . 0.0 112.223 -175.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.2 mt -79.72 147.19 32.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.823 0.82 . . . . 0.0 111.373 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.45 172.33 13.16 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.697 0.761 . . . . 0.0 110.846 171.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.52 HD21 HD13 ' A' ' 87' ' ' ILE . 92.6 mt -116.2 157.51 24.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.342 1.057 . . . . 0.0 111.137 177.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.5 ttm -60.01 158.26 11.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.654 0.782 . . . . 0.0 111.809 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -127.13 163.23 24.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.096 1.758 . . . . 0.0 111.832 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.44 -26.43 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 125.006 1.322 . . . . 0.0 114.045 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -106.09 15.15 26.8 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.55 1.54 . . . . 0.0 112.288 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.4 m120 56.93 34.42 24.83 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 123.473 1.606 . . . . 0.0 112.493 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.94 159.64 84.85 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 112.676 -2.056 . . . . 0.0 111.375 170.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.19 134.3 31.11 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.094 2.529 . . . . 0.0 111.361 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -72.27 122.88 21.86 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.897 0.879 . . . . 0.0 109.893 172.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.6 pt -146.47 142.06 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.38 1.072 . . . . 0.0 111.49 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 171.29 14.76 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.268 1.827 . . . . 0.0 112.997 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.34 109.25 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.236 1.015 . . . . 0.0 109.489 172.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.93 70.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.413 1.085 . . . . 0.0 112.149 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -152.5 167.99 27.0 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.996 1.719 . . . . 0.0 111.268 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -137.36 146.39 44.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.321 1.448 . . . . 0.0 110.677 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -139.39 120.26 14.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.582 1.153 . . . . 0.0 109.957 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -64.04 123.12 18.2 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.94 -0.475 . . . . 0.0 110.303 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 41.4 mt -90.39 -42.96 10.62 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.372 0.269 . . . . 0.0 111.688 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.83 -131.85 4.97 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.853 0.74 . . . . 0.0 112.92 -174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -131.26 72.43 1.5 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.661 1.584 . . . . 0.0 113.101 -167.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -94.41 160.86 14.47 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.831 1.653 . . . . 0.0 111.421 -170.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.05 120.67 12.47 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.519 0.728 . . . . 0.0 111.344 169.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.07 151.99 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.491 0.716 . . . . 0.0 110.635 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -143.67 162.0 37.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.393 -168.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -155.73 120.38 4.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.027 0.931 . . . . 0.0 110.142 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.1 pt -80.4 137.27 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.727 -1.233 . . . . 0.0 111.64 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.02 134.21 12.23 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.022 0.82 . . . . 0.0 111.152 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.471 0.594 0 C-N-CA 124.026 0.93 . . . . 0.0 110.553 -178.554 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 CA--C 1.551 1.01 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -160.53 157.37 27.35 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.116 0.967 . . . . 0.0 112.149 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.05 149.48 44.84 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.64 1.176 . . . . 0.0 113.112 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.7 mt -134.93 174.68 10.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.123 2.169 . . . . 0.0 111.241 -172.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.97 146.99 4.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.246 1.018 . . . . 0.0 111.704 168.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 50.22 23.04 1.07 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.161 1.384 . . . . 0.0 114.451 -173.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.59 25.9 66.62 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 120.861 -1.149 . . . . 0.0 115.636 172.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.403 ' C ' HD12 ' A' ' 134' ' ' ILE . 16.1 m-85 -75.13 155.31 37.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.961 1.381 . . . . 0.0 112.174 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 133' ' ' PHE . 2.9 mp -129.06 103.06 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.475 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -86.67 148.1 25.6 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 170.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.3 t -132.84 147.43 52.3 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.912 1.685 . . . . 0.0 111.086 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 C--O 1.251 1.176 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.079 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.845 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -155.48 170.68 21.39 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.866 0.867 . . . . 0.0 112.11 -169.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -111.99 144.42 41.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.099 1.359 . . . . 0.0 110.029 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -67.94 159.77 29.92 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.65 -0.656 . . . . 0.0 111.868 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -48.47 -43.96 35.16 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.415 1.086 . . . . 0.0 112.761 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -13.42 29.83 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.7 m -70.51 112.35 6.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.528 1.131 . . . . 0.0 110.275 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -91.57 136.02 33.43 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.36 0.6 . . . . 0.0 111.54 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 mm -113.18 123.65 69.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 126.156 1.783 . . . . 0.0 107.512 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -62.37 129.69 41.86 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.371 0.668 . . . . 0.0 110.613 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.6 p -132.31 145.81 51.54 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.934 1.294 . . . . 0.0 111.269 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 t -75.21 -32.67 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.497 -0.752 . . . . 0.0 111.683 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -61.93 -32.56 72.97 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -142.75 -53.39 0.4 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -174.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.37 -144.25 15.9 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.181 0.896 . . . . 0.0 112.196 -171.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 mt -72.77 105.07 4.19 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.254 1.822 . . . . 0.0 111.013 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.0 mt -134.54 147.28 62.68 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.332 1.053 . . . . 0.0 113.744 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.44 127.94 19.22 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.062 3.175 . . . . 0.0 112.468 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.9 tt -55.57 -37.74 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.953 0.901 . . . . 0.0 112.859 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.35 -35.19 91.66 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.63 -0.539 . . . . 0.0 112.393 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -71.31 -33.38 69.64 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.485 1.143 . . . . 0.0 111.9 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.36 -41.82 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.584 0.754 . . . . 0.0 110.308 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.68 -42.83 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.76 0.709 . . . . 0.0 112.566 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -65.98 -29.08 69.41 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.057 0.844 . . . . 0.0 112.3 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -113.15 3.95 16.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.603 1.161 . . . . 0.0 113.484 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 48.3 50.53 16.35 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.931 2.092 . . . . 0.0 112.274 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.9 mt -68.86 117.99 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.119 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -74.23 97.81 3.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.375 1.07 . . . . 0.0 110.131 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.4 p -138.03 164.87 28.0 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.38 1.086 . . . . 0.0 113.195 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.49 154.94 17.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.523 1.529 . . . . 0.0 110.449 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.27 178.77 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.076 1.75 . . . . 0.0 110.756 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -126.18 134.68 51.2 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.511 1.524 . . . . 0.0 110.368 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -161.19 155.44 22.83 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.147 0.979 . . . . 0.0 112.068 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.8 m -79.38 146.89 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.634 1.106 . . . . 0.0 113.19 172.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.9 p30 -83.3 -178.81 7.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.174 0.99 . . . . 0.0 112.398 169.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -55.21 -31.55 61.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.495 1.118 . . . . 0.0 113.584 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -85.16 -10.13 57.06 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.723 0.809 . . . . 0.0 112.571 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.43 21.27 27.37 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.859 1.695 . . . . 0.0 114.678 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -101.9 123.29 45.57 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.193 1.496 . . . . 0.0 109.945 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.7 113.49 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.455 0.57 . . . . 0.0 109.734 177.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -116.87 177.18 4.8 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.882 2.073 . . . . 0.0 111.477 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -124.18 142.46 51.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.227 1.011 . . . . 0.0 112.832 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -154.37 152.77 26.94 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.346 1.059 . . . . 0.0 112.74 -176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.22 153.5 66.77 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.105 2.536 . . . . 0.0 112.992 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.79 140.8 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.713 1.205 . . . . 0.0 110.363 168.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.0 -52.44 5.08 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.924 -0.485 . . . . 0.0 111.333 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -150.99 177.87 9.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.153 1.781 . . . . 0.0 111.132 -175.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -135.7 137.32 41.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.069 1.348 . . . . 0.0 110.406 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -134.0 131.83 39.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.092 0.957 . . . . 0.0 111.862 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -111.71 140.8 46.03 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.591 1.556 . . . . 0.0 108.919 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -106.84 -36.32 6.7 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.79 -54.65 1.66 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.338 1.447 . . . . 0.0 113.791 175.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -169.79 104.7 0.33 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.92 1.36 . . . . 0.0 111.098 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -132.54 158.85 41.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.887 0.875 . . . . 0.0 112.896 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.92 98.55 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.427 1.491 . . . . 0.0 114.062 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.0 142.8 12.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.498 1.519 . . . . 0.0 111.593 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -128.08 135.97 50.56 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.654 1.582 . . . . 0.0 109.708 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.2 134.21 56.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.362 0.665 . . . . 0.0 110.474 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.86 96.94 4.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.694 1.197 . . . . 0.0 108.523 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 34.2 t -106.28 145.18 31.95 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.228 1.011 . . . . 0.0 110.597 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -107.93 164.56 12.16 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.625 1.17 . . . . 0.0 112.917 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -67.87 -21.54 65.16 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -80.27 -23.27 40.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.851 1.26 . . . . 0.0 113.044 172.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.02 -3.85 22.5 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.193 1.378 . . . . 0.0 114.597 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -57.0 139.17 53.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.749 1.274 . . . . 0.0 111.122 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.55 125.76 40.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.656 1.183 . . . . 0.0 109.899 -174.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.2 mt -136.21 150.7 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 108.382 -170.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -135.39 112.01 10.0 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.662 1.185 . . . . 0.0 111.316 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.14 20.83 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.626 1.571 . . . . 0.0 111.188 -175.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.9 p -84.56 161.71 20.09 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.495 -0.753 . . . . 0.0 112.077 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -67.91 -8.26 35.29 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 173.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -100.32 -12.98 19.01 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.301 1.44 . . . . 0.0 112.167 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -77.73 131.86 37.86 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 172.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -88.37 164.44 15.53 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.704 0.764 . . . . 0.0 111.308 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -138.36 135.45 35.36 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.414 0.686 . . . . 0.0 109.151 175.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.9 ttp -74.18 102.0 4.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.827 1.251 . . . . 0.0 109.6 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.6 p -64.23 172.74 2.3 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.755 1.222 . . . . 0.0 112.335 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.74 -28.91 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.4 -10.07 58.65 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.277 1.031 . . . . 0.0 113.593 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.73 -0.07 79.35 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.7 1.143 . . . . 0.0 113.954 -175.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -68.46 129.03 38.72 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.669 1.235 . . . . 0.0 109.49 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -96.25 88.42 4.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.271 1.428 . . . . 0.0 109.821 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.6 mt -115.4 147.19 38.14 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.394 1.077 . . . . 0.0 110.594 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.71 147.2 89.75 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.225 2.616 . . . . 0.0 111.323 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.11 -26.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.21 -37.88 70.25 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.591 1.156 . . . . 0.0 112.733 169.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -80.48 -39.68 27.57 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.247 0.619 . . . . 0.0 110.571 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.05 -36.7 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.26 -0.9 . . . . 0.0 111.346 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -66.49 -35.84 81.27 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.4 -36.92 28.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.716 0.806 . . . . 0.0 112.927 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -75.87 -17.98 59.6 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.573 1.149 . . . . 0.0 112.896 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 55.48 37.78 29.36 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.305 1.442 . . . . 0.0 112.63 -173.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.8 mt -82.69 146.82 28.84 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.93 0.892 . . . . 0.0 112.919 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.14 158.67 18.48 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.47 1.108 . . . . 0.0 112.049 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.7 mt -103.1 149.38 24.66 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 33.3 ttm -70.95 153.29 42.79 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 111.624 171.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -141.18 160.66 39.63 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.563 1.945 . . . . 0.0 112.539 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' HA2' ' A' ' 132' ' ' GLY . 10.0 p -101.11 -26.21 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 126.019 1.728 . . . . 0.0 113.567 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.68 5.29 9.57 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.29 1.436 . . . . 0.0 113.541 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 57.34 27.12 13.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.324 1.849 . . . . 0.0 112.344 -172.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 mt -70.97 155.52 93.26 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.416 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.07 147.65 84.47 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.234 2.622 . . . . 0.0 110.985 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -91.98 125.73 36.79 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.68 -0.638 . . . . 0.0 109.517 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -143.0 139.38 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.144 1.378 . . . . 0.0 111.454 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 173.5 11.86 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.59 1.556 . . . . 0.0 112.891 176.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.8 mt -64.39 118.79 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.348 1.459 . . . . 0.0 110.461 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.24 -44.56 65.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.333 1.053 . . . . 0.0 111.99 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -149.81 147.41 27.95 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.794 1.637 . . . . 0.0 111.137 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -140.27 142.08 35.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.139 1.776 . . . . 0.0 110.061 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -154.76 149.34 26.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.871 2.068 . . . . 0.0 110.566 170.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.14 130.77 45.27 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.751 0.42 . . . . 0.0 109.872 168.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.4 mt -103.2 -52.72 2.97 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.692 0.797 . . . . 0.0 110.857 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 167.19 -141.35 6.84 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 120.961 0.2 . . . . 0.0 113.263 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -131.41 64.6 1.58 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.188 1.47 . . . . 0.0 111.829 -168.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -85.18 158.86 20.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.805 2.042 . . . . 0.0 112.554 -167.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 114.11 4.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.063 0.945 . . . . 0.0 111.109 172.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.91 152.96 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.908 0.883 . . . . 0.0 110.314 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -143.19 158.8 43.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.858 1.663 . . . . 0.0 111.06 -170.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -153.03 134.36 14.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.016 0.927 . . . . 0.0 111.338 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.5 pt -89.99 155.14 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 121.426 -0.797 . . . . 0.0 111.133 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.88 153.37 16.99 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.02 1.295 . . . . 0.0 111.245 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.476 0.865 0 C-N-CA 125.488 1.515 . . . . 0.0 108.984 -172.586 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -174.54 154.72 2.11 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.985 1.314 . . . . 0.0 111.573 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.95 124.15 28.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.788 0.835 . . . . 0.0 112.088 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.51 173.52 5.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.688 1.195 . . . . 0.0 111.139 169.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -45.84 -42.59 12.56 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -91.35 -6.45 52.97 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.648 1.179 . . . . 0.0 113.409 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.524 ' HA2' HG12 ' A' ' 97' ' ' VAL . . . 115.95 -13.79 16.96 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 117.761 -1.577 . . . . 0.0 115.557 173.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -54.45 142.81 25.93 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.079 1.439 . . . . 0.0 112.23 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.76 92.22 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.871 0.843 . . . . 0.0 109.276 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.5 141.37 51.97 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.6 t -138.69 133.79 32.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.007 1.323 . . . . 0.0 110.973 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 C--O 1.254 1.302 0 C-N-CA 124.183 0.993 . . . . 0.0 113.493 -171.445 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.095 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -164.6 177.31 8.17 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.038 0.935 . . . . 0.0 113.354 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.473 HD13 HG21 ' A' ' 6' ' ' THR . 25.4 mt -122.3 151.01 41.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.673 1.989 . . . . 0.0 110.166 -171.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -66.29 159.93 25.58 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.633 -0.667 . . . . 0.0 112.246 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -50.49 -44.74 56.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.464 1.106 . . . . 0.0 112.956 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -64.15 -10.88 25.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.231 1.412 . . . . 0.0 114.163 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.473 HG21 HD13 ' A' ' 2' ' ' LEU . 26.7 m -66.79 94.81 0.33 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.324 1.449 . . . . 0.0 111.523 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -73.45 136.05 44.2 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.282 0.563 . . . . 0.0 111.965 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.3 mm -117.89 122.68 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.099 1.759 . . . . 0.0 107.407 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.6 tp -64.65 124.51 22.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.518 0.727 . . . . 0.0 110.696 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.7 p -125.89 156.12 40.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.683 1.193 . . . . 0.0 112.299 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.97 -31.43 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.076 0.55 . . . . 0.0 111.713 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.49 -34.87 78.72 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -141.22 -50.87 0.43 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.49 -145.14 17.19 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.682 0.673 . . . . 0.0 111.954 -172.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.9 mt -70.79 106.98 3.77 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.288 1.035 . . . . 0.0 111.091 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.8 mt -133.95 149.46 71.76 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.802 1.241 . . . . 0.0 112.697 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.05 128.15 20.03 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.06 3.173 . . . . 0.0 112.196 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 tt -54.63 -36.31 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.812 0.845 . . . . 0.0 112.755 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.97 -35.51 91.98 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 119.306 -0.719 . . . . 0.0 113.004 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -70.84 -34.08 71.31 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.785 1.292 . . . . 0.0 111.745 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.3 mt -69.49 -38.88 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.048 0.939 . . . . 0.0 110.169 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.2 t -83.75 -36.84 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.035 0.934 . . . . 0.0 113.154 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -66.98 -26.35 66.77 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.865 0.757 . . . . 0.0 112.67 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -115.61 1.48 13.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.637 1.175 . . . . 0.0 113.471 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 47.15 53.28 10.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.148 2.179 . . . . 0.0 112.476 -177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.16 115.13 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.491 0.716 . . . . 0.0 109.3 -173.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.15 108.49 3.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.441 1.096 . . . . 0.0 110.27 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.7 p -147.23 168.13 22.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.391 1.076 . . . . 0.0 112.57 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.56 148.97 25.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.656 1.582 . . . . 0.0 108.931 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.88 161.78 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.447 1.499 . . . . 0.0 110.702 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -100.17 153.26 19.4 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.418 1.087 . . . . 0.0 110.512 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.8 t -168.51 146.95 4.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.712 1.205 . . . . 0.0 111.505 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -75.23 130.36 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.127 1.371 . . . . 0.0 112.56 169.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -85.1 179.33 7.28 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.738 0.815 . . . . 0.0 111.748 171.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -57.7 -21.61 41.54 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.856 1.263 . . . . 0.0 113.43 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.76 -13.56 57.59 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.089 1.355 . . . . 0.0 113.242 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.06 4.46 89.9 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.078 1.323 . . . . 0.0 115.084 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -91.34 131.87 36.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.224 1.012 . . . . 0.0 109.787 175.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -69.91 123.82 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.504 0.722 . . . . 0.0 109.554 172.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -120.57 172.15 8.05 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.894 1.678 . . . . 0.0 110.708 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 p -121.47 139.11 53.9 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.072 0.949 . . . . 0.0 112.254 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.75 147.03 34.0 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.797 1.239 . . . . 0.0 112.946 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.3 150.18 52.39 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.118 2.546 . . . . 0.0 112.593 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.81 141.9 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.069 0.948 . . . . 0.0 111.148 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.69 -32.76 11.24 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.641 0.776 . . . . 0.0 112.611 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -170.45 179.33 3.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.316 1.847 . . . . 0.0 111.929 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -136.11 122.8 21.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.018 1.327 . . . . 0.0 109.554 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -109.43 118.42 36.59 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.682 1.193 . . . . 0.0 110.773 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.27 114.68 28.33 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.304 1.442 . . . . 0.0 109.958 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -83.33 -30.53 27.42 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.067 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.11 -44.27 2.82 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.629 1.585 . . . . 0.0 113.538 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 178.81 100.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.429 1.109 . . . . 0.0 113.073 -171.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -129.12 163.97 24.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.527 1.131 . . . . 0.0 113.415 173.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -63.27 100.41 0.24 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.994 1.718 . . . . 0.0 113.154 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.2 t -90.92 137.31 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.027 1.331 . . . . 0.0 111.21 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -120.78 136.7 54.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.44 1.496 . . . . 0.0 109.407 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.06 125.84 25.37 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.85 0.86 . . . . 0.0 110.178 172.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -117.46 99.19 6.83 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.019 1.327 . . . . 0.0 108.032 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.6 t -110.01 147.24 33.9 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.855 0.862 . . . . 0.0 110.674 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.91 164.31 12.71 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.21 1.404 . . . . 0.0 112.429 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -67.47 -24.01 65.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.991 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.96 -25.24 37.49 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.814 1.246 . . . . 0.0 113.272 174.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.07 -7.37 11.81 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.072 1.32 . . . . 0.0 114.75 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -55.47 143.53 28.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.766 1.283 . . . . 0.0 111.542 175.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.47 124.3 31.69 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.535 1.134 . . . . 0.0 110.203 -173.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 43.8 mt -135.11 151.88 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 127.121 2.168 . . . . 0.0 108.225 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -136.59 113.04 9.99 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.575 1.15 . . . . 0.0 110.552 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.89 166.34 25.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.849 1.26 . . . . 0.0 111.967 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 p -83.73 152.11 24.88 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.75 0.82 . . . . 0.0 111.354 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -61.46 -15.17 34.89 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 175.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -89.32 -16.76 30.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.885 1.674 . . . . 0.0 112.246 -176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -80.17 131.5 35.73 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -89.15 156.92 18.5 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.271 0.558 . . . . 0.0 111.444 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -135.93 141.03 44.46 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.657 0.783 . . . . 0.0 109.271 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 46.7 ttm -68.83 108.38 3.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.946 0.898 . . . . 0.0 110.124 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.6 p -70.81 169.84 13.77 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.776 -0.578 . . . . 0.0 112.026 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.4 m -54.56 -23.94 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 174.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -87.63 -7.25 57.7 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.024 . . . . 0.0 113.317 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.45 7.16 65.44 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.402 1.477 . . . . 0.0 113.939 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -79.95 126.64 31.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.228 1.014 . . . . 0.0 110.346 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.28 92.22 6.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.3 1.04 . . . . 0.0 110.433 169.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.7 mt -116.77 146.3 37.41 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.95 0.9 . . . . 0.0 110.978 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.13 146.46 86.91 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.226 2.617 . . . . 0.0 111.061 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.426 HG13 HD11 ' A' ' 105' ' ' ILE . 12.8 tt -59.05 -27.74 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -55.9 -35.55 66.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.531 1.132 . . . . 0.0 113.109 169.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -85.03 -34.71 22.26 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.895 -0.503 . . . . 0.0 111.405 175.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.55 -39.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 119.385 0.993 . . . . 0.0 110.762 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -64.69 -39.16 93.18 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -76.74 -39.35 52.07 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -78.12 -13.15 59.98 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 56.87 30.11 17.32 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.785 1.234 . . . . 0.0 112.151 -174.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.41 142.95 46.93 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.996 0.918 . . . . 0.0 111.302 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -90.78 135.37 33.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.071 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.413 ' HB2' HH12 ' A' ' 96' ' ' ARG . 9.7 mp -66.42 150.78 48.4 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.059 -1.026 . . . . 0.0 111.141 168.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.8 ttp -72.66 172.37 10.79 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.326 0.584 . . . . 0.0 111.791 171.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.413 HH12 ' HB2' ' A' ' 94' ' ' LEU . 87.6 mmt-85 -137.12 164.05 29.35 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.729 1.612 . . . . 0.0 111.433 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 m -106.8 -22.75 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -107.35 21.6 17.25 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.962 1.305 . . . . 0.0 112.386 -172.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 56.08 29.42 14.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.776 1.63 . . . . 0.0 112.454 -172.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.6 mt -63.35 159.26 51.26 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.921 171.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.92 143.99 56.95 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.249 2.633 . . . . 0.0 111.426 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.98 121.23 31.87 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.752 0.821 . . . . 0.0 109.015 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.4 pt -142.22 122.47 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.732 1.213 . . . . 0.0 110.738 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -67.34 170.52 7.17 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.285 1.834 . . . . 0.0 112.962 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.426 HD11 HG13 ' A' ' 84' ' ' ILE . 6.7 mt -61.58 120.1 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.306 1.442 . . . . 0.0 110.194 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.96 -47.29 66.0 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.718 0.807 . . . . 0.0 111.614 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 p -152.29 151.88 31.47 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.351 1.46 . . . . 0.0 111.001 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.65 141.79 48.8 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.057 1.743 . . . . 0.0 110.048 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 134.55 15.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.484 1.913 . . . . 0.0 109.484 177.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -65.1 133.81 52.43 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.081 0.152 . . . . 0.0 110.755 170.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.2 mt -100.97 -42.65 6.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.009 0.524 . . . . 0.0 112.009 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.49 -149.94 21.71 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.665 1.126 . . . . 0.0 111.798 -173.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -123.27 100.16 6.71 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.542 1.137 . . . . 0.0 111.458 -170.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -115.13 155.22 27.5 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.253 1.421 . . . . 0.0 109.88 -171.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.13 116.78 6.27 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.305 0.642 . . . . 0.0 110.144 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.14 150.94 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.396 0.678 . . . . 0.0 110.887 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -139.29 156.15 47.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.305 1.442 . . . . 0.0 111.743 -170.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -157.5 121.35 4.17 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.814 1.245 . . . . 0.0 110.071 -173.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.7 pt -80.52 143.73 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 120.706 -1.246 . . . . 0.0 111.523 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.71 153.97 20.51 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.902 0.763 . . . . 0.0 111.799 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 125.216 1.406 . . . . 0.0 109.739 -173.182 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -166.28 150.86 7.89 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.222 1.409 . . . . 0.0 110.817 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.39 142.16 30.34 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.842 0.857 . . . . 0.0 112.309 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.3 mt -102.16 171.21 7.62 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.675 1.19 . . . . 0.0 112.054 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -19.33 8.28 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -103.74 11.18 36.21 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.516 1.526 . . . . 0.0 112.958 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.04 21.52 75.92 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 121.336 -0.852 . . . . 0.0 113.844 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.41 ' C ' HD12 ' A' ' 134' ' ' ILE . 3.1 m-85 -87.39 163.72 16.61 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.644 1.578 . . . . 0.0 111.985 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.41 HD12 ' C ' ' A' ' 133' ' ' PHE . 3.3 mp -133.01 100.81 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.746 1.218 . . . . 0.0 108.948 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.98 149.68 26.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.9 t -140.83 141.09 34.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.379 0.672 . . . . 0.0 112.477 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.919 1.287 . . . . 0.0 113.097 -173.498 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 CA-C-O 121.134 0.297 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.92 177.91 9.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.445 1.498 . . . . 0.0 112.14 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.99 144.33 44.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.982 1.713 . . . . 0.0 110.383 -172.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -68.86 163.67 23.77 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.633 -0.667 . . . . 0.0 112.441 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -50.83 -42.86 58.82 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.642 -0.661 . . . . 0.0 112.411 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -65.73 -13.95 60.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.814 1.246 . . . . 0.0 114.116 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.2 m -71.0 120.39 16.5 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.515 0.726 . . . . 0.0 110.725 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -102.27 138.38 39.29 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.495 0.664 . . . . 0.0 111.633 -176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.15 116.66 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 126.198 1.799 . . . . 0.0 107.585 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tt -63.12 124.49 21.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.706 0.402 . . . . 0.0 111.19 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.3 p -118.53 155.84 30.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.85 1.26 . . . . 0.0 112.144 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.8 -35.72 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.789 0.836 . . . . 0.0 111.14 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -67.36 -32.42 73.35 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -140.13 -50.29 0.47 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.53 -143.91 15.71 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.147 0.879 . . . . 0.0 112.656 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.36 96.14 0.65 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.381 1.872 . . . . 0.0 112.846 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -129.87 149.63 73.62 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.844 1.258 . . . . 0.0 112.591 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.68 130.26 23.01 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.404 3.403 . . . . 0.0 113.127 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 tt -57.44 -37.59 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.002 0.921 . . . . 0.0 112.922 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.36 -31.34 78.65 Favored Glycine 0 CA--C 1.529 0.917 0 O-C-N 121.718 -0.614 . . . . 0.0 112.846 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -72.06 -38.68 69.43 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.094 0.947 . . . . 0.0 111.317 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.73 -39.34 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.619 0.767 . . . . 0.0 109.76 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.5 t -80.99 -38.92 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.874 0.87 . . . . 0.0 112.938 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.72 -23.94 56.14 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.74 1.155 . . . . 0.0 113.297 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -108.58 2.02 21.8 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.202 1.401 . . . . 0.0 112.12 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.89 52.12 11.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.32 2.248 . . . . 0.0 113.04 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.6 mt -76.35 122.4 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.964 0.906 . . . . 0.0 110.055 -170.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.77 96.59 3.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.655 1.182 . . . . 0.0 111.595 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 68.3 m -135.4 173.45 11.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.072 1.349 . . . . 0.0 112.732 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 m -121.42 140.21 52.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.705 1.602 . . . . 0.0 108.969 -176.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.9 m -125.35 163.21 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.637 1.575 . . . . 0.0 111.19 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -97.94 147.59 24.31 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.597 1.159 . . . . 0.0 110.362 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -157.55 156.21 31.55 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.806 1.642 . . . . 0.0 109.577 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 t -102.6 127.42 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.807 0.843 . . . . 0.0 109.757 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -69.24 175.25 4.01 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.931 1.292 . . . . 0.0 112.58 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -61.47 -26.73 68.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.024 1.33 . . . . 0.0 113.424 175.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -87.84 0.75 55.39 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.242 1.417 . . . . 0.0 113.41 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.98 18.88 76.13 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.771 1.176 . . . . 0.0 114.655 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -92.3 132.89 36.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.598 1.159 . . . . 0.0 110.122 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.14 131.08 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -137.77 176.74 8.43 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.537 1.935 . . . . 0.0 110.715 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 p -125.87 143.53 51.03 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.273 1.029 . . . . 0.0 112.397 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -143.2 141.62 19.81 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.654 1.182 . . . . 0.0 112.336 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.73 150.12 49.69 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.832 2.355 . . . . 0.0 111.464 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.55 136.81 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.381 0.672 . . . . 0.0 110.856 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.45 -45.9 5.95 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.533 0.733 . . . . 0.0 111.832 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -146.16 178.99 7.81 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.287 1.835 . . . . 0.0 111.278 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -135.05 120.64 19.36 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.498 1.519 . . . . 0.0 109.23 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -116.19 119.26 35.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.185 0.994 . . . . 0.0 110.79 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -107.61 113.43 26.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.322 1.449 . . . . 0.0 109.908 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -82.19 -29.93 31.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.778 0.831 . . . . 0.0 112.965 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.54 -54.62 2.37 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.474 1.511 . . . . 0.0 113.888 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -170.33 103.09 0.27 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.157 1.383 . . . . 0.0 111.057 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -132.28 164.88 25.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.226 1.011 . . . . 0.0 111.69 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.55 99.65 0.23 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.594 1.558 . . . . 0.0 113.638 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 t -95.99 141.22 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.499 1.52 . . . . 0.0 111.589 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.83 137.76 54.61 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.239 1.816 . . . . 0.0 109.975 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.66 133.52 56.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.864 0.865 . . . . 0.0 110.715 171.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -127.55 89.29 2.93 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.023 1.329 . . . . 0.0 108.314 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.4 t -97.48 149.24 22.39 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.348 1.059 . . . . 0.0 110.731 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.15 163.53 15.82 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.212 1.405 . . . . 0.0 112.387 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.36 -20.54 63.84 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -81.45 -17.86 47.28 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.238 1.015 . . . . 0.0 113.171 170.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.26 -3.62 33.19 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.042 1.306 . . . . 0.0 114.207 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.9 m -57.71 142.31 45.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.522 1.129 . . . . 0.0 110.994 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -130.9 126.18 35.46 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.712 0.805 . . . . 0.0 111.351 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.5 mt -135.22 152.38 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 126.85 2.06 . . . . 0.0 107.674 -171.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.99 115.29 11.07 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.848 1.259 . . . . 0.0 110.528 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.09 163.24 34.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.626 1.171 . . . . 0.0 111.291 -176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.4 p -78.94 153.2 30.6 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.575 -0.703 . . . . 0.0 111.415 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.49 -24.17 65.08 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -84.05 -10.08 58.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.617 1.167 . . . . 0.0 112.836 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -82.44 133.96 35.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -97.12 156.12 16.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.536 1.134 . . . . 0.0 111.521 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.48 141.26 46.7 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.08 -1.012 . . . . 0.0 110.822 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.8 ttm -73.03 100.13 2.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.043 0.937 . . . . 0.0 109.594 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.5 p -66.96 170.74 6.26 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.8 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -56.09 -20.33 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.94 -4.01 28.46 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.653 1.181 . . . . 0.0 113.307 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 3.79 72.8 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.244 1.402 . . . . 0.0 113.913 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -65.42 122.97 18.39 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.381 1.072 . . . . 0.0 110.55 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.6 mtt -84.71 73.28 10.62 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.703 2.001 . . . . 0.0 110.766 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 43.6 mt -105.93 147.71 35.25 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 123.483 0.713 . . . . 0.0 110.97 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.78 148.27 86.43 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.11 2.54 . . . . 0.0 110.924 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 tt -53.46 -34.62 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.84 -33.12 70.05 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -77.15 -34.78 56.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.625 0.77 . . . . 0.0 111.15 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.1 mt -67.4 -39.4 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.782 0.833 . . . . 0.0 110.367 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -64.2 -34.26 77.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.953 0.901 . . . . 0.0 112.956 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -73.94 -47.25 38.89 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.01 -9.23 58.56 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 58.7 34.18 23.6 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.892 1.277 . . . . 0.0 112.325 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.89 143.85 35.48 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 122.172 0.987 . . . . 0.0 111.905 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.3 158.83 24.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.447 1.099 . . . . 0.0 111.623 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.51 152.2 21.03 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.39 -0.819 . . . . 0.0 111.922 169.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -75.15 146.5 41.27 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.176 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 166.05 23.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.047 1.339 . . . . 0.0 114.135 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.7 m -105.03 -30.03 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.561 1.544 . . . . 0.0 113.07 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.03 -2.73 56.08 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.326 1.05 . . . . 0.0 113.108 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.278 8.6 m-80 59.14 36.0 23.87 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.988 1.375 . . . . 0.0 112.991 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.9 mt -61.89 157.71 48.36 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.839 167.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.5 140.86 84.11 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.633 2.222 . . . . 0.0 110.39 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -66.56 126.05 27.69 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.999 -0.438 . . . . 0.0 110.496 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.5 pt -143.75 132.89 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.946 1.298 . . . . 0.0 111.013 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 176.31 7.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.202 1.401 . . . . 0.0 111.74 176.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.8 mt -64.13 109.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.731 1.212 . . . . 0.0 110.19 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.6 94.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.481 1.112 . . . . 0.0 112.287 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.0 p -151.43 153.25 34.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.939 1.696 . . . . 0.0 111.25 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -137.3 143.19 42.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.956 1.702 . . . . 0.0 110.335 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -152.33 148.31 27.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.591 2.356 . . . . 0.0 110.454 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -72.02 124.17 24.36 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.897 0.479 . . . . 0.0 110.081 168.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.2 mt -91.09 -44.81 9.05 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.022 0.529 . . . . 0.0 111.649 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.13 -145.73 13.9 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.056 0.836 . . . . 0.0 113.116 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -122.44 51.76 1.36 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 123.103 1.43 . . . . 0.0 113.66 -166.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -72.7 158.17 36.12 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 127.64 2.376 . . . . 0.0 112.53 -168.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.58 118.16 6.69 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.992 0.917 . . . . 0.0 111.417 171.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.8 m -126.09 156.2 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.41 0.684 . . . . 0.0 111.789 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -144.31 159.01 43.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.733 1.613 . . . . 0.0 111.559 -168.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -155.78 128.73 8.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.43 1.092 . . . . 0.0 109.952 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.43 142.55 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 121.292 -0.88 . . . . 0.0 111.281 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.65 136.36 14.87 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 126.01 1.724 . . . . 0.0 109.922 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.401 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -163.3 164.79 24.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.443 1.497 . . . . 0.0 112.437 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.75 141.41 28.53 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.675 1.19 . . . . 0.0 112.949 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.4 mt -91.53 171.76 8.97 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.658 1.983 . . . . 0.0 111.997 175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -50.49 -50.84 51.61 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.794 1.638 . . . . 0.0 115.171 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -68.06 -26.96 66.11 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.211 0.604 . . . . 0.0 111.825 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 120.48 -3.0 12.4 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.667 1.603 . . . . 0.0 114.096 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -69.07 163.82 23.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.144 1.472 . . . . 0.0 111.874 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.14 136.97 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 122.033 0.92 . . . . 0.0 110.629 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -121.51 151.48 40.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.37 1.868 . . . . 0.0 109.593 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.6 t -142.81 135.93 28.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.826 0.851 . . . . 0.0 113.089 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.2 t30 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.76 1.224 . . . . 0.0 113.131 -176.099 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.095 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.41 176.73 10.81 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.309 0.644 . . . . 0.0 112.544 -169.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.7 mt -116.74 147.41 42.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.352 1.861 . . . . 0.0 110.415 -173.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t -62.88 161.77 12.25 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -52.37 -44.77 65.46 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.146 -0.971 . . . . 0.0 111.474 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -56.34 -25.47 49.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.721 1.609 . . . . 0.0 114.044 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.6 m -65.5 103.62 0.87 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.883 1.273 . . . . 0.0 112.023 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -85.15 136.09 33.69 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.642 -0.661 . . . . 0.0 111.864 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 mm -109.4 131.94 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.535 1.534 . . . . 0.0 107.875 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -69.7 122.76 19.79 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 122.082 -0.386 . . . . 0.0 111.433 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.7 p -120.63 151.19 39.78 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.716 1.206 . . . . 0.0 112.315 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 t -75.74 -37.34 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.169 0.587 . . . . 0.0 111.84 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.04 -28.4 68.83 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -141.37 -51.12 0.43 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.29 -156.52 23.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.261 0.934 . . . . 0.0 112.505 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.87 105.9 0.43 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.431 1.092 . . . . 0.0 111.163 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.5 mt -135.52 149.75 70.26 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 124.746 1.218 . . . . 0.0 112.888 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.13 128.45 21.71 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.975 3.117 . . . . 0.0 112.351 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.4 tt -56.47 -35.94 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.793 0.837 . . . . 0.0 113.058 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.28 -33.97 88.66 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.548 -0.585 . . . . 0.0 113.072 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -69.33 -35.06 75.55 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.207 1.003 . . . . 0.0 111.806 174.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.3 mt -69.43 -41.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.581 0.752 . . . . 0.0 110.311 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -78.99 -39.67 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.808 0.731 . . . . 0.0 112.435 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.94 -23.67 60.71 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.32 0.964 . . . . 0.0 113.19 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.16 4.09 19.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.975 1.31 . . . . 0.0 112.65 176.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 50.16 45.73 25.41 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.916 1.686 . . . . 0.0 112.643 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.23 127.69 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.944 0.898 . . . . 0.0 109.399 -172.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -78.73 111.21 14.62 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.365 0.602 . . . . 0.0 110.319 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.8 p -133.9 -172.39 2.97 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.263 1.425 . . . . 0.0 111.005 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.3 157.03 35.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.687 1.595 . . . . 0.0 109.103 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.1 m -140.25 163.52 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.588 1.155 . . . . 0.0 111.026 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -104.43 139.96 38.62 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.204 1.402 . . . . 0.0 110.43 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -159.43 150.92 20.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.442 1.497 . . . . 0.0 110.528 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 m -83.41 148.11 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.423 1.01 . . . . 0.0 112.941 171.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.84 -179.92 7.4 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.836 0.854 . . . . 0.0 111.405 169.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -60.76 -20.68 61.88 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.89 1.276 . . . . 0.0 113.023 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -91.75 0.62 57.48 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.682 1.593 . . . . 0.0 113.277 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.2 26.67 63.47 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 121.114 -0.991 . . . . 0.0 114.223 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -107.58 120.21 41.56 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.621 1.568 . . . . 0.0 109.231 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.716 HD13 HG23 ' A' ' 97' ' ' VAL . 67.9 mt -65.45 125.98 23.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 123.594 0.758 . . . . 0.0 109.431 173.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -129.09 173.08 10.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.359 1.863 . . . . 0.0 111.403 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -117.18 142.4 47.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.946 1.298 . . . . 0.0 112.413 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -146.71 142.68 17.51 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.27 1.028 . . . . 0.0 112.873 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.5 154.5 50.28 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.116 2.544 . . . . 0.0 111.813 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.7 t -62.36 140.8 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.615 -0.678 . . . . 0.0 110.062 169.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.9 -40.95 4.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.311 0.645 . . . . 0.0 112.27 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -138.13 164.45 29.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.565 1.146 . . . . 0.0 112.306 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -133.87 131.36 39.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.294 1.838 . . . . 0.0 108.362 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.26 130.78 50.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.022 1.329 . . . . 0.0 111.157 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -139.45 136.56 34.76 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.568 -1.333 . . . . 0.0 112.535 -171.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -111.39 -32.75 6.62 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.201 -1.363 . . . . 0.0 114.62 -168.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.49 -60.75 2.5 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.306 1.431 . . . . 0.0 114.152 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -157.26 96.47 1.56 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.436 1.494 . . . . 0.0 112.616 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -130.11 162.1 29.57 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.391 1.076 . . . . 0.0 113.365 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.23 106.6 2.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.538 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 t -100.26 139.12 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.905 1.282 . . . . 0.0 111.247 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.405 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 38.9 m-85 -124.58 140.61 52.78 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.765 1.226 . . . . 0.0 109.973 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -85.02 123.59 30.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.058 1.343 . . . . 0.0 109.485 169.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.1 100.24 8.45 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.352 1.461 . . . . 0.0 108.934 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.6 t -83.41 145.3 29.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.22 1.008 . . . . 0.0 111.355 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mp -103.92 157.7 16.91 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.434 1.494 . . . . 0.0 112.276 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.56 -20.19 65.37 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -84.22 -16.23 44.06 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 176.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.32 -2.56 25.19 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.302 1.429 . . . . 0.0 114.405 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.4 m -70.16 157.82 36.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.923 1.289 . . . . 0.0 112.746 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.88 148.79 50.49 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.418 1.487 . . . . 0.0 110.855 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -140.01 143.91 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.963 2.105 . . . . 0.0 107.912 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -136.37 112.12 9.45 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.672 1.189 . . . . 0.0 112.382 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.33 172.12 18.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.498 1.119 . . . . 0.0 112.786 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.9 p -86.98 161.78 18.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.341 0.657 . . . . 0.0 110.964 168.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.405 ' HE3' ' CD1' ' A' ' 56' ' ' PHE . 2.2 mptm? -59.88 -25.81 65.37 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 175.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -85.07 -15.52 43.72 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.16 1.384 . . . . 0.0 112.766 -174.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -73.19 132.52 43.32 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 153.03 18.02 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.253 0.933 . . . . 0.0 112.787 176.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -131.94 137.14 47.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.252 -0.905 . . . . 0.0 109.143 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.1 ttp -81.47 113.14 19.33 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.291 0.567 . . . . 0.0 110.066 -173.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.2 p -69.87 171.43 9.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.466 0.706 . . . . 0.0 112.035 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -57.35 -23.67 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 174.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -82.26 -12.93 57.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.663 1.185 . . . . 0.0 113.394 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.06 3.35 70.19 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.247 0.927 . . . . 0.0 114.112 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -77.36 151.85 34.7 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.425 1.112 . . . . 0.0 110.826 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 ptp -119.78 93.93 4.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.565 1.146 . . . . 0.0 110.635 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.4 mt -120.4 149.06 49.03 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.109 1.364 . . . . 0.0 109.905 -170.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.74 145.98 91.57 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.546 2.164 . . . . 0.0 111.344 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.69 -28.69 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -57.85 -37.14 73.35 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.524 1.53 . . . . 0.0 113.289 171.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.07 -43.51 21.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.194 0.997 . . . . 0.0 110.511 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.61 -41.14 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.526 1.13 . . . . 0.0 111.438 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.3 -35.53 80.68 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -80.69 -40.82 24.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.754 0.822 . . . . 0.0 113.03 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -76.95 -13.76 59.94 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.222 1.009 . . . . 0.0 113.284 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 57.75 35.53 25.63 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.872 1.669 . . . . 0.0 112.872 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.89 148.11 25.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.008 0.923 . . . . 0.0 112.561 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -87.19 163.12 17.1 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.551 1.14 . . . . 0.0 113.174 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.2 mt -113.42 153.93 27.81 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.785 1.234 . . . . 0.0 112.5 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 10.7 ttp -81.98 145.08 30.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.189 0.595 . . . . 0.0 111.214 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.92 177.75 7.04 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.773 1.229 . . . . 0.0 113.874 -173.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.716 HG23 HD13 ' A' ' 39' ' ' ILE . 5.1 p -121.44 -25.69 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 126.149 1.78 . . . . 0.0 114.597 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -85.04 6.37 25.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.09 1.356 . . . . 0.0 113.382 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 56.42 32.11 20.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.969 1.708 . . . . 0.0 112.349 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.0 mt -67.41 158.31 82.64 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.76 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.04 147.13 88.68 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.935 2.423 . . . . 0.0 111.166 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -71.46 118.74 14.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.667 0.787 . . . . 0.0 109.989 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.6 126.37 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.895 1.278 . . . . 0.0 112.018 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.85 175.03 7.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.61 1.564 . . . . 0.0 112.393 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.12 106.9 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.68 1.592 . . . . 0.0 110.933 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.8 -41.05 62.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.573 1.149 . . . . 0.0 112.074 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.3 p -152.37 165.89 33.58 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.145 1.778 . . . . 0.0 111.84 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -136.05 143.54 44.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.602 1.561 . . . . 0.0 111.436 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -139.6 130.71 26.48 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.653 1.181 . . . . 0.0 110.88 171.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -67.55 131.31 45.39 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.918 -0.489 . . . . 0.0 110.931 173.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.2 mt -96.64 -42.78 7.86 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.015 0.526 . . . . 0.0 112.32 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.79 -151.59 23.23 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.421 1.01 . . . . 0.0 113.014 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -118.56 69.11 0.79 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.267 1.508 . . . . 0.0 112.417 -168.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -91.85 160.05 15.49 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 127.064 2.146 . . . . 0.0 111.443 -168.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.3 121.31 14.95 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 123.4 0.68 . . . . 0.0 111.075 169.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.81 148.41 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.476 0.655 . . . . 0.0 111.465 174.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -141.55 157.56 44.96 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.171 1.789 . . . . 0.0 111.884 -169.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -148.76 165.75 30.49 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.475 1.51 . . . . 0.0 112.653 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.7 pt -136.76 153.9 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.195 1.798 . . . . 0.0 111.104 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.91 166.69 24.56 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.856 0.741 . . . . 0.0 114.242 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.475 0.787 0 C-N-CA 124.924 1.29 . . . . 0.0 110.608 -174.489 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.6 p30 . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -161.51 158.81 27.08 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.201 1.4 . . . . 0.0 112.307 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.57 128.62 36.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.836 1.254 . . . . 0.0 111.693 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.8 mt -72.54 175.23 6.49 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.282 1.433 . . . . 0.0 113.319 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -51.03 -35.69 35.66 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -93.4 -5.21 49.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.417 1.087 . . . . 0.0 112.86 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 97' ' ' VAL . . . 109.12 -20.12 28.93 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 125.307 1.432 . . . . 0.0 114.447 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -53.51 133.21 40.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.379 1.072 . . . . 0.0 111.476 -173.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.5 mm -82.27 130.31 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.979 0.895 . . . . 0.0 110.938 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -108.79 141.24 41.09 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 126.951 2.1 . . . . 0.0 108.964 170.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.4 t -146.97 140.1 25.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.236 1.014 . . . . 0.0 113.291 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 CA--C 1.556 1.198 0 C-N-CA 125.846 1.658 . . . . 0.0 114.572 -173.569 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 122.206 0.892 . . . . 0.0 113.566 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.94 171.19 15.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.902 1.681 . . . . 0.0 111.202 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.0 mt -120.15 140.41 51.14 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.794 2.038 . . . . 0.0 110.067 -168.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 t -72.59 162.46 29.44 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.47 -0.769 . . . . 0.0 111.62 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -48.35 -43.3 33.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.416 1.086 . . . . 0.0 112.79 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -10.21 5.41 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -75.95 107.82 8.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.449 1.1 . . . . 0.0 110.034 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -100.41 138.2 37.8 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.455 -0.778 . . . . 0.0 112.013 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.7 mm -121.34 116.88 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.414 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.3 tt -60.99 127.08 29.81 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.212 0.605 . . . . 0.0 111.003 175.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.8 p -121.7 157.19 31.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.451 1.101 . . . . 0.0 112.697 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -78.01 -34.63 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.438 0.695 . . . . 0.0 111.462 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.67 -30.69 65.99 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -137.77 -48.73 0.57 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.71 -147.67 17.27 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.346 0.974 . . . . 0.0 112.664 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 4.7 mt -64.23 104.46 0.75 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.711 2.005 . . . . 0.0 110.722 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.1 mt -141.06 150.6 59.58 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 124.814 1.246 . . . . 0.0 114.021 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.89 133.15 28.39 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.774 3.649 . . . . 0.0 113.829 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 tt -59.0 -34.5 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.202 1.001 . . . . 0.0 113.174 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.96 -35.23 91.73 Favored Glycine 0 C--N 1.338 0.652 0 O-C-N 121.875 -0.516 . . . . 0.0 112.157 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -72.73 -32.57 65.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.07 0.935 . . . . 0.0 111.553 176.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -64.76 -38.56 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.309 0.643 . . . . 0.0 110.64 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.4 t -86.38 -38.23 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 118.953 0.797 . . . . 0.0 112.462 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -68.21 -27.58 66.51 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.313 -0.867 . . . . 0.0 113.099 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -114.91 5.61 15.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.956 1.302 . . . . 0.0 113.104 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 49.38 44.2 23.65 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 127.336 2.254 . . . . 0.0 112.798 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.8 mt -67.35 127.21 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.496 1.118 . . . . 0.0 109.522 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -99.01 104.25 16.27 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.634 1.174 . . . . 0.0 111.273 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 62.3 m -136.4 -178.44 5.17 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.505 1.522 . . . . 0.0 111.487 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.8 m -116.21 144.51 44.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.286 1.434 . . . . 0.0 108.534 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.32 160.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.001 1.72 . . . . 0.0 110.083 -175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -99.24 147.67 24.91 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.379 1.072 . . . . 0.0 110.3 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 t -159.43 160.17 34.52 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.296 1.438 . . . . 0.0 109.899 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -100.01 125.07 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.966 0.906 . . . . 0.0 110.201 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -69.62 176.48 3.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.993 1.317 . . . . 0.0 112.584 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -63.5 -26.16 68.59 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.136 1.374 . . . . 0.0 112.949 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.31 -5.31 59.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.045 1.338 . . . . 0.0 113.687 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.86 21.82 58.84 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.464 1.03 . . . . 0.0 114.873 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -96.81 133.1 41.83 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.657 1.183 . . . . 0.0 109.83 172.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.7 mt -74.09 129.26 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -137.59 179.63 6.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.961 2.105 . . . . 0.0 110.949 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.0 p -129.25 144.7 51.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.421 1.089 . . . . 0.0 113.124 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -149.15 142.32 15.9 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.063 1.345 . . . . 0.0 112.314 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.1 155.2 42.42 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.124 2.549 . . . . 0.0 112.981 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.0 t -62.62 132.52 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.344 0.657 . . . . 0.0 110.085 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.71 -48.21 7.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.411 0.684 . . . . 0.0 112.105 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -149.67 172.3 15.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.865 1.666 . . . . 0.0 111.525 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -132.27 129.44 39.61 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.947 1.699 . . . . 0.0 109.096 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -133.4 138.1 46.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.083 0.944 . . . . 0.0 111.418 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -129.08 118.69 22.93 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.123 1.369 . . . . 0.0 110.609 -172.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -84.01 -33.5 24.52 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.806 1.242 . . . . 0.0 112.708 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.01 -51.4 1.46 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.111 1.339 . . . . 0.0 113.62 173.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -172.57 106.35 0.17 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.414 1.485 . . . . 0.0 110.518 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -132.49 168.0 18.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.32 1.048 . . . . 0.0 112.402 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -67.87 101.76 1.14 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.05 140.61 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.765 1.226 . . . . 0.0 111.496 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -122.6 141.26 51.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.657 1.583 . . . . 0.0 110.534 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.55 126.11 26.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.224 1.41 . . . . 0.0 110.583 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -122.78 82.96 2.05 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.451 1.9 . . . . 0.0 108.476 177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 t -86.33 147.84 25.87 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.803 0.841 . . . . 0.0 111.175 171.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.55 165.38 11.71 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.308 1.443 . . . . 0.0 112.814 175.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.61 -23.71 66.88 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -82.35 -19.82 38.52 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.86 -1.4 27.29 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.191 1.377 . . . . 0.0 114.596 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.6 m -57.91 140.98 50.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.498 1.649 . . . . 0.0 110.922 170.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tp -127.01 130.05 49.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.384 1.074 . . . . 0.0 109.884 -174.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mt -139.65 150.26 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.715 1.606 . . . . 0.0 108.145 -170.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -134.0 109.74 9.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.853 1.261 . . . . 0.0 110.86 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.17 169.62 17.24 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.498 1.119 . . . . 0.0 112.519 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 p -86.19 149.26 25.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.89 1.276 . . . . 0.0 111.467 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -62.23 -17.39 58.19 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -86.54 -14.4 43.08 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.053 1.341 . . . . 0.0 112.971 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -79.42 135.52 36.7 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.153 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -93.82 152.41 18.93 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.026 0.917 . . . . 0.0 113.234 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.86 129.2 32.0 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.953 0.901 . . . . 0.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ttp -74.85 111.47 10.09 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.155 0.503 . . . . 0.0 110.416 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 p -71.09 173.48 7.53 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.472 0.653 . . . . 0.0 112.313 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.88 -24.01 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -91.41 -6.52 52.71 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.501 1.12 . . . . 0.0 113.205 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.81 5.81 59.69 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.345 0.974 . . . . 0.0 113.941 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -77.55 126.32 30.7 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.189 0.994 . . . . 0.0 110.906 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.62 78.57 7.74 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.138 1.375 . . . . 0.0 110.702 173.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 mt -104.68 147.77 34.96 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 123.553 0.741 . . . . 0.0 110.673 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.49 147.71 87.07 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.578 2.185 . . . . 0.0 110.603 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.5 tt -60.67 -28.88 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.28 -27.8 62.44 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.419 1.488 . . . . 0.0 113.331 169.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.51 -40.7 18.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.275 1.03 . . . . 0.0 111.528 173.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.82 -37.86 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.317 1.047 . . . . 0.0 110.93 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.8 -35.66 77.04 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.29 -48.24 17.94 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.325 -0.859 . . . . 0.0 113.063 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -14.21 62.23 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 55.75 32.82 20.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.987 1.315 . . . . 0.0 112.225 -172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 42.4 mt -70.43 140.31 51.99 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.997 0.919 . . . . 0.0 111.47 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.01 146.59 25.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.44 0.696 . . . . 0.0 110.847 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 mp -79.2 153.26 30.14 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.449 -0.782 . . . . 0.0 111.553 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.5 ttm -72.45 149.23 44.4 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.87 -0.519 . . . . 0.0 110.812 172.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.64 167.77 15.23 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.001 1.32 . . . . 0.0 113.892 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.434 HG22 ' HA2' ' A' ' 132' ' ' GLY . 2.8 m -118.75 -23.76 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 125.774 1.63 . . . . 0.0 113.235 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -88.98 5.22 45.22 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.997 1.319 . . . . 0.0 112.71 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.49 19.8 11.93 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.496 1.518 . . . . 0.0 112.32 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.1 mt -49.53 156.81 1.06 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.441 1.496 . . . . 0.0 112.028 169.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.3 145.22 88.15 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.64 2.226 . . . . 0.0 110.68 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -68.47 120.44 14.54 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.693 -0.629 . . . . 0.0 110.177 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.4 pt -145.1 159.79 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.289 1.436 . . . . 0.0 111.586 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -128.11 -179.69 5.13 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.28 1.832 . . . . 0.0 111.939 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.0 mt -56.78 110.65 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 125.671 1.589 . . . . 0.0 110.777 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.63 -40.84 66.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.609 1.164 . . . . 0.0 112.273 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.1 p -150.61 162.42 40.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.187 1.795 . . . . 0.0 111.022 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.04 144.13 40.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.634 1.174 . . . . 0.0 111.53 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -156.7 127.12 6.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.488 1.515 . . . . 0.0 110.486 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.06 123.29 18.66 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.775 -0.578 . . . . 0.0 110.234 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 mt -90.56 -42.71 10.66 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.737 0.415 . . . . 0.0 111.812 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.21 -136.27 6.68 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.887 0.756 . . . . 0.0 112.865 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.6 tttp -133.43 77.8 1.74 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.705 1.241 . . . . 0.0 113.089 -168.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -95.24 157.1 16.04 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.335 1.454 . . . . 0.0 110.858 -171.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.79 118.19 6.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.603 0.761 . . . . 0.0 110.525 169.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.6 m -123.02 151.83 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.455 0.645 . . . . 0.0 111.432 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -139.8 159.14 42.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.811 1.644 . . . . 0.0 111.436 -168.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -154.61 134.24 12.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.362 1.065 . . . . 0.0 111.149 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.3 pt -91.94 154.3 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.551 -0.718 . . . . 0.0 110.83 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.13 157.94 16.96 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.765 1.174 . . . . 0.0 111.803 173.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 125.112 1.365 . . . . 0.0 110.169 -175.215 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -164.74 155.48 14.56 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.477 1.111 . . . . 0.0 112.725 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.8 137.35 36.8 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.109 1.364 . . . . 0.0 112.905 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.85 168.14 19.1 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.137 1.775 . . . . 0.0 113.394 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -35.45 50.52 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -82.99 -28.34 29.78 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.662 1.185 . . . . 0.0 112.769 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.434 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . 130.69 -19.59 4.99 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.586 1.565 . . . . 0.0 114.545 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -60.17 159.32 9.89 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.829 1.252 . . . . 0.0 112.229 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.2 mm -116.48 128.69 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 119.328 0.967 . . . . 0.0 111.024 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.37 145.47 29.45 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.568 1.547 . . . . 0.0 109.628 170.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.9 m -138.95 142.06 38.42 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.398 1.079 . . . . 0.0 111.608 177.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 C--O 1.253 1.279 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -168.814 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.898 0 CA-C-O 118.939 -0.923 . . . . 0.0 115.151 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 60.2 -166.95 10.11 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 118.992 1.396 . . . . 0.0 113.837 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.27 171.57 19.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.287 1.035 . . . . 0.0 112.209 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.2 mt -122.05 146.8 46.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.83 2.052 . . . . 0.0 109.527 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -68.9 164.72 21.48 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -53.0 -46.26 68.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.95 -1.093 . . . . 0.0 112.338 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -62.98 -10.63 14.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.617 1.567 . . . . 0.0 114.905 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.8 m -71.55 111.07 6.55 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.863 0.865 . . . . 0.0 110.584 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.8 134.01 34.41 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.615 -0.678 . . . . 0.0 112.265 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.4 mm -107.55 124.53 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.019 1.728 . . . . 0.0 108.113 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -64.44 131.16 46.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.672 0.389 . . . . 0.0 110.815 169.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 p -134.77 150.54 50.56 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.645 1.178 . . . . 0.0 112.36 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.0 t -77.34 -32.78 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.976 0.51 . . . . 0.0 111.823 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -68.77 -31.05 69.8 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -140.13 -50.61 0.48 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.85 -149.35 19.86 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.109 0.861 . . . . 0.0 112.095 -172.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.1 107.88 2.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.015 1.326 . . . . 0.0 111.209 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -133.21 148.91 71.04 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.751 1.22 . . . . 0.0 112.745 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.39 126.55 15.79 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.944 3.096 . . . . 0.0 112.332 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.424 ' HA ' HD12 ' A' ' 21' ' ' ILE . 17.5 tt -54.51 -35.57 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.043 0.937 . . . . 0.0 112.637 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.74 -36.53 93.45 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.604 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -70.31 -34.35 72.6 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.033 1.416 . . . . 0.0 111.554 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 18' ' ' ILE . 60.0 mt -63.86 -36.51 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.643 0.777 . . . . 0.0 110.121 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.37 -38.06 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.837 0.855 . . . . 0.0 112.856 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.58 -26.45 65.4 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.821 -1.174 . . . . 0.0 113.025 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -114.45 2.63 14.7 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.077 1.351 . . . . 0.0 112.878 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 49.09 47.81 21.52 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 127.533 2.333 . . . . 0.0 113.133 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -73.71 129.69 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.613 1.165 . . . . 0.0 109.445 -174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 132.74 36.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 122.703 1.239 . . . . 0.0 111.208 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.0 p -160.39 175.36 12.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.393 1.477 . . . . 0.0 111.659 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 147.03 30.08 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.45 1.5 . . . . 0.0 109.157 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 m -125.46 172.99 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.581 1.952 . . . . 0.0 110.181 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -114.28 139.89 49.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.956 1.302 . . . . 0.0 110.886 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 t -162.03 150.07 14.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.901 1.281 . . . . 0.0 111.566 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.72 144.49 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.195 0.907 . . . . 0.0 113.399 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.44 -178.35 6.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.809 0.844 . . . . 0.0 112.516 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -55.66 -22.53 23.43 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.352 1.461 . . . . 0.0 113.765 173.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -91.94 -10.62 38.81 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.228 1.411 . . . . 0.0 113.719 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.62 14.14 58.71 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.41 1.005 . . . . 0.0 114.916 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -88.93 118.89 28.97 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.574 1.187 . . . . 0.0 110.177 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.45 103.99 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.496 0.719 . . . . 0.0 109.375 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -103.64 178.66 4.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.113 1.765 . . . . 0.0 111.211 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 p -127.7 140.05 52.32 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.126 0.97 . . . . 0.0 112.643 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -144.74 148.02 37.87 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.707 1.203 . . . . 0.0 113.332 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.4 152.67 49.64 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.025 2.483 . . . . 0.0 112.835 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.84 133.31 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.147 0.979 . . . . 0.0 109.784 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.64 -49.46 7.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.008 0.523 . . . . 0.0 111.828 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -148.98 176.01 10.81 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.727 1.611 . . . . 0.0 111.767 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -131.62 129.91 41.47 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.682 1.593 . . . . 0.0 109.311 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -131.78 136.06 47.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.132 0.968 . . . . 0.0 111.3 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -126.8 114.28 17.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.215 1.806 . . . . 0.0 110.118 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -78.2 -29.58 48.46 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.058 0.943 . . . . 0.0 112.058 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.66 -56.67 1.63 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.413 1.483 . . . . 0.0 112.58 172.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -166.68 111.31 0.77 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.207 1.803 . . . . 0.0 109.827 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -129.56 166.0 20.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.519 1.128 . . . . 0.0 112.606 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -61.94 100.6 0.16 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.665 1.186 . . . . 0.0 113.096 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.3 137.93 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.659 1.184 . . . . 0.0 110.787 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -118.31 141.74 48.22 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.085 1.354 . . . . 0.0 109.489 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -65.96 129.53 40.11 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.387 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.424 ' CE1' HG12 ' A' ' 105' ' ' ILE . 1.4 t80 -116.46 106.88 14.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.585 1.154 . . . . 0.0 107.948 169.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.2 t -116.57 141.71 47.84 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.068 0.947 . . . . 0.0 110.82 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp -102.82 166.01 10.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.34 1.456 . . . . 0.0 112.647 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -65.23 -25.73 67.81 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.29 -23.0 35.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.025 1.33 . . . . 0.0 113.096 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.96 -2.66 25.7 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.0 1.286 . . . . 0.0 114.717 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.3 m -57.83 136.97 57.05 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.731 1.265 . . . . 0.0 110.867 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.29 124.51 42.56 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.616 1.166 . . . . 0.0 109.939 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.6 mt -135.13 151.02 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 127.334 2.254 . . . . 0.0 108.299 -171.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -137.4 108.96 6.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.871 1.268 . . . . 0.0 109.986 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.96 170.89 17.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.019 0.928 . . . . 0.0 113.377 -172.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.5 p -91.03 153.08 20.39 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.542 1.137 . . . . 0.0 111.987 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -65.15 -5.04 5.78 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -99.16 -6.33 28.45 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.556 1.143 . . . . 0.0 112.315 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.554 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 9.9 t-80 -85.73 126.88 34.31 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.39 155.24 20.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.755 0.788 . . . . 0.0 110.43 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -138.22 143.12 40.01 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.308 0.643 . . . . 0.0 109.33 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.1 ttp -73.11 103.03 3.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.305 0.642 . . . . 0.0 111.513 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.574 ' HA ' HD23 ' A' ' 94' ' ' LEU . 73.4 p -62.38 171.86 1.75 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.9 m -54.27 -25.33 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.78 -11.99 24.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.773 1.229 . . . . 0.0 113.191 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.2 -6.17 32.16 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.0 1.762 . . . . 0.0 114.332 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -61.25 141.21 57.69 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.986 1.393 . . . . 0.0 111.777 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -101.26 83.22 2.44 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.4 1.08 . . . . 0.0 109.771 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.09 146.77 37.86 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 124.437 1.095 . . . . 0.0 110.76 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.43 148.6 73.71 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.068 2.512 . . . . 0.0 111.783 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 tt -60.57 -26.98 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -55.41 -32.9 63.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.176 0.99 . . . . 0.0 112.92 170.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.44 -31.29 16.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.353 1.061 . . . . 0.0 111.754 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.28 -42.22 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.232 -0.917 . . . . 0.0 110.738 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -62.23 -39.31 92.4 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.28 -44.77 64.59 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -77.76 -11.12 59.85 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 56.51 37.82 29.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.425 1.49 . . . . 0.0 111.751 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.8 mt -78.48 150.9 32.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 122.042 0.925 . . . . 0.0 111.37 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -93.72 167.43 11.66 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.901 0.88 . . . . 0.0 111.069 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 76' ' ' THR . 39.3 mt -116.01 144.93 43.42 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.308 1.043 . . . . 0.0 111.437 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -68.59 148.36 50.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.712 0.805 . . . . 0.0 111.618 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.02 152.04 44.78 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.783 1.233 . . . . 0.0 113.694 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 t -77.31 -35.84 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 128.37 2.668 . . . . 0.0 112.74 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -91.47 10.81 26.18 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.361 1.065 . . . . 0.0 113.495 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.25 7.0 m120 56.38 31.91 19.6 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.076 1.75 . . . . 0.0 112.426 -172.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.9 mt -64.54 155.23 82.02 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 113.659 -1.61 . . . . 0.0 111.622 170.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.98 127.51 17.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.341 2.694 . . . . 0.0 109.987 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -77.69 131.13 37.57 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.751 -0.593 . . . . 0.0 109.595 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -142.08 127.65 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.644 1.178 . . . . 0.0 110.957 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 166.49 3.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.597 1.959 . . . . 0.0 113.202 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.424 HG12 ' CE1' ' A' ' 58' ' ' TYR . 6.8 mt -61.33 116.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.152 1.381 . . . . 0.0 109.691 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.73 -42.1 61.63 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.832 0.853 . . . . 0.0 111.627 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 p -149.24 146.02 27.39 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.018 1.327 . . . . 0.0 111.295 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -143.84 142.79 31.02 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.266 1.827 . . . . 0.0 109.853 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -155.41 151.04 27.35 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.996 2.118 . . . . 0.0 110.416 169.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -67.03 131.2 45.36 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.365 0.666 . . . . 0.0 110.072 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.6 mt -98.27 -45.13 6.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.944 0.498 . . . . 0.0 111.871 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.01 -146.3 15.56 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.179 0.895 . . . . 0.0 112.095 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.59 94.67 4.31 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.246 1.022 . . . . 0.0 111.78 -169.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -110.86 155.79 22.09 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.397 1.479 . . . . 0.0 109.904 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.46 118.32 8.6 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.201 0.6 . . . . 0.0 110.642 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.84 150.45 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.35 0.595 . . . . 0.0 111.46 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -138.44 159.41 42.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.673 1.589 . . . . 0.0 111.494 -170.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -157.29 114.38 3.04 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.418 1.087 . . . . 0.0 110.556 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.0 pt -68.12 154.74 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 O-C-N 121.267 -0.896 . . . . 0.0 110.908 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.46 152.23 17.41 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.69 1.138 . . . . 0.0 111.5 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.05 142.56 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.972 1.309 . . . . 0.0 110.069 -171.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -80.76 -49.22 11.42 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -52.58 24.74 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.842 0.857 . . . . 0.0 112.968 -172.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -149.77 125.99 10.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.558 1.943 . . . . 0.0 108.719 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -75.62 59.37 1.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.78 1.232 . . . . 0.0 112.136 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -148.66 165.88 30.01 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.9 1.68 . . . . 0.0 112.83 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -168.31 146.77 4.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.593 1.157 . . . . 0.0 112.121 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.03 165.32 25.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.124 0.97 . . . . 0.0 113.321 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 67.2 mt -130.57 164.87 23.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.054 2.142 . . . . 0.0 111.621 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -32.61 58.1 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -86.71 9.11 19.84 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.402 1.481 . . . . 0.0 112.519 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.4 0.06 85.94 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.747 1.641 . . . . 0.0 114.046 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -67.37 166.67 14.02 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.205 1.503 . . . . 0.0 113.073 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.97 123.4 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.286 1.034 . . . . 0.0 109.65 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.554 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -97.22 149.99 21.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.984 1.314 . . . . 0.0 109.671 172.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.2 t -142.2 138.73 31.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.151 0.98 . . . . 0.0 112.587 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.529 1.532 . . . . 0.0 112.28 -174.287 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 CA-C-O 121.272 0.373 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -66.57 166.58 38.64 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.21 2.338 . . . . 0.0 114.084 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.32 179.83 7.99 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.137 1.375 . . . . 0.0 112.506 -174.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.5 mt -123.33 146.43 47.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.271 1.829 . . . . 0.0 110.378 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 t -68.62 163.85 22.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.206 0.602 . . . . 0.0 112.378 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -51.75 -44.52 63.35 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.421 -0.799 . . . . 0.0 112.49 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -59.8 -19.77 52.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.655 1.982 . . . . 0.0 113.857 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.8 m -72.32 87.24 1.13 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.644 1.178 . . . . 0.0 111.718 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -77.42 145.96 36.85 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.115 0.959 . . . . 0.0 112.74 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.3 mm -119.53 125.92 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 126.889 2.075 . . . . 0.0 107.18 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -61.1 132.16 52.86 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 122.076 -0.39 . . . . 0.0 111.17 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.7 p -133.05 148.46 52.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.659 1.184 . . . . 0.0 112.698 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.9 -34.61 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.258 0.623 . . . . 0.0 111.9 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -65.11 -28.85 69.72 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -143.86 -62.92 0.39 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.28 -148.35 18.77 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.007 0.813 . . . . 0.0 112.056 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.05 107.05 3.46 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.685 1.194 . . . . 0.0 111.331 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.76 148.63 70.28 Favored Pre-proline 0 N--CA 1.479 1.012 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.03 127.63 18.05 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.694 3.596 . . . . 0.0 112.822 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.44 -35.09 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.615 0.766 . . . . 0.0 113.027 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.61 -36.56 93.5 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.334 -0.703 . . . . 0.0 112.787 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -71.56 -32.22 67.85 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.114 1.457 . . . . 0.0 111.398 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.61 -37.44 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.972 0.909 . . . . 0.0 110.181 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.5 t -88.02 -37.87 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 118.691 0.678 . . . . 0.0 112.586 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -69.24 -25.85 64.49 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.481 1.037 . . . . 0.0 113.008 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -116.24 4.87 13.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.945 1.298 . . . . 0.0 112.45 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 48.46 47.89 19.8 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.136 2.575 . . . . 0.0 113.258 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -72.64 121.86 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.029 1.332 . . . . 0.0 109.469 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -83.27 122.29 28.24 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.44 1.114 . . . . 0.0 110.733 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -152.1 -177.02 5.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.003 1.721 . . . . 0.0 110.909 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -125.24 141.38 52.12 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.184 1.393 . . . . 0.0 108.424 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.48 177.29 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.614 1.965 . . . . 0.0 110.6 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -122.73 140.06 53.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.717 1.207 . . . . 0.0 111.36 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.4 t -161.38 149.61 15.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.355 1.462 . . . . 0.0 110.924 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.39 160.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 119.043 0.838 . . . . 0.0 111.126 167.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -102.23 -174.47 2.58 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.998 1.719 . . . . 0.0 113.089 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.52 -11.54 25.01 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -102.93 -0.86 30.42 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.804 1.642 . . . . 0.0 112.36 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.98 31.48 39.16 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.68 1.133 . . . . 0.0 114.565 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -116.56 121.99 43.37 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.697 1.249 . . . . 0.0 109.991 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.7 mt -63.91 118.82 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.736 0.814 . . . . 0.0 109.305 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -122.87 177.02 5.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.193 1.797 . . . . 0.0 111.014 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.3 p -125.61 139.88 53.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.141 0.977 . . . . 0.0 113.097 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -147.89 148.29 29.61 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.695 1.198 . . . . 0.0 112.808 -175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.15 155.11 52.26 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.165 2.577 . . . . 0.0 112.836 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.94 134.34 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.142 0.977 . . . . 0.0 110.146 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.87 -45.11 9.47 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.466 0.707 . . . . 0.0 112.199 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -149.23 173.28 13.63 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.923 1.689 . . . . 0.0 111.912 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -132.93 132.36 41.91 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.784 1.633 . . . . 0.0 108.973 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -133.28 135.61 44.99 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.04 0.924 . . . . 0.0 111.162 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -126.65 113.08 16.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.348 1.459 . . . . 0.0 110.323 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -79.35 -32.02 43.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.924 1.289 . . . . 0.0 112.866 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.05 -51.2 2.51 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.867 1.222 . . . . 0.0 113.684 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -173.15 96.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.746 1.273 . . . . 0.0 111.258 -170.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -129.67 165.11 22.49 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 112.682 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.83 103.85 0.98 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.105 1.362 . . . . 0.0 113.421 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 t -95.41 139.62 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.03 1.332 . . . . 0.0 111.544 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -123.92 139.28 54.11 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.498 1.919 . . . . 0.0 109.922 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.79 134.2 53.61 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.282 0.633 . . . . 0.0 110.357 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.406 ' CE1' HG12 ' A' ' 105' ' ' ILE . 1.6 t80 -126.62 95.73 4.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.989 1.316 . . . . 0.0 108.579 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.1 t -105.71 140.76 38.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.243 1.017 . . . . 0.0 110.132 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tp -103.86 162.9 12.73 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.911 1.284 . . . . 0.0 112.01 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -66.93 -21.19 65.99 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.1 -29.27 61.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.765 1.226 . . . . 0.0 112.839 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.92 -2.22 25.76 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.941 1.258 . . . . 0.0 114.108 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 m -57.37 138.75 54.55 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.273 1.037 . . . . 0.0 111.205 170.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 tp -128.58 125.62 38.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.335 1.054 . . . . 0.0 111.042 -170.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.4 mt -137.86 151.92 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 126.907 2.083 . . . . 0.0 108.017 -169.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -138.42 115.06 10.59 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.782 1.233 . . . . 0.0 110.804 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.24 167.71 23.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.676 1.19 . . . . 0.0 112.208 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.5 p -82.02 154.16 25.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.712 0.805 . . . . 0.0 111.715 170.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -66.59 -8.57 28.02 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -96.2 -10.83 27.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.813 1.645 . . . . 0.0 112.787 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -81.65 133.04 35.32 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -87.65 165.67 15.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.145 0.974 . . . . 0.0 111.553 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -142.85 147.39 35.33 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.323 1.049 . . . . 0.0 109.824 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 43.3 ttm -79.56 104.05 9.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.677 1.191 . . . . 0.0 110.347 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.2 p -68.87 170.81 8.94 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.715 -0.615 . . . . 0.0 112.062 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.0 m -57.79 -23.22 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -90.03 -3.02 58.21 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.407 1.083 . . . . 0.0 113.042 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.76 66.34 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.327 0.965 . . . . 0.0 113.656 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -86.01 124.9 32.98 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.497 1.119 . . . . 0.0 109.996 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.13 92.84 6.92 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.531 1.132 . . . . 0.0 109.855 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.36 147.12 44.42 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 124.381 1.072 . . . . 0.0 111.418 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.08 146.67 82.73 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.414 2.742 . . . . 0.0 111.687 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.7 tt -58.6 -27.91 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -53.23 -35.99 60.55 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.487 1.115 . . . . 0.0 112.852 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -86.75 -33.29 20.01 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.026 0.53 . . . . 0.0 111.827 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.8 mt -61.44 -38.04 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.311 -0.868 . . . . 0.0 111.06 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -67.75 -32.57 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -82.05 -40.11 22.49 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.443 -0.786 . . . . 0.0 112.514 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.3 mmm-85 -77.0 -13.95 59.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 55.01 29.98 13.34 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.587 1.555 . . . . 0.0 113.117 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -76.23 129.48 36.77 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.653 0.781 . . . . 0.0 111.168 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.17 149.15 47.84 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.617 0.723 . . . . 0.0 112.478 171.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.06 155.94 21.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.515 0.726 . . . . 0.0 112.587 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.5 ttp -78.13 135.79 37.74 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.984 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 166.7 10.22 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.391 1.476 . . . . 0.0 112.947 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.77 -19.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.602 1.961 . . . . 0.0 112.788 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -109.68 15.02 23.1 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.028 1.731 . . . . 0.0 112.263 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.8 m120 65.05 14.15 9.16 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.632 1.573 . . . . 0.0 113.423 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.2 mt -43.9 154.82 0.35 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 127.264 2.226 . . . . 0.0 112.761 169.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.95 148.76 89.93 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.598 2.199 . . . . 0.0 110.904 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -69.66 123.07 20.41 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.45 -0.782 . . . . 0.0 111.152 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.5 pt -148.86 151.76 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.705 1.602 . . . . 0.0 111.055 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.23 179.7 4.21 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.822 1.649 . . . . 0.0 111.249 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.406 HG12 ' CE1' ' A' ' 58' ' ' TYR . 19.4 mt -62.06 110.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.688 1.195 . . . . 0.0 110.618 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.71 -42.02 64.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.166 1.387 . . . . 0.0 111.763 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p -148.75 148.26 29.78 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.263 1.425 . . . . 0.0 111.183 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.9 ttp85 -143.0 141.0 31.25 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.0 1.72 . . . . 0.0 110.174 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -159.85 148.96 17.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.144 1.778 . . . . 0.0 110.703 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -64.99 125.41 24.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.628 0.771 . . . . 0.0 111.459 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.34 -44.39 8.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.401 0.68 . . . . 0.0 111.866 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.62 -147.31 17.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.124 0.868 . . . . 0.0 112.872 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -128.73 80.89 1.99 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 123.083 1.421 . . . . 0.0 111.83 -169.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -100.0 158.91 15.49 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.918 1.687 . . . . 0.0 110.471 -169.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 118.43 7.72 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.79 -0.569 . . . . 0.0 110.739 169.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.94 152.77 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.302 0.641 . . . . 0.0 111.285 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -140.72 158.97 43.2 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.637 1.575 . . . . 0.0 111.737 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -155.72 131.3 9.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.419 1.088 . . . . 0.0 111.089 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.4 pt -87.27 155.36 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 121.323 -0.86 . . . . 0.0 111.08 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.7 155.14 16.27 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.434 1.492 . . . . 0.0 111.703 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.7 156.97 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.63 1.172 . . . . 0.0 110.846 -169.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.05 -40.14 92.49 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -144.52 -53.28 0.31 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.768 1.227 . . . . 0.0 113.188 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.47 90.13 7.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.092 0.957 . . . . 0.0 109.518 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -66.61 34.92 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.809 2.443 . . . . 0.0 113.75 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -147.04 160.39 42.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.82 2.048 . . . . 0.0 111.826 -168.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -163.27 154.23 16.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.456 1.102 . . . . 0.0 112.353 -169.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.81 159.44 30.09 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 45.0 mt -116.89 162.2 18.12 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.975 2.11 . . . . 0.0 112.195 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -55.2 -36.09 65.54 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -73.87 -17.04 61.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.11 0.964 . . . . 0.0 112.381 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.15 34.41 3.7 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.045 1.307 . . . . 0.0 114.699 171.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -135.53 165.34 25.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.721 1.608 . . . . 0.0 111.026 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -107.64 129.35 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.563 0.745 . . . . 0.0 110.015 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -110.75 155.26 22.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.582 1.553 . . . . 0.0 110.163 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.1 p -142.95 122.21 13.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.818 0.847 . . . . 0.0 112.605 -168.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 124.695 1.198 . . . . 0.0 113.671 -176.312 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.057 0 N-CA-C 115.567 0.987 . . . . 0.0 115.567 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -157.58 158.46 29.03 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 128.481 2.943 . . . . 0.0 108.243 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -157.79 175.4 13.93 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 117.759 0.779 . . . . 0.0 113.077 -167.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.67 147.24 44.79 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.467 1.507 . . . . 0.0 111.218 -170.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 t -64.77 162.79 15.35 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -54.2 -44.43 71.59 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.151 -0.968 . . . . 0.0 112.002 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -57.69 -23.89 53.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.873 1.669 . . . . 0.0 113.697 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.5 m -66.92 103.59 1.18 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.443 1.497 . . . . 0.0 111.472 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -87.56 141.19 28.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.836 0.826 . . . . 0.0 112.361 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.4 mm -120.4 119.54 60.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 126.628 1.971 . . . . 0.0 106.956 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.07 131.65 51.26 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.406 0.283 . . . . 0.0 110.772 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.4 p -126.2 157.7 37.53 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.166 . . . . 0.0 112.768 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.94 -35.45 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.576 0.75 . . . . 0.0 111.182 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -67.22 -29.53 69.21 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.24 -54.28 0.47 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.23 -148.95 19.93 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.962 0.792 . . . . 0.0 112.434 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.73 109.66 3.93 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.822 1.249 . . . . 0.0 111.099 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.3 mt -136.65 150.2 69.48 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.03 1.332 . . . . 0.0 112.642 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.52 129.56 22.81 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.962 3.108 . . . . 0.0 112.379 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 tt -55.2 -38.96 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.411 0.684 . . . . 0.0 112.318 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.54 -31.74 79.58 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.583 -0.698 . . . . 0.0 113.347 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -70.88 -37.81 73.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.192 0.996 . . . . 0.0 111.26 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.59 -40.34 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 123.662 0.785 . . . . 0.0 109.336 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.3 t -74.46 -42.87 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.23 -21.26 56.6 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.788 1.176 . . . . 0.0 113.465 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -110.37 2.28 18.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.359 1.464 . . . . 0.0 112.197 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 47.38 48.86 16.23 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.998 2.119 . . . . 0.0 113.178 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.0 mt -72.11 126.11 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.868 0.867 . . . . 0.0 109.621 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -85.67 104.47 15.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.41 0.624 . . . . 0.0 111.191 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 64.7 m -133.56 -173.45 3.23 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.451 1.5 . . . . 0.0 111.487 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.31 143.65 51.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.961 1.705 . . . . 0.0 108.754 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.12 171.03 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.697 1.599 . . . . 0.0 111.156 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.04 143.28 45.01 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.951 1.3 . . . . 0.0 111.248 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 t -160.72 150.67 17.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.912 1.685 . . . . 0.0 110.381 -170.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.0 142.66 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.215 1.37 . . . . 0.0 110.729 168.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.64 178.56 7.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.838 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.27 -25.27 63.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.749 1.22 . . . . 0.0 112.754 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -87.79 -1.13 57.77 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.327 1.451 . . . . 0.0 113.339 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.08 29.6 53.49 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 121.251 -0.906 . . . . 0.0 114.373 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -109.39 122.57 47.67 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.539 1.536 . . . . 0.0 109.63 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.593 HD13 HG23 ' A' ' 97' ' ' VAL . 55.4 mt -69.82 117.84 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.498 0.719 . . . . 0.0 109.489 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -124.9 178.4 5.52 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.67 1.988 . . . . 0.0 111.285 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 p -126.08 142.68 51.42 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.386 1.074 . . . . 0.0 112.958 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -144.73 146.13 30.7 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 124.909 1.283 . . . . 0.0 112.898 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.07 152.86 67.89 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.866 2.377 . . . . 0.0 111.985 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.28 119.15 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 168.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.81 -50.45 17.15 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -151.59 179.49 8.34 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.672 1.989 . . . . 0.0 110.909 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -134.82 132.72 38.98 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.342 1.457 . . . . 0.0 109.856 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -134.02 138.82 45.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.833 0.853 . . . . 0.0 111.627 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -132.37 121.03 22.85 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.56 1.544 . . . . 0.0 110.203 -172.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -87.76 -25.65 23.29 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.124 1.37 . . . . 0.0 112.982 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.16 -49.22 2.99 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.589 1.566 . . . . 0.0 114.937 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -171.75 101.25 0.18 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.128 1.464 . . . . 0.0 111.455 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -131.43 167.47 19.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.553 1.141 . . . . 0.0 112.247 172.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.84 105.81 0.9 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.937 1.295 . . . . 0.0 113.554 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.37 140.85 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.473 1.109 . . . . 0.0 111.939 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.481 ' CZ ' ' HE3' ' A' ' 70' ' ' LYS . 46.9 m-85 -125.08 154.55 41.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.585 1.554 . . . . 0.0 110.874 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.68 110.3 22.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.567 1.147 . . . . 0.0 109.169 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -96.7 102.85 14.7 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.852 0.861 . . . . 0.0 109.255 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.5 t -82.34 147.05 29.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.203 1.001 . . . . 0.0 111.057 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -106.99 160.79 15.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.951 1.3 . . . . 0.0 113.47 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.68 -20.47 65.3 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.29 -14.99 36.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.048 1.339 . . . . 0.0 112.945 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.18 -5.11 23.62 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.441 1.496 . . . . 0.0 114.57 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 t -71.82 171.47 11.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.219 1.009 . . . . 0.0 113.213 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -140.74 141.32 34.88 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.896 1.678 . . . . 0.0 111.57 -170.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.5 mt -133.62 143.61 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 126.23 1.812 . . . . 0.0 108.699 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -133.47 101.51 5.17 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.807 1.243 . . . . 0.0 111.376 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.35 166.66 31.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.847 0.859 . . . . 0.0 113.275 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.0 p -78.37 163.03 26.01 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.231 0.538 . . . . 0.0 110.773 168.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 6.5 mtmp? -74.51 -4.83 39.18 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -97.83 -20.76 17.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.588 1.555 . . . . 0.0 112.607 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -71.72 131.01 42.53 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -84.84 157.43 20.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.519 -0.738 . . . . 0.0 111.118 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -139.5 143.62 37.55 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.024 1.33 . . . . 0.0 109.921 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.2 ttp -84.64 110.34 18.67 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.454 1.102 . . . . 0.0 111.278 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.4 p -71.14 176.42 4.48 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -54.96 -26.84 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -94.14 -9.33 36.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.631 1.173 . . . . 0.0 113.521 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.06 8.97 56.43 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.314 0.959 . . . . 0.0 114.875 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -65.81 146.98 54.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.777 1.288 . . . . 0.0 111.165 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 29.2 mtm -110.95 80.51 1.31 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.526 1.53 . . . . 0.0 109.849 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.1 mt -119.64 147.25 43.36 Favored Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 125.396 1.478 . . . . 0.0 110.465 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -63.08 144.43 92.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.643 2.229 . . . . 0.0 110.672 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.7 tt -55.91 -27.14 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -56.01 -40.45 73.41 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.179 1.391 . . . . 0.0 113.006 169.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -79.56 -35.71 39.4 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.993 -0.442 . . . . 0.0 110.855 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 94' ' ' LEU . 72.2 mt -62.58 -40.58 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 119.076 0.853 . . . . 0.0 111.391 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -58.91 -39.35 81.26 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.736 0.814 . . . . 0.0 113.157 172.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -81.49 -38.56 26.13 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.624 1.17 . . . . 0.0 113.085 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -75.47 -16.64 60.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.337 1.055 . . . . 0.0 112.896 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 56.86 34.39 24.69 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.08 1.352 . . . . 0.0 112.452 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -86.98 144.55 26.87 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.876 0.87 . . . . 0.0 111.873 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -81.22 167.67 19.34 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.7 0.8 . . . . 0.0 112.564 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 87' ' ' ILE . 4.9 mp -122.3 157.89 30.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.392 1.092 . . . . 0.0 113.901 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.6 ttm -73.05 154.44 40.44 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.05 1.74 . . . . 0.0 112.601 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.66 159.38 42.12 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.564 1.546 . . . . 0.0 114.683 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.593 HG23 HD13 ' A' ' 39' ' ' ILE . 12.0 p -93.53 -28.14 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 126.707 2.003 . . . . 0.0 113.04 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -83.39 20.81 1.26 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.464 1.506 . . . . 0.0 112.735 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.27 10.4 p30 46.39 19.77 0.08 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.708 2.803 . . . . 0.0 115.675 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.6 mt -60.68 156.99 41.11 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.146 1.378 . . . . 0.0 112.89 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.89 143.98 81.44 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.081 2.521 . . . . 0.0 110.721 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -77.74 125.61 29.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.171 0.589 . . . . 0.0 110.284 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.0 pt -140.34 131.37 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.457 1.103 . . . . 0.0 112.67 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 172.86 13.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.445 1.898 . . . . 0.0 112.701 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -69.95 113.36 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.417 1.087 . . . . 0.0 110.334 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.81 -48.83 75.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.46 1.504 . . . . 0.0 111.856 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 p -152.24 158.11 42.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.326 1.851 . . . . 0.0 111.171 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -126.1 148.84 49.27 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.881 1.672 . . . . 0.0 109.672 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -149.97 133.99 17.03 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.657 1.183 . . . . 0.0 110.688 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -70.87 129.32 38.75 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.244 0.618 . . . . 0.0 110.982 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.9 mt -96.7 -41.39 8.52 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.065 0.546 . . . . 0.0 111.845 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.24 -140.15 9.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.173 0.892 . . . . 0.0 112.58 -174.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -131.71 81.57 1.98 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.964 1.364 . . . . 0.0 113.056 -168.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -98.11 157.82 15.91 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.88 1.672 . . . . 0.0 110.069 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -64.2 121.68 14.81 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 121.64 -0.662 . . . . 0.0 109.695 170.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -123.19 149.23 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.502 0.668 . . . . 0.0 111.84 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -136.22 158.77 43.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.574 1.55 . . . . 0.0 111.791 -168.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -154.22 122.76 6.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.819 1.248 . . . . 0.0 110.177 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.1 pt -77.76 159.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.392 -0.817 . . . . 0.0 111.386 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.16 151.92 18.42 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.535 1.064 . . . . 0.0 111.73 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 m -150.27 -172.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 127.16 2.184 . . . . 0.0 109.756 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -62.74 -177.01 0.13 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.338 1.455 . . . . 0.0 113.84 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -41.61 -38.98 1.49 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 127.008 2.123 . . . . 0.0 114.327 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -73.09 73.6 1.21 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.263 1.825 . . . . 0.0 110.775 170.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -66.19 53.5 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 127.746 2.418 . . . . 0.0 114.633 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -142.16 163.79 31.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.341 1.456 . . . . 0.0 112.659 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -157.47 152.13 25.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.555 1.142 . . . . 0.0 111.999 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.86 149.97 26.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.053 0.941 . . . . 0.0 113.178 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.61 176.07 5.27 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.296 1.839 . . . . 0.0 112.419 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -50.33 -49.5 53.71 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.495 1.518 . . . . 0.0 114.651 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -78.6 -9.36 59.34 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.313 1.045 . . . . 0.0 112.775 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.491 ' HA2' HG12 ' A' ' 97' ' ' VAL . . . 102.09 -7.32 54.61 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.392 1.472 . . . . 0.0 114.997 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.418 ' CE2' HD13 ' A' ' 94' ' ' LEU . 2.7 m-85 -51.26 150.93 3.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.538 1.169 . . . . 0.0 111.444 174.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.4 107.72 22.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.1 143.54 28.0 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 170.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.3 m -132.51 104.4 6.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.487 1.115 . . . . 0.0 109.996 -172.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.0 t30 . . . . . 0 C--O 1.255 1.374 0 C-N-CA 124.236 1.014 . . . . 0.0 113.396 -174.337 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -125.22 159.39 19.79 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.795 2.14 . . . . 0.0 110.748 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -159.6 175.54 13.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.945 1.298 . . . . 0.0 111.977 -174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.58 144.47 39.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.642 1.577 . . . . 0.0 110.422 -172.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -67.05 164.02 18.73 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.564 -0.71 . . . . 0.0 112.51 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.01 -44.38 64.1 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.977 -1.077 . . . . 0.0 112.026 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -64.24 -13.12 47.22 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.683 1.593 . . . . 0.0 114.383 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.7 m -75.18 81.81 2.33 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.332 1.453 . . . . 0.0 110.894 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -71.12 142.34 50.77 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.773 0.797 . . . . 0.0 111.501 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.5 mm -118.61 128.59 75.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 126.13 1.772 . . . . 0.0 106.373 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -58.17 130.85 48.54 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 122.289 -0.257 . . . . 0.0 110.919 170.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.6 p -131.88 145.15 51.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.223 1.409 . . . . 0.0 111.853 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.15 -32.62 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 121.877 -0.514 . . . . 0.0 111.922 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.74 -35.73 81.55 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -140.33 -48.71 0.44 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -170.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.59 -146.68 18.49 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.982 0.81 . . . . 0.0 113.163 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.4 96.84 1.52 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.268 1.427 . . . . 0.0 111.652 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.45 145.73 55.66 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.612 1.165 . . . . 0.0 112.407 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.14 128.4 21.6 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.78 3.653 . . . . 0.0 113.261 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.84 -37.43 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.746 0.818 . . . . 0.0 112.944 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.56 -32.84 84.54 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.618 -0.546 . . . . 0.0 112.956 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -72.52 -36.79 68.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.98 0.89 . . . . 0.0 111.298 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.89 -39.03 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.656 0.782 . . . . 0.0 109.479 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.52 -42.16 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.909 0.884 . . . . 0.0 113.11 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -75.1 -21.97 58.57 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.374 0.988 . . . . 0.0 113.507 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -109.79 1.72 19.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.145 1.378 . . . . 0.0 112.407 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.42 54.23 8.81 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.875 2.07 . . . . 0.0 113.357 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.5 mt -75.03 119.58 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.632 0.773 . . . . 0.0 110.104 -172.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.3 80.49 1.85 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.912 1.685 . . . . 0.0 112.221 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.6 p -119.49 178.49 4.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.02 1.328 . . . . 0.0 112.625 -171.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.5 m -119.25 149.46 41.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.243 1.417 . . . . 0.0 108.339 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.3 175.88 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.794 1.637 . . . . 0.0 110.967 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -121.24 142.59 49.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.428 1.491 . . . . 0.0 110.382 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.9 t -165.18 154.17 12.36 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.686 1.195 . . . . 0.0 110.835 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.4 m -84.91 145.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.665 1.12 . . . . 0.0 112.468 172.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.91 179.1 7.63 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.95 0.9 . . . . 0.0 111.917 172.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -60.59 -20.21 59.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -90.78 -0.73 57.8 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.218 1.407 . . . . 0.0 113.273 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.23 32.26 48.86 Favored Glycine 0 CA--C 1.536 1.387 0 O-C-N 121.33 -0.856 . . . . 0.0 114.099 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -112.64 121.51 44.98 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.494 1.518 . . . . 0.0 109.554 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.96 113.17 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -116.71 178.29 4.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.055 1.742 . . . . 0.0 110.528 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -128.02 143.31 51.07 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.859 0.863 . . . . 0.0 113.106 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -144.59 147.06 34.65 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.295 1.038 . . . . 0.0 113.605 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.62 150.07 50.25 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.108 2.539 . . . . 0.0 112.307 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.53 147.33 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.169 0.988 . . . . 0.0 110.808 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.64 -44.69 3.46 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.036 0.934 . . . . 0.0 111.992 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -142.41 178.17 7.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.759 1.623 . . . . 0.0 111.479 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -137.58 120.52 16.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.309 1.443 . . . . 0.0 109.29 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -118.77 138.73 52.48 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.075 0.941 . . . . 0.0 111.161 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -131.71 115.7 16.36 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.879 1.672 . . . . 0.0 110.046 -171.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -79.84 -32.13 40.53 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.982 1.313 . . . . 0.0 113.052 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.87 -53.24 1.43 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.762 1.648 . . . . 0.0 114.86 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -171.04 99.55 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.214 1.507 . . . . 0.0 111.577 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -134.51 168.05 19.67 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.486 1.114 . . . . 0.0 113.119 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -67.35 97.67 0.58 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.16 1.784 . . . . 0.0 114.278 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.9 t -94.01 138.79 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.194 1.398 . . . . 0.0 111.376 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -119.43 147.07 44.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.333 1.053 . . . . 0.0 110.448 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -82.33 123.99 29.58 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.585 1.154 . . . . 0.0 109.417 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -112.81 105.18 13.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.418 1.087 . . . . 0.0 108.722 174.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.3 t -96.19 122.17 38.76 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mp -79.24 156.72 28.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.697 0.799 . . . . 0.0 110.794 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -67.56 -18.49 65.03 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.62 -26.16 50.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.55 0.74 . . . . 0.0 112.764 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.23 -12.36 7.58 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.433 1.492 . . . . 0.0 114.275 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.1 m -60.02 148.24 36.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.41 1.084 . . . . 0.0 112.405 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -127.92 135.65 50.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.465 1.506 . . . . 0.0 110.715 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.0 mt -135.69 142.9 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.765 1.626 . . . . 0.0 108.095 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -134.03 110.85 9.92 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.784 1.234 . . . . 0.0 111.383 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.69 166.51 30.17 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.636 1.175 . . . . 0.0 110.541 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -70.18 150.04 46.89 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.55 -0.719 . . . . 0.0 111.408 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -61.07 -21.04 63.28 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -85.76 -16.18 39.71 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.883 2.073 . . . . 0.0 112.6 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -73.38 135.66 44.28 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -89.85 154.29 19.99 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.813 0.845 . . . . 0.0 111.932 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -137.2 144.36 42.83 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.084 -1.01 . . . . 0.0 111.465 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 37.6 ttm -73.81 104.0 4.55 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.002 0.921 . . . . 0.0 110.344 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.2 p -67.88 167.15 14.14 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.745 -0.597 . . . . 0.0 111.193 172.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.88 -26.79 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -79.63 -12.15 59.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.515 1.126 . . . . 0.0 113.292 175.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.95 3.7 65.59 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.127 1.346 . . . . 0.0 114.025 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -69.61 161.14 30.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.08 0.952 . . . . 0.0 110.699 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.4 ptp -127.46 80.88 1.98 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.836 1.254 . . . . 0.0 109.763 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.51 150.1 39.68 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 125.075 1.35 . . . . 0.0 110.403 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.38 142.07 77.38 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.491 2.127 . . . . 0.0 110.349 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.4 tt -60.34 -23.23 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.65 -27.72 65.02 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 170.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -89.59 -38.62 13.82 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.428 1.091 . . . . 0.0 111.852 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.35 -38.45 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 121.286 -0.884 . . . . 0.0 111.311 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.18 -36.76 80.71 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -78.92 -41.97 28.21 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.443 0.697 . . . . 0.0 112.467 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -74.34 -13.49 60.75 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 55.64 28.49 12.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.621 1.568 . . . . 0.0 112.86 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.9 128.63 35.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.554 0.742 . . . . 0.0 110.048 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.75 154.19 42.41 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 122.366 1.079 . . . . 0.0 112.329 171.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.3 mt -96.15 152.26 18.72 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.696 1.198 . . . . 0.0 111.924 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 35.3 ttm -72.38 138.39 47.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.501 0.32 . . . . 0.0 110.479 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 162.57 16.25 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.065 1.346 . . . . 0.0 113.782 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.7 -23.09 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.384 1.474 . . . . 0.0 113.978 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -101.44 8.56 42.06 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.003 0.921 . . . . 0.0 113.392 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 m120 67.33 22.15 9.61 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.663 1.585 . . . . 0.0 112.234 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.1 mt -54.34 159.19 3.32 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.497 1.519 . . . . 0.0 112.049 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.65 145.72 82.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.388 2.059 . . . . 0.0 110.722 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -67.13 121.7 16.2 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.519 -0.738 . . . . 0.0 111.162 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.2 pt -144.82 137.61 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.84 1.656 . . . . 0.0 110.317 -174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.6 175.52 5.63 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.715 1.606 . . . . 0.0 111.042 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.72 104.82 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.454 1.102 . . . . 0.0 110.513 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.9 -41.16 78.61 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.759 1.224 . . . . 0.0 112.363 -175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.6 p -146.78 154.72 41.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.537 1.535 . . . . 0.0 111.288 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -133.81 139.16 46.11 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.621 1.568 . . . . 0.0 110.987 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -141.45 130.26 22.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.474 1.51 . . . . 0.0 110.02 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.04 121.74 16.22 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 122.503 0.321 . . . . 0.0 110.392 173.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.3 mt -87.09 -40.34 14.75 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.874 0.469 . . . . 0.0 111.795 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.21 -144.87 15.87 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.329 0.966 . . . . 0.0 112.583 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -124.6 81.46 1.95 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.935 1.35 . . . . 0.0 112.486 -168.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -98.74 158.06 15.87 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.613 1.565 . . . . 0.0 110.948 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -64.44 119.13 9.82 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.644 0.778 . . . . 0.0 110.323 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.87 149.43 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.483 0.713 . . . . 0.0 111.216 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -139.09 158.4 44.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.861 1.664 . . . . 0.0 111.771 -168.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -156.28 121.48 4.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.747 1.219 . . . . 0.0 110.297 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.8 pt -73.27 155.74 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 120.911 -1.118 . . . . 0.0 111.467 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.89 147.61 16.36 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.662 1.125 . . . . 0.0 111.74 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.88 152.43 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.965 2.106 . . . . 0.0 109.845 -169.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -101.13 -33.69 10.01 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -169.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -72.82 -48.24 39.56 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.988 0.915 . . . . 0.0 112.44 -174.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -162.71 162.92 27.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.077 2.551 . . . . 0.0 109.559 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -104.01 57.74 0.72 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.134 0.974 . . . . 0.0 112.167 -169.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -155.62 156.57 35.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.401 1.08 . . . . 0.0 113.776 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -162.14 160.78 27.66 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.389 1.476 . . . . 0.0 112.516 -173.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.44 148.84 21.78 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.489 1.116 . . . . 0.0 113.864 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 54.2 mt -100.73 166.44 10.87 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.267 1.827 . . . . 0.0 113.018 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -57.73 -33.18 68.16 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -75.81 -13.71 60.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.704 0.801 . . . . 0.0 112.625 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.89 30.29 5.83 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 117.579 -1.679 . . . . 0.0 114.841 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.0 165.33 22.38 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.783 1.792 . . . . 0.0 111.778 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.06 139.24 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.104 0.962 . . . . 0.0 110.13 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.04 152.92 46.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.609 1.564 . . . . 0.0 110.654 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.5 t -136.48 140.82 43.35 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.143 1.377 . . . . 0.0 112.342 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -169.487 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 CA-C-O 120.972 0.206 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -143.94 174.24 24.4 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 129.132 3.253 . . . . 0.0 110.23 -171.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.42 170.07 17.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.492 ' HG ' HG21 ' A' ' 6' ' ' THR . 2.2 mm? -106.73 152.32 23.97 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.784 1.233 . . . . 0.0 110.974 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 t -63.2 161.7 13.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -52.49 -43.86 65.28 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.79 0.836 . . . . 0.0 112.221 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -60.9 -23.22 65.05 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.67 1.588 . . . . 0.0 113.52 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.492 HG21 ' HG ' ' A' ' 2' ' ' LEU . 87.7 m -66.15 114.73 5.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.101 0.961 . . . . 0.0 111.557 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -94.58 140.42 29.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.647 0.736 . . . . 0.0 112.439 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 mm -118.03 125.24 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 126.365 1.866 . . . . 0.0 108.103 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 tp -64.25 129.48 40.1 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.558 0.743 . . . . 0.0 111.369 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.9 p -128.4 156.58 42.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.122 1.369 . . . . 0.0 112.063 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 t -78.05 -31.64 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 O-C-N 121.739 -0.601 . . . . 0.0 111.88 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.04 -35.13 79.7 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -139.93 -44.97 0.43 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.33 -143.78 14.96 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.194 0.902 . . . . 0.0 111.288 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.0 mt -67.32 111.77 4.19 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.079 1.351 . . . . 0.0 111.279 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.1 mt -139.76 151.73 66.59 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.829 1.252 . . . . 0.0 113.323 176.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.55 128.72 20.73 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.131 3.221 . . . . 0.0 112.638 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 tt -58.24 -35.91 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.83 -31.54 81.24 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.867 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -71.24 -37.53 71.98 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.491 1.145 . . . . 0.0 111.322 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.45 -37.74 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.523 0.729 . . . . 0.0 110.762 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.6 t -85.7 -36.4 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.35 0.66 . . . . 0.0 112.657 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.77 -25.39 63.79 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.264 -0.897 . . . . 0.0 113.298 174.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -113.44 2.84 15.56 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.086 1.354 . . . . 0.0 113.0 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 46.82 47.98 15.07 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 127.538 2.335 . . . . 0.0 112.702 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.9 mt -70.61 121.31 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.798 1.239 . . . . 0.0 109.38 -174.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -82.37 120.18 25.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.912 0.863 . . . . 0.0 110.93 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.6 p -153.01 164.01 38.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.55 1.14 . . . . 0.0 112.75 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.7 145.8 24.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.074 1.35 . . . . 0.0 109.813 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.47 176.74 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.391 1.876 . . . . 0.0 110.756 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -121.75 144.26 48.9 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.179 1.392 . . . . 0.0 110.697 -176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.2 t -158.73 167.23 30.05 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.586 1.554 . . . . 0.0 110.599 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.78 123.98 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.156 1.382 . . . . 0.0 110.086 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.5 179.52 4.02 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.6 -18.88 65.3 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -90.21 -2.26 58.03 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.643 1.577 . . . . 0.0 112.086 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.79 29.89 62.52 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.053 1.787 . . . . 0.0 114.614 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -111.85 140.15 46.73 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.155 1.382 . . . . 0.0 110.497 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.3 mt -67.95 133.07 32.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -138.47 166.67 23.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.558 1.543 . . . . 0.0 111.452 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 p -118.08 143.53 46.37 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.418 1.087 . . . . 0.0 111.714 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -150.83 146.71 19.7 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.656 1.182 . . . . 0.0 111.951 -172.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.34 151.59 48.59 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.881 2.387 . . . . 0.0 112.495 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.2 139.46 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.103 0.961 . . . . 0.0 111.449 169.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.45 -35.29 9.61 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.186 0.995 . . . . 0.0 113.075 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.14 175.48 13.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.782 1.233 . . . . 0.0 112.777 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -124.14 135.66 53.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.565 1.546 . . . . 0.0 108.809 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -124.36 119.67 29.92 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.04 1.336 . . . . 0.0 110.86 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.57 110.02 16.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 110.432 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -87.37 -30.21 20.94 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.597 1.159 . . . . 0.0 112.988 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.9 -52.01 2.91 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.044 1.307 . . . . 0.0 114.099 171.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -170.97 98.46 0.21 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.588 1.194 . . . . 0.0 111.201 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -129.96 162.98 27.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.33 1.052 . . . . 0.0 112.155 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.39 102.3 1.39 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.69 1.196 . . . . 0.0 113.191 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.6 t -94.93 138.27 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.445 1.498 . . . . 0.0 110.925 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -124.89 144.92 50.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.274 1.43 . . . . 0.0 110.029 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -65.18 127.61 32.41 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.968 0.907 . . . . 0.0 110.469 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -119.51 86.58 2.58 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.874 1.67 . . . . 0.0 108.419 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.0 t -89.7 144.56 25.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.161 0.984 . . . . 0.0 110.787 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.02 163.92 12.88 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.369 1.067 . . . . 0.0 112.668 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.42 -20.33 63.79 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -76.05 -26.52 56.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.526 1.13 . . . . 0.0 112.555 171.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.16 -1.97 23.98 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.969 1.271 . . . . 0.0 113.998 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.59 147.22 42.43 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.937 1.295 . . . . 0.0 111.269 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.1 mt -134.84 130.78 36.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.117 1.367 . . . . 0.0 110.645 -172.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.6 mt -137.91 151.41 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.462 1.905 . . . . 0.0 107.757 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -136.26 106.15 6.26 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.663 1.185 . . . . 0.0 110.165 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.46 166.32 24.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.099 1.36 . . . . 0.0 111.89 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.1 p -86.85 157.32 19.57 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.924 0.869 . . . . 0.0 112.627 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -72.61 -5.01 34.39 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -91.34 -15.58 28.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.341 1.057 . . . . 0.0 112.556 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -77.63 131.67 37.89 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.699 -0.626 . . . . 0.0 111.147 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -90.03 153.97 20.17 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.19 0.996 . . . . 0.0 111.172 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -139.0 143.82 38.65 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.568 0.747 . . . . 0.0 110.416 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.2 ttm -74.11 104.35 4.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.155 0.982 . . . . 0.0 110.533 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.7 p -68.75 171.04 8.36 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.199 0.523 . . . . 0.0 111.936 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.1 m -56.57 -24.79 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 173.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -92.17 -6.15 51.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.145 0.978 . . . . 0.0 113.268 174.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.41 24.04 52.21 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.789 1.185 . . . . 0.0 113.793 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -88.82 120.26 30.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.081 0.952 . . . . 0.0 110.661 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.1 mmt -80.62 80.33 7.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.359 1.064 . . . . 0.0 111.68 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.3 mt -112.96 147.43 37.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 124.754 1.222 . . . . 0.0 110.888 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.84 146.92 84.57 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.57 2.18 . . . . 0.0 110.992 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.24 -25.05 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -55.89 -34.43 65.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.833 1.253 . . . . 0.0 113.014 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.0 -41.54 25.63 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.927 0.891 . . . . 0.0 110.496 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.88 -36.16 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.991 0.916 . . . . 0.0 111.498 -174.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -66.72 -35.44 80.12 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.24 -35.7 21.41 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.491 -0.756 . . . . 0.0 112.642 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -74.11 -17.52 60.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.403 1.081 . . . . 0.0 113.018 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 54.78 33.64 20.1 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.249 1.42 . . . . 0.0 112.963 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.4 mt -76.02 143.39 41.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.768 0.827 . . . . 0.0 111.907 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -88.53 148.07 24.3 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.815 0.846 . . . . 0.0 110.92 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.9 156.86 22.18 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.385 -0.822 . . . . 0.0 112.367 168.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 7.9 ttp -88.84 158.57 18.07 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.75 1.22 . . . . 0.0 111.378 169.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.12 165.57 25.4 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.061 1.345 . . . . 0.0 112.9 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.1 m -88.44 -21.77 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.01 13.52 34.53 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.206 1.002 . . . . 0.0 113.084 -171.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.1 m120 58.44 29.25 18.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.195 1.798 . . . . 0.0 112.429 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 mt -57.66 153.93 28.18 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.223 173.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.83 140.19 50.04 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.648 2.899 . . . . 0.0 111.15 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -79.82 120.59 24.28 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.017 0.527 . . . . 0.0 111.01 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.5 pt -142.8 153.5 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.908 1.683 . . . . 0.0 111.56 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.62 -179.6 3.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.911 1.684 . . . . 0.0 111.806 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.1 mt -64.43 114.65 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.107 0.963 . . . . 0.0 110.214 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.42 -41.16 73.27 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.839 1.256 . . . . 0.0 112.316 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.75 157.81 34.1 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.223 1.409 . . . . 0.0 111.009 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -137.12 143.83 42.72 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.491 1.516 . . . . 0.0 110.562 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -151.09 134.51 16.21 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.49 1.516 . . . . 0.0 109.506 169.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -63.6 123.4 18.72 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.705 0.684 . . . . 0.0 110.375 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.2 mt -90.04 -44.02 10.12 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.01 0.524 . . . . 0.0 111.692 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 148.38 -148.11 19.3 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.329 0.966 . . . . 0.0 112.979 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -126.6 67.87 1.24 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 123.576 1.655 . . . . 0.0 112.469 -168.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -85.74 158.02 20.13 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 126.723 2.009 . . . . 0.0 110.635 -169.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.04 119.65 9.9 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.135 0.574 . . . . 0.0 110.5 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -123.06 150.49 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.41 0.624 . . . . 0.0 111.839 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -140.06 157.84 45.0 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.215 1.806 . . . . 0.0 112.264 -168.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -152.67 167.37 29.17 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.916 1.687 . . . . 0.0 110.969 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.8 145.72 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.417 1.487 . . . . 0.0 111.338 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.09 160.44 23.06 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.79 0.709 . . . . 0.0 112.865 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.68 151.1 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.36 1.864 . . . . 0.0 110.487 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -82.86 150.24 26.65 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.474 -0.766 . . . . 0.0 111.938 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 56.43 16.72 2.58 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 126.159 1.783 . . . . 0.0 114.843 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -159.01 164.92 35.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.124 1.37 . . . . 0.0 111.858 -169.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -142.92 21.06 1.96 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -156.0 173.26 17.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.433 1.493 . . . . 0.0 112.683 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -163.34 166.55 22.87 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.836 1.254 . . . . 0.0 111.809 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.92 140.49 31.38 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.015 0.926 . . . . 0.0 112.949 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 133' ' ' PHE . 65.3 mt -91.73 170.49 9.87 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.143 1.777 . . . . 0.0 111.882 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -47.17 -58.12 4.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.779 1.632 . . . . 0.0 115.22 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -67.13 -39.64 86.65 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.556 0.342 . . . . 0.0 110.861 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.33 -2.97 0.85 Allowed Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.475 -1.181 . . . . 0.0 115.331 172.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.411 ' HB2' HD12 ' A' ' 129' ' ' LEU . 18.7 m-85 -59.49 160.89 6.39 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.176 1.488 . . . . 0.0 112.332 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.91 129.14 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.63 0.729 . . . . 0.0 110.179 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -118.52 145.65 45.16 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.991 1.716 . . . . 0.0 109.977 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.3 t -136.78 149.15 47.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.542 1.137 . . . . 0.0 114.006 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.8 t30 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.895 1.678 . . . . 0.0 113.648 -172.046 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.876 0 CA-C-O 119.108 -0.829 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 62.98 179.15 4.54 Favored Glycine 0 C--N 1.341 0.854 0 C-N-CA 126.039 1.78 . . . . 0.0 115.198 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -151.17 169.13 22.64 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.345 1.058 . . . . 0.0 112.207 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.8 mt -120.78 146.87 46.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.386 1.874 . . . . 0.0 109.514 -172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 t -70.15 160.34 32.26 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.585 -0.697 . . . . 0.0 111.437 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -49.09 -40.9 33.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.292 1.037 . . . . 0.0 112.344 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.88 -24.8 54.47 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.983 1.713 . . . . 0.0 113.777 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.2 m -72.14 102.65 3.09 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.293 1.037 . . . . 0.0 110.942 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -87.52 145.87 26.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.747 0.784 . . . . 0.0 111.67 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -122.81 128.84 75.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 126.501 1.92 . . . . 0.0 107.317 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.2 tp -61.95 127.76 32.94 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.834 0.454 . . . . 0.0 111.37 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.3 p -125.57 150.44 47.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.847 1.259 . . . . 0.0 112.368 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.42 -32.39 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.287 0.635 . . . . 0.0 111.982 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -66.22 -30.42 70.87 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -142.56 -56.55 0.44 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -173.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.26 -147.81 19.44 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.835 0.731 . . . . 0.0 112.681 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.4 104.75 1.97 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.084 1.353 . . . . 0.0 111.347 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.4 mt -134.61 148.68 68.35 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.434 1.094 . . . . 0.0 113.451 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.52 129.53 24.05 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.462 3.441 . . . . 0.0 112.665 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.1 tt -56.29 -35.31 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.609 0.764 . . . . 0.0 112.888 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.79 -34.36 89.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.566 -0.574 . . . . 0.0 112.724 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -73.92 -29.63 62.15 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.654 1.227 . . . . 0.0 112.015 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.6 mt -71.77 -41.96 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.452 1.101 . . . . 0.0 109.769 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.29 -39.99 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.756 0.822 . . . . 0.0 113.004 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.11 -26.3 65.74 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.308 0.958 . . . . 0.0 112.643 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.45 2.04 15.27 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.616 1.166 . . . . 0.0 113.398 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 46.89 50.68 13.4 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.344 2.258 . . . . 0.0 112.139 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.3 mt -67.05 120.19 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.873 0.869 . . . . 0.0 108.868 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -84.4 98.57 10.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.945 0.879 . . . . 0.0 110.321 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p -132.02 -171.14 2.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.08 1.352 . . . . 0.0 111.463 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.25 142.23 50.9 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.458 1.503 . . . . 0.0 108.008 -176.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.48 172.94 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.802 1.641 . . . . 0.0 110.169 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -117.55 145.19 44.43 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.012 1.325 . . . . 0.0 110.194 -173.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.4 t -159.07 167.03 30.31 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.29 1.436 . . . . 0.0 110.139 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -113.31 127.29 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.158 1.383 . . . . 0.0 110.824 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.17 179.61 6.77 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.276 1.036 . . . . 0.0 111.951 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -57.34 -24.84 57.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.142 1.377 . . . . 0.0 113.405 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -88.73 -6.4 57.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.816 1.646 . . . . 0.0 113.827 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.78 4.14 89.0 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.263 0.935 . . . . 0.0 114.786 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -77.37 128.48 34.35 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.11 0.955 . . . . 0.0 109.906 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.68 107.38 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -107.48 175.22 5.56 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.574 1.549 . . . . 0.0 110.403 175.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.6 p -130.99 149.03 52.8 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.703 0.801 . . . . 0.0 112.789 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -146.07 144.52 21.9 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.788 1.235 . . . . 0.0 111.997 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.44 151.21 47.57 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.819 2.346 . . . . 0.0 112.172 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.31 122.0 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 169.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.03 -47.63 12.41 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.27 -0.269 . . . . 0.0 111.56 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -148.7 179.14 8.05 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.021 1.729 . . . . 0.0 111.585 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -137.47 142.08 41.55 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.732 1.613 . . . . 0.0 110.289 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -136.79 132.38 34.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.999 0.92 . . . . 0.0 111.614 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -124.06 119.66 30.16 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.471 1.508 . . . . 0.0 110.595 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -84.82 -32.25 23.41 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.692 1.197 . . . . 0.0 113.086 -173.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 -53.33 1.33 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.528 1.537 . . . . 0.0 113.975 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -170.09 101.51 0.29 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.086 1.354 . . . . 0.0 111.087 -173.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -131.57 160.87 34.04 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.531 1.133 . . . . 0.0 111.899 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.91 106.52 1.25 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.405 1.082 . . . . 0.0 112.925 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.65 134.75 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.25 1.42 . . . . 0.0 111.358 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -119.78 140.78 50.22 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.76 1.224 . . . . 0.0 110.31 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.11 132.01 35.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.127 0.971 . . . . 0.0 108.799 168.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.18 89.04 3.05 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.112 1.365 . . . . 0.0 108.541 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 45.6 t -71.88 129.29 38.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.662 0.785 . . . . 0.0 110.377 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -88.54 164.87 15.21 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.201 1.0 . . . . 0.0 112.304 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.17 -23.02 67.16 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -82.18 -26.59 33.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.654 1.182 . . . . 0.0 113.084 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.95 -4.58 16.41 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.029 1.299 . . . . 0.0 114.264 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 m -58.54 141.34 52.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.556 1.178 . . . . 0.0 110.802 173.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.32 122.2 40.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.939 0.896 . . . . 0.0 109.52 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -110.97 131.09 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -124.66 97.35 5.25 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.38 1.072 . . . . 0.0 109.884 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.9 169.82 17.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.54 1.136 . . . . 0.0 113.03 -168.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 p -84.75 152.2 23.86 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.443 1.097 . . . . 0.0 111.486 169.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -62.65 -12.27 22.3 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.35 -13.49 34.99 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.32 1.448 . . . . 0.0 112.376 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -82.87 134.77 35.08 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.599 0.636 . . . . 0.0 109.666 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -86.91 156.75 19.7 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.657 0.783 . . . . 0.0 111.345 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -137.69 142.64 41.09 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.783 0.833 . . . . 0.0 109.286 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 31.1 ttp -79.52 106.17 11.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.024 0.529 . . . . 0.0 110.0 -174.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.4 p -66.47 169.33 7.67 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.008 0.523 . . . . 0.0 111.909 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 m -56.44 -27.87 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.8 -14.48 54.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.386 1.074 . . . . 0.0 113.283 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.68 6.06 56.45 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.445 1.497 . . . . 0.0 114.705 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -71.7 155.34 40.59 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.692 1.246 . . . . 0.0 111.384 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.7 ptp -116.86 74.24 0.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.803 1.241 . . . . 0.0 110.961 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.73 147.0 33.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.487 1.115 . . . . 0.0 110.977 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.78 146.96 92.53 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.034 2.49 . . . . 0.0 111.159 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tt -59.27 -24.78 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -54.78 -38.69 67.58 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.861 1.265 . . . . 0.0 112.61 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -81.28 -38.75 26.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.19 0.596 . . . . 0.0 110.848 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.452 HD13 HD21 ' A' ' 94' ' ' LEU . 77.2 mt -61.88 -40.89 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.389 -0.82 . . . . 0.0 111.665 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -64.33 -39.36 93.74 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.88 -40.12 25.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.968 0.907 . . . . 0.0 113.069 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -81.03 -11.96 59.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.754 1.222 . . . . 0.0 112.938 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 57.87 32.91 22.58 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.403 1.481 . . . . 0.0 112.737 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 mt -70.31 133.48 47.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.663 1.185 . . . . 0.0 110.971 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -72.11 154.58 41.0 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.546 -0.721 . . . . 0.0 111.76 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.452 HD21 HD13 ' A' ' 87' ' ' ILE . 62.5 mt -105.89 147.66 28.49 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.936 0.894 . . . . 0.0 112.406 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.8 ttm -70.17 151.64 45.18 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.511 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.27 174.04 10.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.481 1.112 . . . . 0.0 112.545 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.0 -0.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 125.775 1.63 . . . . 0.0 114.694 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.29 12.55 21.68 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.299 1.44 . . . . 0.0 113.265 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.8 m120 59.98 25.05 14.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.228 1.811 . . . . 0.0 113.02 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.8 mt -63.75 159.1 56.16 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.976 1.71 . . . . 0.0 112.013 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.19 146.2 80.76 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.004 2.47 . . . . 0.0 111.477 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -76.43 113.54 14.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.095 0.558 . . . . 0.0 109.708 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.95 150.58 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.318 1.447 . . . . 0.0 111.232 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.09 174.23 6.03 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.652 1.581 . . . . 0.0 111.21 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.4 mt -66.18 113.37 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.881 0.872 . . . . 0.0 109.878 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.28 74.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.026 1.331 . . . . 0.0 111.628 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.7 p -153.38 160.76 42.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.212 1.805 . . . . 0.0 111.784 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -117.4 145.26 44.22 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.081 1.752 . . . . 0.0 110.456 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -147.0 121.67 9.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.25 1.02 . . . . 0.0 110.871 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -64.18 135.84 56.68 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.84 -0.538 . . . . 0.0 111.175 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.5 mt -105.99 -37.98 6.47 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.255 0.622 . . . . 0.0 112.167 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.23 -144.78 15.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.458 1.028 . . . . 0.0 112.462 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -128.8 78.77 1.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 123.193 1.473 . . . . 0.0 112.141 -169.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -96.84 160.35 14.41 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.916 1.686 . . . . 0.0 111.074 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.44 119.32 8.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.392 0.677 . . . . 0.0 110.433 169.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.97 150.67 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.451 0.644 . . . . 0.0 111.384 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -138.44 158.76 43.65 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.67 1.588 . . . . 0.0 112.217 -168.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -158.23 133.4 8.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.425 1.09 . . . . 0.0 110.992 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.8 pt -82.3 158.4 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.389 -0.819 . . . . 0.0 111.354 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.22 139.9 15.79 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.84 1.209 . . . . 0.0 111.424 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 m -146.21 151.57 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.652 1.981 . . . . 0.0 110.002 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -117.9 -24.86 6.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.327 1.051 . . . . 0.0 112.916 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -65.7 -28.96 69.45 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.576 1.55 . . . . 0.0 112.91 174.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -157.59 -171.3 3.52 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.111 1.765 . . . . 0.0 110.928 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.06 38.31 2.77 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.924 1.69 . . . . 0.0 112.797 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.37 160.59 13.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.26 1.024 . . . . 0.0 113.29 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -153.96 154.93 34.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.842 1.657 . . . . 0.0 111.984 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.24 131.65 34.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.526 1.131 . . . . 0.0 112.688 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 38.5 mt -82.87 170.59 14.82 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.172 1.389 . . . . 0.0 112.669 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -55.66 -41.15 73.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -75.32 -33.28 61.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.39 0.676 . . . . 0.0 111.577 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.4 -9.15 5.02 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.163 1.363 . . . . 0.0 114.304 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.74 173.1 5.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.614 1.707 . . . . 0.0 111.79 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.29 122.0 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.472 0.709 . . . . 0.0 109.843 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.63 131.48 44.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.336 1.054 . . . . 0.0 108.369 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 p -108.61 143.35 37.78 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.581 1.552 . . . . 0.0 110.775 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--O 1.255 1.394 0 CA-C-O 117.653 -1.165 . . . . 0.0 113.1 -167.811 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 112.382 -0.287 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -139.12 164.1 25.89 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 126.684 2.088 . . . . 0.0 112.182 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.08 179.19 7.69 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.989 1.315 . . . . 0.0 112.55 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.6 150.27 36.93 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.034 1.733 . . . . 0.0 111.015 -173.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 t -69.52 163.77 24.67 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.5 -0.75 . . . . 0.0 112.186 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -50.2 -43.82 52.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.914 0.885 . . . . 0.0 112.011 172.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -62.54 -15.77 52.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.993 1.317 . . . . 0.0 114.322 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.8 m -70.94 102.21 2.35 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.081 0.953 . . . . 0.0 111.043 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -86.24 137.65 32.46 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.357 0.663 . . . . 0.0 112.11 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.2 mm -122.9 119.13 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.896 1.678 . . . . 0.0 107.929 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.24 127.88 33.53 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 122.253 -0.279 . . . . 0.0 111.161 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.6 p -124.93 155.94 38.78 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.72 1.608 . . . . 0.0 112.375 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.6 t -81.24 -33.68 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.992 0.517 . . . . 0.0 111.72 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.31 -25.78 61.7 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -137.88 -53.85 0.65 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.95 0.9 . . . . 0.0 113.281 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.73 -146.46 18.27 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.1 0.857 . . . . 0.0 112.352 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -74.44 107.31 6.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.067 1.747 . . . . 0.0 110.925 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.439 ' CD1' HD11 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -146.56 157.07 48.74 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 177.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.25 132.86 26.91 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.172 3.248 . . . . 0.0 112.925 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.43 ' HA ' HD12 ' A' ' 21' ' ' ILE . 20.6 tt -56.42 -34.79 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.767 0.827 . . . . 0.0 112.987 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.9 -34.22 89.34 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.731 -0.606 . . . . 0.0 112.784 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -71.59 -32.72 68.34 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.481 1.141 . . . . 0.0 111.921 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' A' ' 16' ' ' LEU . 62.9 mt -67.48 -43.38 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.124 0.969 . . . . 0.0 110.153 176.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.5 t -82.66 -36.67 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.832 0.853 . . . . 0.0 112.669 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -65.8 -27.07 68.0 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.141 0.882 . . . . 0.0 112.857 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -116.33 2.65 13.25 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.32 1.048 . . . . 0.0 113.529 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 46.62 52.62 10.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.924 2.49 . . . . 0.0 112.528 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.7 mt -74.11 119.99 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.278 1.031 . . . . 0.0 109.936 -172.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -71.95 108.37 5.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.916 0.887 . . . . 0.0 110.532 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.5 p -148.15 161.09 42.16 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.363 1.078 . . . . 0.0 113.844 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 151.83 19.23 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.909 1.684 . . . . 0.0 109.907 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.35 170.99 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 125.251 1.42 . . . . 0.0 111.347 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -114.87 142.23 46.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.477 1.511 . . . . 0.0 111.093 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.8 t -164.44 152.69 12.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.174 1.389 . . . . 0.0 110.653 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 m -81.67 154.64 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.625 1.102 . . . . 0.0 112.698 170.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -96.08 -174.81 3.2 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.648 1.579 . . . . 0.0 113.221 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -62.77 -13.35 32.04 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -98.55 -5.41 32.12 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.4 1.48 . . . . 0.0 112.361 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.19 26.28 44.78 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.728 1.156 . . . . 0.0 114.588 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -109.82 122.82 48.4 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.135 1.468 . . . . 0.0 110.165 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 mt -67.69 103.12 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.979 0.912 . . . . 0.0 109.41 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -100.86 179.08 4.5 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.737 1.615 . . . . 0.0 111.031 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 p -126.84 143.1 51.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.192 0.997 . . . . 0.0 112.957 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -144.96 144.25 23.33 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 125.004 1.322 . . . . 0.0 112.442 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.51 149.21 43.87 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.098 2.532 . . . . 0.0 112.11 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.34 137.91 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.873 0.869 . . . . 0.0 110.745 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.64 -34.74 12.48 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -167.43 178.6 5.39 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.972 1.709 . . . . 0.0 112.308 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.2 m-90 -132.69 137.28 46.88 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.214 1.405 . . . . 0.0 110.217 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -127.59 114.78 17.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.685 1.194 . . . . 0.0 111.313 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.29 108.19 19.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.424 1.49 . . . . 0.0 109.877 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -78.49 -29.36 46.68 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.304 1.042 . . . . 0.0 112.752 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.31 -45.85 2.22 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.268 1.413 . . . . 0.0 114.026 171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 177.21 102.75 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.436 1.495 . . . . 0.0 112.183 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -132.22 166.66 21.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.747 1.219 . . . . 0.0 112.373 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.86 100.09 0.91 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.401 1.48 . . . . 0.0 113.851 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.86 141.7 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.346 1.458 . . . . 0.0 111.617 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -123.4 140.2 53.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.176 1.791 . . . . 0.0 110.217 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.11 130.05 44.79 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.979 0.912 . . . . 0.0 109.959 172.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -128.15 97.04 4.64 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.381 1.072 . . . . 0.0 108.232 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 45.9 t -111.34 142.16 43.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.166 0.987 . . . . 0.0 110.355 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -104.04 162.26 13.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.772 1.229 . . . . 0.0 112.117 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.85 -20.57 65.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.444 1.098 . . . . 0.0 113.723 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -76.11 -28.25 57.43 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.601 1.161 . . . . 0.0 113.031 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.91 -0.25 19.67 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.737 1.161 . . . . 0.0 114.547 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 m -58.27 146.86 32.65 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.319 1.06 . . . . 0.0 111.173 171.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.0 124.93 27.1 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.486 1.114 . . . . 0.0 110.435 -171.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.2 mt -137.61 150.51 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.942 2.097 . . . . 0.0 108.091 -170.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -136.62 110.91 8.43 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.57 1.148 . . . . 0.0 110.062 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.24 160.57 40.75 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.333 1.453 . . . . 0.0 111.518 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 p -75.31 151.0 38.33 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.385 -0.822 . . . . 0.0 111.782 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -63.19 -19.14 64.24 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.35 -15.18 56.09 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.772 1.629 . . . . 0.0 112.679 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -79.58 132.95 36.42 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.736 0.814 . . . . 0.0 110.038 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -93.79 146.68 23.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.592 1.157 . . . . 0.0 112.385 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.526 ' HB3' HD11 ' A' ' 94' ' ' LEU . 65.6 m-85 -128.74 151.84 49.1 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.845 -1.159 . . . . 0.0 111.483 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.3 ttp -92.78 100.48 12.95 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.447 0.699 . . . . 0.0 110.563 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.7 p -69.33 172.6 6.82 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.583 0.753 . . . . 0.0 112.342 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 m -52.56 -29.55 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -86.94 -10.04 54.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.082 0.953 . . . . 0.0 113.342 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.96 10.89 62.21 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.793 1.187 . . . . 0.0 114.135 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -67.61 158.72 31.45 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.235 1.018 . . . . 0.0 111.024 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 37.0 mtm -126.21 70.99 1.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.783 1.633 . . . . 0.0 109.848 -173.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 mt -111.81 149.28 40.57 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 124.895 1.278 . . . . 0.0 110.599 -170.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.41 149.37 88.13 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.646 2.231 . . . . 0.0 110.379 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.51 -28.57 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -55.19 -35.22 64.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.678 1.191 . . . . 0.0 113.007 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.49 -37.9 59.88 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.283 1.033 . . . . 0.0 111.471 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.542 HG23 ' HB2' ' A' ' 92' ' ' LEU . 68.7 mt -68.24 -38.51 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.603 1.161 . . . . 0.0 109.945 -176.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.96 -37.15 86.34 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -75.09 -46.72 32.74 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -79.43 -5.4 54.61 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 56.48 35.48 26.05 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.626 1.57 . . . . 0.0 112.531 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.542 ' HB2' HG23 ' A' ' 87' ' ' ILE . 66.0 mt -65.99 132.18 47.97 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.524 1.13 . . . . 0.0 110.825 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -75.31 136.85 40.85 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.838 -0.539 . . . . 0.0 110.328 171.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 74' ' ' PHE . 3.0 mm? -69.96 152.64 44.22 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.289 -0.882 . . . . 0.0 111.35 168.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.9 ttm -71.06 150.82 45.17 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.378 168.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.81 161.53 25.07 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.61 1.564 . . . . 0.0 112.598 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -113.6 -13.57 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.941 1.696 . . . . 0.0 114.133 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -109.48 11.55 24.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.046 1.338 . . . . 0.0 112.866 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.9 m120 64.2 25.89 13.7 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.537 1.535 . . . . 0.0 112.672 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.5 mt -55.67 157.12 7.96 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.671 1.588 . . . . 0.0 111.999 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.76 141.53 79.19 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.695 2.264 . . . . 0.0 110.397 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -66.04 128.64 36.87 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.792 -0.568 . . . . 0.0 110.712 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.4 pt -147.16 149.91 15.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 126.538 1.935 . . . . 0.0 109.897 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 -179.95 3.92 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.309 1.444 . . . . 0.0 111.333 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 25.1 mt -63.56 105.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.251 1.02 . . . . 0.0 110.028 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.45 77.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.156 1.382 . . . . 0.0 111.576 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 p -149.44 149.18 30.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.852 1.661 . . . . 0.0 111.076 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -143.43 144.0 31.85 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.908 1.683 . . . . 0.0 110.36 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -159.37 148.71 18.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.423 1.889 . . . . 0.0 110.042 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -65.11 128.39 35.59 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.546 0.612 . . . . 0.0 110.995 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.7 mt -93.53 -46.18 7.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.085 0.554 . . . . 0.0 111.748 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 147.73 -151.24 23.51 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.415 1.007 . . . . 0.0 112.544 -172.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -123.28 86.1 2.52 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 122.689 1.233 . . . . 0.0 112.135 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -102.01 154.56 18.86 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.248 1.419 . . . . 0.0 110.075 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.68 116.61 4.52 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.164 0.586 . . . . 0.0 109.964 169.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.06 151.66 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.541 0.686 . . . . 0.0 110.942 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -141.11 157.38 45.36 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.814 1.645 . . . . 0.0 111.412 -168.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -156.32 146.02 20.98 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.522 0.729 . . . . 0.0 109.872 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.7 pt -100.15 143.68 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.777 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -93.96 151.77 20.42 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.45 0.548 . . . . 0.0 111.772 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.5 t -148.68 133.24 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.758 1.623 . . . . 0.0 108.869 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -79.26 -36.56 39.66 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -69.31 -68.26 0.42 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.672 1.589 . . . . 0.0 111.879 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.33 118.47 9.49 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.762 1.225 . . . . 0.0 109.967 -174.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -71.75 47.41 0.14 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.522 2.329 . . . . 0.0 113.754 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -158.21 163.33 37.58 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.347 -1.47 . . . . 0.0 114.04 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -161.62 156.97 23.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.641 1.576 . . . . 0.0 112.254 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.35 147.08 26.2 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.716 1.206 . . . . 0.0 112.962 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.05 168.86 9.57 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.671 1.588 . . . . 0.0 112.076 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -48.83 -51.02 31.77 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.126 1.37 . . . . 0.0 114.025 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -73.42 -20.47 60.72 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -172.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 127.14 -4.27 7.31 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.791 1.186 . . . . 0.0 114.91 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.31 171.87 11.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.081 1.44 . . . . 0.0 112.279 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.84 138.61 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.247 1.019 . . . . 0.0 109.999 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.5 149.1 50.28 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.306 1.842 . . . . 0.0 109.351 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.0 t -134.96 123.21 23.01 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -171.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.485 2.314 . . . . 0.0 114.074 178.849 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.913 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -116.84 168.24 12.74 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 127.453 2.454 . . . . 0.0 110.948 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.99 175.94 10.64 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.22 1.008 . . . . 0.0 113.166 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -108.92 150.02 28.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.87 1.668 . . . . 0.0 111.071 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -65.81 161.76 20.27 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.405 0.682 . . . . 0.0 112.149 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -52.23 -44.15 64.66 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.823 0.849 . . . . 0.0 112.481 172.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.35 -23.75 64.51 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.791 1.636 . . . . 0.0 113.84 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -63.23 112.92 2.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.176 0.991 . . . . 0.0 111.341 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -96.55 135.3 38.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.42 0.688 . . . . 0.0 111.048 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.6 mm -118.43 122.81 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.653 1.581 . . . . 0.0 107.954 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -64.93 124.38 21.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.279 0.231 . . . . 0.0 111.289 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.2 p -121.83 153.65 38.07 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.632 1.173 . . . . 0.0 112.146 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.9 -30.41 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 121.877 -0.514 . . . . 0.0 111.8 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -65.62 -36.42 83.66 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -140.46 -49.45 0.45 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.32 -146.52 18.5 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.966 0.794 . . . . 0.0 112.51 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.3 mt -66.78 96.31 0.4 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.665 1.586 . . . . 0.0 112.639 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.66 147.8 62.21 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.887 1.275 . . . . 0.0 111.92 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.45 129.14 21.81 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 124.289 3.326 . . . . 0.0 112.794 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.5 tt -56.78 -37.25 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.004 0.921 . . . . 0.0 113.035 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.29 -31.35 78.77 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.662 -0.649 . . . . 0.0 113.291 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -76.23 -30.98 58.13 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.952 0.876 . . . . 0.0 111.817 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.58 -40.51 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.244 1.018 . . . . 0.0 109.642 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.71 -39.83 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.521 0.728 . . . . 0.0 112.951 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.1 -21.81 56.26 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.389 0.995 . . . . 0.0 113.513 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -109.51 1.87 20.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.778 1.231 . . . . 0.0 112.299 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.98 51.26 13.04 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.975 2.11 . . . . 0.0 112.663 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.5 mt -71.59 120.82 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.213 0.605 . . . . 0.0 109.48 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.04 105.6 6.14 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.222 1.009 . . . . 0.0 110.665 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.5 p -144.53 164.73 30.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.457 1.122 . . . . 0.0 113.44 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.5 145.67 26.55 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.315 1.446 . . . . 0.0 109.849 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.22 176.05 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.958 1.703 . . . . 0.0 111.098 -176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -118.24 142.95 46.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.769 1.628 . . . . 0.0 110.537 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.9 t -155.58 152.99 29.45 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.226 1.41 . . . . 0.0 110.419 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -94.27 125.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.456 0.702 . . . . 0.0 109.472 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -70.81 176.45 4.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.392 1.091 . . . . 0.0 112.445 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -60.21 -27.33 67.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.887 1.275 . . . . 0.0 113.066 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -86.2 -2.17 58.12 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.684 1.594 . . . . 0.0 113.498 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.23 19.05 78.85 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.582 1.086 . . . . 0.0 114.592 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -93.97 129.68 40.36 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.023 1.329 . . . . 0.0 109.485 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.2 mt -74.65 134.71 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -138.67 167.91 20.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.626 1.57 . . . . 0.0 111.683 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 p -115.94 144.95 43.35 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.473 1.109 . . . . 0.0 112.187 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -153.26 148.48 20.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.16 0.984 . . . . 0.0 112.767 -176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.62 150.21 45.03 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.963 2.442 . . . . 0.0 112.562 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -58.77 140.33 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.922 0.889 . . . . 0.0 110.568 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.48 -31.07 11.07 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.006 0.922 . . . . 0.0 112.64 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -167.71 175.14 7.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.946 1.698 . . . . 0.0 112.17 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -134.26 124.19 25.5 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.938 1.295 . . . . 0.0 109.303 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -113.77 129.13 56.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.993 0.917 . . . . 0.0 110.839 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -120.24 103.83 9.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.53 1.532 . . . . 0.0 110.043 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -72.77 -29.86 63.64 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.709 1.204 . . . . 0.0 112.967 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.16 -52.74 2.84 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.262 1.411 . . . . 0.0 113.62 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -170.76 105.54 0.26 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.967 1.307 . . . . 0.0 110.269 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -132.66 168.13 18.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.987 0.915 . . . . 0.0 112.349 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -68.82 100.84 1.23 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.854 1.261 . . . . 0.0 113.342 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.9 t -94.36 138.03 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.926 1.29 . . . . 0.0 111.557 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.505 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 53.2 m-85 -120.14 144.41 47.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 110.206 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.36 134.09 55.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.598 0.759 . . . . 0.0 110.652 171.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -127.03 83.34 2.16 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.425 1.49 . . . . 0.0 108.384 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.8 t -98.06 147.77 24.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.001 0.92 . . . . 0.0 110.899 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.09 158.36 23.31 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.199 1.4 . . . . 0.0 112.34 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -69.17 -18.34 63.91 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -77.25 -28.34 53.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.13 0.972 . . . . 0.0 112.786 172.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.62 -9.76 8.63 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.36 1.457 . . . . 0.0 114.253 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.2 m -59.54 150.78 26.07 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.46 1.13 . . . . 0.0 112.153 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.1 tp -137.91 125.6 22.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.162 0.985 . . . . 0.0 110.855 -173.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.6 mt -133.93 148.77 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.367 1.867 . . . . 0.0 107.941 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -131.6 121.41 24.33 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.935 1.294 . . . . 0.0 110.505 174.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.34 163.92 36.35 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.386 1.474 . . . . 0.0 111.197 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -75.37 154.04 37.45 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.434 -0.791 . . . . 0.0 111.973 173.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.505 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 4.8 mtmt -62.93 -20.4 65.17 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -87.47 -9.96 53.17 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.235 1.814 . . . . 0.0 113.054 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -77.68 134.42 38.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.75 0.82 . . . . 0.0 109.755 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -98.02 150.1 21.75 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.289 1.042 . . . . 0.0 111.889 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -136.3 132.57 35.89 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.018 -1.052 . . . . 0.0 109.766 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.1 ttp -72.24 108.87 5.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.206 0.527 . . . . 0.0 110.998 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -68.73 172.12 6.83 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.377 0.671 . . . . 0.0 112.172 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -55.91 -22.75 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -87.1 -6.14 58.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.414 1.085 . . . . 0.0 113.314 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.57 9.23 72.49 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.759 1.171 . . . . 0.0 113.966 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -81.13 130.16 34.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.258 1.029 . . . . 0.0 110.886 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.28 87.31 7.37 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.933 1.293 . . . . 0.0 110.793 169.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.1 mt -112.59 145.4 32.87 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.007 0.923 . . . . 0.0 110.238 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.72 147.06 85.44 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.674 2.25 . . . . 0.0 110.875 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -58.39 -26.84 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -53.79 -37.39 63.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.61 1.164 . . . . 0.0 113.19 169.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -80.43 -39.24 28.61 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.73 0.812 . . . . 0.0 110.669 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.46 -38.85 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.682 0.793 . . . . 0.0 111.103 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -64.78 -38.57 91.45 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -75.86 -38.64 57.73 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.482 -0.761 . . . . 0.0 112.682 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -75.47 -13.36 60.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 57.87 31.53 20.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.522 1.529 . . . . 0.0 111.982 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.8 mt -84.54 157.36 21.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.617 1.199 . . . . 0.0 112.201 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -113.54 156.6 23.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.011 2.124 . . . . 0.0 112.923 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.6 mt -88.21 149.75 23.68 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.552 0.741 . . . . 0.0 112.361 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.3 ttp -72.82 153.67 40.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.455 0.702 . . . . 0.0 111.222 170.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.39 167.3 15.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.412 1.485 . . . . 0.0 112.174 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.27 -12.52 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.981 1.313 . . . . 0.0 114.151 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.08 8.77 36.54 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.069 1.348 . . . . 0.0 113.073 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 52.41 35.39 17.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.987 1.715 . . . . 0.0 113.42 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.75 156.97 86.32 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.064 170.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.66 129.73 27.36 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.213 2.609 . . . . 0.0 111.134 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.19 134.44 44.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.727 0.811 . . . . 0.0 109.748 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.7 pt -143.17 130.75 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.371 1.468 . . . . 0.0 111.044 -169.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.5 171.57 12.42 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.487 1.115 . . . . 0.0 112.351 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.9 mt -63.97 112.52 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.319 1.448 . . . . 0.0 110.111 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.29 -35.81 35.3 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.707 0.803 . . . . 0.0 112.327 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.4 p -146.68 149.88 34.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.106 1.762 . . . . 0.0 110.676 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.07 143.03 32.89 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.795 1.638 . . . . 0.0 110.082 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -160.92 140.53 10.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.827 1.651 . . . . 0.0 110.256 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -65.35 121.98 16.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.842 0.457 . . . . 0.0 110.89 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.3 mt -90.95 -44.57 9.27 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.039 0.536 . . . . 0.0 111.891 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 150.73 -142.46 9.6 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.515 0.579 . . . . 0.0 113.324 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -130.67 86.27 2.36 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.82 1.248 . . . . 0.0 111.754 -168.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -104.43 157.26 17.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.909 1.284 . . . . 0.0 111.047 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 117.66 6.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.386 0.674 . . . . 0.0 110.364 169.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.3 m -124.14 151.7 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.372 0.606 . . . . 0.0 111.088 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -141.02 157.75 44.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.559 1.544 . . . . 0.0 111.74 -168.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -157.01 128.31 6.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.194 0.998 . . . . 0.0 110.799 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.5 pt -80.66 147.45 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.3 -0.875 . . . . 0.0 110.863 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.21 156.04 18.55 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.434 1.016 . . . . 0.0 111.731 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.3 t -143.05 153.48 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.662 1.185 . . . . 0.0 110.261 -169.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -60.84 117.3 5.24 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.791 -1.193 . . . . 0.0 111.937 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 51.83 22.43 1.72 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 126.545 1.938 . . . . 0.0 114.747 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -151.37 166.17 31.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.97 0.908 . . . . 0.0 112.646 -169.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -151.87 23.82 0.67 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.773 1.229 . . . . 0.0 113.068 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -132.13 162.95 29.59 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -166.51 158.43 13.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.711 1.205 . . . . 0.0 112.611 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.4 134.59 35.58 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.31 1.044 . . . . 0.0 112.339 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 38.1 mt -86.57 166.24 15.58 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.732 1.213 . . . . 0.0 111.516 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -52.74 -32.8 45.14 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -88.1 -6.53 57.86 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.505 1.122 . . . . 0.0 113.239 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.88 -11.65 34.78 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.427 1.013 . . . . 0.0 114.973 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -73.13 167.42 21.18 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.36 1.58 . . . . 0.0 112.842 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.69 120.66 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.931 0.893 . . . . 0.0 110.202 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.66 141.15 30.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.442 1.897 . . . . 0.0 109.801 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.7 m -139.16 137.12 35.8 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.472 1.109 . . . . 0.0 113.175 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 125.189 1.396 . . . . 0.0 113.86 -177.835 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.856 -0.497 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -152.02 160.43 28.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 129.442 3.401 . . . . 0.0 108.537 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -156.12 174.8 14.84 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.572 0.701 . . . . 0.0 112.826 -168.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.8 mt -120.89 147.0 46.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.928 1.691 . . . . 0.0 109.964 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 t -66.75 161.17 24.19 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -50.93 -44.64 60.28 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.557 0.743 . . . . 0.0 111.993 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -15.93 41.23 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.5 m -73.54 98.72 2.86 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.595 0.758 . . . . 0.0 110.14 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.15 133.14 42.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.455 0.645 . . . . 0.0 110.746 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.87 126.74 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 125.466 1.507 . . . . 0.0 107.216 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.3 122.56 18.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 170.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.7 p -123.71 150.98 43.66 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.76 1.224 . . . . 0.0 111.966 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.4 t -77.68 -33.59 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.9 -0.5 . . . . 0.0 112.005 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -66.16 -27.63 68.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -144.57 -52.84 0.31 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.37 -150.07 21.1 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.817 0.722 . . . . 0.0 112.217 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.85 108.26 2.93 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.333 1.453 . . . . 0.0 110.939 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.0 mt -134.99 148.89 68.74 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.475 1.11 . . . . 0.0 113.041 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.66 126.56 16.99 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.967 3.111 . . . . 0.0 112.024 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 tt -54.92 -36.48 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.18 -36.0 92.68 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.805 -0.56 . . . . 0.0 112.992 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -68.76 -37.65 79.53 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.558 1.179 . . . . 0.0 111.433 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.46 -38.41 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.761 0.824 . . . . 0.0 109.767 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.53 -39.49 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.158 0.983 . . . . 0.0 113.259 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.28 -27.5 66.37 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.496 1.044 . . . . 0.0 112.667 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -112.71 0.72 15.4 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.719 1.208 . . . . 0.0 112.773 -176.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.95 52.31 11.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.87 2.468 . . . . 0.0 112.418 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.6 mt -72.98 123.78 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.082 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.8 102.41 2.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.893 0.877 . . . . 0.0 110.287 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.5 p -132.25 -178.13 4.77 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.994 1.318 . . . . 0.0 112.496 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.94 147.27 51.05 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.439 1.496 . . . . 0.0 108.227 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.91 158.65 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.657 1.183 . . . . 0.0 111.203 -173.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -96.2 138.19 34.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.38 1.072 . . . . 0.0 110.4 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 t -155.57 153.77 30.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.898 1.279 . . . . 0.0 110.527 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.88 125.47 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.078 0.551 . . . . 0.0 110.316 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -68.42 175.29 3.45 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.835 1.254 . . . . 0.0 112.267 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.71 -25.87 68.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.844 1.258 . . . . 0.0 113.155 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -85.56 -4.76 59.26 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.366 1.466 . . . . 0.0 113.555 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.9 19.02 62.1 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.738 1.161 . . . . 0.0 114.758 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -94.95 128.88 42.08 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.627 1.171 . . . . 0.0 110.259 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.1 mt -74.12 123.52 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -135.11 174.15 10.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.828 2.051 . . . . 0.0 111.504 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -116.93 139.19 50.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.185 0.994 . . . . 0.0 111.905 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -141.22 141.0 21.99 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.545 1.138 . . . . 0.0 111.863 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.14 152.24 39.89 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.885 2.39 . . . . 0.0 112.027 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.66 138.45 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.787 0.835 . . . . 0.0 111.037 169.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.13 -51.95 4.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.544 0.738 . . . . 0.0 111.142 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -144.62 -178.6 6.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.87 1.668 . . . . 0.0 111.034 -173.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -138.98 126.81 22.15 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.399 1.08 . . . . 0.0 109.313 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -122.16 134.72 54.73 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.105 0.955 . . . . 0.0 110.795 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -127.52 122.25 32.84 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.208 1.403 . . . . 0.0 109.996 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -88.96 -34.19 16.96 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.177 0.991 . . . . 0.0 112.326 -173.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.45 -42.55 2.32 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.114 1.34 . . . . 0.0 114.889 172.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -178.69 88.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.066 1.412 . . . . 0.0 114.629 -168.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -125.18 158.98 32.62 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.979 1.311 . . . . 0.0 112.291 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.57 106.76 1.22 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.021 1.328 . . . . 0.0 112.695 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 t -98.59 139.44 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.346 1.458 . . . . 0.0 110.586 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -124.48 140.66 52.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.986 1.315 . . . . 0.0 109.513 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.84 135.1 35.88 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.177 0.991 . . . . 0.0 108.987 169.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -122.07 98.53 5.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.61 1.564 . . . . 0.0 109.011 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.8 t -75.86 132.97 40.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.138 0.575 . . . . 0.0 109.982 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mp -93.28 162.48 13.99 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.614 0.721 . . . . 0.0 112.783 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.81 -22.44 66.56 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.03 -21.27 51.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.954 0.902 . . . . 0.0 112.926 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.04 -1.32 25.59 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.441 1.495 . . . . 0.0 114.531 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.8 p -72.71 171.32 12.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.488 1.144 . . . . 0.0 113.017 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.5 mt -132.6 145.6 51.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.192 1.397 . . . . 0.0 110.983 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.6 mt -137.68 139.64 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.471 1.908 . . . . 0.0 107.323 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.464 HH21 HD22 ' A' ' 111' ' ' LEU . 42.3 mtp180 -131.26 98.18 4.48 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.608 1.163 . . . . 0.0 110.429 -174.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.73 166.29 27.06 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.282 1.039 . . . . 0.0 113.724 -172.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 p -82.43 155.46 24.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.723 1.209 . . . . 0.0 111.535 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -61.55 -23.95 66.31 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -86.74 -11.29 51.52 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.37 1.068 . . . . 0.0 112.605 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -80.02 132.04 35.92 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -87.4 162.72 17.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.509 0.671 . . . . 0.0 111.098 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -138.19 141.23 40.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 43.1 ttm -69.54 107.39 3.36 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -66.89 166.47 13.37 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.204 0.526 . . . . 0.0 111.122 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 m -57.64 -24.33 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.07 -14.39 59.51 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.487 1.115 . . . . 0.0 113.478 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.46 10.9 61.5 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.095 1.331 . . . . 0.0 114.383 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -82.96 164.08 20.63 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.426 1.113 . . . . 0.0 111.522 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.36 81.94 1.86 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.985 1.314 . . . . 0.0 111.33 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.6 mt -113.22 148.41 39.46 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.526 1.131 . . . . 0.0 110.787 -172.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.04 146.03 81.08 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.97 2.447 . . . . 0.0 111.246 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' A' ' 87' ' ' ILE . 6.6 tt -58.43 -26.03 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.55 -35.09 67.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.389 1.076 . . . . 0.0 113.023 170.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -39.03 27.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.531 1.132 . . . . 0.0 111.102 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.525 HD13 HD21 ' A' ' 94' ' ' LEU . 78.6 mt -64.47 -39.45 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.397 1.079 . . . . 0.0 110.919 -175.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -63.73 -34.44 77.87 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -77.14 -48.19 18.35 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.944 0.793 . . . . 0.0 113.055 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -74.55 -12.35 60.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 57.9 35.52 25.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.663 1.585 . . . . 0.0 112.476 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.8 mt -76.74 146.92 37.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.159 0.983 . . . . 0.0 111.834 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.63 164.76 20.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.665 0.786 . . . . 0.0 112.043 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.525 HD21 HD13 ' A' ' 87' ' ' ILE . 84.6 mt -111.05 147.14 35.43 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.5 1.12 . . . . 0.0 111.682 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 31.7 ttm -74.79 141.92 44.3 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.723 -0.611 . . . . 0.0 110.664 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.12 173.19 9.4 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.515 1.126 . . . . 0.0 113.06 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.61 -19.63 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 126.17 1.788 . . . . 0.0 113.8 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.8 4.23 30.05 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.94 1.296 . . . . 0.0 113.916 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.77 31.96 21.22 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.506 1.522 . . . . 0.0 112.859 -175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.9 mt -70.92 158.79 87.33 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.913 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.24 149.83 85.12 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.154 2.569 . . . . 0.0 111.396 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -70.4 123.59 22.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.4 0.68 . . . . 0.0 110.401 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.21 137.92 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.218 1.407 . . . . 0.0 111.386 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.23 176.35 5.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.834 1.654 . . . . 0.0 111.379 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mt -69.71 103.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.511 1.524 . . . . 0.0 110.007 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.93 -42.59 80.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.966 1.306 . . . . 0.0 111.633 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -152.48 162.98 40.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.642 1.977 . . . . 0.0 111.113 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -127.47 144.82 51.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.902 1.681 . . . . 0.0 110.793 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -145.83 116.58 7.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.512 1.125 . . . . 0.0 110.527 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -63.16 127.44 31.26 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.575 -0.703 . . . . 0.0 111.16 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.464 HD22 HH21 ' A' ' 67' ' ' ARG . 68.9 mt -94.74 -42.99 8.45 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.831 0.452 . . . . 0.0 112.094 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 140.64 -147.99 19.64 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.712 1.148 . . . . 0.0 112.588 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -120.8 71.27 0.92 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.476 1.51 . . . . 0.0 112.362 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -90.8 157.34 17.44 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.688 1.595 . . . . 0.0 111.216 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -65.18 118.92 9.93 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.95 0.9 . . . . 0.0 110.35 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.1 150.27 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.42 0.688 . . . . 0.0 111.448 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -137.11 157.96 45.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.051 1.74 . . . . 0.0 111.994 -169.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -158.1 119.1 3.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.713 1.205 . . . . 0.0 110.607 -174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 pt -72.68 148.19 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 O-C-N 120.754 -1.216 . . . . 0.0 111.927 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.49 151.47 19.34 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.488 1.042 . . . . 0.0 111.868 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.7 t -147.45 146.27 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.426 1.49 . . . . 0.0 109.416 -171.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -103.93 -43.74 5.22 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -70.61 -45.19 65.76 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.59 -172.54 3.05 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.475 1.91 . . . . 0.0 109.846 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -143.69 39.23 1.38 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.299 -0.875 . . . . 0.0 112.467 -173.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -161.92 161.86 28.92 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.968 -1.083 . . . . 0.0 113.156 -172.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -160.49 153.4 21.36 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.015 1.326 . . . . 0.0 112.912 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.62 140.68 37.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.496 1.118 . . . . 0.0 113.227 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 74.4 mt -92.62 178.59 5.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.198 1.799 . . . . 0.0 112.528 173.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -46.8 -59.33 3.13 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.734 2.013 . . . . 0.0 115.121 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.94 -22.21 61.49 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.508 0.723 . . . . 0.0 112.163 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.34 -5.73 8.73 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.123 1.344 . . . . 0.0 114.359 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -61.02 136.15 58.0 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.933 1.867 . . . . 0.0 110.743 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.07 118.3 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.6 153.46 17.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.064 1.346 . . . . 0.0 109.256 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.2 p -136.66 147.36 46.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.434 1.094 . . . . 0.0 112.768 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.9 p30 . . . . . 0 C--O 1.252 1.234 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -167.678 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.86 0 N-CA-C 112.78 -0.128 . . . . 0.0 112.78 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -125.06 174.4 17.29 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.478 2.466 . . . . 0.0 110.815 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -171.04 173.8 4.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.738 1.615 . . . . 0.0 112.588 -172.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.9 mt -118.92 149.83 40.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.381 2.273 . . . . 0.0 110.966 -172.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -73.22 160.41 31.97 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.264 -0.897 . . . . 0.0 111.802 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -50.07 -48.18 53.18 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.358 1.063 . . . . 0.0 112.666 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -66.37 -1.14 3.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.913 2.085 . . . . 0.0 114.944 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.2 m -74.27 104.66 5.12 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.081 0.952 . . . . 0.0 110.264 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.09 129.21 34.84 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.514 0.674 . . . . 0.0 111.614 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.6 mm -111.64 121.09 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 126.093 1.757 . . . . 0.0 107.227 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.39 129.81 42.36 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.378 0.671 . . . . 0.0 111.239 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -129.96 152.06 49.83 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.032 1.333 . . . . 0.0 111.781 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.3 t -74.65 -31.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 121.703 -0.623 . . . . 0.0 112.119 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -65.76 -33.99 77.14 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -141.68 -50.53 0.41 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.88 -137.68 9.22 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 118.816 0.735 . . . . 0.0 112.366 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.0 mt -81.29 96.69 7.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.004 1.722 . . . . 0.0 111.619 -175.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -127.36 147.41 62.01 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.794 1.238 . . . . 0.0 112.341 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.38 130.87 23.37 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.14 3.227 . . . . 0.0 112.675 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 tt -55.21 -36.15 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.9 0.88 . . . . 0.0 113.124 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.7 -34.4 83.26 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.671 -0.643 . . . . 0.0 113.177 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -72.69 -31.54 65.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.339 1.07 . . . . 0.0 111.728 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.1 mt -69.2 -38.07 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.827 0.851 . . . . 0.0 109.896 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.9 t -82.18 -38.07 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.22 1.008 . . . . 0.0 113.07 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.13 -23.68 63.06 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.302 -0.874 . . . . 0.0 112.974 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.31 4.88 11.85 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.074 1.35 . . . . 0.0 112.508 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 45.03 51.72 8.67 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.062 2.545 . . . . 0.0 112.692 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 53.8 mt -72.29 120.15 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.984 0.914 . . . . 0.0 109.134 -171.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.99 99.68 3.93 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.352 1.061 . . . . 0.0 110.587 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.4 p -141.15 162.22 36.02 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.588 1.185 . . . . 0.0 114.128 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.76 154.4 19.56 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.655 1.582 . . . . 0.0 110.505 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.65 173.94 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.734 1.614 . . . . 0.0 110.982 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -119.31 140.61 50.03 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.992 1.717 . . . . 0.0 109.929 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.2 t -159.77 165.96 31.38 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.946 1.298 . . . . 0.0 110.568 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.94 127.52 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.842 1.257 . . . . 0.0 111.366 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.13 177.88 7.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.562 1.145 . . . . 0.0 112.238 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -61.21 -23.01 65.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.274 1.43 . . . . 0.0 113.361 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -89.48 -3.04 58.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.203 1.401 . . . . 0.0 113.548 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.69 89.15 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.419 1.009 . . . . 0.0 114.608 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -81.41 134.93 35.62 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.291 1.046 . . . . 0.0 109.587 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.7 mt -72.22 122.17 24.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -121.41 169.12 10.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.913 1.685 . . . . 0.0 110.433 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.8 p -126.67 144.0 51.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.383 0.673 . . . . 0.0 112.02 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -150.48 147.68 22.12 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.468 1.107 . . . . 0.0 112.041 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.82 148.61 36.39 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.16 2.573 . . . . 0.0 112.738 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.31 145.64 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.408 1.083 . . . . 0.0 111.133 168.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.08 -32.26 7.3 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.892 1.277 . . . . 0.0 112.847 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -164.85 174.13 10.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.569 1.547 . . . . 0.0 112.36 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -137.49 110.68 7.83 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.061 1.345 . . . . 0.0 110.05 -174.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -98.62 115.23 28.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.834 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -102.1 107.0 17.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.91 1.284 . . . . 0.0 108.947 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -78.82 -24.5 44.46 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.355 1.062 . . . . 0.0 112.991 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.57 -44.18 3.31 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.287 1.422 . . . . 0.0 114.786 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 176.83 98.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.883 1.273 . . . . 0.0 113.143 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -129.79 167.42 18.12 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.226 1.411 . . . . 0.0 112.761 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.85 101.07 0.45 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.41 1.484 . . . . 0.0 114.041 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.1 t -92.03 143.33 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.147 1.379 . . . . 0.0 112.191 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -127.1 141.74 51.69 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.014 2.126 . . . . 0.0 110.129 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.15 132.89 51.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.351 0.66 . . . . 0.0 110.948 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.9 75.36 1.49 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.739 1.257 . . . . 0.0 108.779 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.6 t -82.22 146.92 29.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.223 1.009 . . . . 0.0 111.132 173.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.09 163.5 15.09 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.693 1.197 . . . . 0.0 112.825 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.02 -24.29 66.73 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.055 1.342 . . . . 0.0 113.051 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.03 -29.64 31.86 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.763 1.225 . . . . 0.0 113.169 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.83 -0.73 10.01 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.516 1.055 . . . . 0.0 114.69 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 m -63.13 139.94 58.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.803 1.301 . . . . 0.0 110.97 170.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.77 132.99 53.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.208 1.403 . . . . 0.0 109.856 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.1 mt -136.8 152.89 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.758 2.023 . . . . 0.0 107.658 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -138.65 115.96 11.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.707 1.203 . . . . 0.0 110.579 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.55 172.32 14.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.172 1.389 . . . . 0.0 112.35 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 p -93.09 151.9 19.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.993 1.317 . . . . 0.0 111.522 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -62.84 -16.56 58.94 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -88.01 -17.15 31.83 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.449 1.099 . . . . 0.0 112.463 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -78.21 137.46 38.15 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -95.02 160.35 14.61 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.217 1.007 . . . . 0.0 110.268 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -142.46 133.76 26.24 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.559 -0.713 . . . . 0.0 109.666 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.5 ttm -77.66 111.22 13.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.98 0.895 . . . . 0.0 111.359 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.1 p -65.31 167.45 8.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.788 1.235 . . . . 0.0 112.828 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.6 m -52.91 -28.77 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -83.79 -11.7 56.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.052 0.941 . . . . 0.0 113.461 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.64 -0.41 61.19 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.381 0.991 . . . . 0.0 114.082 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -76.4 137.67 39.9 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 119.2 1.5 . . . . 0.0 109.745 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.8 ptp -106.63 98.42 8.09 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.715 1.606 . . . . 0.0 108.776 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.63 152.79 59.11 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.084 1.353 . . . . 0.0 109.324 -174.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.53 147.1 86.35 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.266 1.977 . . . . 0.0 110.949 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.4 tt -59.46 -23.33 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -54.49 -35.97 63.66 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.015 1.326 . . . . 0.0 112.632 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -84.48 -39.81 18.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 111.499 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.8 mt -59.88 -36.17 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 119.129 0.877 . . . . 0.0 111.425 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -69.22 -33.41 73.26 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -78.6 -39.23 37.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.438 -0.789 . . . . 0.0 112.399 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -74.51 -14.78 60.86 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.834 0.854 . . . . 0.0 113.178 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 55.35 37.57 29.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.487 1.515 . . . . 0.0 111.905 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.9 mt -92.02 159.5 15.68 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.709 1.242 . . . . 0.0 112.34 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -114.34 154.44 28.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.033 2.133 . . . . 0.0 113.198 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.89 154.06 22.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.773 1.229 . . . . 0.0 112.726 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -70.26 148.7 48.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.758 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -114.1 155.75 25.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.646 1.579 . . . . 0.0 110.894 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.2 5.37 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 125.014 1.325 . . . . 0.0 114.413 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -121.34 20.45 11.27 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.886 1.674 . . . . 0.0 112.421 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.34 16.82 10.4 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 127.023 2.129 . . . . 0.0 113.647 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.1 mt -72.8 157.36 88.89 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.433 1.893 . . . . 0.0 112.54 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.92 166.33 29.89 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.205 3.27 . . . . 0.0 112.25 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -107.02 131.66 53.82 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.494 1.118 . . . . 0.0 110.556 -173.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.1 pt -146.97 135.55 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.443 1.497 . . . . 0.0 110.627 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 175.49 8.9 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.347 1.459 . . . . 0.0 112.127 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.8 mt -63.16 112.04 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.1 1.36 . . . . 0.0 110.206 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.31 -43.38 81.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.257 1.023 . . . . 0.0 111.957 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 p -150.12 147.64 28.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.247 1.819 . . . . 0.0 110.393 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -141.19 139.39 33.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.171 1.389 . . . . 0.0 110.812 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -158.29 150.59 21.96 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.181 1.393 . . . . 0.0 110.51 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -66.03 124.81 23.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.306 0.642 . . . . 0.0 110.891 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.6 mt -90.03 -43.06 10.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.217 0.607 . . . . 0.0 111.955 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 143.01 -149.39 21.3 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.434 1.016 . . . . 0.0 112.096 -173.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -124.11 96.42 4.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.387 1.075 . . . . 0.0 112.041 -169.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -114.36 155.34 26.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.482 1.513 . . . . 0.0 110.035 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -63.03 116.86 5.71 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.415 0.686 . . . . 0.0 110.326 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.41 152.45 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.64 0.776 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -137.95 156.21 48.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.828 1.651 . . . . 0.0 111.851 -168.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -154.09 116.39 4.33 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.67 1.188 . . . . 0.0 110.635 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.0 pt -77.94 142.99 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 120.963 -1.086 . . . . 0.0 111.354 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.75 158.02 17.94 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.392 0.996 . . . . 0.0 111.473 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 t -142.59 159.26 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.586 1.154 . . . . 0.0 110.183 -169.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -79.73 125.25 29.41 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.475 -1.391 . . . . 0.0 111.755 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.3 tpp85 51.29 24.03 1.92 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.729 2.012 . . . . 0.0 114.503 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -159.28 160.12 34.85 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.306 1.842 . . . . 0.0 109.88 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -143.98 24.1 1.67 Allowed 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.352 -0.843 . . . . 0.0 113.19 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -145.08 160.37 41.51 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.157 1.383 . . . . 0.0 114.115 -168.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -166.16 165.14 17.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.383 1.073 . . . . 0.0 112.55 -171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.36 155.26 17.49 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.221 1.008 . . . . 0.0 113.442 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.6 mt -108.37 166.69 10.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.742 2.017 . . . . 0.0 111.568 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -43.2 -50.02 6.43 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.825 1.65 . . . . 0.0 115.296 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -84.67 4.13 33.89 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.192 0.997 . . . . 0.0 113.261 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.78 -4.85 53.52 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.445 1.498 . . . . 0.0 114.92 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -69.36 163.61 24.78 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.734 1.267 . . . . 0.0 111.664 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.1 mm -118.23 142.26 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.531 -0.731 . . . . 0.0 110.555 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.77 143.29 49.48 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.411 1.485 . . . . 0.0 110.385 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.7 t -139.86 144.72 37.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.048 1.739 . . . . 0.0 113.091 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--O 1.256 1.414 0 N-CA-C 117.268 2.321 . . . . 0.0 117.268 -169.63 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 66.44 -169.15 33.54 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.854 1.216 . . . . 0.0 114.368 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.48 173.02 14.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.15 1.38 . . . . 0.0 110.788 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -117.12 146.75 42.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.999 1.72 . . . . 0.0 109.769 -173.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -74.76 160.39 30.78 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.681 -0.637 . . . . 0.0 111.385 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -47.04 -49.55 21.1 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.475 1.51 . . . . 0.0 113.001 -169.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 pm0 -66.94 -1.85 4.54 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.24 2.216 . . . . 0.0 115.089 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.2 m -73.77 104.16 4.58 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.008 0.923 . . . . 0.0 110.013 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.65 129.34 34.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.56 0.695 . . . . 0.0 112.399 -173.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mm -106.33 123.81 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.364 1.465 . . . . 0.0 107.706 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.09 122.89 18.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.588 0.355 . . . . 0.0 110.266 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.1 p -124.2 150.35 45.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.765 1.226 . . . . 0.0 112.087 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.47 -33.43 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.191 0.596 . . . . 0.0 111.993 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -67.82 -30.7 70.18 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -141.28 -50.03 0.42 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.42 -148.99 19.7 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.598 1.094 . . . . 0.0 111.689 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.463 HD22 ' CB ' ' A' ' 130' ' ' LYS . 3.9 mt -61.7 111.96 2.06 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.281 1.433 . . . . 0.0 110.516 171.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 mt -139.96 149.09 57.6 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.365 1.066 . . . . 0.0 113.47 174.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.4 127.44 19.99 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.186 3.257 . . . . 0.0 112.394 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 tt -56.22 -36.36 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.0 -32.49 84.37 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.721 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -71.44 -38.04 71.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.383 1.091 . . . . 0.0 111.31 175.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -64.82 -38.24 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.395 0.678 . . . . 0.0 110.808 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.4 t -83.79 -37.96 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.08 0.952 . . . . 0.0 112.416 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -71.77 -24.56 61.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.088 0.858 . . . . 0.0 113.195 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -114.07 5.84 16.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.226 1.41 . . . . 0.0 113.037 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 48.21 48.92 18.26 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.331 2.252 . . . . 0.0 112.725 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.4 mt -77.73 118.08 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.006 0.923 . . . . 0.0 110.355 -169.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.68 112.17 7.57 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.323 1.049 . . . . 0.0 110.656 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.3 p -150.03 170.87 17.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.43 1.092 . . . . 0.0 112.995 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.4 m -116.86 143.29 45.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.412 1.485 . . . . 0.0 108.906 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.74 165.02 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.898 1.679 . . . . 0.0 110.959 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -102.51 143.75 31.83 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.227 1.411 . . . . 0.0 110.082 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -154.67 151.12 28.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.25 1.42 . . . . 0.0 109.892 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 t -92.91 124.82 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -69.07 173.96 5.01 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.581 1.181 . . . . 0.0 111.79 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -58.16 -27.79 64.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.453 1.901 . . . . 0.0 113.226 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -82.52 -10.06 59.16 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.247 1.419 . . . . 0.0 113.3 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.14 22.5 59.01 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.85 1.214 . . . . 0.0 114.483 -171.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -95.5 132.34 40.7 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.437 1.095 . . . . 0.0 109.85 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.5 mt -74.01 133.4 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.54 1.064 . . . . 0.0 108.899 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.69 174.95 10.01 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.016 1.726 . . . . 0.0 111.036 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.8 p -120.53 143.89 48.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.276 1.03 . . . . 0.0 112.361 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -147.03 142.82 17.42 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.73 1.212 . . . . 0.0 112.433 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -74.97 149.8 37.37 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.012 2.474 . . . . 0.0 112.258 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -59.38 135.89 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.375 0.67 . . . . 0.0 110.43 168.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.62 -47.01 7.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.594 0.758 . . . . 0.0 111.548 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -150.19 177.52 9.85 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.167 1.787 . . . . 0.0 111.397 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -134.23 137.83 44.65 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.139 1.776 . . . . 0.0 108.796 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -132.54 119.65 20.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.598 0.759 . . . . 0.0 111.218 -171.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -116.53 108.21 15.69 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.328 1.451 . . . . 0.0 110.736 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -80.73 -28.89 36.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.756 1.222 . . . . 0.0 113.331 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.41 -52.82 3.1 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.092 1.33 . . . . 0.0 114.219 173.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -171.85 104.91 0.19 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.056 1.428 . . . . 0.0 111.013 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -129.88 169.08 15.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.972 0.909 . . . . 0.0 112.052 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.31 105.42 2.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.23 1.012 . . . . 0.0 112.875 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.7 t -100.38 140.39 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.048 1.339 . . . . 0.0 111.492 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CG ' ' HE3' ' A' ' 70' ' ' LYS . 43.5 m-85 -123.91 146.19 48.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.929 1.292 . . . . 0.0 110.601 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -66.0 128.13 34.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.288 1.035 . . . . 0.0 110.485 173.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -121.87 81.72 1.86 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.592 1.557 . . . . 0.0 108.151 175.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.3 t -88.05 141.66 28.39 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.962 0.905 . . . . 0.0 110.614 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -105.2 165.64 10.96 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.268 1.027 . . . . 0.0 113.267 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -68.03 -20.7 65.02 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.68 -27.94 36.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.73 1.212 . . . . 0.0 112.96 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.76 -3.75 17.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.931 1.253 . . . . 0.0 114.389 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -60.61 148.16 39.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.719 1.26 . . . . 0.0 111.577 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.5 mt -133.15 128.26 35.69 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.365 1.466 . . . . 0.0 110.11 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.1 mt -135.24 149.56 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 126.681 1.992 . . . . 0.0 107.399 -175.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -137.1 112.27 9.1 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.216 1.006 . . . . 0.0 110.111 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.4 169.47 18.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.311 1.445 . . . . 0.0 111.815 -172.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.6 p -87.44 162.02 17.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.546 0.738 . . . . 0.0 112.837 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HE3' ' CG ' ' A' ' 56' ' ' PHE . 19.7 mmtp -72.99 -7.97 53.6 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -90.9 -8.96 47.93 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.784 0.72 . . . . 0.0 112.083 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.479 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 14.3 t-80 -82.56 132.89 35.19 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.785 -0.572 . . . . 0.0 110.091 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -95.19 152.02 18.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.995 0.918 . . . . 0.0 110.285 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -137.94 135.14 35.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.08 0.552 . . . . 0.0 110.626 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 44.7 ttp -73.6 103.98 4.39 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 111.201 -174.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.6 p -66.05 171.8 4.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.134 0.974 . . . . 0.0 112.155 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.26 -22.91 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -93.33 -6.82 46.47 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.214 1.006 . . . . 0.0 113.194 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.4 26.65 24.95 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.323 0.963 . . . . 0.0 113.944 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -88.04 142.05 28.08 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.456 1.128 . . . . 0.0 111.754 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.3 mmt -97.26 77.34 2.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.784 1.634 . . . . 0.0 110.971 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -116.01 148.09 40.64 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.852 0.861 . . . . 0.0 111.44 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.34 148.55 79.97 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.409 2.739 . . . . 0.0 111.771 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.83 -28.76 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -54.05 -30.76 49.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.641 1.177 . . . . 0.0 113.933 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -91.86 -31.14 15.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.44 0.696 . . . . 0.0 111.553 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.84 -38.82 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.042 0.837 . . . . 0.0 111.158 177.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -64.01 -38.1 89.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -78.66 -37.78 41.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.212 0.605 . . . . 0.0 112.553 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -82.41 -8.83 59.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.778 0.831 . . . . 0.0 112.952 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 57.14 35.55 26.41 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.482 1.513 . . . . 0.0 112.383 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.2 mt -85.53 124.01 31.61 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.011 0.91 . . . . 0.0 111.97 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.5 153.72 30.83 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.547 1.139 . . . . 0.0 112.407 169.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.86 150.61 22.14 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.212 -0.93 . . . . 0.0 112.455 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.1 ttp -72.4 156.85 38.63 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.654 0.782 . . . . 0.0 111.163 169.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -138.25 170.1 16.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.528 1.531 . . . . 0.0 111.739 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.18 -2.69 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.62 14.95 29.74 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.127 0.971 . . . . 0.0 113.393 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 56.16 28.57 13.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.405 1.882 . . . . 0.0 112.993 -173.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 70.8 mt -88.32 156.29 51.26 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.385 1.474 . . . . 0.0 112.083 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.36 135.67 32.01 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.906 3.07 . . . . 0.0 112.686 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -75.3 126.25 30.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.73 0.812 . . . . 0.0 110.773 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.2 pt -142.98 151.61 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.555 1.542 . . . . 0.0 111.335 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.3 pttt -95.59 -173.47 2.89 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.21 1.804 . . . . 0.0 111.961 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.1 mt -68.49 122.28 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.764 1.226 . . . . 0.0 109.001 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.46 -44.57 19.02 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.331 1.052 . . . . 0.0 112.49 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.8 p -146.88 152.62 39.0 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.655 1.582 . . . . 0.0 111.03 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.93 145.17 43.93 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.053 1.741 . . . . 0.0 110.235 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -158.0 135.43 10.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.179 1.792 . . . . 0.0 110.017 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -67.85 120.44 14.16 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.382 0.537 . . . . 0.0 110.032 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.7 -42.14 12.85 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.711 0.404 . . . . 0.0 111.702 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.04 -142.19 11.96 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.208 0.909 . . . . 0.0 112.848 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -121.93 97.07 5.32 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.358 1.463 . . . . 0.0 111.626 -168.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -118.09 154.66 31.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.457 1.103 . . . . 0.0 111.286 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.9 117.21 5.61 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.652 0.781 . . . . 0.0 110.709 171.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.44 151.02 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.504 0.668 . . . . 0.0 111.043 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -138.61 159.41 42.16 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.613 1.565 . . . . 0.0 111.408 -169.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -148.82 168.04 24.02 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.705 0.802 . . . . 0.0 111.921 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.2 pt -126.12 139.91 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.449 1.1 . . . . 0.0 110.112 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.33 153.98 20.05 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.843 1.211 . . . . 0.0 111.183 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.77 156.26 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.525 1.13 . . . . 0.0 109.784 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -58.51 -35.0 71.58 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -173.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -158.26 -40.19 0.06 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -100.6 79.5 2.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 108.889 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -52.39 -22.77 5.01 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.681 2.392 . . . . 0.0 115.481 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -73.75 165.16 25.61 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.132 1.373 . . . . 0.0 113.716 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -160.59 161.49 32.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.983 1.313 . . . . 0.0 111.631 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.78 130.48 37.55 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.866 0.866 . . . . 0.0 113.007 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 41.9 mt -72.79 165.71 24.32 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.469 1.108 . . . . 0.0 111.116 168.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.463 ' CB ' HD22 ' A' ' 15' ' ' LEU . 5.6 ptmm? -51.47 -32.57 27.6 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -90.01 -12.24 39.21 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.879 1.271 . . . . 0.0 113.999 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.62 -12.25 18.41 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 118.506 -1.163 . . . . 0.0 115.246 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -60.63 158.45 12.49 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.698 1.749 . . . . 0.0 112.462 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.66 126.02 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.122 0.963 . . . . 0.0 110.859 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.479 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -107.56 157.06 18.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.651 1.58 . . . . 0.0 109.729 172.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.6 t -134.84 128.13 32.11 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 112.839 -176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.936 1.694 . . . . 0.0 113.179 -175.976 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 CA-C-O 119.739 -0.478 . . . . 0.0 113.498 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 62.03 -176.16 6.16 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 126.138 1.828 . . . . 0.0 116.55 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -151.24 171.61 17.14 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.456 1.102 . . . . 0.0 111.848 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.448 HD13 HG21 ' A' ' 6' ' ' THR . 56.8 mt -127.64 148.13 50.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.182 1.793 . . . . 0.0 110.856 -168.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p -61.56 162.11 8.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.774 1.23 . . . . 0.0 114.196 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -53.62 -45.61 70.18 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.141 -0.974 . . . . 0.0 112.158 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.52 -5.84 16.99 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.448 HG21 HD13 ' A' ' 2' ' ' LEU . 63.7 m -71.44 97.65 1.68 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.118 -0.989 . . . . 0.0 110.318 173.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -74.09 135.74 42.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.598 0.759 . . . . 0.0 110.919 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.38 120.54 63.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 126.107 1.763 . . . . 0.0 106.702 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.78 120.69 15.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.73 0.412 . . . . 0.0 110.053 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 p -121.63 153.37 38.2 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.303 1.041 . . . . 0.0 112.424 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.19 -34.38 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.404 0.682 . . . . 0.0 111.758 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.64 -26.42 61.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -140.1 -51.79 0.5 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.92 -152.69 20.41 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.212 0.911 . . . . 0.0 111.707 -171.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 109.37 1.7 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.078 0.951 . . . . 0.0 110.96 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.8 mt -133.8 149.39 71.74 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.93 1.292 . . . . 0.0 112.943 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.42 126.73 14.61 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.886 3.058 . . . . 0.0 112.818 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 tt -55.81 -35.71 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.81 -38.16 96.05 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.895 -0.503 . . . . 0.0 112.469 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -71.58 -34.84 70.27 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.409 1.104 . . . . 0.0 111.657 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.9 mt -66.13 -39.65 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.038 0.935 . . . . 0.0 110.032 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.22 -38.08 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.319 1.048 . . . . 0.0 113.046 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -70.41 -27.43 64.28 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.323 0.965 . . . . 0.0 113.218 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -112.19 3.12 17.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.273 1.029 . . . . 0.0 113.103 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 46.9 50.23 13.82 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.26 2.224 . . . . 0.0 111.911 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.8 mt -68.12 118.5 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.021 0.928 . . . . 0.0 108.678 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.02 118.13 14.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.288 0.566 . . . . 0.0 109.511 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.5 p -151.55 166.77 30.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.096 1.358 . . . . 0.0 112.334 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.16 152.54 20.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.272 1.429 . . . . 0.0 109.74 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.31 167.53 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.189 1.396 . . . . 0.0 110.961 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -108.67 148.97 29.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.151 1.38 . . . . 0.0 111.086 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -168.37 151.74 5.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.607 1.563 . . . . 0.0 110.673 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.12 144.45 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.834 1.197 . . . . 0.0 113.275 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.73 178.45 8.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.544 1.138 . . . . 0.0 113.333 170.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -61.98 -11.11 11.74 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -105.18 0.26 27.17 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.9 1.68 . . . . 0.0 112.312 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.14 22.96 39.43 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.171 1.367 . . . . 0.0 115.253 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -108.08 123.56 48.88 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.158 1.479 . . . . 0.0 110.331 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.61 102.63 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.972 0.909 . . . . 0.0 109.41 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -100.88 179.05 4.51 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.103 1.761 . . . . 0.0 111.275 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.2 p -126.35 144.2 50.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.342 1.057 . . . . 0.0 112.843 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -145.58 137.3 13.01 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.537 1.135 . . . . 0.0 112.308 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.23 143.13 27.99 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.286 2.658 . . . . 0.0 110.944 174.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 p -54.13 147.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.727 0.811 . . . . 0.0 111.601 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.76 -42.93 3.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.712 0.805 . . . . 0.0 112.127 175.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -145.15 172.08 13.61 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.853 1.261 . . . . 0.0 111.875 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -135.49 132.56 37.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.579 1.552 . . . . 0.0 109.664 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -127.15 130.85 50.57 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.51 1.124 . . . . 0.0 111.465 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -126.51 119.77 28.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.441 1.496 . . . . 0.0 110.492 -173.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -91.11 -23.1 20.39 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.631 1.172 . . . . 0.0 113.387 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.61 -46.18 3.53 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 126.812 2.148 . . . . 0.0 114.775 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -173.46 107.55 0.15 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.737 1.615 . . . . 0.0 112.156 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -128.04 159.97 33.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.302 1.441 . . . . 0.0 111.212 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -59.26 104.78 0.28 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.517 1.527 . . . . 0.0 112.953 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.08 136.53 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.119 1.368 . . . . 0.0 111.181 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -118.52 138.21 52.68 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.691 1.196 . . . . 0.0 109.989 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -74.29 134.88 42.59 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.034 0.934 . . . . 0.0 108.946 168.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -129.86 89.2 2.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.122 1.369 . . . . 0.0 109.229 170.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.5 t -74.96 141.99 43.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.059 0.944 . . . . 0.0 110.896 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tp -93.89 170.1 9.8 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.941 1.296 . . . . 0.0 113.249 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -63.99 -26.47 68.59 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.99 -18.53 28.83 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.86 -3.21 28.83 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.126 1.346 . . . . 0.0 114.316 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 m -59.63 150.79 26.43 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.086 1.443 . . . . 0.0 111.449 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -127.11 135.98 51.49 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.492 0.717 . . . . 0.0 110.775 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.481 HD11 ' CZ ' ' A' ' 133' ' ' PHE . 11.3 mt -128.42 126.44 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.435 1.494 . . . . 0.0 107.385 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -123.63 103.11 8.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.876 1.27 . . . . 0.0 109.556 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.66 170.51 15.71 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.563 1.145 . . . . 0.0 112.554 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.1 p -86.69 150.68 24.01 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.869 1.267 . . . . 0.0 111.632 171.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -65.1 -7.52 12.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.703 1.601 . . . . 0.0 115.055 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.8 -11.72 30.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.326 1.85 . . . . 0.0 111.921 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.645 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 5.2 t-80 -83.01 130.94 35.19 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.638 0.654 . . . . 0.0 109.793 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -91.34 155.93 18.15 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.822 0.849 . . . . 0.0 110.238 176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -138.81 137.57 36.74 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.598 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.5 ttp -79.14 106.49 11.21 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.089 0.556 . . . . 0.0 110.515 -171.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.3 p -65.5 172.34 3.38 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.54 0.736 . . . . 0.0 112.746 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.32 -24.97 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.47 -9.28 50.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.556 1.143 . . . . 0.0 113.519 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.99 9.8 60.47 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.054 1.312 . . . . 0.0 114.599 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -69.96 149.92 47.25 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.512 1.156 . . . . 0.0 111.69 -178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.4 mtm -111.94 82.15 1.58 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.23 1.812 . . . . 0.0 108.698 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 37.1 mt -122.85 147.06 50.03 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 125.242 1.417 . . . . 0.0 110.225 -174.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.93 148.32 85.87 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.167 2.578 . . . . 0.0 111.246 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.3 tt -59.71 -25.99 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -56.44 -33.17 65.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.424 1.09 . . . . 0.0 112.998 170.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -85.25 -36.81 20.69 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.459 0.704 . . . . 0.0 111.597 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.85 -40.45 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.131 -0.981 . . . . 0.0 111.417 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -63.44 -38.52 91.45 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -76.74 -42.96 39.1 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.447 -0.783 . . . . 0.0 112.869 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -77.58 -13.17 59.98 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.143 0.977 . . . . 0.0 112.957 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 56.22 37.08 28.49 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.655 1.582 . . . . 0.0 111.854 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.6 mt -75.07 138.52 42.19 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.438 1.095 . . . . 0.0 111.318 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -73.27 157.31 37.32 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.909 0.861 . . . . 0.0 112.104 173.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.3 mt -112.94 143.35 44.39 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.843 1.257 . . . . 0.0 111.234 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 39.8 ttm -62.29 156.92 20.9 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.465 1.506 . . . . 0.0 111.953 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -132.21 158.43 41.77 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.565 1.546 . . . . 0.0 112.509 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.68 -10.93 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -107.69 16.93 23.18 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.915 1.686 . . . . 0.0 112.672 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.269 7.6 m-80 56.49 36.67 27.93 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.194 1.798 . . . . 0.0 112.551 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.97 159.61 68.08 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 112.743 -2.026 . . . . 0.0 112.015 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.68 155.92 58.12 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.561 2.841 . . . . 0.0 112.108 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -89.92 114.22 25.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.852 0.861 . . . . 0.0 110.003 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.6 pt -142.32 131.01 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.805 1.642 . . . . 0.0 111.106 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.61 173.35 10.55 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.061 1.745 . . . . 0.0 112.633 174.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.8 mt -66.01 115.86 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.097 1.359 . . . . 0.0 110.363 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.72 -42.57 73.83 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.819 1.248 . . . . 0.0 112.654 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.77 162.3 40.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.059 0.944 . . . . 0.0 111.828 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.56 145.5 42.95 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.543 1.537 . . . . 0.0 111.615 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.66 133.58 13.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.303 1.041 . . . . 0.0 110.747 177.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -65.7 133.05 50.26 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.415 -0.803 . . . . 0.0 110.707 170.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.2 mt -102.21 -45.23 5.19 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.479 0.712 . . . . 0.0 111.847 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 152.03 -147.59 17.55 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.089 0.852 . . . . 0.0 112.922 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.77 62.6 1.22 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 123.252 1.501 . . . . 0.0 113.013 -167.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -81.07 156.53 25.78 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.556 1.942 . . . . 0.0 110.826 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.42 119.33 8.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.839 0.855 . . . . 0.0 110.184 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.42 150.09 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.601 0.715 . . . . 0.0 111.367 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -138.74 159.36 42.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.651 1.58 . . . . 0.0 111.551 -168.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -154.74 130.81 10.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.543 1.137 . . . . 0.0 110.745 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.8 pt -93.52 156.44 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.009 -1.057 . . . . 0.0 111.488 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.38 153.22 19.8 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.157 0.884 . . . . 0.0 112.835 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.5 t -140.19 153.25 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.599 1.16 . . . . 0.0 111.03 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -72.26 -34.4 68.19 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.77 0.828 . . . . 0.0 112.355 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -74.83 -57.18 4.07 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.069 1.747 . . . . 0.0 113.437 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -149.91 179.2 8.24 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.831 2.452 . . . . 0.0 109.642 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -121.23 -7.7 9.3 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.921 -1.112 . . . . 0.0 113.922 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -76.95 161.16 28.59 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 118.934 0.788 . . . . 0.0 112.191 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -166.84 154.93 9.8 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.101 1.36 . . . . 0.0 111.396 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.06 149.52 35.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.863 1.265 . . . . 0.0 112.488 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 88.7 mt -128.5 -176.71 3.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.07 2.148 . . . . 0.0 111.716 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -51.08 150.55 3.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.961 0.504 . . . . 0.0 110.432 165.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 52.54 18.84 1.04 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.887 1.275 . . . . 0.0 114.342 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.01 22.13 75.74 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 117.624 -1.653 . . . . 0.0 115.94 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.481 ' CZ ' HD11 ' A' ' 66' ' ' ILE . 67.5 m-85 -65.25 157.06 29.96 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.248 2.024 . . . . 0.0 112.369 170.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.02 121.1 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.778 1.231 . . . . 0.0 108.778 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.645 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -107.38 103.63 13.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.925 0.89 . . . . 0.0 110.416 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.4 t -89.26 157.86 18.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.539 0.735 . . . . 0.0 112.331 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.7 t30 . . . . . 0 C--O 1.255 1.362 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 172.259 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -135.18 -175.43 13.84 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 127.762 2.601 . . . . 0.0 111.685 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -171.36 175.55 4.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.918 0.887 . . . . 0.0 113.193 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.584 HD13 HG21 ' A' ' 6' ' ' THR . 86.7 mt -120.32 147.39 45.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.859 2.064 . . . . 0.0 110.37 -175.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -72.8 161.82 30.26 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.857 -0.527 . . . . 0.0 111.946 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -51.96 -46.75 64.91 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.319 1.048 . . . . 0.0 112.464 -173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -61.96 -8.01 4.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.375 1.87 . . . . 0.0 115.141 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.584 HG21 HD13 ' A' ' 2' ' ' LEU . 19.9 m -71.44 107.36 4.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.906 0.883 . . . . 0.0 110.33 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.55 133.09 33.84 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.348 0.594 . . . . 0.0 111.435 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -118.49 115.1 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.332 1.453 . . . . 0.0 107.139 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.1 128.33 34.93 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 122.062 -0.399 . . . . 0.0 110.87 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.4 p -129.18 156.07 44.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.166 1.387 . . . . 0.0 113.013 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.56 -30.87 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 122.955 0.502 . . . . 0.0 112.04 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -65.78 -31.65 72.74 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -140.97 -59.59 0.5 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.628 0.771 . . . . 0.0 113.07 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.13 -133.44 5.83 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.13 108.55 12.71 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.262 1.425 . . . . 0.0 109.952 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.531 HD13 HD11 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -145.8 156.69 51.89 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.23 129.39 17.01 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.932 3.088 . . . . 0.0 112.713 -175.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.81 -37.57 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.511 0.724 . . . . 0.0 112.837 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 -30.95 79.28 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.608 -0.682 . . . . 0.0 113.051 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.79 -36.16 70.24 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.734 0.767 . . . . 0.0 111.445 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.531 HD11 HD13 ' A' ' 16' ' ' LEU . 64.6 mt -64.92 -43.12 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.998 0.519 . . . . 0.0 109.885 176.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 117' ' ' TYR . 57.8 t -75.09 -41.28 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -75.59 -22.49 56.88 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -109.87 1.56 19.29 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.132 1.373 . . . . 0.0 112.493 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.65 48.71 14.3 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.166 2.186 . . . . 0.0 113.322 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.27 124.8 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.471 0.708 . . . . 0.0 109.626 -174.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -83.02 86.23 7.03 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.737 0.78 . . . . 0.0 110.683 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' VAL . 20.6 p -117.44 -177.96 3.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.852 1.261 . . . . 0.0 111.952 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.16 144.67 48.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.426 1.49 . . . . 0.0 108.351 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.67 174.22 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.718 1.607 . . . . 0.0 111.077 -177.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -117.21 139.33 50.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.69 1.596 . . . . 0.0 110.319 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -156.99 151.9 25.94 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.864 1.265 . . . . 0.0 111.177 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.1 p -99.12 131.84 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.679 1.192 . . . . 0.0 111.461 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.7 -176.76 6.17 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.998 1.319 . . . . 0.0 113.67 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.58 -29.69 69.34 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -79.85 -11.21 59.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.277 1.031 . . . . 0.0 113.189 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.27 14.27 59.06 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.464 1.031 . . . . 0.0 114.227 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -91.75 126.23 36.76 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.897 1.348 . . . . 0.0 109.481 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.0 mt -71.95 88.43 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.345 1.058 . . . . 0.0 108.78 172.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -81.88 171.08 14.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.114 0.966 . . . . 0.0 111.136 171.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 p -126.92 145.52 50.65 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.832 0.853 . . . . 0.0 111.777 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -145.39 146.38 29.79 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 124.259 1.023 . . . . 0.0 112.677 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.07 156.19 56.11 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.208 2.605 . . . . 0.0 112.474 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 28' ' ' CYS . 42.1 t -67.55 119.8 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.993 0.917 . . . . 0.0 109.816 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.22 -36.27 35.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.374 0.67 . . . . 0.0 112.578 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -162.14 175.67 11.46 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.381 1.473 . . . . 0.0 112.64 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -135.71 117.36 14.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.08 1.352 . . . . 0.0 109.34 -175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -108.35 130.58 55.2 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.062 0.934 . . . . 0.0 110.369 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.21 103.12 9.22 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.791 1.636 . . . . 0.0 109.514 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -69.78 -33.26 72.15 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.374 1.07 . . . . 0.0 111.908 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.52 -40.39 3.01 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.87 1.224 . . . . 0.0 113.382 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 178.32 109.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.283 1.433 . . . . 0.0 111.62 -174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -133.96 164.96 26.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.131 0.972 . . . . 0.0 112.55 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.07 100.06 0.3 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.489 1.516 . . . . 0.0 113.204 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 t -92.41 137.24 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.038 1.335 . . . . 0.0 110.959 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -119.51 137.13 54.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.295 1.438 . . . . 0.0 109.486 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -56.89 126.0 25.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.99 0.916 . . . . 0.0 110.267 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -118.58 82.88 1.92 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.893 1.277 . . . . 0.0 108.449 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.9 t -94.17 137.51 33.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.666 0.787 . . . . 0.0 110.646 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.82 162.03 13.32 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.223 1.009 . . . . 0.0 112.111 173.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -18.75 62.02 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -78.12 -26.51 48.0 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.123 0.969 . . . . 0.0 112.729 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.74 2.98 18.8 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.629 1.109 . . . . 0.0 114.806 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 m -67.69 132.4 47.4 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.304 1.552 . . . . 0.0 110.356 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.67 132.37 56.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.087 1.355 . . . . 0.0 109.877 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.6 mt -139.01 155.17 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 126.408 1.883 . . . . 0.0 108.478 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -137.96 111.01 7.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.028 1.331 . . . . 0.0 110.675 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.71 166.78 24.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.906 1.283 . . . . 0.0 111.659 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.3 p -88.24 160.14 17.82 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.942 0.877 . . . . 0.0 112.344 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -67.76 -3.8 10.47 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -103.29 -13.0 16.88 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.141 0.977 . . . . 0.0 112.58 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.45 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 11.0 t-80 -76.92 121.01 22.83 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 173.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -82.57 149.74 27.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.268 0.627 . . . . 0.0 109.776 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -132.06 143.82 50.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.523 -0.736 . . . . 0.0 109.737 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.4 ttp -75.22 104.43 5.79 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.074 0.55 . . . . 0.0 110.468 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.4 p -66.27 167.99 9.44 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.941 0.496 . . . . 0.0 111.683 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.3 m -55.07 -26.33 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -84.36 -13.17 53.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.273 1.029 . . . . 0.0 113.376 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.99 30.41 12.93 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.574 1.083 . . . . 0.0 113.557 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -98.75 147.24 25.08 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.241 1.02 . . . . 0.0 110.718 177.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.98 89.91 3.8 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.812 1.245 . . . . 0.0 109.871 176.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.1 mt -121.69 145.79 43.99 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.323 1.049 . . . . 0.0 110.438 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.68 147.48 81.58 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.092 2.528 . . . . 0.0 111.355 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.427 HG13 HD11 ' A' ' 105' ' ' ILE . 11.0 tt -58.0 -27.47 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -54.52 -38.42 66.51 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.583 1.153 . . . . 0.0 112.872 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -82.22 -34.72 28.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.283 0.633 . . . . 0.0 111.586 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.61 -39.21 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.6 -0.688 . . . . 0.0 110.368 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -63.96 -34.81 78.82 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -75.14 -44.77 45.08 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.524 -0.735 . . . . 0.0 112.669 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -76.33 -12.67 60.11 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 56.08 31.48 18.23 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.298 1.439 . . . . 0.0 112.108 -174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 69.5 mt -79.2 150.29 31.7 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.258 1.023 . . . . 0.0 111.586 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.98 155.78 17.32 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.617 0.767 . . . . 0.0 111.491 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt -84.47 159.36 20.77 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.414 -0.804 . . . . 0.0 112.623 168.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.6 ttp -86.52 155.74 20.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.795 1.238 . . . . 0.0 111.294 169.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.52 164.46 27.76 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.337 1.455 . . . . 0.0 112.04 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.6 m -93.02 -19.63 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -99.0 15.65 25.06 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.505 1.122 . . . . 0.0 113.088 -172.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.3 m120 55.57 32.91 20.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.868 1.667 . . . . 0.0 112.099 -173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.53 154.29 73.7 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.676 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.08 144.76 70.84 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.746 2.964 . . . . 0.0 111.26 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -79.79 116.87 20.2 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.681 -0.637 . . . . 0.0 110.635 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.4 pt -142.53 132.77 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.926 1.69 . . . . 0.0 111.261 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 175.72 6.97 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.889 1.676 . . . . 0.0 112.347 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.427 HD11 HG13 ' A' ' 84' ' ' ILE . 10.9 mt -63.66 112.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.197 1.399 . . . . 0.0 110.035 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.65 -43.62 62.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.993 0.917 . . . . 0.0 111.742 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 p -149.02 147.75 28.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.115 1.766 . . . . 0.0 110.056 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -140.6 142.16 35.08 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.415 1.486 . . . . 0.0 110.212 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -152.32 131.64 12.85 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.929 1.692 . . . . 0.0 108.951 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -61.69 121.21 12.26 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.947 0.339 . . . . 0.0 110.545 171.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.9 mt -88.39 -40.54 13.45 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 122.645 0.378 . . . . 0.0 111.721 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.04 -145.22 15.71 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.653 1.121 . . . . 0.0 112.261 -173.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -128.22 74.93 1.58 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 123.206 1.479 . . . . 0.0 113.401 -167.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -89.54 155.19 19.44 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.458 1.503 . . . . 0.0 109.908 -171.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.15 117.26 5.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.436 0.694 . . . . 0.0 109.851 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.63 154.25 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.422 0.63 . . . . 0.0 110.919 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.463 ' HB3' HG21 ' A' ' 22' ' ' VAL . 6.2 m-85 -140.94 157.38 45.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.669 1.588 . . . . 0.0 111.322 -170.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -156.93 117.12 3.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.755 1.222 . . . . 0.0 110.159 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.8 pt -71.46 155.44 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 121.028 -1.045 . . . . 0.0 111.205 172.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -107.07 152.38 16.89 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.494 1.045 . . . . 0.0 111.74 170.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.56 158.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.711 2.004 . . . . 0.0 110.108 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -71.81 -37.78 70.3 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.6 -168.1 0.79 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.202 1.001 . . . . 0.0 111.579 174.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -49.53 130.8 20.78 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.604 -0.685 . . . . 0.0 109.81 167.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -63.88 102.78 0.5 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.349 0.66 . . . . 0.0 110.817 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -162.5 171.16 17.48 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.413 1.485 . . . . 0.0 113.228 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -172.55 157.13 3.83 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.052 1.741 . . . . 0.0 111.061 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.77 144.75 29.95 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.821 0.848 . . . . 0.0 112.461 173.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 28.9 mt -89.76 173.09 8.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.095 1.358 . . . . 0.0 112.188 171.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -48.62 -49.73 35.85 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.708 1.603 . . . . 0.0 114.561 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -73.38 -37.7 65.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.211 0.604 . . . . 0.0 111.652 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 139.68 -6.11 2.91 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.478 -1.179 . . . . 0.0 115.359 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -57.0 155.35 8.28 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.563 1.681 . . . . 0.0 112.619 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.58 110.81 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 122.033 0.921 . . . . 0.0 109.676 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.45 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -96.36 116.75 29.54 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.391 1.076 . . . . 0.0 108.64 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.2 m -109.56 79.87 1.26 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.377 1.071 . . . . 0.0 111.433 -173.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.3 t30 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 127.597 2.359 . . . . 0.0 115.997 -168.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -142.76 158.6 27.14 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.385 1.945 . . . . 0.0 111.074 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.26 178.03 10.62 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.512 1.125 . . . . 0.0 112.653 -169.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.11 148.56 32.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.452 1.501 . . . . 0.0 110.652 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -62.41 161.39 11.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.644 0.777 . . . . 0.0 112.653 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -52.5 -47.01 66.86 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.889 . . . . 0.0 112.541 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -63.65 -20.45 65.7 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.266 1.827 . . . . 0.0 113.403 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.2 m -59.64 105.25 0.35 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.402 1.081 . . . . 0.0 110.862 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -86.23 129.81 34.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.363 0.601 . . . . 0.0 111.0 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.2 mm -113.49 124.95 70.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.075 1.35 . . . . 0.0 107.529 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.39 129.9 44.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.08 0.552 . . . . 0.0 110.899 171.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.8 p -133.02 148.68 52.24 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.296 1.438 . . . . 0.0 111.431 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.8 -31.3 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 122.071 -0.393 . . . . 0.0 111.892 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -64.83 -36.46 84.4 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -141.49 -44.76 0.36 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -172.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.17 -136.82 9.11 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.134 0.879 . . . . 0.0 112.347 -172.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.4 91.19 7.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.885 1.674 . . . . 0.0 111.823 -173.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -122.1 146.09 45.64 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.905 0.882 . . . . 0.0 112.638 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.76 125.33 13.59 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.367 3.378 . . . . 0.0 112.727 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.84 -37.36 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.965 0.906 . . . . 0.0 113.368 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.4 -32.39 79.23 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.559 -0.713 . . . . 0.0 113.097 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -71.88 -35.37 69.76 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 117.787 0.793 . . . . 0.0 111.602 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -67.5 -39.68 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.529 0.732 . . . . 0.0 109.709 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.03 -41.08 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.727 0.811 . . . . 0.0 112.471 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -76.35 -24.4 54.2 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.346 0.976 . . . . 0.0 113.339 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -104.67 -0.01 27.97 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.79 1.236 . . . . 0.0 112.854 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 48.29 49.57 17.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.655 1.982 . . . . 0.0 112.422 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.3 mt -68.61 121.02 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.179 0.992 . . . . 0.0 109.272 -174.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.39 107.77 11.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.439 1.095 . . . . 0.0 110.656 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.0 p -148.16 166.91 26.45 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.256 1.027 . . . . 0.0 113.466 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.5 148.29 23.89 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.433 1.493 . . . . 0.0 109.857 177.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 m -128.95 171.48 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.018 1.727 . . . . 0.0 110.924 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -115.4 140.09 49.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.462 1.505 . . . . 0.0 110.283 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 t -156.15 152.02 27.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.966 1.306 . . . . 0.0 110.672 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.52 128.31 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.199 0.6 . . . . 0.0 109.933 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -69.93 173.79 6.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.601 1.16 . . . . 0.0 111.807 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -62.22 -25.51 67.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.318 1.447 . . . . 0.0 113.328 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -86.23 -2.5 58.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.112 1.365 . . . . 0.0 113.398 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.08 22.52 60.9 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.603 1.097 . . . . 0.0 114.808 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -99.85 129.9 45.99 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.804 1.242 . . . . 0.0 109.991 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.1 mt -70.25 130.59 34.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -134.13 169.72 16.74 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.579 1.552 . . . . 0.0 110.938 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 p -119.55 140.87 49.83 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.956 0.902 . . . . 0.0 111.681 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -149.85 147.36 22.35 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.317 1.047 . . . . 0.0 112.423 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.05 149.91 47.45 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.117 2.545 . . . . 0.0 112.658 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -57.84 137.11 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.741 0.816 . . . . 0.0 110.409 168.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.16 -50.59 5.76 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.993 0.517 . . . . 0.0 111.42 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -149.97 173.55 13.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.029 1.731 . . . . 0.0 111.042 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -129.25 131.67 47.07 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.566 1.546 . . . . 0.0 108.994 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -130.06 138.81 50.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.202 1.001 . . . . 0.0 110.715 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.65 121.49 28.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.914 1.285 . . . . 0.0 110.801 -174.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -86.36 -34.0 20.36 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.216 1.006 . . . . 0.0 112.559 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.76 -44.93 2.71 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.253 1.406 . . . . 0.0 115.17 172.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -174.32 88.78 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 123.083 1.42 . . . . 0.0 114.568 -168.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -127.48 163.19 24.66 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.201 1.0 . . . . 0.0 112.91 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -67.73 103.53 1.43 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.062 1.345 . . . . 0.0 112.714 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -96.5 139.32 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.431 1.492 . . . . 0.0 110.991 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.436 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 75.5 m-85 -123.11 142.48 50.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.512 1.525 . . . . 0.0 109.976 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -65.88 131.26 45.84 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.733 0.813 . . . . 0.0 110.301 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -124.66 87.06 2.65 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.084 1.353 . . . . 0.0 108.439 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.2 t -95.28 146.71 24.16 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.97 0.908 . . . . 0.0 110.627 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.8 164.76 12.44 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.924 1.289 . . . . 0.0 112.368 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -66.86 -23.62 66.04 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.549 1.139 . . . . 0.0 113.284 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.56 -23.56 46.05 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.103 1.361 . . . . 0.0 112.961 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.55 0.68 30.86 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.756 1.17 . . . . 0.0 114.345 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.8 m -57.14 136.41 56.4 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.384 1.092 . . . . 0.0 110.558 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.92 122.78 38.34 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.753 1.221 . . . . 0.0 109.758 -172.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.1 mt -134.07 150.89 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.547 1.939 . . . . 0.0 107.86 -172.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 63.6 mtt85 -136.38 117.37 14.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.616 1.166 . . . . 0.0 109.864 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.6 163.5 38.34 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.518 1.127 . . . . 0.0 111.558 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 p -75.01 151.68 38.76 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.446 -0.784 . . . . 0.0 112.065 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -63.12 -17.22 62.09 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 176.445 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -86.42 -16.28 37.67 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.485 1.514 . . . . 0.0 113.33 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -74.46 135.36 42.29 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.176 0.59 . . . . 0.0 109.436 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 149.19 21.85 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.037 0.922 . . . . 0.0 112.174 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -134.26 127.25 31.46 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.428 -1.42 . . . . 0.0 110.182 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ttp -71.93 111.28 7.04 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.046 0.45 . . . . 0.0 111.084 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.6 p -70.37 171.94 9.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.057 0.543 . . . . 0.0 112.215 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -54.44 -27.2 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.1 -8.19 54.3 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.698 1.199 . . . . 0.0 113.133 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.82 1.09 63.67 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.962 1.267 . . . . 0.0 114.326 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.97 146.71 52.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.523 1.161 . . . . 0.0 111.212 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.2 mtm -117.87 76.55 1.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.31 1.444 . . . . 0.0 109.465 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.64 150.84 43.95 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.006 1.322 . . . . 0.0 110.979 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.34 148.92 80.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.977 2.451 . . . . 0.0 111.559 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 tt -55.66 -29.07 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -53.15 -37.51 61.9 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.643 1.177 . . . . 0.0 113.138 170.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -90.33 -32.83 16.32 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.584 1.153 . . . . 0.0 111.605 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.72 -38.33 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.389 -0.819 . . . . 0.0 111.191 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.64 -34.79 78.66 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.41 -45.98 51.35 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.46 -8.8 58.92 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 58.14 37.68 26.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.673 1.189 . . . . 0.0 111.549 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.5 mt -83.92 155.67 22.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.901 1.334 . . . . 0.0 112.162 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -110.92 155.42 22.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.764 2.426 . . . . 0.0 112.969 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.7 155.09 19.44 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.692 0.797 . . . . 0.0 112.444 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.4 ttp -74.99 138.46 42.25 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.711 173.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.85 157.51 27.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.996 1.318 . . . . 0.0 110.684 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.588 HG22 ' HA2' ' A' ' 132' ' ' GLY . 31.4 m -118.69 -4.18 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.99 13.42 25.07 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.683 1.593 . . . . 0.0 112.587 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 58.89 30.1 19.71 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.763 2.025 . . . . 0.0 112.466 -174.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.6 mt -88.85 155.77 50.01 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.21 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.55 154.32 64.7 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.841 3.027 . . . . 0.0 111.951 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.36 132.14 35.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.476 0.711 . . . . 0.0 110.339 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 pt -146.87 137.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.972 1.309 . . . . 0.0 111.489 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.87 175.98 9.96 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.991 1.317 . . . . 0.0 112.509 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.8 mt -62.17 111.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.081 1.353 . . . . 0.0 110.03 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.73 -45.18 83.62 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.131 0.972 . . . . 0.0 111.883 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 p -151.35 150.67 30.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.287 1.835 . . . . 0.0 110.555 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -133.05 142.87 49.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.725 1.61 . . . . 0.0 110.083 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -156.9 140.6 16.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.696 1.598 . . . . 0.0 109.865 175.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -66.84 128.64 37.08 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.876 -0.515 . . . . 0.0 111.127 172.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.78 -46.43 7.55 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.849 0.459 . . . . 0.0 111.691 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 147.53 -150.94 23.24 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.246 0.927 . . . . 0.0 112.778 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -122.18 79.59 1.61 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.932 1.349 . . . . 0.0 112.763 -168.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -98.36 157.93 15.89 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.793 1.637 . . . . 0.0 110.466 -169.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.57 120.8 13.04 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.633 0.773 . . . . 0.0 110.031 169.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.9 m -125.14 152.68 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.332 0.653 . . . . 0.0 111.182 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -140.93 156.49 46.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.159 1.384 . . . . 0.0 111.942 -168.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -152.4 130.91 12.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.671 1.189 . . . . 0.0 110.8 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.8 pt -91.59 154.11 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.74 173.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.06 159.76 13.91 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.906 1.241 . . . . 0.0 111.44 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 t -141.93 154.91 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.717 1.207 . . . . 0.0 109.649 -172.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.47 107.31 0.65 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.837 -1.164 . . . . 0.0 111.885 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 52.78 26.29 4.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.638 1.975 . . . . 0.0 114.385 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -145.24 166.7 24.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.002 1.721 . . . . 0.0 111.798 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -151.37 37.36 0.6 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.202 1.001 . . . . 0.0 112.43 -174.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -147.57 161.18 41.64 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.905 -1.122 . . . . 0.0 113.407 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -165.13 167.12 18.52 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.054 1.342 . . . . 0.0 112.297 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.38 131.02 40.46 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.622 1.169 . . . . 0.0 112.461 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 32.6 mt -70.33 166.9 19.25 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.304 1.441 . . . . 0.0 111.678 169.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -48.94 -34.59 13.16 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.49 -6.87 24.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.394 1.078 . . . . 0.0 112.526 -172.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . 124.17 -17.59 7.52 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.962 1.267 . . . . 0.0 115.261 171.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -64.32 154.46 35.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.832 1.316 . . . . 0.0 112.697 -174.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.5 mm -104.47 140.31 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.434 1.015 . . . . 0.0 111.012 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.96 140.38 53.04 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.394 1.878 . . . . 0.0 109.418 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.0 t -138.74 124.91 20.19 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.118 1.367 . . . . 0.0 112.383 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.9 t30 . . . . . 0 C--O 1.255 1.384 0 C-N-CA 126.446 1.898 . . . . 0.0 113.991 -168.169 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -144.71 164.9 27.71 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 128.551 2.977 . . . . 0.0 109.135 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -159.54 173.34 16.29 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.715 0.757 . . . . 0.0 112.671 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.61 146.95 38.94 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.844 1.258 . . . . 0.0 110.771 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -65.2 164.1 13.9 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -50.97 -43.73 60.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.4 -19.73 64.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.692 1.197 . . . . 0.0 112.846 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 m -63.67 108.24 1.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.203 1.401 . . . . 0.0 111.133 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -86.47 128.12 34.93 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.116 0.484 . . . . 0.0 110.431 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.8 mm -99.58 122.3 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.396 1.479 . . . . 0.0 107.295 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.2 tp -69.91 122.61 19.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.2 p -125.9 152.11 46.01 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.9 0.88 . . . . 0.0 112.652 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -71.37 -34.05 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.876 0.47 . . . . 0.0 111.942 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -67.74 -32.72 73.53 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -141.78 -48.5 0.38 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.26 -151.39 19.87 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.172 0.892 . . . . 0.0 111.541 -172.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.87 108.49 1.49 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.352 1.061 . . . . 0.0 111.181 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.4 mt -132.23 147.76 67.05 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.74 1.216 . . . . 0.0 112.871 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.93 123.88 11.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.957 3.104 . . . . 0.0 112.212 -177.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 tt -55.21 -36.82 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.77 -33.73 88.01 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.797 -0.564 . . . . 0.0 113.018 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -77.36 -33.64 55.28 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.684 0.794 . . . . 0.0 112.042 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.7 mt -65.69 -38.85 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.141 0.976 . . . . 0.0 109.664 173.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.0 t -78.15 -38.32 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.366 1.067 . . . . 0.0 112.756 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 -25.48 46.64 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.26 0.936 . . . . 0.0 113.467 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -100.91 -2.59 31.54 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.722 1.209 . . . . 0.0 113.23 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 50.11 49.47 20.35 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.475 1.91 . . . . 0.0 112.339 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.4 mt -71.02 121.51 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.23 1.012 . . . . 0.0 109.591 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -74.81 114.03 12.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.409 0.623 . . . . 0.0 110.725 172.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.9 p -143.72 171.67 13.88 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.068 1.347 . . . . 0.0 112.278 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 m -112.83 150.13 32.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.909 1.284 . . . . 0.0 109.035 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.6 m -125.37 178.42 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.053 1.341 . . . . 0.0 111.222 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.83 141.27 49.68 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.841 1.256 . . . . 0.0 110.538 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.42 153.21 15.22 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.14 1.776 . . . . 0.0 109.185 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.5 m -89.09 143.7 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.442 1.019 . . . . 0.0 111.973 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.56 177.57 7.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.495 1.118 . . . . 0.0 111.395 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -62.8 -17.56 61.36 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.887 1.275 . . . . 0.0 113.04 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -95.16 -0.03 53.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.06 1.744 . . . . 0.0 113.133 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.66 35.65 40.08 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 121.33 -0.856 . . . . 0.0 114.147 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -119.31 123.23 43.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.455 1.502 . . . . 0.0 109.71 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -64.08 117.55 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -120.7 167.62 12.27 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.502 1.521 . . . . 0.0 111.669 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.1 p -115.6 137.96 51.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.282 1.033 . . . . 0.0 111.468 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -146.19 140.35 15.38 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.509 1.124 . . . . 0.0 111.412 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.19 148.94 40.02 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.863 2.375 . . . . 0.0 112.027 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.5 147.94 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.504 1.122 . . . . 0.0 111.114 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.17 -42.27 3.76 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.28 1.032 . . . . 0.0 112.237 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -142.6 178.44 7.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.896 1.679 . . . . 0.0 111.656 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -138.08 125.07 21.33 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.244 1.418 . . . . 0.0 109.117 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -118.57 137.82 52.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.345 1.058 . . . . 0.0 110.73 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.82 123.05 34.23 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.248 1.419 . . . . 0.0 110.61 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -89.72 -29.51 18.68 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.508 1.123 . . . . 0.0 112.77 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.58 -58.95 4.84 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.667 1.603 . . . . 0.0 114.002 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -158.92 98.83 1.5 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.77 1.228 . . . . 0.0 112.853 -168.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -133.03 163.13 29.92 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.336 1.054 . . . . 0.0 112.248 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.5 105.97 1.64 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.612 1.165 . . . . 0.0 113.246 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.42 137.44 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.0 0.92 . . . . 0.0 111.54 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -122.61 141.8 51.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.428 1.091 . . . . 0.0 110.849 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -85.84 96.08 9.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.93 1.692 . . . . 0.0 111.009 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -79.09 108.11 12.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.591 0.757 . . . . 0.0 109.418 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.0 t -88.63 132.55 34.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.361 1.064 . . . . 0.0 110.439 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tp -90.06 168.95 11.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.851 1.261 . . . . 0.0 112.628 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.5 -24.96 66.48 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.94 -27.23 36.17 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.482 1.513 . . . . 0.0 113.019 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.38 0.62 31.14 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.428 1.014 . . . . 0.0 114.13 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.0 m -65.36 141.18 58.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.667 1.234 . . . . 0.0 110.628 169.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 mp -119.62 141.02 49.69 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.256 1.422 . . . . 0.0 110.052 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -136.77 136.85 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.731 1.612 . . . . 0.0 108.398 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -123.96 103.3 8.24 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.134 0.974 . . . . 0.0 110.161 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.69 165.07 29.83 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.376 1.084 . . . . 0.0 111.828 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.9 p -78.4 149.2 33.37 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.464 1.106 . . . . 0.0 111.081 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -62.71 -12.78 25.91 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -91.63 -15.44 28.55 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.145 1.778 . . . . 0.0 112.527 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.475 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 2.7 t-80 -78.04 134.54 37.76 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -87.49 160.13 18.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.362 0.665 . . . . 0.0 111.696 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -140.52 140.06 35.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.759 0.823 . . . . 0.0 110.501 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 44.1 ttm -74.01 108.76 7.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.389 1.075 . . . . 0.0 111.604 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.0 p -67.17 172.62 4.49 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -56.39 -23.18 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -98.01 -8.29 28.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.193 1.397 . . . . 0.0 113.165 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.14 1.49 48.16 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.065 1.317 . . . . 0.0 115.094 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -66.32 139.24 58.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.963 1.382 . . . . 0.0 111.44 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.73 76.05 1.77 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.221 1.408 . . . . 0.0 110.956 174.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.3 mt -102.4 147.63 34.27 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 124.165 0.986 . . . . 0.0 110.458 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -64.07 145.92 90.21 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.062 2.508 . . . . 0.0 110.989 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.1 tt -56.69 -28.36 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.82 -30.32 68.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.868 1.267 . . . . 0.0 113.416 172.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.42 -41.09 13.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.682 1.193 . . . . 0.0 111.155 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.52 HD13 HD21 ' A' ' 94' ' ' LEU . 67.2 mt -58.34 -41.21 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.514 1.126 . . . . 0.0 111.789 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -59.68 -33.19 71.26 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.234 1.014 . . . . 0.0 113.165 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -78.48 -46.92 18.51 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -13.73 62.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 56.01 35.36 25.43 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.711 1.604 . . . . 0.0 112.223 -175.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.2 mt -79.72 147.19 32.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.823 0.82 . . . . 0.0 111.373 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.45 172.33 13.16 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.697 0.761 . . . . 0.0 110.846 171.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.52 HD21 HD13 ' A' ' 87' ' ' ILE . 92.6 mt -116.2 157.51 24.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.342 1.057 . . . . 0.0 111.137 177.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.5 ttm -60.01 158.26 11.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.654 0.782 . . . . 0.0 111.809 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -127.13 163.23 24.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.096 1.758 . . . . 0.0 111.832 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.44 -26.43 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 125.006 1.322 . . . . 0.0 114.045 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -106.09 15.15 26.8 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.55 1.54 . . . . 0.0 112.288 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.4 m120 56.93 34.42 24.83 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 123.473 1.606 . . . . 0.0 112.493 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.94 159.64 84.85 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 112.676 -2.056 . . . . 0.0 111.375 170.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.19 134.3 31.11 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.094 2.529 . . . . 0.0 111.361 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -72.27 122.88 21.86 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.897 0.879 . . . . 0.0 109.893 172.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.6 pt -146.47 142.06 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.38 1.072 . . . . 0.0 111.49 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 171.29 14.76 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.268 1.827 . . . . 0.0 112.997 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.34 109.25 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.236 1.015 . . . . 0.0 109.489 172.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.93 70.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.413 1.085 . . . . 0.0 112.149 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -152.5 167.99 27.0 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.996 1.719 . . . . 0.0 111.268 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -137.36 146.39 44.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.321 1.448 . . . . 0.0 110.677 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -139.39 120.26 14.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.582 1.153 . . . . 0.0 109.957 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -64.04 123.12 18.2 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.94 -0.475 . . . . 0.0 110.303 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 41.4 mt -90.39 -42.96 10.62 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.372 0.269 . . . . 0.0 111.688 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.83 -131.85 4.97 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.853 0.74 . . . . 0.0 112.92 -174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -131.26 72.43 1.5 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.661 1.584 . . . . 0.0 113.101 -167.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -94.41 160.86 14.47 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.831 1.653 . . . . 0.0 111.421 -170.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.05 120.67 12.47 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.519 0.728 . . . . 0.0 111.344 169.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.07 151.99 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.491 0.716 . . . . 0.0 110.635 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -143.67 162.0 37.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.393 -168.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -155.73 120.38 4.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.027 0.931 . . . . 0.0 110.142 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.1 pt -80.4 137.27 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.727 -1.233 . . . . 0.0 111.64 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.02 134.21 12.23 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.022 0.82 . . . . 0.0 111.152 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -156.55 132.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.026 0.93 . . . . 0.0 110.553 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -80.99 150.84 28.75 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.907 0.883 . . . . 0.0 111.114 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 64.24 101.66 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.798 2.039 . . . . 0.0 111.616 -171.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.51 86.32 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.305 1.842 . . . . 0.0 112.54 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -53.54 -24.39 13.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -55.01 160.32 2.06 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -160.53 157.37 27.35 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.116 0.967 . . . . 0.0 112.149 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.05 149.48 44.84 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.64 1.176 . . . . 0.0 113.112 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.7 mt -134.93 174.68 10.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.123 2.169 . . . . 0.0 111.241 -172.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.97 146.99 4.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.246 1.018 . . . . 0.0 111.704 168.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 50.22 23.04 1.07 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.161 1.384 . . . . 0.0 114.451 -173.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.59 25.9 66.62 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 120.861 -1.149 . . . . 0.0 115.636 172.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.403 ' C ' HD12 ' A' ' 134' ' ' ILE . 16.1 m-85 -75.13 155.31 37.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.961 1.381 . . . . 0.0 112.174 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 133' ' ' PHE . 2.9 mp -129.06 103.06 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.475 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -86.67 148.1 25.6 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 170.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.3 t -132.84 147.43 52.3 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.912 1.685 . . . . 0.0 111.086 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 C--O 1.251 1.176 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.079 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -147.58 160.42 28.29 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.945 2.212 . . . . 0.0 111.769 -172.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -155.48 170.68 21.39 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.866 0.867 . . . . 0.0 112.11 -169.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -111.99 144.42 41.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.099 1.359 . . . . 0.0 110.029 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -67.94 159.77 29.92 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.65 -0.656 . . . . 0.0 111.868 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -48.47 -43.96 35.16 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.415 1.086 . . . . 0.0 112.761 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -13.42 29.83 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.7 m -70.51 112.35 6.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.528 1.131 . . . . 0.0 110.275 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -91.57 136.02 33.43 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.36 0.6 . . . . 0.0 111.54 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 mm -113.18 123.65 69.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 126.156 1.783 . . . . 0.0 107.512 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -62.37 129.69 41.86 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.371 0.668 . . . . 0.0 110.613 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.6 p -132.31 145.81 51.54 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.934 1.294 . . . . 0.0 111.269 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 t -75.21 -32.67 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.497 -0.752 . . . . 0.0 111.683 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -61.93 -32.56 72.97 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -142.75 -53.39 0.4 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -174.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.37 -144.25 15.9 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.181 0.896 . . . . 0.0 112.196 -171.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 mt -72.77 105.07 4.19 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.254 1.822 . . . . 0.0 111.013 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.0 mt -134.54 147.28 62.68 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.332 1.053 . . . . 0.0 113.744 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.44 127.94 19.22 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.062 3.175 . . . . 0.0 112.468 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.9 tt -55.57 -37.74 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.953 0.901 . . . . 0.0 112.859 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.35 -35.19 91.66 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.63 -0.539 . . . . 0.0 112.393 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -71.31 -33.38 69.64 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.485 1.143 . . . . 0.0 111.9 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.36 -41.82 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.584 0.754 . . . . 0.0 110.308 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.68 -42.83 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.76 0.709 . . . . 0.0 112.566 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -65.98 -29.08 69.41 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.057 0.844 . . . . 0.0 112.3 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -113.15 3.95 16.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.603 1.161 . . . . 0.0 113.484 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 48.3 50.53 16.35 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.931 2.092 . . . . 0.0 112.274 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.9 mt -68.86 117.99 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.119 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -74.23 97.81 3.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.375 1.07 . . . . 0.0 110.131 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.4 p -138.03 164.87 28.0 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.38 1.086 . . . . 0.0 113.195 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.49 154.94 17.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.523 1.529 . . . . 0.0 110.449 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.27 178.77 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.076 1.75 . . . . 0.0 110.756 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -126.18 134.68 51.2 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.511 1.524 . . . . 0.0 110.368 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -161.19 155.44 22.83 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.147 0.979 . . . . 0.0 112.068 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.8 m -79.38 146.89 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.634 1.106 . . . . 0.0 113.19 172.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.9 p30 -83.3 -178.81 7.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.174 0.99 . . . . 0.0 112.398 169.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -55.21 -31.55 61.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.495 1.118 . . . . 0.0 113.584 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -85.16 -10.13 57.06 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.723 0.809 . . . . 0.0 112.571 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.43 21.27 27.37 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.859 1.695 . . . . 0.0 114.678 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -101.9 123.29 45.57 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.193 1.496 . . . . 0.0 109.945 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.7 113.49 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.455 0.57 . . . . 0.0 109.734 177.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -116.87 177.18 4.8 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.882 2.073 . . . . 0.0 111.477 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -124.18 142.46 51.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.227 1.011 . . . . 0.0 112.832 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -154.37 152.77 26.94 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.346 1.059 . . . . 0.0 112.74 -176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.22 153.5 66.77 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.105 2.536 . . . . 0.0 112.992 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.79 140.8 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.713 1.205 . . . . 0.0 110.363 168.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.0 -52.44 5.08 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.924 -0.485 . . . . 0.0 111.333 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -150.99 177.87 9.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.153 1.781 . . . . 0.0 111.132 -175.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -135.7 137.32 41.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.069 1.348 . . . . 0.0 110.406 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -134.0 131.83 39.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.092 0.957 . . . . 0.0 111.862 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -111.71 140.8 46.03 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.591 1.556 . . . . 0.0 108.919 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -106.84 -36.32 6.7 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.79 -54.65 1.66 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.338 1.447 . . . . 0.0 113.791 175.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -169.79 104.7 0.33 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.92 1.36 . . . . 0.0 111.098 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -132.54 158.85 41.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.887 0.875 . . . . 0.0 112.896 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.92 98.55 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.427 1.491 . . . . 0.0 114.062 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.0 142.8 12.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.498 1.519 . . . . 0.0 111.593 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -128.08 135.97 50.56 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.654 1.582 . . . . 0.0 109.708 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.2 134.21 56.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.362 0.665 . . . . 0.0 110.474 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.86 96.94 4.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.694 1.197 . . . . 0.0 108.523 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 34.2 t -106.28 145.18 31.95 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.228 1.011 . . . . 0.0 110.597 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -107.93 164.56 12.16 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.625 1.17 . . . . 0.0 112.917 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -67.87 -21.54 65.16 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -80.27 -23.27 40.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.851 1.26 . . . . 0.0 113.044 172.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.02 -3.85 22.5 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.193 1.378 . . . . 0.0 114.597 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -57.0 139.17 53.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.749 1.274 . . . . 0.0 111.122 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.55 125.76 40.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.656 1.183 . . . . 0.0 109.899 -174.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.2 mt -136.21 150.7 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 108.382 -170.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -135.39 112.01 10.0 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.662 1.185 . . . . 0.0 111.316 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.14 20.83 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.626 1.571 . . . . 0.0 111.188 -175.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.9 p -84.56 161.71 20.09 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.495 -0.753 . . . . 0.0 112.077 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -67.91 -8.26 35.29 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 173.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -100.32 -12.98 19.01 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.301 1.44 . . . . 0.0 112.167 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -77.73 131.86 37.86 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 172.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -88.37 164.44 15.53 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.704 0.764 . . . . 0.0 111.308 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -138.36 135.45 35.36 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.414 0.686 . . . . 0.0 109.151 175.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.9 ttp -74.18 102.0 4.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.827 1.251 . . . . 0.0 109.6 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.6 p -64.23 172.74 2.3 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.755 1.222 . . . . 0.0 112.335 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.74 -28.91 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.4 -10.07 58.65 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.277 1.031 . . . . 0.0 113.593 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.73 -0.07 79.35 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.7 1.143 . . . . 0.0 113.954 -175.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -68.46 129.03 38.72 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.669 1.235 . . . . 0.0 109.49 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -96.25 88.42 4.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.271 1.428 . . . . 0.0 109.821 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.6 mt -115.4 147.19 38.14 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.394 1.077 . . . . 0.0 110.594 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.71 147.2 89.75 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.225 2.616 . . . . 0.0 111.323 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.11 -26.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.21 -37.88 70.25 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.591 1.156 . . . . 0.0 112.733 169.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -80.48 -39.68 27.57 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.247 0.619 . . . . 0.0 110.571 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.05 -36.7 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.26 -0.9 . . . . 0.0 111.346 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -66.49 -35.84 81.27 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.4 -36.92 28.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.716 0.806 . . . . 0.0 112.927 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -75.87 -17.98 59.6 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.573 1.149 . . . . 0.0 112.896 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 55.48 37.78 29.36 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.305 1.442 . . . . 0.0 112.63 -173.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.8 mt -82.69 146.82 28.84 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.93 0.892 . . . . 0.0 112.919 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.14 158.67 18.48 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.47 1.108 . . . . 0.0 112.049 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.7 mt -103.1 149.38 24.66 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 33.3 ttm -70.95 153.29 42.79 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 111.624 171.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -141.18 160.66 39.63 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.563 1.945 . . . . 0.0 112.539 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' HA2' ' A' ' 132' ' ' GLY . 10.0 p -101.11 -26.21 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 126.019 1.728 . . . . 0.0 113.567 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.68 5.29 9.57 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.29 1.436 . . . . 0.0 113.541 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 57.34 27.12 13.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.324 1.849 . . . . 0.0 112.344 -172.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 mt -70.97 155.52 93.26 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.416 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.07 147.65 84.47 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.234 2.622 . . . . 0.0 110.985 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -91.98 125.73 36.79 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.68 -0.638 . . . . 0.0 109.517 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -143.0 139.38 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.144 1.378 . . . . 0.0 111.454 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 173.5 11.86 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.59 1.556 . . . . 0.0 112.891 176.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.8 mt -64.39 118.79 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.348 1.459 . . . . 0.0 110.461 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.24 -44.56 65.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.333 1.053 . . . . 0.0 111.99 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -149.81 147.41 27.95 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.794 1.637 . . . . 0.0 111.137 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -140.27 142.08 35.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.139 1.776 . . . . 0.0 110.061 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -154.76 149.34 26.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.871 2.068 . . . . 0.0 110.566 170.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.14 130.77 45.27 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.751 0.42 . . . . 0.0 109.872 168.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.4 mt -103.2 -52.72 2.97 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.692 0.797 . . . . 0.0 110.857 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 167.19 -141.35 6.84 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 120.961 0.2 . . . . 0.0 113.263 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -131.41 64.6 1.58 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.188 1.47 . . . . 0.0 111.829 -168.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -85.18 158.86 20.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.805 2.042 . . . . 0.0 112.554 -167.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 114.11 4.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.063 0.945 . . . . 0.0 111.109 172.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.91 152.96 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.908 0.883 . . . . 0.0 110.314 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -143.19 158.8 43.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.858 1.663 . . . . 0.0 111.06 -170.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -153.03 134.36 14.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.016 0.927 . . . . 0.0 111.338 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.5 pt -89.99 155.14 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 121.426 -0.797 . . . . 0.0 111.133 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.88 153.37 16.99 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.02 1.295 . . . . 0.0 111.245 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.5 154.34 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.488 1.515 . . . . 0.0 108.984 -172.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -57.6 111.81 1.24 Allowed 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.065 -1.647 . . . . 0.0 112.093 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 49.94 25.15 1.53 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.739 2.016 . . . . 0.0 115.11 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -146.75 160.52 42.14 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.962 1.305 . . . . 0.0 112.153 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -142.58 33.28 1.45 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.111 0.964 . . . . 0.0 111.028 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -131.95 161.32 33.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.493 1.517 . . . . 0.0 113.207 -175.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -174.54 154.72 2.11 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.985 1.314 . . . . 0.0 111.573 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.95 124.15 28.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.788 0.835 . . . . 0.0 112.088 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.51 173.52 5.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.688 1.195 . . . . 0.0 111.139 169.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -45.84 -42.59 12.56 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -91.35 -6.45 52.97 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.648 1.179 . . . . 0.0 113.409 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.524 ' HA2' HG12 ' A' ' 97' ' ' VAL . . . 115.95 -13.79 16.96 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 117.761 -1.577 . . . . 0.0 115.557 173.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -54.45 142.81 25.93 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.079 1.439 . . . . 0.0 112.23 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.76 92.22 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.871 0.843 . . . . 0.0 109.276 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.5 141.37 51.97 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.6 t -138.69 133.79 32.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.007 1.323 . . . . 0.0 110.973 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 C--O 1.254 1.302 0 C-N-CA 124.183 0.993 . . . . 0.0 113.493 -171.445 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -146.55 174.74 26.31 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 127.336 2.398 . . . . 0.0 111.128 -172.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -164.6 177.31 8.17 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.038 0.935 . . . . 0.0 113.354 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.473 HD13 HG21 ' A' ' 6' ' ' THR . 25.4 mt -122.3 151.01 41.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.673 1.989 . . . . 0.0 110.166 -171.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -66.29 159.93 25.58 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.633 -0.667 . . . . 0.0 112.246 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -50.49 -44.74 56.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.464 1.106 . . . . 0.0 112.956 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -64.15 -10.88 25.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.231 1.412 . . . . 0.0 114.163 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.473 HG21 HD13 ' A' ' 2' ' ' LEU . 26.7 m -66.79 94.81 0.33 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.324 1.449 . . . . 0.0 111.523 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -73.45 136.05 44.2 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.282 0.563 . . . . 0.0 111.965 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.3 mm -117.89 122.68 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.099 1.759 . . . . 0.0 107.407 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.6 tp -64.65 124.51 22.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.518 0.727 . . . . 0.0 110.696 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.7 p -125.89 156.12 40.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.683 1.193 . . . . 0.0 112.299 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.97 -31.43 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.076 0.55 . . . . 0.0 111.713 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.49 -34.87 78.72 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -141.22 -50.87 0.43 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.49 -145.14 17.19 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.682 0.673 . . . . 0.0 111.954 -172.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.9 mt -70.79 106.98 3.77 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.288 1.035 . . . . 0.0 111.091 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.8 mt -133.95 149.46 71.76 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.802 1.241 . . . . 0.0 112.697 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.05 128.15 20.03 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.06 3.173 . . . . 0.0 112.196 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 tt -54.63 -36.31 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.812 0.845 . . . . 0.0 112.755 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.97 -35.51 91.98 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 119.306 -0.719 . . . . 0.0 113.004 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -70.84 -34.08 71.31 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.785 1.292 . . . . 0.0 111.745 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.3 mt -69.49 -38.88 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.048 0.939 . . . . 0.0 110.169 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.2 t -83.75 -36.84 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.035 0.934 . . . . 0.0 113.154 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -66.98 -26.35 66.77 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.865 0.757 . . . . 0.0 112.67 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -115.61 1.48 13.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.637 1.175 . . . . 0.0 113.471 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 47.15 53.28 10.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.148 2.179 . . . . 0.0 112.476 -177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.16 115.13 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.491 0.716 . . . . 0.0 109.3 -173.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.15 108.49 3.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.441 1.096 . . . . 0.0 110.27 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.7 p -147.23 168.13 22.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.391 1.076 . . . . 0.0 112.57 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.56 148.97 25.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.656 1.582 . . . . 0.0 108.931 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.88 161.78 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.447 1.499 . . . . 0.0 110.702 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -100.17 153.26 19.4 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.418 1.087 . . . . 0.0 110.512 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.8 t -168.51 146.95 4.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.712 1.205 . . . . 0.0 111.505 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -75.23 130.36 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.127 1.371 . . . . 0.0 112.56 169.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -85.1 179.33 7.28 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.738 0.815 . . . . 0.0 111.748 171.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -57.7 -21.61 41.54 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.856 1.263 . . . . 0.0 113.43 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.76 -13.56 57.59 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.089 1.355 . . . . 0.0 113.242 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.06 4.46 89.9 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.078 1.323 . . . . 0.0 115.084 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -91.34 131.87 36.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.224 1.012 . . . . 0.0 109.787 175.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -69.91 123.82 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.504 0.722 . . . . 0.0 109.554 172.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -120.57 172.15 8.05 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.894 1.678 . . . . 0.0 110.708 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 p -121.47 139.11 53.9 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.072 0.949 . . . . 0.0 112.254 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.75 147.03 34.0 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.797 1.239 . . . . 0.0 112.946 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.3 150.18 52.39 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.118 2.546 . . . . 0.0 112.593 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.81 141.9 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.069 0.948 . . . . 0.0 111.148 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.69 -32.76 11.24 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.641 0.776 . . . . 0.0 112.611 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -170.45 179.33 3.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.316 1.847 . . . . 0.0 111.929 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -136.11 122.8 21.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.018 1.327 . . . . 0.0 109.554 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -109.43 118.42 36.59 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.682 1.193 . . . . 0.0 110.773 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.27 114.68 28.33 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.304 1.442 . . . . 0.0 109.958 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -83.33 -30.53 27.42 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.067 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.11 -44.27 2.82 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.629 1.585 . . . . 0.0 113.538 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 178.81 100.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.429 1.109 . . . . 0.0 113.073 -171.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -129.12 163.97 24.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.527 1.131 . . . . 0.0 113.415 173.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -63.27 100.41 0.24 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.994 1.718 . . . . 0.0 113.154 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.2 t -90.92 137.31 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.027 1.331 . . . . 0.0 111.21 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -120.78 136.7 54.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.44 1.496 . . . . 0.0 109.407 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.06 125.84 25.37 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.85 0.86 . . . . 0.0 110.178 172.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -117.46 99.19 6.83 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.019 1.327 . . . . 0.0 108.032 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.6 t -110.01 147.24 33.9 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.855 0.862 . . . . 0.0 110.674 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.91 164.31 12.71 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.21 1.404 . . . . 0.0 112.429 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -67.47 -24.01 65.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.991 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.96 -25.24 37.49 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.814 1.246 . . . . 0.0 113.272 174.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.07 -7.37 11.81 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.072 1.32 . . . . 0.0 114.75 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -55.47 143.53 28.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.766 1.283 . . . . 0.0 111.542 175.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.47 124.3 31.69 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.535 1.134 . . . . 0.0 110.203 -173.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 43.8 mt -135.11 151.88 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 127.121 2.168 . . . . 0.0 108.225 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -136.59 113.04 9.99 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.575 1.15 . . . . 0.0 110.552 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.89 166.34 25.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.849 1.26 . . . . 0.0 111.967 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 p -83.73 152.11 24.88 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.75 0.82 . . . . 0.0 111.354 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -61.46 -15.17 34.89 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 175.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -89.32 -16.76 30.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.885 1.674 . . . . 0.0 112.246 -176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -80.17 131.5 35.73 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -89.15 156.92 18.5 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.271 0.558 . . . . 0.0 111.444 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -135.93 141.03 44.46 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.657 0.783 . . . . 0.0 109.271 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 46.7 ttm -68.83 108.38 3.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.946 0.898 . . . . 0.0 110.124 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.6 p -70.81 169.84 13.77 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.776 -0.578 . . . . 0.0 112.026 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.4 m -54.56 -23.94 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 174.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -87.63 -7.25 57.7 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.024 . . . . 0.0 113.317 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.45 7.16 65.44 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.402 1.477 . . . . 0.0 113.939 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -79.95 126.64 31.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.228 1.014 . . . . 0.0 110.346 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.28 92.22 6.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.3 1.04 . . . . 0.0 110.433 169.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.7 mt -116.77 146.3 37.41 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.95 0.9 . . . . 0.0 110.978 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.13 146.46 86.91 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.226 2.617 . . . . 0.0 111.061 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.426 HG13 HD11 ' A' ' 105' ' ' ILE . 12.8 tt -59.05 -27.74 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -55.9 -35.55 66.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.531 1.132 . . . . 0.0 113.109 169.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -85.03 -34.71 22.26 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.895 -0.503 . . . . 0.0 111.405 175.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.55 -39.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 119.385 0.993 . . . . 0.0 110.762 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -64.69 -39.16 93.18 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -76.74 -39.35 52.07 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -78.12 -13.15 59.98 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 56.87 30.11 17.32 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.785 1.234 . . . . 0.0 112.151 -174.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.41 142.95 46.93 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.996 0.918 . . . . 0.0 111.302 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -90.78 135.37 33.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.071 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.413 ' HB2' HH12 ' A' ' 96' ' ' ARG . 9.7 mp -66.42 150.78 48.4 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.059 -1.026 . . . . 0.0 111.141 168.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.8 ttp -72.66 172.37 10.79 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.326 0.584 . . . . 0.0 111.791 171.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.413 HH12 ' HB2' ' A' ' 94' ' ' LEU . 87.6 mmt-85 -137.12 164.05 29.35 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.729 1.612 . . . . 0.0 111.433 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 m -106.8 -22.75 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -107.35 21.6 17.25 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.962 1.305 . . . . 0.0 112.386 -172.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 56.08 29.42 14.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.776 1.63 . . . . 0.0 112.454 -172.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.6 mt -63.35 159.26 51.26 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.921 171.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.92 143.99 56.95 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.249 2.633 . . . . 0.0 111.426 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.98 121.23 31.87 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.752 0.821 . . . . 0.0 109.015 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.4 pt -142.22 122.47 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.732 1.213 . . . . 0.0 110.738 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -67.34 170.52 7.17 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.285 1.834 . . . . 0.0 112.962 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.426 HD11 HG13 ' A' ' 84' ' ' ILE . 6.7 mt -61.58 120.1 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.306 1.442 . . . . 0.0 110.194 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.96 -47.29 66.0 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.718 0.807 . . . . 0.0 111.614 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 p -152.29 151.88 31.47 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.351 1.46 . . . . 0.0 111.001 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.65 141.79 48.8 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.057 1.743 . . . . 0.0 110.048 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 134.55 15.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.484 1.913 . . . . 0.0 109.484 177.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -65.1 133.81 52.43 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.081 0.152 . . . . 0.0 110.755 170.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.2 mt -100.97 -42.65 6.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.009 0.524 . . . . 0.0 112.009 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.49 -149.94 21.71 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.665 1.126 . . . . 0.0 111.798 -173.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -123.27 100.16 6.71 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.542 1.137 . . . . 0.0 111.458 -170.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -115.13 155.22 27.5 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.253 1.421 . . . . 0.0 109.88 -171.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.13 116.78 6.27 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.305 0.642 . . . . 0.0 110.144 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.14 150.94 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.396 0.678 . . . . 0.0 110.887 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -139.29 156.15 47.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.305 1.442 . . . . 0.0 111.743 -170.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -157.5 121.35 4.17 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.814 1.245 . . . . 0.0 110.071 -173.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.7 pt -80.52 143.73 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 120.706 -1.246 . . . . 0.0 111.523 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.71 153.97 20.51 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.902 0.763 . . . . 0.0 111.799 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.3 t -147.19 143.55 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.216 1.406 . . . . 0.0 109.739 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -91.01 -47.37 7.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -66.53 -41.16 89.15 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.518 1.127 . . . . 0.0 113.746 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -159.25 123.45 3.92 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.764 1.625 . . . . 0.0 108.709 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -72.93 60.58 0.53 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.299 1.44 . . . . 0.0 112.887 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -154.41 171.66 18.98 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.138 1.775 . . . . 0.0 112.738 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -166.28 150.86 7.89 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.222 1.409 . . . . 0.0 110.817 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.39 142.16 30.34 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.842 0.857 . . . . 0.0 112.309 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.3 mt -102.16 171.21 7.62 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.675 1.19 . . . . 0.0 112.054 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -19.33 8.28 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -103.74 11.18 36.21 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.516 1.526 . . . . 0.0 112.958 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.04 21.52 75.92 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 121.336 -0.852 . . . . 0.0 113.844 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.41 ' C ' HD12 ' A' ' 134' ' ' ILE . 3.1 m-85 -87.39 163.72 16.61 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.644 1.578 . . . . 0.0 111.985 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.41 HD12 ' C ' ' A' ' 133' ' ' PHE . 3.3 mp -133.01 100.81 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.746 1.218 . . . . 0.0 108.948 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.98 149.68 26.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.9 t -140.83 141.09 34.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.379 0.672 . . . . 0.0 112.477 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.919 1.287 . . . . 0.0 113.097 -173.498 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -126.75 162.25 20.91 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.882 1.706 . . . . 0.0 112.854 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.92 177.91 9.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.445 1.498 . . . . 0.0 112.14 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.99 144.33 44.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.982 1.713 . . . . 0.0 110.383 -172.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -68.86 163.67 23.77 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.633 -0.667 . . . . 0.0 112.441 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -50.83 -42.86 58.82 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.642 -0.661 . . . . 0.0 112.411 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -65.73 -13.95 60.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.814 1.246 . . . . 0.0 114.116 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.2 m -71.0 120.39 16.5 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.515 0.726 . . . . 0.0 110.725 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -102.27 138.38 39.29 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.495 0.664 . . . . 0.0 111.633 -176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.15 116.66 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 126.198 1.799 . . . . 0.0 107.585 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tt -63.12 124.49 21.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.706 0.402 . . . . 0.0 111.19 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.3 p -118.53 155.84 30.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.85 1.26 . . . . 0.0 112.144 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.8 -35.72 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.789 0.836 . . . . 0.0 111.14 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -67.36 -32.42 73.35 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -140.13 -50.29 0.47 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.53 -143.91 15.71 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.147 0.879 . . . . 0.0 112.656 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.36 96.14 0.65 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.381 1.872 . . . . 0.0 112.846 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -129.87 149.63 73.62 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.844 1.258 . . . . 0.0 112.591 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.68 130.26 23.01 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.404 3.403 . . . . 0.0 113.127 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 tt -57.44 -37.59 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.002 0.921 . . . . 0.0 112.922 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.36 -31.34 78.65 Favored Glycine 0 CA--C 1.529 0.917 0 O-C-N 121.718 -0.614 . . . . 0.0 112.846 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -72.06 -38.68 69.43 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.094 0.947 . . . . 0.0 111.317 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.73 -39.34 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.619 0.767 . . . . 0.0 109.76 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.5 t -80.99 -38.92 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.874 0.87 . . . . 0.0 112.938 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.72 -23.94 56.14 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.74 1.155 . . . . 0.0 113.297 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -108.58 2.02 21.8 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.202 1.401 . . . . 0.0 112.12 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.89 52.12 11.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.32 2.248 . . . . 0.0 113.04 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.6 mt -76.35 122.4 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.964 0.906 . . . . 0.0 110.055 -170.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.77 96.59 3.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.655 1.182 . . . . 0.0 111.595 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 68.3 m -135.4 173.45 11.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.072 1.349 . . . . 0.0 112.732 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 m -121.42 140.21 52.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.705 1.602 . . . . 0.0 108.969 -176.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.9 m -125.35 163.21 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.637 1.575 . . . . 0.0 111.19 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -97.94 147.59 24.31 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.597 1.159 . . . . 0.0 110.362 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -157.55 156.21 31.55 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.806 1.642 . . . . 0.0 109.577 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 t -102.6 127.42 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.807 0.843 . . . . 0.0 109.757 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -69.24 175.25 4.01 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.931 1.292 . . . . 0.0 112.58 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -61.47 -26.73 68.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.024 1.33 . . . . 0.0 113.424 175.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -87.84 0.75 55.39 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.242 1.417 . . . . 0.0 113.41 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.98 18.88 76.13 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.771 1.176 . . . . 0.0 114.655 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -92.3 132.89 36.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.598 1.159 . . . . 0.0 110.122 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.14 131.08 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -137.77 176.74 8.43 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.537 1.935 . . . . 0.0 110.715 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 p -125.87 143.53 51.03 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.273 1.029 . . . . 0.0 112.397 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -143.2 141.62 19.81 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.654 1.182 . . . . 0.0 112.336 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.73 150.12 49.69 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.832 2.355 . . . . 0.0 111.464 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.55 136.81 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.381 0.672 . . . . 0.0 110.856 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.45 -45.9 5.95 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.533 0.733 . . . . 0.0 111.832 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -146.16 178.99 7.81 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.287 1.835 . . . . 0.0 111.278 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -135.05 120.64 19.36 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.498 1.519 . . . . 0.0 109.23 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -116.19 119.26 35.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.185 0.994 . . . . 0.0 110.79 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -107.61 113.43 26.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.322 1.449 . . . . 0.0 109.908 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -82.19 -29.93 31.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.778 0.831 . . . . 0.0 112.965 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.54 -54.62 2.37 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.474 1.511 . . . . 0.0 113.888 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -170.33 103.09 0.27 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.157 1.383 . . . . 0.0 111.057 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -132.28 164.88 25.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.226 1.011 . . . . 0.0 111.69 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.55 99.65 0.23 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.594 1.558 . . . . 0.0 113.638 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 t -95.99 141.22 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.499 1.52 . . . . 0.0 111.589 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.83 137.76 54.61 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.239 1.816 . . . . 0.0 109.975 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.66 133.52 56.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.864 0.865 . . . . 0.0 110.715 171.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -127.55 89.29 2.93 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.023 1.329 . . . . 0.0 108.314 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.4 t -97.48 149.24 22.39 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.348 1.059 . . . . 0.0 110.731 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.15 163.53 15.82 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.212 1.405 . . . . 0.0 112.387 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.36 -20.54 63.84 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -81.45 -17.86 47.28 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.238 1.015 . . . . 0.0 113.171 170.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.26 -3.62 33.19 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.042 1.306 . . . . 0.0 114.207 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.9 m -57.71 142.31 45.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.522 1.129 . . . . 0.0 110.994 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -130.9 126.18 35.46 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.712 0.805 . . . . 0.0 111.351 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.5 mt -135.22 152.38 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 126.85 2.06 . . . . 0.0 107.674 -171.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.99 115.29 11.07 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.848 1.259 . . . . 0.0 110.528 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.09 163.24 34.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.626 1.171 . . . . 0.0 111.291 -176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.4 p -78.94 153.2 30.6 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.575 -0.703 . . . . 0.0 111.415 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.49 -24.17 65.08 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -84.05 -10.08 58.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.617 1.167 . . . . 0.0 112.836 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -82.44 133.96 35.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -97.12 156.12 16.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.536 1.134 . . . . 0.0 111.521 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.48 141.26 46.7 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.08 -1.012 . . . . 0.0 110.822 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.8 ttm -73.03 100.13 2.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.043 0.937 . . . . 0.0 109.594 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.5 p -66.96 170.74 6.26 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.8 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -56.09 -20.33 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.94 -4.01 28.46 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.653 1.181 . . . . 0.0 113.307 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 3.79 72.8 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.244 1.402 . . . . 0.0 113.913 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -65.42 122.97 18.39 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.381 1.072 . . . . 0.0 110.55 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.6 mtt -84.71 73.28 10.62 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.703 2.001 . . . . 0.0 110.766 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 43.6 mt -105.93 147.71 35.25 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 123.483 0.713 . . . . 0.0 110.97 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.78 148.27 86.43 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.11 2.54 . . . . 0.0 110.924 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 tt -53.46 -34.62 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.84 -33.12 70.05 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -77.15 -34.78 56.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.625 0.77 . . . . 0.0 111.15 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.1 mt -67.4 -39.4 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.782 0.833 . . . . 0.0 110.367 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -64.2 -34.26 77.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.953 0.901 . . . . 0.0 112.956 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -73.94 -47.25 38.89 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.01 -9.23 58.56 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 58.7 34.18 23.6 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.892 1.277 . . . . 0.0 112.325 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.89 143.85 35.48 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 122.172 0.987 . . . . 0.0 111.905 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.3 158.83 24.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.447 1.099 . . . . 0.0 111.623 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.51 152.2 21.03 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.39 -0.819 . . . . 0.0 111.922 169.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -75.15 146.5 41.27 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.176 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 166.05 23.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.047 1.339 . . . . 0.0 114.135 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.7 m -105.03 -30.03 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.561 1.544 . . . . 0.0 113.07 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.03 -2.73 56.08 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.326 1.05 . . . . 0.0 113.108 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.278 8.6 m-80 59.14 36.0 23.87 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.988 1.375 . . . . 0.0 112.991 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.9 mt -61.89 157.71 48.36 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.839 167.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.5 140.86 84.11 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.633 2.222 . . . . 0.0 110.39 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -66.56 126.05 27.69 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.999 -0.438 . . . . 0.0 110.496 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.5 pt -143.75 132.89 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.946 1.298 . . . . 0.0 111.013 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 176.31 7.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.202 1.401 . . . . 0.0 111.74 176.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.8 mt -64.13 109.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.731 1.212 . . . . 0.0 110.19 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.6 94.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.481 1.112 . . . . 0.0 112.287 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.0 p -151.43 153.25 34.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.939 1.696 . . . . 0.0 111.25 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -137.3 143.19 42.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.956 1.702 . . . . 0.0 110.335 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -152.33 148.31 27.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.591 2.356 . . . . 0.0 110.454 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -72.02 124.17 24.36 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.897 0.479 . . . . 0.0 110.081 168.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.2 mt -91.09 -44.81 9.05 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.022 0.529 . . . . 0.0 111.649 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.13 -145.73 13.9 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.056 0.836 . . . . 0.0 113.116 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -122.44 51.76 1.36 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 123.103 1.43 . . . . 0.0 113.66 -166.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -72.7 158.17 36.12 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 127.64 2.376 . . . . 0.0 112.53 -168.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.58 118.16 6.69 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.992 0.917 . . . . 0.0 111.417 171.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.8 m -126.09 156.2 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.41 0.684 . . . . 0.0 111.789 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -144.31 159.01 43.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.733 1.613 . . . . 0.0 111.559 -168.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -155.78 128.73 8.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.43 1.092 . . . . 0.0 109.952 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.43 142.55 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 121.292 -0.88 . . . . 0.0 111.281 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.65 136.36 14.87 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -152.67 93.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.01 1.724 . . . . 0.0 109.922 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.13 -26.57 68.24 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.132 -0.98 . . . . 0.0 113.454 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -60.37 -45.29 94.04 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.106 1.362 . . . . 0.0 112.665 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -166.33 135.76 3.14 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.353 1.861 . . . . 0.0 109.909 169.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 15.12 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -171.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -132.85 163.68 28.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.696 1.598 . . . . 0.0 114.113 -171.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -163.3 164.79 24.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.443 1.497 . . . . 0.0 112.437 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.75 141.41 28.53 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.675 1.19 . . . . 0.0 112.949 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.4 mt -91.53 171.76 8.97 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.658 1.983 . . . . 0.0 111.997 175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -50.49 -50.84 51.61 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.794 1.638 . . . . 0.0 115.171 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -68.06 -26.96 66.11 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.211 0.604 . . . . 0.0 111.825 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 120.48 -3.0 12.4 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.667 1.603 . . . . 0.0 114.096 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -69.07 163.82 23.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.144 1.472 . . . . 0.0 111.874 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.14 136.97 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 122.033 0.92 . . . . 0.0 110.629 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -121.51 151.48 40.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.37 1.868 . . . . 0.0 109.593 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.6 t -142.81 135.93 28.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.826 0.851 . . . . 0.0 113.089 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.2 t30 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.76 1.224 . . . . 0.0 113.131 -176.099 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -145.26 167.1 27.48 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 127.548 2.499 . . . . 0.0 111.36 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.41 176.73 10.81 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.309 0.644 . . . . 0.0 112.544 -169.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.7 mt -116.74 147.41 42.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.352 1.861 . . . . 0.0 110.415 -173.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t -62.88 161.77 12.25 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -52.37 -44.77 65.46 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.146 -0.971 . . . . 0.0 111.474 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -56.34 -25.47 49.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.721 1.609 . . . . 0.0 114.044 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.6 m -65.5 103.62 0.87 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.883 1.273 . . . . 0.0 112.023 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -85.15 136.09 33.69 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.642 -0.661 . . . . 0.0 111.864 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 mm -109.4 131.94 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.535 1.534 . . . . 0.0 107.875 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -69.7 122.76 19.79 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 122.082 -0.386 . . . . 0.0 111.433 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.7 p -120.63 151.19 39.78 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.716 1.206 . . . . 0.0 112.315 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 t -75.74 -37.34 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.169 0.587 . . . . 0.0 111.84 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.04 -28.4 68.83 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -141.37 -51.12 0.43 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.29 -156.52 23.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.261 0.934 . . . . 0.0 112.505 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.87 105.9 0.43 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.431 1.092 . . . . 0.0 111.163 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.5 mt -135.52 149.75 70.26 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 124.746 1.218 . . . . 0.0 112.888 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.13 128.45 21.71 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.975 3.117 . . . . 0.0 112.351 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.4 tt -56.47 -35.94 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.793 0.837 . . . . 0.0 113.058 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.28 -33.97 88.66 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.548 -0.585 . . . . 0.0 113.072 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -69.33 -35.06 75.55 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.207 1.003 . . . . 0.0 111.806 174.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.3 mt -69.43 -41.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.581 0.752 . . . . 0.0 110.311 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -78.99 -39.67 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.808 0.731 . . . . 0.0 112.435 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.94 -23.67 60.71 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.32 0.964 . . . . 0.0 113.19 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.16 4.09 19.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.975 1.31 . . . . 0.0 112.65 176.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 50.16 45.73 25.41 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.916 1.686 . . . . 0.0 112.643 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.23 127.69 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.944 0.898 . . . . 0.0 109.399 -172.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -78.73 111.21 14.62 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.365 0.602 . . . . 0.0 110.319 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.8 p -133.9 -172.39 2.97 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.263 1.425 . . . . 0.0 111.005 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.3 157.03 35.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.687 1.595 . . . . 0.0 109.103 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.1 m -140.25 163.52 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.588 1.155 . . . . 0.0 111.026 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -104.43 139.96 38.62 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.204 1.402 . . . . 0.0 110.43 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -159.43 150.92 20.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.442 1.497 . . . . 0.0 110.528 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 m -83.41 148.11 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.423 1.01 . . . . 0.0 112.941 171.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.84 -179.92 7.4 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.836 0.854 . . . . 0.0 111.405 169.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -60.76 -20.68 61.88 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.89 1.276 . . . . 0.0 113.023 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -91.75 0.62 57.48 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.682 1.593 . . . . 0.0 113.277 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.2 26.67 63.47 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 121.114 -0.991 . . . . 0.0 114.223 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -107.58 120.21 41.56 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.621 1.568 . . . . 0.0 109.231 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.716 HD13 HG23 ' A' ' 97' ' ' VAL . 67.9 mt -65.45 125.98 23.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 123.594 0.758 . . . . 0.0 109.431 173.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -129.09 173.08 10.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.359 1.863 . . . . 0.0 111.403 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -117.18 142.4 47.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.946 1.298 . . . . 0.0 112.413 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -146.71 142.68 17.51 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.27 1.028 . . . . 0.0 112.873 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.5 154.5 50.28 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.116 2.544 . . . . 0.0 111.813 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.7 t -62.36 140.8 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.615 -0.678 . . . . 0.0 110.062 169.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.9 -40.95 4.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.311 0.645 . . . . 0.0 112.27 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -138.13 164.45 29.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.565 1.146 . . . . 0.0 112.306 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -133.87 131.36 39.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.294 1.838 . . . . 0.0 108.362 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.26 130.78 50.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.022 1.329 . . . . 0.0 111.157 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -139.45 136.56 34.76 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.568 -1.333 . . . . 0.0 112.535 -171.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -111.39 -32.75 6.62 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.201 -1.363 . . . . 0.0 114.62 -168.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.49 -60.75 2.5 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.306 1.431 . . . . 0.0 114.152 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -157.26 96.47 1.56 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.436 1.494 . . . . 0.0 112.616 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -130.11 162.1 29.57 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.391 1.076 . . . . 0.0 113.365 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.23 106.6 2.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.538 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 t -100.26 139.12 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.905 1.282 . . . . 0.0 111.247 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.405 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 38.9 m-85 -124.58 140.61 52.78 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.765 1.226 . . . . 0.0 109.973 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -85.02 123.59 30.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.058 1.343 . . . . 0.0 109.485 169.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.1 100.24 8.45 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.352 1.461 . . . . 0.0 108.934 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.6 t -83.41 145.3 29.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.22 1.008 . . . . 0.0 111.355 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mp -103.92 157.7 16.91 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.434 1.494 . . . . 0.0 112.276 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.56 -20.19 65.37 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -84.22 -16.23 44.06 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 176.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.32 -2.56 25.19 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.302 1.429 . . . . 0.0 114.405 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.4 m -70.16 157.82 36.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.923 1.289 . . . . 0.0 112.746 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.88 148.79 50.49 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.418 1.487 . . . . 0.0 110.855 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -140.01 143.91 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.963 2.105 . . . . 0.0 107.912 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -136.37 112.12 9.45 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.672 1.189 . . . . 0.0 112.382 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.33 172.12 18.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.498 1.119 . . . . 0.0 112.786 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.9 p -86.98 161.78 18.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.341 0.657 . . . . 0.0 110.964 168.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' HE3' ' CD1' ' A' ' 56' ' ' PHE . 2.2 mptm? -59.88 -25.81 65.37 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 175.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -85.07 -15.52 43.72 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.16 1.384 . . . . 0.0 112.766 -174.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -73.19 132.52 43.32 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 153.03 18.02 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.253 0.933 . . . . 0.0 112.787 176.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -131.94 137.14 47.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.252 -0.905 . . . . 0.0 109.143 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.1 ttp -81.47 113.14 19.33 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.291 0.567 . . . . 0.0 110.066 -173.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.2 p -69.87 171.43 9.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.466 0.706 . . . . 0.0 112.035 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -57.35 -23.67 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 174.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -82.26 -12.93 57.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.663 1.185 . . . . 0.0 113.394 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.06 3.35 70.19 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.247 0.927 . . . . 0.0 114.112 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -77.36 151.85 34.7 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.425 1.112 . . . . 0.0 110.826 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 ptp -119.78 93.93 4.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.565 1.146 . . . . 0.0 110.635 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.4 mt -120.4 149.06 49.03 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.109 1.364 . . . . 0.0 109.905 -170.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.74 145.98 91.57 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.546 2.164 . . . . 0.0 111.344 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.69 -28.69 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -57.85 -37.14 73.35 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.524 1.53 . . . . 0.0 113.289 171.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.07 -43.51 21.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.194 0.997 . . . . 0.0 110.511 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.61 -41.14 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.526 1.13 . . . . 0.0 111.438 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.3 -35.53 80.68 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -80.69 -40.82 24.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.754 0.822 . . . . 0.0 113.03 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -76.95 -13.76 59.94 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.222 1.009 . . . . 0.0 113.284 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 57.75 35.53 25.63 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.872 1.669 . . . . 0.0 112.872 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.89 148.11 25.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.008 0.923 . . . . 0.0 112.561 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -87.19 163.12 17.1 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.551 1.14 . . . . 0.0 113.174 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.2 mt -113.42 153.93 27.81 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.785 1.234 . . . . 0.0 112.5 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 10.7 ttp -81.98 145.08 30.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.189 0.595 . . . . 0.0 111.214 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.92 177.75 7.04 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.773 1.229 . . . . 0.0 113.874 -173.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.716 HG23 HD13 ' A' ' 39' ' ' ILE . 5.1 p -121.44 -25.69 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 126.149 1.78 . . . . 0.0 114.597 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -85.04 6.37 25.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.09 1.356 . . . . 0.0 113.382 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 56.42 32.11 20.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.969 1.708 . . . . 0.0 112.349 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.0 mt -67.41 158.31 82.64 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.76 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.04 147.13 88.68 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.935 2.423 . . . . 0.0 111.166 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -71.46 118.74 14.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.667 0.787 . . . . 0.0 109.989 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.6 126.37 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.895 1.278 . . . . 0.0 112.018 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.85 175.03 7.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.61 1.564 . . . . 0.0 112.393 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.12 106.9 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.68 1.592 . . . . 0.0 110.933 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.8 -41.05 62.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.573 1.149 . . . . 0.0 112.074 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.3 p -152.37 165.89 33.58 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.145 1.778 . . . . 0.0 111.84 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -136.05 143.54 44.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.602 1.561 . . . . 0.0 111.436 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -139.6 130.71 26.48 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.653 1.181 . . . . 0.0 110.88 171.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -67.55 131.31 45.39 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.918 -0.489 . . . . 0.0 110.931 173.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.2 mt -96.64 -42.78 7.86 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.015 0.526 . . . . 0.0 112.32 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.79 -151.59 23.23 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.421 1.01 . . . . 0.0 113.014 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -118.56 69.11 0.79 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.267 1.508 . . . . 0.0 112.417 -168.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -91.85 160.05 15.49 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 127.064 2.146 . . . . 0.0 111.443 -168.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.3 121.31 14.95 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 123.4 0.68 . . . . 0.0 111.075 169.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.81 148.41 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.476 0.655 . . . . 0.0 111.465 174.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -141.55 157.56 44.96 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.171 1.789 . . . . 0.0 111.884 -169.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -148.76 165.75 30.49 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.475 1.51 . . . . 0.0 112.653 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.7 pt -136.76 153.9 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.195 1.798 . . . . 0.0 111.104 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.91 166.69 24.56 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.856 0.741 . . . . 0.0 114.242 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.15 157.81 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.924 1.29 . . . . 0.0 110.608 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -72.02 -11.43 60.76 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -122.57 -28.56 4.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.264 1.826 . . . . 0.0 114.67 -174.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -152.86 175.23 13.13 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.312 2.245 . . . . 0.0 110.292 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -133.87 23.62 3.92 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.786 -1.196 . . . . 0.0 113.392 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -134.72 160.87 36.79 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -171.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -161.51 158.81 27.08 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.201 1.4 . . . . 0.0 112.307 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.57 128.62 36.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.836 1.254 . . . . 0.0 111.693 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.8 mt -72.54 175.23 6.49 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.282 1.433 . . . . 0.0 113.319 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -51.03 -35.69 35.66 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -93.4 -5.21 49.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.417 1.087 . . . . 0.0 112.86 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 97' ' ' VAL . . . 109.12 -20.12 28.93 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 125.307 1.432 . . . . 0.0 114.447 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -53.51 133.21 40.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.379 1.072 . . . . 0.0 111.476 -173.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.5 mm -82.27 130.31 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.979 0.895 . . . . 0.0 110.938 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -108.79 141.24 41.09 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 126.951 2.1 . . . . 0.0 108.964 170.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.4 t -146.97 140.1 25.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.236 1.014 . . . . 0.0 113.291 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 CA--C 1.556 1.198 0 C-N-CA 125.846 1.658 . . . . 0.0 114.572 -173.569 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.926 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 57.9 -167.72 5.46 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.207 1.384 . . . . 0.0 113.566 -171.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.94 171.19 15.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.902 1.681 . . . . 0.0 111.202 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.0 mt -120.15 140.41 51.14 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.794 2.038 . . . . 0.0 110.067 -168.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 t -72.59 162.46 29.44 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.47 -0.769 . . . . 0.0 111.62 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -48.35 -43.3 33.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.416 1.086 . . . . 0.0 112.79 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -10.21 5.41 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -75.95 107.82 8.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.449 1.1 . . . . 0.0 110.034 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -100.41 138.2 37.8 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.455 -0.778 . . . . 0.0 112.013 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.7 mm -121.34 116.88 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.414 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.3 tt -60.99 127.08 29.81 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.212 0.605 . . . . 0.0 111.003 175.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.8 p -121.7 157.19 31.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.451 1.101 . . . . 0.0 112.697 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -78.01 -34.63 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.438 0.695 . . . . 0.0 111.462 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.67 -30.69 65.99 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -137.77 -48.73 0.57 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.71 -147.67 17.27 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.346 0.974 . . . . 0.0 112.664 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 4.7 mt -64.23 104.46 0.75 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.711 2.005 . . . . 0.0 110.722 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.1 mt -141.06 150.6 59.58 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 124.814 1.246 . . . . 0.0 114.021 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.89 133.15 28.39 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.774 3.649 . . . . 0.0 113.829 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 tt -59.0 -34.5 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.202 1.001 . . . . 0.0 113.174 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.96 -35.23 91.73 Favored Glycine 0 C--N 1.338 0.652 0 O-C-N 121.875 -0.516 . . . . 0.0 112.157 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -72.73 -32.57 65.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.07 0.935 . . . . 0.0 111.553 176.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -64.76 -38.56 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.309 0.643 . . . . 0.0 110.64 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.4 t -86.38 -38.23 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 118.953 0.797 . . . . 0.0 112.462 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -68.21 -27.58 66.51 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.313 -0.867 . . . . 0.0 113.099 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -114.91 5.61 15.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.956 1.302 . . . . 0.0 113.104 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 49.38 44.2 23.65 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 127.336 2.254 . . . . 0.0 112.798 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.8 mt -67.35 127.21 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.496 1.118 . . . . 0.0 109.522 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -99.01 104.25 16.27 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.634 1.174 . . . . 0.0 111.273 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 62.3 m -136.4 -178.44 5.17 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.505 1.522 . . . . 0.0 111.487 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.8 m -116.21 144.51 44.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.286 1.434 . . . . 0.0 108.534 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.32 160.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.001 1.72 . . . . 0.0 110.083 -175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -99.24 147.67 24.91 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.379 1.072 . . . . 0.0 110.3 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 t -159.43 160.17 34.52 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.296 1.438 . . . . 0.0 109.899 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -100.01 125.07 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.966 0.906 . . . . 0.0 110.201 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -69.62 176.48 3.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.993 1.317 . . . . 0.0 112.584 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -63.5 -26.16 68.59 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.136 1.374 . . . . 0.0 112.949 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.31 -5.31 59.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.045 1.338 . . . . 0.0 113.687 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.86 21.82 58.84 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.464 1.03 . . . . 0.0 114.873 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -96.81 133.1 41.83 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.657 1.183 . . . . 0.0 109.83 172.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.7 mt -74.09 129.26 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -137.59 179.63 6.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.961 2.105 . . . . 0.0 110.949 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.0 p -129.25 144.7 51.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.421 1.089 . . . . 0.0 113.124 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -149.15 142.32 15.9 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.063 1.345 . . . . 0.0 112.314 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.1 155.2 42.42 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.124 2.549 . . . . 0.0 112.981 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.0 t -62.62 132.52 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.344 0.657 . . . . 0.0 110.085 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.71 -48.21 7.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.411 0.684 . . . . 0.0 112.105 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -149.67 172.3 15.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.865 1.666 . . . . 0.0 111.525 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -132.27 129.44 39.61 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.947 1.699 . . . . 0.0 109.096 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -133.4 138.1 46.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.083 0.944 . . . . 0.0 111.418 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -129.08 118.69 22.93 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.123 1.369 . . . . 0.0 110.609 -172.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -84.01 -33.5 24.52 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.806 1.242 . . . . 0.0 112.708 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.01 -51.4 1.46 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.111 1.339 . . . . 0.0 113.62 173.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -172.57 106.35 0.17 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.414 1.485 . . . . 0.0 110.518 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -132.49 168.0 18.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.32 1.048 . . . . 0.0 112.402 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -67.87 101.76 1.14 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.05 140.61 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.765 1.226 . . . . 0.0 111.496 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -122.6 141.26 51.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.657 1.583 . . . . 0.0 110.534 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.55 126.11 26.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.224 1.41 . . . . 0.0 110.583 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -122.78 82.96 2.05 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.451 1.9 . . . . 0.0 108.476 177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 t -86.33 147.84 25.87 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.803 0.841 . . . . 0.0 111.175 171.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.55 165.38 11.71 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.308 1.443 . . . . 0.0 112.814 175.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.61 -23.71 66.88 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -82.35 -19.82 38.52 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.86 -1.4 27.29 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.191 1.377 . . . . 0.0 114.596 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.6 m -57.91 140.98 50.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.498 1.649 . . . . 0.0 110.922 170.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tp -127.01 130.05 49.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.384 1.074 . . . . 0.0 109.884 -174.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mt -139.65 150.26 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.715 1.606 . . . . 0.0 108.145 -170.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -134.0 109.74 9.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.853 1.261 . . . . 0.0 110.86 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.17 169.62 17.24 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.498 1.119 . . . . 0.0 112.519 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 p -86.19 149.26 25.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.89 1.276 . . . . 0.0 111.467 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -62.23 -17.39 58.19 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -86.54 -14.4 43.08 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.053 1.341 . . . . 0.0 112.971 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -79.42 135.52 36.7 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.153 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -93.82 152.41 18.93 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.026 0.917 . . . . 0.0 113.234 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.86 129.2 32.0 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.953 0.901 . . . . 0.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ttp -74.85 111.47 10.09 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.155 0.503 . . . . 0.0 110.416 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 p -71.09 173.48 7.53 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.472 0.653 . . . . 0.0 112.313 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.88 -24.01 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -91.41 -6.52 52.71 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.501 1.12 . . . . 0.0 113.205 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.81 5.81 59.69 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.345 0.974 . . . . 0.0 113.941 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -77.55 126.32 30.7 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.189 0.994 . . . . 0.0 110.906 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.62 78.57 7.74 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.138 1.375 . . . . 0.0 110.702 173.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 mt -104.68 147.77 34.96 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 123.553 0.741 . . . . 0.0 110.673 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.49 147.71 87.07 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.578 2.185 . . . . 0.0 110.603 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.5 tt -60.67 -28.88 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.28 -27.8 62.44 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.419 1.488 . . . . 0.0 113.331 169.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.51 -40.7 18.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.275 1.03 . . . . 0.0 111.528 173.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.82 -37.86 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.317 1.047 . . . . 0.0 110.93 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.8 -35.66 77.04 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.29 -48.24 17.94 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.325 -0.859 . . . . 0.0 113.063 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -14.21 62.23 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 55.75 32.82 20.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.987 1.315 . . . . 0.0 112.225 -172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 42.4 mt -70.43 140.31 51.99 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.997 0.919 . . . . 0.0 111.47 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.01 146.59 25.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.44 0.696 . . . . 0.0 110.847 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 mp -79.2 153.26 30.14 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.449 -0.782 . . . . 0.0 111.553 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.5 ttm -72.45 149.23 44.4 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.87 -0.519 . . . . 0.0 110.812 172.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.64 167.77 15.23 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.001 1.32 . . . . 0.0 113.892 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.434 HG22 ' HA2' ' A' ' 132' ' ' GLY . 2.8 m -118.75 -23.76 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 125.774 1.63 . . . . 0.0 113.235 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -88.98 5.22 45.22 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.997 1.319 . . . . 0.0 112.71 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.49 19.8 11.93 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.496 1.518 . . . . 0.0 112.32 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.1 mt -49.53 156.81 1.06 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.441 1.496 . . . . 0.0 112.028 169.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.3 145.22 88.15 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.64 2.226 . . . . 0.0 110.68 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -68.47 120.44 14.54 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.693 -0.629 . . . . 0.0 110.177 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.4 pt -145.1 159.79 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.289 1.436 . . . . 0.0 111.586 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -128.11 -179.69 5.13 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.28 1.832 . . . . 0.0 111.939 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.0 mt -56.78 110.65 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 125.671 1.589 . . . . 0.0 110.777 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.63 -40.84 66.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.609 1.164 . . . . 0.0 112.273 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.1 p -150.61 162.42 40.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.187 1.795 . . . . 0.0 111.022 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.04 144.13 40.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.634 1.174 . . . . 0.0 111.53 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -156.7 127.12 6.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.488 1.515 . . . . 0.0 110.486 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.06 123.29 18.66 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.775 -0.578 . . . . 0.0 110.234 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 mt -90.56 -42.71 10.66 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.737 0.415 . . . . 0.0 111.812 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.21 -136.27 6.68 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.887 0.756 . . . . 0.0 112.865 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.6 tttp -133.43 77.8 1.74 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.705 1.241 . . . . 0.0 113.089 -168.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -95.24 157.1 16.04 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.335 1.454 . . . . 0.0 110.858 -171.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.79 118.19 6.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.603 0.761 . . . . 0.0 110.525 169.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.6 m -123.02 151.83 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.455 0.645 . . . . 0.0 111.432 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -139.8 159.14 42.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.811 1.644 . . . . 0.0 111.436 -168.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -154.61 134.24 12.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.362 1.065 . . . . 0.0 111.149 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.3 pt -91.94 154.3 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.551 -0.718 . . . . 0.0 110.83 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.13 157.94 16.96 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.765 1.174 . . . . 0.0 111.803 173.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.1 t -147.5 140.3 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.112 1.365 . . . . 0.0 110.169 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -78.67 -44.55 23.42 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -57.47 7.96 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.318 1.047 . . . . 0.0 112.081 -177.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -157.74 128.99 6.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.805 1.642 . . . . 0.0 109.38 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 50.0 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 128.456 2.703 . . . . 0.0 116.183 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -146.31 160.28 42.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.199 1.4 . . . . 0.0 113.038 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -164.74 155.48 14.56 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.477 1.111 . . . . 0.0 112.725 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.8 137.35 36.8 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.109 1.364 . . . . 0.0 112.905 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.85 168.14 19.1 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.137 1.775 . . . . 0.0 113.394 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -35.45 50.52 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -82.99 -28.34 29.78 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.662 1.185 . . . . 0.0 112.769 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.434 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . 130.69 -19.59 4.99 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.586 1.565 . . . . 0.0 114.545 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -60.17 159.32 9.89 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.829 1.252 . . . . 0.0 112.229 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.2 mm -116.48 128.69 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 119.328 0.967 . . . . 0.0 111.024 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.37 145.47 29.45 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.568 1.547 . . . . 0.0 109.628 170.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.9 m -138.95 142.06 38.42 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.398 1.079 . . . . 0.0 111.608 177.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 C--O 1.253 1.279 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -168.814 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.597 0 CA-C-O 121.49 0.494 . . . . 0.0 113.837 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.27 171.57 19.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.287 1.035 . . . . 0.0 112.209 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.2 mt -122.05 146.8 46.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.83 2.052 . . . . 0.0 109.527 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -68.9 164.72 21.48 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -53.0 -46.26 68.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.95 -1.093 . . . . 0.0 112.338 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -62.98 -10.63 14.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.617 1.567 . . . . 0.0 114.905 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.8 m -71.55 111.07 6.55 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.863 0.865 . . . . 0.0 110.584 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.8 134.01 34.41 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.615 -0.678 . . . . 0.0 112.265 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.4 mm -107.55 124.53 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.019 1.728 . . . . 0.0 108.113 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -64.44 131.16 46.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.672 0.389 . . . . 0.0 110.815 169.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 p -134.77 150.54 50.56 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.645 1.178 . . . . 0.0 112.36 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.0 t -77.34 -32.78 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.976 0.51 . . . . 0.0 111.823 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -68.77 -31.05 69.8 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -140.13 -50.61 0.48 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.85 -149.35 19.86 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.109 0.861 . . . . 0.0 112.095 -172.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.1 107.88 2.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.015 1.326 . . . . 0.0 111.209 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -133.21 148.91 71.04 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.751 1.22 . . . . 0.0 112.745 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.39 126.55 15.79 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.944 3.096 . . . . 0.0 112.332 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.424 ' HA ' HD12 ' A' ' 21' ' ' ILE . 17.5 tt -54.51 -35.57 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.043 0.937 . . . . 0.0 112.637 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.74 -36.53 93.45 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.604 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -70.31 -34.35 72.6 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.033 1.416 . . . . 0.0 111.554 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 18' ' ' ILE . 60.0 mt -63.86 -36.51 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.643 0.777 . . . . 0.0 110.121 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.37 -38.06 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.837 0.855 . . . . 0.0 112.856 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.58 -26.45 65.4 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.821 -1.174 . . . . 0.0 113.025 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -114.45 2.63 14.7 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.077 1.351 . . . . 0.0 112.878 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 49.09 47.81 21.52 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 127.533 2.333 . . . . 0.0 113.133 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -73.71 129.69 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.613 1.165 . . . . 0.0 109.445 -174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 132.74 36.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 122.703 1.239 . . . . 0.0 111.208 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.0 p -160.39 175.36 12.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.393 1.477 . . . . 0.0 111.659 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 147.03 30.08 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.45 1.5 . . . . 0.0 109.157 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 m -125.46 172.99 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.581 1.952 . . . . 0.0 110.181 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -114.28 139.89 49.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.956 1.302 . . . . 0.0 110.886 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 t -162.03 150.07 14.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.901 1.281 . . . . 0.0 111.566 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.72 144.49 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.195 0.907 . . . . 0.0 113.399 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.44 -178.35 6.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.809 0.844 . . . . 0.0 112.516 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -55.66 -22.53 23.43 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.352 1.461 . . . . 0.0 113.765 173.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -91.94 -10.62 38.81 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.228 1.411 . . . . 0.0 113.719 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.62 14.14 58.71 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.41 1.005 . . . . 0.0 114.916 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -88.93 118.89 28.97 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.574 1.187 . . . . 0.0 110.177 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.45 103.99 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.496 0.719 . . . . 0.0 109.375 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -103.64 178.66 4.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.113 1.765 . . . . 0.0 111.211 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 p -127.7 140.05 52.32 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.126 0.97 . . . . 0.0 112.643 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -144.74 148.02 37.87 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.707 1.203 . . . . 0.0 113.332 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.4 152.67 49.64 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.025 2.483 . . . . 0.0 112.835 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.84 133.31 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.147 0.979 . . . . 0.0 109.784 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.64 -49.46 7.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.008 0.523 . . . . 0.0 111.828 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -148.98 176.01 10.81 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.727 1.611 . . . . 0.0 111.767 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -131.62 129.91 41.47 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.682 1.593 . . . . 0.0 109.311 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -131.78 136.06 47.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.132 0.968 . . . . 0.0 111.3 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -126.8 114.28 17.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.215 1.806 . . . . 0.0 110.118 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -78.2 -29.58 48.46 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.058 0.943 . . . . 0.0 112.058 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.66 -56.67 1.63 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.413 1.483 . . . . 0.0 112.58 172.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -166.68 111.31 0.77 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.207 1.803 . . . . 0.0 109.827 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -129.56 166.0 20.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.519 1.128 . . . . 0.0 112.606 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -61.94 100.6 0.16 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.665 1.186 . . . . 0.0 113.096 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.3 137.93 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.659 1.184 . . . . 0.0 110.787 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -118.31 141.74 48.22 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.085 1.354 . . . . 0.0 109.489 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -65.96 129.53 40.11 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.387 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.424 ' CE1' HG12 ' A' ' 105' ' ' ILE . 1.4 t80 -116.46 106.88 14.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.585 1.154 . . . . 0.0 107.948 169.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.2 t -116.57 141.71 47.84 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.068 0.947 . . . . 0.0 110.82 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp -102.82 166.01 10.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.34 1.456 . . . . 0.0 112.647 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -65.23 -25.73 67.81 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.29 -23.0 35.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.025 1.33 . . . . 0.0 113.096 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.96 -2.66 25.7 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.0 1.286 . . . . 0.0 114.717 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.3 m -57.83 136.97 57.05 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.731 1.265 . . . . 0.0 110.867 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.29 124.51 42.56 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.616 1.166 . . . . 0.0 109.939 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.6 mt -135.13 151.02 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 127.334 2.254 . . . . 0.0 108.299 -171.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -137.4 108.96 6.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.871 1.268 . . . . 0.0 109.986 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.96 170.89 17.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.019 0.928 . . . . 0.0 113.377 -172.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.5 p -91.03 153.08 20.39 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.542 1.137 . . . . 0.0 111.987 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -65.15 -5.04 5.78 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -99.16 -6.33 28.45 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.556 1.143 . . . . 0.0 112.315 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.554 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 9.9 t-80 -85.73 126.88 34.31 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.39 155.24 20.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.755 0.788 . . . . 0.0 110.43 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -138.22 143.12 40.01 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.308 0.643 . . . . 0.0 109.33 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.1 ttp -73.11 103.03 3.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.305 0.642 . . . . 0.0 111.513 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.574 ' HA ' HD23 ' A' ' 94' ' ' LEU . 73.4 p -62.38 171.86 1.75 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.9 m -54.27 -25.33 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.78 -11.99 24.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.773 1.229 . . . . 0.0 113.191 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.2 -6.17 32.16 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.0 1.762 . . . . 0.0 114.332 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -61.25 141.21 57.69 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.986 1.393 . . . . 0.0 111.777 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -101.26 83.22 2.44 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.4 1.08 . . . . 0.0 109.771 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.09 146.77 37.86 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 124.437 1.095 . . . . 0.0 110.76 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.43 148.6 73.71 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.068 2.512 . . . . 0.0 111.783 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 tt -60.57 -26.98 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -55.41 -32.9 63.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.176 0.99 . . . . 0.0 112.92 170.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.44 -31.29 16.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.353 1.061 . . . . 0.0 111.754 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.28 -42.22 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.232 -0.917 . . . . 0.0 110.738 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -62.23 -39.31 92.4 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.28 -44.77 64.59 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -77.76 -11.12 59.85 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 56.51 37.82 29.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.425 1.49 . . . . 0.0 111.751 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.8 mt -78.48 150.9 32.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 122.042 0.925 . . . . 0.0 111.37 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -93.72 167.43 11.66 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.901 0.88 . . . . 0.0 111.069 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 76' ' ' THR . 39.3 mt -116.01 144.93 43.42 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.308 1.043 . . . . 0.0 111.437 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -68.59 148.36 50.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.712 0.805 . . . . 0.0 111.618 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.02 152.04 44.78 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.783 1.233 . . . . 0.0 113.694 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 t -77.31 -35.84 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 128.37 2.668 . . . . 0.0 112.74 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -91.47 10.81 26.18 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.361 1.065 . . . . 0.0 113.495 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.25 7.0 m-80 56.38 31.91 19.6 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.076 1.75 . . . . 0.0 112.426 -172.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.9 mt -64.54 155.23 82.02 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 113.659 -1.61 . . . . 0.0 111.622 170.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.98 127.51 17.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.341 2.694 . . . . 0.0 109.987 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -77.69 131.13 37.57 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.751 -0.593 . . . . 0.0 109.595 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -142.08 127.65 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.644 1.178 . . . . 0.0 110.957 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 166.49 3.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.597 1.959 . . . . 0.0 113.202 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.424 HG12 ' CE1' ' A' ' 58' ' ' TYR . 6.8 mt -61.33 116.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.152 1.381 . . . . 0.0 109.691 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.73 -42.1 61.63 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.832 0.853 . . . . 0.0 111.627 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 p -149.24 146.02 27.39 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.018 1.327 . . . . 0.0 111.295 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -143.84 142.79 31.02 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.266 1.827 . . . . 0.0 109.853 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -155.41 151.04 27.35 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.996 2.118 . . . . 0.0 110.416 169.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -67.03 131.2 45.36 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.365 0.666 . . . . 0.0 110.072 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.6 mt -98.27 -45.13 6.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.944 0.498 . . . . 0.0 111.871 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.01 -146.3 15.56 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.179 0.895 . . . . 0.0 112.095 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.59 94.67 4.31 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.246 1.022 . . . . 0.0 111.78 -169.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -110.86 155.79 22.09 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.397 1.479 . . . . 0.0 109.904 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.46 118.32 8.6 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.201 0.6 . . . . 0.0 110.642 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.84 150.45 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.35 0.595 . . . . 0.0 111.46 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -138.44 159.41 42.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.673 1.589 . . . . 0.0 111.494 -170.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -157.29 114.38 3.04 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.418 1.087 . . . . 0.0 110.556 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.0 pt -68.12 154.74 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 O-C-N 121.267 -0.896 . . . . 0.0 110.908 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.46 152.23 17.41 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.69 1.138 . . . . 0.0 111.5 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 124.972 1.309 . . . . 0.0 110.069 -171.796 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -168.31 146.77 4.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.593 1.157 . . . . 0.0 112.121 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.03 165.32 25.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.124 0.97 . . . . 0.0 113.321 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 67.2 mt -130.57 164.87 23.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.054 2.142 . . . . 0.0 111.621 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -32.61 58.1 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -86.71 9.11 19.84 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.402 1.481 . . . . 0.0 112.519 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.4 0.06 85.94 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.747 1.641 . . . . 0.0 114.046 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -67.37 166.67 14.02 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.205 1.503 . . . . 0.0 113.073 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.97 123.4 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.286 1.034 . . . . 0.0 109.65 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.554 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -97.22 149.99 21.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.984 1.314 . . . . 0.0 109.671 172.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.2 t -142.2 138.73 31.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.151 0.98 . . . . 0.0 112.587 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.529 1.532 . . . . 0.0 112.28 -174.287 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 CA-C-O 121.591 0.551 . . . . 0.0 114.084 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.32 179.83 7.99 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.137 1.375 . . . . 0.0 112.506 -174.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.5 mt -123.33 146.43 47.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.271 1.829 . . . . 0.0 110.378 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 t -68.62 163.85 22.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.206 0.602 . . . . 0.0 112.378 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -51.75 -44.52 63.35 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.421 -0.799 . . . . 0.0 112.49 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -59.8 -19.77 52.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.655 1.982 . . . . 0.0 113.857 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.8 m -72.32 87.24 1.13 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.644 1.178 . . . . 0.0 111.718 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -77.42 145.96 36.85 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.115 0.959 . . . . 0.0 112.74 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.3 mm -119.53 125.92 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 126.889 2.075 . . . . 0.0 107.18 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -61.1 132.16 52.86 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 122.076 -0.39 . . . . 0.0 111.17 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.7 p -133.05 148.46 52.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.659 1.184 . . . . 0.0 112.698 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.9 -34.61 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.258 0.623 . . . . 0.0 111.9 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -65.11 -28.85 69.72 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -143.86 -62.92 0.39 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.28 -148.35 18.77 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.007 0.813 . . . . 0.0 112.056 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.05 107.05 3.46 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.685 1.194 . . . . 0.0 111.331 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.76 148.63 70.28 Favored Pre-proline 0 N--CA 1.479 1.012 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.03 127.63 18.05 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.694 3.596 . . . . 0.0 112.822 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.44 -35.09 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.615 0.766 . . . . 0.0 113.027 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.61 -36.56 93.5 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.334 -0.703 . . . . 0.0 112.787 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -71.56 -32.22 67.85 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.114 1.457 . . . . 0.0 111.398 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.61 -37.44 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.972 0.909 . . . . 0.0 110.181 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.5 t -88.02 -37.87 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 118.691 0.678 . . . . 0.0 112.586 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -69.24 -25.85 64.49 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.481 1.037 . . . . 0.0 113.008 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -116.24 4.87 13.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.945 1.298 . . . . 0.0 112.45 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 48.46 47.89 19.8 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.136 2.575 . . . . 0.0 113.258 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -72.64 121.86 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.029 1.332 . . . . 0.0 109.469 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -83.27 122.29 28.24 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.44 1.114 . . . . 0.0 110.733 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -152.1 -177.02 5.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.003 1.721 . . . . 0.0 110.909 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -125.24 141.38 52.12 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.184 1.393 . . . . 0.0 108.424 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.48 177.29 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.614 1.965 . . . . 0.0 110.6 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -122.73 140.06 53.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.717 1.207 . . . . 0.0 111.36 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.4 t -161.38 149.61 15.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.355 1.462 . . . . 0.0 110.924 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.39 160.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 119.043 0.838 . . . . 0.0 111.126 167.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -102.23 -174.47 2.58 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.998 1.719 . . . . 0.0 113.089 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.52 -11.54 25.01 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -102.93 -0.86 30.42 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.804 1.642 . . . . 0.0 112.36 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.98 31.48 39.16 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.68 1.133 . . . . 0.0 114.565 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -116.56 121.99 43.37 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.697 1.249 . . . . 0.0 109.991 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.7 mt -63.91 118.82 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.736 0.814 . . . . 0.0 109.305 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -122.87 177.02 5.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.193 1.797 . . . . 0.0 111.014 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.3 p -125.61 139.88 53.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.141 0.977 . . . . 0.0 113.097 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -147.89 148.29 29.61 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.695 1.198 . . . . 0.0 112.808 -175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.15 155.11 52.26 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.165 2.577 . . . . 0.0 112.836 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.94 134.34 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.142 0.977 . . . . 0.0 110.146 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.87 -45.11 9.47 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.466 0.707 . . . . 0.0 112.199 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -149.23 173.28 13.63 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.923 1.689 . . . . 0.0 111.912 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -132.93 132.36 41.91 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.784 1.633 . . . . 0.0 108.973 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -133.28 135.61 44.99 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.04 0.924 . . . . 0.0 111.162 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -126.65 113.08 16.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.348 1.459 . . . . 0.0 110.323 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -79.35 -32.02 43.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.924 1.289 . . . . 0.0 112.866 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.05 -51.2 2.51 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.867 1.222 . . . . 0.0 113.684 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -173.15 96.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.746 1.273 . . . . 0.0 111.258 -170.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -129.67 165.11 22.49 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 112.682 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.83 103.85 0.98 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.105 1.362 . . . . 0.0 113.421 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 t -95.41 139.62 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.03 1.332 . . . . 0.0 111.544 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -123.92 139.28 54.11 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.498 1.919 . . . . 0.0 109.922 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.79 134.2 53.61 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.282 0.633 . . . . 0.0 110.357 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.406 ' CE1' HG12 ' A' ' 105' ' ' ILE . 1.6 t80 -126.62 95.73 4.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.989 1.316 . . . . 0.0 108.579 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.1 t -105.71 140.76 38.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.243 1.017 . . . . 0.0 110.132 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tp -103.86 162.9 12.73 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.911 1.284 . . . . 0.0 112.01 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -66.93 -21.19 65.99 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.1 -29.27 61.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.765 1.226 . . . . 0.0 112.839 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.92 -2.22 25.76 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.941 1.258 . . . . 0.0 114.108 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 m -57.37 138.75 54.55 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.273 1.037 . . . . 0.0 111.205 170.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 tp -128.58 125.62 38.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.335 1.054 . . . . 0.0 111.042 -170.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.4 mt -137.86 151.92 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 126.907 2.083 . . . . 0.0 108.017 -169.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -138.42 115.06 10.59 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.782 1.233 . . . . 0.0 110.804 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.24 167.71 23.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.676 1.19 . . . . 0.0 112.208 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.5 p -82.02 154.16 25.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.712 0.805 . . . . 0.0 111.715 170.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -66.59 -8.57 28.02 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -96.2 -10.83 27.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.813 1.645 . . . . 0.0 112.787 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -81.65 133.04 35.32 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -87.65 165.67 15.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.145 0.974 . . . . 0.0 111.553 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -142.85 147.39 35.33 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.323 1.049 . . . . 0.0 109.824 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 43.3 ttm -79.56 104.05 9.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.677 1.191 . . . . 0.0 110.347 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.2 p -68.87 170.81 8.94 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.715 -0.615 . . . . 0.0 112.062 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.0 m -57.79 -23.22 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -90.03 -3.02 58.21 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.407 1.083 . . . . 0.0 113.042 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.76 66.34 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.327 0.965 . . . . 0.0 113.656 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -86.01 124.9 32.98 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.497 1.119 . . . . 0.0 109.996 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.13 92.84 6.92 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.531 1.132 . . . . 0.0 109.855 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.36 147.12 44.42 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 124.381 1.072 . . . . 0.0 111.418 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.08 146.67 82.73 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.414 2.742 . . . . 0.0 111.687 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.7 tt -58.6 -27.91 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -53.23 -35.99 60.55 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.487 1.115 . . . . 0.0 112.852 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -86.75 -33.29 20.01 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.026 0.53 . . . . 0.0 111.827 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.8 mt -61.44 -38.04 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.311 -0.868 . . . . 0.0 111.06 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -67.75 -32.57 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -82.05 -40.11 22.49 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.443 -0.786 . . . . 0.0 112.514 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.3 mmm-85 -77.0 -13.95 59.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 55.01 29.98 13.34 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.587 1.555 . . . . 0.0 113.117 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -76.23 129.48 36.77 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.653 0.781 . . . . 0.0 111.168 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.17 149.15 47.84 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.617 0.723 . . . . 0.0 112.478 171.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.06 155.94 21.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.515 0.726 . . . . 0.0 112.587 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.5 ttp -78.13 135.79 37.74 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.984 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 166.7 10.22 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.391 1.476 . . . . 0.0 112.947 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.77 -19.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.602 1.961 . . . . 0.0 112.788 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -109.68 15.02 23.1 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.028 1.731 . . . . 0.0 112.263 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 65.05 14.15 9.16 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.632 1.573 . . . . 0.0 113.423 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.2 mt -43.9 154.82 0.35 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 127.264 2.226 . . . . 0.0 112.761 169.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.95 148.76 89.93 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.598 2.199 . . . . 0.0 110.904 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -69.66 123.07 20.41 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.45 -0.782 . . . . 0.0 111.152 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.5 pt -148.86 151.76 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.705 1.602 . . . . 0.0 111.055 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.23 179.7 4.21 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.822 1.649 . . . . 0.0 111.249 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.406 HG12 ' CE1' ' A' ' 58' ' ' TYR . 19.4 mt -62.06 110.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.688 1.195 . . . . 0.0 110.618 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.71 -42.02 64.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.166 1.387 . . . . 0.0 111.763 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p -148.75 148.26 29.78 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.263 1.425 . . . . 0.0 111.183 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.9 ttp85 -143.0 141.0 31.25 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.0 1.72 . . . . 0.0 110.174 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -159.85 148.96 17.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.144 1.778 . . . . 0.0 110.703 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -64.99 125.41 24.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.628 0.771 . . . . 0.0 111.459 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.34 -44.39 8.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.401 0.68 . . . . 0.0 111.866 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.62 -147.31 17.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.124 0.868 . . . . 0.0 112.872 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -128.73 80.89 1.99 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 123.083 1.421 . . . . 0.0 111.83 -169.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -100.0 158.91 15.49 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.918 1.687 . . . . 0.0 110.471 -169.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 118.43 7.72 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.79 -0.569 . . . . 0.0 110.739 169.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.94 152.77 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.302 0.641 . . . . 0.0 111.285 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -140.72 158.97 43.2 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.637 1.575 . . . . 0.0 111.737 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -155.72 131.3 9.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.419 1.088 . . . . 0.0 111.089 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.4 pt -87.27 155.36 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 121.323 -0.86 . . . . 0.0 111.08 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.7 155.14 16.27 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.434 1.492 . . . . 0.0 111.703 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.479 1.018 0 C-N-CA 124.63 1.172 . . . . 0.0 110.846 -169.203 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 CA--C 1.543 0.676 0 CA-C-O 121.002 0.429 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -163.27 154.23 16.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.456 1.102 . . . . 0.0 112.353 -169.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.81 159.44 30.09 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 45.0 mt -116.89 162.2 18.12 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.975 2.11 . . . . 0.0 112.195 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -55.2 -36.09 65.54 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -73.87 -17.04 61.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.11 0.964 . . . . 0.0 112.381 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.15 34.41 3.7 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.045 1.307 . . . . 0.0 114.699 171.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -135.53 165.34 25.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.721 1.608 . . . . 0.0 111.026 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -107.64 129.35 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.563 0.745 . . . . 0.0 110.015 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -110.75 155.26 22.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.582 1.553 . . . . 0.0 110.163 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.1 p -142.95 122.21 13.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.818 0.847 . . . . 0.0 112.605 -168.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 124.695 1.198 . . . . 0.0 113.671 -176.312 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.092 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -157.79 175.4 13.93 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 117.759 0.779 . . . . 0.0 113.077 -167.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.67 147.24 44.79 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.467 1.507 . . . . 0.0 111.218 -170.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 t -64.77 162.79 15.35 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -54.2 -44.43 71.59 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.151 -0.968 . . . . 0.0 112.002 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -57.69 -23.89 53.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.873 1.669 . . . . 0.0 113.697 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.5 m -66.92 103.59 1.18 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.443 1.497 . . . . 0.0 111.472 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -87.56 141.19 28.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.836 0.826 . . . . 0.0 112.361 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.4 mm -120.4 119.54 60.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 126.628 1.971 . . . . 0.0 106.956 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.07 131.65 51.26 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.406 0.283 . . . . 0.0 110.772 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.4 p -126.2 157.7 37.53 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.166 . . . . 0.0 112.768 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.94 -35.45 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.576 0.75 . . . . 0.0 111.182 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -67.22 -29.53 69.21 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.24 -54.28 0.47 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.23 -148.95 19.93 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.962 0.792 . . . . 0.0 112.434 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.73 109.66 3.93 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.822 1.249 . . . . 0.0 111.099 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.3 mt -136.65 150.2 69.48 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.03 1.332 . . . . 0.0 112.642 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.52 129.56 22.81 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.962 3.108 . . . . 0.0 112.379 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 tt -55.2 -38.96 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.411 0.684 . . . . 0.0 112.318 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.54 -31.74 79.58 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.583 -0.698 . . . . 0.0 113.347 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -70.88 -37.81 73.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.192 0.996 . . . . 0.0 111.26 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.59 -40.34 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 123.662 0.785 . . . . 0.0 109.336 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.3 t -74.46 -42.87 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.23 -21.26 56.6 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.788 1.176 . . . . 0.0 113.465 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -110.37 2.28 18.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.359 1.464 . . . . 0.0 112.197 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 47.38 48.86 16.23 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.998 2.119 . . . . 0.0 113.178 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.0 mt -72.11 126.11 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.868 0.867 . . . . 0.0 109.621 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -85.67 104.47 15.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.41 0.624 . . . . 0.0 111.191 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 64.7 m -133.56 -173.45 3.23 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.451 1.5 . . . . 0.0 111.487 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.31 143.65 51.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.961 1.705 . . . . 0.0 108.754 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.12 171.03 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.697 1.599 . . . . 0.0 111.156 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.04 143.28 45.01 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.951 1.3 . . . . 0.0 111.248 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 t -160.72 150.67 17.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.912 1.685 . . . . 0.0 110.381 -170.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.0 142.66 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.215 1.37 . . . . 0.0 110.729 168.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.64 178.56 7.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.838 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.27 -25.27 63.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.749 1.22 . . . . 0.0 112.754 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -87.79 -1.13 57.77 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.327 1.451 . . . . 0.0 113.339 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.08 29.6 53.49 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 121.251 -0.906 . . . . 0.0 114.373 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -109.39 122.57 47.67 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.539 1.536 . . . . 0.0 109.63 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.593 HD13 HG23 ' A' ' 97' ' ' VAL . 55.4 mt -69.82 117.84 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.498 0.719 . . . . 0.0 109.489 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -124.9 178.4 5.52 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.67 1.988 . . . . 0.0 111.285 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 p -126.08 142.68 51.42 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.386 1.074 . . . . 0.0 112.958 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -144.73 146.13 30.7 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 124.909 1.283 . . . . 0.0 112.898 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.07 152.86 67.89 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.866 2.377 . . . . 0.0 111.985 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.28 119.15 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 168.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.81 -50.45 17.15 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -151.59 179.49 8.34 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.672 1.989 . . . . 0.0 110.909 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -134.82 132.72 38.98 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.342 1.457 . . . . 0.0 109.856 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -134.02 138.82 45.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.833 0.853 . . . . 0.0 111.627 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -132.37 121.03 22.85 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.56 1.544 . . . . 0.0 110.203 -172.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -87.76 -25.65 23.29 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.124 1.37 . . . . 0.0 112.982 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.16 -49.22 2.99 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.589 1.566 . . . . 0.0 114.937 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -171.75 101.25 0.18 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.128 1.464 . . . . 0.0 111.455 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -131.43 167.47 19.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.553 1.141 . . . . 0.0 112.247 172.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.84 105.81 0.9 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.937 1.295 . . . . 0.0 113.554 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.37 140.85 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.473 1.109 . . . . 0.0 111.939 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.481 ' CZ ' ' HE3' ' A' ' 70' ' ' LYS . 46.9 m-85 -125.08 154.55 41.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.585 1.554 . . . . 0.0 110.874 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.68 110.3 22.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.567 1.147 . . . . 0.0 109.169 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -96.7 102.85 14.7 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.852 0.861 . . . . 0.0 109.255 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.5 t -82.34 147.05 29.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.203 1.001 . . . . 0.0 111.057 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -106.99 160.79 15.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.951 1.3 . . . . 0.0 113.47 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.68 -20.47 65.3 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.29 -14.99 36.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.048 1.339 . . . . 0.0 112.945 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.18 -5.11 23.62 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.441 1.496 . . . . 0.0 114.57 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 t -71.82 171.47 11.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.219 1.009 . . . . 0.0 113.213 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -140.74 141.32 34.88 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.896 1.678 . . . . 0.0 111.57 -170.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.5 mt -133.62 143.61 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 126.23 1.812 . . . . 0.0 108.699 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -133.47 101.51 5.17 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.807 1.243 . . . . 0.0 111.376 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.35 166.66 31.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.847 0.859 . . . . 0.0 113.275 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.0 p -78.37 163.03 26.01 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.231 0.538 . . . . 0.0 110.773 168.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 6.5 mtmp? -74.51 -4.83 39.18 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -97.83 -20.76 17.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.588 1.555 . . . . 0.0 112.607 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -71.72 131.01 42.53 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -84.84 157.43 20.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.519 -0.738 . . . . 0.0 111.118 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -139.5 143.62 37.55 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.024 1.33 . . . . 0.0 109.921 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.2 ttp -84.64 110.34 18.67 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.454 1.102 . . . . 0.0 111.278 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.4 p -71.14 176.42 4.48 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -54.96 -26.84 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -94.14 -9.33 36.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.631 1.173 . . . . 0.0 113.521 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.06 8.97 56.43 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.314 0.959 . . . . 0.0 114.875 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -65.81 146.98 54.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.777 1.288 . . . . 0.0 111.165 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 29.2 mtm -110.95 80.51 1.31 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.526 1.53 . . . . 0.0 109.849 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.1 mt -119.64 147.25 43.36 Favored Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 125.396 1.478 . . . . 0.0 110.465 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -63.08 144.43 92.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.643 2.229 . . . . 0.0 110.672 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.7 tt -55.91 -27.14 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -56.01 -40.45 73.41 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.179 1.391 . . . . 0.0 113.006 169.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -79.56 -35.71 39.4 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.993 -0.442 . . . . 0.0 110.855 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 94' ' ' LEU . 72.2 mt -62.58 -40.58 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 119.076 0.853 . . . . 0.0 111.391 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -58.91 -39.35 81.26 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.736 0.814 . . . . 0.0 113.157 172.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -81.49 -38.56 26.13 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.624 1.17 . . . . 0.0 113.085 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -75.47 -16.64 60.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.337 1.055 . . . . 0.0 112.896 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 56.86 34.39 24.69 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.08 1.352 . . . . 0.0 112.452 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -86.98 144.55 26.87 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.876 0.87 . . . . 0.0 111.873 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -81.22 167.67 19.34 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.7 0.8 . . . . 0.0 112.564 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 87' ' ' ILE . 4.9 mp -122.3 157.89 30.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.392 1.092 . . . . 0.0 113.901 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.6 ttm -73.05 154.44 40.44 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.05 1.74 . . . . 0.0 112.601 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.66 159.38 42.12 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.564 1.546 . . . . 0.0 114.683 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.593 HG23 HD13 ' A' ' 39' ' ' ILE . 12.0 p -93.53 -28.14 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 126.707 2.003 . . . . 0.0 113.04 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -83.39 20.81 1.26 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.464 1.506 . . . . 0.0 112.735 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.27 10.4 p30 46.39 19.77 0.08 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.708 2.803 . . . . 0.0 115.675 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.6 mt -60.68 156.99 41.11 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.146 1.378 . . . . 0.0 112.89 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.89 143.98 81.44 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.081 2.521 . . . . 0.0 110.721 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -77.74 125.61 29.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.171 0.589 . . . . 0.0 110.284 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.0 pt -140.34 131.37 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.457 1.103 . . . . 0.0 112.67 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 172.86 13.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.445 1.898 . . . . 0.0 112.701 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -69.95 113.36 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.417 1.087 . . . . 0.0 110.334 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.81 -48.83 75.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.46 1.504 . . . . 0.0 111.856 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 p -152.24 158.11 42.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.326 1.851 . . . . 0.0 111.171 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -126.1 148.84 49.27 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.881 1.672 . . . . 0.0 109.672 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -149.97 133.99 17.03 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.657 1.183 . . . . 0.0 110.688 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -70.87 129.32 38.75 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.244 0.618 . . . . 0.0 110.982 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.9 mt -96.7 -41.39 8.52 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.065 0.546 . . . . 0.0 111.845 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.24 -140.15 9.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.173 0.892 . . . . 0.0 112.58 -174.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -131.71 81.57 1.98 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.964 1.364 . . . . 0.0 113.056 -168.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -98.11 157.82 15.91 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.88 1.672 . . . . 0.0 110.069 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.2 121.68 14.81 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 121.64 -0.662 . . . . 0.0 109.695 170.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -123.19 149.23 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.502 0.668 . . . . 0.0 111.84 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -136.22 158.77 43.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.574 1.55 . . . . 0.0 111.791 -168.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -154.22 122.76 6.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.819 1.248 . . . . 0.0 110.177 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.1 pt -77.76 159.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.392 -0.817 . . . . 0.0 111.386 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.16 151.92 18.42 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.535 1.064 . . . . 0.0 111.73 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 127.16 2.184 . . . . 0.0 109.756 -179.396 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.2 p30 . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -157.47 152.13 25.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.555 1.142 . . . . 0.0 111.999 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.86 149.97 26.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.053 0.941 . . . . 0.0 113.178 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.61 176.07 5.27 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.296 1.839 . . . . 0.0 112.419 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -50.33 -49.5 53.71 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.495 1.518 . . . . 0.0 114.651 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -78.6 -9.36 59.34 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.313 1.045 . . . . 0.0 112.775 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.491 ' HA2' HG12 ' A' ' 97' ' ' VAL . . . 102.09 -7.32 54.61 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.392 1.472 . . . . 0.0 114.997 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.418 ' CE2' HD13 ' A' ' 94' ' ' LEU . 2.7 m-85 -51.26 150.93 3.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.538 1.169 . . . . 0.0 111.444 174.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.4 107.72 22.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.1 143.54 28.0 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 170.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.3 m -132.51 104.4 6.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.487 1.115 . . . . 0.0 109.996 -172.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.0 t30 . . . . . 0 C--O 1.255 1.374 0 C-N-CA 124.236 1.014 . . . . 0.0 113.396 -174.337 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -159.6 175.54 13.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.945 1.298 . . . . 0.0 111.977 -174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.58 144.47 39.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.642 1.577 . . . . 0.0 110.422 -172.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -67.05 164.02 18.73 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.564 -0.71 . . . . 0.0 112.51 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.01 -44.38 64.1 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.977 -1.077 . . . . 0.0 112.026 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -64.24 -13.12 47.22 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.683 1.593 . . . . 0.0 114.383 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.7 m -75.18 81.81 2.33 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.332 1.453 . . . . 0.0 110.894 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -71.12 142.34 50.77 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.773 0.797 . . . . 0.0 111.501 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.5 mm -118.61 128.59 75.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 126.13 1.772 . . . . 0.0 106.373 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -58.17 130.85 48.54 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 122.289 -0.257 . . . . 0.0 110.919 170.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.6 p -131.88 145.15 51.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.223 1.409 . . . . 0.0 111.853 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.15 -32.62 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 121.877 -0.514 . . . . 0.0 111.922 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.74 -35.73 81.55 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -140.33 -48.71 0.44 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -170.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.59 -146.68 18.49 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.982 0.81 . . . . 0.0 113.163 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.4 96.84 1.52 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.268 1.427 . . . . 0.0 111.652 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.45 145.73 55.66 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.612 1.165 . . . . 0.0 112.407 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.14 128.4 21.6 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.78 3.653 . . . . 0.0 113.261 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.84 -37.43 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.746 0.818 . . . . 0.0 112.944 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.56 -32.84 84.54 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.618 -0.546 . . . . 0.0 112.956 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -72.52 -36.79 68.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.98 0.89 . . . . 0.0 111.298 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.89 -39.03 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.656 0.782 . . . . 0.0 109.479 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.52 -42.16 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.909 0.884 . . . . 0.0 113.11 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -75.1 -21.97 58.57 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.374 0.988 . . . . 0.0 113.507 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -109.79 1.72 19.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.145 1.378 . . . . 0.0 112.407 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.42 54.23 8.81 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.875 2.07 . . . . 0.0 113.357 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.5 mt -75.03 119.58 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.632 0.773 . . . . 0.0 110.104 -172.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.3 80.49 1.85 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.912 1.685 . . . . 0.0 112.221 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.6 p -119.49 178.49 4.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.02 1.328 . . . . 0.0 112.625 -171.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.5 m -119.25 149.46 41.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.243 1.417 . . . . 0.0 108.339 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.3 175.88 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.794 1.637 . . . . 0.0 110.967 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -121.24 142.59 49.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.428 1.491 . . . . 0.0 110.382 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.9 t -165.18 154.17 12.36 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.686 1.195 . . . . 0.0 110.835 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.4 m -84.91 145.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.665 1.12 . . . . 0.0 112.468 172.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.91 179.1 7.63 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.95 0.9 . . . . 0.0 111.917 172.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -60.59 -20.21 59.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -90.78 -0.73 57.8 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.218 1.407 . . . . 0.0 113.273 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.23 32.26 48.86 Favored Glycine 0 CA--C 1.536 1.387 0 O-C-N 121.33 -0.856 . . . . 0.0 114.099 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -112.64 121.51 44.98 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.494 1.518 . . . . 0.0 109.554 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.96 113.17 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -116.71 178.29 4.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.055 1.742 . . . . 0.0 110.528 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -128.02 143.31 51.07 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.859 0.863 . . . . 0.0 113.106 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -144.59 147.06 34.65 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.295 1.038 . . . . 0.0 113.605 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.62 150.07 50.25 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.108 2.539 . . . . 0.0 112.307 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.53 147.33 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.169 0.988 . . . . 0.0 110.808 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.64 -44.69 3.46 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.036 0.934 . . . . 0.0 111.992 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -142.41 178.17 7.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.759 1.623 . . . . 0.0 111.479 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -137.58 120.52 16.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.309 1.443 . . . . 0.0 109.29 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -118.77 138.73 52.48 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.075 0.941 . . . . 0.0 111.161 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -131.71 115.7 16.36 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.879 1.672 . . . . 0.0 110.046 -171.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -79.84 -32.13 40.53 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.982 1.313 . . . . 0.0 113.052 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.87 -53.24 1.43 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.762 1.648 . . . . 0.0 114.86 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -171.04 99.55 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.214 1.507 . . . . 0.0 111.577 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -134.51 168.05 19.67 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.486 1.114 . . . . 0.0 113.119 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -67.35 97.67 0.58 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.16 1.784 . . . . 0.0 114.278 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.9 t -94.01 138.79 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.194 1.398 . . . . 0.0 111.376 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -119.43 147.07 44.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.333 1.053 . . . . 0.0 110.448 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -82.33 123.99 29.58 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.585 1.154 . . . . 0.0 109.417 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -112.81 105.18 13.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.418 1.087 . . . . 0.0 108.722 174.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.3 t -96.19 122.17 38.76 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mp -79.24 156.72 28.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.697 0.799 . . . . 0.0 110.794 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -67.56 -18.49 65.03 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.62 -26.16 50.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.55 0.74 . . . . 0.0 112.764 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.23 -12.36 7.58 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.433 1.492 . . . . 0.0 114.275 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.1 m -60.02 148.24 36.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.41 1.084 . . . . 0.0 112.405 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -127.92 135.65 50.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.465 1.506 . . . . 0.0 110.715 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.0 mt -135.69 142.9 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.765 1.626 . . . . 0.0 108.095 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -134.03 110.85 9.92 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.784 1.234 . . . . 0.0 111.383 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.69 166.51 30.17 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.636 1.175 . . . . 0.0 110.541 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -70.18 150.04 46.89 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.55 -0.719 . . . . 0.0 111.408 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -61.07 -21.04 63.28 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -85.76 -16.18 39.71 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.883 2.073 . . . . 0.0 112.6 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -73.38 135.66 44.28 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -89.85 154.29 19.99 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.813 0.845 . . . . 0.0 111.932 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -137.2 144.36 42.83 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.084 -1.01 . . . . 0.0 111.465 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 37.6 ttm -73.81 104.0 4.55 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.002 0.921 . . . . 0.0 110.344 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.2 p -67.88 167.15 14.14 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.745 -0.597 . . . . 0.0 111.193 172.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.88 -26.79 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -79.63 -12.15 59.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.515 1.126 . . . . 0.0 113.292 175.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.95 3.7 65.59 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.127 1.346 . . . . 0.0 114.025 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -69.61 161.14 30.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.08 0.952 . . . . 0.0 110.699 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.4 ptp -127.46 80.88 1.98 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.836 1.254 . . . . 0.0 109.763 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.51 150.1 39.68 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 125.075 1.35 . . . . 0.0 110.403 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.38 142.07 77.38 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.491 2.127 . . . . 0.0 110.349 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.4 tt -60.34 -23.23 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.65 -27.72 65.02 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 170.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -89.59 -38.62 13.82 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.428 1.091 . . . . 0.0 111.852 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.35 -38.45 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 121.286 -0.884 . . . . 0.0 111.311 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.18 -36.76 80.71 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -78.92 -41.97 28.21 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.443 0.697 . . . . 0.0 112.467 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -74.34 -13.49 60.75 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 55.64 28.49 12.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.621 1.568 . . . . 0.0 112.86 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.9 128.63 35.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.554 0.742 . . . . 0.0 110.048 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.75 154.19 42.41 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 122.366 1.079 . . . . 0.0 112.329 171.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.3 mt -96.15 152.26 18.72 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.696 1.198 . . . . 0.0 111.924 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 35.3 ttm -72.38 138.39 47.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.501 0.32 . . . . 0.0 110.479 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 162.57 16.25 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.065 1.346 . . . . 0.0 113.782 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.7 -23.09 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.384 1.474 . . . . 0.0 113.978 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -101.44 8.56 42.06 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.003 0.921 . . . . 0.0 113.392 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 m120 67.33 22.15 9.61 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.663 1.585 . . . . 0.0 112.234 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.1 mt -54.34 159.19 3.32 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.497 1.519 . . . . 0.0 112.049 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.65 145.72 82.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.388 2.059 . . . . 0.0 110.722 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -67.13 121.7 16.2 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.519 -0.738 . . . . 0.0 111.162 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.2 pt -144.82 137.61 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.84 1.656 . . . . 0.0 110.317 -174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.6 175.52 5.63 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.715 1.606 . . . . 0.0 111.042 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.72 104.82 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.454 1.102 . . . . 0.0 110.513 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.9 -41.16 78.61 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.759 1.224 . . . . 0.0 112.363 -175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.6 p -146.78 154.72 41.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.537 1.535 . . . . 0.0 111.288 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -133.81 139.16 46.11 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.621 1.568 . . . . 0.0 110.987 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -141.45 130.26 22.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.474 1.51 . . . . 0.0 110.02 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.04 121.74 16.22 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 122.503 0.321 . . . . 0.0 110.392 173.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.3 mt -87.09 -40.34 14.75 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.874 0.469 . . . . 0.0 111.795 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.21 -144.87 15.87 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.329 0.966 . . . . 0.0 112.583 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -124.6 81.46 1.95 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.935 1.35 . . . . 0.0 112.486 -168.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -98.74 158.06 15.87 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.613 1.565 . . . . 0.0 110.948 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.44 119.13 9.82 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.644 0.778 . . . . 0.0 110.323 171.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.87 149.43 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.483 0.713 . . . . 0.0 111.216 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -139.09 158.4 44.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.861 1.664 . . . . 0.0 111.771 -168.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -156.28 121.48 4.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.747 1.219 . . . . 0.0 110.297 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.8 pt -73.27 155.74 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 120.911 -1.118 . . . . 0.0 111.467 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.89 147.61 16.36 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.662 1.125 . . . . 0.0 111.74 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.88 0 C-N-CA 126.965 2.106 . . . . 0.0 109.845 -169.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -162.14 160.78 27.66 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.389 1.476 . . . . 0.0 112.516 -173.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.44 148.84 21.78 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.489 1.116 . . . . 0.0 113.864 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 54.2 mt -100.73 166.44 10.87 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.267 1.827 . . . . 0.0 113.018 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -57.73 -33.18 68.16 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -75.81 -13.71 60.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.704 0.801 . . . . 0.0 112.625 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.89 30.29 5.83 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 117.579 -1.679 . . . . 0.0 114.841 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.0 165.33 22.38 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.783 1.792 . . . . 0.0 111.778 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.06 139.24 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.104 0.962 . . . . 0.0 110.13 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.04 152.92 46.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.609 1.564 . . . . 0.0 110.654 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.5 t -136.48 140.82 43.35 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.143 1.377 . . . . 0.0 112.342 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -169.487 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.267 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.42 170.07 17.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.492 ' HG ' HG21 ' A' ' 6' ' ' THR . 2.2 mm? -106.73 152.32 23.97 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.784 1.233 . . . . 0.0 110.974 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 t -63.2 161.7 13.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -52.49 -43.86 65.28 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.79 0.836 . . . . 0.0 112.221 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -60.9 -23.22 65.05 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.67 1.588 . . . . 0.0 113.52 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.492 HG21 ' HG ' ' A' ' 2' ' ' LEU . 87.7 m -66.15 114.73 5.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.101 0.961 . . . . 0.0 111.557 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -94.58 140.42 29.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.647 0.736 . . . . 0.0 112.439 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 mm -118.03 125.24 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 126.365 1.866 . . . . 0.0 108.103 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 tp -64.25 129.48 40.1 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.558 0.743 . . . . 0.0 111.369 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.9 p -128.4 156.58 42.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.122 1.369 . . . . 0.0 112.063 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 t -78.05 -31.64 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 O-C-N 121.739 -0.601 . . . . 0.0 111.88 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.04 -35.13 79.7 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -139.93 -44.97 0.43 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.33 -143.78 14.96 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.194 0.902 . . . . 0.0 111.288 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.0 mt -67.32 111.77 4.19 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.079 1.351 . . . . 0.0 111.279 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.1 mt -139.76 151.73 66.59 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.829 1.252 . . . . 0.0 113.323 176.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.55 128.72 20.73 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.131 3.221 . . . . 0.0 112.638 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 tt -58.24 -35.91 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.83 -31.54 81.24 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.867 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -71.24 -37.53 71.98 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.491 1.145 . . . . 0.0 111.322 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.45 -37.74 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.523 0.729 . . . . 0.0 110.762 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.6 t -85.7 -36.4 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.35 0.66 . . . . 0.0 112.657 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.77 -25.39 63.79 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.264 -0.897 . . . . 0.0 113.298 174.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -113.44 2.84 15.56 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.086 1.354 . . . . 0.0 113.0 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 46.82 47.98 15.07 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 127.538 2.335 . . . . 0.0 112.702 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.9 mt -70.61 121.31 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.798 1.239 . . . . 0.0 109.38 -174.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -82.37 120.18 25.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.912 0.863 . . . . 0.0 110.93 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.6 p -153.01 164.01 38.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.55 1.14 . . . . 0.0 112.75 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.7 145.8 24.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.074 1.35 . . . . 0.0 109.813 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.47 176.74 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.391 1.876 . . . . 0.0 110.756 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -121.75 144.26 48.9 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.179 1.392 . . . . 0.0 110.697 -176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.2 t -158.73 167.23 30.05 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.586 1.554 . . . . 0.0 110.599 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.78 123.98 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.156 1.382 . . . . 0.0 110.086 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.5 179.52 4.02 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.6 -18.88 65.3 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -90.21 -2.26 58.03 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.643 1.577 . . . . 0.0 112.086 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.79 29.89 62.52 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.053 1.787 . . . . 0.0 114.614 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -111.85 140.15 46.73 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.155 1.382 . . . . 0.0 110.497 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.3 mt -67.95 133.07 32.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -138.47 166.67 23.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.558 1.543 . . . . 0.0 111.452 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 p -118.08 143.53 46.37 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.418 1.087 . . . . 0.0 111.714 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -150.83 146.71 19.7 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.656 1.182 . . . . 0.0 111.951 -172.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.34 151.59 48.59 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.881 2.387 . . . . 0.0 112.495 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.2 139.46 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.103 0.961 . . . . 0.0 111.449 169.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.45 -35.29 9.61 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.186 0.995 . . . . 0.0 113.075 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.14 175.48 13.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.782 1.233 . . . . 0.0 112.777 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -124.14 135.66 53.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.565 1.546 . . . . 0.0 108.809 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -124.36 119.67 29.92 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.04 1.336 . . . . 0.0 110.86 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.57 110.02 16.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 110.432 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -87.37 -30.21 20.94 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.597 1.159 . . . . 0.0 112.988 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.9 -52.01 2.91 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.044 1.307 . . . . 0.0 114.099 171.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -170.97 98.46 0.21 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.588 1.194 . . . . 0.0 111.201 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -129.96 162.98 27.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.33 1.052 . . . . 0.0 112.155 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.39 102.3 1.39 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.69 1.196 . . . . 0.0 113.191 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.6 t -94.93 138.27 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.445 1.498 . . . . 0.0 110.925 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -124.89 144.92 50.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.274 1.43 . . . . 0.0 110.029 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -65.18 127.61 32.41 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.968 0.907 . . . . 0.0 110.469 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -119.51 86.58 2.58 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.874 1.67 . . . . 0.0 108.419 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.0 t -89.7 144.56 25.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.161 0.984 . . . . 0.0 110.787 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.02 163.92 12.88 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.369 1.067 . . . . 0.0 112.668 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.42 -20.33 63.79 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -76.05 -26.52 56.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.526 1.13 . . . . 0.0 112.555 171.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.16 -1.97 23.98 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.969 1.271 . . . . 0.0 113.998 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.59 147.22 42.43 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.937 1.295 . . . . 0.0 111.269 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.1 mt -134.84 130.78 36.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.117 1.367 . . . . 0.0 110.645 -172.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.6 mt -137.91 151.41 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.462 1.905 . . . . 0.0 107.757 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -136.26 106.15 6.26 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.663 1.185 . . . . 0.0 110.165 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.46 166.32 24.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.099 1.36 . . . . 0.0 111.89 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.1 p -86.85 157.32 19.57 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.924 0.869 . . . . 0.0 112.627 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -72.61 -5.01 34.39 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -91.34 -15.58 28.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.341 1.057 . . . . 0.0 112.556 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -77.63 131.67 37.89 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.699 -0.626 . . . . 0.0 111.147 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -90.03 153.97 20.17 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.19 0.996 . . . . 0.0 111.172 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -139.0 143.82 38.65 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.568 0.747 . . . . 0.0 110.416 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.2 ttm -74.11 104.35 4.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.155 0.982 . . . . 0.0 110.533 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.7 p -68.75 171.04 8.36 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.199 0.523 . . . . 0.0 111.936 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.1 m -56.57 -24.79 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 173.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -92.17 -6.15 51.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.145 0.978 . . . . 0.0 113.268 174.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.41 24.04 52.21 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.789 1.185 . . . . 0.0 113.793 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -88.82 120.26 30.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.081 0.952 . . . . 0.0 110.661 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.1 mmt -80.62 80.33 7.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.359 1.064 . . . . 0.0 111.68 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.3 mt -112.96 147.43 37.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 124.754 1.222 . . . . 0.0 110.888 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.84 146.92 84.57 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.57 2.18 . . . . 0.0 110.992 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.24 -25.05 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -55.89 -34.43 65.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.833 1.253 . . . . 0.0 113.014 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.0 -41.54 25.63 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.927 0.891 . . . . 0.0 110.496 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.88 -36.16 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.991 0.916 . . . . 0.0 111.498 -174.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -66.72 -35.44 80.12 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.24 -35.7 21.41 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.491 -0.756 . . . . 0.0 112.642 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -74.11 -17.52 60.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.403 1.081 . . . . 0.0 113.018 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 54.78 33.64 20.1 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.249 1.42 . . . . 0.0 112.963 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.4 mt -76.02 143.39 41.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.768 0.827 . . . . 0.0 111.907 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -88.53 148.07 24.3 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.815 0.846 . . . . 0.0 110.92 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.9 156.86 22.18 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.385 -0.822 . . . . 0.0 112.367 168.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 7.9 ttp -88.84 158.57 18.07 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.75 1.22 . . . . 0.0 111.378 169.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.12 165.57 25.4 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.061 1.345 . . . . 0.0 112.9 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.1 m -88.44 -21.77 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.01 13.52 34.53 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.206 1.002 . . . . 0.0 113.084 -171.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.1 m120 58.44 29.25 18.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.195 1.798 . . . . 0.0 112.429 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 mt -57.66 153.93 28.18 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.223 173.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.83 140.19 50.04 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.648 2.899 . . . . 0.0 111.15 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -79.82 120.59 24.28 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.017 0.527 . . . . 0.0 111.01 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.5 pt -142.8 153.5 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.908 1.683 . . . . 0.0 111.56 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.62 -179.6 3.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.911 1.684 . . . . 0.0 111.806 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.1 mt -64.43 114.65 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.107 0.963 . . . . 0.0 110.214 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.42 -41.16 73.27 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.839 1.256 . . . . 0.0 112.316 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.75 157.81 34.1 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.223 1.409 . . . . 0.0 111.009 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -137.12 143.83 42.72 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.491 1.516 . . . . 0.0 110.562 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -151.09 134.51 16.21 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.49 1.516 . . . . 0.0 109.506 169.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -63.6 123.4 18.72 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.705 0.684 . . . . 0.0 110.375 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.2 mt -90.04 -44.02 10.12 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.01 0.524 . . . . 0.0 111.692 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 148.38 -148.11 19.3 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.329 0.966 . . . . 0.0 112.979 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -126.6 67.87 1.24 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 123.576 1.655 . . . . 0.0 112.469 -168.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -85.74 158.02 20.13 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 126.723 2.009 . . . . 0.0 110.635 -169.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.04 119.65 9.9 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.135 0.574 . . . . 0.0 110.5 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -123.06 150.49 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.41 0.624 . . . . 0.0 111.839 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -140.06 157.84 45.0 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.215 1.806 . . . . 0.0 112.264 -168.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -152.67 167.37 29.17 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.916 1.687 . . . . 0.0 110.969 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.8 145.72 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.417 1.487 . . . . 0.0 111.338 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.09 160.44 23.06 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.79 0.709 . . . . 0.0 112.865 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 126.36 1.864 . . . . 0.0 110.487 178.884 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 CA--C 1.549 0.925 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -163.34 166.55 22.87 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.836 1.254 . . . . 0.0 111.809 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.92 140.49 31.38 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.015 0.926 . . . . 0.0 112.949 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 133' ' ' PHE . 65.3 mt -91.73 170.49 9.87 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.143 1.777 . . . . 0.0 111.882 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -47.17 -58.12 4.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.779 1.632 . . . . 0.0 115.22 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -67.13 -39.64 86.65 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.556 0.342 . . . . 0.0 110.861 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.33 -2.97 0.85 Allowed Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.475 -1.181 . . . . 0.0 115.331 172.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.411 ' HB2' HD12 ' A' ' 129' ' ' LEU . 18.7 m-85 -59.49 160.89 6.39 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.176 1.488 . . . . 0.0 112.332 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.91 129.14 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.63 0.729 . . . . 0.0 110.179 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -118.52 145.65 45.16 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.991 1.716 . . . . 0.0 109.977 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.3 t -136.78 149.15 47.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.542 1.137 . . . . 0.0 114.006 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.8 t30 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.895 1.678 . . . . 0.0 113.648 -172.046 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.793 0 CA-C-O 122.307 0.948 . . . . 0.0 115.198 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -151.17 169.13 22.64 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.345 1.058 . . . . 0.0 112.207 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.8 mt -120.78 146.87 46.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.386 1.874 . . . . 0.0 109.514 -172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 t -70.15 160.34 32.26 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.585 -0.697 . . . . 0.0 111.437 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -49.09 -40.9 33.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.292 1.037 . . . . 0.0 112.344 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.88 -24.8 54.47 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.983 1.713 . . . . 0.0 113.777 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.2 m -72.14 102.65 3.09 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.293 1.037 . . . . 0.0 110.942 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -87.52 145.87 26.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.747 0.784 . . . . 0.0 111.67 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -122.81 128.84 75.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 126.501 1.92 . . . . 0.0 107.317 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.2 tp -61.95 127.76 32.94 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.834 0.454 . . . . 0.0 111.37 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.3 p -125.57 150.44 47.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.847 1.259 . . . . 0.0 112.368 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.42 -32.39 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.287 0.635 . . . . 0.0 111.982 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -66.22 -30.42 70.87 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -142.56 -56.55 0.44 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -173.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.26 -147.81 19.44 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.835 0.731 . . . . 0.0 112.681 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.4 104.75 1.97 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.084 1.353 . . . . 0.0 111.347 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.4 mt -134.61 148.68 68.35 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.434 1.094 . . . . 0.0 113.451 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.52 129.53 24.05 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.462 3.441 . . . . 0.0 112.665 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.1 tt -56.29 -35.31 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.609 0.764 . . . . 0.0 112.888 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.79 -34.36 89.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.566 -0.574 . . . . 0.0 112.724 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -73.92 -29.63 62.15 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.654 1.227 . . . . 0.0 112.015 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.6 mt -71.77 -41.96 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.452 1.101 . . . . 0.0 109.769 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.29 -39.99 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.756 0.822 . . . . 0.0 113.004 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.11 -26.3 65.74 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.308 0.958 . . . . 0.0 112.643 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.45 2.04 15.27 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.616 1.166 . . . . 0.0 113.398 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 46.89 50.68 13.4 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.344 2.258 . . . . 0.0 112.139 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.3 mt -67.05 120.19 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.873 0.869 . . . . 0.0 108.868 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -84.4 98.57 10.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.945 0.879 . . . . 0.0 110.321 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p -132.02 -171.14 2.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.08 1.352 . . . . 0.0 111.463 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.25 142.23 50.9 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.458 1.503 . . . . 0.0 108.008 -176.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.48 172.94 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.802 1.641 . . . . 0.0 110.169 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -117.55 145.19 44.43 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.012 1.325 . . . . 0.0 110.194 -173.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.4 t -159.07 167.03 30.31 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.29 1.436 . . . . 0.0 110.139 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -113.31 127.29 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.158 1.383 . . . . 0.0 110.824 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.17 179.61 6.77 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.276 1.036 . . . . 0.0 111.951 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -57.34 -24.84 57.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.142 1.377 . . . . 0.0 113.405 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -88.73 -6.4 57.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.816 1.646 . . . . 0.0 113.827 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.78 4.14 89.0 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.263 0.935 . . . . 0.0 114.786 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -77.37 128.48 34.35 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.11 0.955 . . . . 0.0 109.906 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.68 107.38 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -107.48 175.22 5.56 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.574 1.549 . . . . 0.0 110.403 175.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.6 p -130.99 149.03 52.8 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.703 0.801 . . . . 0.0 112.789 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -146.07 144.52 21.9 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.788 1.235 . . . . 0.0 111.997 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.44 151.21 47.57 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.819 2.346 . . . . 0.0 112.172 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.31 122.0 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 169.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.03 -47.63 12.41 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.27 -0.269 . . . . 0.0 111.56 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -148.7 179.14 8.05 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.021 1.729 . . . . 0.0 111.585 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -137.47 142.08 41.55 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.732 1.613 . . . . 0.0 110.289 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -136.79 132.38 34.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.999 0.92 . . . . 0.0 111.614 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -124.06 119.66 30.16 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.471 1.508 . . . . 0.0 110.595 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -84.82 -32.25 23.41 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.692 1.197 . . . . 0.0 113.086 -173.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 -53.33 1.33 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.528 1.537 . . . . 0.0 113.975 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -170.09 101.51 0.29 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.086 1.354 . . . . 0.0 111.087 -173.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -131.57 160.87 34.04 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.531 1.133 . . . . 0.0 111.899 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.91 106.52 1.25 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.405 1.082 . . . . 0.0 112.925 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.65 134.75 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.25 1.42 . . . . 0.0 111.358 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -119.78 140.78 50.22 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.76 1.224 . . . . 0.0 110.31 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.11 132.01 35.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.127 0.971 . . . . 0.0 108.799 168.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.18 89.04 3.05 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.112 1.365 . . . . 0.0 108.541 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 45.6 t -71.88 129.29 38.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.662 0.785 . . . . 0.0 110.377 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -88.54 164.87 15.21 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.201 1.0 . . . . 0.0 112.304 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.17 -23.02 67.16 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -82.18 -26.59 33.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.654 1.182 . . . . 0.0 113.084 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.95 -4.58 16.41 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.029 1.299 . . . . 0.0 114.264 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 m -58.54 141.34 52.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.556 1.178 . . . . 0.0 110.802 173.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.32 122.2 40.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.939 0.896 . . . . 0.0 109.52 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -110.97 131.09 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -124.66 97.35 5.25 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.38 1.072 . . . . 0.0 109.884 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.9 169.82 17.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.54 1.136 . . . . 0.0 113.03 -168.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 p -84.75 152.2 23.86 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.443 1.097 . . . . 0.0 111.486 169.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -62.65 -12.27 22.3 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.35 -13.49 34.99 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.32 1.448 . . . . 0.0 112.376 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -82.87 134.77 35.08 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.599 0.636 . . . . 0.0 109.666 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -86.91 156.75 19.7 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.657 0.783 . . . . 0.0 111.345 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -137.69 142.64 41.09 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.783 0.833 . . . . 0.0 109.286 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 31.1 ttp -79.52 106.17 11.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.024 0.529 . . . . 0.0 110.0 -174.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.4 p -66.47 169.33 7.67 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.008 0.523 . . . . 0.0 111.909 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 m -56.44 -27.87 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.8 -14.48 54.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.386 1.074 . . . . 0.0 113.283 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.68 6.06 56.45 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.445 1.497 . . . . 0.0 114.705 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -71.7 155.34 40.59 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.692 1.246 . . . . 0.0 111.384 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.7 ptp -116.86 74.24 0.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.803 1.241 . . . . 0.0 110.961 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.73 147.0 33.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.487 1.115 . . . . 0.0 110.977 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.78 146.96 92.53 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.034 2.49 . . . . 0.0 111.159 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tt -59.27 -24.78 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -54.78 -38.69 67.58 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.861 1.265 . . . . 0.0 112.61 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -81.28 -38.75 26.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.19 0.596 . . . . 0.0 110.848 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.452 HD13 HD21 ' A' ' 94' ' ' LEU . 77.2 mt -61.88 -40.89 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.389 -0.82 . . . . 0.0 111.665 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -64.33 -39.36 93.74 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.88 -40.12 25.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.968 0.907 . . . . 0.0 113.069 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -81.03 -11.96 59.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.754 1.222 . . . . 0.0 112.938 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 57.87 32.91 22.58 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.403 1.481 . . . . 0.0 112.737 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 mt -70.31 133.48 47.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.663 1.185 . . . . 0.0 110.971 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -72.11 154.58 41.0 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.546 -0.721 . . . . 0.0 111.76 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.452 HD21 HD13 ' A' ' 87' ' ' ILE . 62.5 mt -105.89 147.66 28.49 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.936 0.894 . . . . 0.0 112.406 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.8 ttm -70.17 151.64 45.18 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.511 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.27 174.04 10.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.481 1.112 . . . . 0.0 112.545 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.0 -0.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 125.775 1.63 . . . . 0.0 114.694 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.29 12.55 21.68 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.299 1.44 . . . . 0.0 113.265 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.8 m120 59.98 25.05 14.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.228 1.811 . . . . 0.0 113.02 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.8 mt -63.75 159.1 56.16 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.976 1.71 . . . . 0.0 112.013 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.19 146.2 80.76 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.004 2.47 . . . . 0.0 111.477 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -76.43 113.54 14.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.095 0.558 . . . . 0.0 109.708 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.95 150.58 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.318 1.447 . . . . 0.0 111.232 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.09 174.23 6.03 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.652 1.581 . . . . 0.0 111.21 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.4 mt -66.18 113.37 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.881 0.872 . . . . 0.0 109.878 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.28 74.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.026 1.331 . . . . 0.0 111.628 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.7 p -153.38 160.76 42.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.212 1.805 . . . . 0.0 111.784 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -117.4 145.26 44.22 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.081 1.752 . . . . 0.0 110.456 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -147.0 121.67 9.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.25 1.02 . . . . 0.0 110.871 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -64.18 135.84 56.68 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.84 -0.538 . . . . 0.0 111.175 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.5 mt -105.99 -37.98 6.47 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.255 0.622 . . . . 0.0 112.167 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.23 -144.78 15.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.458 1.028 . . . . 0.0 112.462 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -128.8 78.77 1.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 123.193 1.473 . . . . 0.0 112.141 -169.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -96.84 160.35 14.41 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.916 1.686 . . . . 0.0 111.074 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.44 119.32 8.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.392 0.677 . . . . 0.0 110.433 169.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.97 150.67 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.451 0.644 . . . . 0.0 111.384 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -138.44 158.76 43.65 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.67 1.588 . . . . 0.0 112.217 -168.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -158.23 133.4 8.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.425 1.09 . . . . 0.0 110.992 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.8 pt -82.3 158.4 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.389 -0.819 . . . . 0.0 111.354 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.22 139.9 15.79 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.84 1.209 . . . . 0.0 111.424 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.472 0.664 0 C-N-CA 126.652 1.981 . . . . 0.0 110.002 178.772 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -153.96 154.93 34.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.842 1.657 . . . . 0.0 111.984 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.24 131.65 34.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.526 1.131 . . . . 0.0 112.688 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 38.5 mt -82.87 170.59 14.82 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.172 1.389 . . . . 0.0 112.669 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -55.66 -41.15 73.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -75.32 -33.28 61.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.39 0.676 . . . . 0.0 111.577 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.4 -9.15 5.02 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.163 1.363 . . . . 0.0 114.304 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.74 173.1 5.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.614 1.707 . . . . 0.0 111.79 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.29 122.0 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.472 0.709 . . . . 0.0 109.843 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.63 131.48 44.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.336 1.054 . . . . 0.0 108.369 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 p -108.61 143.35 37.78 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.581 1.552 . . . . 0.0 110.775 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--O 1.255 1.394 0 CA-C-O 117.653 -1.165 . . . . 0.0 113.1 -167.811 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.274 0 N-CA-C 112.182 -0.367 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.08 179.19 7.69 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.989 1.315 . . . . 0.0 112.55 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.6 150.27 36.93 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.034 1.733 . . . . 0.0 111.015 -173.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 t -69.52 163.77 24.67 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.5 -0.75 . . . . 0.0 112.186 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -50.2 -43.82 52.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.914 0.885 . . . . 0.0 112.011 172.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -62.54 -15.77 52.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.993 1.317 . . . . 0.0 114.322 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.8 m -70.94 102.21 2.35 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.081 0.953 . . . . 0.0 111.043 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -86.24 137.65 32.46 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.357 0.663 . . . . 0.0 112.11 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.2 mm -122.9 119.13 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.896 1.678 . . . . 0.0 107.929 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.24 127.88 33.53 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 122.253 -0.279 . . . . 0.0 111.161 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.6 p -124.93 155.94 38.78 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.72 1.608 . . . . 0.0 112.375 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.6 t -81.24 -33.68 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.992 0.517 . . . . 0.0 111.72 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.31 -25.78 61.7 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -137.88 -53.85 0.65 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.95 0.9 . . . . 0.0 113.281 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.73 -146.46 18.27 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.1 0.857 . . . . 0.0 112.352 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -74.44 107.31 6.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.067 1.747 . . . . 0.0 110.925 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.439 ' CD1' HD11 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -146.56 157.07 48.74 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 177.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.25 132.86 26.91 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.172 3.248 . . . . 0.0 112.925 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.43 ' HA ' HD12 ' A' ' 21' ' ' ILE . 20.6 tt -56.42 -34.79 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.767 0.827 . . . . 0.0 112.987 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.9 -34.22 89.34 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.731 -0.606 . . . . 0.0 112.784 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -71.59 -32.72 68.34 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.481 1.141 . . . . 0.0 111.921 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' A' ' 16' ' ' LEU . 62.9 mt -67.48 -43.38 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.124 0.969 . . . . 0.0 110.153 176.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.5 t -82.66 -36.67 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.832 0.853 . . . . 0.0 112.669 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -65.8 -27.07 68.0 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.141 0.882 . . . . 0.0 112.857 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -116.33 2.65 13.25 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.32 1.048 . . . . 0.0 113.529 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 46.62 52.62 10.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.924 2.49 . . . . 0.0 112.528 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.7 mt -74.11 119.99 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.278 1.031 . . . . 0.0 109.936 -172.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -71.95 108.37 5.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.916 0.887 . . . . 0.0 110.532 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.5 p -148.15 161.09 42.16 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.363 1.078 . . . . 0.0 113.844 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 151.83 19.23 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.909 1.684 . . . . 0.0 109.907 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.35 170.99 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 125.251 1.42 . . . . 0.0 111.347 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -114.87 142.23 46.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.477 1.511 . . . . 0.0 111.093 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.8 t -164.44 152.69 12.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.174 1.389 . . . . 0.0 110.653 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 m -81.67 154.64 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.625 1.102 . . . . 0.0 112.698 170.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -96.08 -174.81 3.2 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.648 1.579 . . . . 0.0 113.221 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -62.77 -13.35 32.04 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -98.55 -5.41 32.12 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.4 1.48 . . . . 0.0 112.361 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.19 26.28 44.78 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.728 1.156 . . . . 0.0 114.588 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -109.82 122.82 48.4 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.135 1.468 . . . . 0.0 110.165 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 mt -67.69 103.12 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.979 0.912 . . . . 0.0 109.41 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -100.86 179.08 4.5 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.737 1.615 . . . . 0.0 111.031 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 p -126.84 143.1 51.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.192 0.997 . . . . 0.0 112.957 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -144.96 144.25 23.33 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 125.004 1.322 . . . . 0.0 112.442 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.51 149.21 43.87 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.098 2.532 . . . . 0.0 112.11 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.34 137.91 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.873 0.869 . . . . 0.0 110.745 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.64 -34.74 12.48 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -167.43 178.6 5.39 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.972 1.709 . . . . 0.0 112.308 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.2 m-90 -132.69 137.28 46.88 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.214 1.405 . . . . 0.0 110.217 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -127.59 114.78 17.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.685 1.194 . . . . 0.0 111.313 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.29 108.19 19.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.424 1.49 . . . . 0.0 109.877 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -78.49 -29.36 46.68 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.304 1.042 . . . . 0.0 112.752 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.31 -45.85 2.22 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.268 1.413 . . . . 0.0 114.026 171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 177.21 102.75 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.436 1.495 . . . . 0.0 112.183 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -132.22 166.66 21.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.747 1.219 . . . . 0.0 112.373 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.86 100.09 0.91 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.401 1.48 . . . . 0.0 113.851 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.86 141.7 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.346 1.458 . . . . 0.0 111.617 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -123.4 140.2 53.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.176 1.791 . . . . 0.0 110.217 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.11 130.05 44.79 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.979 0.912 . . . . 0.0 109.959 172.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -128.15 97.04 4.64 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.381 1.072 . . . . 0.0 108.232 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 45.9 t -111.34 142.16 43.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.166 0.987 . . . . 0.0 110.355 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -104.04 162.26 13.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.772 1.229 . . . . 0.0 112.117 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.85 -20.57 65.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.444 1.098 . . . . 0.0 113.723 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -76.11 -28.25 57.43 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.601 1.161 . . . . 0.0 113.031 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.91 -0.25 19.67 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.737 1.161 . . . . 0.0 114.547 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 m -58.27 146.86 32.65 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.319 1.06 . . . . 0.0 111.173 171.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.0 124.93 27.1 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.486 1.114 . . . . 0.0 110.435 -171.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.2 mt -137.61 150.51 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.942 2.097 . . . . 0.0 108.091 -170.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -136.62 110.91 8.43 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.57 1.148 . . . . 0.0 110.062 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.24 160.57 40.75 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.333 1.453 . . . . 0.0 111.518 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 p -75.31 151.0 38.33 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.385 -0.822 . . . . 0.0 111.782 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -63.19 -19.14 64.24 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.35 -15.18 56.09 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.772 1.629 . . . . 0.0 112.679 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -79.58 132.95 36.42 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.736 0.814 . . . . 0.0 110.038 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -93.79 146.68 23.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.592 1.157 . . . . 0.0 112.385 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.526 ' HB3' HD11 ' A' ' 94' ' ' LEU . 65.6 m-85 -128.74 151.84 49.1 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.845 -1.159 . . . . 0.0 111.483 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.3 ttp -92.78 100.48 12.95 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.447 0.699 . . . . 0.0 110.563 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.7 p -69.33 172.6 6.82 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.583 0.753 . . . . 0.0 112.342 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 m -52.56 -29.55 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -86.94 -10.04 54.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.082 0.953 . . . . 0.0 113.342 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.96 10.89 62.21 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.793 1.187 . . . . 0.0 114.135 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -67.61 158.72 31.45 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.235 1.018 . . . . 0.0 111.024 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 37.0 mtm -126.21 70.99 1.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.783 1.633 . . . . 0.0 109.848 -173.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 mt -111.81 149.28 40.57 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 124.895 1.278 . . . . 0.0 110.599 -170.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.41 149.37 88.13 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.646 2.231 . . . . 0.0 110.379 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.51 -28.57 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -55.19 -35.22 64.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.678 1.191 . . . . 0.0 113.007 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.49 -37.9 59.88 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.283 1.033 . . . . 0.0 111.471 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.542 HG23 ' HB2' ' A' ' 92' ' ' LEU . 68.7 mt -68.24 -38.51 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.603 1.161 . . . . 0.0 109.945 -176.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.96 -37.15 86.34 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -75.09 -46.72 32.74 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -79.43 -5.4 54.61 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 56.48 35.48 26.05 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.626 1.57 . . . . 0.0 112.531 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.542 ' HB2' HG23 ' A' ' 87' ' ' ILE . 66.0 mt -65.99 132.18 47.97 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.524 1.13 . . . . 0.0 110.825 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -75.31 136.85 40.85 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.838 -0.539 . . . . 0.0 110.328 171.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 74' ' ' PHE . 3.0 mm? -69.96 152.64 44.22 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.289 -0.882 . . . . 0.0 111.35 168.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.9 ttm -71.06 150.82 45.17 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.378 168.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.81 161.53 25.07 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.61 1.564 . . . . 0.0 112.598 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -113.6 -13.57 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.941 1.696 . . . . 0.0 114.133 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -109.48 11.55 24.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.046 1.338 . . . . 0.0 112.866 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.9 m120 64.2 25.89 13.7 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.537 1.535 . . . . 0.0 112.672 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.5 mt -55.67 157.12 7.96 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.671 1.588 . . . . 0.0 111.999 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.76 141.53 79.19 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.695 2.264 . . . . 0.0 110.397 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -66.04 128.64 36.87 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.792 -0.568 . . . . 0.0 110.712 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.4 pt -147.16 149.91 15.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 126.538 1.935 . . . . 0.0 109.897 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 -179.95 3.92 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.309 1.444 . . . . 0.0 111.333 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 25.1 mt -63.56 105.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.251 1.02 . . . . 0.0 110.028 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.45 77.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.156 1.382 . . . . 0.0 111.576 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 p -149.44 149.18 30.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.852 1.661 . . . . 0.0 111.076 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -143.43 144.0 31.85 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.908 1.683 . . . . 0.0 110.36 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -159.37 148.71 18.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.423 1.889 . . . . 0.0 110.042 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -65.11 128.39 35.59 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.546 0.612 . . . . 0.0 110.995 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.7 mt -93.53 -46.18 7.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.085 0.554 . . . . 0.0 111.748 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 147.73 -151.24 23.51 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.415 1.007 . . . . 0.0 112.544 -172.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -123.28 86.1 2.52 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 122.689 1.233 . . . . 0.0 112.135 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -102.01 154.56 18.86 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.248 1.419 . . . . 0.0 110.075 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.68 116.61 4.52 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.164 0.586 . . . . 0.0 109.964 169.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.06 151.66 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.541 0.686 . . . . 0.0 110.942 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -141.11 157.38 45.36 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.814 1.645 . . . . 0.0 111.412 -168.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -156.32 146.02 20.98 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.522 0.729 . . . . 0.0 109.872 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.7 pt -100.15 143.68 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.777 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -93.96 151.77 20.42 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.45 0.548 . . . . 0.0 111.772 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.475 0.802 0 C-N-CA 125.758 1.623 . . . . 0.0 108.869 -176.593 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -161.62 156.97 23.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.641 1.576 . . . . 0.0 112.254 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.35 147.08 26.2 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.716 1.206 . . . . 0.0 112.962 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.05 168.86 9.57 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.671 1.588 . . . . 0.0 112.076 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -48.83 -51.02 31.77 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.126 1.37 . . . . 0.0 114.025 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -73.42 -20.47 60.72 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -172.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 127.14 -4.27 7.31 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.791 1.186 . . . . 0.0 114.91 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.31 171.87 11.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.081 1.44 . . . . 0.0 112.279 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.84 138.61 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.247 1.019 . . . . 0.0 109.999 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.5 149.1 50.28 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.306 1.842 . . . . 0.0 109.351 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.0 t -134.96 123.21 23.01 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -171.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.485 2.314 . . . . 0.0 114.074 178.849 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.181 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.99 175.94 10.64 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.22 1.008 . . . . 0.0 113.166 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -108.92 150.02 28.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.87 1.668 . . . . 0.0 111.071 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -65.81 161.76 20.27 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.405 0.682 . . . . 0.0 112.149 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -52.23 -44.15 64.66 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.823 0.849 . . . . 0.0 112.481 172.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.35 -23.75 64.51 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.791 1.636 . . . . 0.0 113.84 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -63.23 112.92 2.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.176 0.991 . . . . 0.0 111.341 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -96.55 135.3 38.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.42 0.688 . . . . 0.0 111.048 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.6 mm -118.43 122.81 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.653 1.581 . . . . 0.0 107.954 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -64.93 124.38 21.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.279 0.231 . . . . 0.0 111.289 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.2 p -121.83 153.65 38.07 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.632 1.173 . . . . 0.0 112.146 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.9 -30.41 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 121.877 -0.514 . . . . 0.0 111.8 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -65.62 -36.42 83.66 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -140.46 -49.45 0.45 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.32 -146.52 18.5 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.966 0.794 . . . . 0.0 112.51 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.3 mt -66.78 96.31 0.4 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.665 1.586 . . . . 0.0 112.639 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.66 147.8 62.21 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.887 1.275 . . . . 0.0 111.92 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.45 129.14 21.81 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 124.289 3.326 . . . . 0.0 112.794 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.5 tt -56.78 -37.25 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.004 0.921 . . . . 0.0 113.035 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.29 -31.35 78.77 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.662 -0.649 . . . . 0.0 113.291 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -76.23 -30.98 58.13 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.952 0.876 . . . . 0.0 111.817 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.58 -40.51 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.244 1.018 . . . . 0.0 109.642 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.71 -39.83 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.521 0.728 . . . . 0.0 112.951 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.1 -21.81 56.26 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.389 0.995 . . . . 0.0 113.513 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -109.51 1.87 20.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.778 1.231 . . . . 0.0 112.299 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.98 51.26 13.04 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.975 2.11 . . . . 0.0 112.663 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.5 mt -71.59 120.82 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.213 0.605 . . . . 0.0 109.48 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.04 105.6 6.14 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.222 1.009 . . . . 0.0 110.665 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.5 p -144.53 164.73 30.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.457 1.122 . . . . 0.0 113.44 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.5 145.67 26.55 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.315 1.446 . . . . 0.0 109.849 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.22 176.05 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.958 1.703 . . . . 0.0 111.098 -176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -118.24 142.95 46.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.769 1.628 . . . . 0.0 110.537 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.9 t -155.58 152.99 29.45 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.226 1.41 . . . . 0.0 110.419 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -94.27 125.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.456 0.702 . . . . 0.0 109.472 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -70.81 176.45 4.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.392 1.091 . . . . 0.0 112.445 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -60.21 -27.33 67.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.887 1.275 . . . . 0.0 113.066 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -86.2 -2.17 58.12 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.684 1.594 . . . . 0.0 113.498 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.23 19.05 78.85 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.582 1.086 . . . . 0.0 114.592 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -93.97 129.68 40.36 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.023 1.329 . . . . 0.0 109.485 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.2 mt -74.65 134.71 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -138.67 167.91 20.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.626 1.57 . . . . 0.0 111.683 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 p -115.94 144.95 43.35 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.473 1.109 . . . . 0.0 112.187 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -153.26 148.48 20.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.16 0.984 . . . . 0.0 112.767 -176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.62 150.21 45.03 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.963 2.442 . . . . 0.0 112.562 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -58.77 140.33 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.922 0.889 . . . . 0.0 110.568 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.48 -31.07 11.07 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.006 0.922 . . . . 0.0 112.64 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -167.71 175.14 7.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.946 1.698 . . . . 0.0 112.17 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -134.26 124.19 25.5 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.938 1.295 . . . . 0.0 109.303 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -113.77 129.13 56.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.993 0.917 . . . . 0.0 110.839 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -120.24 103.83 9.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.53 1.532 . . . . 0.0 110.043 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -72.77 -29.86 63.64 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.709 1.204 . . . . 0.0 112.967 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.16 -52.74 2.84 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.262 1.411 . . . . 0.0 113.62 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -170.76 105.54 0.26 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.967 1.307 . . . . 0.0 110.269 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -132.66 168.13 18.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.987 0.915 . . . . 0.0 112.349 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -68.82 100.84 1.23 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.854 1.261 . . . . 0.0 113.342 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.9 t -94.36 138.03 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.926 1.29 . . . . 0.0 111.557 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.505 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 53.2 m-85 -120.14 144.41 47.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 110.206 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.36 134.09 55.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.598 0.759 . . . . 0.0 110.652 171.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -127.03 83.34 2.16 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.425 1.49 . . . . 0.0 108.384 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.8 t -98.06 147.77 24.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.001 0.92 . . . . 0.0 110.899 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.09 158.36 23.31 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.199 1.4 . . . . 0.0 112.34 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -69.17 -18.34 63.91 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -77.25 -28.34 53.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.13 0.972 . . . . 0.0 112.786 172.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.62 -9.76 8.63 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.36 1.457 . . . . 0.0 114.253 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.2 m -59.54 150.78 26.07 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.46 1.13 . . . . 0.0 112.153 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.1 tp -137.91 125.6 22.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.162 0.985 . . . . 0.0 110.855 -173.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.6 mt -133.93 148.77 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.367 1.867 . . . . 0.0 107.941 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -131.6 121.41 24.33 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.935 1.294 . . . . 0.0 110.505 174.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.34 163.92 36.35 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.386 1.474 . . . . 0.0 111.197 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -75.37 154.04 37.45 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.434 -0.791 . . . . 0.0 111.973 173.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.505 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 4.8 mtmt -62.93 -20.4 65.17 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -87.47 -9.96 53.17 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.235 1.814 . . . . 0.0 113.054 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -77.68 134.42 38.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.75 0.82 . . . . 0.0 109.755 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -98.02 150.1 21.75 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.289 1.042 . . . . 0.0 111.889 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -136.3 132.57 35.89 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.018 -1.052 . . . . 0.0 109.766 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.1 ttp -72.24 108.87 5.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.206 0.527 . . . . 0.0 110.998 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -68.73 172.12 6.83 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.377 0.671 . . . . 0.0 112.172 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -55.91 -22.75 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -87.1 -6.14 58.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.414 1.085 . . . . 0.0 113.314 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.57 9.23 72.49 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.759 1.171 . . . . 0.0 113.966 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -81.13 130.16 34.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.258 1.029 . . . . 0.0 110.886 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.28 87.31 7.37 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.933 1.293 . . . . 0.0 110.793 169.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.1 mt -112.59 145.4 32.87 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.007 0.923 . . . . 0.0 110.238 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.72 147.06 85.44 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.674 2.25 . . . . 0.0 110.875 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -58.39 -26.84 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -53.79 -37.39 63.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.61 1.164 . . . . 0.0 113.19 169.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -80.43 -39.24 28.61 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.73 0.812 . . . . 0.0 110.669 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.46 -38.85 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.682 0.793 . . . . 0.0 111.103 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -64.78 -38.57 91.45 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -75.86 -38.64 57.73 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.482 -0.761 . . . . 0.0 112.682 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -75.47 -13.36 60.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 57.87 31.53 20.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.522 1.529 . . . . 0.0 111.982 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.8 mt -84.54 157.36 21.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.617 1.199 . . . . 0.0 112.201 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -113.54 156.6 23.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.011 2.124 . . . . 0.0 112.923 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.6 mt -88.21 149.75 23.68 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.552 0.741 . . . . 0.0 112.361 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.3 ttp -72.82 153.67 40.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.455 0.702 . . . . 0.0 111.222 170.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.39 167.3 15.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.412 1.485 . . . . 0.0 112.174 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.27 -12.52 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.981 1.313 . . . . 0.0 114.151 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.08 8.77 36.54 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.069 1.348 . . . . 0.0 113.073 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 52.41 35.39 17.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.987 1.715 . . . . 0.0 113.42 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.75 156.97 86.32 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.064 170.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.66 129.73 27.36 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.213 2.609 . . . . 0.0 111.134 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.19 134.44 44.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.727 0.811 . . . . 0.0 109.748 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.7 pt -143.17 130.75 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.371 1.468 . . . . 0.0 111.044 -169.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.5 171.57 12.42 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.487 1.115 . . . . 0.0 112.351 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.9 mt -63.97 112.52 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.319 1.448 . . . . 0.0 110.111 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.29 -35.81 35.3 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.707 0.803 . . . . 0.0 112.327 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.4 p -146.68 149.88 34.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.106 1.762 . . . . 0.0 110.676 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.07 143.03 32.89 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.795 1.638 . . . . 0.0 110.082 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -160.92 140.53 10.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.827 1.651 . . . . 0.0 110.256 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -65.35 121.98 16.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.842 0.457 . . . . 0.0 110.89 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.3 mt -90.95 -44.57 9.27 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.039 0.536 . . . . 0.0 111.891 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 150.73 -142.46 9.6 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.515 0.579 . . . . 0.0 113.324 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -130.67 86.27 2.36 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.82 1.248 . . . . 0.0 111.754 -168.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -104.43 157.26 17.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.909 1.284 . . . . 0.0 111.047 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 117.66 6.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.386 0.674 . . . . 0.0 110.364 169.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.3 m -124.14 151.7 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.372 0.606 . . . . 0.0 111.088 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -141.02 157.75 44.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.559 1.544 . . . . 0.0 111.74 -168.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -157.01 128.31 6.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.194 0.998 . . . . 0.0 110.799 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.5 pt -80.66 147.45 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.3 -0.875 . . . . 0.0 110.863 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.21 156.04 18.55 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.434 1.016 . . . . 0.0 111.731 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 124.662 1.185 . . . . 0.0 110.261 -169.223 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -166.51 158.43 13.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.711 1.205 . . . . 0.0 112.611 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.4 134.59 35.58 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.31 1.044 . . . . 0.0 112.339 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 38.1 mt -86.57 166.24 15.58 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.732 1.213 . . . . 0.0 111.516 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -52.74 -32.8 45.14 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -88.1 -6.53 57.86 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.505 1.122 . . . . 0.0 113.239 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.88 -11.65 34.78 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.427 1.013 . . . . 0.0 114.973 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -73.13 167.42 21.18 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.36 1.58 . . . . 0.0 112.842 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.69 120.66 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.931 0.893 . . . . 0.0 110.202 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.66 141.15 30.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.442 1.897 . . . . 0.0 109.801 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.7 m -139.16 137.12 35.8 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.472 1.109 . . . . 0.0 113.175 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 125.189 1.396 . . . . 0.0 113.86 -177.835 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.185 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -156.12 174.8 14.84 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.572 0.701 . . . . 0.0 112.826 -168.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.8 mt -120.89 147.0 46.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.928 1.691 . . . . 0.0 109.964 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 t -66.75 161.17 24.19 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -50.93 -44.64 60.28 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.557 0.743 . . . . 0.0 111.993 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -15.93 41.23 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.5 m -73.54 98.72 2.86 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.595 0.758 . . . . 0.0 110.14 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.15 133.14 42.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.455 0.645 . . . . 0.0 110.746 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.87 126.74 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 125.466 1.507 . . . . 0.0 107.216 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.3 122.56 18.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 170.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.7 p -123.71 150.98 43.66 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.76 1.224 . . . . 0.0 111.966 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.4 t -77.68 -33.59 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.9 -0.5 . . . . 0.0 112.005 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -66.16 -27.63 68.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -144.57 -52.84 0.31 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.37 -150.07 21.1 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.817 0.722 . . . . 0.0 112.217 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.85 108.26 2.93 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.333 1.453 . . . . 0.0 110.939 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.0 mt -134.99 148.89 68.74 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.475 1.11 . . . . 0.0 113.041 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.66 126.56 16.99 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.967 3.111 . . . . 0.0 112.024 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 tt -54.92 -36.48 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.18 -36.0 92.68 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.805 -0.56 . . . . 0.0 112.992 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -68.76 -37.65 79.53 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.558 1.179 . . . . 0.0 111.433 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.46 -38.41 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.761 0.824 . . . . 0.0 109.767 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.53 -39.49 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.158 0.983 . . . . 0.0 113.259 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.28 -27.5 66.37 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.496 1.044 . . . . 0.0 112.667 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -112.71 0.72 15.4 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.719 1.208 . . . . 0.0 112.773 -176.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.95 52.31 11.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.87 2.468 . . . . 0.0 112.418 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.6 mt -72.98 123.78 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.082 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.8 102.41 2.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.893 0.877 . . . . 0.0 110.287 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.5 p -132.25 -178.13 4.77 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.994 1.318 . . . . 0.0 112.496 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.94 147.27 51.05 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.439 1.496 . . . . 0.0 108.227 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.91 158.65 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.657 1.183 . . . . 0.0 111.203 -173.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -96.2 138.19 34.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.38 1.072 . . . . 0.0 110.4 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 t -155.57 153.77 30.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.898 1.279 . . . . 0.0 110.527 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.88 125.47 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.078 0.551 . . . . 0.0 110.316 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -68.42 175.29 3.45 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.835 1.254 . . . . 0.0 112.267 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.71 -25.87 68.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.844 1.258 . . . . 0.0 113.155 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -85.56 -4.76 59.26 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.366 1.466 . . . . 0.0 113.555 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.9 19.02 62.1 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.738 1.161 . . . . 0.0 114.758 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -94.95 128.88 42.08 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.627 1.171 . . . . 0.0 110.259 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.1 mt -74.12 123.52 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -135.11 174.15 10.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.828 2.051 . . . . 0.0 111.504 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -116.93 139.19 50.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.185 0.994 . . . . 0.0 111.905 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -141.22 141.0 21.99 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.545 1.138 . . . . 0.0 111.863 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.14 152.24 39.89 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.885 2.39 . . . . 0.0 112.027 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.66 138.45 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.787 0.835 . . . . 0.0 111.037 169.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.13 -51.95 4.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.544 0.738 . . . . 0.0 111.142 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -144.62 -178.6 6.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.87 1.668 . . . . 0.0 111.034 -173.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -138.98 126.81 22.15 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.399 1.08 . . . . 0.0 109.313 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -122.16 134.72 54.73 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.105 0.955 . . . . 0.0 110.795 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -127.52 122.25 32.84 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.208 1.403 . . . . 0.0 109.996 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -88.96 -34.19 16.96 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.177 0.991 . . . . 0.0 112.326 -173.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.45 -42.55 2.32 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.114 1.34 . . . . 0.0 114.889 172.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -178.69 88.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.066 1.412 . . . . 0.0 114.629 -168.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -125.18 158.98 32.62 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.979 1.311 . . . . 0.0 112.291 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.57 106.76 1.22 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.021 1.328 . . . . 0.0 112.695 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 t -98.59 139.44 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.346 1.458 . . . . 0.0 110.586 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -124.48 140.66 52.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.986 1.315 . . . . 0.0 109.513 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.84 135.1 35.88 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.177 0.991 . . . . 0.0 108.987 169.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -122.07 98.53 5.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.61 1.564 . . . . 0.0 109.011 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.8 t -75.86 132.97 40.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.138 0.575 . . . . 0.0 109.982 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mp -93.28 162.48 13.99 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.614 0.721 . . . . 0.0 112.783 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.81 -22.44 66.56 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.03 -21.27 51.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.954 0.902 . . . . 0.0 112.926 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.04 -1.32 25.59 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.441 1.495 . . . . 0.0 114.531 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.8 p -72.71 171.32 12.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.488 1.144 . . . . 0.0 113.017 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.5 mt -132.6 145.6 51.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.192 1.397 . . . . 0.0 110.983 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.6 mt -137.68 139.64 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.471 1.908 . . . . 0.0 107.323 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.464 HH21 HD22 ' A' ' 111' ' ' LEU . 42.3 mtp180 -131.26 98.18 4.48 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.608 1.163 . . . . 0.0 110.429 -174.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.73 166.29 27.06 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.282 1.039 . . . . 0.0 113.724 -172.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 p -82.43 155.46 24.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.723 1.209 . . . . 0.0 111.535 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -61.55 -23.95 66.31 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -86.74 -11.29 51.52 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.37 1.068 . . . . 0.0 112.605 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -80.02 132.04 35.92 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -87.4 162.72 17.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.509 0.671 . . . . 0.0 111.098 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -138.19 141.23 40.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 43.1 ttm -69.54 107.39 3.36 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -66.89 166.47 13.37 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.204 0.526 . . . . 0.0 111.122 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 m -57.64 -24.33 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.07 -14.39 59.51 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.487 1.115 . . . . 0.0 113.478 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.46 10.9 61.5 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.095 1.331 . . . . 0.0 114.383 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -82.96 164.08 20.63 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.426 1.113 . . . . 0.0 111.522 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.36 81.94 1.86 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.985 1.314 . . . . 0.0 111.33 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.6 mt -113.22 148.41 39.46 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.526 1.131 . . . . 0.0 110.787 -172.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.04 146.03 81.08 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.97 2.447 . . . . 0.0 111.246 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' A' ' 87' ' ' ILE . 6.6 tt -58.43 -26.03 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.55 -35.09 67.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.389 1.076 . . . . 0.0 113.023 170.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -39.03 27.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.531 1.132 . . . . 0.0 111.102 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.525 HD13 HD21 ' A' ' 94' ' ' LEU . 78.6 mt -64.47 -39.45 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.397 1.079 . . . . 0.0 110.919 -175.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -63.73 -34.44 77.87 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -77.14 -48.19 18.35 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.944 0.793 . . . . 0.0 113.055 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -74.55 -12.35 60.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 57.9 35.52 25.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.663 1.585 . . . . 0.0 112.476 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.8 mt -76.74 146.92 37.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.159 0.983 . . . . 0.0 111.834 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.63 164.76 20.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.665 0.786 . . . . 0.0 112.043 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.525 HD21 HD13 ' A' ' 87' ' ' ILE . 84.6 mt -111.05 147.14 35.43 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.5 1.12 . . . . 0.0 111.682 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 31.7 ttm -74.79 141.92 44.3 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.723 -0.611 . . . . 0.0 110.664 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.12 173.19 9.4 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.515 1.126 . . . . 0.0 113.06 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.61 -19.63 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 126.17 1.788 . . . . 0.0 113.8 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.8 4.23 30.05 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.94 1.296 . . . . 0.0 113.916 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.77 31.96 21.22 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.506 1.522 . . . . 0.0 112.859 -175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.9 mt -70.92 158.79 87.33 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.913 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.24 149.83 85.12 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.154 2.569 . . . . 0.0 111.396 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -70.4 123.59 22.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.4 0.68 . . . . 0.0 110.401 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.21 137.92 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.218 1.407 . . . . 0.0 111.386 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.23 176.35 5.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.834 1.654 . . . . 0.0 111.379 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mt -69.71 103.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.511 1.524 . . . . 0.0 110.007 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.93 -42.59 80.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.966 1.306 . . . . 0.0 111.633 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -152.48 162.98 40.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.642 1.977 . . . . 0.0 111.113 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -127.47 144.82 51.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.902 1.681 . . . . 0.0 110.793 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -145.83 116.58 7.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.512 1.125 . . . . 0.0 110.527 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -63.16 127.44 31.26 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.575 -0.703 . . . . 0.0 111.16 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.464 HD22 HH21 ' A' ' 67' ' ' ARG . 68.9 mt -94.74 -42.99 8.45 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.831 0.452 . . . . 0.0 112.094 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 140.64 -147.99 19.64 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.712 1.148 . . . . 0.0 112.588 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -120.8 71.27 0.92 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.476 1.51 . . . . 0.0 112.362 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -90.8 157.34 17.44 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.688 1.595 . . . . 0.0 111.216 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.18 118.92 9.93 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.95 0.9 . . . . 0.0 110.35 170.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.1 150.27 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.42 0.688 . . . . 0.0 111.448 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -137.11 157.96 45.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.051 1.74 . . . . 0.0 111.994 -169.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -158.1 119.1 3.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.713 1.205 . . . . 0.0 110.607 -174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 pt -72.68 148.19 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 O-C-N 120.754 -1.216 . . . . 0.0 111.927 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.49 151.47 19.34 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.488 1.042 . . . . 0.0 111.868 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 125.426 1.49 . . . . 0.0 109.416 -171.796 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 CA--C 1.546 0.827 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -160.49 153.4 21.36 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.015 1.326 . . . . 0.0 112.912 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.62 140.68 37.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.496 1.118 . . . . 0.0 113.227 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 74.4 mt -92.62 178.59 5.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.198 1.799 . . . . 0.0 112.528 173.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -46.8 -59.33 3.13 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.734 2.013 . . . . 0.0 115.121 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.94 -22.21 61.49 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.508 0.723 . . . . 0.0 112.163 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.34 -5.73 8.73 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.123 1.344 . . . . 0.0 114.359 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -61.02 136.15 58.0 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.933 1.867 . . . . 0.0 110.743 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.07 118.3 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.6 153.46 17.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.064 1.346 . . . . 0.0 109.256 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.2 p -136.66 147.36 46.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.434 1.094 . . . . 0.0 112.768 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.9 p30 . . . . . 0 C--O 1.252 1.234 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -167.678 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.182 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -171.04 173.8 4.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.738 1.615 . . . . 0.0 112.588 -172.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.9 mt -118.92 149.83 40.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.381 2.273 . . . . 0.0 110.966 -172.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -73.22 160.41 31.97 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.264 -0.897 . . . . 0.0 111.802 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -50.07 -48.18 53.18 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.358 1.063 . . . . 0.0 112.666 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -66.37 -1.14 3.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.913 2.085 . . . . 0.0 114.944 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.2 m -74.27 104.66 5.12 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.081 0.952 . . . . 0.0 110.264 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.09 129.21 34.84 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.514 0.674 . . . . 0.0 111.614 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.6 mm -111.64 121.09 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 126.093 1.757 . . . . 0.0 107.227 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.39 129.81 42.36 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.378 0.671 . . . . 0.0 111.239 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -129.96 152.06 49.83 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.032 1.333 . . . . 0.0 111.781 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.3 t -74.65 -31.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 121.703 -0.623 . . . . 0.0 112.119 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -65.76 -33.99 77.14 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -141.68 -50.53 0.41 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.88 -137.68 9.22 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 118.816 0.735 . . . . 0.0 112.366 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.0 mt -81.29 96.69 7.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.004 1.722 . . . . 0.0 111.619 -175.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -127.36 147.41 62.01 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.794 1.238 . . . . 0.0 112.341 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.38 130.87 23.37 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.14 3.227 . . . . 0.0 112.675 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 tt -55.21 -36.15 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.9 0.88 . . . . 0.0 113.124 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.7 -34.4 83.26 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.671 -0.643 . . . . 0.0 113.177 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -72.69 -31.54 65.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.339 1.07 . . . . 0.0 111.728 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.1 mt -69.2 -38.07 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.827 0.851 . . . . 0.0 109.896 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.9 t -82.18 -38.07 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.22 1.008 . . . . 0.0 113.07 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.13 -23.68 63.06 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.302 -0.874 . . . . 0.0 112.974 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.31 4.88 11.85 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.074 1.35 . . . . 0.0 112.508 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 45.03 51.72 8.67 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.062 2.545 . . . . 0.0 112.692 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 53.8 mt -72.29 120.15 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.984 0.914 . . . . 0.0 109.134 -171.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.99 99.68 3.93 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.352 1.061 . . . . 0.0 110.587 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.4 p -141.15 162.22 36.02 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.588 1.185 . . . . 0.0 114.128 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.76 154.4 19.56 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.655 1.582 . . . . 0.0 110.505 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.65 173.94 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.734 1.614 . . . . 0.0 110.982 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -119.31 140.61 50.03 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.992 1.717 . . . . 0.0 109.929 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.2 t -159.77 165.96 31.38 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.946 1.298 . . . . 0.0 110.568 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.94 127.52 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.842 1.257 . . . . 0.0 111.366 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.13 177.88 7.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.562 1.145 . . . . 0.0 112.238 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -61.21 -23.01 65.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.274 1.43 . . . . 0.0 113.361 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -89.48 -3.04 58.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.203 1.401 . . . . 0.0 113.548 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.69 89.15 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.419 1.009 . . . . 0.0 114.608 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -81.41 134.93 35.62 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.291 1.046 . . . . 0.0 109.587 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.7 mt -72.22 122.17 24.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -121.41 169.12 10.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.913 1.685 . . . . 0.0 110.433 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.8 p -126.67 144.0 51.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.383 0.673 . . . . 0.0 112.02 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -150.48 147.68 22.12 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.468 1.107 . . . . 0.0 112.041 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.82 148.61 36.39 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.16 2.573 . . . . 0.0 112.738 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.31 145.64 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.408 1.083 . . . . 0.0 111.133 168.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.08 -32.26 7.3 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.892 1.277 . . . . 0.0 112.847 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -164.85 174.13 10.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.569 1.547 . . . . 0.0 112.36 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -137.49 110.68 7.83 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.061 1.345 . . . . 0.0 110.05 -174.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -98.62 115.23 28.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.834 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -102.1 107.0 17.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.91 1.284 . . . . 0.0 108.947 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -78.82 -24.5 44.46 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.355 1.062 . . . . 0.0 112.991 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.57 -44.18 3.31 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.287 1.422 . . . . 0.0 114.786 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 176.83 98.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.883 1.273 . . . . 0.0 113.143 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -129.79 167.42 18.12 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.226 1.411 . . . . 0.0 112.761 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.85 101.07 0.45 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.41 1.484 . . . . 0.0 114.041 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.1 t -92.03 143.33 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.147 1.379 . . . . 0.0 112.191 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -127.1 141.74 51.69 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.014 2.126 . . . . 0.0 110.129 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.15 132.89 51.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.351 0.66 . . . . 0.0 110.948 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.9 75.36 1.49 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.739 1.257 . . . . 0.0 108.779 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.6 t -82.22 146.92 29.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.223 1.009 . . . . 0.0 111.132 173.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.09 163.5 15.09 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.693 1.197 . . . . 0.0 112.825 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.02 -24.29 66.73 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.055 1.342 . . . . 0.0 113.051 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.03 -29.64 31.86 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.763 1.225 . . . . 0.0 113.169 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.83 -0.73 10.01 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.516 1.055 . . . . 0.0 114.69 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 m -63.13 139.94 58.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.803 1.301 . . . . 0.0 110.97 170.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.77 132.99 53.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.208 1.403 . . . . 0.0 109.856 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.1 mt -136.8 152.89 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.758 2.023 . . . . 0.0 107.658 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -138.65 115.96 11.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.707 1.203 . . . . 0.0 110.579 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.55 172.32 14.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.172 1.389 . . . . 0.0 112.35 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 p -93.09 151.9 19.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.993 1.317 . . . . 0.0 111.522 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -62.84 -16.56 58.94 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -88.01 -17.15 31.83 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.449 1.099 . . . . 0.0 112.463 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.43 ' HE1' ' HB1' ' A' ' 135' ' ' ALA . 27.8 t-80 -78.21 137.46 38.15 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -95.02 160.35 14.61 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.217 1.007 . . . . 0.0 110.268 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -142.46 133.76 26.24 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.559 -0.713 . . . . 0.0 109.666 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.5 ttm -77.66 111.22 13.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.98 0.895 . . . . 0.0 111.359 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.1 p -65.31 167.45 8.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.788 1.235 . . . . 0.0 112.828 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.6 m -52.91 -28.77 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -83.79 -11.7 56.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.052 0.941 . . . . 0.0 113.461 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.64 -0.41 61.19 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.381 0.991 . . . . 0.0 114.082 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -76.4 137.67 39.9 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 119.2 1.5 . . . . 0.0 109.745 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.8 ptp -106.63 98.42 8.09 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.715 1.606 . . . . 0.0 108.776 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.63 152.79 59.11 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.084 1.353 . . . . 0.0 109.324 -174.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.53 147.1 86.35 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.266 1.977 . . . . 0.0 110.949 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.4 tt -59.46 -23.33 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -54.49 -35.97 63.66 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.015 1.326 . . . . 0.0 112.632 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -84.48 -39.81 18.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 111.499 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.8 mt -59.88 -36.17 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 119.129 0.877 . . . . 0.0 111.425 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -69.22 -33.41 73.26 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -78.6 -39.23 37.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.438 -0.789 . . . . 0.0 112.399 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -74.51 -14.78 60.86 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.834 0.854 . . . . 0.0 113.178 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 55.35 37.57 29.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.487 1.515 . . . . 0.0 111.905 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.9 mt -92.02 159.5 15.68 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.709 1.242 . . . . 0.0 112.34 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -114.34 154.44 28.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.033 2.133 . . . . 0.0 113.198 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.89 154.06 22.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.773 1.229 . . . . 0.0 112.726 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -70.26 148.7 48.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.758 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -114.1 155.75 25.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.646 1.579 . . . . 0.0 110.894 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.2 5.37 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 125.014 1.325 . . . . 0.0 114.413 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -121.34 20.45 11.27 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.886 1.674 . . . . 0.0 112.421 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.34 16.82 10.4 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 127.023 2.129 . . . . 0.0 113.647 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.1 mt -72.8 157.36 88.89 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.433 1.893 . . . . 0.0 112.54 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.92 166.33 29.89 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.205 3.27 . . . . 0.0 112.25 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -107.02 131.66 53.82 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.494 1.118 . . . . 0.0 110.556 -173.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.1 pt -146.97 135.55 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.443 1.497 . . . . 0.0 110.627 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 175.49 8.9 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.347 1.459 . . . . 0.0 112.127 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.8 mt -63.16 112.04 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.1 1.36 . . . . 0.0 110.206 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.31 -43.38 81.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.257 1.023 . . . . 0.0 111.957 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 p -150.12 147.64 28.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.247 1.819 . . . . 0.0 110.393 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -141.19 139.39 33.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.171 1.389 . . . . 0.0 110.812 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -158.29 150.59 21.96 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.181 1.393 . . . . 0.0 110.51 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -66.03 124.81 23.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.306 0.642 . . . . 0.0 110.891 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.6 mt -90.03 -43.06 10.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.217 0.607 . . . . 0.0 111.955 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 143.01 -149.39 21.3 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.434 1.016 . . . . 0.0 112.096 -173.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -124.11 96.42 4.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.387 1.075 . . . . 0.0 112.041 -169.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -114.36 155.34 26.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.482 1.513 . . . . 0.0 110.035 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.03 116.86 5.71 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.415 0.686 . . . . 0.0 110.326 173.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.41 152.45 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.64 0.776 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -137.95 156.21 48.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.828 1.651 . . . . 0.0 111.851 -168.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -154.09 116.39 4.33 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.67 1.188 . . . . 0.0 110.635 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.0 pt -77.94 142.99 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 120.963 -1.086 . . . . 0.0 111.354 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.75 158.02 17.94 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.392 0.996 . . . . 0.0 111.473 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.479 0.983 0 C-N-CA 124.586 1.154 . . . . 0.0 110.183 -169.226 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -166.16 165.14 17.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.383 1.073 . . . . 0.0 112.55 -171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.36 155.26 17.49 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.221 1.008 . . . . 0.0 113.442 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.6 mt -108.37 166.69 10.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.742 2.017 . . . . 0.0 111.568 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -43.2 -50.02 6.43 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.825 1.65 . . . . 0.0 115.296 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -84.67 4.13 33.89 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.192 0.997 . . . . 0.0 113.261 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.78 -4.85 53.52 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.445 1.498 . . . . 0.0 114.92 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -69.36 163.61 24.78 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.734 1.267 . . . . 0.0 111.664 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.1 mm -118.23 142.26 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.531 -0.731 . . . . 0.0 110.555 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.43 ' HB1' ' HE1' ' A' ' 72' ' ' HIS . . . -132.77 143.29 49.48 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.411 1.485 . . . . 0.0 110.385 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.7 t -139.86 144.72 37.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.048 1.739 . . . . 0.0 113.091 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--O 1.256 1.414 0 N-CA-C 117.268 2.321 . . . . 0.0 117.268 -169.63 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 CA-C-O 121.771 0.65 . . . . 0.0 114.368 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.48 173.02 14.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.15 1.38 . . . . 0.0 110.788 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -117.12 146.75 42.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.999 1.72 . . . . 0.0 109.769 -173.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -74.76 160.39 30.78 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.681 -0.637 . . . . 0.0 111.385 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -47.04 -49.55 21.1 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.475 1.51 . . . . 0.0 113.001 -169.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 pm0 -66.94 -1.85 4.54 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.24 2.216 . . . . 0.0 115.089 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.2 m -73.77 104.16 4.58 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.008 0.923 . . . . 0.0 110.013 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.65 129.34 34.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.56 0.695 . . . . 0.0 112.399 -173.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mm -106.33 123.81 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.364 1.465 . . . . 0.0 107.706 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.09 122.89 18.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.588 0.355 . . . . 0.0 110.266 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.1 p -124.2 150.35 45.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.765 1.226 . . . . 0.0 112.087 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.47 -33.43 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.191 0.596 . . . . 0.0 111.993 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -67.82 -30.7 70.18 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -141.28 -50.03 0.42 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.42 -148.99 19.7 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.598 1.094 . . . . 0.0 111.689 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.463 HD22 ' CB ' ' A' ' 130' ' ' LYS . 3.9 mt -61.7 111.96 2.06 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.281 1.433 . . . . 0.0 110.516 171.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 mt -139.96 149.09 57.6 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.365 1.066 . . . . 0.0 113.47 174.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.4 127.44 19.99 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.186 3.257 . . . . 0.0 112.394 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 tt -56.22 -36.36 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.0 -32.49 84.37 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.721 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -71.44 -38.04 71.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.383 1.091 . . . . 0.0 111.31 175.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -64.82 -38.24 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.395 0.678 . . . . 0.0 110.808 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.4 t -83.79 -37.96 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.08 0.952 . . . . 0.0 112.416 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -71.77 -24.56 61.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.088 0.858 . . . . 0.0 113.195 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -114.07 5.84 16.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.226 1.41 . . . . 0.0 113.037 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 48.21 48.92 18.26 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.331 2.252 . . . . 0.0 112.725 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.4 mt -77.73 118.08 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.006 0.923 . . . . 0.0 110.355 -169.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.68 112.17 7.57 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.323 1.049 . . . . 0.0 110.656 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.3 p -150.03 170.87 17.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.43 1.092 . . . . 0.0 112.995 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.4 m -116.86 143.29 45.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.412 1.485 . . . . 0.0 108.906 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.74 165.02 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.898 1.679 . . . . 0.0 110.959 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -102.51 143.75 31.83 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.227 1.411 . . . . 0.0 110.082 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -154.67 151.12 28.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.25 1.42 . . . . 0.0 109.892 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 t -92.91 124.82 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -69.07 173.96 5.01 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.581 1.181 . . . . 0.0 111.79 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -58.16 -27.79 64.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.453 1.901 . . . . 0.0 113.226 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -82.52 -10.06 59.16 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.247 1.419 . . . . 0.0 113.3 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.14 22.5 59.01 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.85 1.214 . . . . 0.0 114.483 -171.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -95.5 132.34 40.7 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.437 1.095 . . . . 0.0 109.85 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.5 mt -74.01 133.4 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.54 1.064 . . . . 0.0 108.899 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.69 174.95 10.01 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.016 1.726 . . . . 0.0 111.036 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.8 p -120.53 143.89 48.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.276 1.03 . . . . 0.0 112.361 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -147.03 142.82 17.42 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.73 1.212 . . . . 0.0 112.433 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -74.97 149.8 37.37 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.012 2.474 . . . . 0.0 112.258 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -59.38 135.89 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.375 0.67 . . . . 0.0 110.43 168.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.62 -47.01 7.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.594 0.758 . . . . 0.0 111.548 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -150.19 177.52 9.85 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.167 1.787 . . . . 0.0 111.397 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -134.23 137.83 44.65 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.139 1.776 . . . . 0.0 108.796 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -132.54 119.65 20.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.598 0.759 . . . . 0.0 111.218 -171.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -116.53 108.21 15.69 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.328 1.451 . . . . 0.0 110.736 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -80.73 -28.89 36.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.756 1.222 . . . . 0.0 113.331 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.41 -52.82 3.1 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.092 1.33 . . . . 0.0 114.219 173.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -171.85 104.91 0.19 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.056 1.428 . . . . 0.0 111.013 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -129.88 169.08 15.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.972 0.909 . . . . 0.0 112.052 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.31 105.42 2.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.23 1.012 . . . . 0.0 112.875 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.7 t -100.38 140.39 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.048 1.339 . . . . 0.0 111.492 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CG ' ' HE3' ' A' ' 70' ' ' LYS . 43.5 m-85 -123.91 146.19 48.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.929 1.292 . . . . 0.0 110.601 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -66.0 128.13 34.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.288 1.035 . . . . 0.0 110.485 173.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -121.87 81.72 1.86 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.592 1.557 . . . . 0.0 108.151 175.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.3 t -88.05 141.66 28.39 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.962 0.905 . . . . 0.0 110.614 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -105.2 165.64 10.96 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.268 1.027 . . . . 0.0 113.267 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -68.03 -20.7 65.02 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.68 -27.94 36.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.73 1.212 . . . . 0.0 112.96 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.76 -3.75 17.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.931 1.253 . . . . 0.0 114.389 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -60.61 148.16 39.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.719 1.26 . . . . 0.0 111.577 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.5 mt -133.15 128.26 35.69 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.365 1.466 . . . . 0.0 110.11 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.1 mt -135.24 149.56 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 126.681 1.992 . . . . 0.0 107.399 -175.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -137.1 112.27 9.1 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.216 1.006 . . . . 0.0 110.111 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.4 169.47 18.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.311 1.445 . . . . 0.0 111.815 -172.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.6 p -87.44 162.02 17.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.546 0.738 . . . . 0.0 112.837 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HE3' ' CG ' ' A' ' 56' ' ' PHE . 19.7 mmtp -72.99 -7.97 53.6 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -90.9 -8.96 47.93 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.784 0.72 . . . . 0.0 112.083 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.479 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 14.3 t-80 -82.56 132.89 35.19 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.785 -0.572 . . . . 0.0 110.091 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -95.19 152.02 18.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.995 0.918 . . . . 0.0 110.285 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -137.94 135.14 35.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.08 0.552 . . . . 0.0 110.626 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 44.7 ttp -73.6 103.98 4.39 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 111.201 -174.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.6 p -66.05 171.8 4.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.134 0.974 . . . . 0.0 112.155 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.26 -22.91 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -93.33 -6.82 46.47 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.214 1.006 . . . . 0.0 113.194 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.4 26.65 24.95 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.323 0.963 . . . . 0.0 113.944 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -88.04 142.05 28.08 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.456 1.128 . . . . 0.0 111.754 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.3 mmt -97.26 77.34 2.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.784 1.634 . . . . 0.0 110.971 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -116.01 148.09 40.64 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.852 0.861 . . . . 0.0 111.44 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.34 148.55 79.97 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.409 2.739 . . . . 0.0 111.771 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.83 -28.76 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -54.05 -30.76 49.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.641 1.177 . . . . 0.0 113.933 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -91.86 -31.14 15.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.44 0.696 . . . . 0.0 111.553 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.84 -38.82 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.042 0.837 . . . . 0.0 111.158 177.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -64.01 -38.1 89.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -78.66 -37.78 41.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.212 0.605 . . . . 0.0 112.553 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -82.41 -8.83 59.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.778 0.831 . . . . 0.0 112.952 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 57.14 35.55 26.41 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.482 1.513 . . . . 0.0 112.383 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.2 mt -85.53 124.01 31.61 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.011 0.91 . . . . 0.0 111.97 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.5 153.72 30.83 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.547 1.139 . . . . 0.0 112.407 169.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.86 150.61 22.14 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.212 -0.93 . . . . 0.0 112.455 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.1 ttp -72.4 156.85 38.63 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.654 0.782 . . . . 0.0 111.163 169.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -138.25 170.1 16.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.528 1.531 . . . . 0.0 111.739 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.18 -2.69 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.62 14.95 29.74 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.127 0.971 . . . . 0.0 113.393 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 56.16 28.57 13.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.405 1.882 . . . . 0.0 112.993 -173.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 70.8 mt -88.32 156.29 51.26 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.385 1.474 . . . . 0.0 112.083 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.36 135.67 32.01 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.906 3.07 . . . . 0.0 112.686 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -75.3 126.25 30.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.73 0.812 . . . . 0.0 110.773 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.2 pt -142.98 151.61 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.555 1.542 . . . . 0.0 111.335 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.3 pttt -95.59 -173.47 2.89 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.21 1.804 . . . . 0.0 111.961 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.1 mt -68.49 122.28 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.764 1.226 . . . . 0.0 109.001 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.46 -44.57 19.02 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.331 1.052 . . . . 0.0 112.49 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.8 p -146.88 152.62 39.0 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.655 1.582 . . . . 0.0 111.03 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.93 145.17 43.93 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.053 1.741 . . . . 0.0 110.235 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -158.0 135.43 10.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.179 1.792 . . . . 0.0 110.017 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -67.85 120.44 14.16 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.382 0.537 . . . . 0.0 110.032 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.7 -42.14 12.85 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.711 0.404 . . . . 0.0 111.702 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.04 -142.19 11.96 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.208 0.909 . . . . 0.0 112.848 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -121.93 97.07 5.32 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.358 1.463 . . . . 0.0 111.626 -168.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -118.09 154.66 31.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.457 1.103 . . . . 0.0 111.286 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.9 117.21 5.61 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.652 0.781 . . . . 0.0 110.709 171.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.44 151.02 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.504 0.668 . . . . 0.0 111.043 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -138.61 159.41 42.16 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.613 1.565 . . . . 0.0 111.408 -169.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -148.82 168.04 24.02 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.705 0.802 . . . . 0.0 111.921 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.2 pt -126.12 139.91 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.449 1.1 . . . . 0.0 110.112 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.33 153.98 20.05 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.843 1.211 . . . . 0.0 111.183 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 124.525 1.13 . . . . 0.0 109.784 -174.285 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -160.59 161.49 32.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.983 1.313 . . . . 0.0 111.631 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.78 130.48 37.55 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.866 0.866 . . . . 0.0 113.007 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 41.9 mt -72.79 165.71 24.32 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.469 1.108 . . . . 0.0 111.116 168.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.463 ' CB ' HD22 ' A' ' 15' ' ' LEU . 5.6 ptmm? -51.47 -32.57 27.6 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -90.01 -12.24 39.21 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.879 1.271 . . . . 0.0 113.999 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.62 -12.25 18.41 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 118.506 -1.163 . . . . 0.0 115.246 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -60.63 158.45 12.49 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.698 1.749 . . . . 0.0 112.462 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.66 126.02 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.122 0.963 . . . . 0.0 110.859 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.479 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -107.56 157.06 18.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.651 1.58 . . . . 0.0 109.729 172.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.6 t -134.84 128.13 32.11 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 112.839 -176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.936 1.694 . . . . 0.0 113.179 -175.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -151.24 171.61 17.14 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.456 1.102 . . . . 0.0 111.848 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.448 HD13 HG21 ' A' ' 6' ' ' THR . 56.8 mt -127.64 148.13 50.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.182 1.793 . . . . 0.0 110.856 -168.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p -61.56 162.11 8.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.774 1.23 . . . . 0.0 114.196 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -53.62 -45.61 70.18 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.141 -0.974 . . . . 0.0 112.158 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.52 -5.84 16.99 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.448 HG21 HD13 ' A' ' 2' ' ' LEU . 63.7 m -71.44 97.65 1.68 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.118 -0.989 . . . . 0.0 110.318 173.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -74.09 135.74 42.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.598 0.759 . . . . 0.0 110.919 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.38 120.54 63.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 126.107 1.763 . . . . 0.0 106.702 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.78 120.69 15.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.73 0.412 . . . . 0.0 110.053 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 p -121.63 153.37 38.2 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.303 1.041 . . . . 0.0 112.424 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.19 -34.38 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.404 0.682 . . . . 0.0 111.758 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.64 -26.42 61.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -140.1 -51.79 0.5 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.92 -152.69 20.41 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.212 0.911 . . . . 0.0 111.707 -171.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 109.37 1.7 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.078 0.951 . . . . 0.0 110.96 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.8 mt -133.8 149.39 71.74 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.93 1.292 . . . . 0.0 112.943 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.42 126.73 14.61 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.886 3.058 . . . . 0.0 112.818 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 tt -55.81 -35.71 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.81 -38.16 96.05 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.895 -0.503 . . . . 0.0 112.469 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -71.58 -34.84 70.27 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.409 1.104 . . . . 0.0 111.657 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.9 mt -66.13 -39.65 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.038 0.935 . . . . 0.0 110.032 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.22 -38.08 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.319 1.048 . . . . 0.0 113.046 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -70.41 -27.43 64.28 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.323 0.965 . . . . 0.0 113.218 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -112.19 3.12 17.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.273 1.029 . . . . 0.0 113.103 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 46.9 50.23 13.82 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.26 2.224 . . . . 0.0 111.911 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.8 mt -68.12 118.5 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.021 0.928 . . . . 0.0 108.678 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.02 118.13 14.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.288 0.566 . . . . 0.0 109.511 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.5 p -151.55 166.77 30.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.096 1.358 . . . . 0.0 112.334 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.16 152.54 20.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.272 1.429 . . . . 0.0 109.74 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.31 167.53 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.189 1.396 . . . . 0.0 110.961 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -108.67 148.97 29.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.151 1.38 . . . . 0.0 111.086 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -168.37 151.74 5.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.607 1.563 . . . . 0.0 110.673 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.12 144.45 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.834 1.197 . . . . 0.0 113.275 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.73 178.45 8.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.544 1.138 . . . . 0.0 113.333 170.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -61.98 -11.11 11.74 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -105.18 0.26 27.17 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.9 1.68 . . . . 0.0 112.312 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.14 22.96 39.43 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.171 1.367 . . . . 0.0 115.253 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -108.08 123.56 48.88 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.158 1.479 . . . . 0.0 110.331 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.61 102.63 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.972 0.909 . . . . 0.0 109.41 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -100.88 179.05 4.51 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.103 1.761 . . . . 0.0 111.275 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.2 p -126.35 144.2 50.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.342 1.057 . . . . 0.0 112.843 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -145.58 137.3 13.01 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.537 1.135 . . . . 0.0 112.308 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.23 143.13 27.99 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.286 2.658 . . . . 0.0 110.944 174.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 p -54.13 147.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.727 0.811 . . . . 0.0 111.601 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.76 -42.93 3.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.712 0.805 . . . . 0.0 112.127 175.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -145.15 172.08 13.61 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.853 1.261 . . . . 0.0 111.875 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -135.49 132.56 37.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.579 1.552 . . . . 0.0 109.664 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -127.15 130.85 50.57 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.51 1.124 . . . . 0.0 111.465 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -126.51 119.77 28.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.441 1.496 . . . . 0.0 110.492 -173.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -91.11 -23.1 20.39 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.631 1.172 . . . . 0.0 113.387 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.61 -46.18 3.53 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 126.812 2.148 . . . . 0.0 114.775 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -173.46 107.55 0.15 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.737 1.615 . . . . 0.0 112.156 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -128.04 159.97 33.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.302 1.441 . . . . 0.0 111.212 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -59.26 104.78 0.28 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.517 1.527 . . . . 0.0 112.953 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.08 136.53 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.119 1.368 . . . . 0.0 111.181 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -118.52 138.21 52.68 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.691 1.196 . . . . 0.0 109.989 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -74.29 134.88 42.59 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.034 0.934 . . . . 0.0 108.946 168.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -129.86 89.2 2.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.122 1.369 . . . . 0.0 109.229 170.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.5 t -74.96 141.99 43.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.059 0.944 . . . . 0.0 110.896 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tp -93.89 170.1 9.8 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.941 1.296 . . . . 0.0 113.249 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -63.99 -26.47 68.59 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.99 -18.53 28.83 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.86 -3.21 28.83 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.126 1.346 . . . . 0.0 114.316 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 m -59.63 150.79 26.43 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.086 1.443 . . . . 0.0 111.449 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -127.11 135.98 51.49 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.492 0.717 . . . . 0.0 110.775 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.481 HD11 ' CZ ' ' A' ' 133' ' ' PHE . 11.3 mt -128.42 126.44 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.435 1.494 . . . . 0.0 107.385 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -123.63 103.11 8.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.876 1.27 . . . . 0.0 109.556 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.66 170.51 15.71 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.563 1.145 . . . . 0.0 112.554 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.1 p -86.69 150.68 24.01 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.869 1.267 . . . . 0.0 111.632 171.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -65.1 -7.52 12.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.703 1.601 . . . . 0.0 115.055 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.8 -11.72 30.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.326 1.85 . . . . 0.0 111.921 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.645 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 5.2 t-80 -83.01 130.94 35.19 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.638 0.654 . . . . 0.0 109.793 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -91.34 155.93 18.15 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.822 0.849 . . . . 0.0 110.238 176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -138.81 137.57 36.74 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.598 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.5 ttp -79.14 106.49 11.21 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.089 0.556 . . . . 0.0 110.515 -171.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.3 p -65.5 172.34 3.38 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.54 0.736 . . . . 0.0 112.746 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.32 -24.97 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.47 -9.28 50.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.556 1.143 . . . . 0.0 113.519 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.99 9.8 60.47 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.054 1.312 . . . . 0.0 114.599 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -69.96 149.92 47.25 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.512 1.156 . . . . 0.0 111.69 -178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.4 mtm -111.94 82.15 1.58 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.23 1.812 . . . . 0.0 108.698 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 37.1 mt -122.85 147.06 50.03 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 125.242 1.417 . . . . 0.0 110.225 -174.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.93 148.32 85.87 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.167 2.578 . . . . 0.0 111.246 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.3 tt -59.71 -25.99 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -56.44 -33.17 65.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.424 1.09 . . . . 0.0 112.998 170.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -85.25 -36.81 20.69 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.459 0.704 . . . . 0.0 111.597 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.85 -40.45 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.131 -0.981 . . . . 0.0 111.417 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -63.44 -38.52 91.45 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -76.74 -42.96 39.1 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.447 -0.783 . . . . 0.0 112.869 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -77.58 -13.17 59.98 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.143 0.977 . . . . 0.0 112.957 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 56.22 37.08 28.49 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.655 1.582 . . . . 0.0 111.854 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.6 mt -75.07 138.52 42.19 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.438 1.095 . . . . 0.0 111.318 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -73.27 157.31 37.32 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.909 0.861 . . . . 0.0 112.104 173.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.3 mt -112.94 143.35 44.39 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.843 1.257 . . . . 0.0 111.234 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 39.8 ttm -62.29 156.92 20.9 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.465 1.506 . . . . 0.0 111.953 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -132.21 158.43 41.77 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.565 1.546 . . . . 0.0 112.509 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.68 -10.93 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -107.69 16.93 23.18 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.915 1.686 . . . . 0.0 112.672 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.269 7.6 m-80 56.49 36.67 27.93 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.194 1.798 . . . . 0.0 112.551 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.97 159.61 68.08 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 112.743 -2.026 . . . . 0.0 112.015 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.68 155.92 58.12 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.561 2.841 . . . . 0.0 112.108 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -89.92 114.22 25.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.852 0.861 . . . . 0.0 110.003 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.6 pt -142.32 131.01 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.805 1.642 . . . . 0.0 111.106 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.61 173.35 10.55 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.061 1.745 . . . . 0.0 112.633 174.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.8 mt -66.01 115.86 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.097 1.359 . . . . 0.0 110.363 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.72 -42.57 73.83 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.819 1.248 . . . . 0.0 112.654 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.77 162.3 40.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.059 0.944 . . . . 0.0 111.828 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.56 145.5 42.95 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.543 1.537 . . . . 0.0 111.615 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.66 133.58 13.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.303 1.041 . . . . 0.0 110.747 177.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -65.7 133.05 50.26 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.415 -0.803 . . . . 0.0 110.707 170.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.2 mt -102.21 -45.23 5.19 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.479 0.712 . . . . 0.0 111.847 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 152.03 -147.59 17.55 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.089 0.852 . . . . 0.0 112.922 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.77 62.6 1.22 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 123.252 1.501 . . . . 0.0 113.013 -167.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -81.07 156.53 25.78 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.556 1.942 . . . . 0.0 110.826 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.42 119.33 8.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.839 0.855 . . . . 0.0 110.184 171.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.42 150.09 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.601 0.715 . . . . 0.0 111.367 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -138.74 159.36 42.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.651 1.58 . . . . 0.0 111.551 -168.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -154.74 130.81 10.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.543 1.137 . . . . 0.0 110.745 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.8 pt -93.52 156.44 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.009 -1.057 . . . . 0.0 111.488 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.38 153.22 19.8 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.157 0.884 . . . . 0.0 112.835 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 124.599 1.16 . . . . 0.0 111.03 -176.271 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 . . . . . 0 CA--C 1.551 0.987 0 CA-C-O 121.225 0.536 . . . . 0.0 112.191 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -166.84 154.93 9.8 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.101 1.36 . . . . 0.0 111.396 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.06 149.52 35.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.863 1.265 . . . . 0.0 112.488 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 88.7 mt -128.5 -176.71 3.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.07 2.148 . . . . 0.0 111.716 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -51.08 150.55 3.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.961 0.504 . . . . 0.0 110.432 165.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 52.54 18.84 1.04 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.887 1.275 . . . . 0.0 114.342 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.01 22.13 75.74 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 117.624 -1.653 . . . . 0.0 115.94 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.481 ' CZ ' HD11 ' A' ' 66' ' ' ILE . 67.5 m-85 -65.25 157.06 29.96 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.248 2.024 . . . . 0.0 112.369 170.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.02 121.1 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.778 1.231 . . . . 0.0 108.778 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.645 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -107.38 103.63 13.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.925 0.89 . . . . 0.0 110.416 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.4 t -89.26 157.86 18.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.539 0.735 . . . . 0.0 112.331 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.7 t30 . . . . . 0 C--O 1.255 1.362 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 172.259 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.816 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -171.36 175.55 4.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.918 0.887 . . . . 0.0 113.193 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.584 HD13 HG21 ' A' ' 6' ' ' THR . 86.7 mt -120.32 147.39 45.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.859 2.064 . . . . 0.0 110.37 -175.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -72.8 161.82 30.26 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.857 -0.527 . . . . 0.0 111.946 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -51.96 -46.75 64.91 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.319 1.048 . . . . 0.0 112.464 -173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -61.96 -8.01 4.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.375 1.87 . . . . 0.0 115.141 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.584 HG21 HD13 ' A' ' 2' ' ' LEU . 19.9 m -71.44 107.36 4.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.906 0.883 . . . . 0.0 110.33 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.55 133.09 33.84 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.348 0.594 . . . . 0.0 111.435 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -118.49 115.1 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.332 1.453 . . . . 0.0 107.139 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.1 128.33 34.93 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 122.062 -0.399 . . . . 0.0 110.87 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.4 p -129.18 156.07 44.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.166 1.387 . . . . 0.0 113.013 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.56 -30.87 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 122.955 0.502 . . . . 0.0 112.04 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -65.78 -31.65 72.74 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -140.97 -59.59 0.5 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.628 0.771 . . . . 0.0 113.07 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.13 -133.44 5.83 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.13 108.55 12.71 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.262 1.425 . . . . 0.0 109.952 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.531 HD13 HD11 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -145.8 156.69 51.89 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.23 129.39 17.01 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.932 3.088 . . . . 0.0 112.713 -175.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.81 -37.57 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.511 0.724 . . . . 0.0 112.837 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 -30.95 79.28 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.608 -0.682 . . . . 0.0 113.051 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.79 -36.16 70.24 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.734 0.767 . . . . 0.0 111.445 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.531 HD11 HD13 ' A' ' 16' ' ' LEU . 64.6 mt -64.92 -43.12 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.998 0.519 . . . . 0.0 109.885 176.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 117' ' ' TYR . 57.8 t -75.09 -41.28 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -75.59 -22.49 56.88 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -109.87 1.56 19.29 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.132 1.373 . . . . 0.0 112.493 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.65 48.71 14.3 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.166 2.186 . . . . 0.0 113.322 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.27 124.8 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.471 0.708 . . . . 0.0 109.626 -174.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -83.02 86.23 7.03 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.737 0.78 . . . . 0.0 110.683 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' VAL . 20.6 p -117.44 -177.96 3.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.852 1.261 . . . . 0.0 111.952 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.16 144.67 48.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.426 1.49 . . . . 0.0 108.351 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.67 174.22 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.718 1.607 . . . . 0.0 111.077 -177.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -117.21 139.33 50.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.69 1.596 . . . . 0.0 110.319 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -156.99 151.9 25.94 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.864 1.265 . . . . 0.0 111.177 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.1 p -99.12 131.84 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.679 1.192 . . . . 0.0 111.461 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.7 -176.76 6.17 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.998 1.319 . . . . 0.0 113.67 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.58 -29.69 69.34 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -79.85 -11.21 59.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.277 1.031 . . . . 0.0 113.189 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.27 14.27 59.06 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.464 1.031 . . . . 0.0 114.227 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -91.75 126.23 36.76 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.897 1.348 . . . . 0.0 109.481 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.0 mt -71.95 88.43 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.345 1.058 . . . . 0.0 108.78 172.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -81.88 171.08 14.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.114 0.966 . . . . 0.0 111.136 171.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 p -126.92 145.52 50.65 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.832 0.853 . . . . 0.0 111.777 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -145.39 146.38 29.79 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 124.259 1.023 . . . . 0.0 112.677 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.07 156.19 56.11 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.208 2.605 . . . . 0.0 112.474 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 28' ' ' CYS . 42.1 t -67.55 119.8 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.993 0.917 . . . . 0.0 109.816 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.22 -36.27 35.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.374 0.67 . . . . 0.0 112.578 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -162.14 175.67 11.46 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.381 1.473 . . . . 0.0 112.64 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -135.71 117.36 14.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.08 1.352 . . . . 0.0 109.34 -175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -108.35 130.58 55.2 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.062 0.934 . . . . 0.0 110.369 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.21 103.12 9.22 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.791 1.636 . . . . 0.0 109.514 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -69.78 -33.26 72.15 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.374 1.07 . . . . 0.0 111.908 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.52 -40.39 3.01 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.87 1.224 . . . . 0.0 113.382 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 178.32 109.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.283 1.433 . . . . 0.0 111.62 -174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -133.96 164.96 26.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.131 0.972 . . . . 0.0 112.55 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.07 100.06 0.3 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.489 1.516 . . . . 0.0 113.204 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 t -92.41 137.24 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.038 1.335 . . . . 0.0 110.959 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -119.51 137.13 54.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.295 1.438 . . . . 0.0 109.486 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -56.89 126.0 25.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.99 0.916 . . . . 0.0 110.267 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -118.58 82.88 1.92 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.893 1.277 . . . . 0.0 108.449 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.9 t -94.17 137.51 33.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.666 0.787 . . . . 0.0 110.646 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.82 162.03 13.32 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.223 1.009 . . . . 0.0 112.111 173.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -18.75 62.02 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -78.12 -26.51 48.0 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.123 0.969 . . . . 0.0 112.729 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.74 2.98 18.8 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.629 1.109 . . . . 0.0 114.806 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 m -67.69 132.4 47.4 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.304 1.552 . . . . 0.0 110.356 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.67 132.37 56.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.087 1.355 . . . . 0.0 109.877 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.6 mt -139.01 155.17 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 126.408 1.883 . . . . 0.0 108.478 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -137.96 111.01 7.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.028 1.331 . . . . 0.0 110.675 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.71 166.78 24.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.906 1.283 . . . . 0.0 111.659 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.3 p -88.24 160.14 17.82 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.942 0.877 . . . . 0.0 112.344 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -67.76 -3.8 10.47 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -103.29 -13.0 16.88 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.141 0.977 . . . . 0.0 112.58 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.45 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 11.0 t-80 -76.92 121.01 22.83 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 173.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -82.57 149.74 27.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.268 0.627 . . . . 0.0 109.776 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -132.06 143.82 50.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.523 -0.736 . . . . 0.0 109.737 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.4 ttp -75.22 104.43 5.79 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.074 0.55 . . . . 0.0 110.468 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.4 p -66.27 167.99 9.44 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.941 0.496 . . . . 0.0 111.683 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.3 m -55.07 -26.33 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -84.36 -13.17 53.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.273 1.029 . . . . 0.0 113.376 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.99 30.41 12.93 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.574 1.083 . . . . 0.0 113.557 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -98.75 147.24 25.08 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.241 1.02 . . . . 0.0 110.718 177.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.98 89.91 3.8 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.812 1.245 . . . . 0.0 109.871 176.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.1 mt -121.69 145.79 43.99 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.323 1.049 . . . . 0.0 110.438 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.68 147.48 81.58 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.092 2.528 . . . . 0.0 111.355 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.427 HG13 HD11 ' A' ' 105' ' ' ILE . 11.0 tt -58.0 -27.47 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -54.52 -38.42 66.51 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.583 1.153 . . . . 0.0 112.872 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -82.22 -34.72 28.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.283 0.633 . . . . 0.0 111.586 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.61 -39.21 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.6 -0.688 . . . . 0.0 110.368 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -63.96 -34.81 78.82 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -75.14 -44.77 45.08 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.524 -0.735 . . . . 0.0 112.669 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -76.33 -12.67 60.11 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 56.08 31.48 18.23 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.298 1.439 . . . . 0.0 112.108 -174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 69.5 mt -79.2 150.29 31.7 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.258 1.023 . . . . 0.0 111.586 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.98 155.78 17.32 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.617 0.767 . . . . 0.0 111.491 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt -84.47 159.36 20.77 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.414 -0.804 . . . . 0.0 112.623 168.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.6 ttp -86.52 155.74 20.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.795 1.238 . . . . 0.0 111.294 169.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.52 164.46 27.76 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.337 1.455 . . . . 0.0 112.04 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.6 m -93.02 -19.63 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -99.0 15.65 25.06 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.505 1.122 . . . . 0.0 113.088 -172.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 55.57 32.91 20.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.868 1.667 . . . . 0.0 112.099 -173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.53 154.29 73.7 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.676 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.08 144.76 70.84 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.746 2.964 . . . . 0.0 111.26 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -79.79 116.87 20.2 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.681 -0.637 . . . . 0.0 110.635 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.4 pt -142.53 132.77 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.926 1.69 . . . . 0.0 111.261 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 175.72 6.97 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.889 1.676 . . . . 0.0 112.347 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.427 HD11 HG13 ' A' ' 84' ' ' ILE . 10.9 mt -63.66 112.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.197 1.399 . . . . 0.0 110.035 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.65 -43.62 62.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.993 0.917 . . . . 0.0 111.742 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 p -149.02 147.75 28.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.115 1.766 . . . . 0.0 110.056 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -140.6 142.16 35.08 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.415 1.486 . . . . 0.0 110.212 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -152.32 131.64 12.85 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.929 1.692 . . . . 0.0 108.951 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -61.69 121.21 12.26 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.947 0.339 . . . . 0.0 110.545 171.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.9 mt -88.39 -40.54 13.45 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 122.645 0.378 . . . . 0.0 111.721 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.04 -145.22 15.71 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.653 1.121 . . . . 0.0 112.261 -173.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -128.22 74.93 1.58 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 123.206 1.479 . . . . 0.0 113.401 -167.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -89.54 155.19 19.44 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.458 1.503 . . . . 0.0 109.908 -171.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.15 117.26 5.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.436 0.694 . . . . 0.0 109.851 171.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.63 154.25 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.422 0.63 . . . . 0.0 110.919 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.463 ' HB3' HG21 ' A' ' 22' ' ' VAL . 6.2 m-85 -140.94 157.38 45.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.669 1.588 . . . . 0.0 111.322 -170.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -156.93 117.12 3.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.755 1.222 . . . . 0.0 110.159 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.8 pt -71.46 155.44 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 121.028 -1.045 . . . . 0.0 111.205 172.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -107.07 152.38 16.89 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.494 1.045 . . . . 0.0 111.74 170.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 126.711 2.004 . . . . 0.0 110.108 -175.983 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 . . . . . 0 CA--C 1.545 0.769 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -172.55 157.13 3.83 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.052 1.741 . . . . 0.0 111.061 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.77 144.75 29.95 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.821 0.848 . . . . 0.0 112.461 173.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 28.9 mt -89.76 173.09 8.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.095 1.358 . . . . 0.0 112.188 171.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -48.62 -49.73 35.85 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.708 1.603 . . . . 0.0 114.561 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -73.38 -37.7 65.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.211 0.604 . . . . 0.0 111.652 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 139.68 -6.11 2.91 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.478 -1.179 . . . . 0.0 115.359 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -57.0 155.35 8.28 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.563 1.681 . . . . 0.0 112.619 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.58 110.81 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 122.033 0.921 . . . . 0.0 109.676 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.45 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -96.36 116.75 29.54 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.391 1.076 . . . . 0.0 108.64 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.2 m -109.56 79.87 1.26 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.377 1.071 . . . . 0.0 111.433 -173.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.3 t30 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 127.597 2.359 . . . . 0.0 115.997 -168.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.312 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.26 178.03 10.62 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.512 1.125 . . . . 0.0 112.653 -169.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.11 148.56 32.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.452 1.501 . . . . 0.0 110.652 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -62.41 161.39 11.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.644 0.777 . . . . 0.0 112.653 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -52.5 -47.01 66.86 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.889 . . . . 0.0 112.541 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -63.65 -20.45 65.7 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.266 1.827 . . . . 0.0 113.403 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.2 m -59.64 105.25 0.35 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.402 1.081 . . . . 0.0 110.862 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -86.23 129.81 34.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.363 0.601 . . . . 0.0 111.0 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.2 mm -113.49 124.95 70.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.075 1.35 . . . . 0.0 107.529 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.39 129.9 44.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.08 0.552 . . . . 0.0 110.899 171.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.8 p -133.02 148.68 52.24 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.296 1.438 . . . . 0.0 111.431 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.8 -31.3 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 122.071 -0.393 . . . . 0.0 111.892 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -64.83 -36.46 84.4 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -141.49 -44.76 0.36 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -172.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.17 -136.82 9.11 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.134 0.879 . . . . 0.0 112.347 -172.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.4 91.19 7.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.885 1.674 . . . . 0.0 111.823 -173.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -122.1 146.09 45.64 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.905 0.882 . . . . 0.0 112.638 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.76 125.33 13.59 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.367 3.378 . . . . 0.0 112.727 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.84 -37.36 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.965 0.906 . . . . 0.0 113.368 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.4 -32.39 79.23 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.559 -0.713 . . . . 0.0 113.097 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -71.88 -35.37 69.76 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 117.787 0.793 . . . . 0.0 111.602 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -67.5 -39.68 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.529 0.732 . . . . 0.0 109.709 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.03 -41.08 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.727 0.811 . . . . 0.0 112.471 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -76.35 -24.4 54.2 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.346 0.976 . . . . 0.0 113.339 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -104.67 -0.01 27.97 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.79 1.236 . . . . 0.0 112.854 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 48.29 49.57 17.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.655 1.982 . . . . 0.0 112.422 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.3 mt -68.61 121.02 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.179 0.992 . . . . 0.0 109.272 -174.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.39 107.77 11.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.439 1.095 . . . . 0.0 110.656 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.0 p -148.16 166.91 26.45 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.256 1.027 . . . . 0.0 113.466 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.5 148.29 23.89 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.433 1.493 . . . . 0.0 109.857 177.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 m -128.95 171.48 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.018 1.727 . . . . 0.0 110.924 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -115.4 140.09 49.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.462 1.505 . . . . 0.0 110.283 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 t -156.15 152.02 27.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.966 1.306 . . . . 0.0 110.672 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.52 128.31 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.199 0.6 . . . . 0.0 109.933 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -69.93 173.79 6.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.601 1.16 . . . . 0.0 111.807 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -62.22 -25.51 67.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.318 1.447 . . . . 0.0 113.328 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -86.23 -2.5 58.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.112 1.365 . . . . 0.0 113.398 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.08 22.52 60.9 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.603 1.097 . . . . 0.0 114.808 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -99.85 129.9 45.99 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.804 1.242 . . . . 0.0 109.991 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.1 mt -70.25 130.59 34.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -134.13 169.72 16.74 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.579 1.552 . . . . 0.0 110.938 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 p -119.55 140.87 49.83 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.956 0.902 . . . . 0.0 111.681 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -149.85 147.36 22.35 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.317 1.047 . . . . 0.0 112.423 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.05 149.91 47.45 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.117 2.545 . . . . 0.0 112.658 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -57.84 137.11 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.741 0.816 . . . . 0.0 110.409 168.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.16 -50.59 5.76 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.993 0.517 . . . . 0.0 111.42 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -149.97 173.55 13.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.029 1.731 . . . . 0.0 111.042 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -129.25 131.67 47.07 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.566 1.546 . . . . 0.0 108.994 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -130.06 138.81 50.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.202 1.001 . . . . 0.0 110.715 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.65 121.49 28.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.914 1.285 . . . . 0.0 110.801 -174.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -86.36 -34.0 20.36 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.216 1.006 . . . . 0.0 112.559 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.76 -44.93 2.71 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.253 1.406 . . . . 0.0 115.17 172.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -174.32 88.78 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 123.083 1.42 . . . . 0.0 114.568 -168.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -127.48 163.19 24.66 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.201 1.0 . . . . 0.0 112.91 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -67.73 103.53 1.43 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.062 1.345 . . . . 0.0 112.714 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -96.5 139.32 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.431 1.492 . . . . 0.0 110.991 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.436 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 75.5 m-85 -123.11 142.48 50.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.512 1.525 . . . . 0.0 109.976 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -65.88 131.26 45.84 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.733 0.813 . . . . 0.0 110.301 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -124.66 87.06 2.65 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.084 1.353 . . . . 0.0 108.439 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.2 t -95.28 146.71 24.16 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.97 0.908 . . . . 0.0 110.627 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.8 164.76 12.44 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.924 1.289 . . . . 0.0 112.368 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -66.86 -23.62 66.04 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.549 1.139 . . . . 0.0 113.284 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.56 -23.56 46.05 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.103 1.361 . . . . 0.0 112.961 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.55 0.68 30.86 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.756 1.17 . . . . 0.0 114.345 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.8 m -57.14 136.41 56.4 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.384 1.092 . . . . 0.0 110.558 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.92 122.78 38.34 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.753 1.221 . . . . 0.0 109.758 -172.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.1 mt -134.07 150.89 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.547 1.939 . . . . 0.0 107.86 -172.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 63.6 mtt85 -136.38 117.37 14.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.616 1.166 . . . . 0.0 109.864 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.6 163.5 38.34 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.518 1.127 . . . . 0.0 111.558 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 p -75.01 151.68 38.76 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.446 -0.784 . . . . 0.0 112.065 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -63.12 -17.22 62.09 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 176.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -86.42 -16.28 37.67 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.485 1.514 . . . . 0.0 113.33 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -74.46 135.36 42.29 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.176 0.59 . . . . 0.0 109.436 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 149.19 21.85 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.037 0.922 . . . . 0.0 112.174 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -134.26 127.25 31.46 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.428 -1.42 . . . . 0.0 110.182 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ttp -71.93 111.28 7.04 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.046 0.45 . . . . 0.0 111.084 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.6 p -70.37 171.94 9.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.057 0.543 . . . . 0.0 112.215 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -54.44 -27.2 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.1 -8.19 54.3 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.698 1.199 . . . . 0.0 113.133 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.82 1.09 63.67 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.962 1.267 . . . . 0.0 114.326 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.97 146.71 52.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.523 1.161 . . . . 0.0 111.212 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.2 mtm -117.87 76.55 1.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.31 1.444 . . . . 0.0 109.465 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.64 150.84 43.95 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.006 1.322 . . . . 0.0 110.979 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.34 148.92 80.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.977 2.451 . . . . 0.0 111.559 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 tt -55.66 -29.07 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -53.15 -37.51 61.9 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.643 1.177 . . . . 0.0 113.138 170.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -90.33 -32.83 16.32 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.584 1.153 . . . . 0.0 111.605 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.72 -38.33 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.389 -0.819 . . . . 0.0 111.191 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.64 -34.79 78.66 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.41 -45.98 51.35 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.46 -8.8 58.92 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 58.14 37.68 26.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.673 1.189 . . . . 0.0 111.549 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.5 mt -83.92 155.67 22.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.901 1.334 . . . . 0.0 112.162 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -110.92 155.42 22.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.764 2.426 . . . . 0.0 112.969 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.7 155.09 19.44 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.692 0.797 . . . . 0.0 112.444 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.4 ttp -74.99 138.46 42.25 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.711 173.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.85 157.51 27.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.996 1.318 . . . . 0.0 110.684 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.588 HG22 ' HA2' ' A' ' 132' ' ' GLY . 31.4 m -118.69 -4.18 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.99 13.42 25.07 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.683 1.593 . . . . 0.0 112.587 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 58.89 30.1 19.71 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.763 2.025 . . . . 0.0 112.466 -174.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.6 mt -88.85 155.77 50.01 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.21 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.55 154.32 64.7 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.841 3.027 . . . . 0.0 111.951 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.36 132.14 35.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.476 0.711 . . . . 0.0 110.339 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 pt -146.87 137.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.972 1.309 . . . . 0.0 111.489 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.87 175.98 9.96 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.991 1.317 . . . . 0.0 112.509 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.8 mt -62.17 111.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.081 1.353 . . . . 0.0 110.03 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.73 -45.18 83.62 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.131 0.972 . . . . 0.0 111.883 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 p -151.35 150.67 30.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.287 1.835 . . . . 0.0 110.555 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -133.05 142.87 49.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.725 1.61 . . . . 0.0 110.083 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -156.9 140.6 16.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.696 1.598 . . . . 0.0 109.865 175.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -66.84 128.64 37.08 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.876 -0.515 . . . . 0.0 111.127 172.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.78 -46.43 7.55 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.849 0.459 . . . . 0.0 111.691 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 147.53 -150.94 23.24 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.246 0.927 . . . . 0.0 112.778 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -122.18 79.59 1.61 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.932 1.349 . . . . 0.0 112.763 -168.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -98.36 157.93 15.89 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.793 1.637 . . . . 0.0 110.466 -169.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.57 120.8 13.04 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.633 0.773 . . . . 0.0 110.031 169.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.9 m -125.14 152.68 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.332 0.653 . . . . 0.0 111.182 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -140.93 156.49 46.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.159 1.384 . . . . 0.0 111.942 -168.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -152.4 130.91 12.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.671 1.189 . . . . 0.0 110.8 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.8 pt -91.59 154.11 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.74 173.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.06 159.76 13.91 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.906 1.241 . . . . 0.0 111.44 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 124.717 1.207 . . . . 0.0 109.649 -172.571 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -165.13 167.12 18.52 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.054 1.342 . . . . 0.0 112.297 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.38 131.02 40.46 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.622 1.169 . . . . 0.0 112.461 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 32.6 mt -70.33 166.9 19.25 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.304 1.441 . . . . 0.0 111.678 169.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -48.94 -34.59 13.16 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.49 -6.87 24.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.394 1.078 . . . . 0.0 112.526 -172.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . 124.17 -17.59 7.52 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.962 1.267 . . . . 0.0 115.261 171.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -64.32 154.46 35.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.832 1.316 . . . . 0.0 112.697 -174.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.5 mm -104.47 140.31 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.434 1.015 . . . . 0.0 111.012 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.96 140.38 53.04 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.394 1.878 . . . . 0.0 109.418 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.0 t -138.74 124.91 20.19 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.118 1.367 . . . . 0.0 112.383 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.9 t30 . . . . . 0 C--O 1.255 1.384 0 C-N-CA 126.446 1.898 . . . . 0.0 113.991 -168.169 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.404 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -159.54 173.34 16.29 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.715 0.757 . . . . 0.0 112.671 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.61 146.95 38.94 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.844 1.258 . . . . 0.0 110.771 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -65.2 164.1 13.9 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -50.97 -43.73 60.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.4 -19.73 64.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.692 1.197 . . . . 0.0 112.846 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 m -63.67 108.24 1.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.203 1.401 . . . . 0.0 111.133 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -86.47 128.12 34.93 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.116 0.484 . . . . 0.0 110.431 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.8 mm -99.58 122.3 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.396 1.479 . . . . 0.0 107.295 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.2 tp -69.91 122.61 19.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.2 p -125.9 152.11 46.01 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.9 0.88 . . . . 0.0 112.652 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -71.37 -34.05 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.876 0.47 . . . . 0.0 111.942 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -67.74 -32.72 73.53 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -141.78 -48.5 0.38 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.26 -151.39 19.87 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.172 0.892 . . . . 0.0 111.541 -172.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.87 108.49 1.49 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.352 1.061 . . . . 0.0 111.181 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.4 mt -132.23 147.76 67.05 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.74 1.216 . . . . 0.0 112.871 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.93 123.88 11.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.957 3.104 . . . . 0.0 112.212 -177.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 tt -55.21 -36.82 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.77 -33.73 88.01 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.797 -0.564 . . . . 0.0 113.018 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -77.36 -33.64 55.28 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.684 0.794 . . . . 0.0 112.042 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.7 mt -65.69 -38.85 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.141 0.976 . . . . 0.0 109.664 173.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.0 t -78.15 -38.32 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.366 1.067 . . . . 0.0 112.756 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 -25.48 46.64 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.26 0.936 . . . . 0.0 113.467 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -100.91 -2.59 31.54 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.722 1.209 . . . . 0.0 113.23 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 50.11 49.47 20.35 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.475 1.91 . . . . 0.0 112.339 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.4 mt -71.02 121.51 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.23 1.012 . . . . 0.0 109.591 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -74.81 114.03 12.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.409 0.623 . . . . 0.0 110.725 172.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.9 p -143.72 171.67 13.88 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.068 1.347 . . . . 0.0 112.278 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 m -112.83 150.13 32.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.909 1.284 . . . . 0.0 109.035 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.6 m -125.37 178.42 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.053 1.341 . . . . 0.0 111.222 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.83 141.27 49.68 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.841 1.256 . . . . 0.0 110.538 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.42 153.21 15.22 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.14 1.776 . . . . 0.0 109.185 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.5 m -89.09 143.7 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.442 1.019 . . . . 0.0 111.973 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.56 177.57 7.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.495 1.118 . . . . 0.0 111.395 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -62.8 -17.56 61.36 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.887 1.275 . . . . 0.0 113.04 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -95.16 -0.03 53.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.06 1.744 . . . . 0.0 113.133 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.66 35.65 40.08 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 121.33 -0.856 . . . . 0.0 114.147 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -119.31 123.23 43.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.455 1.502 . . . . 0.0 109.71 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -64.08 117.55 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -120.7 167.62 12.27 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.502 1.521 . . . . 0.0 111.669 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.1 p -115.6 137.96 51.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.282 1.033 . . . . 0.0 111.468 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -146.19 140.35 15.38 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.509 1.124 . . . . 0.0 111.412 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.19 148.94 40.02 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.863 2.375 . . . . 0.0 112.027 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.5 147.94 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.504 1.122 . . . . 0.0 111.114 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.17 -42.27 3.76 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.28 1.032 . . . . 0.0 112.237 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -142.6 178.44 7.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.896 1.679 . . . . 0.0 111.656 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -138.08 125.07 21.33 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.244 1.418 . . . . 0.0 109.117 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -118.57 137.82 52.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.345 1.058 . . . . 0.0 110.73 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.82 123.05 34.23 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.248 1.419 . . . . 0.0 110.61 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -89.72 -29.51 18.68 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.508 1.123 . . . . 0.0 112.77 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.58 -58.95 4.84 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.667 1.603 . . . . 0.0 114.002 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -158.92 98.83 1.5 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.77 1.228 . . . . 0.0 112.853 -168.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -133.03 163.13 29.92 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.336 1.054 . . . . 0.0 112.248 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.5 105.97 1.64 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.612 1.165 . . . . 0.0 113.246 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.42 137.44 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.0 0.92 . . . . 0.0 111.54 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -122.61 141.8 51.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.428 1.091 . . . . 0.0 110.849 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -85.84 96.08 9.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.93 1.692 . . . . 0.0 111.009 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -79.09 108.11 12.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.591 0.757 . . . . 0.0 109.418 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.0 t -88.63 132.55 34.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.361 1.064 . . . . 0.0 110.439 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tp -90.06 168.95 11.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.851 1.261 . . . . 0.0 112.628 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.5 -24.96 66.48 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.94 -27.23 36.17 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.482 1.513 . . . . 0.0 113.019 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.38 0.62 31.14 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.428 1.014 . . . . 0.0 114.13 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.0 m -65.36 141.18 58.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.667 1.234 . . . . 0.0 110.628 169.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 mp -119.62 141.02 49.69 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.256 1.422 . . . . 0.0 110.052 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -136.77 136.85 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.731 1.612 . . . . 0.0 108.398 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -123.96 103.3 8.24 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.134 0.974 . . . . 0.0 110.161 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.69 165.07 29.83 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.376 1.084 . . . . 0.0 111.828 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.9 p -78.4 149.2 33.37 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.464 1.106 . . . . 0.0 111.081 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -62.71 -12.78 25.91 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -91.63 -15.44 28.55 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.145 1.778 . . . . 0.0 112.527 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.475 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 2.7 t-80 -78.04 134.54 37.76 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -87.49 160.13 18.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.362 0.665 . . . . 0.0 111.696 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -140.52 140.06 35.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.759 0.823 . . . . 0.0 110.501 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 44.1 ttm -74.01 108.76 7.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.389 1.075 . . . . 0.0 111.604 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.0 p -67.17 172.62 4.49 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -56.39 -23.18 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -98.01 -8.29 28.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.193 1.397 . . . . 0.0 113.165 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.14 1.49 48.16 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.065 1.317 . . . . 0.0 115.094 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -66.32 139.24 58.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.963 1.382 . . . . 0.0 111.44 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.73 76.05 1.77 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.221 1.408 . . . . 0.0 110.956 174.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.3 mt -102.4 147.63 34.27 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 124.165 0.986 . . . . 0.0 110.458 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -64.07 145.92 90.21 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.062 2.508 . . . . 0.0 110.989 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.1 tt -56.69 -28.36 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.82 -30.32 68.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.868 1.267 . . . . 0.0 113.416 172.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.42 -41.09 13.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.682 1.193 . . . . 0.0 111.155 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.52 HD13 HD21 ' A' ' 94' ' ' LEU . 67.2 mt -58.34 -41.21 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.514 1.126 . . . . 0.0 111.789 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -59.68 -33.19 71.26 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.234 1.014 . . . . 0.0 113.165 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -78.48 -46.92 18.51 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -13.73 62.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 56.01 35.36 25.43 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.711 1.604 . . . . 0.0 112.223 -175.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.2 mt -79.72 147.19 32.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.823 0.82 . . . . 0.0 111.373 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.45 172.33 13.16 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.697 0.761 . . . . 0.0 110.846 171.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.52 HD21 HD13 ' A' ' 87' ' ' ILE . 92.6 mt -116.2 157.51 24.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.342 1.057 . . . . 0.0 111.137 177.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.5 ttm -60.01 158.26 11.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.654 0.782 . . . . 0.0 111.809 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -127.13 163.23 24.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.096 1.758 . . . . 0.0 111.832 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.44 -26.43 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 125.006 1.322 . . . . 0.0 114.045 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -106.09 15.15 26.8 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.55 1.54 . . . . 0.0 112.288 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 56.93 34.42 24.83 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 123.473 1.606 . . . . 0.0 112.493 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.94 159.64 84.85 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 112.676 -2.056 . . . . 0.0 111.375 170.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.19 134.3 31.11 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.094 2.529 . . . . 0.0 111.361 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -72.27 122.88 21.86 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.897 0.879 . . . . 0.0 109.893 172.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.6 pt -146.47 142.06 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.38 1.072 . . . . 0.0 111.49 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 171.29 14.76 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.268 1.827 . . . . 0.0 112.997 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.34 109.25 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.236 1.015 . . . . 0.0 109.489 172.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.93 70.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.413 1.085 . . . . 0.0 112.149 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -152.5 167.99 27.0 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.996 1.719 . . . . 0.0 111.268 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -137.36 146.39 44.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.321 1.448 . . . . 0.0 110.677 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -139.39 120.26 14.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.582 1.153 . . . . 0.0 109.957 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -64.04 123.12 18.2 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.94 -0.475 . . . . 0.0 110.303 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 41.4 mt -90.39 -42.96 10.62 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.372 0.269 . . . . 0.0 111.688 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.83 -131.85 4.97 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.853 0.74 . . . . 0.0 112.92 -174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -131.26 72.43 1.5 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.661 1.584 . . . . 0.0 113.101 -167.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -94.41 160.86 14.47 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.831 1.653 . . . . 0.0 111.421 -170.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.05 120.67 12.47 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.519 0.728 . . . . 0.0 111.344 169.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.07 151.99 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.491 0.716 . . . . 0.0 110.635 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -143.67 162.0 37.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.393 -168.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -155.73 120.38 4.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.027 0.931 . . . . 0.0 110.142 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.1 pt -80.4 137.27 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.727 -1.233 . . . . 0.0 111.64 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.02 134.21 12.23 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.022 0.82 . . . . 0.0 111.152 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.471 0.594 0 C-N-CA 124.026 0.93 . . . . 0.0 110.553 -178.554 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.551 1.01 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -160.53 157.37 27.35 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.116 0.967 . . . . 0.0 112.149 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.05 149.48 44.84 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.64 1.176 . . . . 0.0 113.112 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.7 mt -134.93 174.68 10.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.123 2.169 . . . . 0.0 111.241 -172.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.97 146.99 4.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.246 1.018 . . . . 0.0 111.704 168.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 50.22 23.04 1.07 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.161 1.384 . . . . 0.0 114.451 -173.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.59 25.9 66.62 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 120.861 -1.149 . . . . 0.0 115.636 172.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.403 ' C ' HD12 ' A' ' 134' ' ' ILE . 16.1 m-85 -75.13 155.31 37.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.961 1.381 . . . . 0.0 112.174 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 133' ' ' PHE . 2.9 mp -129.06 103.06 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.475 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -86.67 148.1 25.6 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 170.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.3 t -132.84 147.43 52.3 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.912 1.685 . . . . 0.0 111.086 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 C--O 1.251 1.176 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.079 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.845 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -155.48 170.68 21.39 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.866 0.867 . . . . 0.0 112.11 -169.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -111.99 144.42 41.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.099 1.359 . . . . 0.0 110.029 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -67.94 159.77 29.92 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.65 -0.656 . . . . 0.0 111.868 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -48.47 -43.96 35.16 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.415 1.086 . . . . 0.0 112.761 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -13.42 29.83 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.7 m -70.51 112.35 6.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.528 1.131 . . . . 0.0 110.275 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -91.57 136.02 33.43 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.36 0.6 . . . . 0.0 111.54 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 mm -113.18 123.65 69.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 126.156 1.783 . . . . 0.0 107.512 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -62.37 129.69 41.86 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.371 0.668 . . . . 0.0 110.613 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.6 p -132.31 145.81 51.54 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.934 1.294 . . . . 0.0 111.269 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 t -75.21 -32.67 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.497 -0.752 . . . . 0.0 111.683 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -61.93 -32.56 72.97 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -142.75 -53.39 0.4 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -174.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.37 -144.25 15.9 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.181 0.896 . . . . 0.0 112.196 -171.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 mt -72.77 105.07 4.19 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.254 1.822 . . . . 0.0 111.013 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.0 mt -134.54 147.28 62.68 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.332 1.053 . . . . 0.0 113.744 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.44 127.94 19.22 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.062 3.175 . . . . 0.0 112.468 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.9 tt -55.57 -37.74 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.953 0.901 . . . . 0.0 112.859 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.35 -35.19 91.66 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.63 -0.539 . . . . 0.0 112.393 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -71.31 -33.38 69.64 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.485 1.143 . . . . 0.0 111.9 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.36 -41.82 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.584 0.754 . . . . 0.0 110.308 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.68 -42.83 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.76 0.709 . . . . 0.0 112.566 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -65.98 -29.08 69.41 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.057 0.844 . . . . 0.0 112.3 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -113.15 3.95 16.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.603 1.161 . . . . 0.0 113.484 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 48.3 50.53 16.35 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.931 2.092 . . . . 0.0 112.274 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.9 mt -68.86 117.99 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.119 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -74.23 97.81 3.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.375 1.07 . . . . 0.0 110.131 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.4 p -138.03 164.87 28.0 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.38 1.086 . . . . 0.0 113.195 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.49 154.94 17.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.523 1.529 . . . . 0.0 110.449 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.27 178.77 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.076 1.75 . . . . 0.0 110.756 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -126.18 134.68 51.2 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.511 1.524 . . . . 0.0 110.368 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -161.19 155.44 22.83 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.147 0.979 . . . . 0.0 112.068 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.8 m -79.38 146.89 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.634 1.106 . . . . 0.0 113.19 172.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.9 p30 -83.3 -178.81 7.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.174 0.99 . . . . 0.0 112.398 169.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -55.21 -31.55 61.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.495 1.118 . . . . 0.0 113.584 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -85.16 -10.13 57.06 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.723 0.809 . . . . 0.0 112.571 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.43 21.27 27.37 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.859 1.695 . . . . 0.0 114.678 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -101.9 123.29 45.57 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.193 1.496 . . . . 0.0 109.945 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.7 113.49 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.455 0.57 . . . . 0.0 109.734 177.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -116.87 177.18 4.8 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.882 2.073 . . . . 0.0 111.477 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -124.18 142.46 51.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.227 1.011 . . . . 0.0 112.832 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -154.37 152.77 26.94 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.346 1.059 . . . . 0.0 112.74 -176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.22 153.5 66.77 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.105 2.536 . . . . 0.0 112.992 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.79 140.8 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.713 1.205 . . . . 0.0 110.363 168.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.0 -52.44 5.08 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.924 -0.485 . . . . 0.0 111.333 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -150.99 177.87 9.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.153 1.781 . . . . 0.0 111.132 -175.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -135.7 137.32 41.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.069 1.348 . . . . 0.0 110.406 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -134.0 131.83 39.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.092 0.957 . . . . 0.0 111.862 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -111.71 140.8 46.03 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.591 1.556 . . . . 0.0 108.919 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -106.84 -36.32 6.7 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.79 -54.65 1.66 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.338 1.447 . . . . 0.0 113.791 175.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -169.79 104.7 0.33 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.92 1.36 . . . . 0.0 111.098 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -132.54 158.85 41.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.887 0.875 . . . . 0.0 112.896 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.92 98.55 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.427 1.491 . . . . 0.0 114.062 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.0 142.8 12.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.498 1.519 . . . . 0.0 111.593 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -128.08 135.97 50.56 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.654 1.582 . . . . 0.0 109.708 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.2 134.21 56.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.362 0.665 . . . . 0.0 110.474 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.86 96.94 4.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.694 1.197 . . . . 0.0 108.523 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 34.2 t -106.28 145.18 31.95 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.228 1.011 . . . . 0.0 110.597 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -107.93 164.56 12.16 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.625 1.17 . . . . 0.0 112.917 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -67.87 -21.54 65.16 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -80.27 -23.27 40.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.851 1.26 . . . . 0.0 113.044 172.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.02 -3.85 22.5 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.193 1.378 . . . . 0.0 114.597 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -57.0 139.17 53.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.749 1.274 . . . . 0.0 111.122 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.55 125.76 40.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.656 1.183 . . . . 0.0 109.899 -174.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.2 mt -136.21 150.7 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 108.382 -170.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -135.39 112.01 10.0 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.662 1.185 . . . . 0.0 111.316 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.14 20.83 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.626 1.571 . . . . 0.0 111.188 -175.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.9 p -84.56 161.71 20.09 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.495 -0.753 . . . . 0.0 112.077 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -67.91 -8.26 35.29 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 173.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -100.32 -12.98 19.01 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.301 1.44 . . . . 0.0 112.167 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -77.73 131.86 37.86 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 172.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -88.37 164.44 15.53 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.704 0.764 . . . . 0.0 111.308 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -138.36 135.45 35.36 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.414 0.686 . . . . 0.0 109.151 175.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.9 ttp -74.18 102.0 4.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.827 1.251 . . . . 0.0 109.6 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.6 p -64.23 172.74 2.3 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.755 1.222 . . . . 0.0 112.335 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.74 -28.91 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.4 -10.07 58.65 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.277 1.031 . . . . 0.0 113.593 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.73 -0.07 79.35 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.7 1.143 . . . . 0.0 113.954 -175.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -68.46 129.03 38.72 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.669 1.235 . . . . 0.0 109.49 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -96.25 88.42 4.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.271 1.428 . . . . 0.0 109.821 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.6 mt -115.4 147.19 38.14 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.394 1.077 . . . . 0.0 110.594 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.71 147.2 89.75 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.225 2.616 . . . . 0.0 111.323 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.11 -26.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.21 -37.88 70.25 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.591 1.156 . . . . 0.0 112.733 169.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -80.48 -39.68 27.57 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.247 0.619 . . . . 0.0 110.571 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.05 -36.7 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.26 -0.9 . . . . 0.0 111.346 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -66.49 -35.84 81.27 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.4 -36.92 28.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.716 0.806 . . . . 0.0 112.927 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -75.87 -17.98 59.6 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.573 1.149 . . . . 0.0 112.896 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 55.48 37.78 29.36 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.305 1.442 . . . . 0.0 112.63 -173.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.8 mt -82.69 146.82 28.84 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.93 0.892 . . . . 0.0 112.919 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.14 158.67 18.48 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.47 1.108 . . . . 0.0 112.049 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.7 mt -103.1 149.38 24.66 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 33.3 ttm -70.95 153.29 42.79 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 111.624 171.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -141.18 160.66 39.63 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.563 1.945 . . . . 0.0 112.539 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' HA2' ' A' ' 132' ' ' GLY . 10.0 p -101.11 -26.21 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 126.019 1.728 . . . . 0.0 113.567 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.68 5.29 9.57 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.29 1.436 . . . . 0.0 113.541 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 57.34 27.12 13.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.324 1.849 . . . . 0.0 112.344 -172.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 mt -70.97 155.52 93.26 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.416 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.07 147.65 84.47 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.234 2.622 . . . . 0.0 110.985 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -91.98 125.73 36.79 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.68 -0.638 . . . . 0.0 109.517 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -143.0 139.38 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.144 1.378 . . . . 0.0 111.454 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 173.5 11.86 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.59 1.556 . . . . 0.0 112.891 176.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.8 mt -64.39 118.79 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.348 1.459 . . . . 0.0 110.461 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.24 -44.56 65.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.333 1.053 . . . . 0.0 111.99 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -149.81 147.41 27.95 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.794 1.637 . . . . 0.0 111.137 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -140.27 142.08 35.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.139 1.776 . . . . 0.0 110.061 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -154.76 149.34 26.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.871 2.068 . . . . 0.0 110.566 170.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.14 130.77 45.27 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.751 0.42 . . . . 0.0 109.872 168.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.4 mt -103.2 -52.72 2.97 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.692 0.797 . . . . 0.0 110.857 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 167.19 -141.35 6.84 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 120.961 0.2 . . . . 0.0 113.263 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -131.41 64.6 1.58 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.188 1.47 . . . . 0.0 111.829 -168.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -85.18 158.86 20.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.805 2.042 . . . . 0.0 112.554 -167.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 114.11 4.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.063 0.945 . . . . 0.0 111.109 172.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.91 152.96 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.908 0.883 . . . . 0.0 110.314 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -143.19 158.8 43.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.858 1.663 . . . . 0.0 111.06 -170.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -153.03 134.36 14.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.016 0.927 . . . . 0.0 111.338 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.5 pt -89.99 155.14 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 121.426 -0.797 . . . . 0.0 111.133 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.88 153.37 16.99 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.02 1.295 . . . . 0.0 111.245 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.476 0.865 0 C-N-CA 125.488 1.515 . . . . 0.0 108.984 -172.586 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -174.54 154.72 2.11 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.985 1.314 . . . . 0.0 111.573 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.95 124.15 28.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.788 0.835 . . . . 0.0 112.088 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.51 173.52 5.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.688 1.195 . . . . 0.0 111.139 169.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -45.84 -42.59 12.56 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -91.35 -6.45 52.97 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.648 1.179 . . . . 0.0 113.409 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.524 ' HA2' HG12 ' A' ' 97' ' ' VAL . . . 115.95 -13.79 16.96 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 117.761 -1.577 . . . . 0.0 115.557 173.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -54.45 142.81 25.93 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.079 1.439 . . . . 0.0 112.23 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.76 92.22 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.871 0.843 . . . . 0.0 109.276 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.5 141.37 51.97 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.6 t -138.69 133.79 32.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.007 1.323 . . . . 0.0 110.973 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 C--O 1.254 1.302 0 C-N-CA 124.183 0.993 . . . . 0.0 113.493 -171.445 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.095 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -164.6 177.31 8.17 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.038 0.935 . . . . 0.0 113.354 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.473 HD13 HG21 ' A' ' 6' ' ' THR . 25.4 mt -122.3 151.01 41.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.673 1.989 . . . . 0.0 110.166 -171.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -66.29 159.93 25.58 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.633 -0.667 . . . . 0.0 112.246 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -50.49 -44.74 56.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.464 1.106 . . . . 0.0 112.956 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -64.15 -10.88 25.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.231 1.412 . . . . 0.0 114.163 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.473 HG21 HD13 ' A' ' 2' ' ' LEU . 26.7 m -66.79 94.81 0.33 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.324 1.449 . . . . 0.0 111.523 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -73.45 136.05 44.2 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.282 0.563 . . . . 0.0 111.965 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.3 mm -117.89 122.68 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.099 1.759 . . . . 0.0 107.407 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.6 tp -64.65 124.51 22.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.518 0.727 . . . . 0.0 110.696 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.7 p -125.89 156.12 40.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.683 1.193 . . . . 0.0 112.299 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.97 -31.43 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.076 0.55 . . . . 0.0 111.713 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.49 -34.87 78.72 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -141.22 -50.87 0.43 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.49 -145.14 17.19 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.682 0.673 . . . . 0.0 111.954 -172.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.9 mt -70.79 106.98 3.77 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.288 1.035 . . . . 0.0 111.091 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.8 mt -133.95 149.46 71.76 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.802 1.241 . . . . 0.0 112.697 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.05 128.15 20.03 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.06 3.173 . . . . 0.0 112.196 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 tt -54.63 -36.31 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.812 0.845 . . . . 0.0 112.755 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.97 -35.51 91.98 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 119.306 -0.719 . . . . 0.0 113.004 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -70.84 -34.08 71.31 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.785 1.292 . . . . 0.0 111.745 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.3 mt -69.49 -38.88 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.048 0.939 . . . . 0.0 110.169 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.2 t -83.75 -36.84 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.035 0.934 . . . . 0.0 113.154 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -66.98 -26.35 66.77 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.865 0.757 . . . . 0.0 112.67 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -115.61 1.48 13.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.637 1.175 . . . . 0.0 113.471 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 47.15 53.28 10.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.148 2.179 . . . . 0.0 112.476 -177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.16 115.13 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.491 0.716 . . . . 0.0 109.3 -173.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.15 108.49 3.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.441 1.096 . . . . 0.0 110.27 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.7 p -147.23 168.13 22.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.391 1.076 . . . . 0.0 112.57 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.56 148.97 25.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.656 1.582 . . . . 0.0 108.931 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.88 161.78 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.447 1.499 . . . . 0.0 110.702 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -100.17 153.26 19.4 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.418 1.087 . . . . 0.0 110.512 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.8 t -168.51 146.95 4.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.712 1.205 . . . . 0.0 111.505 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -75.23 130.36 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.127 1.371 . . . . 0.0 112.56 169.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -85.1 179.33 7.28 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.738 0.815 . . . . 0.0 111.748 171.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -57.7 -21.61 41.54 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.856 1.263 . . . . 0.0 113.43 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.76 -13.56 57.59 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.089 1.355 . . . . 0.0 113.242 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.06 4.46 89.9 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.078 1.323 . . . . 0.0 115.084 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -91.34 131.87 36.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.224 1.012 . . . . 0.0 109.787 175.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -69.91 123.82 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.504 0.722 . . . . 0.0 109.554 172.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -120.57 172.15 8.05 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.894 1.678 . . . . 0.0 110.708 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 p -121.47 139.11 53.9 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.072 0.949 . . . . 0.0 112.254 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.75 147.03 34.0 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.797 1.239 . . . . 0.0 112.946 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.3 150.18 52.39 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.118 2.546 . . . . 0.0 112.593 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.81 141.9 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.069 0.948 . . . . 0.0 111.148 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.69 -32.76 11.24 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.641 0.776 . . . . 0.0 112.611 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -170.45 179.33 3.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.316 1.847 . . . . 0.0 111.929 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -136.11 122.8 21.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.018 1.327 . . . . 0.0 109.554 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -109.43 118.42 36.59 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.682 1.193 . . . . 0.0 110.773 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.27 114.68 28.33 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.304 1.442 . . . . 0.0 109.958 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -83.33 -30.53 27.42 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.067 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.11 -44.27 2.82 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.629 1.585 . . . . 0.0 113.538 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 178.81 100.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.429 1.109 . . . . 0.0 113.073 -171.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -129.12 163.97 24.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.527 1.131 . . . . 0.0 113.415 173.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -63.27 100.41 0.24 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.994 1.718 . . . . 0.0 113.154 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.2 t -90.92 137.31 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.027 1.331 . . . . 0.0 111.21 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -120.78 136.7 54.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.44 1.496 . . . . 0.0 109.407 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.06 125.84 25.37 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.85 0.86 . . . . 0.0 110.178 172.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -117.46 99.19 6.83 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.019 1.327 . . . . 0.0 108.032 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.6 t -110.01 147.24 33.9 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.855 0.862 . . . . 0.0 110.674 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.91 164.31 12.71 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.21 1.404 . . . . 0.0 112.429 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -67.47 -24.01 65.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.991 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.96 -25.24 37.49 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.814 1.246 . . . . 0.0 113.272 174.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.07 -7.37 11.81 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.072 1.32 . . . . 0.0 114.75 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -55.47 143.53 28.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.766 1.283 . . . . 0.0 111.542 175.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.47 124.3 31.69 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.535 1.134 . . . . 0.0 110.203 -173.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 43.8 mt -135.11 151.88 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 127.121 2.168 . . . . 0.0 108.225 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -136.59 113.04 9.99 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.575 1.15 . . . . 0.0 110.552 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.89 166.34 25.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.849 1.26 . . . . 0.0 111.967 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 p -83.73 152.11 24.88 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.75 0.82 . . . . 0.0 111.354 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -61.46 -15.17 34.89 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 175.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -89.32 -16.76 30.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.885 1.674 . . . . 0.0 112.246 -176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -80.17 131.5 35.73 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -89.15 156.92 18.5 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.271 0.558 . . . . 0.0 111.444 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -135.93 141.03 44.46 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.657 0.783 . . . . 0.0 109.271 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 46.7 ttm -68.83 108.38 3.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.946 0.898 . . . . 0.0 110.124 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.6 p -70.81 169.84 13.77 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.776 -0.578 . . . . 0.0 112.026 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.4 m -54.56 -23.94 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 174.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -87.63 -7.25 57.7 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.024 . . . . 0.0 113.317 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.45 7.16 65.44 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.402 1.477 . . . . 0.0 113.939 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -79.95 126.64 31.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.228 1.014 . . . . 0.0 110.346 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.28 92.22 6.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.3 1.04 . . . . 0.0 110.433 169.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.7 mt -116.77 146.3 37.41 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.95 0.9 . . . . 0.0 110.978 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.13 146.46 86.91 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.226 2.617 . . . . 0.0 111.061 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.426 HG13 HD11 ' A' ' 105' ' ' ILE . 12.8 tt -59.05 -27.74 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -55.9 -35.55 66.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.531 1.132 . . . . 0.0 113.109 169.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -85.03 -34.71 22.26 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.895 -0.503 . . . . 0.0 111.405 175.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.55 -39.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 119.385 0.993 . . . . 0.0 110.762 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -64.69 -39.16 93.18 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -76.74 -39.35 52.07 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -78.12 -13.15 59.98 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 56.87 30.11 17.32 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.785 1.234 . . . . 0.0 112.151 -174.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.41 142.95 46.93 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.996 0.918 . . . . 0.0 111.302 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -90.78 135.37 33.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.071 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.413 ' HB2' HH12 ' A' ' 96' ' ' ARG . 9.7 mp -66.42 150.78 48.4 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.059 -1.026 . . . . 0.0 111.141 168.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.8 ttp -72.66 172.37 10.79 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.326 0.584 . . . . 0.0 111.791 171.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.413 HH12 ' HB2' ' A' ' 94' ' ' LEU . 87.6 mmt-85 -137.12 164.05 29.35 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.729 1.612 . . . . 0.0 111.433 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 m -106.8 -22.75 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -107.35 21.6 17.25 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.962 1.305 . . . . 0.0 112.386 -172.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 56.08 29.42 14.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.776 1.63 . . . . 0.0 112.454 -172.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.6 mt -63.35 159.26 51.26 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.921 171.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.92 143.99 56.95 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.249 2.633 . . . . 0.0 111.426 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.98 121.23 31.87 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.752 0.821 . . . . 0.0 109.015 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.4 pt -142.22 122.47 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.732 1.213 . . . . 0.0 110.738 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -67.34 170.52 7.17 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.285 1.834 . . . . 0.0 112.962 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.426 HD11 HG13 ' A' ' 84' ' ' ILE . 6.7 mt -61.58 120.1 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.306 1.442 . . . . 0.0 110.194 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.96 -47.29 66.0 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.718 0.807 . . . . 0.0 111.614 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 p -152.29 151.88 31.47 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.351 1.46 . . . . 0.0 111.001 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.65 141.79 48.8 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.057 1.743 . . . . 0.0 110.048 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 134.55 15.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.484 1.913 . . . . 0.0 109.484 177.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -65.1 133.81 52.43 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.081 0.152 . . . . 0.0 110.755 170.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.2 mt -100.97 -42.65 6.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.009 0.524 . . . . 0.0 112.009 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.49 -149.94 21.71 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.665 1.126 . . . . 0.0 111.798 -173.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -123.27 100.16 6.71 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.542 1.137 . . . . 0.0 111.458 -170.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -115.13 155.22 27.5 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.253 1.421 . . . . 0.0 109.88 -171.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 116.78 6.27 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.305 0.642 . . . . 0.0 110.144 172.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.14 150.94 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.396 0.678 . . . . 0.0 110.887 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -139.29 156.15 47.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.305 1.442 . . . . 0.0 111.743 -170.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -157.5 121.35 4.17 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.814 1.245 . . . . 0.0 110.071 -173.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.7 pt -80.52 143.73 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 120.706 -1.246 . . . . 0.0 111.523 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.71 153.97 20.51 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.902 0.763 . . . . 0.0 111.799 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 125.216 1.406 . . . . 0.0 109.739 -173.182 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -166.28 150.86 7.89 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.222 1.409 . . . . 0.0 110.817 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.39 142.16 30.34 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.842 0.857 . . . . 0.0 112.309 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.3 mt -102.16 171.21 7.62 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.675 1.19 . . . . 0.0 112.054 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -19.33 8.28 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -103.74 11.18 36.21 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.516 1.526 . . . . 0.0 112.958 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.04 21.52 75.92 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 121.336 -0.852 . . . . 0.0 113.844 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.41 ' C ' HD12 ' A' ' 134' ' ' ILE . 3.1 m-85 -87.39 163.72 16.61 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.644 1.578 . . . . 0.0 111.985 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.41 HD12 ' C ' ' A' ' 133' ' ' PHE . 3.3 mp -133.01 100.81 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.746 1.218 . . . . 0.0 108.948 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.98 149.68 26.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.9 t -140.83 141.09 34.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.379 0.672 . . . . 0.0 112.477 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.919 1.287 . . . . 0.0 113.097 -173.498 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 CA-C-O 121.134 0.297 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.92 177.91 9.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.445 1.498 . . . . 0.0 112.14 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.99 144.33 44.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.982 1.713 . . . . 0.0 110.383 -172.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -68.86 163.67 23.77 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.633 -0.667 . . . . 0.0 112.441 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -50.83 -42.86 58.82 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.642 -0.661 . . . . 0.0 112.411 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -65.73 -13.95 60.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.814 1.246 . . . . 0.0 114.116 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.2 m -71.0 120.39 16.5 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.515 0.726 . . . . 0.0 110.725 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -102.27 138.38 39.29 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.495 0.664 . . . . 0.0 111.633 -176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.15 116.66 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 126.198 1.799 . . . . 0.0 107.585 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tt -63.12 124.49 21.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.706 0.402 . . . . 0.0 111.19 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.3 p -118.53 155.84 30.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.85 1.26 . . . . 0.0 112.144 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.8 -35.72 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.789 0.836 . . . . 0.0 111.14 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -67.36 -32.42 73.35 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -140.13 -50.29 0.47 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.53 -143.91 15.71 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.147 0.879 . . . . 0.0 112.656 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.36 96.14 0.65 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.381 1.872 . . . . 0.0 112.846 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -129.87 149.63 73.62 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.844 1.258 . . . . 0.0 112.591 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.68 130.26 23.01 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.404 3.403 . . . . 0.0 113.127 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 tt -57.44 -37.59 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.002 0.921 . . . . 0.0 112.922 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.36 -31.34 78.65 Favored Glycine 0 CA--C 1.529 0.917 0 O-C-N 121.718 -0.614 . . . . 0.0 112.846 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -72.06 -38.68 69.43 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.094 0.947 . . . . 0.0 111.317 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.73 -39.34 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.619 0.767 . . . . 0.0 109.76 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.5 t -80.99 -38.92 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.874 0.87 . . . . 0.0 112.938 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.72 -23.94 56.14 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.74 1.155 . . . . 0.0 113.297 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -108.58 2.02 21.8 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.202 1.401 . . . . 0.0 112.12 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.89 52.12 11.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.32 2.248 . . . . 0.0 113.04 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.6 mt -76.35 122.4 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.964 0.906 . . . . 0.0 110.055 -170.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.77 96.59 3.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.655 1.182 . . . . 0.0 111.595 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 68.3 m -135.4 173.45 11.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.072 1.349 . . . . 0.0 112.732 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 m -121.42 140.21 52.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.705 1.602 . . . . 0.0 108.969 -176.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.9 m -125.35 163.21 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.637 1.575 . . . . 0.0 111.19 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -97.94 147.59 24.31 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.597 1.159 . . . . 0.0 110.362 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -157.55 156.21 31.55 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.806 1.642 . . . . 0.0 109.577 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 t -102.6 127.42 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.807 0.843 . . . . 0.0 109.757 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -69.24 175.25 4.01 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.931 1.292 . . . . 0.0 112.58 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -61.47 -26.73 68.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.024 1.33 . . . . 0.0 113.424 175.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -87.84 0.75 55.39 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.242 1.417 . . . . 0.0 113.41 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.98 18.88 76.13 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.771 1.176 . . . . 0.0 114.655 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -92.3 132.89 36.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.598 1.159 . . . . 0.0 110.122 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.14 131.08 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -137.77 176.74 8.43 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.537 1.935 . . . . 0.0 110.715 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 p -125.87 143.53 51.03 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.273 1.029 . . . . 0.0 112.397 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -143.2 141.62 19.81 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.654 1.182 . . . . 0.0 112.336 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.73 150.12 49.69 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.832 2.355 . . . . 0.0 111.464 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.55 136.81 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.381 0.672 . . . . 0.0 110.856 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.45 -45.9 5.95 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.533 0.733 . . . . 0.0 111.832 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -146.16 178.99 7.81 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.287 1.835 . . . . 0.0 111.278 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -135.05 120.64 19.36 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.498 1.519 . . . . 0.0 109.23 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -116.19 119.26 35.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.185 0.994 . . . . 0.0 110.79 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -107.61 113.43 26.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.322 1.449 . . . . 0.0 109.908 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -82.19 -29.93 31.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.778 0.831 . . . . 0.0 112.965 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.54 -54.62 2.37 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.474 1.511 . . . . 0.0 113.888 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -170.33 103.09 0.27 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.157 1.383 . . . . 0.0 111.057 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -132.28 164.88 25.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.226 1.011 . . . . 0.0 111.69 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.55 99.65 0.23 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.594 1.558 . . . . 0.0 113.638 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 t -95.99 141.22 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.499 1.52 . . . . 0.0 111.589 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.83 137.76 54.61 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.239 1.816 . . . . 0.0 109.975 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.66 133.52 56.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.864 0.865 . . . . 0.0 110.715 171.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -127.55 89.29 2.93 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.023 1.329 . . . . 0.0 108.314 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.4 t -97.48 149.24 22.39 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.348 1.059 . . . . 0.0 110.731 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.15 163.53 15.82 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.212 1.405 . . . . 0.0 112.387 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.36 -20.54 63.84 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -81.45 -17.86 47.28 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.238 1.015 . . . . 0.0 113.171 170.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.26 -3.62 33.19 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.042 1.306 . . . . 0.0 114.207 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.9 m -57.71 142.31 45.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.522 1.129 . . . . 0.0 110.994 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -130.9 126.18 35.46 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.712 0.805 . . . . 0.0 111.351 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.5 mt -135.22 152.38 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 126.85 2.06 . . . . 0.0 107.674 -171.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.99 115.29 11.07 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.848 1.259 . . . . 0.0 110.528 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.09 163.24 34.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.626 1.171 . . . . 0.0 111.291 -176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.4 p -78.94 153.2 30.6 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.575 -0.703 . . . . 0.0 111.415 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.49 -24.17 65.08 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -84.05 -10.08 58.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.617 1.167 . . . . 0.0 112.836 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -82.44 133.96 35.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -97.12 156.12 16.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.536 1.134 . . . . 0.0 111.521 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.48 141.26 46.7 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.08 -1.012 . . . . 0.0 110.822 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.8 ttm -73.03 100.13 2.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.043 0.937 . . . . 0.0 109.594 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.5 p -66.96 170.74 6.26 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.8 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -56.09 -20.33 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.94 -4.01 28.46 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.653 1.181 . . . . 0.0 113.307 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 3.79 72.8 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.244 1.402 . . . . 0.0 113.913 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -65.42 122.97 18.39 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.381 1.072 . . . . 0.0 110.55 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.6 mtt -84.71 73.28 10.62 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.703 2.001 . . . . 0.0 110.766 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 43.6 mt -105.93 147.71 35.25 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 123.483 0.713 . . . . 0.0 110.97 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.78 148.27 86.43 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.11 2.54 . . . . 0.0 110.924 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 tt -53.46 -34.62 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.84 -33.12 70.05 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -77.15 -34.78 56.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.625 0.77 . . . . 0.0 111.15 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.1 mt -67.4 -39.4 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.782 0.833 . . . . 0.0 110.367 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -64.2 -34.26 77.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.953 0.901 . . . . 0.0 112.956 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -73.94 -47.25 38.89 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.01 -9.23 58.56 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 58.7 34.18 23.6 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.892 1.277 . . . . 0.0 112.325 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.89 143.85 35.48 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 122.172 0.987 . . . . 0.0 111.905 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.3 158.83 24.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.447 1.099 . . . . 0.0 111.623 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.51 152.2 21.03 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.39 -0.819 . . . . 0.0 111.922 169.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -75.15 146.5 41.27 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.176 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 166.05 23.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.047 1.339 . . . . 0.0 114.135 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.7 m -105.03 -30.03 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.561 1.544 . . . . 0.0 113.07 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.03 -2.73 56.08 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.326 1.05 . . . . 0.0 113.108 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.278 8.6 m-80 59.14 36.0 23.87 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.988 1.375 . . . . 0.0 112.991 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.9 mt -61.89 157.71 48.36 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.839 167.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.5 140.86 84.11 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.633 2.222 . . . . 0.0 110.39 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -66.56 126.05 27.69 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.999 -0.438 . . . . 0.0 110.496 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.5 pt -143.75 132.89 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.946 1.298 . . . . 0.0 111.013 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 176.31 7.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.202 1.401 . . . . 0.0 111.74 176.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.8 mt -64.13 109.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.731 1.212 . . . . 0.0 110.19 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.6 94.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.481 1.112 . . . . 0.0 112.287 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.0 p -151.43 153.25 34.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.939 1.696 . . . . 0.0 111.25 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -137.3 143.19 42.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.956 1.702 . . . . 0.0 110.335 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -152.33 148.31 27.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.591 2.356 . . . . 0.0 110.454 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -72.02 124.17 24.36 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.897 0.479 . . . . 0.0 110.081 168.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.2 mt -91.09 -44.81 9.05 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.022 0.529 . . . . 0.0 111.649 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.13 -145.73 13.9 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.056 0.836 . . . . 0.0 113.116 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -122.44 51.76 1.36 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 123.103 1.43 . . . . 0.0 113.66 -166.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -72.7 158.17 36.12 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 127.64 2.376 . . . . 0.0 112.53 -168.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.58 118.16 6.69 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.992 0.917 . . . . 0.0 111.417 171.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.8 m -126.09 156.2 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.41 0.684 . . . . 0.0 111.789 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -144.31 159.01 43.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.733 1.613 . . . . 0.0 111.559 -168.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -155.78 128.73 8.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.43 1.092 . . . . 0.0 109.952 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.43 142.55 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 121.292 -0.88 . . . . 0.0 111.281 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.65 136.36 14.87 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 126.01 1.724 . . . . 0.0 109.922 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -163.3 164.79 24.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.443 1.497 . . . . 0.0 112.437 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.75 141.41 28.53 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.675 1.19 . . . . 0.0 112.949 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.4 mt -91.53 171.76 8.97 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.658 1.983 . . . . 0.0 111.997 175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -50.49 -50.84 51.61 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.794 1.638 . . . . 0.0 115.171 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -68.06 -26.96 66.11 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.211 0.604 . . . . 0.0 111.825 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 120.48 -3.0 12.4 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.667 1.603 . . . . 0.0 114.096 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -69.07 163.82 23.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.144 1.472 . . . . 0.0 111.874 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.14 136.97 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 122.033 0.92 . . . . 0.0 110.629 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -121.51 151.48 40.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.37 1.868 . . . . 0.0 109.593 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.6 t -142.81 135.93 28.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.826 0.851 . . . . 0.0 113.089 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.2 t30 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.76 1.224 . . . . 0.0 113.131 -176.099 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.095 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.41 176.73 10.81 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.309 0.644 . . . . 0.0 112.544 -169.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.7 mt -116.74 147.41 42.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.352 1.861 . . . . 0.0 110.415 -173.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t -62.88 161.77 12.25 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -52.37 -44.77 65.46 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.146 -0.971 . . . . 0.0 111.474 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -56.34 -25.47 49.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.721 1.609 . . . . 0.0 114.044 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.6 m -65.5 103.62 0.87 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.883 1.273 . . . . 0.0 112.023 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -85.15 136.09 33.69 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.642 -0.661 . . . . 0.0 111.864 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 mm -109.4 131.94 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.535 1.534 . . . . 0.0 107.875 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -69.7 122.76 19.79 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 122.082 -0.386 . . . . 0.0 111.433 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.7 p -120.63 151.19 39.78 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.716 1.206 . . . . 0.0 112.315 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 t -75.74 -37.34 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.169 0.587 . . . . 0.0 111.84 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.04 -28.4 68.83 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -141.37 -51.12 0.43 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.29 -156.52 23.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.261 0.934 . . . . 0.0 112.505 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.87 105.9 0.43 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.431 1.092 . . . . 0.0 111.163 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.5 mt -135.52 149.75 70.26 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 124.746 1.218 . . . . 0.0 112.888 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.13 128.45 21.71 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.975 3.117 . . . . 0.0 112.351 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.4 tt -56.47 -35.94 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.793 0.837 . . . . 0.0 113.058 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.28 -33.97 88.66 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.548 -0.585 . . . . 0.0 113.072 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -69.33 -35.06 75.55 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.207 1.003 . . . . 0.0 111.806 174.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.3 mt -69.43 -41.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.581 0.752 . . . . 0.0 110.311 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -78.99 -39.67 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.808 0.731 . . . . 0.0 112.435 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.94 -23.67 60.71 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.32 0.964 . . . . 0.0 113.19 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.16 4.09 19.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.975 1.31 . . . . 0.0 112.65 176.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 50.16 45.73 25.41 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.916 1.686 . . . . 0.0 112.643 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.23 127.69 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.944 0.898 . . . . 0.0 109.399 -172.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -78.73 111.21 14.62 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.365 0.602 . . . . 0.0 110.319 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.8 p -133.9 -172.39 2.97 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.263 1.425 . . . . 0.0 111.005 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.3 157.03 35.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.687 1.595 . . . . 0.0 109.103 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.1 m -140.25 163.52 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.588 1.155 . . . . 0.0 111.026 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -104.43 139.96 38.62 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.204 1.402 . . . . 0.0 110.43 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -159.43 150.92 20.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.442 1.497 . . . . 0.0 110.528 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 m -83.41 148.11 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.423 1.01 . . . . 0.0 112.941 171.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.84 -179.92 7.4 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.836 0.854 . . . . 0.0 111.405 169.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -60.76 -20.68 61.88 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.89 1.276 . . . . 0.0 113.023 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -91.75 0.62 57.48 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.682 1.593 . . . . 0.0 113.277 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.2 26.67 63.47 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 121.114 -0.991 . . . . 0.0 114.223 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -107.58 120.21 41.56 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.621 1.568 . . . . 0.0 109.231 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.716 HD13 HG23 ' A' ' 97' ' ' VAL . 67.9 mt -65.45 125.98 23.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 123.594 0.758 . . . . 0.0 109.431 173.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -129.09 173.08 10.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.359 1.863 . . . . 0.0 111.403 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -117.18 142.4 47.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.946 1.298 . . . . 0.0 112.413 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -146.71 142.68 17.51 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.27 1.028 . . . . 0.0 112.873 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.5 154.5 50.28 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.116 2.544 . . . . 0.0 111.813 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.7 t -62.36 140.8 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.615 -0.678 . . . . 0.0 110.062 169.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.9 -40.95 4.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.311 0.645 . . . . 0.0 112.27 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -138.13 164.45 29.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.565 1.146 . . . . 0.0 112.306 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -133.87 131.36 39.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.294 1.838 . . . . 0.0 108.362 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.26 130.78 50.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.022 1.329 . . . . 0.0 111.157 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -139.45 136.56 34.76 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.568 -1.333 . . . . 0.0 112.535 -171.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -111.39 -32.75 6.62 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.201 -1.363 . . . . 0.0 114.62 -168.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.49 -60.75 2.5 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.306 1.431 . . . . 0.0 114.152 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -157.26 96.47 1.56 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.436 1.494 . . . . 0.0 112.616 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -130.11 162.1 29.57 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.391 1.076 . . . . 0.0 113.365 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.23 106.6 2.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.538 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 t -100.26 139.12 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.905 1.282 . . . . 0.0 111.247 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.405 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 38.9 m-85 -124.58 140.61 52.78 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.765 1.226 . . . . 0.0 109.973 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -85.02 123.59 30.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.058 1.343 . . . . 0.0 109.485 169.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.1 100.24 8.45 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.352 1.461 . . . . 0.0 108.934 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.6 t -83.41 145.3 29.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.22 1.008 . . . . 0.0 111.355 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mp -103.92 157.7 16.91 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.434 1.494 . . . . 0.0 112.276 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.56 -20.19 65.37 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -84.22 -16.23 44.06 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 176.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.32 -2.56 25.19 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.302 1.429 . . . . 0.0 114.405 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.4 m -70.16 157.82 36.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.923 1.289 . . . . 0.0 112.746 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.88 148.79 50.49 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.418 1.487 . . . . 0.0 110.855 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -140.01 143.91 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.963 2.105 . . . . 0.0 107.912 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -136.37 112.12 9.45 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.672 1.189 . . . . 0.0 112.382 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.33 172.12 18.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.498 1.119 . . . . 0.0 112.786 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.9 p -86.98 161.78 18.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.341 0.657 . . . . 0.0 110.964 168.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.405 ' HE3' ' CD1' ' A' ' 56' ' ' PHE . 2.2 mptm? -59.88 -25.81 65.37 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 175.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -85.07 -15.52 43.72 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.16 1.384 . . . . 0.0 112.766 -174.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -73.19 132.52 43.32 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 153.03 18.02 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.253 0.933 . . . . 0.0 112.787 176.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -131.94 137.14 47.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.252 -0.905 . . . . 0.0 109.143 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.1 ttp -81.47 113.14 19.33 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.291 0.567 . . . . 0.0 110.066 -173.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.2 p -69.87 171.43 9.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.466 0.706 . . . . 0.0 112.035 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -57.35 -23.67 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 174.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -82.26 -12.93 57.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.663 1.185 . . . . 0.0 113.394 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.06 3.35 70.19 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.247 0.927 . . . . 0.0 114.112 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -77.36 151.85 34.7 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.425 1.112 . . . . 0.0 110.826 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 ptp -119.78 93.93 4.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.565 1.146 . . . . 0.0 110.635 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.4 mt -120.4 149.06 49.03 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.109 1.364 . . . . 0.0 109.905 -170.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.74 145.98 91.57 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.546 2.164 . . . . 0.0 111.344 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.69 -28.69 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -57.85 -37.14 73.35 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.524 1.53 . . . . 0.0 113.289 171.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.07 -43.51 21.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.194 0.997 . . . . 0.0 110.511 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.61 -41.14 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.526 1.13 . . . . 0.0 111.438 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.3 -35.53 80.68 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -80.69 -40.82 24.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.754 0.822 . . . . 0.0 113.03 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -76.95 -13.76 59.94 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.222 1.009 . . . . 0.0 113.284 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 57.75 35.53 25.63 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.872 1.669 . . . . 0.0 112.872 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.89 148.11 25.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.008 0.923 . . . . 0.0 112.561 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -87.19 163.12 17.1 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.551 1.14 . . . . 0.0 113.174 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.2 mt -113.42 153.93 27.81 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.785 1.234 . . . . 0.0 112.5 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 10.7 ttp -81.98 145.08 30.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.189 0.595 . . . . 0.0 111.214 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.92 177.75 7.04 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.773 1.229 . . . . 0.0 113.874 -173.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.716 HG23 HD13 ' A' ' 39' ' ' ILE . 5.1 p -121.44 -25.69 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 126.149 1.78 . . . . 0.0 114.597 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -85.04 6.37 25.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.09 1.356 . . . . 0.0 113.382 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 56.42 32.11 20.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.969 1.708 . . . . 0.0 112.349 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.0 mt -67.41 158.31 82.64 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.76 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.04 147.13 88.68 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.935 2.423 . . . . 0.0 111.166 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -71.46 118.74 14.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.667 0.787 . . . . 0.0 109.989 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.6 126.37 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.895 1.278 . . . . 0.0 112.018 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.85 175.03 7.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.61 1.564 . . . . 0.0 112.393 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.12 106.9 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.68 1.592 . . . . 0.0 110.933 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.8 -41.05 62.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.573 1.149 . . . . 0.0 112.074 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.3 p -152.37 165.89 33.58 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.145 1.778 . . . . 0.0 111.84 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -136.05 143.54 44.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.602 1.561 . . . . 0.0 111.436 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -139.6 130.71 26.48 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.653 1.181 . . . . 0.0 110.88 171.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -67.55 131.31 45.39 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.918 -0.489 . . . . 0.0 110.931 173.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.2 mt -96.64 -42.78 7.86 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.015 0.526 . . . . 0.0 112.32 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.79 -151.59 23.23 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.421 1.01 . . . . 0.0 113.014 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -118.56 69.11 0.79 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.267 1.508 . . . . 0.0 112.417 -168.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -91.85 160.05 15.49 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 127.064 2.146 . . . . 0.0 111.443 -168.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.3 121.31 14.95 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 123.4 0.68 . . . . 0.0 111.075 169.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.81 148.41 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.476 0.655 . . . . 0.0 111.465 174.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -141.55 157.56 44.96 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.171 1.789 . . . . 0.0 111.884 -169.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -148.76 165.75 30.49 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.475 1.51 . . . . 0.0 112.653 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.7 pt -136.76 153.9 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.195 1.798 . . . . 0.0 111.104 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.91 166.69 24.56 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.856 0.741 . . . . 0.0 114.242 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.475 0.787 0 C-N-CA 124.924 1.29 . . . . 0.0 110.608 -174.489 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -161.51 158.81 27.08 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.201 1.4 . . . . 0.0 112.307 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.57 128.62 36.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.836 1.254 . . . . 0.0 111.693 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.8 mt -72.54 175.23 6.49 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.282 1.433 . . . . 0.0 113.319 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -51.03 -35.69 35.66 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -93.4 -5.21 49.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.417 1.087 . . . . 0.0 112.86 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 97' ' ' VAL . . . 109.12 -20.12 28.93 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 125.307 1.432 . . . . 0.0 114.447 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -53.51 133.21 40.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.379 1.072 . . . . 0.0 111.476 -173.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.5 mm -82.27 130.31 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.979 0.895 . . . . 0.0 110.938 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -108.79 141.24 41.09 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 126.951 2.1 . . . . 0.0 108.964 170.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.4 t -146.97 140.1 25.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.236 1.014 . . . . 0.0 113.291 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 CA--C 1.556 1.198 0 C-N-CA 125.846 1.658 . . . . 0.0 114.572 -173.569 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 122.206 0.892 . . . . 0.0 113.566 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.94 171.19 15.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.902 1.681 . . . . 0.0 111.202 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.0 mt -120.15 140.41 51.14 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.794 2.038 . . . . 0.0 110.067 -168.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 t -72.59 162.46 29.44 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.47 -0.769 . . . . 0.0 111.62 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -48.35 -43.3 33.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.416 1.086 . . . . 0.0 112.79 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -10.21 5.41 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -75.95 107.82 8.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.449 1.1 . . . . 0.0 110.034 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -100.41 138.2 37.8 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.455 -0.778 . . . . 0.0 112.013 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.7 mm -121.34 116.88 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.414 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.3 tt -60.99 127.08 29.81 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.212 0.605 . . . . 0.0 111.003 175.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.8 p -121.7 157.19 31.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.451 1.101 . . . . 0.0 112.697 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -78.01 -34.63 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.438 0.695 . . . . 0.0 111.462 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.67 -30.69 65.99 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -137.77 -48.73 0.57 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.71 -147.67 17.27 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.346 0.974 . . . . 0.0 112.664 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 4.7 mt -64.23 104.46 0.75 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.711 2.005 . . . . 0.0 110.722 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.1 mt -141.06 150.6 59.58 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 124.814 1.246 . . . . 0.0 114.021 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.89 133.15 28.39 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.774 3.649 . . . . 0.0 113.829 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 tt -59.0 -34.5 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.202 1.001 . . . . 0.0 113.174 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.96 -35.23 91.73 Favored Glycine 0 C--N 1.338 0.652 0 O-C-N 121.875 -0.516 . . . . 0.0 112.157 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -72.73 -32.57 65.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.07 0.935 . . . . 0.0 111.553 176.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -64.76 -38.56 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.309 0.643 . . . . 0.0 110.64 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.4 t -86.38 -38.23 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 118.953 0.797 . . . . 0.0 112.462 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -68.21 -27.58 66.51 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.313 -0.867 . . . . 0.0 113.099 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -114.91 5.61 15.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.956 1.302 . . . . 0.0 113.104 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 49.38 44.2 23.65 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 127.336 2.254 . . . . 0.0 112.798 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.8 mt -67.35 127.21 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.496 1.118 . . . . 0.0 109.522 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -99.01 104.25 16.27 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.634 1.174 . . . . 0.0 111.273 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 62.3 m -136.4 -178.44 5.17 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.505 1.522 . . . . 0.0 111.487 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.8 m -116.21 144.51 44.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.286 1.434 . . . . 0.0 108.534 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.32 160.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.001 1.72 . . . . 0.0 110.083 -175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -99.24 147.67 24.91 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.379 1.072 . . . . 0.0 110.3 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 t -159.43 160.17 34.52 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.296 1.438 . . . . 0.0 109.899 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -100.01 125.07 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.966 0.906 . . . . 0.0 110.201 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -69.62 176.48 3.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.993 1.317 . . . . 0.0 112.584 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -63.5 -26.16 68.59 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.136 1.374 . . . . 0.0 112.949 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.31 -5.31 59.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.045 1.338 . . . . 0.0 113.687 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.86 21.82 58.84 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.464 1.03 . . . . 0.0 114.873 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -96.81 133.1 41.83 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.657 1.183 . . . . 0.0 109.83 172.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.7 mt -74.09 129.26 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -137.59 179.63 6.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.961 2.105 . . . . 0.0 110.949 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.0 p -129.25 144.7 51.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.421 1.089 . . . . 0.0 113.124 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -149.15 142.32 15.9 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.063 1.345 . . . . 0.0 112.314 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.1 155.2 42.42 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.124 2.549 . . . . 0.0 112.981 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.0 t -62.62 132.52 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.344 0.657 . . . . 0.0 110.085 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.71 -48.21 7.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.411 0.684 . . . . 0.0 112.105 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -149.67 172.3 15.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.865 1.666 . . . . 0.0 111.525 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -132.27 129.44 39.61 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.947 1.699 . . . . 0.0 109.096 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -133.4 138.1 46.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.083 0.944 . . . . 0.0 111.418 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -129.08 118.69 22.93 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.123 1.369 . . . . 0.0 110.609 -172.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -84.01 -33.5 24.52 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.806 1.242 . . . . 0.0 112.708 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.01 -51.4 1.46 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.111 1.339 . . . . 0.0 113.62 173.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -172.57 106.35 0.17 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.414 1.485 . . . . 0.0 110.518 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -132.49 168.0 18.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.32 1.048 . . . . 0.0 112.402 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -67.87 101.76 1.14 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.05 140.61 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.765 1.226 . . . . 0.0 111.496 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -122.6 141.26 51.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.657 1.583 . . . . 0.0 110.534 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.55 126.11 26.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.224 1.41 . . . . 0.0 110.583 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -122.78 82.96 2.05 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.451 1.9 . . . . 0.0 108.476 177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 t -86.33 147.84 25.87 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.803 0.841 . . . . 0.0 111.175 171.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.55 165.38 11.71 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.308 1.443 . . . . 0.0 112.814 175.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.61 -23.71 66.88 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -82.35 -19.82 38.52 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.86 -1.4 27.29 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.191 1.377 . . . . 0.0 114.596 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.6 m -57.91 140.98 50.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.498 1.649 . . . . 0.0 110.922 170.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tp -127.01 130.05 49.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.384 1.074 . . . . 0.0 109.884 -174.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mt -139.65 150.26 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.715 1.606 . . . . 0.0 108.145 -170.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -134.0 109.74 9.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.853 1.261 . . . . 0.0 110.86 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.17 169.62 17.24 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.498 1.119 . . . . 0.0 112.519 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 p -86.19 149.26 25.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.89 1.276 . . . . 0.0 111.467 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -62.23 -17.39 58.19 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -86.54 -14.4 43.08 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.053 1.341 . . . . 0.0 112.971 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -79.42 135.52 36.7 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.153 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -93.82 152.41 18.93 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.026 0.917 . . . . 0.0 113.234 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.86 129.2 32.0 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.953 0.901 . . . . 0.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ttp -74.85 111.47 10.09 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.155 0.503 . . . . 0.0 110.416 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 p -71.09 173.48 7.53 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.472 0.653 . . . . 0.0 112.313 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.88 -24.01 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -91.41 -6.52 52.71 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.501 1.12 . . . . 0.0 113.205 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.81 5.81 59.69 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.345 0.974 . . . . 0.0 113.941 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -77.55 126.32 30.7 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.189 0.994 . . . . 0.0 110.906 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.62 78.57 7.74 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.138 1.375 . . . . 0.0 110.702 173.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 mt -104.68 147.77 34.96 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 123.553 0.741 . . . . 0.0 110.673 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.49 147.71 87.07 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.578 2.185 . . . . 0.0 110.603 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.5 tt -60.67 -28.88 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.28 -27.8 62.44 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.419 1.488 . . . . 0.0 113.331 169.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.51 -40.7 18.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.275 1.03 . . . . 0.0 111.528 173.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.82 -37.86 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.317 1.047 . . . . 0.0 110.93 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.8 -35.66 77.04 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.29 -48.24 17.94 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.325 -0.859 . . . . 0.0 113.063 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -14.21 62.23 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 55.75 32.82 20.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.987 1.315 . . . . 0.0 112.225 -172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 42.4 mt -70.43 140.31 51.99 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.997 0.919 . . . . 0.0 111.47 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.01 146.59 25.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.44 0.696 . . . . 0.0 110.847 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 mp -79.2 153.26 30.14 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.449 -0.782 . . . . 0.0 111.553 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.5 ttm -72.45 149.23 44.4 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.87 -0.519 . . . . 0.0 110.812 172.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.64 167.77 15.23 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.001 1.32 . . . . 0.0 113.892 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.434 HG22 ' HA2' ' A' ' 132' ' ' GLY . 2.8 m -118.75 -23.76 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 125.774 1.63 . . . . 0.0 113.235 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -88.98 5.22 45.22 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.997 1.319 . . . . 0.0 112.71 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 64.49 19.8 11.93 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.496 1.518 . . . . 0.0 112.32 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.1 mt -49.53 156.81 1.06 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.441 1.496 . . . . 0.0 112.028 169.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.3 145.22 88.15 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.64 2.226 . . . . 0.0 110.68 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -68.47 120.44 14.54 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.693 -0.629 . . . . 0.0 110.177 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.4 pt -145.1 159.79 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.289 1.436 . . . . 0.0 111.586 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -128.11 -179.69 5.13 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.28 1.832 . . . . 0.0 111.939 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.0 mt -56.78 110.65 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 125.671 1.589 . . . . 0.0 110.777 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.63 -40.84 66.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.609 1.164 . . . . 0.0 112.273 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.1 p -150.61 162.42 40.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.187 1.795 . . . . 0.0 111.022 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.04 144.13 40.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.634 1.174 . . . . 0.0 111.53 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -156.7 127.12 6.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.488 1.515 . . . . 0.0 110.486 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.06 123.29 18.66 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.775 -0.578 . . . . 0.0 110.234 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 mt -90.56 -42.71 10.66 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.737 0.415 . . . . 0.0 111.812 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.21 -136.27 6.68 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.887 0.756 . . . . 0.0 112.865 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.6 tttp -133.43 77.8 1.74 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.705 1.241 . . . . 0.0 113.089 -168.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -95.24 157.1 16.04 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.335 1.454 . . . . 0.0 110.858 -171.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.79 118.19 6.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.603 0.761 . . . . 0.0 110.525 169.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.6 m -123.02 151.83 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.455 0.645 . . . . 0.0 111.432 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -139.8 159.14 42.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.811 1.644 . . . . 0.0 111.436 -168.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -154.61 134.24 12.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.362 1.065 . . . . 0.0 111.149 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.3 pt -91.94 154.3 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.551 -0.718 . . . . 0.0 110.83 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.13 157.94 16.96 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.765 1.174 . . . . 0.0 111.803 173.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 125.112 1.365 . . . . 0.0 110.169 -175.215 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -164.74 155.48 14.56 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.477 1.111 . . . . 0.0 112.725 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.8 137.35 36.8 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.109 1.364 . . . . 0.0 112.905 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.85 168.14 19.1 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.137 1.775 . . . . 0.0 113.394 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -35.45 50.52 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -82.99 -28.34 29.78 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.662 1.185 . . . . 0.0 112.769 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.434 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . 130.69 -19.59 4.99 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.586 1.565 . . . . 0.0 114.545 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -60.17 159.32 9.89 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.829 1.252 . . . . 0.0 112.229 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.2 mm -116.48 128.69 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 119.328 0.967 . . . . 0.0 111.024 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.37 145.47 29.45 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.568 1.547 . . . . 0.0 109.628 170.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.9 m -138.95 142.06 38.42 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.398 1.079 . . . . 0.0 111.608 177.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 C--O 1.253 1.279 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -168.814 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.898 0 CA-C-O 118.939 -0.923 . . . . 0.0 115.151 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 60.2 -166.95 10.11 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 118.992 1.396 . . . . 0.0 113.837 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.27 171.57 19.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.287 1.035 . . . . 0.0 112.209 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.2 mt -122.05 146.8 46.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.83 2.052 . . . . 0.0 109.527 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -68.9 164.72 21.48 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -53.0 -46.26 68.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.95 -1.093 . . . . 0.0 112.338 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -62.98 -10.63 14.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.617 1.567 . . . . 0.0 114.905 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.8 m -71.55 111.07 6.55 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.863 0.865 . . . . 0.0 110.584 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.8 134.01 34.41 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.615 -0.678 . . . . 0.0 112.265 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.4 mm -107.55 124.53 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.019 1.728 . . . . 0.0 108.113 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -64.44 131.16 46.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.672 0.389 . . . . 0.0 110.815 169.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 p -134.77 150.54 50.56 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.645 1.178 . . . . 0.0 112.36 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.0 t -77.34 -32.78 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.976 0.51 . . . . 0.0 111.823 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -68.77 -31.05 69.8 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -140.13 -50.61 0.48 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.85 -149.35 19.86 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.109 0.861 . . . . 0.0 112.095 -172.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.1 107.88 2.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.015 1.326 . . . . 0.0 111.209 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -133.21 148.91 71.04 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.751 1.22 . . . . 0.0 112.745 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.39 126.55 15.79 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.944 3.096 . . . . 0.0 112.332 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.424 ' HA ' HD12 ' A' ' 21' ' ' ILE . 17.5 tt -54.51 -35.57 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.043 0.937 . . . . 0.0 112.637 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.74 -36.53 93.45 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.604 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -70.31 -34.35 72.6 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.033 1.416 . . . . 0.0 111.554 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 18' ' ' ILE . 60.0 mt -63.86 -36.51 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.643 0.777 . . . . 0.0 110.121 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.37 -38.06 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.837 0.855 . . . . 0.0 112.856 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.58 -26.45 65.4 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.821 -1.174 . . . . 0.0 113.025 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -114.45 2.63 14.7 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.077 1.351 . . . . 0.0 112.878 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 49.09 47.81 21.52 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 127.533 2.333 . . . . 0.0 113.133 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -73.71 129.69 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.613 1.165 . . . . 0.0 109.445 -174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 132.74 36.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 122.703 1.239 . . . . 0.0 111.208 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.0 p -160.39 175.36 12.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.393 1.477 . . . . 0.0 111.659 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 147.03 30.08 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.45 1.5 . . . . 0.0 109.157 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 m -125.46 172.99 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.581 1.952 . . . . 0.0 110.181 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -114.28 139.89 49.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.956 1.302 . . . . 0.0 110.886 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 t -162.03 150.07 14.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.901 1.281 . . . . 0.0 111.566 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.72 144.49 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.195 0.907 . . . . 0.0 113.399 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.44 -178.35 6.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.809 0.844 . . . . 0.0 112.516 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -55.66 -22.53 23.43 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.352 1.461 . . . . 0.0 113.765 173.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -91.94 -10.62 38.81 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.228 1.411 . . . . 0.0 113.719 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.62 14.14 58.71 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.41 1.005 . . . . 0.0 114.916 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -88.93 118.89 28.97 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.574 1.187 . . . . 0.0 110.177 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.45 103.99 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.496 0.719 . . . . 0.0 109.375 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -103.64 178.66 4.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.113 1.765 . . . . 0.0 111.211 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 p -127.7 140.05 52.32 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.126 0.97 . . . . 0.0 112.643 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -144.74 148.02 37.87 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.707 1.203 . . . . 0.0 113.332 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.4 152.67 49.64 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.025 2.483 . . . . 0.0 112.835 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.84 133.31 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.147 0.979 . . . . 0.0 109.784 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.64 -49.46 7.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.008 0.523 . . . . 0.0 111.828 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -148.98 176.01 10.81 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.727 1.611 . . . . 0.0 111.767 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -131.62 129.91 41.47 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.682 1.593 . . . . 0.0 109.311 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -131.78 136.06 47.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.132 0.968 . . . . 0.0 111.3 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -126.8 114.28 17.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.215 1.806 . . . . 0.0 110.118 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -78.2 -29.58 48.46 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.058 0.943 . . . . 0.0 112.058 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.66 -56.67 1.63 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.413 1.483 . . . . 0.0 112.58 172.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -166.68 111.31 0.77 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.207 1.803 . . . . 0.0 109.827 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -129.56 166.0 20.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.519 1.128 . . . . 0.0 112.606 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -61.94 100.6 0.16 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.665 1.186 . . . . 0.0 113.096 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.3 137.93 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.659 1.184 . . . . 0.0 110.787 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -118.31 141.74 48.22 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.085 1.354 . . . . 0.0 109.489 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -65.96 129.53 40.11 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.387 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.424 ' CE1' HG12 ' A' ' 105' ' ' ILE . 1.4 t80 -116.46 106.88 14.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.585 1.154 . . . . 0.0 107.948 169.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.2 t -116.57 141.71 47.84 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.068 0.947 . . . . 0.0 110.82 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp -102.82 166.01 10.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.34 1.456 . . . . 0.0 112.647 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -65.23 -25.73 67.81 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.29 -23.0 35.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.025 1.33 . . . . 0.0 113.096 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.96 -2.66 25.7 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.0 1.286 . . . . 0.0 114.717 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.3 m -57.83 136.97 57.05 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.731 1.265 . . . . 0.0 110.867 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.29 124.51 42.56 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.616 1.166 . . . . 0.0 109.939 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.6 mt -135.13 151.02 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 127.334 2.254 . . . . 0.0 108.299 -171.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -137.4 108.96 6.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.871 1.268 . . . . 0.0 109.986 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.96 170.89 17.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.019 0.928 . . . . 0.0 113.377 -172.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.5 p -91.03 153.08 20.39 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.542 1.137 . . . . 0.0 111.987 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -65.15 -5.04 5.78 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -99.16 -6.33 28.45 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.556 1.143 . . . . 0.0 112.315 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.554 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 9.9 t-80 -85.73 126.88 34.31 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.39 155.24 20.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.755 0.788 . . . . 0.0 110.43 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -138.22 143.12 40.01 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.308 0.643 . . . . 0.0 109.33 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.1 ttp -73.11 103.03 3.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.305 0.642 . . . . 0.0 111.513 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.574 ' HA ' HD23 ' A' ' 94' ' ' LEU . 73.4 p -62.38 171.86 1.75 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.9 m -54.27 -25.33 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.78 -11.99 24.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.773 1.229 . . . . 0.0 113.191 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.2 -6.17 32.16 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.0 1.762 . . . . 0.0 114.332 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -61.25 141.21 57.69 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.986 1.393 . . . . 0.0 111.777 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -101.26 83.22 2.44 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.4 1.08 . . . . 0.0 109.771 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.09 146.77 37.86 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 124.437 1.095 . . . . 0.0 110.76 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.43 148.6 73.71 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.068 2.512 . . . . 0.0 111.783 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 tt -60.57 -26.98 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -55.41 -32.9 63.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.176 0.99 . . . . 0.0 112.92 170.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.44 -31.29 16.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.353 1.061 . . . . 0.0 111.754 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.28 -42.22 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.232 -0.917 . . . . 0.0 110.738 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -62.23 -39.31 92.4 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.28 -44.77 64.59 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -77.76 -11.12 59.85 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 56.51 37.82 29.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.425 1.49 . . . . 0.0 111.751 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.8 mt -78.48 150.9 32.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 122.042 0.925 . . . . 0.0 111.37 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -93.72 167.43 11.66 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.901 0.88 . . . . 0.0 111.069 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 76' ' ' THR . 39.3 mt -116.01 144.93 43.42 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.308 1.043 . . . . 0.0 111.437 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -68.59 148.36 50.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.712 0.805 . . . . 0.0 111.618 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.02 152.04 44.78 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.783 1.233 . . . . 0.0 113.694 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 t -77.31 -35.84 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 128.37 2.668 . . . . 0.0 112.74 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -91.47 10.81 26.18 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.361 1.065 . . . . 0.0 113.495 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.25 7.0 m-80 56.38 31.91 19.6 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.076 1.75 . . . . 0.0 112.426 -172.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.9 mt -64.54 155.23 82.02 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 113.659 -1.61 . . . . 0.0 111.622 170.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.98 127.51 17.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.341 2.694 . . . . 0.0 109.987 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -77.69 131.13 37.57 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.751 -0.593 . . . . 0.0 109.595 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -142.08 127.65 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.644 1.178 . . . . 0.0 110.957 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 166.49 3.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.597 1.959 . . . . 0.0 113.202 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.424 HG12 ' CE1' ' A' ' 58' ' ' TYR . 6.8 mt -61.33 116.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.152 1.381 . . . . 0.0 109.691 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.73 -42.1 61.63 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.832 0.853 . . . . 0.0 111.627 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 p -149.24 146.02 27.39 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.018 1.327 . . . . 0.0 111.295 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -143.84 142.79 31.02 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.266 1.827 . . . . 0.0 109.853 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -155.41 151.04 27.35 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.996 2.118 . . . . 0.0 110.416 169.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -67.03 131.2 45.36 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.365 0.666 . . . . 0.0 110.072 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.6 mt -98.27 -45.13 6.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.944 0.498 . . . . 0.0 111.871 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.01 -146.3 15.56 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.179 0.895 . . . . 0.0 112.095 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.59 94.67 4.31 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.246 1.022 . . . . 0.0 111.78 -169.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -110.86 155.79 22.09 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.397 1.479 . . . . 0.0 109.904 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.46 118.32 8.6 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.201 0.6 . . . . 0.0 110.642 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.84 150.45 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.35 0.595 . . . . 0.0 111.46 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -138.44 159.41 42.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.673 1.589 . . . . 0.0 111.494 -170.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -157.29 114.38 3.04 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.418 1.087 . . . . 0.0 110.556 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.0 pt -68.12 154.74 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 O-C-N 121.267 -0.896 . . . . 0.0 110.908 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.46 152.23 17.41 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.69 1.138 . . . . 0.0 111.5 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.05 142.56 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.972 1.309 . . . . 0.0 110.069 -171.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -80.76 -49.22 11.42 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -52.58 24.74 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.842 0.857 . . . . 0.0 112.968 -172.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -149.77 125.99 10.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.558 1.943 . . . . 0.0 108.719 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -75.62 59.37 1.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.78 1.232 . . . . 0.0 112.136 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -148.66 165.88 30.01 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.9 1.68 . . . . 0.0 112.83 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -168.31 146.77 4.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.593 1.157 . . . . 0.0 112.121 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.03 165.32 25.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.124 0.97 . . . . 0.0 113.321 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 67.2 mt -130.57 164.87 23.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.054 2.142 . . . . 0.0 111.621 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -32.61 58.1 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -86.71 9.11 19.84 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.402 1.481 . . . . 0.0 112.519 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.4 0.06 85.94 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.747 1.641 . . . . 0.0 114.046 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -67.37 166.67 14.02 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.205 1.503 . . . . 0.0 113.073 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.97 123.4 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.286 1.034 . . . . 0.0 109.65 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.554 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -97.22 149.99 21.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.984 1.314 . . . . 0.0 109.671 172.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.2 t -142.2 138.73 31.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.151 0.98 . . . . 0.0 112.587 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.529 1.532 . . . . 0.0 112.28 -174.287 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 CA-C-O 121.272 0.373 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -66.57 166.58 38.64 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.21 2.338 . . . . 0.0 114.084 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.32 179.83 7.99 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.137 1.375 . . . . 0.0 112.506 -174.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.5 mt -123.33 146.43 47.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.271 1.829 . . . . 0.0 110.378 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 t -68.62 163.85 22.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.206 0.602 . . . . 0.0 112.378 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -51.75 -44.52 63.35 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.421 -0.799 . . . . 0.0 112.49 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -59.8 -19.77 52.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.655 1.982 . . . . 0.0 113.857 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.8 m -72.32 87.24 1.13 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.644 1.178 . . . . 0.0 111.718 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -77.42 145.96 36.85 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.115 0.959 . . . . 0.0 112.74 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.3 mm -119.53 125.92 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 126.889 2.075 . . . . 0.0 107.18 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -61.1 132.16 52.86 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 122.076 -0.39 . . . . 0.0 111.17 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.7 p -133.05 148.46 52.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.659 1.184 . . . . 0.0 112.698 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.9 -34.61 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.258 0.623 . . . . 0.0 111.9 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -65.11 -28.85 69.72 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -143.86 -62.92 0.39 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.28 -148.35 18.77 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.007 0.813 . . . . 0.0 112.056 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.05 107.05 3.46 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.685 1.194 . . . . 0.0 111.331 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.76 148.63 70.28 Favored Pre-proline 0 N--CA 1.479 1.012 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.03 127.63 18.05 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.694 3.596 . . . . 0.0 112.822 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.44 -35.09 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.615 0.766 . . . . 0.0 113.027 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.61 -36.56 93.5 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.334 -0.703 . . . . 0.0 112.787 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -71.56 -32.22 67.85 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.114 1.457 . . . . 0.0 111.398 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.61 -37.44 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.972 0.909 . . . . 0.0 110.181 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.5 t -88.02 -37.87 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 118.691 0.678 . . . . 0.0 112.586 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -69.24 -25.85 64.49 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.481 1.037 . . . . 0.0 113.008 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -116.24 4.87 13.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.945 1.298 . . . . 0.0 112.45 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 48.46 47.89 19.8 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.136 2.575 . . . . 0.0 113.258 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -72.64 121.86 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.029 1.332 . . . . 0.0 109.469 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -83.27 122.29 28.24 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.44 1.114 . . . . 0.0 110.733 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -152.1 -177.02 5.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.003 1.721 . . . . 0.0 110.909 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -125.24 141.38 52.12 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.184 1.393 . . . . 0.0 108.424 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.48 177.29 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.614 1.965 . . . . 0.0 110.6 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -122.73 140.06 53.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.717 1.207 . . . . 0.0 111.36 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.4 t -161.38 149.61 15.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.355 1.462 . . . . 0.0 110.924 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.39 160.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 119.043 0.838 . . . . 0.0 111.126 167.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -102.23 -174.47 2.58 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.998 1.719 . . . . 0.0 113.089 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.52 -11.54 25.01 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -102.93 -0.86 30.42 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.804 1.642 . . . . 0.0 112.36 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.98 31.48 39.16 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.68 1.133 . . . . 0.0 114.565 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -116.56 121.99 43.37 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.697 1.249 . . . . 0.0 109.991 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.7 mt -63.91 118.82 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.736 0.814 . . . . 0.0 109.305 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -122.87 177.02 5.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.193 1.797 . . . . 0.0 111.014 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.3 p -125.61 139.88 53.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.141 0.977 . . . . 0.0 113.097 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -147.89 148.29 29.61 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.695 1.198 . . . . 0.0 112.808 -175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.15 155.11 52.26 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.165 2.577 . . . . 0.0 112.836 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.94 134.34 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.142 0.977 . . . . 0.0 110.146 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.87 -45.11 9.47 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.466 0.707 . . . . 0.0 112.199 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -149.23 173.28 13.63 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.923 1.689 . . . . 0.0 111.912 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -132.93 132.36 41.91 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.784 1.633 . . . . 0.0 108.973 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -133.28 135.61 44.99 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.04 0.924 . . . . 0.0 111.162 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -126.65 113.08 16.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.348 1.459 . . . . 0.0 110.323 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -79.35 -32.02 43.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.924 1.289 . . . . 0.0 112.866 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.05 -51.2 2.51 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.867 1.222 . . . . 0.0 113.684 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -173.15 96.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.746 1.273 . . . . 0.0 111.258 -170.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -129.67 165.11 22.49 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 112.682 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.83 103.85 0.98 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.105 1.362 . . . . 0.0 113.421 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 t -95.41 139.62 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.03 1.332 . . . . 0.0 111.544 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -123.92 139.28 54.11 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.498 1.919 . . . . 0.0 109.922 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.79 134.2 53.61 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.282 0.633 . . . . 0.0 110.357 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.406 ' CE1' HG12 ' A' ' 105' ' ' ILE . 1.6 t80 -126.62 95.73 4.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.989 1.316 . . . . 0.0 108.579 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.1 t -105.71 140.76 38.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.243 1.017 . . . . 0.0 110.132 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tp -103.86 162.9 12.73 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.911 1.284 . . . . 0.0 112.01 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -66.93 -21.19 65.99 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.1 -29.27 61.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.765 1.226 . . . . 0.0 112.839 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.92 -2.22 25.76 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.941 1.258 . . . . 0.0 114.108 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 m -57.37 138.75 54.55 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.273 1.037 . . . . 0.0 111.205 170.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 tp -128.58 125.62 38.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.335 1.054 . . . . 0.0 111.042 -170.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.4 mt -137.86 151.92 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 126.907 2.083 . . . . 0.0 108.017 -169.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -138.42 115.06 10.59 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.782 1.233 . . . . 0.0 110.804 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.24 167.71 23.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.676 1.19 . . . . 0.0 112.208 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.5 p -82.02 154.16 25.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.712 0.805 . . . . 0.0 111.715 170.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -66.59 -8.57 28.02 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -96.2 -10.83 27.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.813 1.645 . . . . 0.0 112.787 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -81.65 133.04 35.32 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -87.65 165.67 15.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.145 0.974 . . . . 0.0 111.553 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -142.85 147.39 35.33 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.323 1.049 . . . . 0.0 109.824 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 43.3 ttm -79.56 104.05 9.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.677 1.191 . . . . 0.0 110.347 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.2 p -68.87 170.81 8.94 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.715 -0.615 . . . . 0.0 112.062 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.0 m -57.79 -23.22 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -90.03 -3.02 58.21 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.407 1.083 . . . . 0.0 113.042 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.76 66.34 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.327 0.965 . . . . 0.0 113.656 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -86.01 124.9 32.98 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.497 1.119 . . . . 0.0 109.996 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.13 92.84 6.92 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.531 1.132 . . . . 0.0 109.855 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.36 147.12 44.42 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 124.381 1.072 . . . . 0.0 111.418 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.08 146.67 82.73 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.414 2.742 . . . . 0.0 111.687 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.7 tt -58.6 -27.91 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -53.23 -35.99 60.55 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.487 1.115 . . . . 0.0 112.852 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -86.75 -33.29 20.01 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.026 0.53 . . . . 0.0 111.827 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.8 mt -61.44 -38.04 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.311 -0.868 . . . . 0.0 111.06 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -67.75 -32.57 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -82.05 -40.11 22.49 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.443 -0.786 . . . . 0.0 112.514 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.3 mmm-85 -77.0 -13.95 59.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 55.01 29.98 13.34 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.587 1.555 . . . . 0.0 113.117 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -76.23 129.48 36.77 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.653 0.781 . . . . 0.0 111.168 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.17 149.15 47.84 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.617 0.723 . . . . 0.0 112.478 171.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.06 155.94 21.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.515 0.726 . . . . 0.0 112.587 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.5 ttp -78.13 135.79 37.74 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.984 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 166.7 10.22 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.391 1.476 . . . . 0.0 112.947 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.77 -19.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.602 1.961 . . . . 0.0 112.788 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -109.68 15.02 23.1 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.028 1.731 . . . . 0.0 112.263 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 65.05 14.15 9.16 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.632 1.573 . . . . 0.0 113.423 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.2 mt -43.9 154.82 0.35 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 127.264 2.226 . . . . 0.0 112.761 169.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.95 148.76 89.93 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.598 2.199 . . . . 0.0 110.904 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -69.66 123.07 20.41 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.45 -0.782 . . . . 0.0 111.152 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.5 pt -148.86 151.76 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.705 1.602 . . . . 0.0 111.055 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.23 179.7 4.21 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.822 1.649 . . . . 0.0 111.249 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.406 HG12 ' CE1' ' A' ' 58' ' ' TYR . 19.4 mt -62.06 110.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.688 1.195 . . . . 0.0 110.618 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.71 -42.02 64.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.166 1.387 . . . . 0.0 111.763 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p -148.75 148.26 29.78 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.263 1.425 . . . . 0.0 111.183 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.9 ttp85 -143.0 141.0 31.25 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.0 1.72 . . . . 0.0 110.174 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -159.85 148.96 17.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.144 1.778 . . . . 0.0 110.703 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -64.99 125.41 24.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.628 0.771 . . . . 0.0 111.459 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.34 -44.39 8.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.401 0.68 . . . . 0.0 111.866 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.62 -147.31 17.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.124 0.868 . . . . 0.0 112.872 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -128.73 80.89 1.99 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 123.083 1.421 . . . . 0.0 111.83 -169.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -100.0 158.91 15.49 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.918 1.687 . . . . 0.0 110.471 -169.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 118.43 7.72 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.79 -0.569 . . . . 0.0 110.739 169.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.94 152.77 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.302 0.641 . . . . 0.0 111.285 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -140.72 158.97 43.2 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.637 1.575 . . . . 0.0 111.737 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -155.72 131.3 9.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.419 1.088 . . . . 0.0 111.089 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.4 pt -87.27 155.36 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 121.323 -0.86 . . . . 0.0 111.08 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.7 155.14 16.27 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.434 1.492 . . . . 0.0 111.703 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.7 156.97 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.63 1.172 . . . . 0.0 110.846 -169.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.05 -40.14 92.49 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -144.52 -53.28 0.31 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.768 1.227 . . . . 0.0 113.188 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.47 90.13 7.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.092 0.957 . . . . 0.0 109.518 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -66.61 34.92 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.809 2.443 . . . . 0.0 113.75 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -147.04 160.39 42.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.82 2.048 . . . . 0.0 111.826 -168.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -163.27 154.23 16.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.456 1.102 . . . . 0.0 112.353 -169.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.81 159.44 30.09 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 45.0 mt -116.89 162.2 18.12 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.975 2.11 . . . . 0.0 112.195 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -55.2 -36.09 65.54 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -73.87 -17.04 61.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.11 0.964 . . . . 0.0 112.381 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.15 34.41 3.7 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.045 1.307 . . . . 0.0 114.699 171.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -135.53 165.34 25.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.721 1.608 . . . . 0.0 111.026 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -107.64 129.35 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.563 0.745 . . . . 0.0 110.015 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -110.75 155.26 22.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.582 1.553 . . . . 0.0 110.163 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.1 p -142.95 122.21 13.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.818 0.847 . . . . 0.0 112.605 -168.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 124.695 1.198 . . . . 0.0 113.671 -176.312 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.057 0 N-CA-C 115.567 0.987 . . . . 0.0 115.567 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -157.58 158.46 29.03 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 128.481 2.943 . . . . 0.0 108.243 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -157.79 175.4 13.93 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 117.759 0.779 . . . . 0.0 113.077 -167.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.67 147.24 44.79 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.467 1.507 . . . . 0.0 111.218 -170.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 t -64.77 162.79 15.35 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -54.2 -44.43 71.59 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.151 -0.968 . . . . 0.0 112.002 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -57.69 -23.89 53.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.873 1.669 . . . . 0.0 113.697 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.5 m -66.92 103.59 1.18 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.443 1.497 . . . . 0.0 111.472 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -87.56 141.19 28.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.836 0.826 . . . . 0.0 112.361 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.4 mm -120.4 119.54 60.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 126.628 1.971 . . . . 0.0 106.956 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.07 131.65 51.26 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.406 0.283 . . . . 0.0 110.772 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.4 p -126.2 157.7 37.53 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.166 . . . . 0.0 112.768 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.94 -35.45 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.576 0.75 . . . . 0.0 111.182 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -67.22 -29.53 69.21 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.24 -54.28 0.47 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.23 -148.95 19.93 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.962 0.792 . . . . 0.0 112.434 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.73 109.66 3.93 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.822 1.249 . . . . 0.0 111.099 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.3 mt -136.65 150.2 69.48 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.03 1.332 . . . . 0.0 112.642 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.52 129.56 22.81 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.962 3.108 . . . . 0.0 112.379 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 tt -55.2 -38.96 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.411 0.684 . . . . 0.0 112.318 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.54 -31.74 79.58 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.583 -0.698 . . . . 0.0 113.347 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -70.88 -37.81 73.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.192 0.996 . . . . 0.0 111.26 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.59 -40.34 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 123.662 0.785 . . . . 0.0 109.336 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.3 t -74.46 -42.87 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.23 -21.26 56.6 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.788 1.176 . . . . 0.0 113.465 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -110.37 2.28 18.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.359 1.464 . . . . 0.0 112.197 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 47.38 48.86 16.23 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.998 2.119 . . . . 0.0 113.178 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.0 mt -72.11 126.11 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.868 0.867 . . . . 0.0 109.621 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -85.67 104.47 15.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.41 0.624 . . . . 0.0 111.191 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 64.7 m -133.56 -173.45 3.23 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.451 1.5 . . . . 0.0 111.487 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.31 143.65 51.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.961 1.705 . . . . 0.0 108.754 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.12 171.03 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.697 1.599 . . . . 0.0 111.156 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.04 143.28 45.01 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.951 1.3 . . . . 0.0 111.248 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 t -160.72 150.67 17.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.912 1.685 . . . . 0.0 110.381 -170.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.0 142.66 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.215 1.37 . . . . 0.0 110.729 168.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.64 178.56 7.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.838 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.27 -25.27 63.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.749 1.22 . . . . 0.0 112.754 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -87.79 -1.13 57.77 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.327 1.451 . . . . 0.0 113.339 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.08 29.6 53.49 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 121.251 -0.906 . . . . 0.0 114.373 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -109.39 122.57 47.67 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.539 1.536 . . . . 0.0 109.63 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.593 HD13 HG23 ' A' ' 97' ' ' VAL . 55.4 mt -69.82 117.84 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.498 0.719 . . . . 0.0 109.489 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -124.9 178.4 5.52 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.67 1.988 . . . . 0.0 111.285 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 p -126.08 142.68 51.42 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.386 1.074 . . . . 0.0 112.958 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -144.73 146.13 30.7 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 124.909 1.283 . . . . 0.0 112.898 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.07 152.86 67.89 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.866 2.377 . . . . 0.0 111.985 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.28 119.15 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 168.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.81 -50.45 17.15 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -151.59 179.49 8.34 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.672 1.989 . . . . 0.0 110.909 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -134.82 132.72 38.98 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.342 1.457 . . . . 0.0 109.856 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -134.02 138.82 45.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.833 0.853 . . . . 0.0 111.627 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -132.37 121.03 22.85 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.56 1.544 . . . . 0.0 110.203 -172.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -87.76 -25.65 23.29 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.124 1.37 . . . . 0.0 112.982 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.16 -49.22 2.99 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.589 1.566 . . . . 0.0 114.937 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -171.75 101.25 0.18 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.128 1.464 . . . . 0.0 111.455 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -131.43 167.47 19.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.553 1.141 . . . . 0.0 112.247 172.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.84 105.81 0.9 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.937 1.295 . . . . 0.0 113.554 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.37 140.85 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.473 1.109 . . . . 0.0 111.939 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.481 ' CZ ' ' HE3' ' A' ' 70' ' ' LYS . 46.9 m-85 -125.08 154.55 41.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.585 1.554 . . . . 0.0 110.874 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.68 110.3 22.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.567 1.147 . . . . 0.0 109.169 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -96.7 102.85 14.7 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.852 0.861 . . . . 0.0 109.255 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.5 t -82.34 147.05 29.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.203 1.001 . . . . 0.0 111.057 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -106.99 160.79 15.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.951 1.3 . . . . 0.0 113.47 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.68 -20.47 65.3 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.29 -14.99 36.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.048 1.339 . . . . 0.0 112.945 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.18 -5.11 23.62 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.441 1.496 . . . . 0.0 114.57 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 t -71.82 171.47 11.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.219 1.009 . . . . 0.0 113.213 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -140.74 141.32 34.88 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.896 1.678 . . . . 0.0 111.57 -170.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.5 mt -133.62 143.61 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 126.23 1.812 . . . . 0.0 108.699 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -133.47 101.51 5.17 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.807 1.243 . . . . 0.0 111.376 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.35 166.66 31.92 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.847 0.859 . . . . 0.0 113.275 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.0 p -78.37 163.03 26.01 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.231 0.538 . . . . 0.0 110.773 168.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 6.5 mtmp? -74.51 -4.83 39.18 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -97.83 -20.76 17.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.588 1.555 . . . . 0.0 112.607 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -71.72 131.01 42.53 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -84.84 157.43 20.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.519 -0.738 . . . . 0.0 111.118 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -139.5 143.62 37.55 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.024 1.33 . . . . 0.0 109.921 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.2 ttp -84.64 110.34 18.67 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.454 1.102 . . . . 0.0 111.278 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.4 p -71.14 176.42 4.48 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -54.96 -26.84 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -94.14 -9.33 36.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.631 1.173 . . . . 0.0 113.521 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.06 8.97 56.43 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.314 0.959 . . . . 0.0 114.875 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -65.81 146.98 54.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.777 1.288 . . . . 0.0 111.165 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 29.2 mtm -110.95 80.51 1.31 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.526 1.53 . . . . 0.0 109.849 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.1 mt -119.64 147.25 43.36 Favored Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 125.396 1.478 . . . . 0.0 110.465 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -63.08 144.43 92.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.643 2.229 . . . . 0.0 110.672 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.7 tt -55.91 -27.14 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -56.01 -40.45 73.41 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.179 1.391 . . . . 0.0 113.006 169.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -79.56 -35.71 39.4 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.993 -0.442 . . . . 0.0 110.855 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 94' ' ' LEU . 72.2 mt -62.58 -40.58 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 119.076 0.853 . . . . 0.0 111.391 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -58.91 -39.35 81.26 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.736 0.814 . . . . 0.0 113.157 172.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -81.49 -38.56 26.13 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.624 1.17 . . . . 0.0 113.085 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -75.47 -16.64 60.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.337 1.055 . . . . 0.0 112.896 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 56.86 34.39 24.69 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.08 1.352 . . . . 0.0 112.452 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -86.98 144.55 26.87 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.876 0.87 . . . . 0.0 111.873 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -81.22 167.67 19.34 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.7 0.8 . . . . 0.0 112.564 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 87' ' ' ILE . 4.9 mp -122.3 157.89 30.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.392 1.092 . . . . 0.0 113.901 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.6 ttm -73.05 154.44 40.44 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.05 1.74 . . . . 0.0 112.601 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.66 159.38 42.12 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.564 1.546 . . . . 0.0 114.683 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.593 HG23 HD13 ' A' ' 39' ' ' ILE . 12.0 p -93.53 -28.14 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 126.707 2.003 . . . . 0.0 113.04 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -83.39 20.81 1.26 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.464 1.506 . . . . 0.0 112.735 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.27 10.4 p30 46.39 19.77 0.08 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.708 2.803 . . . . 0.0 115.675 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.6 mt -60.68 156.99 41.11 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.146 1.378 . . . . 0.0 112.89 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.89 143.98 81.44 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.081 2.521 . . . . 0.0 110.721 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -77.74 125.61 29.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.171 0.589 . . . . 0.0 110.284 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.0 pt -140.34 131.37 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.457 1.103 . . . . 0.0 112.67 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 172.86 13.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.445 1.898 . . . . 0.0 112.701 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -69.95 113.36 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.417 1.087 . . . . 0.0 110.334 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.81 -48.83 75.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.46 1.504 . . . . 0.0 111.856 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 p -152.24 158.11 42.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.326 1.851 . . . . 0.0 111.171 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -126.1 148.84 49.27 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.881 1.672 . . . . 0.0 109.672 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -149.97 133.99 17.03 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.657 1.183 . . . . 0.0 110.688 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -70.87 129.32 38.75 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.244 0.618 . . . . 0.0 110.982 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.9 mt -96.7 -41.39 8.52 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.065 0.546 . . . . 0.0 111.845 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.24 -140.15 9.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.173 0.892 . . . . 0.0 112.58 -174.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -131.71 81.57 1.98 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.964 1.364 . . . . 0.0 113.056 -168.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -98.11 157.82 15.91 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.88 1.672 . . . . 0.0 110.069 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.2 121.68 14.81 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 121.64 -0.662 . . . . 0.0 109.695 170.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -123.19 149.23 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.502 0.668 . . . . 0.0 111.84 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -136.22 158.77 43.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.574 1.55 . . . . 0.0 111.791 -168.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -154.22 122.76 6.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.819 1.248 . . . . 0.0 110.177 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.1 pt -77.76 159.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.392 -0.817 . . . . 0.0 111.386 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.16 151.92 18.42 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.535 1.064 . . . . 0.0 111.73 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 m -150.27 -172.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 127.16 2.184 . . . . 0.0 109.756 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -62.74 -177.01 0.13 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.338 1.455 . . . . 0.0 113.84 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -41.61 -38.98 1.49 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 127.008 2.123 . . . . 0.0 114.327 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -73.09 73.6 1.21 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.263 1.825 . . . . 0.0 110.775 170.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -66.19 53.5 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 127.746 2.418 . . . . 0.0 114.633 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -142.16 163.79 31.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.341 1.456 . . . . 0.0 112.659 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -157.47 152.13 25.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.555 1.142 . . . . 0.0 111.999 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.86 149.97 26.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.053 0.941 . . . . 0.0 113.178 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.61 176.07 5.27 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.296 1.839 . . . . 0.0 112.419 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -50.33 -49.5 53.71 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.495 1.518 . . . . 0.0 114.651 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -78.6 -9.36 59.34 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.313 1.045 . . . . 0.0 112.775 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.491 ' HA2' HG12 ' A' ' 97' ' ' VAL . . . 102.09 -7.32 54.61 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.392 1.472 . . . . 0.0 114.997 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.418 ' CE2' HD13 ' A' ' 94' ' ' LEU . 2.7 m-85 -51.26 150.93 3.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.538 1.169 . . . . 0.0 111.444 174.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.4 107.72 22.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.1 143.54 28.0 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 170.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.3 m -132.51 104.4 6.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.487 1.115 . . . . 0.0 109.996 -172.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.0 t30 . . . . . 0 C--O 1.255 1.374 0 C-N-CA 124.236 1.014 . . . . 0.0 113.396 -174.337 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -125.22 159.39 19.79 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.795 2.14 . . . . 0.0 110.748 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -159.6 175.54 13.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.945 1.298 . . . . 0.0 111.977 -174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.58 144.47 39.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.642 1.577 . . . . 0.0 110.422 -172.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -67.05 164.02 18.73 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.564 -0.71 . . . . 0.0 112.51 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -52.01 -44.38 64.1 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.977 -1.077 . . . . 0.0 112.026 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -64.24 -13.12 47.22 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.683 1.593 . . . . 0.0 114.383 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.7 m -75.18 81.81 2.33 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.332 1.453 . . . . 0.0 110.894 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -71.12 142.34 50.77 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.773 0.797 . . . . 0.0 111.501 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.5 mm -118.61 128.59 75.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 126.13 1.772 . . . . 0.0 106.373 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -58.17 130.85 48.54 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 122.289 -0.257 . . . . 0.0 110.919 170.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.6 p -131.88 145.15 51.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.223 1.409 . . . . 0.0 111.853 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.15 -32.62 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 121.877 -0.514 . . . . 0.0 111.922 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.74 -35.73 81.55 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -140.33 -48.71 0.44 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -170.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.59 -146.68 18.49 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.982 0.81 . . . . 0.0 113.163 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.4 96.84 1.52 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.268 1.427 . . . . 0.0 111.652 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.45 145.73 55.66 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.612 1.165 . . . . 0.0 112.407 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.14 128.4 21.6 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.78 3.653 . . . . 0.0 113.261 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.84 -37.43 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.746 0.818 . . . . 0.0 112.944 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.56 -32.84 84.54 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.618 -0.546 . . . . 0.0 112.956 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -72.52 -36.79 68.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.98 0.89 . . . . 0.0 111.298 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.89 -39.03 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.656 0.782 . . . . 0.0 109.479 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.52 -42.16 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.909 0.884 . . . . 0.0 113.11 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -75.1 -21.97 58.57 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.374 0.988 . . . . 0.0 113.507 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -109.79 1.72 19.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.145 1.378 . . . . 0.0 112.407 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.42 54.23 8.81 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.875 2.07 . . . . 0.0 113.357 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.5 mt -75.03 119.58 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.632 0.773 . . . . 0.0 110.104 -172.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.3 80.49 1.85 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.912 1.685 . . . . 0.0 112.221 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.6 p -119.49 178.49 4.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.02 1.328 . . . . 0.0 112.625 -171.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.5 m -119.25 149.46 41.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.243 1.417 . . . . 0.0 108.339 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.3 175.88 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.794 1.637 . . . . 0.0 110.967 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -121.24 142.59 49.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.428 1.491 . . . . 0.0 110.382 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.9 t -165.18 154.17 12.36 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.686 1.195 . . . . 0.0 110.835 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.4 m -84.91 145.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.665 1.12 . . . . 0.0 112.468 172.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.91 179.1 7.63 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.95 0.9 . . . . 0.0 111.917 172.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -60.59 -20.21 59.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -90.78 -0.73 57.8 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.218 1.407 . . . . 0.0 113.273 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.23 32.26 48.86 Favored Glycine 0 CA--C 1.536 1.387 0 O-C-N 121.33 -0.856 . . . . 0.0 114.099 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -112.64 121.51 44.98 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.494 1.518 . . . . 0.0 109.554 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.96 113.17 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -116.71 178.29 4.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.055 1.742 . . . . 0.0 110.528 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -128.02 143.31 51.07 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.859 0.863 . . . . 0.0 113.106 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -144.59 147.06 34.65 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.295 1.038 . . . . 0.0 113.605 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.62 150.07 50.25 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.108 2.539 . . . . 0.0 112.307 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.53 147.33 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.169 0.988 . . . . 0.0 110.808 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.64 -44.69 3.46 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.036 0.934 . . . . 0.0 111.992 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -142.41 178.17 7.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.759 1.623 . . . . 0.0 111.479 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -137.58 120.52 16.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.309 1.443 . . . . 0.0 109.29 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -118.77 138.73 52.48 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.075 0.941 . . . . 0.0 111.161 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -131.71 115.7 16.36 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.879 1.672 . . . . 0.0 110.046 -171.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -79.84 -32.13 40.53 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.982 1.313 . . . . 0.0 113.052 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.87 -53.24 1.43 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.762 1.648 . . . . 0.0 114.86 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -171.04 99.55 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.214 1.507 . . . . 0.0 111.577 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -134.51 168.05 19.67 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.486 1.114 . . . . 0.0 113.119 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -67.35 97.67 0.58 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.16 1.784 . . . . 0.0 114.278 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.9 t -94.01 138.79 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.194 1.398 . . . . 0.0 111.376 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -119.43 147.07 44.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.333 1.053 . . . . 0.0 110.448 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -82.33 123.99 29.58 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.585 1.154 . . . . 0.0 109.417 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -112.81 105.18 13.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.418 1.087 . . . . 0.0 108.722 174.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.3 t -96.19 122.17 38.76 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mp -79.24 156.72 28.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.697 0.799 . . . . 0.0 110.794 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -67.56 -18.49 65.03 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.62 -26.16 50.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.55 0.74 . . . . 0.0 112.764 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.23 -12.36 7.58 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.433 1.492 . . . . 0.0 114.275 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.1 m -60.02 148.24 36.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.41 1.084 . . . . 0.0 112.405 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -127.92 135.65 50.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.465 1.506 . . . . 0.0 110.715 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.0 mt -135.69 142.9 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.765 1.626 . . . . 0.0 108.095 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -134.03 110.85 9.92 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.784 1.234 . . . . 0.0 111.383 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.69 166.51 30.17 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.636 1.175 . . . . 0.0 110.541 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -70.18 150.04 46.89 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.55 -0.719 . . . . 0.0 111.408 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -61.07 -21.04 63.28 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -85.76 -16.18 39.71 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.883 2.073 . . . . 0.0 112.6 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -73.38 135.66 44.28 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -89.85 154.29 19.99 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.813 0.845 . . . . 0.0 111.932 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -137.2 144.36 42.83 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.084 -1.01 . . . . 0.0 111.465 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 37.6 ttm -73.81 104.0 4.55 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.002 0.921 . . . . 0.0 110.344 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.2 p -67.88 167.15 14.14 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.745 -0.597 . . . . 0.0 111.193 172.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.88 -26.79 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -79.63 -12.15 59.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.515 1.126 . . . . 0.0 113.292 175.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.95 3.7 65.59 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.127 1.346 . . . . 0.0 114.025 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -69.61 161.14 30.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.08 0.952 . . . . 0.0 110.699 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.4 ptp -127.46 80.88 1.98 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.836 1.254 . . . . 0.0 109.763 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.51 150.1 39.68 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 125.075 1.35 . . . . 0.0 110.403 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.38 142.07 77.38 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.491 2.127 . . . . 0.0 110.349 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.4 tt -60.34 -23.23 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.65 -27.72 65.02 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 170.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -89.59 -38.62 13.82 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.428 1.091 . . . . 0.0 111.852 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.35 -38.45 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 121.286 -0.884 . . . . 0.0 111.311 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.18 -36.76 80.71 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -78.92 -41.97 28.21 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.443 0.697 . . . . 0.0 112.467 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -74.34 -13.49 60.75 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 55.64 28.49 12.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.621 1.568 . . . . 0.0 112.86 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.9 128.63 35.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.554 0.742 . . . . 0.0 110.048 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.75 154.19 42.41 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 122.366 1.079 . . . . 0.0 112.329 171.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.3 mt -96.15 152.26 18.72 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.696 1.198 . . . . 0.0 111.924 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 35.3 ttm -72.38 138.39 47.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.501 0.32 . . . . 0.0 110.479 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 162.57 16.25 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.065 1.346 . . . . 0.0 113.782 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.7 -23.09 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.384 1.474 . . . . 0.0 113.978 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -101.44 8.56 42.06 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.003 0.921 . . . . 0.0 113.392 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 m120 67.33 22.15 9.61 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.663 1.585 . . . . 0.0 112.234 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.1 mt -54.34 159.19 3.32 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.497 1.519 . . . . 0.0 112.049 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.65 145.72 82.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.388 2.059 . . . . 0.0 110.722 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -67.13 121.7 16.2 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.519 -0.738 . . . . 0.0 111.162 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.2 pt -144.82 137.61 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.84 1.656 . . . . 0.0 110.317 -174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.6 175.52 5.63 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.715 1.606 . . . . 0.0 111.042 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.72 104.82 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.454 1.102 . . . . 0.0 110.513 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.9 -41.16 78.61 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.759 1.224 . . . . 0.0 112.363 -175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.6 p -146.78 154.72 41.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.537 1.535 . . . . 0.0 111.288 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -133.81 139.16 46.11 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.621 1.568 . . . . 0.0 110.987 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -141.45 130.26 22.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.474 1.51 . . . . 0.0 110.02 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.04 121.74 16.22 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 122.503 0.321 . . . . 0.0 110.392 173.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.3 mt -87.09 -40.34 14.75 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.874 0.469 . . . . 0.0 111.795 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.21 -144.87 15.87 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.329 0.966 . . . . 0.0 112.583 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -124.6 81.46 1.95 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.935 1.35 . . . . 0.0 112.486 -168.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -98.74 158.06 15.87 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.613 1.565 . . . . 0.0 110.948 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.44 119.13 9.82 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.644 0.778 . . . . 0.0 110.323 171.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.87 149.43 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.483 0.713 . . . . 0.0 111.216 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -139.09 158.4 44.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.861 1.664 . . . . 0.0 111.771 -168.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -156.28 121.48 4.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.747 1.219 . . . . 0.0 110.297 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.8 pt -73.27 155.74 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 120.911 -1.118 . . . . 0.0 111.467 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.89 147.61 16.36 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.662 1.125 . . . . 0.0 111.74 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.88 152.43 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.965 2.106 . . . . 0.0 109.845 -169.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -101.13 -33.69 10.01 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -169.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -72.82 -48.24 39.56 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.988 0.915 . . . . 0.0 112.44 -174.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -162.71 162.92 27.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.077 2.551 . . . . 0.0 109.559 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -104.01 57.74 0.72 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.134 0.974 . . . . 0.0 112.167 -169.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -155.62 156.57 35.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.401 1.08 . . . . 0.0 113.776 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -162.14 160.78 27.66 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.389 1.476 . . . . 0.0 112.516 -173.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.44 148.84 21.78 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.489 1.116 . . . . 0.0 113.864 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 54.2 mt -100.73 166.44 10.87 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.267 1.827 . . . . 0.0 113.018 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -57.73 -33.18 68.16 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -75.81 -13.71 60.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.704 0.801 . . . . 0.0 112.625 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.89 30.29 5.83 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 117.579 -1.679 . . . . 0.0 114.841 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.0 165.33 22.38 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.783 1.792 . . . . 0.0 111.778 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.06 139.24 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.104 0.962 . . . . 0.0 110.13 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.04 152.92 46.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.609 1.564 . . . . 0.0 110.654 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.5 t -136.48 140.82 43.35 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.143 1.377 . . . . 0.0 112.342 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -169.487 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 CA-C-O 120.972 0.206 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -143.94 174.24 24.4 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 129.132 3.253 . . . . 0.0 110.23 -171.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.42 170.07 17.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.492 ' HG ' HG21 ' A' ' 6' ' ' THR . 2.2 mm? -106.73 152.32 23.97 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.784 1.233 . . . . 0.0 110.974 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 t -63.2 161.7 13.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -52.49 -43.86 65.28 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.79 0.836 . . . . 0.0 112.221 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -60.9 -23.22 65.05 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.67 1.588 . . . . 0.0 113.52 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.492 HG21 ' HG ' ' A' ' 2' ' ' LEU . 87.7 m -66.15 114.73 5.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.101 0.961 . . . . 0.0 111.557 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -94.58 140.42 29.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.647 0.736 . . . . 0.0 112.439 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 mm -118.03 125.24 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 126.365 1.866 . . . . 0.0 108.103 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 tp -64.25 129.48 40.1 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.558 0.743 . . . . 0.0 111.369 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.9 p -128.4 156.58 42.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.122 1.369 . . . . 0.0 112.063 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 t -78.05 -31.64 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 O-C-N 121.739 -0.601 . . . . 0.0 111.88 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.04 -35.13 79.7 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -139.93 -44.97 0.43 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.33 -143.78 14.96 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.194 0.902 . . . . 0.0 111.288 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.0 mt -67.32 111.77 4.19 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.079 1.351 . . . . 0.0 111.279 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.1 mt -139.76 151.73 66.59 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.829 1.252 . . . . 0.0 113.323 176.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.55 128.72 20.73 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.131 3.221 . . . . 0.0 112.638 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 tt -58.24 -35.91 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.83 -31.54 81.24 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.867 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -71.24 -37.53 71.98 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.491 1.145 . . . . 0.0 111.322 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.45 -37.74 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.523 0.729 . . . . 0.0 110.762 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.6 t -85.7 -36.4 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.35 0.66 . . . . 0.0 112.657 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.77 -25.39 63.79 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.264 -0.897 . . . . 0.0 113.298 174.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -113.44 2.84 15.56 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.086 1.354 . . . . 0.0 113.0 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 46.82 47.98 15.07 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 127.538 2.335 . . . . 0.0 112.702 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.9 mt -70.61 121.31 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.798 1.239 . . . . 0.0 109.38 -174.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -82.37 120.18 25.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.912 0.863 . . . . 0.0 110.93 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.6 p -153.01 164.01 38.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.55 1.14 . . . . 0.0 112.75 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.7 145.8 24.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.074 1.35 . . . . 0.0 109.813 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.47 176.74 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.391 1.876 . . . . 0.0 110.756 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -121.75 144.26 48.9 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.179 1.392 . . . . 0.0 110.697 -176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.2 t -158.73 167.23 30.05 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.586 1.554 . . . . 0.0 110.599 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.78 123.98 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.156 1.382 . . . . 0.0 110.086 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.5 179.52 4.02 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.6 -18.88 65.3 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -90.21 -2.26 58.03 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.643 1.577 . . . . 0.0 112.086 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.79 29.89 62.52 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.053 1.787 . . . . 0.0 114.614 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -111.85 140.15 46.73 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.155 1.382 . . . . 0.0 110.497 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.3 mt -67.95 133.07 32.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -138.47 166.67 23.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.558 1.543 . . . . 0.0 111.452 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 p -118.08 143.53 46.37 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.418 1.087 . . . . 0.0 111.714 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -150.83 146.71 19.7 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.656 1.182 . . . . 0.0 111.951 -172.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.34 151.59 48.59 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.881 2.387 . . . . 0.0 112.495 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.2 139.46 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.103 0.961 . . . . 0.0 111.449 169.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.45 -35.29 9.61 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.186 0.995 . . . . 0.0 113.075 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.14 175.48 13.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.782 1.233 . . . . 0.0 112.777 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -124.14 135.66 53.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.565 1.546 . . . . 0.0 108.809 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -124.36 119.67 29.92 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.04 1.336 . . . . 0.0 110.86 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.57 110.02 16.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 110.432 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -87.37 -30.21 20.94 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.597 1.159 . . . . 0.0 112.988 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.9 -52.01 2.91 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.044 1.307 . . . . 0.0 114.099 171.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -170.97 98.46 0.21 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.588 1.194 . . . . 0.0 111.201 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -129.96 162.98 27.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.33 1.052 . . . . 0.0 112.155 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.39 102.3 1.39 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.69 1.196 . . . . 0.0 113.191 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.6 t -94.93 138.27 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.445 1.498 . . . . 0.0 110.925 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -124.89 144.92 50.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.274 1.43 . . . . 0.0 110.029 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -65.18 127.61 32.41 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.968 0.907 . . . . 0.0 110.469 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -119.51 86.58 2.58 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.874 1.67 . . . . 0.0 108.419 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.0 t -89.7 144.56 25.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.161 0.984 . . . . 0.0 110.787 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.02 163.92 12.88 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.369 1.067 . . . . 0.0 112.668 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.42 -20.33 63.79 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -76.05 -26.52 56.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.526 1.13 . . . . 0.0 112.555 171.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.16 -1.97 23.98 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.969 1.271 . . . . 0.0 113.998 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.59 147.22 42.43 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.937 1.295 . . . . 0.0 111.269 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.1 mt -134.84 130.78 36.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.117 1.367 . . . . 0.0 110.645 -172.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.6 mt -137.91 151.41 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.462 1.905 . . . . 0.0 107.757 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -136.26 106.15 6.26 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.663 1.185 . . . . 0.0 110.165 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.46 166.32 24.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.099 1.36 . . . . 0.0 111.89 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.1 p -86.85 157.32 19.57 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.924 0.869 . . . . 0.0 112.627 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -72.61 -5.01 34.39 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -91.34 -15.58 28.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.341 1.057 . . . . 0.0 112.556 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -77.63 131.67 37.89 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.699 -0.626 . . . . 0.0 111.147 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -90.03 153.97 20.17 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.19 0.996 . . . . 0.0 111.172 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -139.0 143.82 38.65 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.568 0.747 . . . . 0.0 110.416 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.2 ttm -74.11 104.35 4.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.155 0.982 . . . . 0.0 110.533 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.7 p -68.75 171.04 8.36 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.199 0.523 . . . . 0.0 111.936 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.1 m -56.57 -24.79 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 173.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -92.17 -6.15 51.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.145 0.978 . . . . 0.0 113.268 174.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.41 24.04 52.21 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.789 1.185 . . . . 0.0 113.793 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -88.82 120.26 30.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.081 0.952 . . . . 0.0 110.661 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.1 mmt -80.62 80.33 7.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.359 1.064 . . . . 0.0 111.68 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.3 mt -112.96 147.43 37.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 124.754 1.222 . . . . 0.0 110.888 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.84 146.92 84.57 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.57 2.18 . . . . 0.0 110.992 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.24 -25.05 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -55.89 -34.43 65.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.833 1.253 . . . . 0.0 113.014 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.0 -41.54 25.63 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.927 0.891 . . . . 0.0 110.496 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.88 -36.16 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.991 0.916 . . . . 0.0 111.498 -174.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -66.72 -35.44 80.12 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.24 -35.7 21.41 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.491 -0.756 . . . . 0.0 112.642 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -74.11 -17.52 60.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.403 1.081 . . . . 0.0 113.018 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 54.78 33.64 20.1 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.249 1.42 . . . . 0.0 112.963 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.4 mt -76.02 143.39 41.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.768 0.827 . . . . 0.0 111.907 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -88.53 148.07 24.3 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.815 0.846 . . . . 0.0 110.92 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.9 156.86 22.18 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.385 -0.822 . . . . 0.0 112.367 168.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 7.9 ttp -88.84 158.57 18.07 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.75 1.22 . . . . 0.0 111.378 169.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.12 165.57 25.4 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.061 1.345 . . . . 0.0 112.9 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.1 m -88.44 -21.77 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.01 13.52 34.53 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.206 1.002 . . . . 0.0 113.084 -171.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.1 m120 58.44 29.25 18.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.195 1.798 . . . . 0.0 112.429 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 mt -57.66 153.93 28.18 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.223 173.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.83 140.19 50.04 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.648 2.899 . . . . 0.0 111.15 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -79.82 120.59 24.28 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.017 0.527 . . . . 0.0 111.01 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.5 pt -142.8 153.5 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.908 1.683 . . . . 0.0 111.56 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.62 -179.6 3.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.911 1.684 . . . . 0.0 111.806 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.1 mt -64.43 114.65 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.107 0.963 . . . . 0.0 110.214 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.42 -41.16 73.27 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.839 1.256 . . . . 0.0 112.316 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.75 157.81 34.1 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.223 1.409 . . . . 0.0 111.009 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -137.12 143.83 42.72 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.491 1.516 . . . . 0.0 110.562 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -151.09 134.51 16.21 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.49 1.516 . . . . 0.0 109.506 169.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -63.6 123.4 18.72 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.705 0.684 . . . . 0.0 110.375 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.2 mt -90.04 -44.02 10.12 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.01 0.524 . . . . 0.0 111.692 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 148.38 -148.11 19.3 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.329 0.966 . . . . 0.0 112.979 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -126.6 67.87 1.24 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 123.576 1.655 . . . . 0.0 112.469 -168.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -85.74 158.02 20.13 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 126.723 2.009 . . . . 0.0 110.635 -169.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.04 119.65 9.9 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.135 0.574 . . . . 0.0 110.5 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -123.06 150.49 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.41 0.624 . . . . 0.0 111.839 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -140.06 157.84 45.0 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.215 1.806 . . . . 0.0 112.264 -168.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -152.67 167.37 29.17 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.916 1.687 . . . . 0.0 110.969 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.8 145.72 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.417 1.487 . . . . 0.0 111.338 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.09 160.44 23.06 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.79 0.709 . . . . 0.0 112.865 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.68 151.1 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.36 1.864 . . . . 0.0 110.487 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -82.86 150.24 26.65 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.474 -0.766 . . . . 0.0 111.938 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 56.43 16.72 2.58 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 126.159 1.783 . . . . 0.0 114.843 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -159.01 164.92 35.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.124 1.37 . . . . 0.0 111.858 -169.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -142.92 21.06 1.96 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -156.0 173.26 17.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.433 1.493 . . . . 0.0 112.683 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -163.34 166.55 22.87 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.836 1.254 . . . . 0.0 111.809 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.92 140.49 31.38 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.015 0.926 . . . . 0.0 112.949 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 133' ' ' PHE . 65.3 mt -91.73 170.49 9.87 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.143 1.777 . . . . 0.0 111.882 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -47.17 -58.12 4.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.779 1.632 . . . . 0.0 115.22 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -67.13 -39.64 86.65 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.556 0.342 . . . . 0.0 110.861 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.33 -2.97 0.85 Allowed Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.475 -1.181 . . . . 0.0 115.331 172.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.411 ' HB2' HD12 ' A' ' 129' ' ' LEU . 18.7 m-85 -59.49 160.89 6.39 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.176 1.488 . . . . 0.0 112.332 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.91 129.14 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.63 0.729 . . . . 0.0 110.179 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -118.52 145.65 45.16 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.991 1.716 . . . . 0.0 109.977 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.3 t -136.78 149.15 47.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.542 1.137 . . . . 0.0 114.006 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.8 t30 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.895 1.678 . . . . 0.0 113.648 -172.046 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.876 0 CA-C-O 119.108 -0.829 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 62.98 179.15 4.54 Favored Glycine 0 C--N 1.341 0.854 0 C-N-CA 126.039 1.78 . . . . 0.0 115.198 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -151.17 169.13 22.64 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.345 1.058 . . . . 0.0 112.207 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.8 mt -120.78 146.87 46.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.386 1.874 . . . . 0.0 109.514 -172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 t -70.15 160.34 32.26 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.585 -0.697 . . . . 0.0 111.437 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -49.09 -40.9 33.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.292 1.037 . . . . 0.0 112.344 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.88 -24.8 54.47 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.983 1.713 . . . . 0.0 113.777 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.2 m -72.14 102.65 3.09 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.293 1.037 . . . . 0.0 110.942 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -87.52 145.87 26.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.747 0.784 . . . . 0.0 111.67 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -122.81 128.84 75.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 126.501 1.92 . . . . 0.0 107.317 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.2 tp -61.95 127.76 32.94 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.834 0.454 . . . . 0.0 111.37 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.3 p -125.57 150.44 47.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.847 1.259 . . . . 0.0 112.368 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.42 -32.39 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.287 0.635 . . . . 0.0 111.982 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -66.22 -30.42 70.87 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -142.56 -56.55 0.44 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -173.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.26 -147.81 19.44 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.835 0.731 . . . . 0.0 112.681 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.4 104.75 1.97 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.084 1.353 . . . . 0.0 111.347 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.4 mt -134.61 148.68 68.35 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.434 1.094 . . . . 0.0 113.451 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.52 129.53 24.05 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.462 3.441 . . . . 0.0 112.665 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.1 tt -56.29 -35.31 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.609 0.764 . . . . 0.0 112.888 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.79 -34.36 89.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.566 -0.574 . . . . 0.0 112.724 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -73.92 -29.63 62.15 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.654 1.227 . . . . 0.0 112.015 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.6 mt -71.77 -41.96 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.452 1.101 . . . . 0.0 109.769 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.29 -39.99 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.756 0.822 . . . . 0.0 113.004 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.11 -26.3 65.74 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.308 0.958 . . . . 0.0 112.643 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.45 2.04 15.27 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.616 1.166 . . . . 0.0 113.398 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 46.89 50.68 13.4 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.344 2.258 . . . . 0.0 112.139 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.3 mt -67.05 120.19 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.873 0.869 . . . . 0.0 108.868 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -84.4 98.57 10.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.945 0.879 . . . . 0.0 110.321 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p -132.02 -171.14 2.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.08 1.352 . . . . 0.0 111.463 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.25 142.23 50.9 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.458 1.503 . . . . 0.0 108.008 -176.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.48 172.94 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.802 1.641 . . . . 0.0 110.169 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -117.55 145.19 44.43 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.012 1.325 . . . . 0.0 110.194 -173.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.4 t -159.07 167.03 30.31 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.29 1.436 . . . . 0.0 110.139 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -113.31 127.29 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.158 1.383 . . . . 0.0 110.824 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.17 179.61 6.77 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.276 1.036 . . . . 0.0 111.951 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -57.34 -24.84 57.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.142 1.377 . . . . 0.0 113.405 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -88.73 -6.4 57.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.816 1.646 . . . . 0.0 113.827 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.78 4.14 89.0 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.263 0.935 . . . . 0.0 114.786 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -77.37 128.48 34.35 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.11 0.955 . . . . 0.0 109.906 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.68 107.38 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -107.48 175.22 5.56 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.574 1.549 . . . . 0.0 110.403 175.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.6 p -130.99 149.03 52.8 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.703 0.801 . . . . 0.0 112.789 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -146.07 144.52 21.9 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.788 1.235 . . . . 0.0 111.997 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.44 151.21 47.57 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.819 2.346 . . . . 0.0 112.172 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.31 122.0 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 169.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.03 -47.63 12.41 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.27 -0.269 . . . . 0.0 111.56 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -148.7 179.14 8.05 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.021 1.729 . . . . 0.0 111.585 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -137.47 142.08 41.55 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.732 1.613 . . . . 0.0 110.289 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -136.79 132.38 34.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.999 0.92 . . . . 0.0 111.614 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -124.06 119.66 30.16 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.471 1.508 . . . . 0.0 110.595 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -84.82 -32.25 23.41 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.692 1.197 . . . . 0.0 113.086 -173.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 -53.33 1.33 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.528 1.537 . . . . 0.0 113.975 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -170.09 101.51 0.29 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.086 1.354 . . . . 0.0 111.087 -173.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -131.57 160.87 34.04 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.531 1.133 . . . . 0.0 111.899 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.91 106.52 1.25 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.405 1.082 . . . . 0.0 112.925 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.65 134.75 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.25 1.42 . . . . 0.0 111.358 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -119.78 140.78 50.22 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.76 1.224 . . . . 0.0 110.31 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.11 132.01 35.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.127 0.971 . . . . 0.0 108.799 168.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.18 89.04 3.05 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.112 1.365 . . . . 0.0 108.541 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 45.6 t -71.88 129.29 38.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.662 0.785 . . . . 0.0 110.377 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -88.54 164.87 15.21 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.201 1.0 . . . . 0.0 112.304 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.17 -23.02 67.16 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -82.18 -26.59 33.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.654 1.182 . . . . 0.0 113.084 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.95 -4.58 16.41 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.029 1.299 . . . . 0.0 114.264 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 m -58.54 141.34 52.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.556 1.178 . . . . 0.0 110.802 173.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.32 122.2 40.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.939 0.896 . . . . 0.0 109.52 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -110.97 131.09 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -124.66 97.35 5.25 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.38 1.072 . . . . 0.0 109.884 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.9 169.82 17.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.54 1.136 . . . . 0.0 113.03 -168.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 p -84.75 152.2 23.86 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.443 1.097 . . . . 0.0 111.486 169.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -62.65 -12.27 22.3 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.35 -13.49 34.99 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.32 1.448 . . . . 0.0 112.376 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -82.87 134.77 35.08 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.599 0.636 . . . . 0.0 109.666 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -86.91 156.75 19.7 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.657 0.783 . . . . 0.0 111.345 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -137.69 142.64 41.09 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.783 0.833 . . . . 0.0 109.286 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 31.1 ttp -79.52 106.17 11.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.024 0.529 . . . . 0.0 110.0 -174.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.4 p -66.47 169.33 7.67 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.008 0.523 . . . . 0.0 111.909 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 m -56.44 -27.87 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.8 -14.48 54.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.386 1.074 . . . . 0.0 113.283 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.68 6.06 56.45 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.445 1.497 . . . . 0.0 114.705 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -71.7 155.34 40.59 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.692 1.246 . . . . 0.0 111.384 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.7 ptp -116.86 74.24 0.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.803 1.241 . . . . 0.0 110.961 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.73 147.0 33.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.487 1.115 . . . . 0.0 110.977 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.78 146.96 92.53 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.034 2.49 . . . . 0.0 111.159 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tt -59.27 -24.78 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -54.78 -38.69 67.58 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.861 1.265 . . . . 0.0 112.61 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -81.28 -38.75 26.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.19 0.596 . . . . 0.0 110.848 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.452 HD13 HD21 ' A' ' 94' ' ' LEU . 77.2 mt -61.88 -40.89 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.389 -0.82 . . . . 0.0 111.665 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -64.33 -39.36 93.74 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.88 -40.12 25.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.968 0.907 . . . . 0.0 113.069 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -81.03 -11.96 59.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.754 1.222 . . . . 0.0 112.938 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 57.87 32.91 22.58 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.403 1.481 . . . . 0.0 112.737 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 mt -70.31 133.48 47.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.663 1.185 . . . . 0.0 110.971 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -72.11 154.58 41.0 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.546 -0.721 . . . . 0.0 111.76 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.452 HD21 HD13 ' A' ' 87' ' ' ILE . 62.5 mt -105.89 147.66 28.49 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.936 0.894 . . . . 0.0 112.406 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.8 ttm -70.17 151.64 45.18 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.511 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.27 174.04 10.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.481 1.112 . . . . 0.0 112.545 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.0 -0.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 125.775 1.63 . . . . 0.0 114.694 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.29 12.55 21.68 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.299 1.44 . . . . 0.0 113.265 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.8 m120 59.98 25.05 14.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.228 1.811 . . . . 0.0 113.02 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.8 mt -63.75 159.1 56.16 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.976 1.71 . . . . 0.0 112.013 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.19 146.2 80.76 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.004 2.47 . . . . 0.0 111.477 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -76.43 113.54 14.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.095 0.558 . . . . 0.0 109.708 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.95 150.58 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.318 1.447 . . . . 0.0 111.232 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.09 174.23 6.03 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.652 1.581 . . . . 0.0 111.21 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.4 mt -66.18 113.37 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.881 0.872 . . . . 0.0 109.878 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.28 74.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.026 1.331 . . . . 0.0 111.628 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.7 p -153.38 160.76 42.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.212 1.805 . . . . 0.0 111.784 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -117.4 145.26 44.22 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.081 1.752 . . . . 0.0 110.456 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -147.0 121.67 9.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.25 1.02 . . . . 0.0 110.871 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -64.18 135.84 56.68 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.84 -0.538 . . . . 0.0 111.175 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.5 mt -105.99 -37.98 6.47 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.255 0.622 . . . . 0.0 112.167 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.23 -144.78 15.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.458 1.028 . . . . 0.0 112.462 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -128.8 78.77 1.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 123.193 1.473 . . . . 0.0 112.141 -169.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -96.84 160.35 14.41 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.916 1.686 . . . . 0.0 111.074 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.44 119.32 8.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.392 0.677 . . . . 0.0 110.433 169.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.97 150.67 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.451 0.644 . . . . 0.0 111.384 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -138.44 158.76 43.65 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.67 1.588 . . . . 0.0 112.217 -168.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -158.23 133.4 8.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.425 1.09 . . . . 0.0 110.992 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.8 pt -82.3 158.4 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.389 -0.819 . . . . 0.0 111.354 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.22 139.9 15.79 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.84 1.209 . . . . 0.0 111.424 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 m -146.21 151.57 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.652 1.981 . . . . 0.0 110.002 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -117.9 -24.86 6.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.327 1.051 . . . . 0.0 112.916 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -65.7 -28.96 69.45 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.576 1.55 . . . . 0.0 112.91 174.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -157.59 -171.3 3.52 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.111 1.765 . . . . 0.0 110.928 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.06 38.31 2.77 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.924 1.69 . . . . 0.0 112.797 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.37 160.59 13.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.26 1.024 . . . . 0.0 113.29 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -153.96 154.93 34.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.842 1.657 . . . . 0.0 111.984 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.24 131.65 34.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.526 1.131 . . . . 0.0 112.688 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 38.5 mt -82.87 170.59 14.82 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.172 1.389 . . . . 0.0 112.669 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -55.66 -41.15 73.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -75.32 -33.28 61.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.39 0.676 . . . . 0.0 111.577 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.4 -9.15 5.02 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.163 1.363 . . . . 0.0 114.304 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.74 173.1 5.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.614 1.707 . . . . 0.0 111.79 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.29 122.0 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.472 0.709 . . . . 0.0 109.843 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.63 131.48 44.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.336 1.054 . . . . 0.0 108.369 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 p -108.61 143.35 37.78 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.581 1.552 . . . . 0.0 110.775 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--O 1.255 1.394 0 CA-C-O 117.653 -1.165 . . . . 0.0 113.1 -167.811 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 112.382 -0.287 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -139.12 164.1 25.89 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 126.684 2.088 . . . . 0.0 112.182 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.08 179.19 7.69 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.989 1.315 . . . . 0.0 112.55 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.6 150.27 36.93 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.034 1.733 . . . . 0.0 111.015 -173.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 t -69.52 163.77 24.67 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.5 -0.75 . . . . 0.0 112.186 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -50.2 -43.82 52.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.914 0.885 . . . . 0.0 112.011 172.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -62.54 -15.77 52.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.993 1.317 . . . . 0.0 114.322 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.8 m -70.94 102.21 2.35 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.081 0.953 . . . . 0.0 111.043 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -86.24 137.65 32.46 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.357 0.663 . . . . 0.0 112.11 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.2 mm -122.9 119.13 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.896 1.678 . . . . 0.0 107.929 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.24 127.88 33.53 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 122.253 -0.279 . . . . 0.0 111.161 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.6 p -124.93 155.94 38.78 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.72 1.608 . . . . 0.0 112.375 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.6 t -81.24 -33.68 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.992 0.517 . . . . 0.0 111.72 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.31 -25.78 61.7 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -137.88 -53.85 0.65 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.95 0.9 . . . . 0.0 113.281 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.73 -146.46 18.27 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.1 0.857 . . . . 0.0 112.352 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -74.44 107.31 6.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.067 1.747 . . . . 0.0 110.925 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.439 ' CD1' HD11 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -146.56 157.07 48.74 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 177.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.25 132.86 26.91 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.172 3.248 . . . . 0.0 112.925 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.43 ' HA ' HD12 ' A' ' 21' ' ' ILE . 20.6 tt -56.42 -34.79 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.767 0.827 . . . . 0.0 112.987 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.9 -34.22 89.34 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.731 -0.606 . . . . 0.0 112.784 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -71.59 -32.72 68.34 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.481 1.141 . . . . 0.0 111.921 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' A' ' 16' ' ' LEU . 62.9 mt -67.48 -43.38 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.124 0.969 . . . . 0.0 110.153 176.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.5 t -82.66 -36.67 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.832 0.853 . . . . 0.0 112.669 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -65.8 -27.07 68.0 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.141 0.882 . . . . 0.0 112.857 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -116.33 2.65 13.25 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.32 1.048 . . . . 0.0 113.529 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 46.62 52.62 10.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.924 2.49 . . . . 0.0 112.528 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.7 mt -74.11 119.99 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.278 1.031 . . . . 0.0 109.936 -172.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -71.95 108.37 5.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.916 0.887 . . . . 0.0 110.532 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.5 p -148.15 161.09 42.16 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.363 1.078 . . . . 0.0 113.844 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 151.83 19.23 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.909 1.684 . . . . 0.0 109.907 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.35 170.99 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 125.251 1.42 . . . . 0.0 111.347 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -114.87 142.23 46.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.477 1.511 . . . . 0.0 111.093 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.8 t -164.44 152.69 12.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.174 1.389 . . . . 0.0 110.653 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 m -81.67 154.64 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.625 1.102 . . . . 0.0 112.698 170.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -96.08 -174.81 3.2 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.648 1.579 . . . . 0.0 113.221 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -62.77 -13.35 32.04 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -98.55 -5.41 32.12 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.4 1.48 . . . . 0.0 112.361 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.19 26.28 44.78 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.728 1.156 . . . . 0.0 114.588 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -109.82 122.82 48.4 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.135 1.468 . . . . 0.0 110.165 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 mt -67.69 103.12 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.979 0.912 . . . . 0.0 109.41 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -100.86 179.08 4.5 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.737 1.615 . . . . 0.0 111.031 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 p -126.84 143.1 51.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.192 0.997 . . . . 0.0 112.957 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -144.96 144.25 23.33 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 125.004 1.322 . . . . 0.0 112.442 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.51 149.21 43.87 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.098 2.532 . . . . 0.0 112.11 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.34 137.91 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.873 0.869 . . . . 0.0 110.745 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.64 -34.74 12.48 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -167.43 178.6 5.39 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.972 1.709 . . . . 0.0 112.308 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.2 m-90 -132.69 137.28 46.88 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.214 1.405 . . . . 0.0 110.217 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -127.59 114.78 17.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.685 1.194 . . . . 0.0 111.313 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.29 108.19 19.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.424 1.49 . . . . 0.0 109.877 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -78.49 -29.36 46.68 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.304 1.042 . . . . 0.0 112.752 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.31 -45.85 2.22 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.268 1.413 . . . . 0.0 114.026 171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 177.21 102.75 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.436 1.495 . . . . 0.0 112.183 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -132.22 166.66 21.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.747 1.219 . . . . 0.0 112.373 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.86 100.09 0.91 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.401 1.48 . . . . 0.0 113.851 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.86 141.7 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.346 1.458 . . . . 0.0 111.617 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -123.4 140.2 53.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.176 1.791 . . . . 0.0 110.217 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.11 130.05 44.79 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.979 0.912 . . . . 0.0 109.959 172.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -128.15 97.04 4.64 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.381 1.072 . . . . 0.0 108.232 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 45.9 t -111.34 142.16 43.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.166 0.987 . . . . 0.0 110.355 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -104.04 162.26 13.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.772 1.229 . . . . 0.0 112.117 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.85 -20.57 65.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.444 1.098 . . . . 0.0 113.723 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -76.11 -28.25 57.43 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.601 1.161 . . . . 0.0 113.031 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.91 -0.25 19.67 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.737 1.161 . . . . 0.0 114.547 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 m -58.27 146.86 32.65 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.319 1.06 . . . . 0.0 111.173 171.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.0 124.93 27.1 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.486 1.114 . . . . 0.0 110.435 -171.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.2 mt -137.61 150.51 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.942 2.097 . . . . 0.0 108.091 -170.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -136.62 110.91 8.43 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.57 1.148 . . . . 0.0 110.062 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.24 160.57 40.75 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.333 1.453 . . . . 0.0 111.518 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 p -75.31 151.0 38.33 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.385 -0.822 . . . . 0.0 111.782 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -63.19 -19.14 64.24 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.35 -15.18 56.09 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.772 1.629 . . . . 0.0 112.679 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -79.58 132.95 36.42 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.736 0.814 . . . . 0.0 110.038 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -93.79 146.68 23.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.592 1.157 . . . . 0.0 112.385 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.526 ' HB3' HD11 ' A' ' 94' ' ' LEU . 65.6 m-85 -128.74 151.84 49.1 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.845 -1.159 . . . . 0.0 111.483 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.3 ttp -92.78 100.48 12.95 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.447 0.699 . . . . 0.0 110.563 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.7 p -69.33 172.6 6.82 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.583 0.753 . . . . 0.0 112.342 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 m -52.56 -29.55 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -86.94 -10.04 54.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.082 0.953 . . . . 0.0 113.342 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.96 10.89 62.21 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.793 1.187 . . . . 0.0 114.135 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -67.61 158.72 31.45 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.235 1.018 . . . . 0.0 111.024 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 37.0 mtm -126.21 70.99 1.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.783 1.633 . . . . 0.0 109.848 -173.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 mt -111.81 149.28 40.57 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 124.895 1.278 . . . . 0.0 110.599 -170.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.41 149.37 88.13 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.646 2.231 . . . . 0.0 110.379 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.51 -28.57 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -55.19 -35.22 64.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.678 1.191 . . . . 0.0 113.007 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.49 -37.9 59.88 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.283 1.033 . . . . 0.0 111.471 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.542 HG23 ' HB2' ' A' ' 92' ' ' LEU . 68.7 mt -68.24 -38.51 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.603 1.161 . . . . 0.0 109.945 -176.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.96 -37.15 86.34 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -75.09 -46.72 32.74 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -79.43 -5.4 54.61 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 56.48 35.48 26.05 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.626 1.57 . . . . 0.0 112.531 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.542 ' HB2' HG23 ' A' ' 87' ' ' ILE . 66.0 mt -65.99 132.18 47.97 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.524 1.13 . . . . 0.0 110.825 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -75.31 136.85 40.85 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.838 -0.539 . . . . 0.0 110.328 171.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 74' ' ' PHE . 3.0 mm? -69.96 152.64 44.22 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.289 -0.882 . . . . 0.0 111.35 168.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.9 ttm -71.06 150.82 45.17 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.378 168.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.81 161.53 25.07 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.61 1.564 . . . . 0.0 112.598 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -113.6 -13.57 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.941 1.696 . . . . 0.0 114.133 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -109.48 11.55 24.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.046 1.338 . . . . 0.0 112.866 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.9 m120 64.2 25.89 13.7 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.537 1.535 . . . . 0.0 112.672 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.5 mt -55.67 157.12 7.96 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.671 1.588 . . . . 0.0 111.999 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.76 141.53 79.19 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.695 2.264 . . . . 0.0 110.397 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -66.04 128.64 36.87 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.792 -0.568 . . . . 0.0 110.712 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.4 pt -147.16 149.91 15.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 126.538 1.935 . . . . 0.0 109.897 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 -179.95 3.92 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.309 1.444 . . . . 0.0 111.333 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 25.1 mt -63.56 105.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.251 1.02 . . . . 0.0 110.028 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.45 77.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.156 1.382 . . . . 0.0 111.576 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 p -149.44 149.18 30.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.852 1.661 . . . . 0.0 111.076 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -143.43 144.0 31.85 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.908 1.683 . . . . 0.0 110.36 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -159.37 148.71 18.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.423 1.889 . . . . 0.0 110.042 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -65.11 128.39 35.59 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.546 0.612 . . . . 0.0 110.995 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.7 mt -93.53 -46.18 7.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.085 0.554 . . . . 0.0 111.748 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 147.73 -151.24 23.51 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.415 1.007 . . . . 0.0 112.544 -172.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -123.28 86.1 2.52 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 122.689 1.233 . . . . 0.0 112.135 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -102.01 154.56 18.86 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.248 1.419 . . . . 0.0 110.075 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.68 116.61 4.52 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.164 0.586 . . . . 0.0 109.964 169.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.06 151.66 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.541 0.686 . . . . 0.0 110.942 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -141.11 157.38 45.36 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.814 1.645 . . . . 0.0 111.412 -168.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -156.32 146.02 20.98 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.522 0.729 . . . . 0.0 109.872 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.7 pt -100.15 143.68 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.777 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -93.96 151.77 20.42 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.45 0.548 . . . . 0.0 111.772 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.5 t -148.68 133.24 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.758 1.623 . . . . 0.0 108.869 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -79.26 -36.56 39.66 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -69.31 -68.26 0.42 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.672 1.589 . . . . 0.0 111.879 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.33 118.47 9.49 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.762 1.225 . . . . 0.0 109.967 -174.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -71.75 47.41 0.14 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.522 2.329 . . . . 0.0 113.754 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.21 163.33 37.58 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.347 -1.47 . . . . 0.0 114.04 -174.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -161.62 156.97 23.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.641 1.576 . . . . 0.0 112.254 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.35 147.08 26.2 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.716 1.206 . . . . 0.0 112.962 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.05 168.86 9.57 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.671 1.588 . . . . 0.0 112.076 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -48.83 -51.02 31.77 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.126 1.37 . . . . 0.0 114.025 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -73.42 -20.47 60.72 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -172.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 127.14 -4.27 7.31 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.791 1.186 . . . . 0.0 114.91 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.31 171.87 11.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.081 1.44 . . . . 0.0 112.279 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.84 138.61 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.247 1.019 . . . . 0.0 109.999 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.5 149.1 50.28 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.306 1.842 . . . . 0.0 109.351 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.0 t -134.96 123.21 23.01 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -171.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.485 2.314 . . . . 0.0 114.074 178.849 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.913 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -116.84 168.24 12.74 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 127.453 2.454 . . . . 0.0 110.948 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.99 175.94 10.64 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.22 1.008 . . . . 0.0 113.166 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -108.92 150.02 28.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.87 1.668 . . . . 0.0 111.071 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -65.81 161.76 20.27 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.405 0.682 . . . . 0.0 112.149 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -52.23 -44.15 64.66 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.823 0.849 . . . . 0.0 112.481 172.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.35 -23.75 64.51 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.791 1.636 . . . . 0.0 113.84 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -63.23 112.92 2.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.176 0.991 . . . . 0.0 111.341 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -96.55 135.3 38.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.42 0.688 . . . . 0.0 111.048 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.6 mm -118.43 122.81 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.653 1.581 . . . . 0.0 107.954 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -64.93 124.38 21.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.279 0.231 . . . . 0.0 111.289 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.2 p -121.83 153.65 38.07 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.632 1.173 . . . . 0.0 112.146 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.9 -30.41 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 121.877 -0.514 . . . . 0.0 111.8 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -65.62 -36.42 83.66 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -140.46 -49.45 0.45 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.32 -146.52 18.5 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.966 0.794 . . . . 0.0 112.51 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.3 mt -66.78 96.31 0.4 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.665 1.586 . . . . 0.0 112.639 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.66 147.8 62.21 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.887 1.275 . . . . 0.0 111.92 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.45 129.14 21.81 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 124.289 3.326 . . . . 0.0 112.794 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.5 tt -56.78 -37.25 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.004 0.921 . . . . 0.0 113.035 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.29 -31.35 78.77 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.662 -0.649 . . . . 0.0 113.291 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -76.23 -30.98 58.13 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.952 0.876 . . . . 0.0 111.817 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.58 -40.51 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.244 1.018 . . . . 0.0 109.642 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.71 -39.83 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.521 0.728 . . . . 0.0 112.951 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.1 -21.81 56.26 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.389 0.995 . . . . 0.0 113.513 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -109.51 1.87 20.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.778 1.231 . . . . 0.0 112.299 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.98 51.26 13.04 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.975 2.11 . . . . 0.0 112.663 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.5 mt -71.59 120.82 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.213 0.605 . . . . 0.0 109.48 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.04 105.6 6.14 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.222 1.009 . . . . 0.0 110.665 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.5 p -144.53 164.73 30.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.457 1.122 . . . . 0.0 113.44 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.5 145.67 26.55 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.315 1.446 . . . . 0.0 109.849 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.22 176.05 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.958 1.703 . . . . 0.0 111.098 -176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -118.24 142.95 46.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.769 1.628 . . . . 0.0 110.537 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.9 t -155.58 152.99 29.45 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.226 1.41 . . . . 0.0 110.419 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -94.27 125.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.456 0.702 . . . . 0.0 109.472 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -70.81 176.45 4.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.392 1.091 . . . . 0.0 112.445 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -60.21 -27.33 67.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.887 1.275 . . . . 0.0 113.066 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -86.2 -2.17 58.12 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.684 1.594 . . . . 0.0 113.498 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.23 19.05 78.85 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.582 1.086 . . . . 0.0 114.592 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -93.97 129.68 40.36 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.023 1.329 . . . . 0.0 109.485 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.2 mt -74.65 134.71 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -138.67 167.91 20.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.626 1.57 . . . . 0.0 111.683 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 p -115.94 144.95 43.35 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.473 1.109 . . . . 0.0 112.187 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -153.26 148.48 20.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.16 0.984 . . . . 0.0 112.767 -176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.62 150.21 45.03 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.963 2.442 . . . . 0.0 112.562 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -58.77 140.33 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.922 0.889 . . . . 0.0 110.568 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.48 -31.07 11.07 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.006 0.922 . . . . 0.0 112.64 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -167.71 175.14 7.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.946 1.698 . . . . 0.0 112.17 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -134.26 124.19 25.5 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.938 1.295 . . . . 0.0 109.303 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -113.77 129.13 56.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.993 0.917 . . . . 0.0 110.839 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -120.24 103.83 9.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.53 1.532 . . . . 0.0 110.043 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -72.77 -29.86 63.64 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.709 1.204 . . . . 0.0 112.967 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.16 -52.74 2.84 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.262 1.411 . . . . 0.0 113.62 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -170.76 105.54 0.26 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.967 1.307 . . . . 0.0 110.269 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -132.66 168.13 18.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.987 0.915 . . . . 0.0 112.349 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -68.82 100.84 1.23 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.854 1.261 . . . . 0.0 113.342 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.9 t -94.36 138.03 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.926 1.29 . . . . 0.0 111.557 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.505 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 53.2 m-85 -120.14 144.41 47.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 110.206 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.36 134.09 55.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.598 0.759 . . . . 0.0 110.652 171.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -127.03 83.34 2.16 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.425 1.49 . . . . 0.0 108.384 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.8 t -98.06 147.77 24.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.001 0.92 . . . . 0.0 110.899 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.09 158.36 23.31 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.199 1.4 . . . . 0.0 112.34 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -69.17 -18.34 63.91 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -77.25 -28.34 53.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.13 0.972 . . . . 0.0 112.786 172.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.62 -9.76 8.63 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.36 1.457 . . . . 0.0 114.253 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.2 m -59.54 150.78 26.07 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.46 1.13 . . . . 0.0 112.153 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.1 tp -137.91 125.6 22.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.162 0.985 . . . . 0.0 110.855 -173.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.6 mt -133.93 148.77 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.367 1.867 . . . . 0.0 107.941 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -131.6 121.41 24.33 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.935 1.294 . . . . 0.0 110.505 174.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.34 163.92 36.35 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.386 1.474 . . . . 0.0 111.197 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -75.37 154.04 37.45 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.434 -0.791 . . . . 0.0 111.973 173.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.505 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 4.8 mtmt -62.93 -20.4 65.17 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -87.47 -9.96 53.17 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.235 1.814 . . . . 0.0 113.054 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -77.68 134.42 38.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.75 0.82 . . . . 0.0 109.755 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -98.02 150.1 21.75 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.289 1.042 . . . . 0.0 111.889 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -136.3 132.57 35.89 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.018 -1.052 . . . . 0.0 109.766 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.1 ttp -72.24 108.87 5.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.206 0.527 . . . . 0.0 110.998 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -68.73 172.12 6.83 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.377 0.671 . . . . 0.0 112.172 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -55.91 -22.75 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -87.1 -6.14 58.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.414 1.085 . . . . 0.0 113.314 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.57 9.23 72.49 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.759 1.171 . . . . 0.0 113.966 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -81.13 130.16 34.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.258 1.029 . . . . 0.0 110.886 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.28 87.31 7.37 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.933 1.293 . . . . 0.0 110.793 169.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.1 mt -112.59 145.4 32.87 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.007 0.923 . . . . 0.0 110.238 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.72 147.06 85.44 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.674 2.25 . . . . 0.0 110.875 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -58.39 -26.84 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -53.79 -37.39 63.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.61 1.164 . . . . 0.0 113.19 169.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -80.43 -39.24 28.61 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.73 0.812 . . . . 0.0 110.669 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.46 -38.85 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.682 0.793 . . . . 0.0 111.103 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -64.78 -38.57 91.45 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -75.86 -38.64 57.73 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.482 -0.761 . . . . 0.0 112.682 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -75.47 -13.36 60.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 57.87 31.53 20.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.522 1.529 . . . . 0.0 111.982 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.8 mt -84.54 157.36 21.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.617 1.199 . . . . 0.0 112.201 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -113.54 156.6 23.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.011 2.124 . . . . 0.0 112.923 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.6 mt -88.21 149.75 23.68 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.552 0.741 . . . . 0.0 112.361 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.3 ttp -72.82 153.67 40.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.455 0.702 . . . . 0.0 111.222 170.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.39 167.3 15.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.412 1.485 . . . . 0.0 112.174 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.27 -12.52 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.981 1.313 . . . . 0.0 114.151 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.08 8.77 36.54 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.069 1.348 . . . . 0.0 113.073 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 52.41 35.39 17.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.987 1.715 . . . . 0.0 113.42 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.75 156.97 86.32 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.064 170.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.66 129.73 27.36 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.213 2.609 . . . . 0.0 111.134 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.19 134.44 44.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.727 0.811 . . . . 0.0 109.748 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.7 pt -143.17 130.75 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.371 1.468 . . . . 0.0 111.044 -169.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.5 171.57 12.42 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.487 1.115 . . . . 0.0 112.351 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.9 mt -63.97 112.52 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.319 1.448 . . . . 0.0 110.111 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.29 -35.81 35.3 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.707 0.803 . . . . 0.0 112.327 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.4 p -146.68 149.88 34.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.106 1.762 . . . . 0.0 110.676 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.07 143.03 32.89 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.795 1.638 . . . . 0.0 110.082 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -160.92 140.53 10.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.827 1.651 . . . . 0.0 110.256 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -65.35 121.98 16.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.842 0.457 . . . . 0.0 110.89 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.3 mt -90.95 -44.57 9.27 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.039 0.536 . . . . 0.0 111.891 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 150.73 -142.46 9.6 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.515 0.579 . . . . 0.0 113.324 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -130.67 86.27 2.36 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.82 1.248 . . . . 0.0 111.754 -168.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -104.43 157.26 17.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.909 1.284 . . . . 0.0 111.047 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 117.66 6.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.386 0.674 . . . . 0.0 110.364 169.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.3 m -124.14 151.7 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.372 0.606 . . . . 0.0 111.088 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -141.02 157.75 44.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.559 1.544 . . . . 0.0 111.74 -168.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -157.01 128.31 6.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.194 0.998 . . . . 0.0 110.799 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.5 pt -80.66 147.45 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.3 -0.875 . . . . 0.0 110.863 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.21 156.04 18.55 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.434 1.016 . . . . 0.0 111.731 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.3 t -143.05 153.48 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.662 1.185 . . . . 0.0 110.261 -169.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -60.84 117.3 5.24 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.791 -1.193 . . . . 0.0 111.937 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 51.83 22.43 1.72 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 126.545 1.938 . . . . 0.0 114.747 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -151.37 166.17 31.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.97 0.908 . . . . 0.0 112.646 -169.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -151.87 23.82 0.67 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.773 1.229 . . . . 0.0 113.068 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.13 162.95 29.59 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -166.51 158.43 13.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.711 1.205 . . . . 0.0 112.611 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.4 134.59 35.58 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.31 1.044 . . . . 0.0 112.339 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 38.1 mt -86.57 166.24 15.58 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.732 1.213 . . . . 0.0 111.516 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -52.74 -32.8 45.14 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -88.1 -6.53 57.86 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.505 1.122 . . . . 0.0 113.239 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.88 -11.65 34.78 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.427 1.013 . . . . 0.0 114.973 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -73.13 167.42 21.18 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.36 1.58 . . . . 0.0 112.842 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.69 120.66 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.931 0.893 . . . . 0.0 110.202 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.66 141.15 30.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.442 1.897 . . . . 0.0 109.801 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.7 m -139.16 137.12 35.8 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.472 1.109 . . . . 0.0 113.175 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 125.189 1.396 . . . . 0.0 113.86 -177.835 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.856 -0.497 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -152.02 160.43 28.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 129.442 3.401 . . . . 0.0 108.537 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -156.12 174.8 14.84 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.572 0.701 . . . . 0.0 112.826 -168.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.8 mt -120.89 147.0 46.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.928 1.691 . . . . 0.0 109.964 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 t -66.75 161.17 24.19 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -50.93 -44.64 60.28 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.557 0.743 . . . . 0.0 111.993 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -15.93 41.23 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.5 m -73.54 98.72 2.86 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.595 0.758 . . . . 0.0 110.14 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.15 133.14 42.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.455 0.645 . . . . 0.0 110.746 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.87 126.74 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 125.466 1.507 . . . . 0.0 107.216 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.3 122.56 18.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 170.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.7 p -123.71 150.98 43.66 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.76 1.224 . . . . 0.0 111.966 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.4 t -77.68 -33.59 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.9 -0.5 . . . . 0.0 112.005 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -66.16 -27.63 68.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -144.57 -52.84 0.31 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.37 -150.07 21.1 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.817 0.722 . . . . 0.0 112.217 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.85 108.26 2.93 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.333 1.453 . . . . 0.0 110.939 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.0 mt -134.99 148.89 68.74 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.475 1.11 . . . . 0.0 113.041 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.66 126.56 16.99 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.967 3.111 . . . . 0.0 112.024 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 tt -54.92 -36.48 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.18 -36.0 92.68 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.805 -0.56 . . . . 0.0 112.992 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -68.76 -37.65 79.53 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.558 1.179 . . . . 0.0 111.433 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.46 -38.41 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.761 0.824 . . . . 0.0 109.767 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.53 -39.49 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.158 0.983 . . . . 0.0 113.259 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.28 -27.5 66.37 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.496 1.044 . . . . 0.0 112.667 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -112.71 0.72 15.4 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.719 1.208 . . . . 0.0 112.773 -176.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.95 52.31 11.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.87 2.468 . . . . 0.0 112.418 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.6 mt -72.98 123.78 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.082 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.8 102.41 2.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.893 0.877 . . . . 0.0 110.287 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.5 p -132.25 -178.13 4.77 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.994 1.318 . . . . 0.0 112.496 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.94 147.27 51.05 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.439 1.496 . . . . 0.0 108.227 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.91 158.65 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.657 1.183 . . . . 0.0 111.203 -173.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -96.2 138.19 34.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.38 1.072 . . . . 0.0 110.4 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 t -155.57 153.77 30.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.898 1.279 . . . . 0.0 110.527 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.88 125.47 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.078 0.551 . . . . 0.0 110.316 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -68.42 175.29 3.45 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.835 1.254 . . . . 0.0 112.267 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.71 -25.87 68.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.844 1.258 . . . . 0.0 113.155 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -85.56 -4.76 59.26 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.366 1.466 . . . . 0.0 113.555 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.9 19.02 62.1 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.738 1.161 . . . . 0.0 114.758 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -94.95 128.88 42.08 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.627 1.171 . . . . 0.0 110.259 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.1 mt -74.12 123.52 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -135.11 174.15 10.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.828 2.051 . . . . 0.0 111.504 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -116.93 139.19 50.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.185 0.994 . . . . 0.0 111.905 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -141.22 141.0 21.99 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.545 1.138 . . . . 0.0 111.863 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.14 152.24 39.89 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.885 2.39 . . . . 0.0 112.027 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.66 138.45 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.787 0.835 . . . . 0.0 111.037 169.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.13 -51.95 4.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.544 0.738 . . . . 0.0 111.142 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -144.62 -178.6 6.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.87 1.668 . . . . 0.0 111.034 -173.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -138.98 126.81 22.15 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.399 1.08 . . . . 0.0 109.313 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -122.16 134.72 54.73 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.105 0.955 . . . . 0.0 110.795 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -127.52 122.25 32.84 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.208 1.403 . . . . 0.0 109.996 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -88.96 -34.19 16.96 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.177 0.991 . . . . 0.0 112.326 -173.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.45 -42.55 2.32 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.114 1.34 . . . . 0.0 114.889 172.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -178.69 88.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.066 1.412 . . . . 0.0 114.629 -168.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -125.18 158.98 32.62 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.979 1.311 . . . . 0.0 112.291 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.57 106.76 1.22 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.021 1.328 . . . . 0.0 112.695 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 t -98.59 139.44 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.346 1.458 . . . . 0.0 110.586 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -124.48 140.66 52.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.986 1.315 . . . . 0.0 109.513 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.84 135.1 35.88 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.177 0.991 . . . . 0.0 108.987 169.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -122.07 98.53 5.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.61 1.564 . . . . 0.0 109.011 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.8 t -75.86 132.97 40.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.138 0.575 . . . . 0.0 109.982 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mp -93.28 162.48 13.99 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.614 0.721 . . . . 0.0 112.783 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.81 -22.44 66.56 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.03 -21.27 51.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.954 0.902 . . . . 0.0 112.926 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.04 -1.32 25.59 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.441 1.495 . . . . 0.0 114.531 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.8 p -72.71 171.32 12.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.488 1.144 . . . . 0.0 113.017 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.5 mt -132.6 145.6 51.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.192 1.397 . . . . 0.0 110.983 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.6 mt -137.68 139.64 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.471 1.908 . . . . 0.0 107.323 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.464 HH21 HD22 ' A' ' 111' ' ' LEU . 42.3 mtp180 -131.26 98.18 4.48 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.608 1.163 . . . . 0.0 110.429 -174.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.73 166.29 27.06 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.282 1.039 . . . . 0.0 113.724 -172.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 p -82.43 155.46 24.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.723 1.209 . . . . 0.0 111.535 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -61.55 -23.95 66.31 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -86.74 -11.29 51.52 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.37 1.068 . . . . 0.0 112.605 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -80.02 132.04 35.92 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -87.4 162.72 17.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.509 0.671 . . . . 0.0 111.098 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -138.19 141.23 40.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 43.1 ttm -69.54 107.39 3.36 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -66.89 166.47 13.37 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.204 0.526 . . . . 0.0 111.122 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 m -57.64 -24.33 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.07 -14.39 59.51 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.487 1.115 . . . . 0.0 113.478 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.46 10.9 61.5 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.095 1.331 . . . . 0.0 114.383 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -82.96 164.08 20.63 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.426 1.113 . . . . 0.0 111.522 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.36 81.94 1.86 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.985 1.314 . . . . 0.0 111.33 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.6 mt -113.22 148.41 39.46 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.526 1.131 . . . . 0.0 110.787 -172.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.04 146.03 81.08 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.97 2.447 . . . . 0.0 111.246 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' A' ' 87' ' ' ILE . 6.6 tt -58.43 -26.03 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.55 -35.09 67.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.389 1.076 . . . . 0.0 113.023 170.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -39.03 27.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.531 1.132 . . . . 0.0 111.102 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.525 HD13 HD21 ' A' ' 94' ' ' LEU . 78.6 mt -64.47 -39.45 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.397 1.079 . . . . 0.0 110.919 -175.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -63.73 -34.44 77.87 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -77.14 -48.19 18.35 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.944 0.793 . . . . 0.0 113.055 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -74.55 -12.35 60.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 57.9 35.52 25.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.663 1.585 . . . . 0.0 112.476 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.8 mt -76.74 146.92 37.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.159 0.983 . . . . 0.0 111.834 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.63 164.76 20.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.665 0.786 . . . . 0.0 112.043 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.525 HD21 HD13 ' A' ' 87' ' ' ILE . 84.6 mt -111.05 147.14 35.43 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.5 1.12 . . . . 0.0 111.682 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 31.7 ttm -74.79 141.92 44.3 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.723 -0.611 . . . . 0.0 110.664 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.12 173.19 9.4 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.515 1.126 . . . . 0.0 113.06 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.61 -19.63 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 126.17 1.788 . . . . 0.0 113.8 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.8 4.23 30.05 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.94 1.296 . . . . 0.0 113.916 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.77 31.96 21.22 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.506 1.522 . . . . 0.0 112.859 -175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.9 mt -70.92 158.79 87.33 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.913 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.24 149.83 85.12 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.154 2.569 . . . . 0.0 111.396 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -70.4 123.59 22.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.4 0.68 . . . . 0.0 110.401 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.21 137.92 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.218 1.407 . . . . 0.0 111.386 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.23 176.35 5.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.834 1.654 . . . . 0.0 111.379 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mt -69.71 103.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.511 1.524 . . . . 0.0 110.007 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.93 -42.59 80.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.966 1.306 . . . . 0.0 111.633 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -152.48 162.98 40.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.642 1.977 . . . . 0.0 111.113 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -127.47 144.82 51.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.902 1.681 . . . . 0.0 110.793 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -145.83 116.58 7.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.512 1.125 . . . . 0.0 110.527 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -63.16 127.44 31.26 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.575 -0.703 . . . . 0.0 111.16 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.464 HD22 HH21 ' A' ' 67' ' ' ARG . 68.9 mt -94.74 -42.99 8.45 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.831 0.452 . . . . 0.0 112.094 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 140.64 -147.99 19.64 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.712 1.148 . . . . 0.0 112.588 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -120.8 71.27 0.92 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.476 1.51 . . . . 0.0 112.362 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -90.8 157.34 17.44 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.688 1.595 . . . . 0.0 111.216 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.18 118.92 9.93 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.95 0.9 . . . . 0.0 110.35 170.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.1 150.27 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.42 0.688 . . . . 0.0 111.448 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -137.11 157.96 45.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.051 1.74 . . . . 0.0 111.994 -169.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -158.1 119.1 3.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.713 1.205 . . . . 0.0 110.607 -174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 pt -72.68 148.19 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 O-C-N 120.754 -1.216 . . . . 0.0 111.927 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.49 151.47 19.34 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.488 1.042 . . . . 0.0 111.868 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.7 t -147.45 146.27 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.426 1.49 . . . . 0.0 109.416 -171.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -103.93 -43.74 5.22 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -70.61 -45.19 65.76 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.59 -172.54 3.05 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.475 1.91 . . . . 0.0 109.846 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -143.69 39.23 1.38 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.299 -0.875 . . . . 0.0 112.467 -173.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -161.92 161.86 28.92 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.968 -1.083 . . . . 0.0 113.156 -172.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -160.49 153.4 21.36 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.015 1.326 . . . . 0.0 112.912 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.62 140.68 37.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.496 1.118 . . . . 0.0 113.227 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 74.4 mt -92.62 178.59 5.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.198 1.799 . . . . 0.0 112.528 173.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -46.8 -59.33 3.13 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.734 2.013 . . . . 0.0 115.121 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.94 -22.21 61.49 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.508 0.723 . . . . 0.0 112.163 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.34 -5.73 8.73 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.123 1.344 . . . . 0.0 114.359 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -61.02 136.15 58.0 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.933 1.867 . . . . 0.0 110.743 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.07 118.3 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.6 153.46 17.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.064 1.346 . . . . 0.0 109.256 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.2 p -136.66 147.36 46.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.434 1.094 . . . . 0.0 112.768 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.9 p30 . . . . . 0 C--O 1.252 1.234 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -167.678 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.86 0 N-CA-C 112.78 -0.128 . . . . 0.0 112.78 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -125.06 174.4 17.29 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.478 2.466 . . . . 0.0 110.815 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -171.04 173.8 4.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.738 1.615 . . . . 0.0 112.588 -172.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.9 mt -118.92 149.83 40.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.381 2.273 . . . . 0.0 110.966 -172.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -73.22 160.41 31.97 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.264 -0.897 . . . . 0.0 111.802 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -50.07 -48.18 53.18 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.358 1.063 . . . . 0.0 112.666 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -66.37 -1.14 3.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.913 2.085 . . . . 0.0 114.944 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.2 m -74.27 104.66 5.12 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.081 0.952 . . . . 0.0 110.264 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.09 129.21 34.84 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.514 0.674 . . . . 0.0 111.614 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.6 mm -111.64 121.09 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 126.093 1.757 . . . . 0.0 107.227 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.39 129.81 42.36 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.378 0.671 . . . . 0.0 111.239 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -129.96 152.06 49.83 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.032 1.333 . . . . 0.0 111.781 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.3 t -74.65 -31.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 121.703 -0.623 . . . . 0.0 112.119 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -65.76 -33.99 77.14 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -141.68 -50.53 0.41 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.88 -137.68 9.22 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 118.816 0.735 . . . . 0.0 112.366 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.0 mt -81.29 96.69 7.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.004 1.722 . . . . 0.0 111.619 -175.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -127.36 147.41 62.01 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.794 1.238 . . . . 0.0 112.341 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.38 130.87 23.37 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.14 3.227 . . . . 0.0 112.675 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 tt -55.21 -36.15 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.9 0.88 . . . . 0.0 113.124 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.7 -34.4 83.26 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.671 -0.643 . . . . 0.0 113.177 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -72.69 -31.54 65.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.339 1.07 . . . . 0.0 111.728 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.1 mt -69.2 -38.07 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.827 0.851 . . . . 0.0 109.896 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.9 t -82.18 -38.07 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.22 1.008 . . . . 0.0 113.07 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.13 -23.68 63.06 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.302 -0.874 . . . . 0.0 112.974 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.31 4.88 11.85 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.074 1.35 . . . . 0.0 112.508 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 45.03 51.72 8.67 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.062 2.545 . . . . 0.0 112.692 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 53.8 mt -72.29 120.15 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.984 0.914 . . . . 0.0 109.134 -171.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.99 99.68 3.93 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.352 1.061 . . . . 0.0 110.587 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.4 p -141.15 162.22 36.02 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.588 1.185 . . . . 0.0 114.128 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.76 154.4 19.56 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.655 1.582 . . . . 0.0 110.505 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.65 173.94 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.734 1.614 . . . . 0.0 110.982 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -119.31 140.61 50.03 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.992 1.717 . . . . 0.0 109.929 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.2 t -159.77 165.96 31.38 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.946 1.298 . . . . 0.0 110.568 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.94 127.52 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.842 1.257 . . . . 0.0 111.366 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.13 177.88 7.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.562 1.145 . . . . 0.0 112.238 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -61.21 -23.01 65.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.274 1.43 . . . . 0.0 113.361 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -89.48 -3.04 58.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.203 1.401 . . . . 0.0 113.548 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.69 89.15 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.419 1.009 . . . . 0.0 114.608 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -81.41 134.93 35.62 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.291 1.046 . . . . 0.0 109.587 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.7 mt -72.22 122.17 24.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -121.41 169.12 10.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.913 1.685 . . . . 0.0 110.433 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.8 p -126.67 144.0 51.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.383 0.673 . . . . 0.0 112.02 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -150.48 147.68 22.12 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.468 1.107 . . . . 0.0 112.041 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.82 148.61 36.39 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.16 2.573 . . . . 0.0 112.738 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.31 145.64 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.408 1.083 . . . . 0.0 111.133 168.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.08 -32.26 7.3 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.892 1.277 . . . . 0.0 112.847 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -164.85 174.13 10.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.569 1.547 . . . . 0.0 112.36 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -137.49 110.68 7.83 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.061 1.345 . . . . 0.0 110.05 -174.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -98.62 115.23 28.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.834 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -102.1 107.0 17.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.91 1.284 . . . . 0.0 108.947 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -78.82 -24.5 44.46 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.355 1.062 . . . . 0.0 112.991 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.57 -44.18 3.31 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.287 1.422 . . . . 0.0 114.786 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 176.83 98.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.883 1.273 . . . . 0.0 113.143 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -129.79 167.42 18.12 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.226 1.411 . . . . 0.0 112.761 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.85 101.07 0.45 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.41 1.484 . . . . 0.0 114.041 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.1 t -92.03 143.33 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.147 1.379 . . . . 0.0 112.191 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -127.1 141.74 51.69 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.014 2.126 . . . . 0.0 110.129 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.15 132.89 51.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.351 0.66 . . . . 0.0 110.948 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.9 75.36 1.49 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.739 1.257 . . . . 0.0 108.779 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.6 t -82.22 146.92 29.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.223 1.009 . . . . 0.0 111.132 173.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.09 163.5 15.09 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.693 1.197 . . . . 0.0 112.825 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.02 -24.29 66.73 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.055 1.342 . . . . 0.0 113.051 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.03 -29.64 31.86 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.763 1.225 . . . . 0.0 113.169 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.83 -0.73 10.01 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.516 1.055 . . . . 0.0 114.69 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 m -63.13 139.94 58.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.803 1.301 . . . . 0.0 110.97 170.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.77 132.99 53.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.208 1.403 . . . . 0.0 109.856 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.1 mt -136.8 152.89 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.758 2.023 . . . . 0.0 107.658 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -138.65 115.96 11.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.707 1.203 . . . . 0.0 110.579 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.55 172.32 14.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.172 1.389 . . . . 0.0 112.35 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 p -93.09 151.9 19.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.993 1.317 . . . . 0.0 111.522 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -62.84 -16.56 58.94 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -88.01 -17.15 31.83 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.449 1.099 . . . . 0.0 112.463 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.43 ' HE1' ' HB1' ' A' ' 135' ' ' ALA . 27.8 t-80 -78.21 137.46 38.15 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -95.02 160.35 14.61 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.217 1.007 . . . . 0.0 110.268 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -142.46 133.76 26.24 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.559 -0.713 . . . . 0.0 109.666 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.5 ttm -77.66 111.22 13.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.98 0.895 . . . . 0.0 111.359 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.1 p -65.31 167.45 8.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.788 1.235 . . . . 0.0 112.828 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.6 m -52.91 -28.77 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -83.79 -11.7 56.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.052 0.941 . . . . 0.0 113.461 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.64 -0.41 61.19 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.381 0.991 . . . . 0.0 114.082 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -76.4 137.67 39.9 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 119.2 1.5 . . . . 0.0 109.745 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.8 ptp -106.63 98.42 8.09 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.715 1.606 . . . . 0.0 108.776 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.63 152.79 59.11 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.084 1.353 . . . . 0.0 109.324 -174.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.53 147.1 86.35 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.266 1.977 . . . . 0.0 110.949 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.4 tt -59.46 -23.33 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -54.49 -35.97 63.66 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.015 1.326 . . . . 0.0 112.632 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -84.48 -39.81 18.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 111.499 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.8 mt -59.88 -36.17 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 119.129 0.877 . . . . 0.0 111.425 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -69.22 -33.41 73.26 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -78.6 -39.23 37.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.438 -0.789 . . . . 0.0 112.399 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -74.51 -14.78 60.86 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.834 0.854 . . . . 0.0 113.178 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 55.35 37.57 29.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.487 1.515 . . . . 0.0 111.905 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.9 mt -92.02 159.5 15.68 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.709 1.242 . . . . 0.0 112.34 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -114.34 154.44 28.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.033 2.133 . . . . 0.0 113.198 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.89 154.06 22.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.773 1.229 . . . . 0.0 112.726 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -70.26 148.7 48.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.758 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -114.1 155.75 25.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.646 1.579 . . . . 0.0 110.894 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.2 5.37 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 125.014 1.325 . . . . 0.0 114.413 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -121.34 20.45 11.27 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.886 1.674 . . . . 0.0 112.421 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.34 16.82 10.4 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 127.023 2.129 . . . . 0.0 113.647 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.1 mt -72.8 157.36 88.89 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.433 1.893 . . . . 0.0 112.54 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.92 166.33 29.89 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.205 3.27 . . . . 0.0 112.25 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -107.02 131.66 53.82 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.494 1.118 . . . . 0.0 110.556 -173.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.1 pt -146.97 135.55 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.443 1.497 . . . . 0.0 110.627 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 175.49 8.9 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.347 1.459 . . . . 0.0 112.127 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.8 mt -63.16 112.04 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.1 1.36 . . . . 0.0 110.206 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.31 -43.38 81.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.257 1.023 . . . . 0.0 111.957 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 p -150.12 147.64 28.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.247 1.819 . . . . 0.0 110.393 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -141.19 139.39 33.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.171 1.389 . . . . 0.0 110.812 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -158.29 150.59 21.96 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.181 1.393 . . . . 0.0 110.51 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -66.03 124.81 23.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.306 0.642 . . . . 0.0 110.891 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.6 mt -90.03 -43.06 10.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.217 0.607 . . . . 0.0 111.955 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 143.01 -149.39 21.3 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.434 1.016 . . . . 0.0 112.096 -173.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -124.11 96.42 4.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.387 1.075 . . . . 0.0 112.041 -169.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -114.36 155.34 26.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.482 1.513 . . . . 0.0 110.035 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.03 116.86 5.71 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.415 0.686 . . . . 0.0 110.326 173.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.41 152.45 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.64 0.776 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -137.95 156.21 48.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.828 1.651 . . . . 0.0 111.851 -168.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -154.09 116.39 4.33 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.67 1.188 . . . . 0.0 110.635 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.0 pt -77.94 142.99 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 120.963 -1.086 . . . . 0.0 111.354 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.75 158.02 17.94 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.392 0.996 . . . . 0.0 111.473 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 t -142.59 159.26 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.586 1.154 . . . . 0.0 110.183 -169.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -79.73 125.25 29.41 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.475 -1.391 . . . . 0.0 111.755 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.3 tpp85 51.29 24.03 1.92 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.729 2.012 . . . . 0.0 114.503 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -159.28 160.12 34.85 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.306 1.842 . . . . 0.0 109.88 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -143.98 24.1 1.67 Allowed 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.352 -0.843 . . . . 0.0 113.19 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -145.08 160.37 41.51 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.157 1.383 . . . . 0.0 114.115 -168.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -166.16 165.14 17.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.383 1.073 . . . . 0.0 112.55 -171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.36 155.26 17.49 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.221 1.008 . . . . 0.0 113.442 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.6 mt -108.37 166.69 10.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.742 2.017 . . . . 0.0 111.568 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -43.2 -50.02 6.43 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.825 1.65 . . . . 0.0 115.296 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -84.67 4.13 33.89 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.192 0.997 . . . . 0.0 113.261 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.78 -4.85 53.52 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.445 1.498 . . . . 0.0 114.92 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -69.36 163.61 24.78 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.734 1.267 . . . . 0.0 111.664 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.1 mm -118.23 142.26 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.531 -0.731 . . . . 0.0 110.555 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.43 ' HB1' ' HE1' ' A' ' 72' ' ' HIS . . . -132.77 143.29 49.48 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.411 1.485 . . . . 0.0 110.385 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.7 t -139.86 144.72 37.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.048 1.739 . . . . 0.0 113.091 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--O 1.256 1.414 0 N-CA-C 117.268 2.321 . . . . 0.0 117.268 -169.63 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 66.44 -169.15 33.54 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.854 1.216 . . . . 0.0 114.368 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.48 173.02 14.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.15 1.38 . . . . 0.0 110.788 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -117.12 146.75 42.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.999 1.72 . . . . 0.0 109.769 -173.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -74.76 160.39 30.78 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.681 -0.637 . . . . 0.0 111.385 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -47.04 -49.55 21.1 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.475 1.51 . . . . 0.0 113.001 -169.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 pm0 -66.94 -1.85 4.54 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.24 2.216 . . . . 0.0 115.089 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.2 m -73.77 104.16 4.58 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.008 0.923 . . . . 0.0 110.013 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.65 129.34 34.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.56 0.695 . . . . 0.0 112.399 -173.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mm -106.33 123.81 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.364 1.465 . . . . 0.0 107.706 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.09 122.89 18.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.588 0.355 . . . . 0.0 110.266 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.1 p -124.2 150.35 45.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.765 1.226 . . . . 0.0 112.087 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.47 -33.43 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.191 0.596 . . . . 0.0 111.993 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -67.82 -30.7 70.18 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -141.28 -50.03 0.42 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.42 -148.99 19.7 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.598 1.094 . . . . 0.0 111.689 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.463 HD22 ' CB ' ' A' ' 130' ' ' LYS . 3.9 mt -61.7 111.96 2.06 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.281 1.433 . . . . 0.0 110.516 171.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 mt -139.96 149.09 57.6 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.365 1.066 . . . . 0.0 113.47 174.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.4 127.44 19.99 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.186 3.257 . . . . 0.0 112.394 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 tt -56.22 -36.36 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.0 -32.49 84.37 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.721 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -71.44 -38.04 71.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.383 1.091 . . . . 0.0 111.31 175.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -64.82 -38.24 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.395 0.678 . . . . 0.0 110.808 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.4 t -83.79 -37.96 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.08 0.952 . . . . 0.0 112.416 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -71.77 -24.56 61.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.088 0.858 . . . . 0.0 113.195 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -114.07 5.84 16.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.226 1.41 . . . . 0.0 113.037 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 48.21 48.92 18.26 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.331 2.252 . . . . 0.0 112.725 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.4 mt -77.73 118.08 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.006 0.923 . . . . 0.0 110.355 -169.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.68 112.17 7.57 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.323 1.049 . . . . 0.0 110.656 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.3 p -150.03 170.87 17.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.43 1.092 . . . . 0.0 112.995 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.4 m -116.86 143.29 45.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.412 1.485 . . . . 0.0 108.906 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.74 165.02 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.898 1.679 . . . . 0.0 110.959 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -102.51 143.75 31.83 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.227 1.411 . . . . 0.0 110.082 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -154.67 151.12 28.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.25 1.42 . . . . 0.0 109.892 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 t -92.91 124.82 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -69.07 173.96 5.01 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.581 1.181 . . . . 0.0 111.79 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -58.16 -27.79 64.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.453 1.901 . . . . 0.0 113.226 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -82.52 -10.06 59.16 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.247 1.419 . . . . 0.0 113.3 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.14 22.5 59.01 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.85 1.214 . . . . 0.0 114.483 -171.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -95.5 132.34 40.7 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.437 1.095 . . . . 0.0 109.85 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.5 mt -74.01 133.4 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.54 1.064 . . . . 0.0 108.899 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.69 174.95 10.01 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.016 1.726 . . . . 0.0 111.036 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.8 p -120.53 143.89 48.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.276 1.03 . . . . 0.0 112.361 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -147.03 142.82 17.42 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.73 1.212 . . . . 0.0 112.433 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -74.97 149.8 37.37 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.012 2.474 . . . . 0.0 112.258 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -59.38 135.89 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.375 0.67 . . . . 0.0 110.43 168.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.62 -47.01 7.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.594 0.758 . . . . 0.0 111.548 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -150.19 177.52 9.85 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.167 1.787 . . . . 0.0 111.397 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -134.23 137.83 44.65 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.139 1.776 . . . . 0.0 108.796 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -132.54 119.65 20.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.598 0.759 . . . . 0.0 111.218 -171.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -116.53 108.21 15.69 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.328 1.451 . . . . 0.0 110.736 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -80.73 -28.89 36.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.756 1.222 . . . . 0.0 113.331 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.41 -52.82 3.1 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.092 1.33 . . . . 0.0 114.219 173.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -171.85 104.91 0.19 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.056 1.428 . . . . 0.0 111.013 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -129.88 169.08 15.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.972 0.909 . . . . 0.0 112.052 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.31 105.42 2.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.23 1.012 . . . . 0.0 112.875 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.7 t -100.38 140.39 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.048 1.339 . . . . 0.0 111.492 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CG ' ' HE3' ' A' ' 70' ' ' LYS . 43.5 m-85 -123.91 146.19 48.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.929 1.292 . . . . 0.0 110.601 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -66.0 128.13 34.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.288 1.035 . . . . 0.0 110.485 173.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -121.87 81.72 1.86 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.592 1.557 . . . . 0.0 108.151 175.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.3 t -88.05 141.66 28.39 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.962 0.905 . . . . 0.0 110.614 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -105.2 165.64 10.96 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.268 1.027 . . . . 0.0 113.267 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -68.03 -20.7 65.02 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.68 -27.94 36.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.73 1.212 . . . . 0.0 112.96 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.76 -3.75 17.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.931 1.253 . . . . 0.0 114.389 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -60.61 148.16 39.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.719 1.26 . . . . 0.0 111.577 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.5 mt -133.15 128.26 35.69 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.365 1.466 . . . . 0.0 110.11 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.1 mt -135.24 149.56 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 126.681 1.992 . . . . 0.0 107.399 -175.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -137.1 112.27 9.1 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.216 1.006 . . . . 0.0 110.111 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.4 169.47 18.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.311 1.445 . . . . 0.0 111.815 -172.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.6 p -87.44 162.02 17.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.546 0.738 . . . . 0.0 112.837 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HE3' ' CG ' ' A' ' 56' ' ' PHE . 19.7 mmtp -72.99 -7.97 53.6 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -90.9 -8.96 47.93 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.784 0.72 . . . . 0.0 112.083 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.479 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 14.3 t-80 -82.56 132.89 35.19 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.785 -0.572 . . . . 0.0 110.091 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -95.19 152.02 18.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.995 0.918 . . . . 0.0 110.285 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -137.94 135.14 35.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.08 0.552 . . . . 0.0 110.626 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 44.7 ttp -73.6 103.98 4.39 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 111.201 -174.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.6 p -66.05 171.8 4.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.134 0.974 . . . . 0.0 112.155 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.26 -22.91 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -93.33 -6.82 46.47 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.214 1.006 . . . . 0.0 113.194 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.4 26.65 24.95 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.323 0.963 . . . . 0.0 113.944 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -88.04 142.05 28.08 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.456 1.128 . . . . 0.0 111.754 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.3 mmt -97.26 77.34 2.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.784 1.634 . . . . 0.0 110.971 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -116.01 148.09 40.64 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.852 0.861 . . . . 0.0 111.44 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.34 148.55 79.97 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.409 2.739 . . . . 0.0 111.771 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.83 -28.76 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -54.05 -30.76 49.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.641 1.177 . . . . 0.0 113.933 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -91.86 -31.14 15.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.44 0.696 . . . . 0.0 111.553 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.84 -38.82 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.042 0.837 . . . . 0.0 111.158 177.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -64.01 -38.1 89.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -78.66 -37.78 41.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.212 0.605 . . . . 0.0 112.553 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -82.41 -8.83 59.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.778 0.831 . . . . 0.0 112.952 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 57.14 35.55 26.41 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.482 1.513 . . . . 0.0 112.383 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.2 mt -85.53 124.01 31.61 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.011 0.91 . . . . 0.0 111.97 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.5 153.72 30.83 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.547 1.139 . . . . 0.0 112.407 169.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.86 150.61 22.14 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.212 -0.93 . . . . 0.0 112.455 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.1 ttp -72.4 156.85 38.63 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.654 0.782 . . . . 0.0 111.163 169.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -138.25 170.1 16.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.528 1.531 . . . . 0.0 111.739 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.18 -2.69 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.62 14.95 29.74 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.127 0.971 . . . . 0.0 113.393 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 56.16 28.57 13.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.405 1.882 . . . . 0.0 112.993 -173.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 70.8 mt -88.32 156.29 51.26 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.385 1.474 . . . . 0.0 112.083 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.36 135.67 32.01 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.906 3.07 . . . . 0.0 112.686 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -75.3 126.25 30.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.73 0.812 . . . . 0.0 110.773 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.2 pt -142.98 151.61 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.555 1.542 . . . . 0.0 111.335 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.3 pttt -95.59 -173.47 2.89 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.21 1.804 . . . . 0.0 111.961 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.1 mt -68.49 122.28 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.764 1.226 . . . . 0.0 109.001 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.46 -44.57 19.02 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.331 1.052 . . . . 0.0 112.49 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.8 p -146.88 152.62 39.0 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.655 1.582 . . . . 0.0 111.03 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.93 145.17 43.93 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.053 1.741 . . . . 0.0 110.235 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -158.0 135.43 10.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.179 1.792 . . . . 0.0 110.017 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -67.85 120.44 14.16 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.382 0.537 . . . . 0.0 110.032 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.7 -42.14 12.85 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.711 0.404 . . . . 0.0 111.702 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.04 -142.19 11.96 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.208 0.909 . . . . 0.0 112.848 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -121.93 97.07 5.32 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.358 1.463 . . . . 0.0 111.626 -168.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -118.09 154.66 31.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.457 1.103 . . . . 0.0 111.286 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.9 117.21 5.61 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.652 0.781 . . . . 0.0 110.709 171.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.44 151.02 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.504 0.668 . . . . 0.0 111.043 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -138.61 159.41 42.16 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.613 1.565 . . . . 0.0 111.408 -169.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -148.82 168.04 24.02 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.705 0.802 . . . . 0.0 111.921 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.2 pt -126.12 139.91 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.449 1.1 . . . . 0.0 110.112 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.33 153.98 20.05 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.843 1.211 . . . . 0.0 111.183 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.77 156.26 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.525 1.13 . . . . 0.0 109.784 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -58.51 -35.0 71.58 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -173.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -158.26 -40.19 0.06 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -100.6 79.5 2.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 108.889 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -52.39 -22.77 5.01 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.681 2.392 . . . . 0.0 115.481 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -73.75 165.16 25.61 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.132 1.373 . . . . 0.0 113.716 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -160.59 161.49 32.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.983 1.313 . . . . 0.0 111.631 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.78 130.48 37.55 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.866 0.866 . . . . 0.0 113.007 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 41.9 mt -72.79 165.71 24.32 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.469 1.108 . . . . 0.0 111.116 168.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.463 ' CB ' HD22 ' A' ' 15' ' ' LEU . 5.6 ptmm? -51.47 -32.57 27.6 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -90.01 -12.24 39.21 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.879 1.271 . . . . 0.0 113.999 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.62 -12.25 18.41 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 118.506 -1.163 . . . . 0.0 115.246 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -60.63 158.45 12.49 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.698 1.749 . . . . 0.0 112.462 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.66 126.02 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.122 0.963 . . . . 0.0 110.859 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.479 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -107.56 157.06 18.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.651 1.58 . . . . 0.0 109.729 172.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.6 t -134.84 128.13 32.11 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 112.839 -176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.936 1.694 . . . . 0.0 113.179 -175.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 CA-C-O 119.739 -0.478 . . . . 0.0 113.498 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 62.03 -176.16 6.16 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 126.138 1.828 . . . . 0.0 116.55 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -151.24 171.61 17.14 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.456 1.102 . . . . 0.0 111.848 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.448 HD13 HG21 ' A' ' 6' ' ' THR . 56.8 mt -127.64 148.13 50.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.182 1.793 . . . . 0.0 110.856 -168.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p -61.56 162.11 8.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.774 1.23 . . . . 0.0 114.196 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -53.62 -45.61 70.18 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.141 -0.974 . . . . 0.0 112.158 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.52 -5.84 16.99 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.448 HG21 HD13 ' A' ' 2' ' ' LEU . 63.7 m -71.44 97.65 1.68 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.118 -0.989 . . . . 0.0 110.318 173.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -74.09 135.74 42.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.598 0.759 . . . . 0.0 110.919 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.38 120.54 63.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 126.107 1.763 . . . . 0.0 106.702 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.78 120.69 15.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.73 0.412 . . . . 0.0 110.053 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 p -121.63 153.37 38.2 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.303 1.041 . . . . 0.0 112.424 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.19 -34.38 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.404 0.682 . . . . 0.0 111.758 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.64 -26.42 61.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -140.1 -51.79 0.5 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.92 -152.69 20.41 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.212 0.911 . . . . 0.0 111.707 -171.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 109.37 1.7 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.078 0.951 . . . . 0.0 110.96 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.8 mt -133.8 149.39 71.74 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 124.93 1.292 . . . . 0.0 112.943 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.42 126.73 14.61 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.886 3.058 . . . . 0.0 112.818 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 tt -55.81 -35.71 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.81 -38.16 96.05 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.895 -0.503 . . . . 0.0 112.469 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -71.58 -34.84 70.27 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.409 1.104 . . . . 0.0 111.657 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.9 mt -66.13 -39.65 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.038 0.935 . . . . 0.0 110.032 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.22 -38.08 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.319 1.048 . . . . 0.0 113.046 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -70.41 -27.43 64.28 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.323 0.965 . . . . 0.0 113.218 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -112.19 3.12 17.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.273 1.029 . . . . 0.0 113.103 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 46.9 50.23 13.82 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.26 2.224 . . . . 0.0 111.911 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.8 mt -68.12 118.5 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.021 0.928 . . . . 0.0 108.678 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.02 118.13 14.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.288 0.566 . . . . 0.0 109.511 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.5 p -151.55 166.77 30.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.096 1.358 . . . . 0.0 112.334 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.16 152.54 20.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.272 1.429 . . . . 0.0 109.74 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.31 167.53 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.189 1.396 . . . . 0.0 110.961 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -108.67 148.97 29.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.151 1.38 . . . . 0.0 111.086 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -168.37 151.74 5.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.607 1.563 . . . . 0.0 110.673 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.12 144.45 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.834 1.197 . . . . 0.0 113.275 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.73 178.45 8.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.544 1.138 . . . . 0.0 113.333 170.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -61.98 -11.11 11.74 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -105.18 0.26 27.17 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.9 1.68 . . . . 0.0 112.312 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.14 22.96 39.43 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.171 1.367 . . . . 0.0 115.253 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -108.08 123.56 48.88 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.158 1.479 . . . . 0.0 110.331 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.61 102.63 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.972 0.909 . . . . 0.0 109.41 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -100.88 179.05 4.51 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.103 1.761 . . . . 0.0 111.275 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.2 p -126.35 144.2 50.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.342 1.057 . . . . 0.0 112.843 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -145.58 137.3 13.01 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.537 1.135 . . . . 0.0 112.308 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.23 143.13 27.99 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.286 2.658 . . . . 0.0 110.944 174.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 p -54.13 147.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.727 0.811 . . . . 0.0 111.601 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.76 -42.93 3.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.712 0.805 . . . . 0.0 112.127 175.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -145.15 172.08 13.61 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.853 1.261 . . . . 0.0 111.875 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -135.49 132.56 37.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.579 1.552 . . . . 0.0 109.664 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -127.15 130.85 50.57 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.51 1.124 . . . . 0.0 111.465 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -126.51 119.77 28.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.441 1.496 . . . . 0.0 110.492 -173.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -91.11 -23.1 20.39 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.631 1.172 . . . . 0.0 113.387 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.61 -46.18 3.53 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 126.812 2.148 . . . . 0.0 114.775 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -173.46 107.55 0.15 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.737 1.615 . . . . 0.0 112.156 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -128.04 159.97 33.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.302 1.441 . . . . 0.0 111.212 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -59.26 104.78 0.28 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.517 1.527 . . . . 0.0 112.953 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.08 136.53 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.119 1.368 . . . . 0.0 111.181 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -118.52 138.21 52.68 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.691 1.196 . . . . 0.0 109.989 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -74.29 134.88 42.59 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.034 0.934 . . . . 0.0 108.946 168.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -129.86 89.2 2.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.122 1.369 . . . . 0.0 109.229 170.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.5 t -74.96 141.99 43.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.059 0.944 . . . . 0.0 110.896 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tp -93.89 170.1 9.8 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.941 1.296 . . . . 0.0 113.249 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -63.99 -26.47 68.59 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.99 -18.53 28.83 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.86 -3.21 28.83 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.126 1.346 . . . . 0.0 114.316 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 m -59.63 150.79 26.43 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.086 1.443 . . . . 0.0 111.449 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -127.11 135.98 51.49 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.492 0.717 . . . . 0.0 110.775 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.481 HD11 ' CZ ' ' A' ' 133' ' ' PHE . 11.3 mt -128.42 126.44 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.435 1.494 . . . . 0.0 107.385 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -123.63 103.11 8.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.876 1.27 . . . . 0.0 109.556 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.66 170.51 15.71 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.563 1.145 . . . . 0.0 112.554 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.1 p -86.69 150.68 24.01 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.869 1.267 . . . . 0.0 111.632 171.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -65.1 -7.52 12.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.703 1.601 . . . . 0.0 115.055 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.8 -11.72 30.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.326 1.85 . . . . 0.0 111.921 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.645 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 5.2 t-80 -83.01 130.94 35.19 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.638 0.654 . . . . 0.0 109.793 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -91.34 155.93 18.15 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.822 0.849 . . . . 0.0 110.238 176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -138.81 137.57 36.74 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.598 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.5 ttp -79.14 106.49 11.21 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.089 0.556 . . . . 0.0 110.515 -171.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.3 p -65.5 172.34 3.38 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.54 0.736 . . . . 0.0 112.746 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.32 -24.97 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.47 -9.28 50.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.556 1.143 . . . . 0.0 113.519 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.99 9.8 60.47 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.054 1.312 . . . . 0.0 114.599 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -69.96 149.92 47.25 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.512 1.156 . . . . 0.0 111.69 -178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.4 mtm -111.94 82.15 1.58 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.23 1.812 . . . . 0.0 108.698 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 37.1 mt -122.85 147.06 50.03 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 125.242 1.417 . . . . 0.0 110.225 -174.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.93 148.32 85.87 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.167 2.578 . . . . 0.0 111.246 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.3 tt -59.71 -25.99 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -56.44 -33.17 65.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.424 1.09 . . . . 0.0 112.998 170.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -85.25 -36.81 20.69 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.459 0.704 . . . . 0.0 111.597 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.85 -40.45 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.131 -0.981 . . . . 0.0 111.417 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -63.44 -38.52 91.45 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -76.74 -42.96 39.1 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.447 -0.783 . . . . 0.0 112.869 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -77.58 -13.17 59.98 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.143 0.977 . . . . 0.0 112.957 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 56.22 37.08 28.49 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.655 1.582 . . . . 0.0 111.854 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.6 mt -75.07 138.52 42.19 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.438 1.095 . . . . 0.0 111.318 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -73.27 157.31 37.32 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.909 0.861 . . . . 0.0 112.104 173.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.3 mt -112.94 143.35 44.39 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.843 1.257 . . . . 0.0 111.234 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 39.8 ttm -62.29 156.92 20.9 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.465 1.506 . . . . 0.0 111.953 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -132.21 158.43 41.77 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.565 1.546 . . . . 0.0 112.509 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.68 -10.93 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -107.69 16.93 23.18 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.915 1.686 . . . . 0.0 112.672 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.269 7.6 m-80 56.49 36.67 27.93 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.194 1.798 . . . . 0.0 112.551 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.97 159.61 68.08 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 112.743 -2.026 . . . . 0.0 112.015 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.68 155.92 58.12 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.561 2.841 . . . . 0.0 112.108 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -89.92 114.22 25.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.852 0.861 . . . . 0.0 110.003 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.6 pt -142.32 131.01 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.805 1.642 . . . . 0.0 111.106 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.61 173.35 10.55 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.061 1.745 . . . . 0.0 112.633 174.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.8 mt -66.01 115.86 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.097 1.359 . . . . 0.0 110.363 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.72 -42.57 73.83 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.819 1.248 . . . . 0.0 112.654 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.77 162.3 40.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.059 0.944 . . . . 0.0 111.828 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.56 145.5 42.95 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.543 1.537 . . . . 0.0 111.615 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.66 133.58 13.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.303 1.041 . . . . 0.0 110.747 177.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -65.7 133.05 50.26 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.415 -0.803 . . . . 0.0 110.707 170.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.2 mt -102.21 -45.23 5.19 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.479 0.712 . . . . 0.0 111.847 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 152.03 -147.59 17.55 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.089 0.852 . . . . 0.0 112.922 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.77 62.6 1.22 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 123.252 1.501 . . . . 0.0 113.013 -167.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -81.07 156.53 25.78 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.556 1.942 . . . . 0.0 110.826 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.42 119.33 8.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.839 0.855 . . . . 0.0 110.184 171.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.42 150.09 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.601 0.715 . . . . 0.0 111.367 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -138.74 159.36 42.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.651 1.58 . . . . 0.0 111.551 -168.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -154.74 130.81 10.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.543 1.137 . . . . 0.0 110.745 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.8 pt -93.52 156.44 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.009 -1.057 . . . . 0.0 111.488 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.38 153.22 19.8 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.157 0.884 . . . . 0.0 112.835 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.5 t -140.19 153.25 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.599 1.16 . . . . 0.0 111.03 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -72.26 -34.4 68.19 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.77 0.828 . . . . 0.0 112.355 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -74.83 -57.18 4.07 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.069 1.747 . . . . 0.0 113.437 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -149.91 179.2 8.24 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.831 2.452 . . . . 0.0 109.642 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -121.23 -7.7 9.3 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.921 -1.112 . . . . 0.0 113.922 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -76.95 161.16 28.59 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 118.934 0.788 . . . . 0.0 112.191 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -166.84 154.93 9.8 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.101 1.36 . . . . 0.0 111.396 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.06 149.52 35.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.863 1.265 . . . . 0.0 112.488 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 88.7 mt -128.5 -176.71 3.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.07 2.148 . . . . 0.0 111.716 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -51.08 150.55 3.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.961 0.504 . . . . 0.0 110.432 165.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 52.54 18.84 1.04 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.887 1.275 . . . . 0.0 114.342 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.01 22.13 75.74 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 117.624 -1.653 . . . . 0.0 115.94 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.481 ' CZ ' HD11 ' A' ' 66' ' ' ILE . 67.5 m-85 -65.25 157.06 29.96 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.248 2.024 . . . . 0.0 112.369 170.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.02 121.1 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.778 1.231 . . . . 0.0 108.778 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.645 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -107.38 103.63 13.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.925 0.89 . . . . 0.0 110.416 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.4 t -89.26 157.86 18.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.539 0.735 . . . . 0.0 112.331 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.7 t30 . . . . . 0 C--O 1.255 1.362 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 172.259 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -135.18 -175.43 13.84 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 127.762 2.601 . . . . 0.0 111.685 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -171.36 175.55 4.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.918 0.887 . . . . 0.0 113.193 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.584 HD13 HG21 ' A' ' 6' ' ' THR . 86.7 mt -120.32 147.39 45.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.859 2.064 . . . . 0.0 110.37 -175.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -72.8 161.82 30.26 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.857 -0.527 . . . . 0.0 111.946 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -51.96 -46.75 64.91 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.319 1.048 . . . . 0.0 112.464 -173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -61.96 -8.01 4.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.375 1.87 . . . . 0.0 115.141 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.584 HG21 HD13 ' A' ' 2' ' ' LEU . 19.9 m -71.44 107.36 4.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.906 0.883 . . . . 0.0 110.33 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.55 133.09 33.84 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.348 0.594 . . . . 0.0 111.435 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -118.49 115.1 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.332 1.453 . . . . 0.0 107.139 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.1 128.33 34.93 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 122.062 -0.399 . . . . 0.0 110.87 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.4 p -129.18 156.07 44.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.166 1.387 . . . . 0.0 113.013 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.56 -30.87 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 122.955 0.502 . . . . 0.0 112.04 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -65.78 -31.65 72.74 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -140.97 -59.59 0.5 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.628 0.771 . . . . 0.0 113.07 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.13 -133.44 5.83 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.13 108.55 12.71 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.262 1.425 . . . . 0.0 109.952 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.531 HD13 HD11 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -145.8 156.69 51.89 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.23 129.39 17.01 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.932 3.088 . . . . 0.0 112.713 -175.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.81 -37.57 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.511 0.724 . . . . 0.0 112.837 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 -30.95 79.28 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.608 -0.682 . . . . 0.0 113.051 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.79 -36.16 70.24 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.734 0.767 . . . . 0.0 111.445 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.531 HD11 HD13 ' A' ' 16' ' ' LEU . 64.6 mt -64.92 -43.12 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.998 0.519 . . . . 0.0 109.885 176.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 117' ' ' TYR . 57.8 t -75.09 -41.28 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -75.59 -22.49 56.88 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -109.87 1.56 19.29 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.132 1.373 . . . . 0.0 112.493 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.65 48.71 14.3 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.166 2.186 . . . . 0.0 113.322 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.27 124.8 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.471 0.708 . . . . 0.0 109.626 -174.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -83.02 86.23 7.03 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.737 0.78 . . . . 0.0 110.683 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' VAL . 20.6 p -117.44 -177.96 3.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.852 1.261 . . . . 0.0 111.952 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.16 144.67 48.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.426 1.49 . . . . 0.0 108.351 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.67 174.22 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.718 1.607 . . . . 0.0 111.077 -177.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -117.21 139.33 50.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.69 1.596 . . . . 0.0 110.319 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -156.99 151.9 25.94 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.864 1.265 . . . . 0.0 111.177 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.1 p -99.12 131.84 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.679 1.192 . . . . 0.0 111.461 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.7 -176.76 6.17 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.998 1.319 . . . . 0.0 113.67 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.58 -29.69 69.34 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -79.85 -11.21 59.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.277 1.031 . . . . 0.0 113.189 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.27 14.27 59.06 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.464 1.031 . . . . 0.0 114.227 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -91.75 126.23 36.76 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.897 1.348 . . . . 0.0 109.481 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.0 mt -71.95 88.43 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.345 1.058 . . . . 0.0 108.78 172.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -81.88 171.08 14.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.114 0.966 . . . . 0.0 111.136 171.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 p -126.92 145.52 50.65 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.832 0.853 . . . . 0.0 111.777 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -145.39 146.38 29.79 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 124.259 1.023 . . . . 0.0 112.677 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.07 156.19 56.11 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.208 2.605 . . . . 0.0 112.474 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 28' ' ' CYS . 42.1 t -67.55 119.8 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.993 0.917 . . . . 0.0 109.816 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.22 -36.27 35.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.374 0.67 . . . . 0.0 112.578 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -162.14 175.67 11.46 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.381 1.473 . . . . 0.0 112.64 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -135.71 117.36 14.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.08 1.352 . . . . 0.0 109.34 -175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -108.35 130.58 55.2 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.062 0.934 . . . . 0.0 110.369 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.21 103.12 9.22 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.791 1.636 . . . . 0.0 109.514 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -69.78 -33.26 72.15 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.374 1.07 . . . . 0.0 111.908 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.52 -40.39 3.01 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.87 1.224 . . . . 0.0 113.382 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 178.32 109.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.283 1.433 . . . . 0.0 111.62 -174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -133.96 164.96 26.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.131 0.972 . . . . 0.0 112.55 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.07 100.06 0.3 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.489 1.516 . . . . 0.0 113.204 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 t -92.41 137.24 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.038 1.335 . . . . 0.0 110.959 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -119.51 137.13 54.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.295 1.438 . . . . 0.0 109.486 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -56.89 126.0 25.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.99 0.916 . . . . 0.0 110.267 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -118.58 82.88 1.92 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.893 1.277 . . . . 0.0 108.449 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.9 t -94.17 137.51 33.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.666 0.787 . . . . 0.0 110.646 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.82 162.03 13.32 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.223 1.009 . . . . 0.0 112.111 173.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -18.75 62.02 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -78.12 -26.51 48.0 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.123 0.969 . . . . 0.0 112.729 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.74 2.98 18.8 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.629 1.109 . . . . 0.0 114.806 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 m -67.69 132.4 47.4 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.304 1.552 . . . . 0.0 110.356 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.67 132.37 56.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.087 1.355 . . . . 0.0 109.877 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.6 mt -139.01 155.17 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 126.408 1.883 . . . . 0.0 108.478 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -137.96 111.01 7.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.028 1.331 . . . . 0.0 110.675 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.71 166.78 24.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.906 1.283 . . . . 0.0 111.659 -175.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.3 p -88.24 160.14 17.82 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.942 0.877 . . . . 0.0 112.344 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -67.76 -3.8 10.47 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -103.29 -13.0 16.88 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.141 0.977 . . . . 0.0 112.58 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.45 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 11.0 t-80 -76.92 121.01 22.83 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 173.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -82.57 149.74 27.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.268 0.627 . . . . 0.0 109.776 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -132.06 143.82 50.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.523 -0.736 . . . . 0.0 109.737 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.4 ttp -75.22 104.43 5.79 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.074 0.55 . . . . 0.0 110.468 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.4 p -66.27 167.99 9.44 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.941 0.496 . . . . 0.0 111.683 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.3 m -55.07 -26.33 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -84.36 -13.17 53.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.273 1.029 . . . . 0.0 113.376 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.99 30.41 12.93 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.574 1.083 . . . . 0.0 113.557 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -98.75 147.24 25.08 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.241 1.02 . . . . 0.0 110.718 177.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.98 89.91 3.8 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.812 1.245 . . . . 0.0 109.871 176.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.1 mt -121.69 145.79 43.99 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.323 1.049 . . . . 0.0 110.438 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.68 147.48 81.58 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.092 2.528 . . . . 0.0 111.355 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.427 HG13 HD11 ' A' ' 105' ' ' ILE . 11.0 tt -58.0 -27.47 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -54.52 -38.42 66.51 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.583 1.153 . . . . 0.0 112.872 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -82.22 -34.72 28.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.283 0.633 . . . . 0.0 111.586 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.61 -39.21 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.6 -0.688 . . . . 0.0 110.368 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -63.96 -34.81 78.82 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -75.14 -44.77 45.08 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.524 -0.735 . . . . 0.0 112.669 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -76.33 -12.67 60.11 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 56.08 31.48 18.23 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.298 1.439 . . . . 0.0 112.108 -174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 69.5 mt -79.2 150.29 31.7 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.258 1.023 . . . . 0.0 111.586 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.98 155.78 17.32 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.617 0.767 . . . . 0.0 111.491 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt -84.47 159.36 20.77 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.414 -0.804 . . . . 0.0 112.623 168.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.6 ttp -86.52 155.74 20.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.795 1.238 . . . . 0.0 111.294 169.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.52 164.46 27.76 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.337 1.455 . . . . 0.0 112.04 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.6 m -93.02 -19.63 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -99.0 15.65 25.06 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.505 1.122 . . . . 0.0 113.088 -172.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 55.57 32.91 20.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.868 1.667 . . . . 0.0 112.099 -173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.53 154.29 73.7 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.676 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.08 144.76 70.84 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.746 2.964 . . . . 0.0 111.26 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -79.79 116.87 20.2 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.681 -0.637 . . . . 0.0 110.635 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.4 pt -142.53 132.77 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.926 1.69 . . . . 0.0 111.261 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 175.72 6.97 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.889 1.676 . . . . 0.0 112.347 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.427 HD11 HG13 ' A' ' 84' ' ' ILE . 10.9 mt -63.66 112.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.197 1.399 . . . . 0.0 110.035 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.65 -43.62 62.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.993 0.917 . . . . 0.0 111.742 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 p -149.02 147.75 28.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.115 1.766 . . . . 0.0 110.056 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -140.6 142.16 35.08 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.415 1.486 . . . . 0.0 110.212 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -152.32 131.64 12.85 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.929 1.692 . . . . 0.0 108.951 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -61.69 121.21 12.26 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.947 0.339 . . . . 0.0 110.545 171.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.9 mt -88.39 -40.54 13.45 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 122.645 0.378 . . . . 0.0 111.721 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.04 -145.22 15.71 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.653 1.121 . . . . 0.0 112.261 -173.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -128.22 74.93 1.58 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 123.206 1.479 . . . . 0.0 113.401 -167.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -89.54 155.19 19.44 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.458 1.503 . . . . 0.0 109.908 -171.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.15 117.26 5.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.436 0.694 . . . . 0.0 109.851 171.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.63 154.25 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.422 0.63 . . . . 0.0 110.919 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.463 ' HB3' HG21 ' A' ' 22' ' ' VAL . 6.2 m-85 -140.94 157.38 45.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.669 1.588 . . . . 0.0 111.322 -170.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -156.93 117.12 3.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.755 1.222 . . . . 0.0 110.159 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.8 pt -71.46 155.44 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 121.028 -1.045 . . . . 0.0 111.205 172.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -107.07 152.38 16.89 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.494 1.045 . . . . 0.0 111.74 170.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.56 158.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.711 2.004 . . . . 0.0 110.108 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -71.81 -37.78 70.3 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.6 -168.1 0.79 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.202 1.001 . . . . 0.0 111.579 174.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -49.53 130.8 20.78 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.604 -0.685 . . . . 0.0 109.81 167.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -63.88 102.78 0.5 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.349 0.66 . . . . 0.0 110.817 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -162.5 171.16 17.48 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.413 1.485 . . . . 0.0 113.228 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -172.55 157.13 3.83 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.052 1.741 . . . . 0.0 111.061 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.77 144.75 29.95 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.821 0.848 . . . . 0.0 112.461 173.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 28.9 mt -89.76 173.09 8.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.095 1.358 . . . . 0.0 112.188 171.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -48.62 -49.73 35.85 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.708 1.603 . . . . 0.0 114.561 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -73.38 -37.7 65.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.211 0.604 . . . . 0.0 111.652 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 139.68 -6.11 2.91 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.478 -1.179 . . . . 0.0 115.359 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -57.0 155.35 8.28 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.563 1.681 . . . . 0.0 112.619 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.58 110.81 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 122.033 0.921 . . . . 0.0 109.676 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.45 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -96.36 116.75 29.54 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.391 1.076 . . . . 0.0 108.64 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.2 m -109.56 79.87 1.26 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.377 1.071 . . . . 0.0 111.433 -173.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.3 t30 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 127.597 2.359 . . . . 0.0 115.997 -168.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -142.76 158.6 27.14 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.385 1.945 . . . . 0.0 111.074 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.26 178.03 10.62 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.512 1.125 . . . . 0.0 112.653 -169.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.11 148.56 32.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.452 1.501 . . . . 0.0 110.652 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -62.41 161.39 11.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.644 0.777 . . . . 0.0 112.653 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -52.5 -47.01 66.86 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.889 . . . . 0.0 112.541 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -63.65 -20.45 65.7 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.266 1.827 . . . . 0.0 113.403 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.2 m -59.64 105.25 0.35 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.402 1.081 . . . . 0.0 110.862 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -86.23 129.81 34.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.363 0.601 . . . . 0.0 111.0 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.2 mm -113.49 124.95 70.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.075 1.35 . . . . 0.0 107.529 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.39 129.9 44.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.08 0.552 . . . . 0.0 110.899 171.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.8 p -133.02 148.68 52.24 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.296 1.438 . . . . 0.0 111.431 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.8 -31.3 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 122.071 -0.393 . . . . 0.0 111.892 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -64.83 -36.46 84.4 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -141.49 -44.76 0.36 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -172.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.17 -136.82 9.11 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.134 0.879 . . . . 0.0 112.347 -172.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.4 91.19 7.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.885 1.674 . . . . 0.0 111.823 -173.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -122.1 146.09 45.64 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.905 0.882 . . . . 0.0 112.638 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.76 125.33 13.59 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.367 3.378 . . . . 0.0 112.727 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.84 -37.36 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.965 0.906 . . . . 0.0 113.368 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.4 -32.39 79.23 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.559 -0.713 . . . . 0.0 113.097 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -71.88 -35.37 69.76 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 117.787 0.793 . . . . 0.0 111.602 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -67.5 -39.68 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.529 0.732 . . . . 0.0 109.709 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.03 -41.08 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.727 0.811 . . . . 0.0 112.471 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -76.35 -24.4 54.2 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.346 0.976 . . . . 0.0 113.339 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -104.67 -0.01 27.97 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.79 1.236 . . . . 0.0 112.854 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 48.29 49.57 17.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.655 1.982 . . . . 0.0 112.422 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.3 mt -68.61 121.02 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.179 0.992 . . . . 0.0 109.272 -174.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.39 107.77 11.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.439 1.095 . . . . 0.0 110.656 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.0 p -148.16 166.91 26.45 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.256 1.027 . . . . 0.0 113.466 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.5 148.29 23.89 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.433 1.493 . . . . 0.0 109.857 177.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 m -128.95 171.48 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.018 1.727 . . . . 0.0 110.924 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -115.4 140.09 49.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.462 1.505 . . . . 0.0 110.283 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 t -156.15 152.02 27.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.966 1.306 . . . . 0.0 110.672 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.52 128.31 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.199 0.6 . . . . 0.0 109.933 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -69.93 173.79 6.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.601 1.16 . . . . 0.0 111.807 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -62.22 -25.51 67.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.318 1.447 . . . . 0.0 113.328 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -86.23 -2.5 58.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.112 1.365 . . . . 0.0 113.398 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.08 22.52 60.9 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.603 1.097 . . . . 0.0 114.808 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -99.85 129.9 45.99 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.804 1.242 . . . . 0.0 109.991 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.1 mt -70.25 130.59 34.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -134.13 169.72 16.74 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.579 1.552 . . . . 0.0 110.938 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 p -119.55 140.87 49.83 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.956 0.902 . . . . 0.0 111.681 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -149.85 147.36 22.35 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.317 1.047 . . . . 0.0 112.423 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.05 149.91 47.45 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.117 2.545 . . . . 0.0 112.658 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -57.84 137.11 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.741 0.816 . . . . 0.0 110.409 168.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.16 -50.59 5.76 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.993 0.517 . . . . 0.0 111.42 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -149.97 173.55 13.69 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.029 1.731 . . . . 0.0 111.042 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -129.25 131.67 47.07 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.566 1.546 . . . . 0.0 108.994 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -130.06 138.81 50.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.202 1.001 . . . . 0.0 110.715 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.65 121.49 28.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.914 1.285 . . . . 0.0 110.801 -174.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -86.36 -34.0 20.36 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.216 1.006 . . . . 0.0 112.559 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.76 -44.93 2.71 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.253 1.406 . . . . 0.0 115.17 172.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -174.32 88.78 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 123.083 1.42 . . . . 0.0 114.568 -168.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -127.48 163.19 24.66 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.201 1.0 . . . . 0.0 112.91 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -67.73 103.53 1.43 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.062 1.345 . . . . 0.0 112.714 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -96.5 139.32 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.431 1.492 . . . . 0.0 110.991 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.436 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 75.5 m-85 -123.11 142.48 50.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.512 1.525 . . . . 0.0 109.976 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -65.88 131.26 45.84 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.733 0.813 . . . . 0.0 110.301 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -124.66 87.06 2.65 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.084 1.353 . . . . 0.0 108.439 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.2 t -95.28 146.71 24.16 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.97 0.908 . . . . 0.0 110.627 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.8 164.76 12.44 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.924 1.289 . . . . 0.0 112.368 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -66.86 -23.62 66.04 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.549 1.139 . . . . 0.0 113.284 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.56 -23.56 46.05 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.103 1.361 . . . . 0.0 112.961 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.55 0.68 30.86 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.756 1.17 . . . . 0.0 114.345 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.8 m -57.14 136.41 56.4 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.384 1.092 . . . . 0.0 110.558 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.92 122.78 38.34 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.753 1.221 . . . . 0.0 109.758 -172.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.1 mt -134.07 150.89 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.547 1.939 . . . . 0.0 107.86 -172.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 63.6 mtt85 -136.38 117.37 14.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.616 1.166 . . . . 0.0 109.864 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.6 163.5 38.34 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.518 1.127 . . . . 0.0 111.558 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 p -75.01 151.68 38.76 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.446 -0.784 . . . . 0.0 112.065 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -63.12 -17.22 62.09 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 176.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -86.42 -16.28 37.67 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.485 1.514 . . . . 0.0 113.33 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -74.46 135.36 42.29 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.176 0.59 . . . . 0.0 109.436 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 149.19 21.85 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.037 0.922 . . . . 0.0 112.174 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -134.26 127.25 31.46 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.428 -1.42 . . . . 0.0 110.182 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ttp -71.93 111.28 7.04 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.046 0.45 . . . . 0.0 111.084 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.6 p -70.37 171.94 9.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.057 0.543 . . . . 0.0 112.215 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -54.44 -27.2 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.1 -8.19 54.3 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.698 1.199 . . . . 0.0 113.133 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.82 1.09 63.67 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.962 1.267 . . . . 0.0 114.326 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.97 146.71 52.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.523 1.161 . . . . 0.0 111.212 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.2 mtm -117.87 76.55 1.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.31 1.444 . . . . 0.0 109.465 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.64 150.84 43.95 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.006 1.322 . . . . 0.0 110.979 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.34 148.92 80.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.977 2.451 . . . . 0.0 111.559 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 tt -55.66 -29.07 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -53.15 -37.51 61.9 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.643 1.177 . . . . 0.0 113.138 170.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -90.33 -32.83 16.32 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.584 1.153 . . . . 0.0 111.605 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.72 -38.33 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.389 -0.819 . . . . 0.0 111.191 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.64 -34.79 78.66 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.41 -45.98 51.35 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.46 -8.8 58.92 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 58.14 37.68 26.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.673 1.189 . . . . 0.0 111.549 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.5 mt -83.92 155.67 22.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.901 1.334 . . . . 0.0 112.162 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -110.92 155.42 22.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.764 2.426 . . . . 0.0 112.969 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.7 155.09 19.44 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.692 0.797 . . . . 0.0 112.444 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.4 ttp -74.99 138.46 42.25 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.711 173.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.85 157.51 27.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.996 1.318 . . . . 0.0 110.684 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.588 HG22 ' HA2' ' A' ' 132' ' ' GLY . 31.4 m -118.69 -4.18 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.99 13.42 25.07 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.683 1.593 . . . . 0.0 112.587 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 58.89 30.1 19.71 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.763 2.025 . . . . 0.0 112.466 -174.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.6 mt -88.85 155.77 50.01 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.21 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.55 154.32 64.7 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.841 3.027 . . . . 0.0 111.951 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.36 132.14 35.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.476 0.711 . . . . 0.0 110.339 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 pt -146.87 137.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.972 1.309 . . . . 0.0 111.489 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.87 175.98 9.96 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.991 1.317 . . . . 0.0 112.509 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.8 mt -62.17 111.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.081 1.353 . . . . 0.0 110.03 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.73 -45.18 83.62 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.131 0.972 . . . . 0.0 111.883 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 p -151.35 150.67 30.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.287 1.835 . . . . 0.0 110.555 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -133.05 142.87 49.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.725 1.61 . . . . 0.0 110.083 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -156.9 140.6 16.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.696 1.598 . . . . 0.0 109.865 175.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -66.84 128.64 37.08 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.876 -0.515 . . . . 0.0 111.127 172.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.78 -46.43 7.55 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.849 0.459 . . . . 0.0 111.691 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 147.53 -150.94 23.24 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.246 0.927 . . . . 0.0 112.778 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -122.18 79.59 1.61 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.932 1.349 . . . . 0.0 112.763 -168.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -98.36 157.93 15.89 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.793 1.637 . . . . 0.0 110.466 -169.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.57 120.8 13.04 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.633 0.773 . . . . 0.0 110.031 169.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.9 m -125.14 152.68 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.332 0.653 . . . . 0.0 111.182 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -140.93 156.49 46.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.159 1.384 . . . . 0.0 111.942 -168.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -152.4 130.91 12.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.671 1.189 . . . . 0.0 110.8 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.8 pt -91.59 154.11 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.74 173.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.06 159.76 13.91 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.906 1.241 . . . . 0.0 111.44 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.0 t -141.93 154.91 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.717 1.207 . . . . 0.0 109.649 -172.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.47 107.31 0.65 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.837 -1.164 . . . . 0.0 111.885 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 52.78 26.29 4.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.638 1.975 . . . . 0.0 114.385 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -145.24 166.7 24.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.002 1.721 . . . . 0.0 111.798 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -151.37 37.36 0.6 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.202 1.001 . . . . 0.0 112.43 -174.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -147.57 161.18 41.64 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.905 -1.122 . . . . 0.0 113.407 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -165.13 167.12 18.52 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.054 1.342 . . . . 0.0 112.297 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.38 131.02 40.46 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.622 1.169 . . . . 0.0 112.461 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 32.6 mt -70.33 166.9 19.25 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.304 1.441 . . . . 0.0 111.678 169.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -48.94 -34.59 13.16 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.49 -6.87 24.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.394 1.078 . . . . 0.0 112.526 -172.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . 124.17 -17.59 7.52 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.962 1.267 . . . . 0.0 115.261 171.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -64.32 154.46 35.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.832 1.316 . . . . 0.0 112.697 -174.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.5 mm -104.47 140.31 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.434 1.015 . . . . 0.0 111.012 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.96 140.38 53.04 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.394 1.878 . . . . 0.0 109.418 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.0 t -138.74 124.91 20.19 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.118 1.367 . . . . 0.0 112.383 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.9 t30 . . . . . 0 C--O 1.255 1.384 0 C-N-CA 126.446 1.898 . . . . 0.0 113.991 -168.169 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -144.71 164.9 27.71 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 128.551 2.977 . . . . 0.0 109.135 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -159.54 173.34 16.29 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.715 0.757 . . . . 0.0 112.671 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.61 146.95 38.94 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.844 1.258 . . . . 0.0 110.771 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -65.2 164.1 13.9 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -50.97 -43.73 60.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.4 -19.73 64.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.692 1.197 . . . . 0.0 112.846 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 m -63.67 108.24 1.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.203 1.401 . . . . 0.0 111.133 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -86.47 128.12 34.93 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.116 0.484 . . . . 0.0 110.431 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.8 mm -99.58 122.3 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.396 1.479 . . . . 0.0 107.295 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.2 tp -69.91 122.61 19.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.2 p -125.9 152.11 46.01 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.9 0.88 . . . . 0.0 112.652 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -71.37 -34.05 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.876 0.47 . . . . 0.0 111.942 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -67.74 -32.72 73.53 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -141.78 -48.5 0.38 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.26 -151.39 19.87 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.172 0.892 . . . . 0.0 111.541 -172.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.87 108.49 1.49 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.352 1.061 . . . . 0.0 111.181 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.4 mt -132.23 147.76 67.05 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.74 1.216 . . . . 0.0 112.871 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.93 123.88 11.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.957 3.104 . . . . 0.0 112.212 -177.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 tt -55.21 -36.82 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.77 -33.73 88.01 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.797 -0.564 . . . . 0.0 113.018 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -77.36 -33.64 55.28 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.684 0.794 . . . . 0.0 112.042 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.7 mt -65.69 -38.85 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.141 0.976 . . . . 0.0 109.664 173.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.0 t -78.15 -38.32 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.366 1.067 . . . . 0.0 112.756 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 -25.48 46.64 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.26 0.936 . . . . 0.0 113.467 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -100.91 -2.59 31.54 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.722 1.209 . . . . 0.0 113.23 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 50.11 49.47 20.35 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.475 1.91 . . . . 0.0 112.339 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.4 mt -71.02 121.51 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.23 1.012 . . . . 0.0 109.591 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -74.81 114.03 12.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.409 0.623 . . . . 0.0 110.725 172.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.9 p -143.72 171.67 13.88 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.068 1.347 . . . . 0.0 112.278 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 m -112.83 150.13 32.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.909 1.284 . . . . 0.0 109.035 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.6 m -125.37 178.42 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.053 1.341 . . . . 0.0 111.222 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.83 141.27 49.68 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.841 1.256 . . . . 0.0 110.538 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.42 153.21 15.22 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.14 1.776 . . . . 0.0 109.185 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.5 m -89.09 143.7 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.442 1.019 . . . . 0.0 111.973 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.56 177.57 7.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.495 1.118 . . . . 0.0 111.395 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -62.8 -17.56 61.36 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.887 1.275 . . . . 0.0 113.04 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -95.16 -0.03 53.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.06 1.744 . . . . 0.0 113.133 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.66 35.65 40.08 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 121.33 -0.856 . . . . 0.0 114.147 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -119.31 123.23 43.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.455 1.502 . . . . 0.0 109.71 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -64.08 117.55 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -120.7 167.62 12.27 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.502 1.521 . . . . 0.0 111.669 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.1 p -115.6 137.96 51.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.282 1.033 . . . . 0.0 111.468 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -146.19 140.35 15.38 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.509 1.124 . . . . 0.0 111.412 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.19 148.94 40.02 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.863 2.375 . . . . 0.0 112.027 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.5 147.94 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.504 1.122 . . . . 0.0 111.114 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.17 -42.27 3.76 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.28 1.032 . . . . 0.0 112.237 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -142.6 178.44 7.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.896 1.679 . . . . 0.0 111.656 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -138.08 125.07 21.33 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.244 1.418 . . . . 0.0 109.117 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -118.57 137.82 52.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.345 1.058 . . . . 0.0 110.73 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.82 123.05 34.23 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.248 1.419 . . . . 0.0 110.61 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -89.72 -29.51 18.68 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.508 1.123 . . . . 0.0 112.77 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.58 -58.95 4.84 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.667 1.603 . . . . 0.0 114.002 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -158.92 98.83 1.5 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.77 1.228 . . . . 0.0 112.853 -168.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -133.03 163.13 29.92 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.336 1.054 . . . . 0.0 112.248 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.5 105.97 1.64 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.612 1.165 . . . . 0.0 113.246 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.42 137.44 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.0 0.92 . . . . 0.0 111.54 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -122.61 141.8 51.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.428 1.091 . . . . 0.0 110.849 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -85.84 96.08 9.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.93 1.692 . . . . 0.0 111.009 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -79.09 108.11 12.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.591 0.757 . . . . 0.0 109.418 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.0 t -88.63 132.55 34.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.361 1.064 . . . . 0.0 110.439 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tp -90.06 168.95 11.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.851 1.261 . . . . 0.0 112.628 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.5 -24.96 66.48 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.94 -27.23 36.17 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.482 1.513 . . . . 0.0 113.019 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.38 0.62 31.14 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.428 1.014 . . . . 0.0 114.13 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.0 m -65.36 141.18 58.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.667 1.234 . . . . 0.0 110.628 169.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 mp -119.62 141.02 49.69 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.256 1.422 . . . . 0.0 110.052 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -136.77 136.85 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.731 1.612 . . . . 0.0 108.398 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -123.96 103.3 8.24 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.134 0.974 . . . . 0.0 110.161 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.69 165.07 29.83 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.376 1.084 . . . . 0.0 111.828 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.9 p -78.4 149.2 33.37 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.464 1.106 . . . . 0.0 111.081 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -62.71 -12.78 25.91 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -91.63 -15.44 28.55 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.145 1.778 . . . . 0.0 112.527 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.475 ' CE1' ' HB1' ' A' ' 135' ' ' ALA . 2.7 t-80 -78.04 134.54 37.76 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -87.49 160.13 18.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.362 0.665 . . . . 0.0 111.696 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -140.52 140.06 35.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.759 0.823 . . . . 0.0 110.501 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 44.1 ttm -74.01 108.76 7.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.389 1.075 . . . . 0.0 111.604 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.0 p -67.17 172.62 4.49 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -56.39 -23.18 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -98.01 -8.29 28.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.193 1.397 . . . . 0.0 113.165 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.14 1.49 48.16 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.065 1.317 . . . . 0.0 115.094 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -66.32 139.24 58.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.963 1.382 . . . . 0.0 111.44 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.73 76.05 1.77 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.221 1.408 . . . . 0.0 110.956 174.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.3 mt -102.4 147.63 34.27 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 124.165 0.986 . . . . 0.0 110.458 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -64.07 145.92 90.21 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.062 2.508 . . . . 0.0 110.989 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.1 tt -56.69 -28.36 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.82 -30.32 68.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.868 1.267 . . . . 0.0 113.416 172.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.42 -41.09 13.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.682 1.193 . . . . 0.0 111.155 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.52 HD13 HD21 ' A' ' 94' ' ' LEU . 67.2 mt -58.34 -41.21 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.514 1.126 . . . . 0.0 111.789 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -59.68 -33.19 71.26 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.234 1.014 . . . . 0.0 113.165 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -78.48 -46.92 18.51 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -13.73 62.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 56.01 35.36 25.43 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.711 1.604 . . . . 0.0 112.223 -175.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.2 mt -79.72 147.19 32.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.823 0.82 . . . . 0.0 111.373 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.45 172.33 13.16 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.697 0.761 . . . . 0.0 110.846 171.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.52 HD21 HD13 ' A' ' 87' ' ' ILE . 92.6 mt -116.2 157.51 24.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.342 1.057 . . . . 0.0 111.137 177.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.5 ttm -60.01 158.26 11.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.654 0.782 . . . . 0.0 111.809 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -127.13 163.23 24.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.096 1.758 . . . . 0.0 111.832 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.44 -26.43 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 125.006 1.322 . . . . 0.0 114.045 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -106.09 15.15 26.8 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.55 1.54 . . . . 0.0 112.288 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 56.93 34.42 24.83 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 123.473 1.606 . . . . 0.0 112.493 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.94 159.64 84.85 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 112.676 -2.056 . . . . 0.0 111.375 170.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.19 134.3 31.11 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.094 2.529 . . . . 0.0 111.361 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -72.27 122.88 21.86 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.897 0.879 . . . . 0.0 109.893 172.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.6 pt -146.47 142.06 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.38 1.072 . . . . 0.0 111.49 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 171.29 14.76 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.268 1.827 . . . . 0.0 112.997 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.34 109.25 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.236 1.015 . . . . 0.0 109.489 172.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.93 70.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.413 1.085 . . . . 0.0 112.149 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -152.5 167.99 27.0 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.996 1.719 . . . . 0.0 111.268 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -137.36 146.39 44.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.321 1.448 . . . . 0.0 110.677 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -139.39 120.26 14.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.582 1.153 . . . . 0.0 109.957 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -64.04 123.12 18.2 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.94 -0.475 . . . . 0.0 110.303 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 41.4 mt -90.39 -42.96 10.62 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.372 0.269 . . . . 0.0 111.688 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 141.83 -131.85 4.97 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.853 0.74 . . . . 0.0 112.92 -174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -131.26 72.43 1.5 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.661 1.584 . . . . 0.0 113.101 -167.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -94.41 160.86 14.47 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.831 1.653 . . . . 0.0 111.421 -170.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.05 120.67 12.47 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.519 0.728 . . . . 0.0 111.344 169.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.07 151.99 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.491 0.716 . . . . 0.0 110.635 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -143.67 162.0 37.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.393 -168.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -155.73 120.38 4.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.027 0.931 . . . . 0.0 110.142 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.1 pt -80.4 137.27 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.727 -1.233 . . . . 0.0 111.64 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.02 134.21 12.23 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.022 0.82 . . . . 0.0 111.152 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -156.55 132.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.026 0.93 . . . . 0.0 110.553 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -80.99 150.84 28.75 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.907 0.883 . . . . 0.0 111.114 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 64.24 101.66 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.798 2.039 . . . . 0.0 111.616 -171.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.51 86.32 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.305 1.842 . . . . 0.0 112.54 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -53.54 -24.39 13.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.01 160.32 2.06 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 174.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -160.53 157.37 27.35 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.116 0.967 . . . . 0.0 112.149 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.05 149.48 44.84 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.64 1.176 . . . . 0.0 113.112 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.7 mt -134.93 174.68 10.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.123 2.169 . . . . 0.0 111.241 -172.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.97 146.99 4.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.246 1.018 . . . . 0.0 111.704 168.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 50.22 23.04 1.07 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.161 1.384 . . . . 0.0 114.451 -173.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.59 25.9 66.62 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 120.861 -1.149 . . . . 0.0 115.636 172.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.403 ' C ' HD12 ' A' ' 134' ' ' ILE . 16.1 m-85 -75.13 155.31 37.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.961 1.381 . . . . 0.0 112.174 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 133' ' ' PHE . 2.9 mp -129.06 103.06 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.475 ' HB1' ' CE1' ' A' ' 72' ' ' HIS . . . -86.67 148.1 25.6 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 170.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.3 t -132.84 147.43 52.3 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.912 1.685 . . . . 0.0 111.086 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 C--O 1.251 1.176 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.079 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -147.58 160.42 28.29 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.945 2.212 . . . . 0.0 111.769 -172.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -155.48 170.68 21.39 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.866 0.867 . . . . 0.0 112.11 -169.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -111.99 144.42 41.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.099 1.359 . . . . 0.0 110.029 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -67.94 159.77 29.92 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.65 -0.656 . . . . 0.0 111.868 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -48.47 -43.96 35.16 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.415 1.086 . . . . 0.0 112.761 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -13.42 29.83 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.7 m -70.51 112.35 6.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.528 1.131 . . . . 0.0 110.275 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -91.57 136.02 33.43 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.36 0.6 . . . . 0.0 111.54 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 mm -113.18 123.65 69.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 126.156 1.783 . . . . 0.0 107.512 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -62.37 129.69 41.86 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.371 0.668 . . . . 0.0 110.613 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.6 p -132.31 145.81 51.54 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.934 1.294 . . . . 0.0 111.269 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 t -75.21 -32.67 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.497 -0.752 . . . . 0.0 111.683 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -61.93 -32.56 72.97 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -142.75 -53.39 0.4 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -174.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.37 -144.25 15.9 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.181 0.896 . . . . 0.0 112.196 -171.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 mt -72.77 105.07 4.19 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.254 1.822 . . . . 0.0 111.013 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.0 mt -134.54 147.28 62.68 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.332 1.053 . . . . 0.0 113.744 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.44 127.94 19.22 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.062 3.175 . . . . 0.0 112.468 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.9 tt -55.57 -37.74 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.953 0.901 . . . . 0.0 112.859 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.35 -35.19 91.66 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.63 -0.539 . . . . 0.0 112.393 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -71.31 -33.38 69.64 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.485 1.143 . . . . 0.0 111.9 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.36 -41.82 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.584 0.754 . . . . 0.0 110.308 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.68 -42.83 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.76 0.709 . . . . 0.0 112.566 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -65.98 -29.08 69.41 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.057 0.844 . . . . 0.0 112.3 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -113.15 3.95 16.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.603 1.161 . . . . 0.0 113.484 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 48.3 50.53 16.35 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.931 2.092 . . . . 0.0 112.274 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.9 mt -68.86 117.99 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.119 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -74.23 97.81 3.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.375 1.07 . . . . 0.0 110.131 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.4 p -138.03 164.87 28.0 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.38 1.086 . . . . 0.0 113.195 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.49 154.94 17.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.523 1.529 . . . . 0.0 110.449 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.27 178.77 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.076 1.75 . . . . 0.0 110.756 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -126.18 134.68 51.2 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.511 1.524 . . . . 0.0 110.368 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -161.19 155.44 22.83 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.147 0.979 . . . . 0.0 112.068 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.8 m -79.38 146.89 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.634 1.106 . . . . 0.0 113.19 172.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.9 p30 -83.3 -178.81 7.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.174 0.99 . . . . 0.0 112.398 169.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -55.21 -31.55 61.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.495 1.118 . . . . 0.0 113.584 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -85.16 -10.13 57.06 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.723 0.809 . . . . 0.0 112.571 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.43 21.27 27.37 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.859 1.695 . . . . 0.0 114.678 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -101.9 123.29 45.57 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.193 1.496 . . . . 0.0 109.945 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.7 113.49 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.455 0.57 . . . . 0.0 109.734 177.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -116.87 177.18 4.8 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.882 2.073 . . . . 0.0 111.477 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -124.18 142.46 51.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.227 1.011 . . . . 0.0 112.832 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -154.37 152.77 26.94 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.346 1.059 . . . . 0.0 112.74 -176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.22 153.5 66.77 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.105 2.536 . . . . 0.0 112.992 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.79 140.8 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.713 1.205 . . . . 0.0 110.363 168.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.0 -52.44 5.08 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.924 -0.485 . . . . 0.0 111.333 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -150.99 177.87 9.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.153 1.781 . . . . 0.0 111.132 -175.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -135.7 137.32 41.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.069 1.348 . . . . 0.0 110.406 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -134.0 131.83 39.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.092 0.957 . . . . 0.0 111.862 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -111.71 140.8 46.03 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.591 1.556 . . . . 0.0 108.919 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -106.84 -36.32 6.7 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.79 -54.65 1.66 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.338 1.447 . . . . 0.0 113.791 175.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -169.79 104.7 0.33 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.92 1.36 . . . . 0.0 111.098 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -132.54 158.85 41.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.887 0.875 . . . . 0.0 112.896 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.92 98.55 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.427 1.491 . . . . 0.0 114.062 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.0 142.8 12.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.498 1.519 . . . . 0.0 111.593 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -128.08 135.97 50.56 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.654 1.582 . . . . 0.0 109.708 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.2 134.21 56.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.362 0.665 . . . . 0.0 110.474 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.86 96.94 4.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.694 1.197 . . . . 0.0 108.523 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 34.2 t -106.28 145.18 31.95 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.228 1.011 . . . . 0.0 110.597 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -107.93 164.56 12.16 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.625 1.17 . . . . 0.0 112.917 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -67.87 -21.54 65.16 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -80.27 -23.27 40.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.851 1.26 . . . . 0.0 113.044 172.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.02 -3.85 22.5 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.193 1.378 . . . . 0.0 114.597 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -57.0 139.17 53.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.749 1.274 . . . . 0.0 111.122 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.55 125.76 40.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.656 1.183 . . . . 0.0 109.899 -174.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.2 mt -136.21 150.7 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 108.382 -170.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -135.39 112.01 10.0 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.662 1.185 . . . . 0.0 111.316 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.14 20.83 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.626 1.571 . . . . 0.0 111.188 -175.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.9 p -84.56 161.71 20.09 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.495 -0.753 . . . . 0.0 112.077 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -67.91 -8.26 35.29 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 173.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -100.32 -12.98 19.01 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.301 1.44 . . . . 0.0 112.167 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -77.73 131.86 37.86 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 172.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -88.37 164.44 15.53 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.704 0.764 . . . . 0.0 111.308 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -138.36 135.45 35.36 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.414 0.686 . . . . 0.0 109.151 175.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.9 ttp -74.18 102.0 4.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.827 1.251 . . . . 0.0 109.6 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.6 p -64.23 172.74 2.3 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.755 1.222 . . . . 0.0 112.335 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.74 -28.91 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.4 -10.07 58.65 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.277 1.031 . . . . 0.0 113.593 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.73 -0.07 79.35 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.7 1.143 . . . . 0.0 113.954 -175.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -68.46 129.03 38.72 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.669 1.235 . . . . 0.0 109.49 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -96.25 88.42 4.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.271 1.428 . . . . 0.0 109.821 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.6 mt -115.4 147.19 38.14 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.394 1.077 . . . . 0.0 110.594 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.71 147.2 89.75 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.225 2.616 . . . . 0.0 111.323 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.11 -26.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.21 -37.88 70.25 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.591 1.156 . . . . 0.0 112.733 169.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -80.48 -39.68 27.57 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.247 0.619 . . . . 0.0 110.571 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.05 -36.7 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.26 -0.9 . . . . 0.0 111.346 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -66.49 -35.84 81.27 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.4 -36.92 28.94 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.716 0.806 . . . . 0.0 112.927 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -75.87 -17.98 59.6 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.573 1.149 . . . . 0.0 112.896 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 55.48 37.78 29.36 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.305 1.442 . . . . 0.0 112.63 -173.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.8 mt -82.69 146.82 28.84 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.93 0.892 . . . . 0.0 112.919 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.14 158.67 18.48 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.47 1.108 . . . . 0.0 112.049 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.7 mt -103.1 149.38 24.66 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 33.3 ttm -70.95 153.29 42.79 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 111.624 171.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -141.18 160.66 39.63 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.563 1.945 . . . . 0.0 112.539 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' HA2' ' A' ' 132' ' ' GLY . 10.0 p -101.11 -26.21 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 126.019 1.728 . . . . 0.0 113.567 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.68 5.29 9.57 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.29 1.436 . . . . 0.0 113.541 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 57.34 27.12 13.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.324 1.849 . . . . 0.0 112.344 -172.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 mt -70.97 155.52 93.26 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.416 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.07 147.65 84.47 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.234 2.622 . . . . 0.0 110.985 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -91.98 125.73 36.79 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.68 -0.638 . . . . 0.0 109.517 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -143.0 139.38 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.144 1.378 . . . . 0.0 111.454 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 173.5 11.86 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.59 1.556 . . . . 0.0 112.891 176.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.8 mt -64.39 118.79 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.348 1.459 . . . . 0.0 110.461 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.24 -44.56 65.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.333 1.053 . . . . 0.0 111.99 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -149.81 147.41 27.95 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.794 1.637 . . . . 0.0 111.137 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -140.27 142.08 35.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.139 1.776 . . . . 0.0 110.061 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -154.76 149.34 26.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.871 2.068 . . . . 0.0 110.566 170.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.14 130.77 45.27 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.751 0.42 . . . . 0.0 109.872 168.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.4 mt -103.2 -52.72 2.97 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.692 0.797 . . . . 0.0 110.857 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 167.19 -141.35 6.84 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 120.961 0.2 . . . . 0.0 113.263 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -131.41 64.6 1.58 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.188 1.47 . . . . 0.0 111.829 -168.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -85.18 158.86 20.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.805 2.042 . . . . 0.0 112.554 -167.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 114.11 4.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.063 0.945 . . . . 0.0 111.109 172.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.91 152.96 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.908 0.883 . . . . 0.0 110.314 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -143.19 158.8 43.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.858 1.663 . . . . 0.0 111.06 -170.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -153.03 134.36 14.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.016 0.927 . . . . 0.0 111.338 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.5 pt -89.99 155.14 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 121.426 -0.797 . . . . 0.0 111.133 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.88 153.37 16.99 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.02 1.295 . . . . 0.0 111.245 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.5 154.34 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.488 1.515 . . . . 0.0 108.984 -172.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -57.6 111.81 1.24 Allowed 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.065 -1.647 . . . . 0.0 112.093 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 49.94 25.15 1.53 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.739 2.016 . . . . 0.0 115.11 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -146.75 160.52 42.14 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.962 1.305 . . . . 0.0 112.153 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -142.58 33.28 1.45 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.111 0.964 . . . . 0.0 111.028 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -131.95 161.32 33.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.493 1.517 . . . . 0.0 113.207 -175.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -174.54 154.72 2.11 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.985 1.314 . . . . 0.0 111.573 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.95 124.15 28.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.788 0.835 . . . . 0.0 112.088 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.51 173.52 5.88 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.688 1.195 . . . . 0.0 111.139 169.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -45.84 -42.59 12.56 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -91.35 -6.45 52.97 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.648 1.179 . . . . 0.0 113.409 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.524 ' HA2' HG12 ' A' ' 97' ' ' VAL . . . 115.95 -13.79 16.96 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 117.761 -1.577 . . . . 0.0 115.557 173.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -54.45 142.81 25.93 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.079 1.439 . . . . 0.0 112.23 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.76 92.22 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.871 0.843 . . . . 0.0 109.276 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.5 141.37 51.97 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.6 t -138.69 133.79 32.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.007 1.323 . . . . 0.0 110.973 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 C--O 1.254 1.302 0 C-N-CA 124.183 0.993 . . . . 0.0 113.493 -171.445 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -146.55 174.74 26.31 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 127.336 2.398 . . . . 0.0 111.128 -172.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -164.6 177.31 8.17 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.038 0.935 . . . . 0.0 113.354 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.473 HD13 HG21 ' A' ' 6' ' ' THR . 25.4 mt -122.3 151.01 41.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.673 1.989 . . . . 0.0 110.166 -171.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 t -66.29 159.93 25.58 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.633 -0.667 . . . . 0.0 112.246 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -50.49 -44.74 56.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.464 1.106 . . . . 0.0 112.956 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -64.15 -10.88 25.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.231 1.412 . . . . 0.0 114.163 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.473 HG21 HD13 ' A' ' 2' ' ' LEU . 26.7 m -66.79 94.81 0.33 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.324 1.449 . . . . 0.0 111.523 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -73.45 136.05 44.2 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.282 0.563 . . . . 0.0 111.965 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.3 mm -117.89 122.68 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.099 1.759 . . . . 0.0 107.407 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.6 tp -64.65 124.51 22.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.518 0.727 . . . . 0.0 110.696 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.7 p -125.89 156.12 40.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.683 1.193 . . . . 0.0 112.299 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.97 -31.43 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.076 0.55 . . . . 0.0 111.713 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.49 -34.87 78.72 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -141.22 -50.87 0.43 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.49 -145.14 17.19 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.682 0.673 . . . . 0.0 111.954 -172.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.9 mt -70.79 106.98 3.77 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.288 1.035 . . . . 0.0 111.091 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.8 mt -133.95 149.46 71.76 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.802 1.241 . . . . 0.0 112.697 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.05 128.15 20.03 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.06 3.173 . . . . 0.0 112.196 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 tt -54.63 -36.31 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.812 0.845 . . . . 0.0 112.755 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.97 -35.51 91.98 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 119.306 -0.719 . . . . 0.0 113.004 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -70.84 -34.08 71.31 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.785 1.292 . . . . 0.0 111.745 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.3 mt -69.49 -38.88 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.048 0.939 . . . . 0.0 110.169 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.2 t -83.75 -36.84 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.035 0.934 . . . . 0.0 113.154 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -66.98 -26.35 66.77 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.865 0.757 . . . . 0.0 112.67 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -115.61 1.48 13.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.637 1.175 . . . . 0.0 113.471 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 47.15 53.28 10.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.148 2.179 . . . . 0.0 112.476 -177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.16 115.13 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.491 0.716 . . . . 0.0 109.3 -173.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.15 108.49 3.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.441 1.096 . . . . 0.0 110.27 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.7 p -147.23 168.13 22.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.391 1.076 . . . . 0.0 112.57 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.56 148.97 25.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.656 1.582 . . . . 0.0 108.931 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.88 161.78 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.447 1.499 . . . . 0.0 110.702 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -100.17 153.26 19.4 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.418 1.087 . . . . 0.0 110.512 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.8 t -168.51 146.95 4.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.712 1.205 . . . . 0.0 111.505 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -75.23 130.36 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.127 1.371 . . . . 0.0 112.56 169.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -85.1 179.33 7.28 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.738 0.815 . . . . 0.0 111.748 171.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -57.7 -21.61 41.54 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.856 1.263 . . . . 0.0 113.43 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.76 -13.56 57.59 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.089 1.355 . . . . 0.0 113.242 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.06 4.46 89.9 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.078 1.323 . . . . 0.0 115.084 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -91.34 131.87 36.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.224 1.012 . . . . 0.0 109.787 175.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -69.91 123.82 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.504 0.722 . . . . 0.0 109.554 172.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -120.57 172.15 8.05 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.894 1.678 . . . . 0.0 110.708 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 p -121.47 139.11 53.9 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.072 0.949 . . . . 0.0 112.254 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.75 147.03 34.0 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.797 1.239 . . . . 0.0 112.946 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.3 150.18 52.39 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.118 2.546 . . . . 0.0 112.593 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.81 141.9 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.069 0.948 . . . . 0.0 111.148 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.69 -32.76 11.24 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.641 0.776 . . . . 0.0 112.611 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -170.45 179.33 3.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.316 1.847 . . . . 0.0 111.929 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -136.11 122.8 21.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.018 1.327 . . . . 0.0 109.554 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -109.43 118.42 36.59 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.682 1.193 . . . . 0.0 110.773 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.27 114.68 28.33 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.304 1.442 . . . . 0.0 109.958 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -83.33 -30.53 27.42 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.067 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.11 -44.27 2.82 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.629 1.585 . . . . 0.0 113.538 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 178.81 100.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.429 1.109 . . . . 0.0 113.073 -171.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -129.12 163.97 24.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.527 1.131 . . . . 0.0 113.415 173.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -63.27 100.41 0.24 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.994 1.718 . . . . 0.0 113.154 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.2 t -90.92 137.31 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.027 1.331 . . . . 0.0 111.21 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -120.78 136.7 54.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.44 1.496 . . . . 0.0 109.407 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.06 125.84 25.37 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.85 0.86 . . . . 0.0 110.178 172.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -117.46 99.19 6.83 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.019 1.327 . . . . 0.0 108.032 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.6 t -110.01 147.24 33.9 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.855 0.862 . . . . 0.0 110.674 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.91 164.31 12.71 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.21 1.404 . . . . 0.0 112.429 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -67.47 -24.01 65.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.991 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.96 -25.24 37.49 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.814 1.246 . . . . 0.0 113.272 174.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.07 -7.37 11.81 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.072 1.32 . . . . 0.0 114.75 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -55.47 143.53 28.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.766 1.283 . . . . 0.0 111.542 175.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.47 124.3 31.69 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.535 1.134 . . . . 0.0 110.203 -173.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 43.8 mt -135.11 151.88 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 127.121 2.168 . . . . 0.0 108.225 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -136.59 113.04 9.99 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.575 1.15 . . . . 0.0 110.552 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.89 166.34 25.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.849 1.26 . . . . 0.0 111.967 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 p -83.73 152.11 24.88 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.75 0.82 . . . . 0.0 111.354 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -61.46 -15.17 34.89 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 175.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -89.32 -16.76 30.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.885 1.674 . . . . 0.0 112.246 -176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -80.17 131.5 35.73 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -89.15 156.92 18.5 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.271 0.558 . . . . 0.0 111.444 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -135.93 141.03 44.46 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.657 0.783 . . . . 0.0 109.271 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 46.7 ttm -68.83 108.38 3.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.946 0.898 . . . . 0.0 110.124 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.6 p -70.81 169.84 13.77 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.776 -0.578 . . . . 0.0 112.026 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.4 m -54.56 -23.94 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 174.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -87.63 -7.25 57.7 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.024 . . . . 0.0 113.317 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.45 7.16 65.44 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.402 1.477 . . . . 0.0 113.939 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -79.95 126.64 31.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.228 1.014 . . . . 0.0 110.346 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.28 92.22 6.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.3 1.04 . . . . 0.0 110.433 169.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.7 mt -116.77 146.3 37.41 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.95 0.9 . . . . 0.0 110.978 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.13 146.46 86.91 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.226 2.617 . . . . 0.0 111.061 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.426 HG13 HD11 ' A' ' 105' ' ' ILE . 12.8 tt -59.05 -27.74 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -55.9 -35.55 66.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.531 1.132 . . . . 0.0 113.109 169.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -85.03 -34.71 22.26 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.895 -0.503 . . . . 0.0 111.405 175.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.55 -39.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 119.385 0.993 . . . . 0.0 110.762 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -64.69 -39.16 93.18 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -76.74 -39.35 52.07 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -78.12 -13.15 59.98 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 56.87 30.11 17.32 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.785 1.234 . . . . 0.0 112.151 -174.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.41 142.95 46.93 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.996 0.918 . . . . 0.0 111.302 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -90.78 135.37 33.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.071 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.413 ' HB2' HH12 ' A' ' 96' ' ' ARG . 9.7 mp -66.42 150.78 48.4 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.059 -1.026 . . . . 0.0 111.141 168.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.8 ttp -72.66 172.37 10.79 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.326 0.584 . . . . 0.0 111.791 171.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.413 HH12 ' HB2' ' A' ' 94' ' ' LEU . 87.6 mmt-85 -137.12 164.05 29.35 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.729 1.612 . . . . 0.0 111.433 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 m -106.8 -22.75 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -107.35 21.6 17.25 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.962 1.305 . . . . 0.0 112.386 -172.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 56.08 29.42 14.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.776 1.63 . . . . 0.0 112.454 -172.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.6 mt -63.35 159.26 51.26 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.921 171.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.92 143.99 56.95 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.249 2.633 . . . . 0.0 111.426 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.98 121.23 31.87 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.752 0.821 . . . . 0.0 109.015 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.4 pt -142.22 122.47 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.732 1.213 . . . . 0.0 110.738 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -67.34 170.52 7.17 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.285 1.834 . . . . 0.0 112.962 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.426 HD11 HG13 ' A' ' 84' ' ' ILE . 6.7 mt -61.58 120.1 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.306 1.442 . . . . 0.0 110.194 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.96 -47.29 66.0 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.718 0.807 . . . . 0.0 111.614 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 p -152.29 151.88 31.47 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.351 1.46 . . . . 0.0 111.001 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.65 141.79 48.8 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.057 1.743 . . . . 0.0 110.048 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 134.55 15.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.484 1.913 . . . . 0.0 109.484 177.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -65.1 133.81 52.43 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.081 0.152 . . . . 0.0 110.755 170.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.2 mt -100.97 -42.65 6.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.009 0.524 . . . . 0.0 112.009 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.49 -149.94 21.71 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.665 1.126 . . . . 0.0 111.798 -173.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -123.27 100.16 6.71 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.542 1.137 . . . . 0.0 111.458 -170.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -115.13 155.22 27.5 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.253 1.421 . . . . 0.0 109.88 -171.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 116.78 6.27 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.305 0.642 . . . . 0.0 110.144 172.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.14 150.94 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.396 0.678 . . . . 0.0 110.887 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -139.29 156.15 47.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.305 1.442 . . . . 0.0 111.743 -170.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -157.5 121.35 4.17 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.814 1.245 . . . . 0.0 110.071 -173.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.7 pt -80.52 143.73 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 120.706 -1.246 . . . . 0.0 111.523 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.71 153.97 20.51 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.902 0.763 . . . . 0.0 111.799 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.3 t -147.19 143.55 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.216 1.406 . . . . 0.0 109.739 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -91.01 -47.37 7.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -66.53 -41.16 89.15 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.518 1.127 . . . . 0.0 113.746 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -159.25 123.45 3.92 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.764 1.625 . . . . 0.0 108.709 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -72.93 60.58 0.53 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.299 1.44 . . . . 0.0 112.887 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -154.41 171.66 18.98 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.138 1.775 . . . . 0.0 112.738 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -166.28 150.86 7.89 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.222 1.409 . . . . 0.0 110.817 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.39 142.16 30.34 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.842 0.857 . . . . 0.0 112.309 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.3 mt -102.16 171.21 7.62 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.675 1.19 . . . . 0.0 112.054 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -19.33 8.28 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -103.74 11.18 36.21 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.516 1.526 . . . . 0.0 112.958 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.04 21.52 75.92 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 121.336 -0.852 . . . . 0.0 113.844 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.41 ' C ' HD12 ' A' ' 134' ' ' ILE . 3.1 m-85 -87.39 163.72 16.61 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.644 1.578 . . . . 0.0 111.985 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.41 HD12 ' C ' ' A' ' 133' ' ' PHE . 3.3 mp -133.01 100.81 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.746 1.218 . . . . 0.0 108.948 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.98 149.68 26.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.9 t -140.83 141.09 34.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.379 0.672 . . . . 0.0 112.477 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.919 1.287 . . . . 0.0 113.097 -173.498 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -126.75 162.25 20.91 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.882 1.706 . . . . 0.0 112.854 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.92 177.91 9.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.445 1.498 . . . . 0.0 112.14 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.99 144.33 44.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.982 1.713 . . . . 0.0 110.383 -172.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -68.86 163.67 23.77 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.633 -0.667 . . . . 0.0 112.441 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -50.83 -42.86 58.82 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.642 -0.661 . . . . 0.0 112.411 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -65.73 -13.95 60.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.814 1.246 . . . . 0.0 114.116 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.2 m -71.0 120.39 16.5 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.515 0.726 . . . . 0.0 110.725 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -102.27 138.38 39.29 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.495 0.664 . . . . 0.0 111.633 -176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.15 116.66 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 126.198 1.799 . . . . 0.0 107.585 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tt -63.12 124.49 21.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.706 0.402 . . . . 0.0 111.19 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.3 p -118.53 155.84 30.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.85 1.26 . . . . 0.0 112.144 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.8 -35.72 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.789 0.836 . . . . 0.0 111.14 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -67.36 -32.42 73.35 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -140.13 -50.29 0.47 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.53 -143.91 15.71 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.147 0.879 . . . . 0.0 112.656 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.36 96.14 0.65 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.381 1.872 . . . . 0.0 112.846 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -129.87 149.63 73.62 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.844 1.258 . . . . 0.0 112.591 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.68 130.26 23.01 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.404 3.403 . . . . 0.0 113.127 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 tt -57.44 -37.59 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.002 0.921 . . . . 0.0 112.922 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.36 -31.34 78.65 Favored Glycine 0 CA--C 1.529 0.917 0 O-C-N 121.718 -0.614 . . . . 0.0 112.846 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -72.06 -38.68 69.43 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.094 0.947 . . . . 0.0 111.317 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.73 -39.34 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.619 0.767 . . . . 0.0 109.76 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.5 t -80.99 -38.92 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.874 0.87 . . . . 0.0 112.938 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.72 -23.94 56.14 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.74 1.155 . . . . 0.0 113.297 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -108.58 2.02 21.8 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.202 1.401 . . . . 0.0 112.12 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.89 52.12 11.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.32 2.248 . . . . 0.0 113.04 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.6 mt -76.35 122.4 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.964 0.906 . . . . 0.0 110.055 -170.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -74.77 96.59 3.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.655 1.182 . . . . 0.0 111.595 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 68.3 m -135.4 173.45 11.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.072 1.349 . . . . 0.0 112.732 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 m -121.42 140.21 52.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.705 1.602 . . . . 0.0 108.969 -176.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.9 m -125.35 163.21 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.637 1.575 . . . . 0.0 111.19 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -97.94 147.59 24.31 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.597 1.159 . . . . 0.0 110.362 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -157.55 156.21 31.55 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.806 1.642 . . . . 0.0 109.577 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 t -102.6 127.42 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.807 0.843 . . . . 0.0 109.757 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -69.24 175.25 4.01 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.931 1.292 . . . . 0.0 112.58 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -61.47 -26.73 68.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.024 1.33 . . . . 0.0 113.424 175.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -87.84 0.75 55.39 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.242 1.417 . . . . 0.0 113.41 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.98 18.88 76.13 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.771 1.176 . . . . 0.0 114.655 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -92.3 132.89 36.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.598 1.159 . . . . 0.0 110.122 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.14 131.08 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -137.77 176.74 8.43 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.537 1.935 . . . . 0.0 110.715 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 p -125.87 143.53 51.03 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.273 1.029 . . . . 0.0 112.397 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -143.2 141.62 19.81 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.654 1.182 . . . . 0.0 112.336 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.73 150.12 49.69 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.832 2.355 . . . . 0.0 111.464 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.55 136.81 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.381 0.672 . . . . 0.0 110.856 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.45 -45.9 5.95 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.533 0.733 . . . . 0.0 111.832 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -146.16 178.99 7.81 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.287 1.835 . . . . 0.0 111.278 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -135.05 120.64 19.36 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.498 1.519 . . . . 0.0 109.23 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -116.19 119.26 35.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.185 0.994 . . . . 0.0 110.79 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -107.61 113.43 26.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.322 1.449 . . . . 0.0 109.908 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -82.19 -29.93 31.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.778 0.831 . . . . 0.0 112.965 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.54 -54.62 2.37 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.474 1.511 . . . . 0.0 113.888 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -170.33 103.09 0.27 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.157 1.383 . . . . 0.0 111.057 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -132.28 164.88 25.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.226 1.011 . . . . 0.0 111.69 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.55 99.65 0.23 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.594 1.558 . . . . 0.0 113.638 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 t -95.99 141.22 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.499 1.52 . . . . 0.0 111.589 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.83 137.76 54.61 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.239 1.816 . . . . 0.0 109.975 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.66 133.52 56.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.864 0.865 . . . . 0.0 110.715 171.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -127.55 89.29 2.93 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.023 1.329 . . . . 0.0 108.314 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.4 t -97.48 149.24 22.39 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.348 1.059 . . . . 0.0 110.731 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.15 163.53 15.82 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.212 1.405 . . . . 0.0 112.387 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.36 -20.54 63.84 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -81.45 -17.86 47.28 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.238 1.015 . . . . 0.0 113.171 170.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.26 -3.62 33.19 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.042 1.306 . . . . 0.0 114.207 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.9 m -57.71 142.31 45.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.522 1.129 . . . . 0.0 110.994 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -130.9 126.18 35.46 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.712 0.805 . . . . 0.0 111.351 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.5 mt -135.22 152.38 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 126.85 2.06 . . . . 0.0 107.674 -171.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.99 115.29 11.07 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.848 1.259 . . . . 0.0 110.528 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.09 163.24 34.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.626 1.171 . . . . 0.0 111.291 -176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.4 p -78.94 153.2 30.6 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.575 -0.703 . . . . 0.0 111.415 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.49 -24.17 65.08 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -84.05 -10.08 58.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.617 1.167 . . . . 0.0 112.836 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -82.44 133.96 35.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -97.12 156.12 16.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.536 1.134 . . . . 0.0 111.521 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.48 141.26 46.7 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.08 -1.012 . . . . 0.0 110.822 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.8 ttm -73.03 100.13 2.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.043 0.937 . . . . 0.0 109.594 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.5 p -66.96 170.74 6.26 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.8 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -56.09 -20.33 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.94 -4.01 28.46 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.653 1.181 . . . . 0.0 113.307 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 3.79 72.8 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.244 1.402 . . . . 0.0 113.913 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -65.42 122.97 18.39 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.381 1.072 . . . . 0.0 110.55 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.6 mtt -84.71 73.28 10.62 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.703 2.001 . . . . 0.0 110.766 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 43.6 mt -105.93 147.71 35.25 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 123.483 0.713 . . . . 0.0 110.97 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.78 148.27 86.43 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.11 2.54 . . . . 0.0 110.924 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 tt -53.46 -34.62 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.84 -33.12 70.05 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -77.15 -34.78 56.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.625 0.77 . . . . 0.0 111.15 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.1 mt -67.4 -39.4 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.782 0.833 . . . . 0.0 110.367 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -64.2 -34.26 77.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.953 0.901 . . . . 0.0 112.956 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -73.94 -47.25 38.89 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.01 -9.23 58.56 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 58.7 34.18 23.6 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.892 1.277 . . . . 0.0 112.325 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.89 143.85 35.48 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 122.172 0.987 . . . . 0.0 111.905 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.3 158.83 24.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.447 1.099 . . . . 0.0 111.623 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.51 152.2 21.03 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.39 -0.819 . . . . 0.0 111.922 169.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.9 ttp -75.15 146.5 41.27 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.176 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 166.05 23.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.047 1.339 . . . . 0.0 114.135 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.7 m -105.03 -30.03 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.561 1.544 . . . . 0.0 113.07 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.03 -2.73 56.08 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.326 1.05 . . . . 0.0 113.108 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . 0.278 8.6 m-80 59.14 36.0 23.87 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.988 1.375 . . . . 0.0 112.991 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.9 mt -61.89 157.71 48.36 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.839 167.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.5 140.86 84.11 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.633 2.222 . . . . 0.0 110.39 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -66.56 126.05 27.69 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.999 -0.438 . . . . 0.0 110.496 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.5 pt -143.75 132.89 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.946 1.298 . . . . 0.0 111.013 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 176.31 7.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.202 1.401 . . . . 0.0 111.74 176.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.8 mt -64.13 109.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.731 1.212 . . . . 0.0 110.19 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.6 94.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.481 1.112 . . . . 0.0 112.287 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.0 p -151.43 153.25 34.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.939 1.696 . . . . 0.0 111.25 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -137.3 143.19 42.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.956 1.702 . . . . 0.0 110.335 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -152.33 148.31 27.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.591 2.356 . . . . 0.0 110.454 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -72.02 124.17 24.36 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.897 0.479 . . . . 0.0 110.081 168.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.2 mt -91.09 -44.81 9.05 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.022 0.529 . . . . 0.0 111.649 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.13 -145.73 13.9 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.056 0.836 . . . . 0.0 113.116 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -122.44 51.76 1.36 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 123.103 1.43 . . . . 0.0 113.66 -166.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -72.7 158.17 36.12 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 127.64 2.376 . . . . 0.0 112.53 -168.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.58 118.16 6.69 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.992 0.917 . . . . 0.0 111.417 171.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.8 m -126.09 156.2 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.41 0.684 . . . . 0.0 111.789 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -144.31 159.01 43.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.733 1.613 . . . . 0.0 111.559 -168.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -155.78 128.73 8.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.43 1.092 . . . . 0.0 109.952 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.43 142.55 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 121.292 -0.88 . . . . 0.0 111.281 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.65 136.36 14.87 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -152.67 93.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.01 1.724 . . . . 0.0 109.922 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.13 -26.57 68.24 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.132 -0.98 . . . . 0.0 113.454 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -60.37 -45.29 94.04 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.106 1.362 . . . . 0.0 112.665 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -166.33 135.76 3.14 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.353 1.861 . . . . 0.0 109.909 169.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 15.12 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -171.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -132.85 163.68 28.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.696 1.598 . . . . 0.0 114.113 -171.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -163.3 164.79 24.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.443 1.497 . . . . 0.0 112.437 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.75 141.41 28.53 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.675 1.19 . . . . 0.0 112.949 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.4 mt -91.53 171.76 8.97 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.658 1.983 . . . . 0.0 111.997 175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -50.49 -50.84 51.61 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.794 1.638 . . . . 0.0 115.171 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -68.06 -26.96 66.11 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.211 0.604 . . . . 0.0 111.825 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 120.48 -3.0 12.4 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.667 1.603 . . . . 0.0 114.096 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -69.07 163.82 23.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.144 1.472 . . . . 0.0 111.874 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.14 136.97 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 122.033 0.92 . . . . 0.0 110.629 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -121.51 151.48 40.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.37 1.868 . . . . 0.0 109.593 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.6 t -142.81 135.93 28.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.826 0.851 . . . . 0.0 113.089 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.2 t30 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.76 1.224 . . . . 0.0 113.131 -176.099 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -145.26 167.1 27.48 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 127.548 2.499 . . . . 0.0 111.36 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.41 176.73 10.81 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.309 0.644 . . . . 0.0 112.544 -169.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.7 mt -116.74 147.41 42.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.352 1.861 . . . . 0.0 110.415 -173.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t -62.88 161.77 12.25 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -52.37 -44.77 65.46 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.146 -0.971 . . . . 0.0 111.474 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -56.34 -25.47 49.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.721 1.609 . . . . 0.0 114.044 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.6 m -65.5 103.62 0.87 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.883 1.273 . . . . 0.0 112.023 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -85.15 136.09 33.69 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.642 -0.661 . . . . 0.0 111.864 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 mm -109.4 131.94 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.535 1.534 . . . . 0.0 107.875 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -69.7 122.76 19.79 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 122.082 -0.386 . . . . 0.0 111.433 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.7 p -120.63 151.19 39.78 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.716 1.206 . . . . 0.0 112.315 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 t -75.74 -37.34 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.169 0.587 . . . . 0.0 111.84 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.04 -28.4 68.83 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -141.37 -51.12 0.43 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.29 -156.52 23.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.261 0.934 . . . . 0.0 112.505 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.87 105.9 0.43 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.431 1.092 . . . . 0.0 111.163 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.5 mt -135.52 149.75 70.26 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 124.746 1.218 . . . . 0.0 112.888 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.13 128.45 21.71 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.975 3.117 . . . . 0.0 112.351 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.4 tt -56.47 -35.94 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.793 0.837 . . . . 0.0 113.058 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.28 -33.97 88.66 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.548 -0.585 . . . . 0.0 113.072 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -69.33 -35.06 75.55 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.207 1.003 . . . . 0.0 111.806 174.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.3 mt -69.43 -41.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.581 0.752 . . . . 0.0 110.311 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -78.99 -39.67 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.808 0.731 . . . . 0.0 112.435 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.94 -23.67 60.71 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.32 0.964 . . . . 0.0 113.19 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.16 4.09 19.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.975 1.31 . . . . 0.0 112.65 176.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 50.16 45.73 25.41 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.916 1.686 . . . . 0.0 112.643 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.23 127.69 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.944 0.898 . . . . 0.0 109.399 -172.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -78.73 111.21 14.62 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.365 0.602 . . . . 0.0 110.319 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.8 p -133.9 -172.39 2.97 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.263 1.425 . . . . 0.0 111.005 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.3 157.03 35.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.687 1.595 . . . . 0.0 109.103 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.1 m -140.25 163.52 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.588 1.155 . . . . 0.0 111.026 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -104.43 139.96 38.62 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.204 1.402 . . . . 0.0 110.43 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -159.43 150.92 20.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.442 1.497 . . . . 0.0 110.528 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 m -83.41 148.11 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.423 1.01 . . . . 0.0 112.941 171.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.84 -179.92 7.4 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.836 0.854 . . . . 0.0 111.405 169.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -60.76 -20.68 61.88 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.89 1.276 . . . . 0.0 113.023 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -91.75 0.62 57.48 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.682 1.593 . . . . 0.0 113.277 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.2 26.67 63.47 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 121.114 -0.991 . . . . 0.0 114.223 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -107.58 120.21 41.56 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.621 1.568 . . . . 0.0 109.231 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.716 HD13 HG23 ' A' ' 97' ' ' VAL . 67.9 mt -65.45 125.98 23.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 123.594 0.758 . . . . 0.0 109.431 173.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -129.09 173.08 10.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.359 1.863 . . . . 0.0 111.403 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -117.18 142.4 47.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.946 1.298 . . . . 0.0 112.413 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -146.71 142.68 17.51 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.27 1.028 . . . . 0.0 112.873 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.5 154.5 50.28 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.116 2.544 . . . . 0.0 111.813 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.7 t -62.36 140.8 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.615 -0.678 . . . . 0.0 110.062 169.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.9 -40.95 4.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.311 0.645 . . . . 0.0 112.27 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -138.13 164.45 29.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.565 1.146 . . . . 0.0 112.306 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -133.87 131.36 39.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.294 1.838 . . . . 0.0 108.362 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.26 130.78 50.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.022 1.329 . . . . 0.0 111.157 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -139.45 136.56 34.76 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.568 -1.333 . . . . 0.0 112.535 -171.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -111.39 -32.75 6.62 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.201 -1.363 . . . . 0.0 114.62 -168.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.49 -60.75 2.5 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.306 1.431 . . . . 0.0 114.152 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -157.26 96.47 1.56 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.436 1.494 . . . . 0.0 112.616 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -130.11 162.1 29.57 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.391 1.076 . . . . 0.0 113.365 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.23 106.6 2.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.538 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 t -100.26 139.12 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.905 1.282 . . . . 0.0 111.247 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.405 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 38.9 m-85 -124.58 140.61 52.78 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.765 1.226 . . . . 0.0 109.973 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -85.02 123.59 30.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.058 1.343 . . . . 0.0 109.485 169.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.1 100.24 8.45 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.352 1.461 . . . . 0.0 108.934 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.6 t -83.41 145.3 29.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.22 1.008 . . . . 0.0 111.355 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mp -103.92 157.7 16.91 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.434 1.494 . . . . 0.0 112.276 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.56 -20.19 65.37 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -84.22 -16.23 44.06 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 176.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.32 -2.56 25.19 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.302 1.429 . . . . 0.0 114.405 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.4 m -70.16 157.82 36.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.923 1.289 . . . . 0.0 112.746 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.88 148.79 50.49 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.418 1.487 . . . . 0.0 110.855 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -140.01 143.91 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.963 2.105 . . . . 0.0 107.912 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -136.37 112.12 9.45 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.672 1.189 . . . . 0.0 112.382 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.33 172.12 18.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.498 1.119 . . . . 0.0 112.786 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.9 p -86.98 161.78 18.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.341 0.657 . . . . 0.0 110.964 168.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' HE3' ' CD1' ' A' ' 56' ' ' PHE . 2.2 mptm? -59.88 -25.81 65.37 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 175.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -85.07 -15.52 43.72 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.16 1.384 . . . . 0.0 112.766 -174.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -73.19 132.52 43.32 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 153.03 18.02 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.253 0.933 . . . . 0.0 112.787 176.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -131.94 137.14 47.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.252 -0.905 . . . . 0.0 109.143 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.1 ttp -81.47 113.14 19.33 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.291 0.567 . . . . 0.0 110.066 -173.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.2 p -69.87 171.43 9.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.466 0.706 . . . . 0.0 112.035 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -57.35 -23.67 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 174.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -82.26 -12.93 57.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.663 1.185 . . . . 0.0 113.394 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.06 3.35 70.19 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.247 0.927 . . . . 0.0 114.112 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -77.36 151.85 34.7 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.425 1.112 . . . . 0.0 110.826 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 ptp -119.78 93.93 4.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.565 1.146 . . . . 0.0 110.635 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.4 mt -120.4 149.06 49.03 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.109 1.364 . . . . 0.0 109.905 -170.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.74 145.98 91.57 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.546 2.164 . . . . 0.0 111.344 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.69 -28.69 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -57.85 -37.14 73.35 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.524 1.53 . . . . 0.0 113.289 171.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.07 -43.51 21.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.194 0.997 . . . . 0.0 110.511 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.61 -41.14 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.526 1.13 . . . . 0.0 111.438 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.3 -35.53 80.68 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -80.69 -40.82 24.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.754 0.822 . . . . 0.0 113.03 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -76.95 -13.76 59.94 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.222 1.009 . . . . 0.0 113.284 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 57.75 35.53 25.63 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.872 1.669 . . . . 0.0 112.872 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.89 148.11 25.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.008 0.923 . . . . 0.0 112.561 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -87.19 163.12 17.1 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.551 1.14 . . . . 0.0 113.174 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.2 mt -113.42 153.93 27.81 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.785 1.234 . . . . 0.0 112.5 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 10.7 ttp -81.98 145.08 30.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.189 0.595 . . . . 0.0 111.214 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.92 177.75 7.04 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.773 1.229 . . . . 0.0 113.874 -173.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.716 HG23 HD13 ' A' ' 39' ' ' ILE . 5.1 p -121.44 -25.69 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 126.149 1.78 . . . . 0.0 114.597 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -85.04 6.37 25.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.09 1.356 . . . . 0.0 113.382 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 56.42 32.11 20.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.969 1.708 . . . . 0.0 112.349 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.0 mt -67.41 158.31 82.64 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.76 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.04 147.13 88.68 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.935 2.423 . . . . 0.0 111.166 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -71.46 118.74 14.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.667 0.787 . . . . 0.0 109.989 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.6 126.37 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.895 1.278 . . . . 0.0 112.018 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.85 175.03 7.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.61 1.564 . . . . 0.0 112.393 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.12 106.9 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.68 1.592 . . . . 0.0 110.933 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.8 -41.05 62.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.573 1.149 . . . . 0.0 112.074 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.3 p -152.37 165.89 33.58 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.145 1.778 . . . . 0.0 111.84 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -136.05 143.54 44.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.602 1.561 . . . . 0.0 111.436 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -139.6 130.71 26.48 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.653 1.181 . . . . 0.0 110.88 171.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -67.55 131.31 45.39 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.918 -0.489 . . . . 0.0 110.931 173.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.2 mt -96.64 -42.78 7.86 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.015 0.526 . . . . 0.0 112.32 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 142.79 -151.59 23.23 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.421 1.01 . . . . 0.0 113.014 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -118.56 69.11 0.79 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.267 1.508 . . . . 0.0 112.417 -168.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -91.85 160.05 15.49 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 127.064 2.146 . . . . 0.0 111.443 -168.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.3 121.31 14.95 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 123.4 0.68 . . . . 0.0 111.075 169.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.81 148.41 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.476 0.655 . . . . 0.0 111.465 174.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -141.55 157.56 44.96 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.171 1.789 . . . . 0.0 111.884 -169.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -148.76 165.75 30.49 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.475 1.51 . . . . 0.0 112.653 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.7 pt -136.76 153.9 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.195 1.798 . . . . 0.0 111.104 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.91 166.69 24.56 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.856 0.741 . . . . 0.0 114.242 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.15 157.81 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.924 1.29 . . . . 0.0 110.608 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -72.02 -11.43 60.76 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -122.57 -28.56 4.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.264 1.826 . . . . 0.0 114.67 -174.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -152.86 175.23 13.13 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.312 2.245 . . . . 0.0 110.292 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -133.87 23.62 3.92 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.786 -1.196 . . . . 0.0 113.392 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -134.72 160.87 36.79 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -171.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -161.51 158.81 27.08 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.201 1.4 . . . . 0.0 112.307 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.57 128.62 36.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.836 1.254 . . . . 0.0 111.693 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.8 mt -72.54 175.23 6.49 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.282 1.433 . . . . 0.0 113.319 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -51.03 -35.69 35.66 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -93.4 -5.21 49.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.417 1.087 . . . . 0.0 112.86 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 97' ' ' VAL . . . 109.12 -20.12 28.93 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 125.307 1.432 . . . . 0.0 114.447 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -53.51 133.21 40.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.379 1.072 . . . . 0.0 111.476 -173.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.5 mm -82.27 130.31 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.979 0.895 . . . . 0.0 110.938 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -108.79 141.24 41.09 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 126.951 2.1 . . . . 0.0 108.964 170.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.4 t -146.97 140.1 25.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.236 1.014 . . . . 0.0 113.291 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 CA--C 1.556 1.198 0 C-N-CA 125.846 1.658 . . . . 0.0 114.572 -173.569 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.926 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 57.9 -167.72 5.46 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.207 1.384 . . . . 0.0 113.566 -171.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.94 171.19 15.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.902 1.681 . . . . 0.0 111.202 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.0 mt -120.15 140.41 51.14 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.794 2.038 . . . . 0.0 110.067 -168.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 t -72.59 162.46 29.44 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.47 -0.769 . . . . 0.0 111.62 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -48.35 -43.3 33.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.416 1.086 . . . . 0.0 112.79 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -10.21 5.41 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -75.95 107.82 8.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.449 1.1 . . . . 0.0 110.034 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -100.41 138.2 37.8 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.455 -0.778 . . . . 0.0 112.013 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.7 mm -121.34 116.88 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.414 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.3 tt -60.99 127.08 29.81 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.212 0.605 . . . . 0.0 111.003 175.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.8 p -121.7 157.19 31.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.451 1.101 . . . . 0.0 112.697 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -78.01 -34.63 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.438 0.695 . . . . 0.0 111.462 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.67 -30.69 65.99 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -137.77 -48.73 0.57 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.71 -147.67 17.27 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.346 0.974 . . . . 0.0 112.664 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 4.7 mt -64.23 104.46 0.75 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.711 2.005 . . . . 0.0 110.722 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.1 mt -141.06 150.6 59.58 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 124.814 1.246 . . . . 0.0 114.021 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.89 133.15 28.39 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.774 3.649 . . . . 0.0 113.829 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 tt -59.0 -34.5 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.202 1.001 . . . . 0.0 113.174 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.96 -35.23 91.73 Favored Glycine 0 C--N 1.338 0.652 0 O-C-N 121.875 -0.516 . . . . 0.0 112.157 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -72.73 -32.57 65.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.07 0.935 . . . . 0.0 111.553 176.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -64.76 -38.56 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.309 0.643 . . . . 0.0 110.64 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.4 t -86.38 -38.23 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 118.953 0.797 . . . . 0.0 112.462 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -68.21 -27.58 66.51 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.313 -0.867 . . . . 0.0 113.099 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -114.91 5.61 15.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.956 1.302 . . . . 0.0 113.104 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 49.38 44.2 23.65 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 127.336 2.254 . . . . 0.0 112.798 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.8 mt -67.35 127.21 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.496 1.118 . . . . 0.0 109.522 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -99.01 104.25 16.27 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.634 1.174 . . . . 0.0 111.273 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 62.3 m -136.4 -178.44 5.17 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.505 1.522 . . . . 0.0 111.487 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.8 m -116.21 144.51 44.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.286 1.434 . . . . 0.0 108.534 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.32 160.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.001 1.72 . . . . 0.0 110.083 -175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -99.24 147.67 24.91 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.379 1.072 . . . . 0.0 110.3 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 t -159.43 160.17 34.52 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.296 1.438 . . . . 0.0 109.899 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 t -100.01 125.07 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.966 0.906 . . . . 0.0 110.201 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -69.62 176.48 3.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.993 1.317 . . . . 0.0 112.584 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -63.5 -26.16 68.59 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.136 1.374 . . . . 0.0 112.949 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.31 -5.31 59.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.045 1.338 . . . . 0.0 113.687 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.86 21.82 58.84 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.464 1.03 . . . . 0.0 114.873 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -96.81 133.1 41.83 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.657 1.183 . . . . 0.0 109.83 172.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.7 mt -74.09 129.26 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -137.59 179.63 6.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.961 2.105 . . . . 0.0 110.949 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.0 p -129.25 144.7 51.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.421 1.089 . . . . 0.0 113.124 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -149.15 142.32 15.9 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.063 1.345 . . . . 0.0 112.314 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.1 155.2 42.42 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.124 2.549 . . . . 0.0 112.981 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.0 t -62.62 132.52 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.344 0.657 . . . . 0.0 110.085 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.71 -48.21 7.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.411 0.684 . . . . 0.0 112.105 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -149.67 172.3 15.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.865 1.666 . . . . 0.0 111.525 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -132.27 129.44 39.61 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.947 1.699 . . . . 0.0 109.096 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -133.4 138.1 46.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.083 0.944 . . . . 0.0 111.418 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -129.08 118.69 22.93 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.123 1.369 . . . . 0.0 110.609 -172.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -84.01 -33.5 24.52 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.806 1.242 . . . . 0.0 112.708 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.01 -51.4 1.46 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.111 1.339 . . . . 0.0 113.62 173.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -172.57 106.35 0.17 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.414 1.485 . . . . 0.0 110.518 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -132.49 168.0 18.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.32 1.048 . . . . 0.0 112.402 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -67.87 101.76 1.14 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.05 140.61 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.765 1.226 . . . . 0.0 111.496 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -122.6 141.26 51.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.657 1.583 . . . . 0.0 110.534 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.55 126.11 26.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.224 1.41 . . . . 0.0 110.583 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -122.78 82.96 2.05 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.451 1.9 . . . . 0.0 108.476 177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 t -86.33 147.84 25.87 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.803 0.841 . . . . 0.0 111.175 171.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.55 165.38 11.71 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.308 1.443 . . . . 0.0 112.814 175.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.61 -23.71 66.88 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -82.35 -19.82 38.52 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.86 -1.4 27.29 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.191 1.377 . . . . 0.0 114.596 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.6 m -57.91 140.98 50.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.498 1.649 . . . . 0.0 110.922 170.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tp -127.01 130.05 49.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.384 1.074 . . . . 0.0 109.884 -174.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mt -139.65 150.26 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.715 1.606 . . . . 0.0 108.145 -170.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -134.0 109.74 9.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.853 1.261 . . . . 0.0 110.86 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.17 169.62 17.24 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.498 1.119 . . . . 0.0 112.519 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 p -86.19 149.26 25.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.89 1.276 . . . . 0.0 111.467 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -62.23 -17.39 58.19 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -86.54 -14.4 43.08 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.053 1.341 . . . . 0.0 112.971 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -79.42 135.52 36.7 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.153 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -93.82 152.41 18.93 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.026 0.917 . . . . 0.0 113.234 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.86 129.2 32.0 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.953 0.901 . . . . 0.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ttp -74.85 111.47 10.09 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.155 0.503 . . . . 0.0 110.416 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 p -71.09 173.48 7.53 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.472 0.653 . . . . 0.0 112.313 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.88 -24.01 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -91.41 -6.52 52.71 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.501 1.12 . . . . 0.0 113.205 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.81 5.81 59.69 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.345 0.974 . . . . 0.0 113.941 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -77.55 126.32 30.7 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.189 0.994 . . . . 0.0 110.906 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.62 78.57 7.74 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.138 1.375 . . . . 0.0 110.702 173.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 mt -104.68 147.77 34.96 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 123.553 0.741 . . . . 0.0 110.673 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.49 147.71 87.07 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.578 2.185 . . . . 0.0 110.603 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.5 tt -60.67 -28.88 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.28 -27.8 62.44 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.419 1.488 . . . . 0.0 113.331 169.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.51 -40.7 18.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.275 1.03 . . . . 0.0 111.528 173.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.82 -37.86 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.317 1.047 . . . . 0.0 110.93 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.8 -35.66 77.04 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.29 -48.24 17.94 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.325 -0.859 . . . . 0.0 113.063 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -14.21 62.23 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 55.75 32.82 20.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.987 1.315 . . . . 0.0 112.225 -172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 42.4 mt -70.43 140.31 51.99 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.997 0.919 . . . . 0.0 111.47 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.01 146.59 25.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.44 0.696 . . . . 0.0 110.847 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 mp -79.2 153.26 30.14 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.449 -0.782 . . . . 0.0 111.553 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.5 ttm -72.45 149.23 44.4 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.87 -0.519 . . . . 0.0 110.812 172.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.64 167.77 15.23 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.001 1.32 . . . . 0.0 113.892 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.434 HG22 ' HA2' ' A' ' 132' ' ' GLY . 2.8 m -118.75 -23.76 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 125.774 1.63 . . . . 0.0 113.235 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -88.98 5.22 45.22 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.997 1.319 . . . . 0.0 112.71 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 64.49 19.8 11.93 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.496 1.518 . . . . 0.0 112.32 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.1 mt -49.53 156.81 1.06 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.441 1.496 . . . . 0.0 112.028 169.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.3 145.22 88.15 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.64 2.226 . . . . 0.0 110.68 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -68.47 120.44 14.54 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.693 -0.629 . . . . 0.0 110.177 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.4 pt -145.1 159.79 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.289 1.436 . . . . 0.0 111.586 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -128.11 -179.69 5.13 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.28 1.832 . . . . 0.0 111.939 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.0 mt -56.78 110.65 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 125.671 1.589 . . . . 0.0 110.777 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.63 -40.84 66.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.609 1.164 . . . . 0.0 112.273 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.1 p -150.61 162.42 40.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.187 1.795 . . . . 0.0 111.022 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.04 144.13 40.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.634 1.174 . . . . 0.0 111.53 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -156.7 127.12 6.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.488 1.515 . . . . 0.0 110.486 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.06 123.29 18.66 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.775 -0.578 . . . . 0.0 110.234 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 mt -90.56 -42.71 10.66 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.737 0.415 . . . . 0.0 111.812 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.21 -136.27 6.68 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.887 0.756 . . . . 0.0 112.865 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.6 tttp -133.43 77.8 1.74 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.705 1.241 . . . . 0.0 113.089 -168.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -95.24 157.1 16.04 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.335 1.454 . . . . 0.0 110.858 -171.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.79 118.19 6.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.603 0.761 . . . . 0.0 110.525 169.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.6 m -123.02 151.83 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.455 0.645 . . . . 0.0 111.432 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -139.8 159.14 42.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.811 1.644 . . . . 0.0 111.436 -168.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -154.61 134.24 12.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.362 1.065 . . . . 0.0 111.149 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.3 pt -91.94 154.3 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.551 -0.718 . . . . 0.0 110.83 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.13 157.94 16.96 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.765 1.174 . . . . 0.0 111.803 173.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.1 t -147.5 140.3 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.112 1.365 . . . . 0.0 110.169 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -78.67 -44.55 23.42 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -57.47 7.96 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.318 1.047 . . . . 0.0 112.081 -177.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -157.74 128.99 6.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.805 1.642 . . . . 0.0 109.38 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 50.0 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 128.456 2.703 . . . . 0.0 116.183 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -146.31 160.28 42.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.199 1.4 . . . . 0.0 113.038 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -164.74 155.48 14.56 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.477 1.111 . . . . 0.0 112.725 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.8 137.35 36.8 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.109 1.364 . . . . 0.0 112.905 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.85 168.14 19.1 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.137 1.775 . . . . 0.0 113.394 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -35.45 50.52 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -82.99 -28.34 29.78 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.662 1.185 . . . . 0.0 112.769 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.434 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . 130.69 -19.59 4.99 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.586 1.565 . . . . 0.0 114.545 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -60.17 159.32 9.89 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.829 1.252 . . . . 0.0 112.229 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.2 mm -116.48 128.69 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 119.328 0.967 . . . . 0.0 111.024 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.37 145.47 29.45 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.568 1.547 . . . . 0.0 109.628 170.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.9 m -138.95 142.06 38.42 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.398 1.079 . . . . 0.0 111.608 177.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 C--O 1.253 1.279 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -168.814 . . . . . . . . 0 0 . 1 stop_ save_